<SEC-DOCUMENT>0001437749-24-037840.txt : 20241218
<SEC-HEADER>0001437749-24-037840.hdr.sgml : 20241218
<ACCEPTANCE-DATETIME>20241218160556
ACCESSION NUMBER:		0001437749-24-037840
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		91
CONFORMED PERIOD OF REPORT:	20240930
FILED AS OF DATE:		20241218
DATE AS OF CHANGE:		20241218

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			cbdMD, Inc.
		CENTRAL INDEX KEY:			0001644903
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				473414576
		STATE OF INCORPORATION:			NC
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38299
		FILM NUMBER:		241559207

	BUSINESS ADDRESS:	
		STREET 1:		8845 RED OAK BOULEVARD
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28217
		BUSINESS PHONE:		704-445-3060

	MAIL ADDRESS:	
		STREET 1:		8845 RED OAK BOULEVARD
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28217

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Level Brands, Inc.
		DATE OF NAME CHANGE:	20170202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEVEL BEAUTY GROUP, INC.
		DATE OF NAME CHANGE:	20150611
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ycbd20240930c_10k.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ycbd="http://www.cbdmd.com/20240930" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:rr="http://xbrl.sec.gov/rr/2023" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
 <head>
  <title>ycbd20240930c_10k.htm</title>
  <!-- Generated by ThunderDome Portal - 12/18/2024 4:49:25 PM -->
  <meta http-equiv="Content-Type" content="text/html"/></head>
 <body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none;"><ix:header><ix:hidden>
<ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="dei:EntityCentralIndexKey" id="thunderdome-EntityCentralIndexKey">0001644903</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="dei:EntityRegistrantName" id="thunderdome-EntityRegistrantName">cbdMD, Inc.</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="dei:AmendmentFlag" format="ixt:fixed-false" id="ixv-13116">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="dei:CurrentFiscalYearEndDate" id="ixv-13117">--09-30</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="dei:DocumentFiscalPeriodFocus" id="ixv-13118">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="dei:DocumentFiscalYearFocus" id="ixv-13119">2024</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2024-07-01_2024-09-30" name="ecd:Rule10b51ArrAdoptedFlag" id="c121825173" format="ixt:fixed-false">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2024-07-01_2024-09-30" name="ecd:NonRule10b51ArrAdoptedFlag" id="c121825647" format="ixt:fixed-false">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2024-07-01_2024-09-30" name="ecd:Rule10b51ArrTrmntdFlag" id="c121825648" format="ixt:fixed-false">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2024-07-01_2024-09-30" name="ecd:NonRule10b51ArrTrmntdFlag" id="c121825649" format="ixt:fixed-false">false</ix:nonNumeric>
<ix:nonFraction id="c121824077" contextRef="i_2024-09-30" unitRef="USD" name="ycbd:LongtermDebtExcludingConvertibleNotesNoncurrent" scale="0" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction id="c121827158" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:CommitmentsAndContingencies" scale="0" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction id="c121827159" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:CommitmentsAndContingencies" scale="0" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction id="c121825623" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:PreferredStockSharesAuthorized" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,000,000</ix:nonFraction>
<ix:nonFraction id="c121825624" contextRef="i_2023-09-30" unitRef="Share" name="us-gaap:PreferredStockSharesAuthorized" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,000,000</ix:nonFraction>
<ix:nonFraction id="c121825625" contextRef="i_2024-09-30" unitRef="USDPerShare" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.001</ix:nonFraction>
<ix:nonFraction id="c121825626" contextRef="i_2023-09-30" unitRef="USDPerShare" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.001</ix:nonFraction>
<ix:nonFraction id="c121825627" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:PreferredStockSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction>
<ix:nonFraction id="c121825629" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:PreferredStockSharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction>
<ix:nonFraction id="c121825628" contextRef="i_2023-09-30" unitRef="Share" name="us-gaap:PreferredStockSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction>
<ix:nonFraction id="c121825630" contextRef="i_2023-09-30" unitRef="Share" name="us-gaap:PreferredStockSharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction>
<ix:nonFraction id="c121825631" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:CommonStockSharesAuthorized" scale="0" format="ixt:num-dot-decimal" decimals="INF">150,000,000</ix:nonFraction>
<ix:nonFraction id="c121825632" contextRef="i_2023-09-30" unitRef="Share" name="us-gaap:CommonStockSharesAuthorized" scale="0" format="ixt:num-dot-decimal" decimals="INF">150,000,000</ix:nonFraction>
<ix:nonFraction id="c121825633" contextRef="i_2024-09-30" unitRef="USDPerShare" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.001</ix:nonFraction>
<ix:nonFraction id="c121825634" contextRef="i_2023-09-30" unitRef="USDPerShare" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.001</ix:nonFraction>
<ix:nonFraction id="c121825635" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:CommonStockSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,939,057</ix:nonFraction>
<ix:nonFraction id="c121825637" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:CommonStockSharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,939,057</ix:nonFraction>
<ix:nonFraction id="c121825636" contextRef="i_2023-09-30" unitRef="Share" name="us-gaap:CommonStockSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,960,573</ix:nonFraction>
<ix:nonFraction id="c121825638" contextRef="i_2023-09-30" unitRef="Share" name="us-gaap:CommonStockSharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,960,573</ix:nonFraction>
<ix:nonFraction id="c121825181" contextRef="d_2023-04-12_2023-04-12_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember" unitRef="Pure" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" format="ixt:num-dot-decimal" decimals="INF">45</ix:nonFraction>
<ix:nonNumeric contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-ManufacturingEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="c121825195" format="ixt-sec:duryear">5</ix:nonNumeric>
<ix:nonNumeric contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-SoftwareMember" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="c121825196" format="ixt-sec:duryear">3</ix:nonNumeric>
<ix:nonFraction id="c121825240" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:RevenueRemainingPerformanceObligation" scale="0" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction>
<ix:nonFraction id="c121825244" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:ContractWithCustomerAssetNet" scale="0" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction>
<ix:nonFraction id="c121825261" contextRef="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember" unitRef="Pure" name="ycbd:NumberOfMajorCustomers" scale="0" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction>
<ix:nonFraction id="c121825285" contextRef="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember_RangeAxis-MinimumMember" unitRef="Pure" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" format="ixt:num-dot-decimal" decimals="INF">20</ix:nonFraction>
<ix:nonFraction id="c121825286" contextRef="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember_RangeAxis-MaximumMember" unitRef="Pure" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" format="ixt:num-dot-decimal" decimals="INF">50</ix:nonFraction>
<ix:nonFraction id="c121825288" contextRef="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember" unitRef="Pure" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" format="ixt:num-dot-decimal" decimals="INF">45</ix:nonFraction>
<ix:nonNumeric contextRef="d_2024-08-01_2024-08-31_CounterpartyNameAxis-MajikMedicinesMember" name="ycbd:LengthOfConsultingAgreement" id="c121825337" format="ixt-sec:duryear">5</ix:nonNumeric>
<ix:nonNumeric contextRef="i_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStockMember" name="ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod" id="c121825352" format="ixt-sec:duryear">5</ix:nonNumeric>
<ix:nonFraction id="c121825661" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member_RangeAxis-MinimumMember" unitRef="USD" name="ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">1</ix:nonFraction>
<ix:nonFraction id="c121825662" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member_RangeAxis-MaximumMember" unitRef="USD" name="ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">20,000,000</ix:nonFraction>
<ix:nonFraction id="c121825663" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member_RangeAxis-MinimumMember" unitRef="USD" name="ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">20,000,001</ix:nonFraction>
<ix:nonFraction id="c121825664" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member_RangeAxis-MaximumMember" unitRef="USD" name="ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">60,000,000</ix:nonFraction>
<ix:nonFraction id="c121825665" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member_RangeAxis-MinimumMember" unitRef="USD" name="ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">60,000,001</ix:nonFraction>
<ix:nonFraction id="c121825666" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member_RangeAxis-MaximumMember" unitRef="USD" name="ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">140,000,000</ix:nonFraction>
<ix:nonFraction id="c121825667" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween140000001And300000000Member_RangeAxis-MinimumMember" unitRef="USD" name="ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">140,000,001</ix:nonFraction>
<ix:nonFraction id="c121825668" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween140000001And300000000Member_RangeAxis-MaximumMember" unitRef="USD" name="ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">300,000,000</ix:nonFraction>
<ix:nonFraction id="c121825669" contextRef="i_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" unitRef="Share" name="us-gaap:PreferredStockSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction>
<ix:nonFraction id="c121825670" contextRef="i_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" unitRef="Share" name="us-gaap:PreferredStockSharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction>
<ix:nonFraction id="c121825671" contextRef="i_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" unitRef="Share" name="us-gaap:PreferredStockSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction>
<ix:nonFraction id="c121825672" contextRef="d_2022-10-01_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" unitRef="Pure" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" format="ixt:num-dot-decimal" decimals="2">8.0</ix:nonFraction>
<ix:nonFraction id="c121825673" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:CommonStockSharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,939,057</ix:nonFraction>
<ix:nonFraction id="c121825674" contextRef="i_2023-09-30" unitRef="Share" name="us-gaap:CommonStockSharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,960,573</ix:nonFraction>
<ix:nonNumeric contextRef="d_2024-04-01_2024-04-01_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="c121825448" format="ixt-sec:duryear">5</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-01-30_2023-02-28_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="c121825454" format="ixt-sec:duryear">5</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-01-01_2023-01-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="c121825459" format="ixt-sec:duryear">5</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2022-12-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="c121825465" format="ixt-sec:duryear">5</ix:nonNumeric>



<ix:nonNumeric contextRef="d_2023-10-01_2024-09-30_RangeAxis-MinimumMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="c121825508" format="ixt-sec:duryear">5</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-10-01_2024-09-30_RangeAxis-MaximumMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="c121825509" format="ixt-sec:duryear">10</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-10-01_2024-09-30_RangeAxis-MinimumMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="c121825510" format="ixt-sec:duryear">1</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-10-01_2024-09-30_RangeAxis-MaximumMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="c121825511" format="ixt-sec:duryear">3</ix:nonNumeric>
<ix:nonFraction id="c121825521" contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheOneMember" unitRef="Pure" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="4">0.25</ix:nonFraction>
<ix:nonFraction id="c121825696" contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheOneMember" unitRef="Pure" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="4">0.25</ix:nonFraction>
<ix:nonFraction id="c121825697" contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheTwoMember" unitRef="Pure" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="4">0.25</ix:nonFraction>
<ix:nonFraction id="c121825524" contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheOneMember" unitRef="Pure" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="4">0.25</ix:nonFraction>
<ix:nonFraction id="c121825698" contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheThreeMember" unitRef="Pure" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="4">0.25</ix:nonFraction>
<ix:nonFraction id="c121825525" contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheThreeMember" unitRef="Pure" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="4">0.25</ix:nonFraction>
<ix:nonFraction id="c121825699" contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-SharebasedPaymentArrangementTrancheFourMember" unitRef="Pure" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="4">0.25</ix:nonFraction>
<ix:nonFraction id="c121825527" contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-SharebasedPaymentArrangementTrancheFourMember" unitRef="Pure" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="4">0.25</ix:nonFraction>
<ix:nonNumeric contextRef="i_2024-11-26_LeaseContractualTermAxis-WarehouseLeaseMember_SubsequentEventTypeAxis-SubsequentEventMember" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="c121825615" format="ixt-sec:durmonth">19</ix:nonNumeric></ix:hidden>
<ix:references>
<link:schemaRef xlink:href="ycbd-20240930.xsd" xlink:type="simple"/></ix:references>
<ix:resources>
<xbrli:context id="d_2023-10-01_2024-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:context id="i_2024-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:unit id="Share"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:context id="i_2024-12-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-16</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:unit id="NonApplicable"><xbrli:measure>thunderdome:item</xbrli:measure></xbrli:unit>
<xbrli:context id="d_2024-07-01_2024-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:unit id="USDPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:context id="d_2022-10-01_2023-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-12-31_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-03-31_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-06-30_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-06-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-09-30_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-09-30_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-12-31_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-PublicOfferingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-PublicOfferingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-PublicOfferingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-PublicOfferingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-PublicOfferingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_SubsidiarySaleOfStockAxis-PublicOfferingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-06-30_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-06-30_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-06-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_SubsidiarySaleOfStockAxis-CommitmentSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-09-30_SubsidiarySaleOfStockAxis-CapitalRaiseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:context id="d_2023-04-12_2023-04-12_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">ycbd:ReverseStockSplitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-12</xbrli:startDate><xbrli:endDate>2023-04-12</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_RangeAxis-MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_RangeAxis-MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:unit id="Year"><xbrli:measure>utr:Y</xbrli:measure></xbrli:unit>
<xbrli:context id="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-ManufacturingEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ycbd:ManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-SoftwareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ycbd:SoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdmdAndDirectcbdonlineTrademarksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:CbdmdAndDirectcbdonlineTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TrademarkRelatedToHempMdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-30_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-30</xbrli:startDate><xbrli:endDate>2024-01-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember_RangeAxis-MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">ycbd:ReverseStockSplitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-16</xbrli:startDate><xbrli:endDate>2023-02-16</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember_RangeAxis-MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">ycbd:ReverseStockSplitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-16</xbrli:startDate><xbrli:endDate>2023-02-16</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">ycbd:ReverseStockSplitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-16</xbrli:startDate><xbrli:endDate>2023-02-16</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-04-07_2022-04-07_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ycbd:SteadyStateLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-07</xbrli:startDate><xbrli:endDate>2022-04-07</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-04-07_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ycbd:SteadyStateLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-07</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-09-30_2023-09-30_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ycbd:SteadyStateLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-30</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-09-30_2024-09-30_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ycbd:SteadyStateLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-30</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-ComputersFurnitureAndEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ycbd:ComputersFurnitureAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-ComputersFurnitureAndEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ycbd:ComputersFurnitureAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-ManufacturingEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ycbd:ManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-AutomobilesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-AutomobilesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdmdAndDirectcbdonlineTrademarksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:CbdmdAndDirectcbdonlineTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-08-01_2024-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ycbd:CaseWithMajikMedicinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-08-01_2025-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember_StatementScenarioAxis-ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ycbd:CaseWithMajikMedicinesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-01</xbrli:startDate><xbrli:endDate>2025-08-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-08-01_2024-08-31_CounterpartyNameAxis-MajikMedicinesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToCbdmdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TrademarkRelatedToCbdmdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToCbdmdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TrademarkRelatedToCbdmdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TrademarkRelatedToHempMdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TrademarkRelatedToHempMdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdMdLimintedMarkMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:CbdMdLimintedMarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdMdLimintedMarkMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:CbdMdLimintedMarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TradenameRelatedToDirectCBDOnlineComMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TradenameRelatedToDirectCBDOnlineComMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TradenameRelatedToDirectCBDOnlineComMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TradenameRelatedToDirectCBDOnlineComMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-RegisteredCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:RegisteredCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStock2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:UnregisteredCommonStock2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:UnregisteredCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:UnregisteredCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:unit id="Month"><xbrli:measure>utr:M</xbrli:measure></xbrli:unit>
<xbrli:context id="d_2018-12-20_2018-12-20_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-20</xbrli:startDate><xbrli:endDate>2018-12-20</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member_RangeAxis-MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween1And20000000Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member_RangeAxis-MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween1And20000000Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween1And20000000Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member_RangeAxis-MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween20000001And60000000Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member_RangeAxis-MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween20000001And60000000Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween20000001And60000000Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member_RangeAxis-MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween60000001And140000000Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member_RangeAxis-MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween60000001And140000000Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween60000001And140000000Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween140000001And300000000Member_RangeAxis-MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween140000001And300000000Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween140000001And300000000Member_RangeAxis-MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween140000001And300000000Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-11_2024-01-11_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-11</xbrli:startDate><xbrli:endDate>2024-01-11</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2019-10-31_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2019-10-01_2019-10-31_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-08-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-08-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-02</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-02</xbrli:startDate><xbrli:endDate>2023-03-02</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-02-13_2024-02-13_CounterpartyNameAxis-KeystoneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-13</xbrli:startDate><xbrli:endDate>2024-02-13</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-06-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-09-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-08-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-04-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-03-01_2024-03-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-01-31_CounterpartyNameAxis-KeystoneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-01-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-01-31_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-01-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-09-01_2023-09-30_CounterpartyNameAxis-KeystoneMember_SubsidiarySaleOfStockAxis-PurchaseagreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PurchaseagreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-07-01_2023-07-31_CounterpartyNameAxis-KeystoneMember_SubsidiarySaleOfStockAxis-PurchaseagreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PurchaseagreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-07-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-03</xbrli:startDate><xbrli:endDate>2023-05-03</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-03</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-OverAllotmentOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-03</xbrli:startDate><xbrli:endDate>2023-05-03</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-05-03_ClassOfWarrantOrRightAxis-WarrantsWithPublicOfferingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsWithPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-03</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-24_2023-04-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-24</xbrli:startDate><xbrli:endDate>2023-04-24</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-04-01_2023-04-30_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-30_2023-02-02_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:A360MediaLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:AdvertisingPlacementAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-30</xbrli:startDate><xbrli:endDate>2023-02-02</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-02-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:A360MediaLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:AdvertisingPlacementAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-01</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-06-30_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:A360MediaLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:AdvertisingPlacementAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-06-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:A360MediaLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:AdvertisingPlacementAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-01</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-01-31_CounterpartyNameAxis-TwentyTwoCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:TwentyTwoCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-04-01_TitleOfIndividualAxis-BoardOfDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-04-01_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-04-01_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-30_2023-02-28_TitleOfIndividualAxis-BoardOfDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-30</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-02-28_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-30_2023-02-28_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-30</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-01-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-01-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-01-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:VestingAnnuallyOverThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:VestingAnnuallyOverThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-12-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:VestingAnnuallyOverThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestUponAchievingCertainRevenuePerformanceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:VestUponAchievingCertainRevenuePerformanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2015-06-02_PlanNameAxis-The2015PlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ycbd:The2015PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-06-02</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2015-06-02_PlanNameAxis-The2015PlanMember_RangeAxis-MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ycbd:The2015PlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-06-02</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2019-04-19_2019-04-19_PlanNameAxis-The2015PlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ycbd:The2015PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-19</xbrli:startDate><xbrli:endDate>2019-04-19</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2021-01-08_PlanNameAxis-The2021PlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ycbd:The2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-08</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2021-01-08_PlanNameAxis-The2021PlanMember_RangeAxis-MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ycbd:The2021PlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-08</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_RangeAxis-MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_RangeAxis-MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-10-01_2022-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-SharebasedPaymentArrangementTrancheFourMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:SharebasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-SharebasedPaymentArrangementTrancheFourMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:SharebasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-01-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ycbd:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2022-10-01_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ycbd:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-01</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ycbd:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ycbd:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringSeptember2023Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsExpiringSeptember2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringMay2024Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsExpiringMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringOctober2024Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsExpiringOctober2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringJanuary2025Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsExpiringJanuary2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringApril2028Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsExpiringApril2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-03-20_LeaseContractualTermAxis-ForbearanceAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:ForbearanceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-20</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember_RangeAxis-MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2023-03-31_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-04-01_2024-06-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-SeriesACumulativeConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2018-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-10-01_2024-12-17_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_SubsequentEventTypeAxis-SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-17</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2024-12-17_SubsequentEventTypeAxis-SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-17</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:unit id="SquareFoot"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit>
<xbrli:context id="i_2024-11-26_LeaseContractualTermAxis-WarehouseLeaseMember_SubsequentEventTypeAxis-SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:WarehouseLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-26</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="i_2026-02-28_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:WarehouseLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-02-28</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:unit id="USDPerPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>thunderdome:item</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:context id="d_2025-03-01_2026-02-28_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:WarehouseLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2026-02-28</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="i_2026-09-30_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:WarehouseLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="d_2026-03-01_2026-09-30_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:WarehouseLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-03-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-11-01_2024-11-30_AwardTypeAxis-RestrictedStockMember_CounterpartyNameAxis-ConsultantMember_SubsequentEventTypeAxis-SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:ConsultantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ClassOfWarrantOrRightAxis-EquityClassifiedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:EquityClassifiedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-10-01_2024-09-30_ClassOfWarrantOrRightAxis-CommonStockPurchaseWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001644903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:CommonStockPurchaseWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources>
</ix:header></div>
  <div>
   &#160;
  </div>
  <div><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#toc" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt">Table of Contents</a></p>
<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0"/>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b>&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric name="dei:DocumentType" contextRef="d_2023-10-01_2024-09-30" id="ixv-16191">10-K</ix:nonNumeric></b></p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>(Mark One)</b>&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><ix:nonNumeric name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" contextRef="d_2023-10-01_2024-09-30" id="ixv-16192">&#9746;</ix:nonNumeric> ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">For the fiscal year ended <b><ix:nonNumeric name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" contextRef="d_2023-10-01_2024-09-30" id="ixv-16193">September 30, 2024</ix:nonNumeric></b></p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">or</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><ix:nonNumeric name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" contextRef="d_2023-10-01_2024-09-30" id="ixv-16194">&#9744;</ix:nonNumeric> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">For the transition period from&#160;_________ to __________</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Commission file number <ix:nonNumeric name="dei:EntityFileNumber" contextRef="d_2023-10-01_2024-09-30" id="ixv-16195">001-38299</ix:nonNumeric></p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
<div style="text-align: center;">
 <div>
  <img alt="ycbd_10klogo.jpg" src="ycbd_10klogo.jpg"/>
 </div>
</div>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 60%; margin-left: 20%; margin-right: 20%;"><tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>cbdMD, INC.</b></p> </td></tr>
<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="vertical-align: middle; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(Exact Name of Registrant as Specified in its Charter)</p> </td></tr>
</tbody></table>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:85%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="border-bottom:solid 1px #000000;vertical-align:middle;width:28.4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" contextRef="d_2023-10-01_2024-09-30" id="ixv-16196">North Carolina</ix:nonNumeric> </b></p> </td><td style="vertical-align:middle;width:6.3%;">&#160;</td><td style="border-bottom:solid 1px #000000;vertical-align:middle;width:28.4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="d_2023-10-01_2024-09-30" id="ixv-16197">47-3414576</ix:nonNumeric> </b></p> </td></tr>
<tr><td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">State or Other Jurisdiction of</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Incorporation or Organization</p> </td><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">I.R.S. Employer</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Identification No.</p> </td></tr>
<tr><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:middle;width:auto;">&#160;</td></tr>
<tr><td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: auto; text-align: center;"><b><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="d_2023-10-01_2024-09-30" id="ixv-16198">2101 Westinghouse Blvd., Suite A</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="d_2023-10-01_2024-09-30" id="ixv-16199">Charlotte</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="d_2023-10-01_2024-09-30" id="ixv-16200">NC</ix:nonNumeric></b></td><td style="vertical-align:middle;width:auto;">&#160;</td><td style="border-bottom:solid 1px #000000;vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="d_2023-10-01_2024-09-30" id="ixv-16201">28273</ix:nonNumeric></b></p> </td></tr>
<tr><td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Address of Principal Executive Offices</p> </td><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Zip Code</p> </td></tr>
</tbody></table>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline; "><ix:nonNumeric name="dei:CityAreaCode" contextRef="d_2023-10-01_2024-09-30" id="ixv-16202">704</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="d_2023-10-01_2024-09-30" id="ixv-16203">445-3060</ix:nonNumeric></span></b></p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Registrant&#8217;s Telephone Number, Including Area Code</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align:top;width:17.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Title of each class</p> </td><td style="vertical-align:top;width:17.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Trading Symbol(s)</p> </td><td style="vertical-align:top;width:18.3%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Name of each exchange on which registered</p> </td></tr>
<tr><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric name="dei:Security12bTitle" contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-CommonStockMember" id="ixv-16204">common</ix:nonNumeric></p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric name="dei:TradingSymbol" contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-CommonStockMember" id="ixv-16205">YCBD</ix:nonNumeric></p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-CommonStockMember" id="ixv-16206">NYSE</ix:nonNumeric> American</p> </td></tr>
<tr><td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric name="dei:Security12bTitle" contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" id="ixv-16207">8% Series A Cumulative Convertible Preferred Stock</ix:nonNumeric></p> </td><td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric name="dei:TradingSymbol" contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" id="ixv-16208">YCBDpA</ix:nonNumeric></p> </td><td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" id="ixv-16209">NYSE</ix:nonNumeric> American</p> </td></tr>
</tbody></table>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Securities registered pursuant to Section 12(g) of the Act:</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline; ">None</span></b></p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Title of class)</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Indicate by check mark if the registrant is a well-known seasonal issuer, as defined in Rule 405 of the Securities Act. Yes &#9744;&#160;&#160;&#160;&#160; <ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" contextRef="d_2023-10-01_2024-09-30" id="ixv-16210">No</ix:nonNumeric> &#9746;</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Indicate by check mark if the registrant is&#160;not&#160;required to file reports pursuant to Section 13 of Section 15(d) of the Act. Yes &#9744;&#160;&#160;&#160;&#160; <ix:nonNumeric name="dei:EntityVoluntaryFilers" contextRef="d_2023-10-01_2024-09-30" id="ixv-16211">No</ix:nonNumeric> &#9746;</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric name="dei:EntityCurrentReportingStatus" contextRef="d_2023-10-01_2024-09-30" id="ixv-16212">Yes</ix:nonNumeric> &#9746;&#160;&#160;&#160;&#160; No &#9744;</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric name="dei:EntityInteractiveDataCurrent" contextRef="d_2023-10-01_2024-09-30" id="ixv-16213">Yes</ix:nonNumeric> &#9746;&#160;&#160;&#160;&#160; No &#9744;</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
 <div class="PGFTR" style="text-align: center; width: 100%">
  <div class="hf-row">
   <div class="hf-cell PGNUM">
    &#160;
   </div>
  </div>
 </div>
 <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
 <div class="PGHDR" style="text-align: left; width: 100%">
  <div class="hf-row">
   <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
    <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
   </div>
  </div>
 </div>
</div>
<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:85%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align:middle;width:18.9%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Large accelerated filer</p> </td><td style="vertical-align:middle;width:12.6%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p> </td><td style="vertical-align:middle;width:18.9%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accelerated filer</p> </td><td style="vertical-align:middle;width:12.6%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p> </td></tr>
<tr><td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" contextRef="d_2023-10-01_2024-09-30" id="ixv-16214">Non-accelerated filer</ix:nonNumeric></p> </td><td style="vertical-align:middle;width:auto;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9746;</p> </td><td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Smaller reporting company</p> </td><td style="vertical-align:middle;width:auto;"><ix:nonNumeric name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" contextRef="d_2023-10-01_2024-09-30" id="ixv-16215">&#9746;</ix:nonNumeric></td></tr>
<tr><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Emerging growth company</p> </td><td style="vertical-align:middle;width:auto;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" contextRef="d_2023-10-01_2024-09-30" id="ixv-16216">&#9744;</ix:nonNumeric></td></tr>
</tbody></table>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C 7262(b)) by the registered public&#160;accounting firm that prepared or issued its audit report. <ix:nonNumeric name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" contextRef="d_2023-10-01_2024-09-30" id="ixv-16217">&#9744;</ix:nonNumeric></p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. <ix:nonNumeric name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt-sec:boolballotbox" contextRef="d_2023-10-01_2024-09-30" id="ixv-16218">&#9744;</ix:nonNumeric></p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b). &#9744;</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes <ix:nonNumeric name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" contextRef="d_2023-10-01_2024-09-30" id="ixv-16219">&#9744;</ix:nonNumeric> No &#9746;</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was sold, or the average bid and asked prices of such common equity, as of the last business day of the registrant&#8217;s most recently completed second fiscal quarter. $<ix:nonFraction name="dei:EntityPublicFloat" scale="0" unitRef="USD" decimals="INF" format="ixt:num-dot-decimal" contextRef="i_2024-03-31" id="ixv-16220">2,832,040</ix:nonFraction><span style="color: #000000; ">&#160;</span>on March 31, 2024.</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">APPLICABLE ONLY TO CORPORATE ISSUERS</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date. <ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal" contextRef="i_2024-12-16" id="ixv-16221">5,539,124</ix:nonFraction> shares of common stock are issued and outstanding as of December 16, 2024.</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DOCUMENTS INCORPORATED BY REFERENCE</b></p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Part III of this report incorporates by reference certain portions of the registrant&#8217;s definitive Proxy Statement for its&#160;2025&#160;Annual Meeting of Shareholders which the registrant currently anticipates will be filed with the SEC on or before January 28, 2025.</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0"/>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
 <div class="PGFTR" style="text-align: center; width: 100%">
  <div class="hf-row">
   <div class="hf-cell PGNUM">
    &#160;
   </div>
  </div>
 </div>
 <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
 <div class="PGHDR" style="text-align: left; width: 100%">
  <div class="hf-row">
   <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
    <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
   </div>
  </div>
 </div>
</div>
<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;&#160;</p></div>
  <div>
   &#160;
  </div>
  <div>
   <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="toc" title="toc" href="#"></a>TABLE OF CONTENTS</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
    <tbody>
     <tr>
      <td style="vertical-align: middle; width: 13%;">&#160;</td>
      <td style="vertical-align: middle; width: 80%;">&#160;</td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Page</b></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;">&#160;</td>
      <td style="vertical-align: middle; width: 80%;">&#160;</td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>No</b></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;">&#160;</td>
      <td style="vertical-align: middle; width: 80%;">&#160;</td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;">&#160;</td>
     </tr>

     <tr>
      <td colspan="4" style="vertical-align: middle; width: 99%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a href="#part1" style="-sec-extract:exhibit;"><b>PART 1</b></a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;">&#160;</td>
      <td style="vertical-align: middle; width: 80%;">&#160;</td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;">&#160;</td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#business" style="-sec-extract:exhibit;">ITEM 1.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#business" style="-sec-extract:exhibit;">Business.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;"><a class="tocPGNUM" href="#business">4</a></td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#RiskFactors" style="-sec-extract:exhibit;">ITEM 1A.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#RiskFactors" style="-sec-extract:exhibit;">Risk Factors.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;"><a class="tocPGNUM" href="#RiskFactors">10</a></td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#unresolved" style="-sec-extract:exhibit;">ITEM 1B.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#unresolved" style="-sec-extract:exhibit;">Unresolved Staff Comments.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;"><a class="tocPGNUM" href="#unresolved">17</a></td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"><a href="#item1c" style="-sec-extract:exhibit;">ITEM 1C.</a></td>
      <td style="vertical-align: middle; width: 80%;"><a href="#item1c" style="-sec-extract:exhibit;">Cybersecurity</a></td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;"><a class="tocPGNUM" href="#item1c">17</a></td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#descriptionprop" style="-sec-extract:exhibit;">ITEM 2.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#descriptionprop" style="-sec-extract:exhibit;">Properties.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;"><a class="tocPGNUM" href="#descriptionprop">18</a></td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#legalpro" style="-sec-extract:exhibit;">ITEM 3.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#legalpro" style="-sec-extract:exhibit;">Legal Proceedings.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;"><a class="tocPGNUM" href="#legalpro">18</a></td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#minesafety" style="-sec-extract:exhibit;">ITEM 4.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#minesafety" style="-sec-extract:exhibit;">Mine Safety Disclosures. </a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;"><a class="tocPGNUM" href="#minesafety">18</a></td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;">&#160;</td>
      <td style="vertical-align: middle; width: 80%;">&#160;</td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;">&#160;</td>
     </tr>

     <tr>
      <td colspan="4" style="vertical-align: middle; width: 99%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a href="#part2" style="-sec-extract:exhibit;"><b>PART II</b></a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;">&#160;</td>
      <td style="vertical-align: middle; width: 80%;">&#160;</td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;">&#160;</td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#item5" style="-sec-extract:exhibit;">ITEM 5.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#item5" style="-sec-extract:exhibit;">Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;"><a class="tocPGNUM" href="#item5">19</a></td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#item6" style="-sec-extract:exhibit;">ITEM 6.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#item6" style="-sec-extract:exhibit;">[Reserved]</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;"><a class="tocPGNUM" href="#item6">19</a></td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#mda" style="-sec-extract:exhibit;">ITEM 7. </a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#mda" style="-sec-extract:exhibit;">Management's Discussion and Analysis of Financial Condition and Results of Operation.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;"><a class="tocPGNUM" href="#mda">20</a></td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#qqd" style="-sec-extract:exhibit;">ITEM 7A.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#qqd" style="-sec-extract:exhibit;">Quantitative and Qualitative Disclosures About Market Risk.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#qqd">25</a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#fs" style="-sec-extract:exhibit;">ITEM 8.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#fs" style="-sec-extract:exhibit;">Financial Statements and Supplementary Data. </a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#fs">25</a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#changes" style="-sec-extract:exhibit;">ITEM 9.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#changes" style="-sec-extract:exhibit;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#changes">25</a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#controls" style="-sec-extract:exhibit;">ITEM 9A.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#controls" style="-sec-extract:exhibit;">Controls and Procedures. </a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#controls">25</a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#otherinfo9b" style="-sec-extract:exhibit;">ITEM 9B.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#otherinfo9b" style="-sec-extract:exhibit;">Other Information.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#otherinfo9b">26</a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"><a href="#disclosureregarind" style="-sec-extract:exhibit;">ITEM 9C.</a></td>
      <td style="vertical-align: middle; width: 80%;"><a href="#disclosureregarind" style="-sec-extract:exhibit;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</a></td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;"><a class="tocPGNUM" href="#disclosureregarind">26</a></td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;">&#160;</td>
      <td style="vertical-align: middle; width: 80%;">&#160;</td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;">&#160;</td>
     </tr>

     <tr>
      <td colspan="4" style="vertical-align: middle; width: 99%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a href="#part3" style="-sec-extract:exhibit;"><b>PART III</b></a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;">&#160;</td>
      <td style="vertical-align: middle; width: 80%;">&#160;</td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;">&#160;</td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#directors" style="-sec-extract:exhibit;">ITEM 10.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#directors" style="-sec-extract:exhibit;">Directors, Executive Officers and Corporate Governance.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#directors">27</a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#execcomp" style="-sec-extract:exhibit;">ITEM 11.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#execcomp" style="-sec-extract:exhibit;">Executive Compensation.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#execcomp">27</a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#securityown" style="-sec-extract:exhibit;">ITEM 12.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#securityown" style="-sec-extract:exhibit;">Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters. </a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#securityown">27</a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#certainrelations" style="-sec-extract:exhibit;">ITEM 13.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#certainrelations" style="-sec-extract:exhibit;">Certain Relationships and Related Transactions, and Director Independence. </a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#certainrelations">27</a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#principal" style="-sec-extract:exhibit;">ITEM 14.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#principal" style="-sec-extract:exhibit;">Principal Accounting Fees and Services.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#principal">27</a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;">&#160;</td>
      <td style="vertical-align: middle; width: 80%;">&#160;</td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;">&#160;</td>
     </tr>

     <tr>
      <td colspan="4" style="vertical-align: middle; width: 99%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a href="#part4" style="-sec-extract:exhibit;"><b>PART IV</b></a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;">&#160;</td>
      <td style="vertical-align: middle; width: 80%;">&#160;</td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%; text-align: right;">&#160;</td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#exhibits" style="-sec-extract:exhibit;">ITEM 15.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#exhibits" style="-sec-extract:exhibit;">Exhibits and Consolidated Financial Statement Schedules.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#exhibits">28</a></p> </td>
     </tr>

     <tr>
      <td style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#summary" style="-sec-extract:exhibit;">ITEM 16.</a></p> </td>
      <td style="vertical-align: middle; width: 80%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#disclosureregarind" style="-sec-extract:exhibit;">Form 10-K Summary.</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#summary">28</a></p> </td>
     </tr>

     <tr>
      <td colspan="2" rowspan="1" style="vertical-align: middle; width: 13%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="#signatures" style="-sec-extract:exhibit;">SIGNATURES</a></p> </td>
      <td style="vertical-align: middle; width: 1%;">&#160;</td>
      <td style="vertical-align: middle; width: 5%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><a class="tocPGNUM" href="#signatures">31</a></p> </td>
     </tr>

    </tbody>
   </table>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;&#160;</p>
  </div>
  <div>
   &#160;
  </div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>OTHER PERTINENT INFORMATION</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">Unless the context otherwise indicates, when used in this report, the terms the &#8220;Company,&#8221; &#8220;cbdMD, &#8220;we,&#8221; &#8220;us, &#8220;our&#8221; and similar terms refer to cbdMD, Inc., a North Carolina corporation formerly known as Level Brands, Inc., and our subsidiaries CBD Industries LLC, a North Carolina limited liability company formerly known as cbdMD LLC, which we refer to as &#8220;CBDI&#8221;, Paw CBD, Inc., a North Carolina corporation which we refer to as &#8220;Paw CBD&#8221; and cbdMD Therapeutics LLC, a North Carolina limited liability company which we refer to as &#8220;Therapeutics&#8221; and Proline Global, LLC a North Carolina limited liability company which we refer to as "Proline Global". In addition, "fiscal 2023" refers to the year ended September 30, 2023, and &#8220;fiscal 2024&#8221; refers to the year ended September 30, 2024.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">We maintain a corporate website at www.cbdmd.com. The information contained on our corporate website and our various social media platforms are not part of this report<b>.</b></p>
  <div>
   &#160;
  </div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      2
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;targets,&#8221; &#8220;likely,&#8221; &#8220;aim,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; and similar expressions or phrases identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and future events and financial trends that we believe may affect our financial condition, results of operation, business strategy and financial needs. Forward-looking statements include, but are not limited to, statements about:</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">
   <tbody>
    <tr style="vertical-align: top;">
     <td style="width: 36pt;">&#160;</td>
     <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">material risks associated with our overall business, including:</p> </td>
    </tr>

   </tbody>
  </table>
  <table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">
   <tbody>
    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">our history of losses, potential liquidity concerns, need to raise additional capital to fund our business in the future, and our ability to continue as a going concern;</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">our current capitalization limits our ability to make strategic or accretive acquisitions or attract new investors;</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">risks associated with our ability to repay outstanding Notes;</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">our reliance to market in key digital channels;</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">our ability to acquire new customers at a profitable rate;</p> </td>
    </tr>

    <tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9679;</td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">our ability to bring new and compelling dietary ingredients to market;</td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">our reliance on third party raw material suppliers and manufacturers; and</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">our reliance on third party compliance with our supplier verification program and testing protocols.</p> </td>
    </tr>

   </tbody>
  </table>
  <table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">
   <tbody>
    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">material risks associated with regulatory environment for dietary ingredients including but not limited to CBD, including:</td>
    </tr>

   </tbody>
  </table>
  <table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">
   <tbody>
    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">federal laws as well as FDA, FTC, and DEA interpretation of existing regulation;</td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">state and local laws pertaining to regulated dietary ingredients (such as industrial hemp) and their derivatives;</td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">costs to us for compliance with laws and the risks of increased litigation; and</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">possible changes in the use of dietary ingredients such as CBD.</td>
    </tr>

   </tbody>
  </table>
  <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">
   <tbody>
    <tr style="vertical-align: top;">
     <td style="width: 36pt;">&#160;</td>
     <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">material risks associated with the ownership of our securities, including;</p> </td>
    </tr>

   </tbody>
  </table>
  <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">
   <tbody>
    <tr>
     <td style="width: 72pt;">&#160;</td>
     <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the risks for failing to regain compliance with and continue to comply with the continued listing standards of the NYSE American;</p> </td>
    </tr>

    <tr style="vertical-align: top;">
     <td style="width: 72pt;">&#160;</td>
     <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">availability of sufficient liquidity;</p> </td>
    </tr>

    <tr style="vertical-align: top;">
     <td style="width: 72pt;">&#160;</td>
     <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the designations, rights and preferences of our 8% Series A Cumulative Convertible Preferred Stock;</p> </td>
    </tr>

   </tbody>
  </table>
  <table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">
   <tbody>
    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 72pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9679;</td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">the designations, rights and preferences of our Convertible Notes;</p> </td>
    </tr>

   </tbody>
  </table>
  <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">
   <tbody>
    <tr>
     <td style="width: 72pt;">&#160;</td>
     <td style="width: 36pt; font-size: 10pt;">&#9679;</td>
     <td style="width: auto; font-size: 10pt;">our inability to pay dividends on our Series A&#160;Convertible Preferred Stock; and</td>
    </tr>

    <tr style="vertical-align: top;">
     <td style="width: 72pt;">&#160;</td>
     <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">dilution upon the issuance of shares of common stock underlying outstanding Notes, warrants, options and the Series A Convertible Preferred Stock.</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">Most of these factors are difficult to predict accurately and are generally beyond our control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. Readers are cautioned not to place undue reliance on these forward-looking statements and readers should carefully review this report in its entirety, including the risk factors contained herein. Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      3
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <div>
   &#160;
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><b><a id="part1" title="part1" href="#"></a>PART 1</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="business" title="business" href="#"></a>ITEM 1. DESCRIPTION OF BUSINESS</b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div style="text-align: center;">
   <img alt="ycbd_10klogo.jpg" src="ycbd_10klogo.jpg"/></div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Our Company</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i><span style="text-decoration: underline; ">General</span></i></b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">We own and operate the nationally recognized CBD (cannabidiol) brands cbdMD and Paw CBD as well as our ATRx Labs brand of functional mushrooms. We believe that we are an industry leader producing and distributing dietary supplements and topical products, with an initial focus on hemp derived products including broad spectrum CBD products and full spectrum CBD products. Our mission is to identify and formulate products with novel, compelling ingredients and blends to enhance our customer&#8217;s overall quality of life while bringing education, awareness and accessibility of high quality and effective products to all. We source cannabinoids, including CBD, which are extracted from non-GMO hemp grown on farms in the United States. Our innovative broad spectrum formula utilizes a clinically studied hemp extract blend, containing CBD, CBG and CBN, while eliminating the presence of tetrahydrocannabinol (THC). Non-THC is defined as below the level of detection using validated scientific analytical methods. Our full spectrum and Delta 9 products contain a variety of cannabinoids and terpenes while maintaining small amounts of THC that fall within the limits set in the 2018 Farm Act. The ATRx brand was launched to bring non cannabinoid products to market, starting with non-psychoactive functional dietary mushrooms such as Lion&#8217;s Mane, Cordyceps and Reshi. In addition to our core brands, we also operate Therapeutics to capture the Company&#8217;s ongoing investments in science related to its existing and future products, including research and development activities for therapeutic applications and Proline Global that houses some of our newer brands.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Our cbdMD brand of products includes an array of high-grade, premium every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixers and ready to drink cans; and sleep, focus and calming aids.&#160; In addition, we have clinical based claims and industry leading strength and concentrations to drive product efficacy.</p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div style="text-align: center;">
   <div>
    <img alt="cbd01.jpg" src="cbd01.jpg"/></div>
  </div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths and formulas. Paw CBD products have undergone the National Animal Safety Council&#8217;s rigorous audit and meet their Quality Seal standard.</p>
  <div style="text-align: center;">
   &#160;
  </div>
  <div style="text-align: center;">
   <div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
    <img alt="c02.jpg" src="c02.jpg"/></div>
   <div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
    &#160;
   </div>
   <div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
    <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our ATRx brand was developed using the power of functional mushrooms to provide consumers a complementary natural ingredient solution for immunity, focus, digestive health, cognitive and mood benefits.</p>
    <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
    <div>
     <img alt="c03.jpg" src="c03.jpg"/></div>
   </div>
   <div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
    &#160;
   </div>
  </div>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">cbdMD, Paw CBD and ATRx products are distributed through our e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.</p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      4
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Recent Developments</i></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Management&#8217;s efforts to drive shareholder value have&#160;been two fold: (i) deliver positive earnings through a combination of optimizing our product portfolio, rationalizing our cost structure, and growing revenue; and, (ii) simplifying our capital structure.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">During fiscal 2024 we continued to make some sweeping changes to our cost structure and re-tooled our marketing efforts, all while launching our new line of nootropic functional mushrooms ATRx Labs. Year over year we improved GAAP operating loss&#160;by approximately&#160;$19.2&#160;million, including impairment loss of $13.2 million in fiscal 2023,&#160;and our non-GAAP adjusted EBTIDA by $3.2 million. In addition, we reduced the cash consumed in fiscal 2023 of $4.9&#160;million to approximately $0.7&#160;million during fiscal 2024, including a significantly lower amount during the second half of fiscal 2024.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">During the second quarter of fiscal 2024 we re-attempted to convert the Series A Preferred stock to common stock through a shareholder vote to amend our Series A Preferred Stock designation.&#160; Ultimately, we were unable to secure the required votes needed to approve&#160;the amendment, and we canceled the shareholder meeting. While we did not successfully get the vote needed, we received productive feedback and continued to have dialogue with preferred shareholders during the remainder of the year.&#160;We believe the combined market capitalization of both our common and Series A Preferred is being impacted due to our current capital structure. Our goal is to simplify our capital structure and we believe it will help unlock additional equity value and open up more strategic activity for the Company. We are planning a new proposal to our shareholders in the current fiscal year for the automatic conversion of our Series A Preferred Stock.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During the fiscal fourth quarter of 2024 the Company continued to make progress despite some short-term revenue impacts. A few items that impacted the quarter include: (i) During the fourth quarter, one of our agencies made a recommendation which unexpectedly resulted in a&#160;sharp decline in emails delivered. We have reacted accordingly to address the issue and have seen deliverability and metrics began to rebound during early&#160;fiscal 2025, however we believe this had greater than $200,000 impact to our direct-to-consumer revenue during the quarter. (ii) We continued to face ongoing down time on various digital marketing platforms tied to the CBD category. To help offset this ongoing challenge, we made a change to our marketing resources during the summer. As a result, we have seen our SEO rankings improve&#160;significantly and we are now ranking atop a number of key high-traffic, strategic terms resulting in strong gains on high-intent traffic during the first quarter of fiscal 2025. (iii) A number of our larger international wholesale clients faced a new regulatory registration requirement which ultimately impacted sales for approximately 100 days, most of which overlapped the fourth quarter. We have since seen&#160;wholesale demand rebound toward the end of October and continues to strengthen as of the filing of this report.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">We have spent significant resources focused on state and national regulatory matters and believe lack of a clear regulatory framework has a negative impact and limits the opportunity for CBD companies that act with integrity and invest in responsible quality and safety standards.&#160; We continue to believe in the long term benefits of hemp-derived cannabinoids, but see a longer-term horizon for federal regulatory clarity. As a result, during fiscal 2024 the Company has focused on expanding into categories that do not have as many regulatory and channel hurdles.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">During November of 2024, the Company launched its new functional mushroom line of products with its Super Gummy under the ATRx brand available on ATRxlabs.com and Amazon.&#160; At our core, we believe in natural health and wellness solutions and we believe in the benefits derived from functional mushrooms in addition to hemp.&#160; During April 2024 we successfully launched the ATRx Platinum line in GNC.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Growth Strategies</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">We continued to pursue many strategies to grow our revenues and expand the scope of our business in fiscal 2024&#160;and beyond:</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">
   <tbody>
    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i><span style="text-decoration: underline; ">Product Innovation:</span></i>&#160;Our goal is to provide our customers superior functional based products using compelling ingredients with greater efficacy and absorption. We regularly assess and evaluate our product portfolio and devote resources to ongoing research and development processes with the goal of improving our product offerings. During fiscal 2024 we focused on expanding some of our core line of products. In November of 2023 we launched our new CBG tincture and during the first quarter of fiscal 2024 we launched our new nootropic mushroom line under the ATRx brand.&#160; We also&#160;added several new products in the rapidly expanding hemp derived beverage category, including the cbdMD Mixer and Herbal Oasis Social Tonics, a carbonated non-alcoholic beverage featuring CBD, THC and functional mushrooms.&#160;</td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Expand our revenue channels:</span></i>&#160;During fiscal year&#160;2024, our wholesale business continued to face macro industry contraction trends that we believe are tied to low-dose, high-priced products. We continued to pursue relationships with traditional retail accounts and believe our top brand awareness and effective marketing positions us as a preferred CBD partner for key traditional retail accounts as this channel has continued to normalize. During the first quarter of fiscal 2024 we launched several SKUs into Sprouts retail footprint. During October 2024 we added KeHe as a distributor for several cbdMD products.&#160;&#160;We continue to assess our product channel fit and working with retailers and distributors alike to further grow this channel.</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i><span style="text-decoration: underline; ">International Expansion:</span></i>&#160;We&#160;continue to explore sales in markets outside of the United States. Our products are currently available in approximately 31 countries. We generally partner with local wholesalers and local legal counsel who can help navigate the laws and regulatory requirements within their jurisdiction. We continue to pursue key wholesale accounts in several international markets and are gaining market share in South America through our sanitary registration approvals and import approval listings. We continue to sell select product in the UK through Amazon and other limited channels while we wait for the final regulatory certifications.</td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      5
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">
   <tbody>
    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><i><span style="text-decoration: underline; ">Cultivate Additional Brands:</span></i>&#160;During fiscal 2024 we launched our new nootropic mushroom line under the ATRx brand. We believe there is ongoing opportunities with these brands to focus on education, cross-selling and customer retention.</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Acquisitions:</span></i><i>&#160;</i>We evaluate acquisitions where we believe (i) there is an accretive customer base that can lower our cost of customer acquisitions through either a complementary direct to consumer base or wholesale channels, or (ii) the target has a profitable business or easily attainable cost synergies that can quickly help contribute and accelerate profitability of our Company. As disclosed in this report, we believe our current capital structure is impeding our company from attracting any quality potential acquisition candidates.</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Marketing</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">cbdMD and its brands are primarily direct to consumer brands and our focus is to grow our base of customers by profitably acquiring new customers while minimizing churn.&#160; We employ a multi-channel media approach that allows us to market our brand and products through various distribution efforts, including professional partnerships, social media engagement, podcasts, digital and television advertising, affiliate marketing, search engine optimization, and influencer endorsements. In addition, we work with our retail partners on various marketing efforts to focus on shelf velocity.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">During fiscal year 2024 and fiscal year 2023 we spent approximately $4.2 million and $6.9&#160;million, respectively, on brand development, sponsorships and marketing.&#160; During fiscal 2023, we took a strategic approach to understanding our customer analytics, focusing on habits, attribution, and opportunities to optimize our customer acquisition costs and improve lifetime value. This ongoing learning process led us to make more informed decisions, reallocating marketing spend to areas with clearer attribution, stronger returns on investment, and greater brand impact. We streamlined spending by eliminating costly sponsorships, athlete endorsement deals, influencer partnerships, and digital campaigns that did not meet these criteria.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Moving forward, we remain committed to thoughtful, data-driven investments to expand our well-established brand. We are placing greater emphasis on consumer, retailer, and regulatory education to build awareness of our superior science, safety, and clinical efficacy. By refining our messaging and outreach, we aim to attract more consumers, engage more retailers, and foster broader regulatory acceptance, always working in the best interests of the company.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      6
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Sales</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We distribute our products both through our online sales channel as well as through a number of wholesalers and retailers that resell our products both in brick and mortar locations as well as via their online websites. Sales of our products primarily come from online sales at our websites www.cbdmd.com, www.pawcbd.com, www.atrxlabs.com, cbdmdbotanicals.com and&#160;www.directcbdonline.com and through our inside sales department. Our inside sales team concentrates on B2B niche specialty retailers as well as wholesale distributors, including international distributors, who we believe can help amplify the reach of cbdMD products and brand recognition at physical retail locations.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During fiscal year&#160;2024, our e-commerce business experienced continued growth, with year over year increases in new e-commerce customers. For fiscal&#160;2024&#160;and fiscal 2023, approximately 80% of sales were e-commerce. While our revenue trends continue an e-commerce increase, we continue to work to expand the stores we serve on our B2B brick and mortar side of our business in addition to distributors that carry our products.&#160;</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Product manufacturing</b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We are committed to producing a safe, high-quality product with testing transparency. We only use cannabinoids extracted from hemp grown in the United States in our products. We maintain strict cGMP compliance. All suppliers and manufacturers meet strict quality requirements and are validated producers of hemp under state and federal laws.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Most of our products are outsourced to various manufacturers under short term agreements.&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">We develop detailed product specifications and utilize several manufacturers with specific formulation and format expertise to deliver finished products within specification. All suppliers undergo a detailed supplier verification process and are required to become GMP certified. Master Manufacturing Agreements and Quality Assurance Agreements are required for all of our critical supply contract manufacturers. All finished goods are tested by the supplier at an independent ISO 17025 accredited third-party laboratory to ensure they meet ingredient label claims, including purity and strength of cannabinoid levels and comply with the THC content requirements in the 2018 Farm Act, before they are released for shipment. We have no long term obligations with any manufacturers or suppliers.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As a consumer goods brand dedicated to providing the highest quality hemp extracted cannabinoid consumer products on the market, we strive to meet or exceed the FDAs Good Manufacturing Practice (GMP) guidelines. These guidelines provide a system of processes procedures and documentation to assure a product is manufactured consistently, in a safe manner, and meets label claims for identity, strength, composition, quality, and purity. Our warehouse operation encompassing 80,000 square feet, is fully GMP compliant and NSF certified. Quality of products is a key tenant of our operations. During the second quarter of fiscal 2024 we renewed our NSF GMP 455-2 certification. We also hold the National Animal Supplement Counsel&#8217;s (&#8220;NASC&#8221;) prestigious Quality Seal Award. In addition, during fiscal 2022 we were the first CBD company to commercialize THC Free SKUs that were NSF Certified Products, which is a prestigious third-party guarantee that ensures what we say is in the product is actually in the product. We also spearheaded NSF&#8217;s Certified for Sport (CFS) for cannabinoid products and were the first company to commercialize products under this rigorous program that gives assurances that a person consuming an NSF CFS product will not fail a World Anti Doping Agency (WADA) test for banned substances, thus assuring our customers they can safely consume our CFS products.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Research and development and product enhancements</b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">New product development efforts are focused on both near-term and long-term results for the Company. The key objectives and input points driving cbdMD&#8217;s research and development process include current product improvement efforts and new product development activities. Our product improvement efforts include consumer feedback analysis, market research on emerging trends, and feedback from panels of product testers, among others. In the fourth quarter of fiscal 2023 we expanded our feedback analysis to include biometric device monitoring and in fiscal 2024 we concluded a study that demonstrated our Broad Spectrum CBD improves sleep with regular use. The results of this study will be used in marketing and may become the subject of future publications. It also informs future product development and iterations of existing products to improve efficacy.&#160;We also conduct in-depth market research campaigns and sample size testing and research. Our new product development activities include market research, projecting future product trends, research and identification of clinically proven, proprietary functional ingredients, and research to develop new product offerings, in-depth product testing, and package and graphic development. The Company is continually exploring exclusive partnerships with well-known and established dietary supplement ingredient manufacturers to include their proprietary and clinically studied ingredients in functional combination products to address specific consumer needs in large market segments.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      7
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">cbdMD Therapeutics, the clinical research arm of the Company, completed two clinical studies in fiscal year 2023:</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In&#160;the first quarter of fiscal 2023, the Company concluded a randomized, double blind, placebo controlled clinical trial in healthy adults utilizing its proprietary hemp extract blend which demonstrated significant benefits in many areas, including reduction of pain, reduced inflammation, and improved mood, and these results are further driving the refinement of current products and the development of new products which utilize the same proprietary blend of hemp extracted cannabinoids. The results of this study were published in the <span style="text-decoration: underline; ">Journal of the International Society of Sports Nutrition in June 2024</span>.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In the third quarter of fiscal&#160;2023 the Company concluded a randomized, double blind, placebo controlled clinical study in dogs performed in conjunction with Colorado&#160;State University&#8217;s veterinary program. Results indicate that our proprietary broad spectrum hemp extract improved mobility, gait, and quality of life in dogs with osteoarthritis. These results provide claims related to our proprietary broad spectrum blend&#8217;s efficacy and drive new product development to address the needs of the nearly $2 billion canine arthritis treatment market according to Expert Market Research. The results of this study were published in <span style="text-decoration: underline; ">Frontiers in Veterinary Science in September 2024</span></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The second paper from the Company&#8217;s comprehensive safety study was published in the fourth quarter of fiscal 2023. We believe the paper was groundbreaking in the hemp derived cannabinoid industry and was immediately cited in additional safety papers. To our knowledge the data in the publication established cbdMD as only the second company in the world to publish actual clinical safety data on CBD isolates with an extensive number of studies and data in the publication.&#160; These papers can be found in <span style="text-decoration: underline; ">Regulatory Toxicology and Pharmacology.</span></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Intellectual property </b></p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">We hold a portfolio of U.S. trademark applications which are held for current and future product offerings and extended branding capability. The portfolio, includes but is not limited to, the trademarks set forth below:</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">
   <tbody>
    <tr>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Mark</b></p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:1pt;"><b>US Serial No.</b></p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 14pt;text-indent:-14pt;"><b>US Registration No.</b></p> </td>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Filing date</b></p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Description of Mark Usage</b></p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255);">
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">DIRECT CBD ONLINE</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 19%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">88424644</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6324509</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5/10/2019</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Service mark</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255);">
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">DIRECT CBD ONLINE</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 19%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">88424628</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6399287</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5/10/2019</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Service mark</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255);">
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CBD MD</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 19%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">86914580</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5173264</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2/21/2016</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Standard word mark</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255);">
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">cbdMD</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">88451429</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;">&#160;</td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5/29/2019</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:1pt;">Stylized word mark (logo in color)</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255);">
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">cbdMD</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">88451502</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;">&#160;</td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5/29/2019</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Standard word mark</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255);">
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Paw CBD</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">88697605</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;">&#160;</td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10/19/2019</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Standard word mark</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255);">
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CBDMD</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">88944504</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;">&#160;</td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6/2/2020</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
     <td style="vertical-align: bottom; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Standard word mark</p> </td>
     <td style="vertical-align: bottom; width: 1%;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255);">
     <td style="vertical-align: middle; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">hempMD</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 19%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">88109782</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 19%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6/29/2021</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Standard word mark</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255);">
     <td style="vertical-align: middle; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">ATRX</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 19%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">98209919</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 19%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10/04/2023</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 19%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Standard word mark</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We currently have filed multiple foreign trademark applications for CBDMD and PAWCBD and have secured marks in the following countries: Chile, Costa Rica, Argentina, Peru, Ecuador, European Union, United Kingdom, Czech Republic, New Zealand, Columbia, Australia, and Switzerland. We continue to prosecute the CBDMD and PAWCBD trademarks in the following countries: Brazil, Canada, China, Spain, Mexico, Norway, and South Africa. Additionally, a growing number of our products hold sanitary registrations in certain Central and South American countries.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company&#8217;s U.S. Patent Application No.: 17/359,193 is currently under examination. In Q4 2024 the Company filed a response to an office action making several amendments to its claims based on data from the Company&#8217;s clinical studies. This patent, if granted, is expected to provide protection in several key areas, including novel formulations for the treatment of mood and sleep disorders.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In addition to our trademarks and our patent filing, we rely on a combination of trade secret laws and restrictions on disclosure to protect our intellectual property rights. Our success depends on the protection of the proprietary aspects of our product development, formulation and knowhow, as well as our ability to operate without infringing on the proprietary rights of others. We also enter into proprietary information and confidentiality agreements with our employees, consultants and commercial partners and control access to, and distribution of, our formulas and other proprietary information.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In addition to www.cbdmd.com, www.pawcbdmd.com, www.atrxlabs.com, and www.directcbdonline.com, we own multiple domain names that we may or may not operate in the future. However, as with phone numbers, we do not have and cannot acquire any property rights in an Internet address. The regulation of domain names in the United States and in other countries is subject to change. Regulatory bodies could establish additional top-level domains, appoint additional domain name registers or modify the requirements for holding domain names. As a result, we might not be able to maintain our domain names or obtain comparable domain names, which could harm our business.</p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Competition</b></p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The dietary supplement market is highly competitive, with new products and new brands entering frequently. The Company is attempting to distinguish itself by focusing on hemp derived cannabinoids and seeking to identify new, emerging ingredients with functional efficacy for key consumer need states such as sleep, mood, focus and energy. Specifically, the hemp derived cannabinoid market has remained fragmented with over 2,000 brands in the category and no clear dominant brand in the US. Our competitors of hemp derived cannabinoid products include a combination of public and private companies who operate as combination of e-commerce and wholesale brands as well as brick and mortar retail operations. In addition to cbdMD&#8217;s hemp derived CBD and Delta&#160;9 products, there are several other synthetic compounds including, but not limited to delta-8; delta 10 and HHC, that do not have long market history or safety data which have taken market share over the last 2 years. The launch of ATRx and the Company&#8217;s functional mushroom line also faces significant competitive pressure as functional mushrooms have emerged as a fast growing segment of the overall dietary supplement market.&#160; By focusing on specific functional formulas to address consumer need states, the Company believes it can differentiate itself in the market.&#160;</p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      8
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Government Regulations </b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On December 20, 2018, the President of the United States signed the Agriculture Improvement Act of 2018 (the &#8220;Farm Bill&#8221;) into law. Among other things, Farm Bill changed certain federal regulations&#160;relating to the cultivation. Production, manufacturing, and marketing of hemp. The Farm Bill defined Hemp as &#8220;[t]he plant <i>Cannabis sativa L.</i> and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis. The Farm Bill removed hemp and derivatives of hemp from the Controlled Substance Act. On January 15, 2021 the USDA issued its final rule regarding the Establishment of a Domestic Hemp Production Program which authorized hemp to be grown and processed legally in the United States and made it legal to transport hemp and its derivatives in interstate commerce.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Farm Bill recognizes hemp as distinct from its genetic cousin, marijuana, and specifically excluded hemp from U.S. drug laws, but deferred the regulation of consumable and topical products to the US Food and Drug Administration. The Farm Bill allows for each individual state to regulate industrial hemp and industrial hemp-based products or accept the USDA rules. Although no longer a controlled substance under federal law, cannabinoids derived from industrial hemp are still subject to Federal regulation under food and dietary supplement laws, as well as a patchwork of state regulations. We actively monitor the regulations and proposed regulations in each state to ensure our operations are compliant.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In conjunction with the enactment of the Farm Bill, the FDA released a statement about the status of CBD and the agency&#8217;s actions to date guide the Company. The statement noted that the Farm Bill explicitly preserved the FDA&#8217;s authority to regulate products containing cannabis or cannabis-derived compounds under the FDCA and Section 351 of the Public Health Service Act. This authority allows the FDA to continue enforcing the law to protect patients and the public while also providing potential regulatory pathways for products containing cannabis and cannabis-derived compounds. The statement also noted the growing public interest in cannabis and cannabis-derived products, including CBD, and informed the public that the FDA will treat products containing cannabis or cannabis-derived compounds as it does any other FDA-regulated products &#8212; meaning the products will be subject to the same authorities and requirements as FDA-regulated products containing any other substance, regardless of the source of the substance, including whether the substance is derived from a plant that is classified as hemp under the Farm Bill.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As of the date of this report, and based upon publicly available information, to our knowledge the FDA has not taken any enforcement actions against CBD companies. The FDA, however, has sent warning letters to companies demanding they cease and desist from the production, distribution, or advertising of CBD products, only relating to instances that such CBD companies have made misleading and unapproved label claims. We will continue to monitor the FDA&#8217;s position on CBD. In December 2020, the FTC announced it was going to seek penalties against companies making deceptive marketing claims and named 6 companies which it had targeted for making egregious and unsupported health claims. On March 5, 2021, the FTC approved the final administrative consent orders with all 6 companies. In April of 2023, the FTC sent a blanket Notice of Penalty Offenses on Substantiation of Product Claims to a group of over 700 companies in the dietary supplement and personal care industries, which named the Company and many of its competitors among the almost 700 other companies.&#160; This letter was sent without any proof or claim of violation as a perfunctory matter to establish that the FTC met its burden under applicable law to warn companies before investigating and making claims. To date, the Company has not received any follow-up and does not believe it is the target of any investigation. We are unaware of any further actions, and we will continue to monitor the FTC&#8217;s position with regards to deceptive marketing claims.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We are subject to federal and state consumer protection laws, including laws protecting the privacy of customer non-public information and the handling of customer complaints and regulations prohibiting unfair and deceptive trade practices. The growth and demand for online commerce has and may continue to result in more stringent consumer protection laws that impose additional compliance burdens on online companies. These laws may cover issues such as user privacy, spyware and the tracking of consumer activities, marketing e-mails and communications, other advertising and promotional practices, money transfers, pricing, product safety, content and quality of products and services, taxation, electronic contracts and other communications and information security.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company is subject to regulations in foreign jurisdictions which establish the rules by which new consumer products may be introduced into commerce, and which vary country by country. In fiscal 2021, we submitted a Novel Foods dossier with both the EU Food Safety Agency (FSA) and the United Kingdom&#8217;s Food Safety Agency (UK FSA). &#8220;Novel Foods&#8221; are foods which have not been widely consumed in the UK or the EU before May 1997. Before a Novel Food can be marketed in the UK or EU, it is required to have a pre-market safety assessment and authorization. The UK has waived the pre-market requirement and is allowing post market submissions for products that were in the marketplace prior to February 2020, which qualifies several products.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As of this filing, the Company is in the Risk Assessment stage of the Novel Food approval process in the UK and on hold in the EU pending further determinations by the EU Food Standard Agency. The Company is one of only a handful of original companies submitting Novel Food applications which have been validated and entered the Risk Assessment phase in the UK. The Company is currently actively selling its products in the UK and strongly believes its products will ultimately be approved once the administrative delays in the UK are cleared. As of the end of Fiscal 2024, the Companies dossier was reviewed and received a favorable ruling of safety, with the final daily serving size still to be determined through further risk analysis by the Agency. Recent statements by the Agency indicate they will be making final determinations sometime in calendar year 2025.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company has submitted multiple Sanitary Registrations for its products across several LATAM countries, which is the basis for exporting and selling hemp derived cannabinoids in those countries.&#160; In Brazil the company has obtained registration and listing under the 660 exemptions for the personal importation of cannabis products by citizens of Brazil.&#160; This authorization allows the Company to work directly with care givers to facilitate the sale of our products to Brazil.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Human Capital</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">At December 1, 2024 we had approximately 42 full-time employees. There are no collective bargaining agreements covering any of our employees.</p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">We believe that cbdMD&#8217;s success depends on our ability to attract, develop and retain key personnel. We believe that the skills, experience and industry knowledge of our key employees significantly benefit our operations and performance.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Employee levels and expertise are assessed and reviewed on a regular basis and management believes it has sufficient human capital to operate its business successfully.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      9
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Additional information</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Information on the history of our company can be found in Note&#160;1 to the notes to our consolidated financial statements appearing later in this report.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We file annual, quarterly and other reports, proxy statements and other information with the SEC. The SEC maintains a website at www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers such as our company that file electronically with the SEC.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our corporate website address is www.cbdmd.com. We make available free of charge, through the Investor section of our website, annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information which appears on our corporate website is not part of this report.</p>
  <div>
   &#160;
  </div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="RiskFactors" title="RiskFactors" href="#"></a>ITEM 1A. RISK FACTORS.</b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Investing in our securities involves risks. You should carefully consider the risks described below in addition to the other information set forth in this Annual Report on Form 10-K, including the Management</i>&#8217;<i>s Discussion and Analysis of Financial Conditions and Results of Operations section and the consolidated financial statements and related notes. If any of the risks and uncertainties described in the cautionary factors described below actually occur or continue to occur, our business, financial condition and results of operations and the trading price of our common stock and our Series A Convertible Preferred Stock could be materially and adversely affected. Moreover, the risks below are not the only risks we face and additional risks not currently known to us or that we presently deem immaterial may emerge or become material at any time and may negatively impact our business, reputation, financial condition, results of operations or the trading price of our securities.</i></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>RISKS RELATED TO OUR OVERALL BUSINESS</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>We have a history of losses from operations and there are no assurances we will report profitable operations in future periods or continue as a going concern.</i></b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We reported losses from operations&#160;of $3.3&#160;million and $22.5&#160;million fiscal year 2024 and fiscal year 2023, respectively. Included in our loss from operation in fiscal 2023 is an impairment of $13.2 on our trade name for fiscal 2023. Not included in our loss from operations for fiscal 2024 is a $0.4 increase in the valuation on the convertible Notes.&#160; Not included in our loss from operations for fiscal 2023 is a $0.70 million impairment non-cash charge pertaining to our ownership interest in Steady State, LLC as well as a non-cash income of $0.09 million and $0.19 million for fiscal 2024 and fiscal 2023, respectively, reflecting a change in value of the contingent liability associated with the Earnout Shares. Until such time, if ever, that we are successful in generating gross profits which are sufficient to pay our operating expenses it is likely we will continue to report losses from operations in future periods.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">While the Company is taking strong action and believes that it can execute its strategy and path to profitability within its balance sheet, and in its ability to raise additional funds, there can be no assurances to that effect. The Company&#8217;s working capital position may not be sufficient to support the Company&#8217;s daily operations for the twelve months subsequent to the issuance of these annual financial statements. The Company&#8217;s ability to continue as a going concern is dependent upon its ability to improve profitability and cash flow and the ability to acquire additional funding. These and other factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern within twelve months after the date that the annual financial statements are issued. These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result in the Company not being able to continue as a going concern.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><b>In the event our revenues do not increase, we will need to raise additional capital to fund our operations in furtherance of our business plan.</b></i></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Until we are profitable, we may&#160;need to raise additional capital during the current fiscal year in order to fund our operations in furtherance of our business plan and repay the Notes. A potential financing may include shares of common stock, shares of preferred stock, warrants to purchase shares of common stock or preferred stock, debt securities, units consisting of the foregoing securities, equity investments from strategic development partners or some combination of each. Any additional equity financings may be financially dilutive to, and will be dilutive from an ownership perspective to, our stockholders, and such dilution may be significant based upon the size of such financing. Additionally, we cannot assure that such funding will be available on a timely basis, in needed quantities, or on terms favorable to us, if at all.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our current capitalization limits our ability to make strategic or accretive acquisitions or attract new investors</i>.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our management has engaged in several strategic discussions for both soliciting strategic investment as well as mergers and acquisitions (&#8220;M&amp;A&#8221;). Our outstanding shares of Series A Preferred Stock continues&#160;to substantially limit opportunities to negotiate strategic investment or M&amp;A. Potential investors and merger candidates view both the dividend obligation as well as the $50 million in Series A Preferred Stock liquidation preference a challenging burden, which impacts management&#8217;s ability to negotiate potential opportunities at reasonable terms and conditions.&#160;Additionally, the change of control rights of the Series A Preferred, which provide for a $55 million redemption right, effectively prevents any future third party from making a bona fide offering to acquire our company or our assets which could provide value to our shareholders. As we continue to act on our plan to rebuild revenues and seek accretive acquisition opportunities and working capital (although as of the date of this report we currently do not have any pending or potential acquisitions or financing alternatives), our outstanding shares of Series A Preferred Stock negatively affect our ability to seek, engage and conduct strategic transactions or raise capital that could have a significant positive impact for its shareholders.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>In the event the holders of our Notes do not convert the Notes, our ability to repay our Notes upon their maturity in July 2025 is uncertain, and we will face additional risks if we are unable to repay the Notes.</i></b></p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As of December 16, 2024, we had approximately $364,000&#160;of Notes due on July 30, 2025 outstanding. The Notes are secured by our assets. Our ability to repay the Notes, in whole or in part, upon their maturity, is uncertain. In addition, the Notes impose certain customary affirmative and negative covenants upon us.&#160; If we are not in compliance with certain of these covenants or we are unable to repay the Notes on or before July 30, 2025, in addition to other actions the note holders may require, the amounts outstanding under the Notes to become immediately due and payable. In addition, the Notes and the preferences of our outstanding Series A Preferred likely harm our ability to incur additional indebtedness on acceptable terms. Our cash flow and capital resources may be insufficient to pay interest and principal on the Notes in the future, in which case we would have to extend such maturity date, or otherwise repay, refinance, and/or restructure the obligations under the Notes, including with proceeds from the sale of assets, and additional equity or debt capital. If we are unsuccessful in obtaining such extension, or entering into such repayment, refinance, or restructure prior to maturity, or any other default existed under the Notes, the holders could accelerate the indebtedness under the Notes, foreclose against its collateral, or seek other remedies, which would jeopardize our ability to continue our current operations.&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      10
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our recent negative growth rates may&#160;continue. </i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Although we have made consistent and significant reductions in marketing spend as we rationalize expenses, we&#160;had&#160;consecutive fiscal years of revenue declines as the industry and Company have faced numerous headwinds. Net sales decreased $4.7 million or 19% to $19.5 million in fiscal 2024 and $11.2 million or 32% to $24.2 million in fiscal 2023 as compared to $35.4 million in 2022. This decrease was primarily driven by a decrease in total orders year over year in both our direct to consumer and wholesale divisions and we believe associate with (i) changes in social algorithms and IOS that affect effectiveness and cost of marketing and acquiring new customers, (ii) access to certain channels, (iii) ongoing competitive environment, (iv) statements from the FDA that negatively impacted retailer interest in the category, (v) significant inflationary pressures on consumers and businesses alike and (vi) we have reduced advertising and marketing as we have&#160;made consistent reduction of cash consumed by advertising and marketing over this 2 year period. We believe that our revenue growth will depend upon, among other factors:</p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:2.1%;">&#160;</td>
     <td style="vertical-align:top;width:2.1%;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Increasing U.S. brand awareness;</p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our ability to obtain adequate protections for our intellectual property;</p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Product innovation to expand our total addressable market; and</p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">International expansion.</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">We made significant changes to our headcount to rationalize our expenses.&#160; We are continuing to implement policies and procedures that we believe are appropriate for a company of our size. We may continue to experience difficulties as we continue to implement changes to our business and related policies and procedures to manage our business to positive cash flow. &#160;This process may increase the strain on our resources, and we could experience operating difficulties, including without limitations, difficulties in sourcing, logistics, recruiting, maintaining internal controls, marketing, designing innovative products, and meeting consumer needs. If we do not adapt to meet these evolving challenges, the strength of our brand may erode, the quality of our products may suffer, we may not be able to deliver products on a timely basis to our customers, and our corporate culture may be harmed.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In addition, we may make investments in our research and development and sales and marketing organizations, expand our operations and infrastructure both domestically and internationally, design and develop new products, and enhance our existing products with newly developed products and through acquisitions. If our sales do not increase at a sufficient rate to offset our operating expenses, our losses may increase in future periods.</p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our business depends on maintaining and strengthening our brand and generating and maintaining ongoing demand for our products, and a significant reduction in such demand could harm our results of operations. </i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We have developed a strong and trusted brand that we believe has contributed significantly to the success of our business, and we believe our continued success depends on our ability to maintain and grow the value and reputation of cbdMD. Maintaining, promoting and positioning our brand and reputation will depend on, among other factors, the success of our product offerings, quality assurance, marketing and merchandising efforts, the reliability and reputation of our supply chain, our ability to grow and capture share of the CBD category, and our ability to provide a consistent, high-quality consumer experience. We have made substantial investments in these areas in order to maintain and enhance our brand and these experiences, but such investments may not be successful. Any negative publicity, regardless of its accuracy, could materially adversely affect our business. For example, our business depends in part on our ability to maintain a strong community of engaged customers and social media and influencers. We may not be able to maintain and enhance a loyal customer base if we receive customer complaints, negative publicity or otherwise fail to live up to consumers&#8217; expectations, which could materially adversely affect our business, operating results and growth prospects.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The growing use of social and digital media by us, our consumers and third parties increases the speed and extent that information or misinformation and opinions can be shared. Negative publicity about us, our brand or our products on social or digital media could seriously damage our brand and reputation. For example, consumer perception could be influenced by negative media attention regarding any consumer complaints about our products, our management team, ownership structure, sourcing practices and supply chain partners, employment practices, ability to execute against our mission and values, and our products or brand, such as any advertising campaigns or media allegations that challenge the sustainability of our products and our supply chain, or that challenge our marketing efforts regarding the quality of our products, which could have an adverse effect on our business, brand and reputation. Similar factors or events could impact the success of any brands or products we introduce in the future.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our company image and brands are very important to our vision and growth strategies, particularly our focus on being a &#8220;good company&#8221; and operating consistent with our mission and values. We will need to continue to invest in actions that support our mission and values and adjust our offerings to appeal to a broader audience in the future in order to sustain our business and to achieve growth, and there can be no assurance that we will be able to do so. If we do not maintain the favorable perception of our company and our brand, our sales and results of operations could be negatively impacted. Our brand and company image is based on perceptions of subjective qualities, and any incident that erodes the loyalty of our consumers, customers, suppliers or manufacturers, including adverse publicity or a governmental investigation or litigation, could significantly reduce the value of our brand and significantly damage our business, which would have a material adverse effect on our business, financial condition, results of operations and cash flows.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      11
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>If we fail to attract new customers in a cost-effective manner, our business may be harmed. </i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">A large part of our success depends on our ability to attract new customers in a cost-effective manner. We have made, and may continue to make, significant investments in attracting new customers through advertising spends on social media, radio, podcasts, targeted email communications, other media and events, sponsorships, and influencer sponsorships. Marketing campaigns can be expensive and may not result in the cost-effective acquisition of customers. Further, as our brand becomes more widely known, future marketing campaigns may not attract new customers at the same rate as past campaigns and the cost of acquiring new customers may increase over time. Additionally, regulation, algorithms, or participants in the digital marketing ecosystem may change rules for our industry or access to available demographics which may result in significant changes in the ability to target key demographic pools, impacting our ability to target our customers effectively. If we are unable to attract new customers, or fail to do so in a cost-effective manner, our business may be harmed.</p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our growth depends, in part, on expanding into additional consumer markets, and we may not be successful in doing so. </i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We believe that our future growth depends not only on continuing to provide our current customers with new products, but also continuing to enlarge our customer base. The growth of our business will depend, in part, on our ability to continue to expand in the United States, as well as into international markets. We are investing significant resources in these areas, and although we hope that our products will gain popularity, we may face challenges that are different from those we currently encounter, including competitive, merchandising, distribution, hiring, and other difficulties. We may also encounter difficulties in attracting customers due to a lack of consumer familiarity with or acceptance of our brand, or a resistance to paying for premium products, particularly in international markets. In addition, although we are investing in sales and marketing activities to further penetrate newer regions, including expansion of our dedicated sales force, we may not be successful. If we are not successful, our business and results of operations may be harmed.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our plans for international expansion may not be successful. </i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Continued expansion into markets outside the United States is one of our key long-term strategies for the future growth of our business. This expansion requires significant investment of capital and human resources, new business processes and marketing platforms, legal compliance, and the attention of many managers and other employees who would otherwise be focused on other aspects of our business. There are significant costs and risks inherent in selling our products in international markets, including: (a) failure to effectively establish our core brand identity; (b) increased employment costs; (c) increased shipping and distribution costs, which could increase our expenses and reduce our margins; (d) potentially lower margins in some regions; (e) longer collection cycles in some regions; (f) increased competition from local providers of similar products; (g) compliance with foreign laws and regulations, including but not limited to product registrations/approvals, taxes and duties, laws governing the marketing and use of e-commerce websites and enhanced data privacy laws and security, rules, and regulations; (h) establishing and maintaining effective internal controls at foreign locations and the associated increased costs; (i) increased counterfeiting and the uncertainty of protection for intellectual property rights in some countries and practical difficulties of enforcing rights abroad; (j) compliance with anti-bribery, anti-corruption, and anti-money laundering laws, such as the FCPA, the Bribery Act, and OFAC regulations, by us, our employees, and our business partners; (k) currency exchange rate fluctuations and related effects on our results of operations; (l) economic weakness, including inflation, or political instability in foreign economies and markets; (m) compliance with tax, employment, immigration, and labor laws for employees living or traveling abroad; (n) workforce uncertainty in countries where labor unrest is more common than in the United States; (o) business interruptions resulting from geopolitical actions, including war and terrorism, or natural disasters, including earthquakes, typhoons, floods, fires, and public health issues, including the outbreak of a pandemic or contagious disease, such as COVID-19, or xenophobia resulting therefrom; (p) the imposition of tariffs on products that we import into international markets that could make such products more expensive compared to those of our competitors; (q) that our ability to expand internationally could be impacted by the intellectual property rights of third parties that conflict with or are superior to ours; (r) difficulty developing retail relationships; and (s) other costs and risks of doing business internationally.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">These and other factors could harm our international operations and, consequently, harm our business, results of operations, and financial condition. Further, we may incur significant operating expenses as a result of our planned international expansion, and it may not be successful. We have limited experience with regulatory environments and market practices internationally, and we may not be able to penetrate or successfully operate in new markets. We may also encounter difficulty expanding into international markets because of limited brand recognition, leading to delayed or limited acceptance of our products by customers in these markets, and increased marketing and customer acquisition costs to establish our brand. Accordingly, if we are unable to successfully expand internationally or manage the complexity of our global operations, we may not achieve the expected benefits of this expansion and our financial condition and results of operations could be harmed.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Fluctuations in the cost and availability of raw materials, equipment, labor, and transportation could cause manufacturing delays or increase our costs. </i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The price and availability of key components used to manufacture our products has been increasing and may continue to fluctuate significantly. In addition, the cost of labor within our company or at our third-party manufacturers could increase significantly due to regulation or inflationary pressures. Additionally, the cost of logistics and transportation fluctuates in large part due to the price of oil, and availability can be limited due to political and economic issues. Any fluctuations in the cost and availability of any of our raw materials, packaging, or other sourcing or transportation costs could harm our gross margins and our ability to meet customer demand. If we are unable to successfully mitigate a significant portion of these product cost increases or fluctuations, our results of operations could be harmed.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>We rely on third-parties for raw materials and to manufacture and compound our products. We have no control over these third parties and if these relationships are disrupted our results of operations in future periods will be adversely impacted.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">We currently hold short-term supply and manufacturing agreements with unaffiliated third-party vendors for our critical raw materials. In addition, our products are manufactured, compounded, and packaged by unaffiliated third parties and the use of these third-parties changes from time to time due to customer demand and the composition of our product mix and product portfolio. We do not have any long-term committed contracts with any of these third parties, and we expect to compete with other companies for raw materials, production and imported materials. If we experience significant increased demand or need to replace an existing raw material supplier or third-party manufacturer, there can be no assurances that replacements for these third-party vendors will be available when required on terms that are acceptable to us, or at all, or that any manufacturer or compounder would allocate sufficient capacity to us in order to meet our requirements. In addition, even if we are able to expand existing or find new sources, we may encounter delays in production and added costs as a result of the time it takes to engage third parties. Any delays, interruption or increased costs in raw materials and/or the manufacturing or compounding of our products could have an adverse effect on our ability to meet retail customer and consumer demand for our products and result in lower revenues and net income both in the short and long-term.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      12
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Failures in our third-party verification and testing protocols may have an adverse impact on our brands which could suppress sales.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The quality of our products is essential to our business strategy. We require our raw material suppliers and farms to participate in our supplier verification program and to certify that their source material was grown using strict standards of cultivation. We also employ third-party testing procedures and all incoming cannabinoid ingredients are first tested by an independent, third-party laboratory before they reach our production facilities and then re-tested in-house throughout the production process before sending the ingredients off for final verification by an independent accredited third-party laboratories. We are reliant on these third parties to adhere to our supplier verification program and properly perform the third-party testing procedures. Any intentional or unintentional failure of any of these parties to perform the functions for which we have engaged them would adversely impact the quality of our products and could result in delays in meeting consumer demand or a decline in our sales.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>Failures to comply with applicable laws, including hemp laws, by our third-party suppliers could create disruptions in the supply chain and adversely impact our ability to manufacture products effectively.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company&#8217;s suppliers and manufacturers must comply with the hemp production and manufacturing laws of their respective states. Since these laws can vary significantly between states, the Company relies on its partners to adhere to both state-specific regulations and USDA requirements. If any supplier or manufacturer fails to comply with local laws or loses their permits or licenses, their ability to continue operations may be jeopardized, which could, in turn, disrupt the Company&#8217;s supply chain and manufacturing processes. Such disruptions may negatively impact the Company&#8217;s ability to conduct its business as planned.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>Product inventory may expire prior to sale due to limited shelf life.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">While the Company actively manages its inventory, it is possible that products could reach their expiration date and remain unsold. In such cases, the Company may need to write down the value of the expired inventory, which could negatively impact its business, financial position, and operational outcomes.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>Consumers of the Company</i></b>&#8217;<b><i>s products may face adverse consequences should they test positive for THC which could negatively impact the Company</i></b>&#8217;<b><i>s reputation, lead to litigation, or other potentially negative impacts to the Company.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Many of the Company&#8217;s products are derived from cannabis and may contain trace amounts of tetrahydrocannabinol (THC), which may be below the level of detection but could build up in a regular consumer&#8217;s system. Although these levels are generally low, historically THC has been a banned substance in many jurisdictions, and regulations regarding permissible THC limits are continually evolving. As a result, there is a potential risk for end users who test positive for THC due to consumption of the Company&#8217;s products. This may be of particular concern in the case of full-spectrum hemp products, which contain not only CBD but also trace levels of THC and other cannabinoids. These trace amounts could lead to false positives on drug tests, especially with certain testing methods that do not differentiate between THC from hemp and that from other sources. There is also the possibility that certain approved tests for THC may not properly differentiate between the metabolites of THC and the metabolites of CBD, thus leading to a false positive for THC consumption. Additionally, metabolic processes in the body may cause CBD and its metabolites to convert into forms that could affect drug test results. Positive test results, even from trace amounts of THC, can have significant consequences for individuals, potentially affecting their reputation, employment, or participation in specific activities, including professional sports. Furthermore, a claim or regulatory action based on such positive test results could damage the Company&#8217;s reputation and adversely affect its operations, potentially leading to legal or regulatory challenges.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i>We could be harmed by data loss or other security breaches.</i></b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Like all companies that utilize technology, we are subject to threats of breaches of our technology systems and cybersecurity risks. Some of our systems have experienced past security incidents, including an incident that compromised some customers' personal and payment information. We conducted a forensic examination, made all notices to customers, governments, banks and card associations as required under local, state and federal laws, merchant agreements and card association rules. We also offered free credit monitoring and reporting to all affected customers and are maintaining a call center to handle any customer issues. We have implemented all remedial measures advised by the forensic examiner engaged by us, and, although we do not believe that any of these incidents have had a material adverse effect on our operating results, there can be no assurance the remedial measures will be effective or of a similar result in the future which could materially and adversely impact our business and operations in future periods.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>We face risks related to system interruption and lack of redundancy.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">From time to time we experience system interruptions and delays that make our websites and product sales unavailable or slow to respond and prevent us from efficiently fulfilling orders which could adversely impact our net sales and the attractiveness of our products. If we are unable to add software and hardware as needed, effectively upgrade our systems and network infrastructure, and take other steps to improve the efficiency of our systems, these failures could cause system interruptions or delays and adversely affect our operating results in future periods. In addition, our computer and communications systems and operations could be damaged or interrupted by fire, flood, power loss, telecommunications failure, earthquakes, acts of war or terrorism, acts of God, computer viruses, physical or electronic break-ins, and similar events or disruptions. Any of these events could cause system interruption, delays, and loss of critical data, and could prevent us from accepting and fulfilling customer orders which could make our product offerings less attractive and subject us to liability. Our systems are not fully redundant, and our disaster recovery planning may not be sufficient. In addition, we may have inadequate insurance coverage to compensate for any related losses. Any of these events could damage our reputation and be expensive to remedy.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Our future success depends on the continuing efforts of our management and key employees, and on our ability to attract and retain highly skilled personnel and senior management. </i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We depend on the talents and continued efforts of our senior management and key employees. We currently do not have any long-term employment agreements with our executive officers. The loss of members of our management or key employees may disrupt our business and harm our results of operations. Furthermore, our ability to manage further expansion will require us to continue to attract, motivate, and retain additional qualified personnel. Competition for this type of personnel is intense, and we may not be successful in attracting, integrating, and retaining the personnel required to grow and operate our business effectively. There can be no assurance that our current management team, or any new members of our management team, will be able to successfully execute our business and operating strategies.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      13
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>If our other intangible assets, or fixed assets become impaired, we may be required to record a charge to our earnings. </i></b></p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During fiscal year&#160;2023, we incurred $13.22 million of intangible impairment as noted in Note 5&#160;of our financial statements. We may be required to record future impairments of other intangible assets, or fixed assets to the extent the fair value of these assets falls below their book value. Our estimates of fair value are based on assumptions regarding future cash flows, gross margins, expenses, discount rates applied to these cash flows, and current market estimates of value. Estimates used for future sales growth rates, gross profit performance, and other assumptions used to estimate fair value could cause us to record material non-cash impairment charges, which could harm our results of operations and financial condition.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>RISKS RELATED TO THE REGULATORY ENVIRONMENT FOR CBD</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>Lack of clarity and changes to Federal or state laws pertaining to industrial hemp could slow the use of industrial hemp which would materially impact our revenues in future periods.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Continued development of the industrial hemp industry will be dependent upon new legislative authorization of industrial hemp at the state level, expansion of current state approvals for hemp products, and further authorization, amendment or supplementation of legislation at the federal level, including re-authorization and expansion of the hemp language in the next Agriculture Improvement&#160;Act. Any number of events or occurrences could slow or halt progress all together in this space. While progress within the industrial hemp industry is currently encouraging, growth is not assured. While there appears to be ample public support for favorable legislative action, numerous factors may impact or negatively affect the legislative process(es) within the various states where we have business interests. Any one of these factors could slow or halt use of industrial hemp, which could negatively impact the business up to possibly causing us to discontinue operations as a whole. In addition, changes in Federal or state laws could require us to alter the way we conduct our business in order to remain compliant with applicable state laws in ways we are presently unable to foresee. These possible changes, if necessary, could be costly and may adversely impact our results of operations in future periods.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>Final designation of hemp derived cannabinoids as impermissible adulterants, FDAs refusal to accept hemp derived cannabinoids as New Dietary Ingredients (NDI) or FDAs interpretation of IND Preclusion could negatively impact the Company</i>&#8217;<i>s operations.</i></b></p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The regulatory framework surrounding cannabinoids, particularly CBD, raises significant challenges for the Company. First, concerns about CBD as an impermissible adulterant persist due to the FDA's position that cannabinoids cannot legally be added to food or beverages. The FDA has consistently objected to such uses, asserting that CBD-containing products may be adulterated and subject to enforcement action. Second, under the FD&amp;C Act, unless a product was in the food supply and marketed to the public prior to October 15, 1994, manufacturers must notify the FDA before marketing dietary supplements containing NDIs, providing evidence that the ingredient is expected to be safe. However, there is ongoing uncertainty regarding whether hemp-derived cannabinoids were in the food supply and marketed to the public before October 15, 1994, as required to avoid classification as an NDI. As of the end of fiscal 2024, the FDA has uniformly objected to several New Dietary Ingredient Notifications (NDIN) submitted to the Agency by competitors, asserting it does not meet the definition of a dietary supplement due to the FDA's stance that CBD was not marketed as a dietary ingredient before its investigation as a new drug. The Company disagrees with this position and believes there are counterarguments. The FDA has consistently taken the position that CBD cannot be marketed as a dietary supplement or added to food because it was investigated as a new drug before its inclusion in the food supply, known as IND Preclusion. This position has been outlined in the majority of Warning Letters the FDA has sent to CBD companies since the enactment of the Farm Bill. Any enforcement of the IND Preclusion could require the Company to allocate significant resources to defend its position, adversely affecting its business and operations. Without changes in federal law, regulation, or judicial interpretation, the FDA&#8217;s current stance could materially and adversely impact the Company&#8217;s ability to operate.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>Failure or inability to secure required state or federal regulatory approvals and permits could negatively impact the Company</i>&#8217;<i>s ability to conduct business.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company must secure and maintain specific approvals and permits in many jurisdictions where its products are sold, and failure to do so could delay or inhibit its operations. Regulatory approval and permit requirements are subject to change without notice.&#160;There is no guarantee that the Company will be able to acquire or retain these essential approvals. Any substantial delays or inability to obtain the required permits or licenses would negatively impact the Company&#8217;s ability to conduct its business, potentially leading to material adverse effects on its financial condition and operations.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>Costs associated with compliance with numerous laws and regulations could impact our financial results. In addition, we could become subject to increased litigation risks associated with the CBD industry </i></b><b><i>and the overall Dietary Supplement Industry.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The manufacture, labeling and distribution by us of the products in our portfolio are regulated by various federal, state and local agencies. These governmental authorities may commence regulatory or legal proceedings, which could restrict the permissible scope of our product claims or the ability to sell products in the future. We are subject to regulation by the federal government and other state and local agencies as a result of our product offering, including but not limited to hemp-based cannabinoid products and other natural health products. The shifting compliance environment and the need to build and maintain robust systems to comply with different compliance in multiple jurisdictions increases the possibility that we may violate one or more of the requirements. If our operations are found to be in violation of any of such laws or any other governmental regulations that apply to our company, we may be subject to penalties, including, without limitation, civil and criminal penalties, damages, fines, the curtailment or restructuring of our operations, any of which could adversely affect the ability to operate our business and our financial results. Failure to comply with the various federal, state and local requirements may result in, among other things, injunctions, product withdrawals, recalls, product seizures, fines and criminal prosecutions. We are seeing increasing state-level potency, labeling and package size requirements that may increase our costs with respect to monitoring and adhering to unique requirements in addition to potential product and packaging obsolescence costs as well as stop sales or product withdrawals. Our advertising is subject to regulation by, among others, the FDA under the Federal Food, Drug &amp; Cosmetics Act, and the U.S. Federal Trade Commission, or FTC, under the Federal Trade Commission Act, and is also subject to various state regulations enforced by state agencies and state attorneys general. Additionally, some states also permit advertising and labeling laws to be enforced by private attorneys general who may seek relief for consumers, seek class-action certifications, seek class-wide damages and product withdrawals of products sold by us. Any actions against our company by governmental authorities or private litigants could be time consuming, costly to defend and could have a material adverse effect on our business, financial condition, and results of operations.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>Uncertainty caused by potential changes to legal regulations could impact the use of the Company</i></b>&#8217;<b><i>s products.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">There is substantial uncertainty and different interpretations among federal, state and local regulatory agencies, legislators, academics and businesses as to the scope of operation of Farm Bill-compliant hemp programs relative to the emerging regulation of cannabinoids. These different opinions include, but are not limited to, the regulation of cannabinoids by the U.S. Drug Enforcement Administration and/or the FDA, various administrative determinations and court decisions, all of which impact the extent to which manufacturers and processors of products containing Farm Bill-compliant cannabinoids may engage in interstate commerce. There are currently no consistent regulations applicable to hemp derived cannabinoids in the United States or globally. There is no assurance the Company will remain compliant with all of these laws, rules and regulations as changes to such laws, rules and regulations are promulgated and this may have a negative impact on the Company&#8217;s operations. By way of example, through the end of Fiscal 2024, multiple states including Alaska, Florida, Maryland, Minnesota, New York, Utah and Virginia had implemented new regulations which impact the Company&#8217;s ability to sell some of its products as they exist now in formulation and packaging. The uncertainties, conflicts and lack of uniformity cannot be resolved without further federal, and perhaps even state-level, legislation, regulation or a definitive judicial interpretation of existing legislation and rules. If these uncertainties continue, they may have an adverse effect upon the introduction of our products in different markets.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      14
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"><b><i>The FTC may seek to pursue enforcement actions against companies selling hemp derived cannabinoids, including the Company.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Federal Trade Commission (FTC) has increasingly focused on the regulation of advertising, labeling, and promotion of CBD and other health-related products. In the CBD product marketplace, the FTC has collaborated with the FDA to issue warnings about advertisements lacking competent and reliable scientific evidence, which violates the FTC Act. In addition, the FTC has independently issued warning letters to companies marketing CBD products with exaggerated or unsupported health claims. Although the FTC has primarily issued warning letters, it initiated its first law enforcement administrative action in December 2020, taking action against six CBD companies for allegedly making unsupported health claims, resulting in settlement agreements requiring cessation of such claims and monetary penalties. The FTC further heightened its scrutiny in May 2021 and, more recently, issued its <i>April 2023 Notice of Penalty Offenses</i>, which stresses the need for rigorous substantiation of health-related product claims. This notice emphasizes that companies must provide scientific evidence, including high-quality, randomized, placebo-controlled human clinical trials, to substantiate claims. Failure to comply with these standards could result in significant penalties under Section 5 of the FTC Act. The FTC&#8217;s actions, along with the potential for increased enforcement in the future, present additional risks to companies in the CBD industry. The Company must be cautious in making health claims, ensuring all advertising is adequately supported by scientific evidence, as any violations could result in penalties, corrective measures, and reputational damage.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Risks associated with international regulations.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company faces significant regulatory challenges and risks in expanding its operations internationally, which could materially impact its business. As the Company conducts sales and expands into new markets, it must adhere to the laws and regulations of each jurisdiction, as well as any relevant international treaties. Non-compliance with these regulations could result in civil or criminal penalties, fines, operational restructuring, asset seizures, or the denial of regulatory applications. Moreover, international authorities could determine that past or current operations violated local regulations, exposing the Company to potential enforcement actions. The evolving legal landscape in certain jurisdictions, including proposed legislative changes, may present opportunities for portfolio expansion but also introduces undetermined compliance risks. Additionally, cannabis-related financial transactions are governed by complex and unsettled laws that vary by jurisdiction, and financial benefits derived from activities deemed unlawful in certain regions could expose the Company, its investors, or affiliates to liability. Increased regulation of natural health products and heightened scrutiny of nutritional supplements and advertising claims further compound these challenges. Anticipated regulatory changes may require the Company to adapt its products or marketing strategies, and any delays or failures to comply could disrupt operations. These risks underscore the need for prospective investors to consult legal counsel to assess potential liabilities associated with the Company's activities in specific jurisdictions.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>RISKS RELATED TO OWNERSHIP OF OUR SECURITIES</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><b>We are subject to the continued listing standards of the NYSE American and our failure to satisfy these criteria may result in de-listing of our securities. </b></i></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Both our common stock and our Series A Convertible Preferred Stock are listed on the NYSE American. In order to maintain these listings, we must maintain certain share prices, financial and share distribution targets, including maintaining a minimum amount of shareholders&#8217; equity and a minimum number of public shareholders. In addition to these objective standards, the NYSE American may delist the securities of any issuer (i) if, in its opinion, the issuer&#8217;s financial condition and/or operating results appear unsatisfactory; (ii) if it appears that the extent of public distribution or the aggregate market value of the security has become so reduced as to make continued listing on the NYSE American inadvisable; (iii) if the issuer sells or disposes of principal operating assets or ceases to be an operating company; (iv) if an issuer fails to comply with the NYSE American&#8217;s listing requirements; (v) if an issuer&#8217;s securities sell at what the NYSE American considers a &#8220;low selling price&#8221; and the issuer fails to correct this via a reverse split of shares after notification by the NYSE American; or (vi) if any other event occurs or any condition exists which makes continued listing on the NYSE American, in its opinion, inadvisable. If the NYSE American delists either our common stock and/or our Series A Convertible Preferred Stock, investors may face material adverse consequences, including, but not limited to, a lack of trading market for our securities, reduced liquidity, decreased analyst coverage of our securities, and an inability for us to obtain any additional financing to fund our operations that we may need.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>The Company has received notification from the NYSE American LLC that the Company is no longer in compliance with NYSE American</i></b>&#8217;<b><i>s continued listing standards and in the event we do not ultimately regain compliance, our securities could ultimately be delisted from the NYSE American.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On June 5, 2024, we received notification (the &#8220;Notice&#8221;) from the NYSE American that the Company is no longer in compliance with NYSE American&#8217;s continued listing standards. On August 20, 2024, we received notice from the NYSE American LLC that it had accepted the Company&#8217;s plan to regain compliance with the NYSE American continued listing standards and granted a plan period through December 5,&#160;2025 (&#8220;Deadline Date&#8221;). As previously disclosed on June 5, 2024, the Company received a letter from the NYSE American LLC stating that the Company was not in compliance with the continued listing standards set forth in Sections 1003(a)(ii) of the NYSE American Company Guide. Section 1003(a)(ii) requires a listed company to have stockholders&#8217; equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The Company reported stockholders&#8217; equity of $3.1 million as of March 31, 2024 ($1.96 million as of September 30, 2024), and has had losses from continuing operations and/or net losses in three of its four most recent fiscal years ended September 30, 2023 (and September 30,2024). While the Company&#8217;s preferred stock and common stock will continue to be listed on the NYSE American during the plan period pursuant to an extension and the Company's receipt of such notification from the NYSE American does not affect the Company's business, operations or reporting requirements with the U.S. Securities and Exchange Commission, during the plan period, the Company will be subject to quarterly review to determine if it is making progress consistent with the plan. If the Company does not regain compliance with the NYSE American listing standards by the Deadline Date, or if the Company does not make sufficient progress consistent with its plan, then the NYSE American may initiate delisting proceedings.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company can provide no assurances that it will be able to make progress with respect to its plan that NYSE American will determine to be satisfactory, that it will regain compliance with Section 1003(a)(ii) of the Company Guide on or before the Deadline Date, or that developments and events occurring subsequent to the Company&#8217;s formulation of the plan or its acceptance by the NYSE American will not adversely affect the Company&#8217;s ability to make sufficient progress and/or regain compliance with Section 1003(a)(ii) of the Company Guide on or before the Deadline Date or result in the Company&#8217;s failure to be in compliance with other NYSE American continued listing standards.&#160; While the Notice has no immediate impact on the listing of the Company&#8217;s shares of common stock or Series A Preferred Stock, which will continue to be listed and traded on the NYSE American during this period, subject to the Company&#8217;s compliance with the other listing requirements of the NYSE American, if the Common Stock and Preferred Stock ultimately were to be delisted for any reason, it could negatively impact the Company by (i) reducing the liquidity and market price of the Company&#8217;s Common Stock and Preferred Stock; (ii) reducing the number of investors willing to hold or acquire the Common Stock and Preferred Stock, which could negatively impact the Company&#8217;s ability to raise equity financing; (iii) limiting the Company&#8217;s ability to use a registration statement to offer and sell freely tradable securities, thereby preventing the Company from accessing the public capital markets; and (iv) triggering an event of default under the Company&#8217;s outstanding Notes.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>The Series A Convertible Preferred Stock ranks junior to all of our indebtedness and other liabilities and is effectively junior to all indebtedness and other liabilities of our subsidiaries.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In the event of our bankruptcy, liquidation, dissolution or winding-up of our affairs, our assets will be available to pay obligations on the Series A Convertible Preferred Stock only after all of our indebtedness and other liabilities have been paid. The rights of holders of the Series A Convertible Preferred Stock to participate in the distribution of our assets will rank junior to the prior claims of our current and future creditors and any future series or class of preferred stock we may issue (subject to Series A Convertible Preferred Stockholder approval) that ranks senior to the Series A Convertible Preferred Stock. In addition, the Series A Convertible Preferred Stock effectively ranks junior to all existing and future indebtedness and other liabilities of our existing subsidiaries and any future subsidiaries. Our existing subsidiaries are, and any future subsidiaries would be, separate legal entities and have no legal obligation to pay any amounts to us in respect of dividends due on the Series A Convertible Preferred Stock. If we are forced to liquidate our assets to pay our creditors, we may not have sufficient assets to pay amounts due on any or all of the Series A Convertible Preferred Stock then outstanding.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>We are currently unable to pay dividends on the Series A Convertible Preferred Stock.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During August 2023, the Company&#8217;s board of directors suspended dividend payment on the Series A Convertible Preferred Stock. We do not anticipate paying any accrued or future dividends on our&#160;Series A Convertible Preferred Stock in the future.&#160;In order for us to be eligible to pay the dividend, state law requires us to (i) either be able to pay our debts as they become due in the usual course of business, or (ii) have total assets that are greater than the sum of our total liabilities plus the amount that would be needed if we were to be dissolved at the time of the distribution to satisfy the preferential rights upon dissolution of shareholders whose preferential rights are superior to those receiving the distribution. Payment of our dividends depends upon our financial condition and other factors as our board of directors may deem relevant from time to time. We cannot assure you that our businesses will generate sufficient cash flow from operations in an amount sufficient to enable us to make distributions on our common stock and preferred stock, including the Series A Convertible Preferred Stock, or to fund our other liquidity needs.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      15
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Holders of the Series A Convertible Preferred Stock may be unable to use the dividends-received deduction and may not be eligible for the preferential tax rates applicable to </i></b>&#8220;<b><i>qualified dividend income.</i></b>&#8221;</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Distributions paid to corporate U.S. holders of the Series A Convertible Preferred Stock may be eligible for the dividends-received deduction, and distributions paid to non-corporate U.S. holders of the Series A Convertible Preferred Stock may be subject to tax at the preferential tax rates applicable to &#8220;qualified dividend income,&#8221; if we have current or accumulated earnings and profits, as determined for U.S. federal income tax purposes. We do not currently have any accumulated earnings and profits. Additionally, we may not have sufficient current earnings and profits during future fiscal years for the distributions on the Series A Convertible Preferred Stock to qualify as dividends for U.S. federal income tax purposes. If the distributions fail to qualify as dividends, U.S. holders would be unable to use the dividends-received deduction and may not be eligible for the preferential tax rates applicable to &#8220;qualified dividend income.&#8221; If any distributions on the Series A Convertible Preferred Stock with respect to any fiscal year are not eligible for the dividends-received deduction or preferential tax rates applicable to &#8220;qualified dividend income&#8221; because of insufficient current or accumulated earnings and profits, it is possible that the market value of the Series A Convertible Preferred Stock might decline.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>The Series A Convertible Preferred Stock represents perpetual equity interests in us, and investors should not expect us to redeem or convert the Series A Convertible Preferred Stock on the date the Series A Convertible Preferred Stock becomes redeemable or convertible by us or on any particular date afterwards.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Series A Convertible Preferred Stock represents perpetual equity interests in our company, and it has no maturity or mandatory redemption except upon a Change of Control, and is not redeemable at the option of investors under any other circumstances. A &#8220;Change of Control&#8221; will generally be deemed to occur when, after the original issuance of the Series A Convertible Preferred Stock, the acquisition by any person, including any syndicate or group deemed to be a &#8220;person&#8221; under Section 13(d)(3) of the Exchange Act, of beneficial ownership, directly or indirectly, through a purchase, merger or other acquisition transaction or series of purchases, mergers or other acquisition transactions which were pre-approved by our board of directors of our stock entitling that person to exercise more than 50% of the total voting power of all of our stock entitled to vote generally in the election of the our directors, subject to certain exclusions. As a result, the Series A Convertible Preferred Stock will not give rise to a claim for payment of any amount at a particular date. As a result, holders of the Series A Convertible Preferred Stock may be required to bear the financial risks of an investment in the Series A Convertible Preferred Stock for an indefinite period of time unless the holder chooses to voluntarily convert the shares of Series A Convertible Preferred Stock into shares of our common stock.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Change of Control redemption obligations of the Series A Convertible Preferred Stock may make it more difficult for a party to acquire us or discourage a party from acquiring us.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Change of Control redemption feature of the Series A Convertible Preferred Stock may have the effect of discouraging a third party from making an acquisition proposal for our company or of delaying, deferring or preventing certain of change of control transactions under circumstances that otherwise could provide the holders of our common stock and Series A Convertible Preferred Stock with the opportunity to realize a premium over the then-current market price of such stock or that shareholders may otherwise believe is in their best interests.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>A holder of Series A Convertible Preferred Stock has extremely limited voting rights.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The voting rights for a holder of Series A Convertible Preferred Stock are limited. Our shares of common stock are the only class of our securities that carry full voting rights. Holders of the shares of Series A Convertible Preferred Stock do not have any voting rights other than as set forth below in the next two sentences or unless dividends on the Series A Convertible Preferred Stock are in arrears for each of 12 or more consecutive monthly periods, in which case the holders of the Series A Convertible Preferred Stock will be entitled to vote as a separate class for the election of two additional directors to serve on the board of directors until all dividends that are owed have been paid. Holders of shares of Series A Convertible Preferred Stock, voting as a class, are also entitled to vote if we should seek to issue or create any class or series of capital stock ranking senior to the Series A Convertible Preferred Stock with respect to dividends or distributions, in which event the consent of holders of at least two thirds of the then outstanding Series A Convertible Preferred Stock is required. The consent of the holders of two thirds of the Series A Convertible Preferred Stock, voting as a class, is required if we were to seek to adopt any amendment to our articles of incorporation or bylaws that would materially affect existing terms of the Series A Convertible Preferred Stock, or increase the number of authorized shares of that series, other than in connection with the anti-dilution provisions, or if we seek to create a series or class which ranks pari passu with the Series A Convertible Preferred Stock. Other than these limited circumstances and except to the extent required by law, holders of Series A Convertible Preferred Stock do not have any voting rights.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>We may redeem the Series A Convertible Preferred Stock at our option, we will be required to redeem the Series A Convertible Preferred Stock upon a Change of Control and we may convert shares of Series A Convertible Preferred Stock upon a Market Trigger into shares of our common stock. In the event of any of these occurrences, you may not receive dividends that you anticipate.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We may, at our option, redeem the Series A Convertible Preferred Stock, in whole or in part, at any time or from time to time. In addition, upon the occurrence of a board approved Change of Control, we are required to redeem any or all of the shares of Series A Convertible Preferred Stock at a redemption price of $11.00 per share, plus any accrued but unpaid dividends to, but excluding, the redemption date. Furthermore, upon a Market Trigger (as that term is defined in the designations, rights and preferences of the Series A Convertible Preferred Stock), we may convert all or any portion of those shares of Series A Convertible Preferred Stock into shares of our common stock. We may have an incentive to redeem or convert the Series A Convertible Preferred Stock voluntarily if market conditions allow us to issue other preferred stock or debt securities at a rate that is lower than the dividend rate on the Series A Convertible Preferred Stock. If we redeem or convert the Series A Convertible Preferred Stock, then from and after the redemption date or conversion date, as applicable, dividends will cease to accrue on shares of Series A Convertible Preferred Stock, the shares of Series A Convertible Preferred Stock shall no longer be deemed outstanding and all rights as a holder of those shares will terminate, including the rights to receive dividend payments.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>The liquidation preference of the shares of our Series A Convertible Preferred Stock would reduce the amount available to our common shareholders in the event of our liquidation or winding up.</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Holders of our Series A Convertible Preferred Stock have a liquidation preference of $10.00 per share in the event of our liquidation or winding up. This means that those holders are entitled to receive the liquidation preference before any payment or other distribution of assets to our common shareholders, and the amount of any such payment or other distribution will be reduced by that amount.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>The issuance of shares upon the conversions of our outstanding Notes may cause immediate and substantial dilution to our existing shareholders.</i></b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="background-color:#ffffff;">We presently have Notes, that if converted would result in the issuance of approximately an additional 718,000&#160;shares of our common stock. The issuance of shares upon the conversion of Notes will result in dilution to the interests of other shareholders.</span></p>
  <div>
   &#160;
  </div>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      16
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="unresolved" title="unresolved" href="#"></a>ITEM 1B. UNRESOLVED STAFF COMMENTS.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Not applicable to a smaller reporting company.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><a id="item1c" title="item1c" href="#"></a>ITEM 1C</b>. <b>CYBERSECURITY</b></p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Like all companies that utilize technology, we are subject to threats of breaches of our technology systems. To mitigate the threat to our business, we take a comprehensive approach to cybersecurity risk management. Our IT department and our management actively oversee our risk management program, including the management of cybersecurity risks. We have contracted with cybersecurity and risk assessment experts to help test our systems and guide the ongoing development of best practices policies. We have established policies, standards, processes and practices for assessing, identifying, and managing material risks from cybersecurity threats, including those discussed in our Risk Factors.&#160;&#160; We have devoted resources to implement and maintain security measures to meet regulatory requirements and shareholder expectations, and we intend to continue to make investments to maintain the security of our data and cybersecurity infrastructure. While there can be no guarantee that our policies and procedures will be properly followed in every instance or that those policies and procedures will be effective, we believe that our company&#8217;s sustained investment in these efforts and technologies have put the Company in a position to protect against potential compromises, and we do not believe that risks from prior cybersecurity threats have materially affected our business to date. We can provide no assurance that there will not be incidents in the future or that past or future attacks will not materially affect us, including our business strategy, results of operations, or financial condition.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Risk management and strategy</b>.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We employ a multi-layered cybersecurity defense strategy that includes:</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">
   <tbody>
    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p> </td>
     <td colspan="2" rowspan="1" style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Network and endpoint protection: Utilizing firewalls, intrusion detection systems, antivirus software, and advanced encryption protocols to safeguard sensitive data and systems.</p> </td>
    </tr>

    <tr>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9679;</td>
     <td colspan="2" style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Multi-factor authentication, security and principle of least privileged (PoLP)</td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p> </td>
     <td colspan="2" rowspan="1" style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Employee training and awareness programs: Educating employees on cybersecurity best practices and conducting phishing simulations to promote vigilance against social engineering attacks.</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p> </td>
     <td colspan="2" rowspan="1" style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Incident detection and response plans: Maintaining real-time monitoring and implementing a structured incident response plan that allows us to quickly detect, respond to, and recover from cyber incidents.</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p> </td>
     <td colspan="2" rowspan="1" style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Third-party risk management: Vetting the cybersecurity controls of vendors and partners to ensure that their practices align with our standards for protecting sensitive information.</td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p> </td>
     <td colspan="2" rowspan="1" style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">While we have not experienced a cybersecurity incident that has had a material impact to date, the threat of potential incidents remains high. We continually evaluate our exposure to risks such as:</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p> </td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9675;</td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Operational disruption from ransomware or other cyberattacks.</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p> </td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9675;</td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Data breaches that could compromise customer or proprietary information.</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p> </td>
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9675;</td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Regulatory and legal exposure arising from cybersecurity failures.</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      17
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As part of our risk management framework, we regularly assess whether any cybersecurity incidents, or the likelihood of such incidents, could materially affect our business. We are also committed to continuous improvements to address emerging threats.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Governance.</b></p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our board of directors plays an active role in overseeing the company&#8217;s approach to managing cybersecurity risks. The board receives regular updates from senior management regarding the company's cybersecurity strategy, potential risks, and any incidents that may arise. These updates ensure that the board remains informed and able to provide guidance on cybersecurity matters.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The board is also regularly briefed by management on the Company&#8217;s cybersecurity policies, risk assessments, and mitigation strategies. This reporting structure allows the board to remain engaged with the company&#8217;s efforts to address and manage evolving cyber threats, ensuring that cybersecurity is aligned with our overall risk management framework.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Management, led by the IT department, plays a critical role in assessing and managing material risks related to cybersecurity. This includes implementing day-to-day cybersecurity measures, conducting regular risk assessments, and ensuring the timely response to any cyber threats or incidents. The IT department is responsible for ensuring that cybersecurity is integrated into our company&#8217;s broader risk management strategy, with direct reporting lines to both senior executives and the board of directors.&#160;</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="descriptionprop" title="descriptionprop" href="#"></a>ITEM 2. DESCRIPTION OF PROPERTY.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We operate our executive offices and warehouse from an 80,000 square foot facility in Charlotte, North Carolina under a lease agreement which commenced in November 2019.&#160; Through February 2025 the agreement calls for an annual base monthly rent of $34,766, inclusive of monthly TICAM for the first year and the rent escalates 3% annually. Effective&#160;November&#160;26,&#160;2024 we&#160;entered into a Second Amendment to Lease to extend the lease. The amendment extends the term of the&#160;lease&#160;for a period of nineteen months beginning on March 1, 2025 with a new expiration date of September 30, 2026. The Company has no further rights to extend or renew the terms of the&#160;lease. The amendment provides for the monthly base rent of $65,000, with an annual base rent of $9.75 per square feet from March 1, 2025 through February 28, 2026, and $67,600 with an annual base rent of&#160;$10.14 per square feet from March 1, 2026 through September 30, 2026. The Company shall also continue to pay additional rent and all other amounts (other than &#8220;Monthly Base Rent&#8221;) in accordance with the terms of the lease, except the &#8220;Controllable CAM Charges" provision have been deleted. Furthermore, the landlord has approved certain subleases entered into by and between the Company and sub tenants for portions of the facility. This facility is sufficient for our current and anticipated operations through September 2026.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">See footnote 11 to our financial statements including with this annual report for a discussion on the termination of our former executive office lease pursuant to agreements entered into in March 2024.</p>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="legalpro" title="legalpro" href="#"></a>ITEM 3. LEGAL PROCEEDINGS. </b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In December 2019, Cynthia Davis filed a purported collective and class action lawsuit in the United States District Court for the Central District of California against cbdMD and certain of our competitors alleging violations of the California&#8217;s Unfair Competition Law, California&#8217;s False Advertising Law and California&#8217;s Consumer Legal Remedies Act, as well as claims for Breach of Express Warranties, Breach of Implied Warranty of Merchantability and Declaratory Relief. On March 4, 2021 the Court granted cbdMD&#8217;s motion to stay the case until the FDA or Congress takes definitive action on the regulatory status of CBD and the case remains in this status as of this filing. The Company believes this matter will eventually be dismissed but there is no timeline on when the FDA or Congress will take action so the case is expected to be stayed indefinitely.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As previously disclosed, the Company&#8217;s subsidiary, CBD Industries, LLC, initiated a trademark cancellation proceeding in 2019 against Majik Medicine, LLC regarding Majik Medicine&#8217;s &#8220;CBD MD&#8221; trademark. In a Settlement, Purchase, and Release Agreement, effective August 23, 2024, the Company acquired the trademark, resolving all related legal claims. The agreement included a $100,000 initial payment, four additional annual payments of $50,000, the issuance of 75,000 shares of common stock, and 50,000 more shares on the one-year anniversary. Failure to make the additional payments would reassign the trademark to Majik Medicine. We believe that this acquisition strengthens the Company&#8217;s IP portfolio, avoids litigation costs, and expedites trademark issuance. Majik Medicine also appointed board member William Raines III as a voting proxy for the Initial Shares for a period of 12 months.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="minesafety" title="minesafety" href="#"></a>ITEM 4. MINE SAFETY DISCLOSURES.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Not applicable to our company.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      18
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <div>
   &#160;
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="part2" title="part2" href="#"></a>PART II</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="item5" title="item5" href="#"></a>ITEM 5. MARKET FOR REGISTRANT</b>&#8217;<b>S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Since May 1, 2019, commensurate with our name change, our common stock has been listed on the NYSE American under the symbol &#8220;YCBD&#8221; and from November 17, 2017 through May 1, 2019 our common stock was listed on the NYSE American under the symbol &#8220;LEVB.&#8221;</p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Series A Convertible Preferred Stock has been listed on the NYSE American since October 21, 2019 under the symbol &#8220;YCBDpA.&#8221;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of December 16, 2024, there were approximately 13,308&#160;street owners of our common stock and 995&#160;street holders of our Series A Convertible Preferred Stock. These amounts do not reflect persons or entities that hold our securities in nominee or &#8220;street&#8221; name through various brokerage firms.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Dividend policy</i></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Common Stock</i></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We do not currently intend to pay dividends on our common stock. The declaration, amount and payment of any future dividends on shares of our common stock, if any, is subject to the designations, rights and preferences of the Series A Convertible Preferred Stock and will be at the sole discretion of our Board, which may take into account general and economic conditions, our financial condition and results of operations, our available cash and current and anticipated cash needs, capital requirements, contractual, legal, tax and regulatory restrictions, the implications of the payment of dividends by us to our shareholders or by our subsidiaries to us, and any other factors that our Board may deem relevant.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Series A Convertible Preferred Stock</i></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As of the date of this filing, there are 5 million shares of our Series A Convertible Preferred Stock outstanding. The designations, rights and preferences of our Series A Convertible Preferred Stock provide that we will pay, when, as and if declared by our board of directors, monthly cumulative cash dividends at an annual rate of 8.0%, which is equivalent to $0.80 per annum per share, based on the $10.00 liquidation preference. Dividends on the Series A Convertible Preferred Stock will accrue daily and be cumulative from, and including, the first day of the calendar month in which the shares are issued and will be payable monthly in arrears approximately on the 15<sup style="vertical-align:top;line-height:120%;">th</sup> day of each calendar month. From November 1, 2019 until August 1, 2023 the Audit Committee of our board of directors declared a cash dividend of $0.0667 per share of Series A Convertible Preferred Stock payable on or around the 15th of each month to holders of record on the first of each month. On August 22, 2023 the Board of Directors suspended the monthly cash dividend payment on the Company&#8217;s 8.0% Series A Cumulative Convertible Preferred Stock beginning with the month ending August 31, 2023 as the Company conserves cash in order to continue its efforts to increase sales, develop additional products, continue research and development, reduce operating expenses and attempt to achieve profitability. See &#8220;Risk Factors&#8221;.</p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Recent sales of unregistered securities</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In addition to those unregistered securities previously disclosed in reports filed with the SEC during the period covered by this report, we have sold the securities disclosed below without registration under the Securities Act of 1933, as amended, during the period covered by this report, except as provided below. The issuances were exempt from registration pursuant to Section 4(a)(2) of the Securities Act.&#160; The securities contain a legend restricting their transferability absent registration or applicable exemption.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In November 2024, the Company issued 175,000 shares of common stock to a consultant for advisory services.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Purchases of equity securities by the issuer and affiliated purchasers</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">None.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="item6" title="item6" href="#"></a>ITEM 6. [Reserved]</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      19
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <div>
   &#160;
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="mda" title="mda" href="#"></a>ITEM 7.</b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following discussion of our financial condition and results of operations should be read in conjunction with the audited consolidated financial statements and the notes to those statements that are included elsewhere in this report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements because of several factors, including those set forth under the Part I, Item 1A, Risk Factors and Business sections in this report, and our other filings with the Securities and Exchange Commission. We use words such as &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;continuing,&#8221; &#8220;ongoing,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; and similar expressions to identify forward-looking statements. In addition, any statements that refer to projections of our future financial performance, our anticipated growth and trends in our businesses, and other characterizations of future events or circumstances are forward-looking statements. Such statements are based on our current expectations and could be affected by the uncertainties and risk factors described throughout this report.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Overview</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">We own and operate the nationally recognized CBD (cannabidiol) brands cbdMD, Paw CBD as well as the functional mushroom brand ATRx Labs. We believe that we are an industry leader in producing and distributing broad spectrum and full spectrum CBD products. Our mission is to enhance our customer&#8217;s overall quality of life while bringing CBD education, awareness and accessibility of high quality and effective products to all. We source cannabinoids, which are extracted from non-GMO hemp grown on farms in the United States. Our innovative broad spectrum formula utilizes one of the purest hemp extracts, containing CBD, CBG and CBN, while eliminating the presence of tetrahydrocannabinol (THC). Non-THC is defined as below the level of detection using validated scientific analytical methods. Our full spectrum products contain a variety of cannabinoids and terpenes in addition to CBD while maintaining trace amounts of THC that fall within the limits set in the 2018 Farm Bill. In addition to our core brands, we also operate cbdMD Therapeutics, LLC to capture the Company&#8217;s ongoing investments in science related to its existing and future products, including research and development activities for therapeutic applications.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During 2024 we continued to focus on our path to profitability by lowering our costs and focusing on the customer experience. We transitioned a significant part of our organization during the first half of the year in addition to our ecommerce platform at the end of the third quarter. While we have not yet achieved positive operating income, management has worked hard to rationalize cost structure during fiscal 2024 and we have successfully achieved 3 sequential years of Non-GAAP Adjusted Operating Income (Loss) improvement, although our revenues were negatively impacted as we tightened our marketing spend and consumers were impacted by inflation trends. During fiscal 2024, we launched 2 important categories to the business (i) our line of ATRx functional mushroom supplements, that launched in GNC and Amazon and (ii) entered into the hemp derived beverage category starting with our Mixer line and followed up in November 2024 by our line of Herbal Oasis Social Tonics. With our leaner cost structure and some exciting new categories, we believe we are well positioned to start growing revenue during fiscal 2025.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Results of operations</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following tables provide certain selected consolidated financial information for the fiscal years ended September 30, 2024 and 2023:</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;">
   <tbody>
    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="text-align: center; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2024</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Change</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt; width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total net sales</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">19,482,167</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">24,155,362</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(4,673,195</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cost of sales</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">7,486,626</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">9,177,703</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(1,691,077</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Gross profit as a percentage of net sales</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">61.6</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">62.0</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-0.4</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating expenses</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">15,310,951</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">24,246,208</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(8,935,257</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Impairment of goodwill and other intangible assets</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">-</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">13,219,000</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">(13,219,000</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating loss from operations</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(3,315,410</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(22,487,549</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">19,172,139</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">(Increase) decrease on contingent liability</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">74,580</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">185,638</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(111,058</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss before taxes</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(3,700,126</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(22,938,209</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">19,238,083</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss attributable to cbdMD Inc. common shareholders</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">(7,704,127</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">(26,940,209</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">19,236,082</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following tables provide certain selected unaudited consolidated financial information for the three months ended September 30, 2024 and 2023:</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;">
   <tbody>
    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>September</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>September</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="text-align: center; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2024</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Change</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt; width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total net sales</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,556,367</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,710,745</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(1,154,378</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cost of sales</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,102,564</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,161,900</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(59,336</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Gross profit as a percentage of net sales</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">53.9</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">62.1</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-8.3</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating expenses</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,770,356</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,546,915</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(2,776,559</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Impairment of goodwill and other intangible assets</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0px; margin: 0px;">-</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0px; margin: 0px;">13,219,000</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0px; margin: 0px;">(13,219,000</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating income from operations</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(316,553</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(15,217,070</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">14,900,517</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">(Increase) decrease on contingent liability</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">15,573</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">31,867</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(16,294</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss before taxes</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(152,798</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(15,874,941</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">15,722,143</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss attributable to cbdMD Inc. common shareholders</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">(1,155,298</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">(16,875,436</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">15,720,138</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      20
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Sales</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We record product sales primarily through two main delivery channels, direct to consumers via our E-commerce sales and direct to wholesalers utilizing our internal sales team. The following table provides information on the contribution of net sales by type of sale to our total net sales for the fiscal years ended September 30, 2024 and 2023.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 9pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: 0pt;">
   <tbody>
    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Fiscal 2024</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>% of total</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Fiscal 2023</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>% of total</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">E-commerce sales</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">15,655,337</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">80.4</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; padding-bottom: 1px;">%</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">19,436,124</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">80.5</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; padding-bottom: 1px;">%</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 52%;"> <p style="margin: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Wholesale sales</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">3,826,830</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">19.6</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">%</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">4,719,238</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">19.5</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">%</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Total Net Sales</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double black;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double black;">19,482,167</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 3px double black;">&#160;</td>
     <td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 3px double black;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double black;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double black;">24,155,362</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 3px double black;">&#160;</td>
     <td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 3px double black;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In addition, the following table provides information on the contribution of net sales by type of sale to our total net sales for the three months ended September 30, 2024 and 2023 (unaudited):</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 9pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: 0pt;">
   <tbody>
    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>September 30,</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"><b>&#160;</b></td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>September 30,</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"><b>&#160;</b></td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2024</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>% of total</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>% of total</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">E-commerce sales</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">3,667,458</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">80.5</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; padding-bottom: 1px;">%</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">4,639,651</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">81.2</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; padding-bottom: 1px;">%</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Wholesale sales</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">888,908</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">19.5</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">%</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">1,070,946</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 1px solid black;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid black;">18.8</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">%</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Total Net Sales</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double black;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double black;">4,556,366</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 3px double black;">&#160;</td>
     <td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 3px double black;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double black;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double black;">5,710,597</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 3px double black;">&#160;</td>
     <td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 3px double black;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Total net sales during the fiscal year ended September 30, 2024 decreased by approximately $4.7 million, or 19% as compared to fiscal year ended September 30, 2023. Wholesale sales decreased by approximately $0.9 million, or 19% year over year while E-commerce sales decreased by $3.7 million or 19%.&#160; The change in revenue was driven by a combination of broader CBD category softness which we believe is partially attributed to the macro inflationary environment in addition to lower marketing spend.&#160;</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Net sales for the fourth quarter declined 20% year over year. A few items that impacted the quarter include: (i) During the 2024 fiscal fourth quarter, one of our agencies made a recommendation which resulted in&#160;a sharp decline in emails delivered. We have reacted accordingly to address the issue and have seen deliverability and metrics rebound during early fiscal 2025, however we believe this had greater than $200,000 impact to our direct-to-consumer revenue during the quarter. (ii) We continued to face ongoing down time on various digital marketing platforms tied to our regulated category. To help offset this ongoing challenge, we made a change to our marketing resources during the summer of 2024. As a result, we have seen our SEO rankings jump&#160;significantly and we are now ranking atop a number of key high-traffic, strategic terms resulting in strong gains on high-intent traffic during the first quarter of fiscal 2025. (iii) A number of our larger international wholesale clients faced a new regulatory registration requirement which ultimately impacted sales for approximately 100 days, most of which overlapped the fourth quarter. The wholesale demand rebounded in late&#160;October and continues to strengthen. Un-audited revenues for October and November have rebounded, trending ahead of&#160;the fourth fiscal quarter of 2024 and management currently anticipates being able to recapture most of the revenue lost in the September 2024 quarter during the first quarter of fiscal 2025.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Of our total net sales as indicated above, during the fiscal years ended September 30, 2024 and 2023 our Paw CBD line accounted for net sales of $1,445,644&#160;and $2,404,787, respectively. The year over year decline in our Paw CBD brand is due to increasing competition in the pet product industry and a rationalization in marketing efforts specific to the brand.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Cost of sales</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Our cost of sales includes costs associated with distribution, fill and labor expense, components, manufacturing overhead, third-party providers, and freight for our product sales. Our cost of sales as a percentage of net sales was 38.4% and 38.0% for fiscal years ended September 30, 2024 and 2023, respectively. While we made significant strides to reduce our overall fixed overhead cost associated with our cost of goods sold during fiscal 2024, gross margins for the year were impacted by lower overhead absorption based on lower revenue and ongoing product mix change from high-margin tinctures to gummies and functional products. For the fourth quarter of fiscal 2024&#160;our cost of sales as a percentage of net sales was 46.1% as compared to 37.9% in the prior year comparative period.&#160; The change reflects approximately $588,000 one-time non-cash inventory write down related to inventory loss related to regulatory changes impacting labels and packaging and obsolete/expired inventory, with most all of this inventory older than 2 years. Excluding this one-time write down, our non-GAAP&#160;adjusted cost of sales would have been 33% for the fourth quarter of fiscal 2024.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Operating expenses</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Our principal operating expenses include staff related expenses, advertising (which includes expenses related to industry distribution and trade shows), sponsorships, affiliate commissions, merchant fees, technology, travel, rent, professional service fees, and business insurance expenses. Our operating expenses on a consolidated basis decreased approximately $8.9&#160;million, excluding impairment charges, or 36.4% for the fiscal year ended September 30, 2024 versus the fiscal year ended September 30, 2023. The decrease can be attributed to management&#8217;s efforts to rationalize and right size our expenses across all areas of our business, especially a $1.9 million reduction in payroll and a $2.8 million reduction of marketing expenses in fiscal 2024. All other expenses includes a $0.7 million gain related to the settlement of our former executive office (&#8220;HQ&#8221;) lease in 2024 while all other expenses in 2023 includes $0.7 million of impairment of the Steady State Holdings investment.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Consolidated Operating Expenses</i></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The following tables provide information on our operating expenses for the fiscal years ended September 30, 2024 and 2023:</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 9pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: 0pt;">
   <tbody>
    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Fiscal 2024</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Fiscal 2023</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Change</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Staff related expense</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">5,521,869</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">7,440,687</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">(1,918,818</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Accounting/Legal/Professional outside expense</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">1,527,456</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">1,832,770</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">(305,314</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Marketing</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">4,181,026</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">6,950,340</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">(2,769,314</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Merchant Fees</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">642,102</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">791,475</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">(149,373</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">R&amp;D and regulatory</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">39,021</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">173,038</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">(134,017</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Non-cash stock compensation</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">43,688</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">349,245</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">(305,557</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;"> <p style="margin: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Intangibles amortization</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">697,510</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">1,396,459</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">(698,949</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;"> <p style="margin: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Rent and Utilities</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">1,349,284</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">1,569,906</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">(220,622</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding: 0px; margin: 0px;">)</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Depreciation</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">452,326</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">404,280</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">48,046</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">All other expenses</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">856,669</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,338,008</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(2,481,339</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; padding-bottom: 1px;">)</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Totals</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">15,310,951</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">24,246,208</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
     <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(8,935,257</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 3px; margin-left: 0pt;">)</td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      21
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Corporate overhead and allocation of management fees to our segments</i></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Included in our consolidated operating expenses are expenses associated with our corporate overhead which are not allocated to the operating business unit, including (i) staff related expenses; (ii) accounting and legal expenses; (iii) professional outside services; (iv) travel and entertainment expenses; (v) rent; (vi) business insurance; and (vii) non-cash stock compensation expense.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The following tables provide information on our corporate overhead for the fiscal years ended September 30, 2024 and 2023:</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;">
   <tbody>
    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2024</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal 2023</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Change</b></p> </td>
     <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt; width: 55%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Staff related expense</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">288,602</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">318,762</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(30,160</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounting/Legal expense</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">710,188</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">704,933</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">5,255</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Professional outside services</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">310,448</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">428,923</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(118,475</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Business insurance</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">626,027</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">783,781</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(157,754</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-cash stock compensation</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">43,688</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">349,245</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(305,557</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Totals</p> </td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,978,953</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,585,644</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
     <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(606,691</td>
     <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The 23% decrease in corporate related expenses for the fiscal year ended September 30, 2024 over prior year is primarily due to the decreases in non-cash stock compensation to employees and directors tied to fewer shares issued under our equity incentive plans and at lower prices per share and, decreases in legal, accounting and insurance costs.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The corporate operating expenses are primarily related to the ongoing public company related activities.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Other income and other non-operating expenses</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We also record income and expenses associated with non-operating items. The material components of those are set forth below.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Decrease in contingent liability</i></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As described in Note 6 to the notes to the consolidated financial statements appearing elsewhere in this report, the earn-out provision for the Earnout Shares is accounted for and recorded as a contingent liability with increases in the liability recorded as non-cash other expense and decreases in the liability recorded as non- cash other income. The earnout ended November 2023 and we recorded a final change in the non-cash contingent liability in the first quarter of fiscal 2024. For the twelve months ended September 30, 2023, the contingent liability decreased $0.19 million,&#160;primarily related to the change in our common stock share price between September 30, 2022 to September 30, 2023 from $10.25 per share to $1.03 per share.&#160;</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Liquidity and Capital Resources</b></p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We had cash and cash equivalents on hand of $2.4 million and working capital of negative $1.1&#160;million at September 30, 2024. Our working capital is reduced by approximately $4.7 million of accrued Series A Preferred dividend payments. On September 30, 2023 we had cash and cash equivalents on hand of $1.8 million and working capital of $3.4 million, which was reduced by approximately $0.7 million for accrued Series A Preferred dividend payments. Our current assets decreased approximately 20% at September 30, 2024 from September 30, 2023, which is primarily attributable to reduction of inventory. Our current liabilities increase approximately 55% at September 30, 2024 from September 30, 2023. This increase is primarily attributable to a $4 million increase in dividend payable, partially offset by a $1.1 reduction in the current portion of rent as a result of the elimination the lease liability associated with the HQ lease.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We entered into a securities Purchase Agreement dated January 30, 2024 with five accredited Investors whereby the Investors advanced the Company an aggregate of $1,250,000 gross proceeds and the Company issued each Investor an 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note (each a &#8220;Note&#8221; and collectively, the &#8220;Notes&#8221;), in the aggregate principal amount of $1,541,666. The Company has used the proceeds from the issuance of the Notes for working capital and general corporate purposes, including, but not limited to inventory investment to assist with orders and administrative and corporate governance costs. As of the filing date of this report, the principal balance of the Notes has been reduced to approximately $364,000&#160;and $5,000&#160;of accrued interest.</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">During the three and twelve months ended September 30, 2024 we used cash primarily to fund our operations.<br/> &#160;<br/> We do not have any commitments for capital expenditures. We have a commitment for cumulative dividends at an annual rate of 8% payable monthly in arrears for the prior month to our preferred shareholders. As of September 2023, we have stopped paying the dividends&#160;in cash monthly and are accruing this dividend instead.&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">
      22
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">While the Company is taking strong action and believes that it can execute its strategy and path to profitability within its balance sheet, and in its ability to raise additional funds, there can be no assurances to that effect. The Company&#8217;s working capital position may not be sufficient to support the Company&#8217;s daily operations for the twelve months subsequent to the issuance this report. The Company&#8217;s ability to continue as a going concern is dependent upon its ability to improve profitability and cash flow and the ability to acquire additional funding. These and other factors raise substantial doubt&#160;about the Company&#8217;s ability to continue as a going concern within twelve months after the date that our annual financial statements are issued. These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result in the Company not being able to continue as a going concern.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Our goal from a liquidity perspective is to use operating cash flows to fund day to day operations and we have not met this goal as cash flow from operations has been a net generation of $0.2 million and use of $1.0 for the three months ended September 30, 2024 and 2023, respectively and &#160;a use of $0.6 (net of $1.25 million of proceeds from the Notes) and $4.3 million for the twelve months ended September 30, 2024 and 2023, respectively.&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Non-GAAP Adjusted Operating Income </b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The non-GAAP Adjusted Income (loss) for the three and twelve months&#160;ended September 30, 2024 and September 30, 2023&#160;is as follows:</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">
   <tbody>
    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td colspan="6" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Three Months</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"><b>&#160;</b></td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td colspan="6" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year Ended</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"><b>&#160;</b></td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>September 30,</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>September 30,</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>September 30,</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>September 30,</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2024</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2024</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>(Unaudited)</b></p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
     <td>&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>GAAP (loss) from operations</b></p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>(316,553</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>)</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>(15,217,070</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>)</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>(3,315,410</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>)</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>(22,487,549</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>)</b></td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Adjustments:</p> </td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Depreciation &amp; Amortization</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;">287,783</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">667,950</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,149,836</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,800,739</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Employee and director stock compensation (1)</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5,881</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">33,263</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 27pt;">43,688</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">349,245</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory adjustment(2)</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">588,160</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">70,000</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">588,160</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">70,000</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Impairment of Goodwill and other intangible assets (3)</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">13,219,000</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">13,219,000</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Incremental bad debt</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">45,000</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">45,000</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
    </tr>

    <tr>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">Non-cash expense incurred as a credit (4)</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">- <p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">439,926</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
    </tr>

    <tr>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">Non-cash accelerated amortization of expense related to terminated IT contracts</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">72,101</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Termination of HQ lease</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(696,280</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(696,280</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr>
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Mergers and acquisitions expense</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">125,838</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td>
    </tr>

    <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">a360 non-cash trade credit</p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">609,732</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">-</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">1,476,967</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
    </tr>

    <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
     <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Non-GAAP adjusted (loss) from operations</b></p> </td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 90pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 90pt; border-bottom: 3px double rgb(0, 0, 0);"><b>(131,009</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"><b>)</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>(572,125</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"><b>)</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>(1,592,141</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"><b>)</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
     <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>(5,526,598</b></td>
     <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"><b>)</b></td>
    </tr>

   </tbody>
  </table>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family: Times New Roman; font-size: 10pt; width: 100%;">
   <tbody>
    <tr>
     <td style="vertical-align:bottom;width:66.9%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(1) Represents non-cash expense related to options, warrants, restricted stock expenses that have been amortized during the period.</p> </td>
    </tr>

    <tr>
     <td style="vertical-align:bottom;width:66.9%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(2) Represents an operating expense related to inventory loss related to regulatory changes impacting labels and packaging and obsolete/expired inventory.</p> </td>
    </tr>

    <tr>
     <td style="vertical-align:bottom;width:66.9%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(3) Represents non-cash impairment of the cbdMD, DCO and Technology Relief from Royalty&#160;trademarks of $13.21 million during the fourth quarter of fiscal 2023, non-cash impairment of the cbdMD trademark&#160;of $4.28 million during the first quarter of fiscal year 2022 and $56.67 million of goodwill impairment during the fiscal year ended 2022.</p> </td>
    </tr>

    <tr>
     <td style="vertical-align:bottom;width:66.9%;">(4)&#160;Represents non-cash expense incurred as a credit provided to GNC to replace expired product.</td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      23
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Earnout Shares</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As described in Note 6 in notes to our consolidated financial statements appearing elsewhere in this report, the Earnout Right ran through November 2023. The Earnout period has expired.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Critical accounting policies</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements and related disclosures in conformity with US GAAP and our discussion and analysis of our financial condition and operating results require our management to make judgments, assumptions and estimates that affect the amounts reported in our consolidated financial statements and accompanying notes. Note 1, &#8220;Organization and Summary of Significant Accounting Policies,&#8221; of the Notes to our consolidated financial statements appearing elsewhere in this report describes the significant accounting policies and methods used in the preparation of our consolidated financial statements. Management bases its estimates on historical experience and on various other assumptions it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates, and such differences may be material.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We believe that the following critical accounting policies involve the more significant judgments and estimates used in the preparation of our consolidated financial statements and are the most critical to aid you in fully understanding and evaluating our reported financial results. Management considers these policies critical because they are both important to the portrayal of our financial condition and operating results, and they require management to make judgments and estimates about inherently uncertain matters.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Inventory</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Inventory is stated at the lower of cost or net realizable value with cost being determined on a weighted average basis. The cost of inventory includes product cost, freight-in, and production fill and labor (portions of which we outsource to third party manufacturers). Write-offs of potentially slow moving or damaged inventory are recorded based on management&#8217;s analysis of inventory levels, forecasted future sales volume and pricing and through specific identification of obsolete or damaged products. We assess inventory quarterly for slow moving products and potential impairments and at a minimum perform a physical inventory count annually near fiscal year end.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Revenue Recognition </b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customer (&#8220;ASC 606&#8221;). The Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to arrangements that meet the definition of a contract under the standard, including when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of revenue accounting, the Company evaluates the goods or services promised within each contract related performance obligation and assesses whether each promised good or service is distinct. The Company recognizes as revenue, the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company records revenue from the sale of its products when risk of loss and title to the product are transferred to the customer, which is upon shipping (and is typically FOB shipping) which is when our performance obligation is met. Net sales are comprised of gross revenues less product returns, trade discounts and customer allowances, which include costs associated with off-invoice mark-downs and other price reductions, as well as trade promotions. These incentive costs are recognized at the later of the date on which the Company recognizes the related revenue or the date on which the Company offers the incentive. The Company currently offers a 60-day, money back guarantee.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Impairment of Long Lived Assets</b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company reviews all intangible assets for impairment whenever events or changes in circumstances indicate the carrying amount of the assets may not be recoverable. Long-lived assets, such as property and equipment and intangible assets subject to depreciation and amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable or that the useful life is shorter than the Company had originally estimated. Recoverability of these assets is measured by comparison of the carrying amount of each asset or asset group to the future undiscounted cash flows the asset or asset group is expected to generate over their remaining lives. If the asset or asset group is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset or asset group. If the useful life is shorter than originally estimated, the Company amortizes the remaining carrying value over the new shorter useful life. Impairment losses are recorded in selling, general, and administrative expense in the consolidated statements of operations. There was $0 and&#160;$13,219,000 of impairment losses recognized related to long-lived assets for the year ended September 30, 2024 and September 30, 2023, respectively.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Fair Value of Convertible Notes</b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company elected the fair value option under ASC 825 Fair Value Measurements for the Notes. The Notes were initially recognized at a fair value of $2,702,000 on the balance sheet as of March 31,2024. All subsequent changes in fair value, excluding the impact of the change in fair value related to instrument-specific credit risk are recorded in non-operating income. The changes in fair value related to instrument-specific credit risk is recorded through other comprehensive income (loss).&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The overall change in fair value of the Notes during the year&#160;ended September 30, 2024 was a decrease of $1,357,096. The overall change in principal value related to the conversion of Notes to commons stock during the year&#160;ended September 30,2024 was a decrease of $508,757. As of September 30, 2024, total fair value of the Notes is $1,021,935, of which $1,032,909 represents the total principal outstanding.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      24
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Recent accounting pronouncements</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Please see Note 1 &#8211; Organization and Summary of Significant Accounting Policies appearing in the consolidated financial statements included in this report for information on accounting pronouncements.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Off balance sheet arrangements</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of the date of this report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. The term "off-balance sheet arrangement" generally means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with us is a party, under which we have any obligation arising under a guarantee contract, derivative instrument or variable interest or a retained or contingent interest in assets transferred to such entity or similar arrangement that serves as credit, liquidity or market risk support for such assets.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="qqd" title="qqd" href="#"></a>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">Not applicable for a smaller reporting company.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="fs" title="fs" href="#"></a>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">Please see our Financial Statements beginning on page 32&#160;of this annual report.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">The Auditor Firm ID for our external auditors, Cherry Bekaert LLP, is <ix:nonNumeric name="dei:AuditorFirmId" contextRef="d_2023-10-01_2024-09-30" id="ixv-16222">677</ix:nonNumeric>.</p>
  <div>
   &#160;
  </div>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="changes" title="changes" href="#"></a>ITEM 9.</b> <b>CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">None.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="controls" title="controls" href="#"></a>ITEM 9A. CONTROLS AND PROCEDURES. </b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;"><i>Evaluation of Disclosure Controls and Procedures. </i></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed pursuant to the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Commission&#8217;s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal accounting officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As required by Exchange Act Rule 13a-15(e), we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and our principal accounting officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on that evaluation, our principal executive officer and principal accounting officer concluded that our disclosure controls were effective at September 30, 2024.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;"><i>Management</i>&#8217;<i>s Report on Internal Control over Financial Reporting. </i></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">
   <tbody>
    <tr style="vertical-align: top;">
     <td style="width: 36pt;">&#160;</td>
     <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;</p> </td>
    </tr>

    <tr style="vertical-align: top;">
     <td style="width: 36pt;">&#160;</td>
     <td style="width: 36pt;">&#160;</td>
     <td style="width: auto;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</p> </td>
    </tr>

    <tr style="vertical-align: top;">
     <td style="width: 36pt;">&#160;</td>
     <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and</p> </td>
    </tr>

    <tr style="vertical-align: top;">
     <td style="width: 36pt;">&#160;</td>
     <td style="width: 36pt;">&#160;</td>
     <td style="width: auto;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</p> </td>
    </tr>

    <tr style="vertical-align: top;">
     <td style="width: 36pt;">&#160;</td>
     <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p> </td>
     <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      25
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Because of the inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">&#160;</p>
  <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our management, including our principal executive officer and principal accounting officer assessed the effectiveness of our internal control over financial reporting as of September 30, 2024. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the 2013 Treadway Commission (&#8220;COSO&#8221;) in Internal Control-Integrated Framework. Based on that evaluation, they concluded that, during the period covered by this report, such internal controls and procedures were effective.</p>
  <p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</p>
  <p style="margin: 0pt 0pt 0pt 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>Changes in Internal Control over Financial Reporting</i></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">There have been no changes in our internal control over financial reporting during our last fiscal year that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, but for the additional review procedures renumerated above.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div>
   &#160;
  </div>
  <div>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>&#160;<a id="otherinfo9b" title="otherinfo9b" href="#"></a>ITEM <em style="font: inherit;">9B.</em> OTHER INFORMATION.</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;"><span style="-sec-ix-hidden:c121825173"><span style="-sec-ix-hidden:c121825647"><span style="-sec-ix-hidden:c121825648"><span style="-sec-ix-hidden:c121825649">None.</span></span></span></span></p>
  </div>
  <div>
   &#160;
  </div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><a id="disclosureregarind" title="disclosureregarind" href="#"></a>ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">None.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      26
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="part3" title="part3" href="#"></a>PART III</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="directors" title="directors" href="#"></a>ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">The information required by this Item will be contained in our proxy statement for our 2024 Annual Meeting of shareholders to be filed on or prior to January 28, 2025&#160;(the &#8220;Proxy Statement&#8221;) and is incorporated herein by this reference.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="execcomp" title="execcomp" href="#"></a>ITEM 11. EXECUTIVE COMPENSATION.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">The information required by this item will be contained in our Proxy Statement and is incorporated herein by this reference.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="securityown" title="securityown" href="#"></a>ITEM 12.</b> <b>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">The information required by this item will be contained in our Proxy Statement and is incorporated herein by this reference.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="certainrelations" title="certainrelations" href="#"></a>ITEM 13.</b> <b>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">The information required by this item will be contained in our Proxy Statement and is incorporated herein by this reference.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="principal" title="principal" href="#"></a>ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">The information required by this item will be contained in our Proxy Statement and is incorporated herein by this reference.</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      27
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="part4" title="part4" href="#"></a>PART IV</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="exhibits" title="exhibits" href="#"></a>ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:top;width:2.1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(a)</p> </td>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1) Financial statements.</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">The consolidated financial statements and Report of Independent Registered Accounting Firm begin&#160;on page 32.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">(2) Financial statement schedules</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">All schedules for which provision is made in the applicable accounting regulations of the SEC are either not required under the related instructions, are not applicable (and therefore have been omitted), or the required disclosures are contained in the consolidated financial statements herein.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">(3) Exhibits.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">The exhibits that are required to be filed or incorporated by reference herein are listed in the Exhibit Index.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><a id="summary" title="summary" href="#"></a>ITEM 16. FORM 10-K SUMMARY.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">None</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      28
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>EXHIBIT INDEX</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align: middle; width: 7%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 69%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td colspan="5" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Incorporated by</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Reference</b></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Filed or</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Furnished</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Herewith</b></p> </td>
    </tr>

    <tr>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>No.</b></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Exhibit Description</b></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Form</b></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Date Filed</b></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number</b></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: middle; width: 7%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 69%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923012366/ex_511758.htm" style="-sec-extract:exhibit;">1.1</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923012366/ex_511758.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Underwriting Agreement, dated as of April 30, 2023, between cbdMD, Inc. and Maxim Group LLC</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">5/3/23</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495418013530/levb_ex2-1.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">2.1</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495418013530/levb_ex2-1.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Merger Agreement dated December 3, 2018 by and among Level Brands, Inc., AcqCo, LLC, cbdMD LLC and Cure Based Development, LLC</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">12/4/18</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419001576/level_ex2-1.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">2.2</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419001576/level_ex2-1.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Articles of Merger dated December 20, 2018 as filed with the Secretary of State of Nevada merging AcqCo, LLC with and into Cure Based Development, LLC</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10-Q</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2/14/19</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.2</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419001576/level_ex2-2.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">2.3</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419001576/level_ex2-2.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Articles of Merger dated December 20, 2018 as filed with the Secretary of State of North Carolina merging AcqCo, LLC with and into Cure Based Development, LLC</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10-Q</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2/14/19</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.3</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419001576/level_ex2-3.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">2.4</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419001576/level_ex2-3.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Articles of Merger dated December 20, 2018 as filed with the Secretary of State of Nevada merging Cure Based Development, LLC with an into cbdMD LLC</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10-Q</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2/14/19</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.4</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419001576/level_ex2-4.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">2.5</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419001576/level_ex2-4.htm" style="-sec-extract:exhibit;">Articles of Merger dated December 20, 2018 as filed&#160;with the Secretary of State of North Carolina merging Cure Based Development, LLC with an into cbdMD LLC</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10-Q</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2/14/19</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.5</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex21.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">3.1</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex21.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Articles of Incorporation</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9/18/17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex22.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">3.2</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex22.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Articles of Amendment to the Articles of Incorporation filed April 22, 2015</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9/18/17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.2</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex23.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">3.3</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex23.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Articles of Amendment to the Articles of Incorporation filed June 22, 2015</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9/18/17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.3</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex24.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">3.4</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex24.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Articles of Amendment to the Articles of Incorporation filed November 17, 2016</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9/18/17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.4</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex25.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">3.5</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex25.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Articles of Amendment to the Articles of Incorporation filed December 5, 2016</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9/18/17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.5</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex26.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">3.6</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex26.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Bylaws, as amended</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9/18/17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.6</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419004936/levb_ex37.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">3.7</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419004936/levb_ex37.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Articles of Amendment to Articles of Incorporation dated April 22, 2019</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4/29/19</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3.7</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419011679/ycbd_31f.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">3.8</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419011679/ycbd_31f.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Articles of Amendment to the Articles of Incorporation including the Certificate of Designations, Rights and Preferences of the 8% Series A Cumulative Convertible Preferred Stock filed October 11, 2019</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10/11/19</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3.1(f)</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex37.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">4.1</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex37.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Form of common stock certificate of the registrant</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9/18/17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3.7</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex38.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">4.2</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex38.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">2015 Equity Compensation Plan+</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9/18/17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3.8</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex39.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">4.3</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex39.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Form of stock option award under 2015 Equity Compensation Plan+ </span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9/18/17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3.9</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421000468/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">4.4</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421000468/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">2021 Equity Compensation Plan+</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1/14/21</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419005886/levb_ex4-1.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">4.5</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419005886/levb_ex4-1.htm" style="-sec-extract:exhibit;">Form of Representative&#8217;s Warrant dated May 15, 2019</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">5/14/19</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419011803/ycbd_ex41.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">4.6</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419011803/ycbd_ex41.htm" style="-sec-extract:exhibit;">Form of Representative&#8217;s Warrant dated October 16, 2019</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10/16/19</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495420000297/ycbd_ex41.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">4.7</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495420000297/ycbd_ex41.htm" style="-sec-extract:exhibit;">Form of Representative&#8217;s Warrant dated January 9, 2020</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1/10/20</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495420013331/ycbd_ex41.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">4.8</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495420013331/ycbd_ex41.htm" style="-sec-extract:exhibit;">Form of Representative&#8217;s Warrant dated December 11, 2020</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">12/9/20</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421007411/ycbd_ex41.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">4.9</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421007411/ycbd_ex41.htm" style="-sec-extract:exhibit;">Form of Representative&#8217;s Warrant dated June 28, 2021</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">6/30/21</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923012366/ex_511759.htm" style="-sec-extract:exhibit;">4.10</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923012366/ex_511759.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Form of Representative&#8217;s Warrant dated May 3, 2023</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">5/3/23</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001644903/000143774923012366/ycbd20230501_8k.htm" style="-sec-extract:exhibit;">4.11</a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001644903/000143774923012366/ycbd20230501_8k.htm" style="-sec-extract:exhibit;">Form of Senior Secured Convertible Promissory Note dated January 30, 2024</a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">8-K</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">2/2/24</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">4.1</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex621.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">10.1</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex621.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Form of Indemnification Agreement</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9/18/17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">6.21</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419009562/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">10.2</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495419009562/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Office Lease dated July 11, 2019</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10-Q</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8/14/19</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495420001499/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">10.3</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495420001499/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Westinghouse Boulevard Lease dated August 27, 2019</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10-Q</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2/13/20</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421004490/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">10.4</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421004490/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Amended and Restated Executive Employment Agreement dated April 19, 2021 by and between cbdMD, Inc. and Martin A. Sumichrast+</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4/21/21</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421004490/ycbd_ex102.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">10.5</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421004490/ycbd_ex102.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Amended and Restated Executive Employment Agreement dated April 19, 2021 by and between CBD Industries LLC and R. Scott Coffman+</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4/21/21</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.2</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421008238/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">10.6</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421008238/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Asset Purchase Agreement by and among Twenty Two Capital, LLC, cbdMD, Inc., John J. Wiesehan III, Vieo Design, LLC and Bradley D. Trawick dated June 22, 2021</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">7/27/21</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

   </tbody>
  </table>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      29
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421010818/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">10.7</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421010818/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Executive Employment Agreement dated October 1, 2021 between cbdMD, Inc. and T. Ronan Kennedy+</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10/5/21</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495422000535/ycbd_ex101.htm" style="-sec-extract:exhibit;">10.8</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495422000535/ycbd_ex101.htm" style="-sec-extract:exhibit;">Amendment 1 to the Amended and Restated Executive Employment Agreement by and between cbd Industries, LLC and R. Scott Coffman Restated Agreement effective January 11, 2022+</a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1/18/22</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495422006755/ycbd_ex1021.htm" style="-sec-extract:exhibit;">10.9</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495422006755/ycbd_ex1021.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Equipment Purchase Agreement effective April 7, 2022 by and between cbd Industries, LLC and Old Belts Extracts LLC</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10-Q</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">5/13/22</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.21</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495422008274/ycbd_ex101.htm" style="-sec-extract:exhibit;">10.10</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495422008274/ycbd_ex101.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Separation Agreement by and between Martin A. Sumichrast and cbdMD, Inc., and its subsidiaries effective June 11, 2022+</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">6/13/22</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774922020140/ex_410604.htm" style="-sec-extract:exhibit;">10.11</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774922020140/ex_410604.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Membership Interest Transfer Agreement dated June 22, 2022</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10-Q</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8/11/22</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.22</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923006378/ex_485900.htm" style="-sec-extract:exhibit;">10.12</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923006378/ex_485900.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Agreement for Advertising Placement dated February 1, 2023</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">S-1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3/13/23</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923006378/ex_487228.htm" style="-sec-extract:exhibit;">10.13</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923006378/ex_487228.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Side Letter &#8211;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">Keystone Capital Partners, LLC</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">S-1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3/13/23</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.20</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923005246/ex_482976.htm" style="-sec-extract:exhibit;">10.14</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923005246/ex_482976.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Common Stock Purchase Agreement dated March 2, 2023 by and among cbdMD, Inc. and Keystone Capital Partners, LLC</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">8-K</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3/2/23</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923005246/ex_482977.htm" style="-sec-extract:exhibit;">10.15</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923005246/ex_482977.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Registration Rights Agreement dated March 2, 2023 by and among cbdMD, Inc. and Keystone Capital Partners, LLC</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">8-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3/2/23</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.2</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774924002975/ex_621910.htm" style="-sec-extract:exhibit;">10.16</a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774924002975/ex_621910.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Securities Purchase Agreement, dated as of January 30, 2024, by and between cbdMD, Inc. and the Investors*</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">8-K</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">2/2/24</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">10.1</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774924002975/ex_621912.htm" style="-sec-extract:exhibit;">10.17</a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774924002975/ex_621912.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Security Agreement, dated as of January 30, 2024, by and between cbdMD, Inc. and the Investors*</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">8-K</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">2/2/24</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">10.2</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774924002975/ex_621913.htm" style="-sec-extract:exhibit;">10.18</a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774924002975/ex_621913.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Registration Rights Agreement, dated January 30, 2024, by and between cbdMD, Inc. and the Investors</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">8-K</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">2/2/24</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">10.3</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774924008153/ex_640353.htm" style="-sec-extract:exhibit;">10.19</a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774924008153/ex_640353.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">License Agreement, effective as of March 20, 2024, by and between cbdMD, Inc. and HSKL, Inc.</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">8-K</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">3/18/24</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">10.1</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774924008153/ex_640354.htm" style="-sec-extract:exhibit;">10.20</a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774924008153/ex_640354.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Lease Forbearance Agreement, dated as of March 14, 2024, by and between cbdMD, Inc. and HSKL, Inc.</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">8-K</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">3/18/24</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">10.2</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1644903/000143774924036298/ycbd20241126_8k.htm" style="-sec-extract:exhibit;">10.21</a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1644903/000143774924036298/ycbd20241126_8k.htm" style="-sec-extract:exhibit;">Amendment to Extend Westinghouse Boulevard Lease dated November 26, 2024</a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">8-K</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">11/26/24</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: top; width: 5%; text-align: center;">10.1</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex151.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">14.1</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495417008542/level_ex151.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Code of Business Conduct and Ethics</span></a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1-A</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9/18/17</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">15.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923035228/ex_601519.htm" style="-sec-extract:exhibit;">19.1</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000143774923035228/ex_601519.htm" style="-sec-extract:exhibit;">Insider Trading Policy</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%; text-align: center;">10-K</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: middle; width: 5%; text-align: center;">12/22/23</td>
     <td style="vertical-align: middle; width: 1%; text-align: center;">&#160;</td>
     <td style="vertical-align: middle; width: 5%; text-align: center;">19.1</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421013292/ycbd_ex211.htm" style="-sec-extract:exhibit;">21.1</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"><a href="http://www.sec.gov/Archives/edgar/data/1644903/000165495421013292/ycbd_ex211.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline; ">Subsidiaries of the Registrant</span></a></td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">10-K</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">12/17/21</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">21.1</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_722096.htm" style="-sec-extract:exhibit;">23.1</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_722096.htm" style="-sec-extract:exhibit;">Consent of Cherry Bekaert LLP</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Filed</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#poa" style="-sec-extract:exhibit;">24.1</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="#poa" style="-sec-extract:exhibit;">Power of attorney (included on signature page of this report)</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Filed</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_722097.htm" style="-sec-extract:exhibit;">31.1</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_722097.htm" style="-sec-extract:exhibit;">Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Filed</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_722098.htm" style="-sec-extract:exhibit;">31.2</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_722098.htm" style="-sec-extract:exhibit;">Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Filed</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_722099.htm" style="-sec-extract:exhibit;">32.1</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_722099.htm" style="-sec-extract:exhibit;">Section 1350 Certification of Chief Executive Officer and Chief Financial Officer</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Filed</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1644903/000143774923035228/ycbd20230930_10k.htm" style="-sec-extract:exhibit;">97.1</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1644903/000143774923035228/ycbd20230930_10k.htm" style="-sec-extract:exhibit;">Clawback Policy</a></p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%; text-align: center;">10-K</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%; text-align: center;">12/22/23</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%; text-align: center;">97.1</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">101 INS</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inline XBRL Instance Document</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Filed</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">101 SCH</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inline XBRL Taxonomy Extension Schema</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Filed</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">101 CAL</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inline XBRL Taxonomy Extension Calculation Linkbase</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Filed</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">101 LAB</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inline XBRL Taxonomy Extension Label Linkbase</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Filed</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">101 PRE</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inline XBRL Taxonomy Extension Presentation Linkbase</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: middle; width: 5%;">&#160;</td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 4%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Filed</p> </td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">101 DEF</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inline XBRL Taxonomy Extension Definition Linkbase</p> </td>
     <td colspan="8" style="vertical-align: middle; width: 19%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align: top; width: 7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">104</p> </td>
     <td style="vertical-align: middle; width: 1%;">&#160;</td>
     <td style="vertical-align: top; width: 69%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)</p> </td>
     <td colspan="8" style="vertical-align: middle; width: 19%;">&#160;</td>
    </tr>

   </tbody>
  </table>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
   <tbody>
    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 9pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">+</td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="margin: 0pt; text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Indicates management contract or compensatory plan.</p> </td>
    </tr>

    <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
     <td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
     <td style="width: 9pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="margin: 0pt; text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">*</p> </td>
     <td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="margin: 0pt; text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Certain exhibits and schedules have been omitted in accordance with Item 601(a)(5) of Regulation S-K. The registrant agrees to furnish supplementally a copy of any omitted exhibit or schedule to the Commission upon its request.</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      30
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="signatures" title="signatures" href="#"></a>SIGNATURES</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: December 18, 2024</p> </td>
     <td colspan="3" style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">cbdMD, Inc.</p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:26.8%;">&#160;</td>
     <td style="vertical-align:middle;width:1.6%;">&#160;</td>
     <td style="vertical-align:middle;width:18.8%;">&#160;</td>
     <td style="vertical-align:middle;width:6.4%;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p> </td>
     <td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">/s/ T. Ronan Kennedy</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:bottom;width:auto;">T. Ronan Kennedy</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Executive Officer&#160;(Principal Executive Officer)</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td colspan="3" style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td colspan="3" style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: December 18, 2024</p> </td>
     <td colspan="3" style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">cbdMD, Inc.</p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p> </td>
     <td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ T. Ronan Kennedy</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:bottom;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">T. Ronan Kennedy</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer (Principal Financial Officer)</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">Date: December 18, 2024</td>
     <td colspan="2" rowspan="1" style="vertical-align:middle;width:auto;">cbdMD, Inc.</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">By:</td>
     <td style="vertical-align: top; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">/s/ Brad Whitford</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;">Brad Whitford</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;">Chief Accounting Officer</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="poa" title="poa" href="#"></a>POWER OF ATTORNEY</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">KNOW ALL BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Ronan Kennedy his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments and supplements to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="border-bottom:solid 1px #000000;vertical-align:top;width:18.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Name</b></p> </td>
     <td style="vertical-align:middle;width:2.7%;">&#160;</td>
     <td style="border-bottom:solid 1px #000000;vertical-align:top;width:18.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Positions</b></p> </td>
     <td style="vertical-align:middle;width:2.7%;">&#160;</td>
     <td style="border-bottom:solid 1px #000000;vertical-align:top;width:10.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Date</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align: middle; width: auto; text-align: center;">&#160;</td>
    </tr>

    <tr>
     <td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Scott Stephen</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chairman of the Board of Directors</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align: top; width: auto; text-align: center;">December 18, 2024</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">Scott Stephen</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align: middle; width: auto; text-align: center;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align: middle; width: auto; text-align: center;">&#160;</td>
    </tr>

    <tr>
     <td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Bakari Sellers</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align: top; width: auto; text-align: center;">December 18, 2024</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Bakari Sellers</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align: middle; width: auto; text-align: center;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align: middle; width: auto; text-align: center;">&#160;</td>
    </tr>

    <tr>
     <td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ William Raines III</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align: top; width: auto; text-align: center;">December 18, 2024</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">William Raines III</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align: middle; width: auto; text-align: center;">&#160;</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align: top; width: auto; text-align: center;">&#160;</td>
    </tr>

    <tr>
     <td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Sibyl Swift</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align: middle; width: auto; text-align: center;">December 18, 2024</td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sibyl Swift, PhD</p> </td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
     <td style="vertical-align:middle;width:auto;">&#160;</td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      31
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <div>
   &#160;
  </div>
  <div><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">To the Shareholders</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">cbdMD, Inc. and subsidiaries</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">Charlotte, North Carolina</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>Opinion on the Financial Statements</b></p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">We have audited the accompanying balance sheets of cbdMD, Inc. and subsidiaries (the Company) as of September 20, 2024 and 2023, and the related statements of operations, comprehensive loss, stockholders&#8217; (deficit) equity, and cash flows for each of the years in the two-year period ended September 30, 2024, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of September 30, 2024 and 2023, and the results of its operations and its cash flows for each of the years in the two-year period ended September 30, 2024, in conformity with accounting principles generally accepted in the United States of America.</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>Substantial Doubt about the Company</b>&#8217;<b>s Ability to Continue as a Going Concern</b></p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the accompanying financial statements, the Company has historically incurred losses, including a net loss of approximately $3.7 million in the current year, resulting in an accumulated deficit of approximately $182 million as of September 30, 2024. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s evaluations of the events and conditions and management&#8217;s plans regarding those matters are also described in Note 1 to the accompanying financial statements. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>Basis for Opinion</b></p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provide a reasonable basis for our opinion</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">.</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>Critical Audit Matters</b></p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that were communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">As disclosed in Note 12 to the financial statements, the Company has entered into convertible note agreements in which management evaluated required accounting considerations including, significant estimates, and judgements around certain assumptions associated with the convertible notes. The transactions were deemed complex by management as they required valuation of the convertible notes and conversion feature in the debt instrument. These notes were initially measured at fair value and have been subsequently remeasured to fair value each reporting period.&#160;</p>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><i>How the Critical Audit Matter Was Addressed in the Audit</i></p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: justify;">Our audit procedures with respect to management&#8217;s assessment of certain fair value measurements included the following, among others:</p>
<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;"><tbody><tr><td style="width: 40pt; text-align: justify;">&#160;</td><td style="vertical-align:top;width:18pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p> </td><td style="vertical-align:top;">We obtained a listing of all convertible notes elected to be carried at fair value and management&#8217;s accounting analysis supporting these transactions. We evaluated the conclusions reached to ensure these were recorded in accordance with the relevant accounting guidance.</td></tr>
</tbody></table>
<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;"><tbody><tr><td style="width: 40pt; text-align: justify;">&#160;</td><td style="vertical-align:top;width:18pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p> </td><td style="vertical-align:top;">We identified and evaluated the considerations related to the determination of the fair value of the convertible notes and the conversion features that included valuation models and assumptions utilized by management. We reviewed the fair value models used, significant assumptions, and underlying data used in the models and evaluated whether the estimates and assumptions were consistent with audit evidence obtained.</td></tr>
</tbody></table>
<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;"><tbody><tr><td style="width: 40pt; text-align: justify;">&#160;</td><td style="vertical-align:top;width:18pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p> </td><td style="vertical-align:top;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We evaluated the disclosures surrounding fair value measurements to ensure they are disclosed in accordance with relevant accounting guidance.</p> </td></tr>
</tbody></table>
<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td colspan="2" style="vertical-align:top;width:auto;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">/s/ <i><ix:nonNumeric name="dei:AuditorName" contextRef="d_2023-10-01_2024-09-30" id="ixv-16223">Cherry Bekaert LLP</ix:nonNumeric></i></p> </td></tr>
<tr><td style="vertical-align: middle; width: 18.8%; text-align: justify;">&#160;</td><td style="vertical-align: middle; width: auto; text-align: justify;">&#160;</td></tr>
<tr><td colspan="2" style="vertical-align:top;width:auto;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have served as the Company&#8217;s auditor since 2016.</p> </td></tr>
<tr><td style="vertical-align: middle; width: auto; text-align: justify;">&#160;</td><td style="vertical-align: middle; width: auto; text-align: justify;">&#160;</td></tr>
<tr><td colspan="2" style="vertical-align:top;width:auto;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><ix:nonNumeric name="dei:AuditorLocation" contextRef="d_2023-10-01_2024-09-30" id="ixv-16224">Charlotte, North Carolina</ix:nonNumeric></p> </td></tr>
<tr><td style="vertical-align: top; width: auto; text-align: justify;">December 18, 2024</td><td style="vertical-align: middle; width: auto; text-align: justify;">&#160;</td></tr>
</tbody></table>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
 <div class="PGFTR" style="text-align: center; width: 100%">
  <div class="hf-row">
   <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
    32
   </div>
  </div>
 </div>
 <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
 <div class="PGHDR" style="text-align: left; width: 100%">
  <div class="hf-row">
   <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
    <a style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;" href="#toc">Table of Contents</a>
   </div>
  </div>
 </div>
</div>
<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p></div>
  <div>
   &#160;
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PART 1 </b>&#8211;<b> FINANCIAL INFORMATION</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS.</b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>cbdMD, INC.</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSOLIDATED BALANCE SHEETS</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-transform:uppercase;">September 30, 2024 and 2023</span></b></p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div>
   <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Assets</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Current assets:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash and cash equivalents</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824026" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,452,553</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824027" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,797,860</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts receivable</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824028" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:AccountsReceivableGrossCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">983,910</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824029" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:AccountsReceivableGrossCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,216,090</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824030" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:InventoryGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,365,187</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824031" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:InventoryGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,052,972</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory prepaid</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824032" contextRef="i_2024-09-30" unitRef="USD" name="ycbd:PrepaidInventory" scale="0" format="ixt:num-dot-decimal" decimals="INF">159,006</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824033" contextRef="i_2023-09-30" unitRef="USD" name="ycbd:PrepaidInventory" scale="0" format="ixt:num-dot-decimal" decimals="INF">182,675</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid sponsorship</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824034" contextRef="i_2024-09-30" unitRef="USD" name="ycbd:PrepaidSponsorship" scale="0" format="ixt:num-dot-decimal" decimals="INF">21,754</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824035" contextRef="i_2023-09-30" unitRef="USD" name="ycbd:PrepaidSponsorship" scale="0" format="ixt:num-dot-decimal" decimals="INF">70,061</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid expenses and other current assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824036" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">406,674</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824037" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">750,383</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total current assets</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824038" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:AssetsCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">6,389,084</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824039" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:AssetsCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">8,070,041</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Other assets:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Property and equipment, net</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824040" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">454,268</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824041" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">716,579</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating lease assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824042" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" format="ixt:num-dot-decimal" decimals="INF">85,817</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824043" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,350,865</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deposits for facilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824044" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DepositsAssetsNoncurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">62,708</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824045" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DepositsAssetsNoncurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">138,708</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Intangible assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824046" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,889,580</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824047" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,219,090</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px;"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Investment in other securities, noncurrent</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824048" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:OtherLongTermInvestments" scale="0" format="ixt:num-dot-decimal" decimals="INF">700,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824049" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:OtherLongTermInvestments" scale="0" format="ixt:num-dot-decimal" decimals="INF">700,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total other assets</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824050" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:OtherAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,192,373</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824051" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:OtherAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF">8,125,242</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total assets</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction id="c121824052" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:Assets" scale="0" format="ixt:num-dot-decimal" decimals="INF">10,581,457</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction id="c121824053" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:Assets" scale="0" format="ixt:num-dot-decimal" decimals="INF">16,195,283</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td></tr>
</tbody></table>
  </div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:55.2%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">See Notes to Consolidated Financial Statements</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      33
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:57.3%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSOLIDATED BALANCE SHEETS</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align: middle; width: 57.3%; text-align: center;"><span style="text-transform:uppercase;"><b>September 30, 2024 and 2023</b></span></td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:57.3%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(continued)</b></p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div>
   <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Liabilities and shareholders' equity</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Current liabilities:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts payable</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824061" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:AccountsPayableCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,541,108</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824062" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:AccountsPayableCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,906,319</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accrued expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824063" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">632,674</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824064" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">632,195</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Accrued dividends</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824065" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DividendsPayableCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,671,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824066" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DividendsPayableCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">667,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Deferred Revenue</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824067" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">503,254</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824068" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">185,246</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating leases &#8211; current portion</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824069" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">98,696</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824070" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,277,089</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;">Convertible notes, at fair value</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824071" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:ConvertibleDebtCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,171,308</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824072" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:ConvertibleDebtCurrent" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824073" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:NotesPayableCurrent" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824074" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:NotesPayableCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,492</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total current liabilities</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction id="c121824075" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:LiabilitiesCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">8,618,040</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction id="c121824076" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:LiabilitiesCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,670,341</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Long term liabilities:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Long term liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><span style="-sec-ix-hidden:c121824077"> </span><p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">-</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824078" contextRef="i_2023-09-30" unitRef="USD" name="ycbd:LongtermDebtExcludingConvertibleNotesNoncurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">9</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating leases - long term portion</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824079" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824080" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,403,286</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Contingent liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824081" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824082" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">90,363</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total long term liabilities</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824083" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:LiabilitiesNoncurrent" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction id="c121824084" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:LiabilitiesNoncurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,493,658</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total liabilities</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction id="c121824085" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:Liabilities" scale="0" format="ixt:num-dot-decimal" decimals="INF">8,618,040</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction id="c121824086" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:Liabilities" scale="0" format="ixt:num-dot-decimal" decimals="INF">7,163,999</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Commitments and Contingencies (Note 11)</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;<span style="-sec-ix-hidden:c121827158">&#160;</span></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;<span style="-sec-ix-hidden:c121827159">&#160;</span></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td><td style="padding: 0; margin: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">cbdMD, Inc. shareholders' equity:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred stock, authorized <span style="-sec-ix-hidden:c121825623"><span style="-sec-ix-hidden:c121825624">50,000,000</span></span> shares, $<span style="-sec-ix-hidden:c121825625"><span style="-sec-ix-hidden:c121825626">0.001</span></span> par value, <span style="-sec-ix-hidden:c121825627"><span style="-sec-ix-hidden:c121825629">5,000,000</span></span> and <span style="-sec-ix-hidden:c121825628"><span style="-sec-ix-hidden:c121825630">5,000,000</span></span> shares issued and outstanding, respectively</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824087" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:PreferredStockValue" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824088" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:PreferredStockValue" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Common stock, authorized <span style="-sec-ix-hidden:c121825631"><span style="-sec-ix-hidden:c121825632">150,000,000</span></span> shares, $<span style="-sec-ix-hidden:c121825633"><span style="-sec-ix-hidden:c121825634">0.001</span></span> par value, <span style="-sec-ix-hidden:c121825635"><span style="-sec-ix-hidden:c121825637">3,939,057</span></span> and <span style="-sec-ix-hidden:c121825636"><span style="-sec-ix-hidden:c121825638">2,960,573</span></span> shares issued and outstanding, respectively</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824089" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:CommonStockValue" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,939</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824090" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:CommonStockValue" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,961</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Additional paid in capital</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824091" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:AdditionalPaidInCapital" scale="0" format="ixt:num-dot-decimal" decimals="INF">184,029,565</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824092" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:AdditionalPaidInCapital" scale="0" format="ixt:num-dot-decimal" decimals="INF">183,387,095</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;">Comprehensive other expense</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121824093" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">7,189</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824094" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accumulated deficit</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824095" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">182,067,898</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824096" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">174,363,772</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total cbdMD, Inc. shareholders' equity</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction id="c121824097" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,963,417</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction id="c121824098" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">9,031,284</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total liabilities and shareholders' equity</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction id="c121824099" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">10,581,457</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction id="c121824100" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">16,195,283</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td></tr>
</tbody></table>
  </div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:57.3%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">See Notes to Consolidated Financial Statements</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      34
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <div>
   &#160;
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:bottom;width:42.9%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>cbdMD, INC.</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:42.9%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSOLIDATED STATEMENTS OF OPERATIONS</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:42.9%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><span style="text-transform:uppercase;"><b>September 30, 2024 and 2023</b></span></p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div>
   <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Gross Sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824108" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="0" format="ixt:num-dot-decimal" decimals="INF">19,922,319</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824109" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="0" format="ixt:num-dot-decimal" decimals="INF">25,053,857</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Allowances</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824110" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:SalesAllowances" scale="0" format="ixt:num-dot-decimal" decimals="INF">440,152</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824111" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="ycbd:SalesAllowances" scale="0" format="ixt:num-dot-decimal" decimals="INF">898,495</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total Net Sales</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction id="c121824112" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:Revenues" scale="0" format="ixt:num-dot-decimal" decimals="INF">19,482,167</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction id="c121824113" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:Revenues" scale="0" format="ixt:num-dot-decimal" decimals="INF">24,155,362</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cost of sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824114" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:CostOfRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">7,486,626</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824115" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:CostOfRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">9,177,703</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Gross Profit</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction id="c121824116" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:GrossProfit" scale="0" format="ixt:num-dot-decimal" decimals="INF">11,995,541</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b><ix:nonFraction id="c121824117" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:GrossProfit" scale="0" format="ixt:num-dot-decimal" decimals="INF">14,977,659</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824118" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:OperatingExpensesExcludingImpairment" scale="0" format="ixt:num-dot-decimal" decimals="INF">15,310,951</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824119" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="ycbd:OperatingExpensesExcludingImpairment" scale="0" format="ixt:num-dot-decimal" decimals="INF">24,246,208</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px;"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Impairment of goodwill and other intangible assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824120" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-top: 0px; padding-right: 0px; padding-left: 0px; margin: 0px; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824121" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" format="ixt:num-dot-decimal" decimals="INF">13,219,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0px 0px 1px; margin: 0px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Loss from operations</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121824122" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:OperatingIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">3,315,410</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121824123" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:OperatingIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">22,487,549</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Realized and unrealized loss on marketable and other securities, including impairments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824124" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121824125" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">700,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Decrease of contingent liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824126" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">74,580</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824127" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">185,638</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Increase in fair value of convertible debt</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">(<ix:nonFraction id="c121824128" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:FairValueAdjustmentOfDebt" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">429,789</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824129" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="ycbd:FairValueAdjustmentOfDebt" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Interest (expense) income</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824130" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:InterestIncomeExpenseNet" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">29,507</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824131" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:InterestIncomeExpenseNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">63,702</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Loss before provision for income taxes</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction id="c121824132" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">3,700,126</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>)</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>(<ix:nonFraction id="c121824133" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">22,938,209</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>)</b></td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Benefit (expense) for income taxes</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824134" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824135" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Net Loss</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824136" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">3,700,126</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824137" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">22,938,209</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividends</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction id="c121824138" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,004,001</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction id="c121824139" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,002,000</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Net Loss attributable to common shareholders</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction id="c121824140" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">7,704,127</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction id="c121824141" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">26,940,209</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Net Loss per share:</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Basic and Diluted loss per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824142" contextRef="d_2023-10-01_2024-09-30" unitRef="USDPerShare" name="us-gaap:EarningsPerShareBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1.79</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824143" contextRef="d_2022-10-01_2023-09-30" unitRef="USDPerShare" name="us-gaap:EarningsPerShareBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">13.32</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average number of shares Basic and Diluted:</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824144" contextRef="d_2023-10-01_2024-09-30" unitRef="Share" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,312,546</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824145" contextRef="d_2022-10-01_2023-09-30" unitRef="Share" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,022,320</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
</tbody></table>
  </div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:42.9%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">See Notes to Consolidated Financial Statements</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      35
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <div>
   &#160;
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:34.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>cbdMD, INC.</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:34.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:34.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FOR THE YEARS ENDED <span style="text-transform:uppercase;">September 30, 2024 and 2023</span></b></p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div>
   <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net Loss</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824149" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">3,700,126</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824150" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">22,938,209</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Comprehensive Loss</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824151" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">3,700,126</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824152" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="ycbd:ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">22,938,209</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividends</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824153" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,004,001</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824154" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,002,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Comprehensive Loss available to common shareholders</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction id="c121824155" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">7,704,127</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><b>(<ix:nonFraction id="c121824156" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">26,940,209</ix:nonFraction></b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td></tr>
</tbody></table>
  </div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:34.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">See Notes to Consolidated Financial Statements</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      36
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <div>
   &#160;
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:47.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>cbdMD, INC.</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:47.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSOLIDATED STATEMENT OF CASH FLOWS</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:47.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FOR THE YEARS ENDED <span style="text-transform:uppercase;">September 30, 2024 and 2023</span></b></p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div>
   <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Cash flows from operating activities:</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net Loss</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824159" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">3,700,126</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824160" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">22,938,209</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Adjustments to reconcile net loss to net cash used by operating activities:</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Stock based compensation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824161" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:StockOptionPlanExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,015</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824162" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:StockOptionPlanExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">233,666</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Restricted stock expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824163" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:RestrictedStockExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">11,885</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824164" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:RestrictedStockExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">109,202</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Write off of prepaid assets due to termination of contractual obligation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824165" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:WriteOffOfPrepaidAssets" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824166" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="ycbd:WriteOffOfPrepaidAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF">884,892</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory and materials impairment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824167" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:InventoryWriteDown" scale="0" format="ixt:num-dot-decimal" decimals="INF">921,314</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824168" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:InventoryWriteDown" scale="0" format="ixt:num-dot-decimal" decimals="INF">175,499</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Intangibles amortization</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824169" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF">697,510</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824170" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,396,459</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Depreciation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824171" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:Depreciation" scale="0" format="ixt:num-dot-decimal" decimals="INF">452,326</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824172" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:Depreciation" scale="0" format="ixt:num-dot-decimal" decimals="INF">404,280</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Impairment of goodwill and other intangible assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824173" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824174" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" format="ixt:num-dot-decimal" decimals="INF">13,219,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Increase/(Decrease) in contingent liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824175" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">74,580</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824176" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">185,638</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Increase in fair value of convertible debt</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824177" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:FairValueAdjustmentOfDebt" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">429,789</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824178" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="ycbd:FairValueAdjustmentOfDebt" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Other-than-temporary impairment on other investments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824179" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:OtherthantemporaryImpairmentsOnOtherInvestments" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824180" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="ycbd:OtherthantemporaryImpairmentsOnOtherInvestments" scale="0" format="ixt:num-dot-decimal" decimals="INF">700,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;">Gain on termination of operating lease&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824181" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:GainLossOnTerminationOfLease" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">696,280</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824182" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:GainLossOnTerminationOfLease" scale="0" xsi:nil="true"></ix:nonFraction><p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">-</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Amortization of operating lease asset</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824183" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">670,621</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824184" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,126,976</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Changes in operating assets and liabilities:</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts receivable</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824185" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">232,180</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824186" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">278,482</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deposits</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824187" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInDepositOtherAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">76,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824188" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInDepositOtherAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">105,898</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824189" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInInventories" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">766,472</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824190" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInInventories" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">27,443</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid inventory</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824191" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:IncreaseDecreaseInPrepaidInventoryTotal" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">23,670</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824192" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="ycbd:IncreaseDecreaseInPrepaidInventoryTotal" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">328,784</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid expenses and other current assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824193" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">396,311</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824194" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">2,095,323</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts payable and accrued expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824195" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,124,141</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824196" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,290,141</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating lease liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824197" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,151,326</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824198" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,178,683</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred revenue / customer deposits</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824199" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">318,008</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824200" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="0" format="ixt:num-dot-decimal" decimals="INF">203,341</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Collection on discontinued operations accounts receivable</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824201" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:CollectionOnDiscontinuedOperationsAccountsReceivable" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824202" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="ycbd:CollectionOnDiscontinuedOperationsAccountsReceivable" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,375</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Cash used by operating activities</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824203" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">352,792</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824204" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">4,302,051</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Cash flows from investing activities:</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Proceeds from sale of other investment securities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824205" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824206" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Purchase of intangible assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; text-align: right; padding: 0; margin: 0">(<ix:nonFraction id="c121824207" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF">100,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824208" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Purchase of property and equipment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824209" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" format="ixt:num-dot-decimal" decimals="INF">190,015</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824210" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" format="ixt:num-dot-decimal" decimals="INF">297,549</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Cash (used) provided by investing activities</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824211" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">290,015</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824212" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" format="ixt:num-dot-decimal" decimals="INF">702,451</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Cash flows from financing activities:</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Proceeds from issuance of common stock</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824213" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,001</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824214" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,478,325</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Note payable</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824215" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:ProceedsFromRepaymentsOfNotesPayable" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,247,499</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824216" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:ProceedsFromRepaymentsOfNotesPayable" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">132,599</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividend distribution</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824217" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824218" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,668,500</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Cash provided (used) by financing activities</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824219" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,297,500</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824220" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,322,774</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net increase (decrease) in cash</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824221" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" format="ixt:num-dot-decimal" decimals="INF">654,693</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824222" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">4,922,374</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash and cash equivalents, beginning of year</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824223" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,797,860</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824224" contextRef="i_2022-09-30" unitRef="USD" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="0" format="ixt:num-dot-decimal" decimals="INF">6,720,234</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Cash and cash equivalents, end of year</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824225" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,452,553</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824226" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,797,860</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td></tr>
</tbody></table>
  </div>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><b>Supplemental Disclosures of Cash Flow Information:</b></p>
  <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <div>
   <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;">
    <tbody>
     <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td>
      <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td>
      <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     </tr>

     <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
     </tr>

     <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
      <td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash Payments for:</p> </td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     </tr>

     <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
      <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Interest expense</p> </td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
      <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><ix:nonFraction id="c121824234" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:InterestPaidNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">74,638</ix:nonFraction></p> </td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
      <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824235" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:InterestPaidNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">6,399</ix:nonFraction></td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td>
     </tr>

     <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td>
     </tr>

     <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
      <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-cash financial/investing activities:</p> </td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
      <td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td>
     </tr>

     <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom">
      <td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Issuance of shares for conversion of debt and accrued interest</p> </td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">$</td>
      <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824236" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:IssuanceOfSharesForConversionOfDebtAndAccruedInterest" scale="0" format="ixt:num-dot-decimal" decimals="INF">515,601</ix:nonFraction></td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">$</td>
      <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824237" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="ycbd:IssuanceOfSharesForConversionOfDebtAndAccruedInterest" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     </tr>

     <tr>
      <td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">Issuance of shares for intangible asset</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">$</td>
      <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824238" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:StockIssued1" scale="0" format="ixt:num-dot-decimal" decimals="INF">40,725</ix:nonFraction></td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">$</td>
      <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824239" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:StockIssued1" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td>
     </tr>

     <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom">
      <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividends accrued but not paid</p> </td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
      <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824240" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:PreferredDividendsAccruedNotYetPaid" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,004,001</ix:nonFraction></td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
      <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824241" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="ycbd:PreferredDividendsAccruedNotYetPaid" scale="0" format="ixt:num-dot-decimal" decimals="INF">667,000</ix:nonFraction></td>
      <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td>
     </tr>

    </tbody>
   </table>
  </div>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:47.7%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">See Notes to Consolidated Financial Statements</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      37
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <div>
   &#160;
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>cbdMD, INC.</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSOLIDATED STATEMENTS OF SHAREHOLDERS'&#160;EQUITY</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FOR THE YEARS ENDED <span style="text-transform:uppercase;">September 30, 2024 and 2023</span></b></p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div>
   <table cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: 0pt;"><tbody><tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Other</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Additional</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#160;</b></td></tr>
<tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 10%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Common Stock</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 10%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Preferred Stock</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Comprehensive</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Paid in</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Accumulated</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#160;</b></td></tr>
<tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Shares</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Amount</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Shares</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Amount</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Income</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Capital</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Deficit</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">Total</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Balance, September 30, 2023</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824268" contextRef="i_2023-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,960,573</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824269" contextRef="i_2023-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,961</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824270" contextRef="i_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824271" contextRef="i_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824272" contextRef="i_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824273" contextRef="i_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">183,387,095</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>(<ix:nonFraction id="c121824274" contextRef="i_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">174,363,772</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>)</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824275" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">9,031,284</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824276" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">483</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824277" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824278" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824279" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824280" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824281" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824282" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824283" contextRef="d_2023-10-01_2023-12-31" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of options for share based compensation</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824285" contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824287" contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824288" contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824289" contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,772</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824290" contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824291" contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,772</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of restricted stock for share based compensation</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824293" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824295" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824296" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824297" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">689</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824298" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824299" contextRef="d_2023-10-01_2023-12-31" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">689</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividend declared, not paid</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824301" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824303" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824304" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824305" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824306" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,501</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824307" contextRef="d_2023-10-01_2023-12-31" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,501</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net Loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><ix:nonFraction id="c121824309" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><ix:nonFraction id="c121824311" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><ix:nonFraction id="c121824312" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><ix:nonFraction id="c121824313" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(<ix:nonFraction id="c121824314" contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">996,501</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(<ix:nonFraction id="c121824315" contextRef="d_2023-10-01_2023-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">996,501</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Balance, December 31, 2023</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824316" contextRef="i_2023-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,961,056</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824317" contextRef="i_2023-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,961</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824318" contextRef="i_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824319" contextRef="i_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824320" contextRef="i_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824321" contextRef="i_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">183,389,556</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b>(<ix:nonFraction id="c121824322" contextRef="i_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">176,360,774</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824323" contextRef="i_2023-12-31" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">7,036,743</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824324" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">19,930</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824325" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">20</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824326" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824327" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824328" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824329" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">15,763</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824330" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824331" contextRef="d_2024-01-01_2024-03-31" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">15,783</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of options for share based compensation</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824333" contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824335" contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824336" contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824337" contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,080</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824338" contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824339" contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,080</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of restricted stock for share based compensation</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824341" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824343" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824344" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824345" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">303</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824346" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824347" contextRef="d_2024-01-01_2024-03-31" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">303</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in far value of debt related to credit risk</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824349" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824351" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824352" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:num-dot-decimal" decimals="INF">6,000</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824353" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824354" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824355" contextRef="d_2024-01-01_2024-03-31" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:num-dot-decimal" decimals="INF">6,000</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock - Keystone</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824356" contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">64,218</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824357" contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">64</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824358" contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824359" contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824360" contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824361" contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">49,936</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824362" contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824363" contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,000</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividend declared, not paid</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824365" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824367" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824368" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824369" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824370" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,500</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824371" contextRef="d_2024-01-01_2024-03-31" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,500</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net Income (loss)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824373" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824375" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824376" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824377" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824378" contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">3,010,562</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824379" contextRef="d_2024-01-01_2024-03-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">3,010,562</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Balance, March 31, 2024</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824380" contextRef="i_2024-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,045,204</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824381" contextRef="i_2024-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,045</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824382" contextRef="i_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824383" contextRef="i_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b>(<ix:nonFraction id="c121824384" contextRef="i_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">6,000</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824385" contextRef="i_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">183,456,639</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b>(<ix:nonFraction id="c121824386" contextRef="i_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">180,371,836</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824387" contextRef="i_2024-03-31" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,086,847</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of options for share based compensation, net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824389" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824391" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824392" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824393" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,376</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824394" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824395" contextRef="d_2024-04-01_2024-06-30" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">5.376</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of restricted stock for share based compensation, net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824397" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824399" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824400" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824401" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">7,167</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824402" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824403" contextRef="d_2024-04-01_2024-06-30" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">7.167</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in far value of debt related to credit risk</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824405" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824407" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824408" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">4,800</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824409" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824410" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824411" contextRef="d_2024-04-01_2024-06-30" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">4,800</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common Stock, Convertible Notes</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824412" contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" format="ixt:num-dot-decimal" decimals="INF">714,229</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824413" contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:num-dot-decimal" decimals="INF">714</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824414" contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824415" contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824416" contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824417" contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:num-dot-decimal" decimals="INF">463,980</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824418" contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824419" contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:num-dot-decimal" decimals="INF">464,694</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividend declared, not paid</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824421" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824423" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824424" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824425" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824426" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,500</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824427" contextRef="d_2024-04-01_2024-06-30" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,500</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net Income</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824429" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824431" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824432" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824433" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824434" contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF">459,737</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824435" contextRef="d_2024-04-01_2024-06-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF">459,737</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Balance, June 30, 2024</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824436" contextRef="i_2024-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,759,433</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824437" contextRef="i_2024-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,759</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824438" contextRef="i_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824439" contextRef="i_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b>(<ix:nonFraction id="c121824440" contextRef="i_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,200</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824441" contextRef="i_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">183,933,162</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b>(<ix:nonFraction id="c121824442" contextRef="i_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">180,912,600</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824443" contextRef="i_2024-06-30" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,028,121</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824444" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,000</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824445" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">4</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824446" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824447" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824448" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824449" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="ycbd:DecreaseInApicIssuanceOfStock" scale="0" format="ixt:num-dot-decimal" decimals="INF">4</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824450" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824451" contextRef="d_2024-07-01_2024-09-30" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of options for share based compensation</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824453" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824455" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824456" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824457" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,080</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824458" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824459" contextRef="d_2024-07-01_2024-09-30" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">1.080</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of restricted stock for share based compensation</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824461" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824463" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824464" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"> <p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><ix:nonFraction id="c121824465" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,727</ix:nonFraction></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824466" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824467" contextRef="d_2024-07-01_2024-09-30" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">3.727</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in far value of debt related to credit risk</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824469" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824471" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824472" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,989</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824473" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824474" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824475" contextRef="d_2024-07-01_2024-09-30" unitRef="USD" name="ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,989</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Issuance of Common Stock, Majik Settlement</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824476" contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">75,000</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824477" contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">75</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824478" contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" xsi:nil="true"></ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824479" contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" xsi:nil="true"></ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824480" contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" xsi:nil="true"></ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824481" contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">40,725</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824482" contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" xsi:nil="true"></ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right; padding: 0; margin: 0"><ix:nonFraction id="c121824483" contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">40,800</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common Stock, Convertible Notes</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824484" contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" format="ixt:num-dot-decimal" decimals="INF">100,624</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824485" contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:num-dot-decimal" decimals="INF">101</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824486" contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824487" contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824488" contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824489" contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,875</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824490" contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824491" contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,976</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividend declared, not paid</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824493" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824495" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824496" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824497" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824498" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,002,500</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824499" contextRef="d_2024-07-01_2024-09-30" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,002,500</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net Loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824501" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824503" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824504" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824505" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824506" contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">152,798</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824507" contextRef="d_2024-07-01_2024-09-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">152,798</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Balance, Balance at September 30, 2024</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824508" contextRef="i_2024-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,939,057</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824509" contextRef="i_2024-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,939</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824510" contextRef="i_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824511" contextRef="i_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b>(<ix:nonFraction id="c121824512" contextRef="i_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">7,189</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824513" contextRef="i_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">184,029,565</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b>(<ix:nonFraction id="c121824514" contextRef="i_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">182,067,898</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824515" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,963,417</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
  </div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">See Notes to Condensed Consolidated Financial Statements</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      38
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>cbdMD, INC.</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY</b></p> </td>
    </tr>

    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FOR THE YEARS ENDED <span style="text-transform:uppercase">September 30, 2024 and 2023</span></b></p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div>
   <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">
    <tbody>
     <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Other </b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Additional</b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
     </tr>

     <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Common Stock</b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Preferred Stock</b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Comprehensive </b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Paid in </b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Accumulated </b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
     </tr>

     <tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Shares</b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Amount</b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Shares</b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Amount</b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Income</b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Capital</b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Deficit</b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Total</b></p> </td>
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Balance, September 30, 2022</b></p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824516" contextRef="i_2022-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,348,125</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824517" contextRef="i_2022-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,348</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824518" contextRef="i_2022-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824519" contextRef="i_2022-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824520" contextRef="i_2022-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824521" contextRef="i_2022-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">178,841,646</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>(<ix:nonFraction id="c121824522" contextRef="i_2022-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">147,423,563</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>)</b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><b><ix:nonFraction id="c121824523" contextRef="i_2022-09-30" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">31,424,431</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824524" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,038</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824525" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">1</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824526" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824527" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824528" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824529" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="ycbd:DecreaseInApicIssuanceOfStock" scale="0" format="ixt:num-dot-decimal" decimals="INF">1</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824530" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824531" contextRef="d_2022-10-01_2022-12-31" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of options for share based compensation</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824533" contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824535" contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824536" contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824537" contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">79,446</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824538" contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824539" contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">79,446</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of restricted stock for share based compensation</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824541" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824543" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824544" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824545" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">43,449</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824546" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824547" contextRef="d_2022-10-01_2022-12-31" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">43,449</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividend</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824549" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824551" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824552" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824553" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824554" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,502</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824555" contextRef="d_2022-10-01_2022-12-31" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,502</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net Income (loss)</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><ix:nonFraction id="c121824557" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><ix:nonFraction id="c121824559" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><ix:nonFraction id="c121824560" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><ix:nonFraction id="c121824561" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(<ix:nonFraction id="c121824562" contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">3,956,062</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(<ix:nonFraction id="c121824563" contextRef="d_2022-10-01_2022-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">3,956,062</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Balance, December 31, 2022</b></p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824564" contextRef="i_2022-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,349,163</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824565" contextRef="i_2022-12-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,349</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824566" contextRef="i_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824567" contextRef="i_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824568" contextRef="i_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824569" contextRef="i_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">178,964,539</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b>(<ix:nonFraction id="c121824570" contextRef="i_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">152,380,127</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824571" contextRef="i_2022-12-31" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">26,590,761</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824572" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">8,417</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824573" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">8</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824574" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824575" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824576" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824577" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="ycbd:DecreaseInApicIssuanceOfStock" scale="0" format="ixt:num-dot-decimal" decimals="INF">8</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824578" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824579" contextRef="d_2023-01-01_2023-03-31" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of options for share based compensation</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824581" contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824583" contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824584" contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824585" contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">16,770</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824586" contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824587" contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">16,770</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of restricted stock for share based compensation</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824589" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824591" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824592" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824593" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">56,801</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824594" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824595" contextRef="d_2023-01-01_2023-03-31" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">56,801</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock - A360</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824596" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" format="ixt:num-dot-decimal" decimals="INF">94,277</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824597" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:num-dot-decimal" decimals="INF">94</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824598" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824599" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824600" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824601" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,399,906</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824602" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824603" contextRef="d_2023-01-01_2023-03-31" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,400,000</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock - DCO</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824604" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,223</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824605" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="0" format="ixt:num-dot-decimal" decimals="INF">2</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824606" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824607" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824608" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824609" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="0" format="ixt:num-dot-decimal" decimals="INF">29,998</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824610" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824611" contextRef="d_2023-01-01_2023-03-31" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="0" format="ixt:num-dot-decimal" decimals="INF">30,000</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock - Keystone</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824612" contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,616</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824613" contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">3</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824614" contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824615" contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824616" contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824617" contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">29,190</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824618" contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824619" contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">29,193</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Roundup fractional shares resulting from reverse split</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824621" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesStockSplits" scale="0" format="ixt:num-dot-decimal" decimals="INF">1</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824623" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesStockSplits" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824624" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesStockSplits" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824625" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesStockSplits" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824626" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesStockSplits" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824627" contextRef="d_2023-01-01_2023-03-31" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesStockSplits" scale="0" format="ixt:num-dot-decimal" decimals="INF">1</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividend</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824629" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824631" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824632" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824633" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824634" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,500</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824635" contextRef="d_2023-01-01_2023-03-31" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,500</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net Income (loss)</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824637" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824639" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824640" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824641" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824642" contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,336,802</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824643" contextRef="d_2023-01-01_2023-03-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,336,802</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Balance, March 31, 2023</b></p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824644" contextRef="i_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,456,696</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824645" contextRef="i_2023-03-31_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,457</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824646" contextRef="i_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824647" contextRef="i_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824648" contextRef="i_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824649" contextRef="i_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">180,497,196</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b>(<ix:nonFraction id="c121824650" contextRef="i_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">154,717,429</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824651" contextRef="i_2023-03-31" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">25,786,224</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824652" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">9,000</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824653" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">9</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824654" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824655" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824656" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824657" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">69,606</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824658" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824659" contextRef="d_2023-04-01_2023-06-30" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">69,615</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of options for share based compensation, net</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824661" contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824663" contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824664" contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824665" contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">34,663</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824666" contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824667" contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">34,663</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of restricted stock for share based compensation, net</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824669" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824671" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824672" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824673" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,845</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824674" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824675" contextRef="d_2023-04-01_2023-06-30" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,845</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock - A360</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824677" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-PublicOfferingMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824679" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-PublicOfferingMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824680" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-PublicOfferingMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824681" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-PublicOfferingMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:num-dot-decimal" decimals="INF">133,200</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824682" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-PublicOfferingMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824683" contextRef="d_2023-04-01_2023-06-30_SubsidiarySaleOfStockAxis-PublicOfferingMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" format="ixt:num-dot-decimal" decimals="INF">133,200</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock - Maxim</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824684" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,350,000</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824685" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,350</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824686" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824687" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824688" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824689" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,472,730</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824690" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824691" contextRef="d_2023-04-01_2023-06-30_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,474,080</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Fractional share true-up</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824692" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits" scale="0" format="ixt:num-dot-decimal" decimals="INF">39,533</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824693" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="ycbd:StockIssuedDuringPeriodValueReverseStockSplits" scale="0" format="ixt:num-dot-decimal" decimals="INF">39</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824694" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824695" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="ycbd:StockIssuedDuringPeriodValueReverseStockSplits" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824696" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="ycbd:StockIssuedDuringPeriodValueReverseStockSplits" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824697" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="ycbd:StockIssuedDuringPeriodValueReverseStockSplits" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">39</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824698" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="ycbd:StockIssuedDuringPeriodValueReverseStockSplits" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824699" contextRef="d_2023-04-01_2023-06-30" unitRef="USD" name="ycbd:StockIssuedDuringPeriodValueReverseStockSplits" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividend</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824701" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824703" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824704" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824705" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824706" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,501</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824707" contextRef="d_2023-04-01_2023-06-30" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,501</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net Income (loss)</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824709" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824711" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824712" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824713" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824714" contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,770,404</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824715" contextRef="d_2023-04-01_2023-06-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,770,404</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Balance, June 30, 2023</b></p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824716" contextRef="i_2023-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,855,229</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824717" contextRef="i_2023-06-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,855</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824718" contextRef="i_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824719" contextRef="i_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824720" contextRef="i_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824721" contextRef="i_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">183,212,202</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b>(<ix:nonFraction id="c121824722" contextRef="i_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">157,488,334</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824723" contextRef="i_2023-06-30" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">25,731,723</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824724" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">112</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824725" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824726" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824727" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824728" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824729" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="ycbd:DecreaseInApicIssuanceOfStock" scale="0" format="ixt:num-dot-decimal" decimals="INF">112</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824730" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824731" contextRef="d_2023-07-01_2023-09-30" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">112</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of options for share based compensation</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824733" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824735" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824736" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824737" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">33,171</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824738" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824739" contextRef="d_2023-07-01_2023-09-30" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" format="ixt:num-dot-decimal" decimals="INF">33,171</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of restricted stock for share based compensation</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824741" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824743" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824744" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824745" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,996</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824746" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824747" contextRef="d_2023-07-01_2023-09-30" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,996</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issuance of Common stock - Keystone</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824748" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">105,232</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824749" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">105</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824750" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824751" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824752" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824753" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">97,338</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824754" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824755" contextRef="d_2023-07-01_2023-09-30_SubsidiarySaleOfStockAxis-CommitmentSharesMember" unitRef="USD" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">97,443</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Maxim transaction expenses</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824757" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824759" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824760" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824761" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="0" format="ixt:num-dot-decimal" decimals="INF">40,500</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824762" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824763" contextRef="d_2023-07-01_2023-09-30_SubsidiarySaleOfStockAxis-CapitalRaiseMember" unitRef="USD" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="0" format="ixt:num-dot-decimal" decimals="INF">40,500</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividend</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824765" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824767" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824768" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><ix:nonFraction id="c121824769" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824770" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,497</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(<ix:nonFraction id="c121824771" contextRef="d_2023-07-01_2023-09-30" unitRef="USD" name="us-gaap:DividendsPreferredStockCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,000,497</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net Income (loss)</p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824773" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824775" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824776" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824777" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824778" contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">15,874,941</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824779" contextRef="d_2023-07-01_2023-09-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">15,874,941</ix:nonFraction></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td>
     </tr>

     <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
      <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Balance, Balance at September 30, 2023</b></p> </td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824780" contextRef="i_2023-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,960,573</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824781" contextRef="i_2023-09-30_StatementEquityComponentsAxis-CommonStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,961</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&#160;</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824782" contextRef="i_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="Share" name="us-gaap:SharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824783" contextRef="i_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824784" contextRef="i_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824785" contextRef="i_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">183,387,095</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b>(<ix:nonFraction id="c121824786" contextRef="i_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">174,363,772</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"><b>)</b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>$</b></td>
      <td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><b><ix:nonFraction id="c121824787" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:StockholdersEquity" scale="0" format="ixt:num-dot-decimal" decimals="INF">9,031,284</ix:nonFraction></b></td>
      <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
     </tr>

    </tbody>
   </table>
  </div>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">
   <tbody>
    <tr>
     <td style="vertical-align:middle;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">See Notes to Condensed Consolidated Financial Statements</p> </td>
    </tr>

   </tbody>
  </table>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
   <div class="PGFTR" style="text-align: center; width: 100%">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      39
     </div>
    </div>
   </div>
   <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
   <div class="PGHDR" style="text-align: left; width: 100%">
    <div class="hf-row">
     <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
      <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
     </div>
    </div>
   </div>
  </div>
  <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;&#160;</p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>cbdMD, INC.</b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </b></p>
  <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FOR THE YEAR ENDED<span style="text-transform:uppercase;"> September 30, 2024 and 2023</span></b></p>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="c2808709" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">1</em> </b>&#8211;<b> ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Organization and Nature of Business</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">cbdMD, Inc. ("cbdMD", "we", "us", &#8220;our&#8221;, or the &#8220;Company&#8221;) is a North Carolina corporation formed on <em style="font: inherit;"> March 17, 2015 </em>as Level Beauty Group, Inc. In <em style="font: inherit;"> November 2016 </em>we changed the name of the Company to Level Brands, Inc. and on <em style="font: inherit;"> May 1, 2019 </em>we changed the name of our Company to cbdMD, Inc. We operate from our offices located in Charlotte, North Carolina. Our fiscal year end is established as <em style="font: inherit;"> September 30.</em><br/> &#160;<br/> There have been <em style="font: inherit;">no</em> material changes in the Company's significant accounting policies from those previously disclosed in the <em style="font: inherit;">2023</em> <em style="font: inherit;">10</em>-K.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The accompanying unaudited interim condensed consolidated financial statements of cbdMD have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;) and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the <em style="font: inherit;">2024</em>&#160;<em style="font: inherit;">10</em>-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of consolidated financial position and the consolidated results of operations for the interim periods presented have been reflected herein.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:StockholdersEquityPolicyTextBlock" id="c121827937" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Reverse Stock Split</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> April 12, 2023, </em>the board effected a reverse stock split at a ratio of <em style="font: inherit;">one</em>-for-<span style="-sec-ix-hidden:c121825181">forty</span>-five, effective as of <em style="font: inherit;"> April 24, 2023. </em>Unless otherwise indicated, all share numbers in this filing, including shares of common stock and all securities convertible into, or exercisable for, shares of common stock, give effect to the reverse stock split.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ConsolidationPolicyTextBlock" id="c121827938" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Principles of Consolidation</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries CBDI, Paw CBD, Proline Global, and Therapeutics. All material intercompany transactions and balances have been eliminated in consolidation.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:UseOfEstimates" id="c121827939" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Use of Estimates</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's consolidated financial statements have been prepared in accordance with US GAAP and requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Significant estimates made in the accompanying consolidated financial statements include, but are <em style="font: inherit;">not</em> limited to, allowances for doubtful accounts, inventory valuation reserves, certain assumptions related to the valuation of investments other securities, and acquired intangible and long-lived assets and the recoverability of intangible and long-lived assets.&#160;Actual results could differ from these estimates.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="c121827940" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Cash and Cash Equivalents</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For financial statements purposes, the Company considers all highly liquid investments with a maturity of less than <em style="font: inherit;">three</em> months when purchased to be cash equivalents.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="c121827941" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Accounts Receivable</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Accounts receivables are stated at cost less an allowance for credit losses, if applicable. Credit is extended to customers after an evaluation of the customer&#8217;s financial condition, and generally collateral is <em style="font: inherit;">not</em> required as a condition of credit extension. Management&#8217;s determination of the allowance for credit losses&#160;is based on an evaluation of the receivables, past experience, current economic conditions, and other risks inherent in the receivables portfolio. As of <em style="font: inherit;"> September 30, 2024</em> and <em style="font: inherit;"> September 30, 2023</em>, we had an allowance for credit losses&#160;of $<ix:nonFraction id="c121825185" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="0" format="ixt:num-dot-decimal" decimals="INF">346,197</ix:nonFraction>&#160;and $<ix:nonFraction id="c121825186" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="0" format="ixt:num-dot-decimal" decimals="INF">42,180</ix:nonFraction>, respectively.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p></ix:nonNumeric><p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"></p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">40</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="ycbd:MerchantReceivableAndReservePolicyTextBlock" id="c121827942" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Merchant Receivable</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company primarily sells its products through the internet and has an arrangement to process customer payments with multiple <em style="font: inherit;">third</em>-party payment processors. The Company pays a fee between <ix:nonFraction id="c121825189" contextRef="i_2024-09-30_RangeAxis-MinimumMember" unitRef="Pure" name="ycbd:Merchantprocessingfee" scale="-2" format="ixt:num-dot-decimal" decimals="3">2.5</ix:nonFraction>% and <ix:nonFraction id="c121825190" contextRef="i_2024-09-30_RangeAxis-MaximumMember" unitRef="Pure" name="ycbd:Merchantprocessingfee" scale="-2" format="ixt:num-dot-decimal" decimals="2">4.0</ix:nonFraction>% of the transaction amounts processed. Pursuant to these agreements, there can be a waiting period between <em style="font: inherit;">2</em> to <em style="font: inherit;">5</em> days prior to reimbursement to the Company, as well as a calculated reserve which some payment processors hold back. Fees and reserves can change periodically with notice from the processors. At <em style="font: inherit;"> September 30, 2024, </em>the receivable from payment processors included $<ix:nonFraction id="c121825193" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:AccountsReceivableNetCurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">621,678</ix:nonFraction>&#160;for the waiting period amount and is recorded as accounts receivable in the accompanying consolidated balance sheet.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p></ix:nonNumeric><p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"></p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:InventoryPolicyTextBlock" id="c121827943" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Inventory</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Inventory is stated at the lower of cost or net realizable value with cost being determined on a weighted average basis. The cost of inventory includes product cost, freight-in, and production fill and labor (portions of which we outsource to <em style="font: inherit;">third</em> party manufacturers). Write-offs of potentially slow moving or damaged inventory are recorded based on management&#8217;s analysis of inventory levels, forecasted future sales volume and pricing and through specific identification of obsolete or damaged products. We assess inventory quarterly for slow moving products and potential impairments and at a minimum perform a physical inventory count annually near fiscal year end.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:DepositContractsPolicy" id="c121827944" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Customer Deposits</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Customer deposits consist of payments received in advance of revenue recognition. Revenue is recognized as revenue recognition criteria are met.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="c121827945" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Property and Equipment</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Property and equipment items are stated at cost less accumulated depreciation. Expenditures for routine maintenance and repairs are charged to operations as incurred. Depreciation is charged to expense over the estimated useful lives of the assets using the straight-line method. Generally, the useful lives are <span style="-sec-ix-hidden:c121825195">five</span> years for manufacturing equipment and automobiles and <span style="-sec-ix-hidden:c121825196">three</span> years for software, computer, and furniture and equipment. The useful life for leasehold improvements are over the term of the lease or expected life of the asset, whichever is less. The cost and accumulated depreciation of property are eliminated from the accounts upon disposal, and any resulting gain or loss is included in the consolidated statements of operations for the applicable period. Long-lived assets held and used by the Company are reviewed for impairment whenever changes in circumstance indicate the carrying value of an asset <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="c121827946" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Fair Value Accounting</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company utilizes accounting standards for fair value, which include the definition of fair value, the framework for measuring fair value, and disclosures about fair value measurements. Fair value is a market-based measurement, <em style="font: inherit;">not</em> an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, fair value accounting standards establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels <em style="font: inherit;">1</em> and <em style="font: inherit;">2</em> of the hierarchy) and the reporting entity&#8217;s own assumptions about market participant assumptions (unobservable inputs classified within Level <em style="font: inherit;">3</em> of the hierarchy).</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Level <em style="font: inherit;">1</em> inputs utilize quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Level <em style="font: inherit;">2</em> inputs are inputs other than quoted prices included in Level <em style="font: inherit;">1</em> that are directly or indirectly observable for the asset or liability. Level <em style="font: inherit;">2</em> inputs <em style="font: inherit;"> may </em>include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability. Level <em style="font: inherit;">3</em> inputs are unobservable inputs for the asset or liability, which are based on an entity&#8217;s own assumptions, as there is little, if any, observable market activity. In instances where the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">When the Company records an investment in marketable securities the carrying value is&#160;recorded at fair value. Any changes in fair value for marketable securities during a given period will be recorded as an unrealized gain or loss in the consolidated statement of operations. For investments other securities without a readily determinable fair value, the Company <em style="font: inherit;"> may </em>elect to estimate its fair value at cost less impairment plus or minus changes resulting from observable price changes. The Company has elected the fair value method and will make individual determinations on and instrument by instrument basis.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">41</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="c121827947" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Intangible Assets</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's intangible assets consist of trademarks and other intellectual property, all of which were previously accounted for in accordance with Accounting Standards Codification (ASC) Topic <em style="font: inherit;">350,</em> <i>Intangibles </i>&#8211;<i> Goodwill and Other</i>. The Company employed&#160;the non-amortization approach to account for purchased intangible assets having indefinite lives. Under the non-amortization approach, intangible assets having indefinite lives were <em style="font: inherit;">not</em> amortized into the results of operations, but instead were reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value. We previously performed an annual impairment analysis each fiscal year on the indefinite-lived intangible assets following the steps laid out in ASC <em style="font: inherit;">350</em>-<em style="font: inherit;">30</em>-<em style="font: inherit;">35</em>-<em style="font: inherit;">18.</em> Our annual impairment analysis included a qualitative assessment to determine if it was&#160;necessary to perform the quantitative impairment test. In performing a qualitative assessment, we reviewed events and circumstances that could affect the significant inputs used to determine if the fair value was less than the carrying value of the intangible assets. If a quantitative analysis was necessary, we would analyze various aspects including revenues from the business, associated with the intangible assets. In addition, intangible assets would be tested on an interim basis if an event or circumstance indicates that it is more likely than <em style="font: inherit;">not</em> that an impairment loss has been incurred. The Company analyzed a variety of factors on its business to determine if a circumstance could trigger an impairment loss, and, at the time and based on the information then known, had determined that is it was more likely than <em style="font: inherit;">not</em> that an impairment loss had occurred. See Note <em style="font: inherit;">5</em> more further information on the impairment testing procedures performed at <em style="font: inherit;"> December 31, 2022&#160;</em>and the Company&#8217;s decision to change from indefinite to definite lived status for its trademarks.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company now accounts for its trademarks in accordance with Accounting Standards Codification (ASC) Topic <em style="font: inherit;">360,</em> Property, Plant and Equipment. The Company began amortizing its trademarks over <em style="font: inherit;">20</em> years beginning <em style="font: inherit;"> January 1, 2023&#160;</em>and will perform impairment tests as prescribed by ASC <em style="font: inherit;">360,</em> which states that impairment testing should be completed whenever events or changes in circumstances indicate that the asset group's&#160;carrying value <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable. If there are indications that the asset group's&#160;carrying value <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable, there are <em style="font: inherit;">two</em> further steps involved in long-lived asset impairment testing. Step I of the impairment test, as per ASC <em style="font: inherit;">360,</em> involves estimating the recoverable amount of the asset group and determining the potential for impairment. Step II of the impairment test, as per ASC <em style="font: inherit;">360,</em> if necessary, involves quantifying the fair value of the asset group. As further outlined in Note <em style="font: inherit;">5,</em> during <em style="font: inherit;"> July </em>of fiscal <em style="font: inherit;">2023,</em> the Company determined that based on regulatory uncertainty and ongoing Company performance it was prudent to change the amortization of the &#8220;cbdMD&#8221; and &#8220;directCBDonline&#8221; trademarks to <ix:nonNumeric contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdmdAndDirectcbdonlineTrademarksMember" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="c121825227" format="ixt-sec:duryear">5</ix:nonNumeric> years and &#8220;hempMD&#8221; trademark to <ix:nonNumeric contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="c121825228" format="ixt-sec:duryear">10</ix:nonNumeric> years.&#160; This became a triggering event for an impairment test under <em style="font: inherit;">ASC360</em> which resulted in an impairment of the intangibles in <em style="font: inherit;"> July 2023.&#160; </em>As of the end of the <em style="font: inherit;">fourth</em> quarter and fiscal <em style="font: inherit;">2023,</em> a significant decline in market capitalization of both classes of equity as a result of the proxy vote triggered a subsequent impairment test, resulting in additional impairment during the <em style="font: inherit;">fourth</em> quarter of <em style="font: inherit;">2023.</em></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:BusinessCombinationsPolicy" id="c121827948" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Contingent Liability</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A significant component of the purchase price consideration for the Company&#8217;s acquisition of Cure Based Development includes a fixed number of future shares to be issued as well as a variable number of future shares to be issued based upon the post-acquisition entity reaching certain specified future revenue targets, as further described in Note <em style="font: inherit;">6.</em> The Company made a determination of the fair value of the contingent liabilities as part of the valuation of the assets acquired and liabilities assumed in the business combination.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="c121827949" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Revenue Recognition</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Under ASC <em style="font: inherit;">606,</em> <i>Revenue from Contracts with Customers, </i>the Company recognizes revenues when its customer obtains control of promised goods or services, in an amount that reflects the consideration which it expects to receive in exchange for those goods. The Company recognizes revenues following the <em style="font: inherit;">five</em>-step model prescribed under ASC <em style="font: inherit;">606:</em> (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Performance Obligations</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A performance obligation is a promise in a contract to transfer a distinct good or service to a customer. The Company meets that obligation when it has shipped products which have been ordered&#160;by the customer. The Company has reviewed its various revenue streams for its other contracts under the <em style="font: inherit;">five</em>-step approach.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">42</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Allocation of Transaction Price</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In the Company&#8217;s current business model, it does <span style="-sec-ix-hidden:c121825240">not</span> have contracts with customers which have multiple elements as revenue is driven purely by online product sales or purchase order-based product sales.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Revenue Recognition</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company records revenue from the sale of its products when risk of loss and title to the product are transferred to the customer, which is upon shipping (and is typically FOB shipping) which is when our performance obligation is met. Net sales are comprised of gross revenues less product returns, trade discounts and customer allowances, which include costs associated with off-invoice mark-downs and other price reductions, as well as trade promotions. These incentive costs are recognized at the later of the date on which the Company recognizes the related revenue or the date on which the Company offers the incentive. The Company currently offers a <em style="font: inherit;">60</em>-day, money-back guarantee.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Disaggregated Revenue</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company&#8217;s product revenue is generated primarily through <em style="font: inherit;">two</em> sales channels, E-commerce sales (formerly referred to as consumer sales) and wholesale sales. The Company believes that these categories appropriately reflect how the nature, amount, timing and uncertainty of revenue and cash flows are impacted by economic factors.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A description of the Company&#8217;s principal revenue generating activities are as follows:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align:middle;width:2.1%;">&#160;</td><td style="vertical-align:top;width:2.1%;"> <p style="font-family:Symbol;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">-</p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">E-commerce sales - consumer products sold through the Company&#8217;s online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due prior to the date of shipment; and</p> </td></tr>
<tr><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:middle;width:auto;">&#160;</td></tr>
<tr><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:top;width:auto;"> <p style="font-family:Symbol;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">-</p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Wholesale sales - products sold to the Company&#8217;s wholesale customers for subsequent resale. Revenue is recognized when control of the goods is transferred to the customer, in accordance with the terms of the applicable agreement. Payment terms vary and can typically be <em style="font: inherit;">30</em> days from the date control over the product is transferred to the customer</p> </td></tr>
</tbody></table>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table represents a disaggregation of revenue by sales channel:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="c2808710" escape="true">
     <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Fiscal 2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of total</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Fiscal 2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of total</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">E-commerce sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824792" contextRef="d_2023-10-01_2024-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember" unitRef="USD" name="us-gaap:Revenues" scale="0" format="ixt:num-dot-decimal" decimals="INF">15,655,337</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824793" contextRef="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember" unitRef="Pure" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" format="ixt:num-dot-decimal" decimals="3">80.4</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824794" contextRef="d_2022-10-01_2023-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember" unitRef="USD" name="us-gaap:Revenues" scale="0" format="ixt:num-dot-decimal" decimals="INF">19,436,124</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824795" contextRef="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember" unitRef="Pure" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" format="ixt:num-dot-decimal" decimals="3">80.5</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Wholesale sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c121824796" contextRef="d_2023-10-01_2024-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember" unitRef="USD" name="us-gaap:Revenues" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,826,830</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c121824797" contextRef="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember" unitRef="Pure" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" format="ixt:num-dot-decimal" decimals="3">19.6</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c121824798" contextRef="d_2022-10-01_2023-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember" unitRef="USD" name="us-gaap:Revenues" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,719,238</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c121824799" contextRef="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember" unitRef="Pure" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" format="ixt:num-dot-decimal" decimals="3">19.5</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Net Sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"><ix:nonFraction id="c121824800" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:Revenues" scale="0" format="ixt:num-dot-decimal" decimals="INF">19,482,167</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;"><ix:nonFraction id="c121824801" contextRef="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember" unitRef="Pure" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" xsi:nil="true"></ix:nonFraction></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"><ix:nonFraction id="c121824802" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:Revenues" scale="0" format="ixt:num-dot-decimal" decimals="INF">24,155,362</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;"><ix:nonFraction id="c121824803" contextRef="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember" unitRef="Pure" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" xsi:nil="true"></ix:nonFraction></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
</tbody></table>
    </ix:nonNumeric>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Contract assets represent unbilled receivables and are presented within accounts receivable, net on the consolidated balance sheets. Contract liabilities represent unearned revenues and are presented as deferred revenue or customer deposits on the consolidated balance sheets. The Company had <span style="-sec-ix-hidden:c121825244">no</span> material contract assets or liabilities at the beginning or ending of <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:CostOfSalesPolicyTextBlock" id="c121827950" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Cost of Sales</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company&#8217;s cost of sales includes costs associated with distribution, fill and labor expense, components, manufacturing overhead, <em style="font: inherit;">third</em>-party providers, and outbound freight for the Company&#8217;s products sales. For the Company&#8217;s product sales, cost of sales also includes the cost of refurbishing products returned by customers that will be offered for resale, if any, and the cost of inventory write-downs associated with adjustments of held inventories to their net realizable value. These expenses are reflected in the Company&#8217;s consolidated statements of operations when the product is sold and net sales revenues are recognized or, in the case of inventory write-downs, when circumstances indicate that the carrying value of inventories is in excess of their net realizable value.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="c121827951" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Advertising Costs</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company expenses all costs of advertising and related marketing and promotional costs as incurred. The Company incurred $<ix:nonFraction id="c121825247" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:MarketingAndAdvertisingExpense" scale="6" format="ixt:num-dot-decimal" decimals="-5">4.2</ix:nonFraction> million and $<ix:nonFraction id="c121825248" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:MarketingAndAdvertisingExpense" scale="6" format="ixt:num-dot-decimal" decimals="-6">6.0</ix:nonFraction>&#160;million in advertising and marketing and promotional costs included in operating expenses during the years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> respectively. The Company believes driving its advertising aids in brand awareness and is critical to maintain brand recognition. We are constantly evaluating advertising methods and costs and working to drive down our cost of customer acquisition.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p></ix:nonNumeric><p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:IncomeTaxPolicyTextBlock" id="c121827952" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Income Taxes</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is a North Carolina corporation that is treated as a corporation for federal and state income tax purposes. As of <em style="font: inherit;"> October 1, 2019, </em>CBDI and Paw CBD were wholly owned subsidiaries and are disregarded entities for tax purposes and their entire share of taxable income or loss is included in the tax return of the Company and as of <em style="font: inherit;"> March 15, 2021, </em>Therapeutics is also a wholly owned subsidiary and is a disregarded entity for tax purposes and its entire share of taxable income or loss is included in the tax return of the Company.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for income taxes pursuant to the provisions of the <i>Accounting for Income Taxes </i>topic of the Financial Accounting Standards Board&#160;("FASB") ASC <em style="font: inherit;">740</em> which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. The Company uses the inside basis approach to determine deferred tax assets and liabilities associated with its investment in a consolidated pass-through entity. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than <em style="font: inherit;">not</em> that the net deferred asset will <em style="font: inherit;">not</em> be realized.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">43</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">US GAAP requires management to evaluate tax positions taken by the Company and recognize a tax liability (or asset) if the Company has taken an uncertain tax position that more likely than <em style="font: inherit;">not</em> would <em style="font: inherit;">not</em> be sustained upon examination by the Internal Revenue Service. Management has analyzed the tax positions taken by the Company, and has concluded that as of <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>, there were <em style="font: inherit;">no</em> uncertain tax positions taken or expected to be taken that would require recognition of a liability (or asset) or disclosure in the consolidated financial statements.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ConcentrationRiskCreditRisk" id="c121827953" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Concentrations</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) covers <em style="font: inherit;">$250,000</em> for substantially all depository accounts. The Company from time to time <em style="font: inherit;"> may </em>have amounts on deposit in excess of the insured limits. The Company had a $<ix:nonFraction id="c121825259" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:CashUninsuredAmount" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,893,606</ix:nonFraction>&#160;uninsured balance at <em style="font: inherit;"> September 30, 2024</em> and a $<ix:nonFraction id="c121825260" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:CashUninsuredAmount" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,163,360</ix:nonFraction>&#160;uninsured balance at <em style="font: inherit;"> September 30, 2023</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did <span style="-sec-ix-hidden:c121825261">not</span> have any customers that represented a significant amount of our sales for the year ended <em style="font: inherit;"> September 30, 2024</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="c121827954" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Stock-Based Compensation</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for its stock compensation under the ASC <em style="font: inherit;">718</em>-<em style="font: inherit;">10</em>-<em style="font: inherit;">30,</em> <i>Compensation - Stock Compensation </i>using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity's equity instruments or that <em style="font: inherit;"> may </em>be settled by the issuance of those equity instruments.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company uses the Black-Scholes model for measuring the fair value of options and warrants. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. The Company recognizes forfeitures when they occur.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="ycbd:LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" id="c121827955" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Liquidity and Going Concern Considerations</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company experienced a loss of $<ix:nonFraction id="c121825265" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="ycbd:NetIncomeLossIncludingImpairment" scale="6" format="ixt:num-dot-decimal" decimals="-5">3.7</ix:nonFraction>&#160;million for the fiscal year&#160;ended <em style="font: inherit;"> September 30, 2024</em>,&#160;resulting in a working capital deficit of $<ix:nonFraction id="c121825266" contextRef="i_2024-09-30" unitRef="USD" name="ycbd:WorkingCapital" scale="6" format="ixt:num-dot-decimal" decimals="-5">1.1</ix:nonFraction> million&#160;at <em style="font: inherit;"> September&#160;</em><em style="font: inherit;">30,</em> <em style="font: inherit;">2024.</em></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">While the Company is taking strong action, believes in the viability of its strategy&#160;and&#160;path to profitability, and in its ability to raise additional funds, there can be&#160;<em style="font: inherit;">no</em>&#160;assurances to that effect.&#160;&#160;The Company&#8217;s working capital position <em style="font: inherit;"> may </em><em style="font: inherit;">not</em>&#160;be sufficient to support the Company&#8217;s daily operations for the <em style="font: inherit;">twelve</em>&#160;months subsequent to the issuance of these annual financial statements.&#160;The Company&#8217;s ability to continue as a going concern is dependent upon its ability to improve profitability and the ability to acquire additional funding. These and other factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern within <em style="font: inherit;">twelve</em> months after the date that the annual financial statements are issued. These financial statements do <em style="font: inherit;">not</em> include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that <em style="font: inherit;"> may&#160;</em>result in the Company <em style="font: inherit;">not</em> being able to continue as a going concern.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:DebtPolicyTextBlock" id="c121827956" escape="true"><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Convertible Notes</b></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Effective <em style="font: inherit;"> February 1, 2024 (</em>the &#8220;Effective Date&#8221;), the Company entered into a Securities Purchase Agreement dated <em style="font: inherit;"> January 30, 2024 (</em>the &#8220;Purchase Agreement&#8221;) with <em style="font: inherit;">five</em> institutional investors (the &#8220;Investors&#8221;) whereby the Investors advanced the Company an aggregate of $<ix:nonFraction id="c121825276" contextRef="d_2024-01-30_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="USD" name="us-gaap:ProceedsFromConvertibleDebt" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,250,000</ix:nonFraction> gross proceeds and the Company issued each Investor an <ix:nonFraction id="c121825277" contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="Pure" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="2">8</ix:nonFraction>% Senior Secured Original Issue <ix:nonFraction id="c121825278" contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="Pure" name="ycbd:DebtInstrumentDiscountedPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="1">20</ix:nonFraction>% Discount Convertible Promissory Note, in the aggregate principal amount of $<ix:nonFraction id="c121825279" contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="USD" name="us-gaap:DebtInstrumentFaceAmount" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,541,666</ix:nonFraction> (the &#8220;Notes&#8221;). The Company is using the proceeds from the issuance of the Notes for working capital and general corporate purposes. The Company elected the fair value option under ASC <em style="font: inherit;">825</em> Fair Value Measurements for the Notes. The Notes were initially recognized at fair value on the balance sheet. All subsequent changes in fair value, excluding the impact of the change in fair value related to instrument-specific credit risk are recorded in non-operating income. The changes in fair value related to instrument-specific credit risk is recorded through other comprehensive income (loss). See Note <em style="font: inherit;">12</em> for more information related to the Notes.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:EarningsPerSharePolicyTextBlock" id="c121827957" escape="true"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Earnings (Loss) Per Share</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company uses ASC <em style="font: inherit;">260</em>-<em style="font: inherit;">10,</em> <i>Earnings Per Share </i>for calculating the basic and diluted income (loss) per share. The Company computes basic income (loss) per share by dividing net income (loss) and net income (loss) attributable to common shareholders, after deducting preferred stock dividends, by the weighted average number of common shares outstanding. Common equivalent shares are excluded from the computation of net loss per share if their effect is anti-dilutive.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> February 16, 2023, </em>we held an annual meeting of stockholders. At the annual meeting, our stockholders approved an amendment to our articles of incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of common stock by a ratio of between <em style="font: inherit;">one</em>-for-<span style="-sec-ix-hidden:c121825285">twenty</span> to <span style="-sec-ix-hidden:c121825286">one</span>-for-fifty, inclusive, with the exact ratio to be set at the discretion of our board of directors, at any time after approval of the amendment and prior to <em style="font: inherit;"> February 16, 2024. </em>On <em style="font: inherit;"> April 12, 2023, </em>the board effected a reverse stock split at a ratio of <em style="font: inherit;">one</em>-for-<span style="-sec-ix-hidden:c121825288">forty</span>-five, effective as of <em style="font: inherit;"> April 24, 2023 (</em>the "Reverse Stock Split"). Unless otherwise indicated, all share numbers in this report, including shares of common stock and all securities convertible into, or exercisable for, shares of common stock, give effect to the Reverse Stock Split.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="c121827958" escape="true"><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>New Accounting</b>&#160;<b>Standards</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company adopted ASU <em style="font: inherit;">2016</em>-<em style="font: inherit;">13</em> Financial Instruments &#8211; Credit Losses (Topic <em style="font: inherit;">326</em>): Measurement of Credit Losses on Financial Instruments (ASC <em style="font: inherit;">326</em>) effective <em style="font: inherit;"> October 1, 2023. </em>This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (&#8220;CECL&#8221;) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities, and some off-balance sheet credit exposures such as unfunded commitments to extend credit. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses.&#160;The adoption of&#160;this standard had <em style="font: inherit;">no</em> material impact&#160;on the consolidated financial statements.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160;&#160;</p></ix:nonNumeric><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">44</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="c2808711" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">2</em> </b>&#8211;<b> MARKETABLE SECURITIES AND INVESTMENT OTHER SECURITIES</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On <em style="font: inherit;"> April 7, 2022, </em>the Company&#160;entered into an asset sale agreement to sell substantially all its manufacturing assets to a subsidiary of Steady State, LLC ("Steady State"). The equipment sale was initially valued at approximately $<ix:nonFraction id="c121825296" contextRef="d_2022-04-07_2022-04-07_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember" unitRef="USD" name="ycbd:EquipmentSoldValue" scale="6" format="ixt:num-dot-decimal" decimals="-5">1.8</ix:nonFraction> million for accounting purposes, the sale price consisting of a trade credit for products to be provided to the Company under the manufacturing and supply agreement and $<ix:nonFraction id="c121825297" contextRef="i_2022-04-07_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember" unitRef="USD" name="us-gaap:Investments" scale="6" format="ixt:num-dot-decimal" decimals="-5">1.4</ix:nonFraction> million of which the Company invested into Steady State in the form of an equity investment consistent with the terms of Steady State's completed Series C financing. &#160; The Company performed a valuation analysis and as of <em style="font: inherit;"> September 30, 2023 </em>determined a $<ix:nonFraction id="c121825298" contextRef="d_2023-09-30_2023-09-30_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember" unitRef="USD" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="0" format="ixt:num-dot-decimal" decimals="INF">700,000</ix:nonFraction> impairment was needed on the carrying value of this investment. The determination was based on a number of factors, including Steady State&#8217;s financial performance, our experience with production and cbdMD&#8217;s determination to re-source production to other suppliers. As such we believe it was prudent to reassess the carrying value of this non-liquid security. The Company performed an additional valuation analysis as of <em style="font: inherit;"> September 30, 2024 </em>and determined that <ix:nonFraction id="c121825299" contextRef="d_2024-09-30_2024-09-30_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember" unitRef="USD" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="0" format="ixt-sec:numwordsen" decimals="-3">no</ix:nonFraction> further impairment was needed based on factors such as Steady State's financial performance and re-alignment of the business.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">For the year ended <em style="font: inherit;"> September 30, 2024</em> and&#160;<em style="font: inherit;"> September 30, 2023</em> the Company recorded $<ix:nonFraction id="c121825300" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" scale="0" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction> and an unrealized loss of $<ix:nonFraction id="c121825301" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">700,000</ix:nonFraction>, respectively of realized and unrealized loss&#160;on marketable and other securities, including impairments.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The table below summarizes the&#160;assets and liabilities related to marketable and other securities valued at fair value as of <em style="font: inherit;"> September 30, 2024</em>:</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="c2808712" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">In Active</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><b><em style="font: inherit;">Markets for</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><b><em style="font: inherit;">Significant Other</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><b><em style="font: inherit;">Significant</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Identical Assets</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Observable</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Unobservable</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">and Liabilities</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Inputs</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Inputs</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(Level 1)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(Level 2)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(Level 3)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 55%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at September 30, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824819" contextRef="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member" unitRef="USD" name="us-gaap:FairValueNetAssetLiability" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824820" contextRef="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member" unitRef="USD" name="us-gaap:FairValueNetAssetLiability" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824821" contextRef="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member" unitRef="USD" name="us-gaap:FairValueNetAssetLiability" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">276,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in value of equities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824822" contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member" unitRef="USD" name="us-gaap:EquityFairValueAdjustment" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824823" contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member" unitRef="USD" name="us-gaap:EquityFairValueAdjustment" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824824" contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member" unitRef="USD" name="us-gaap:EquityFairValueAdjustment" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: Times New Roman;">Change in value of contingent liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824825" contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember" unitRef="USD" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824826" contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember" unitRef="USD" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824827" contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember" unitRef="USD" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Additional Investment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824828" contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member" unitRef="USD" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824829" contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member" unitRef="USD" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824830" contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member" unitRef="USD" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" scale="0" format="ixt:num-dot-decimal" decimals="INF">185,638</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at September 30, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824831" contextRef="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member" unitRef="USD" name="us-gaap:FairValueNetAssetLiability" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824832" contextRef="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member" unitRef="USD" name="us-gaap:FairValueNetAssetLiability" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824833" contextRef="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member" unitRef="USD" name="us-gaap:FairValueNetAssetLiability" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">90,362</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in value of contingent liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824834" contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember" unitRef="USD" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><ix:nonFraction id="c121824835" contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember" unitRef="USD" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824836" contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember" unitRef="USD" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" format="ixt:num-dot-decimal" decimals="INF">90,362</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr><td style="font-family: Times New Roman; font-size: 10pt;">Fair value of convertible notes</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824837" contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember" unitRef="USD" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" xsi:nil="true"></ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824838" contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember" unitRef="USD" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" xsi:nil="true"></ix:nonFraction></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824839" contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember" unitRef="USD" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,171,308</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824840" contextRef="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member" unitRef="USD" name="us-gaap:FairValueNetAssetLiability" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824841" contextRef="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member" unitRef="USD" name="us-gaap:FairValueNetAssetLiability" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824842" contextRef="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member" unitRef="USD" name="us-gaap:FairValueNetAssetLiability" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,171,308</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160; &#160;</p>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:InventoryDisclosureTextBlock" id="c2808713" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">3</em> </b>&#8211;<b> INVENTORY</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Inventory at <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> consists of the following:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="c2808714" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Finished Goods</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824847" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:InventoryFinishedGoods" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,534,718</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824848" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:InventoryFinishedGoods" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,782,680</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory Components</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824849" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:InventoryRawMaterialsAndSupplies" scale="0" format="ixt:num-dot-decimal" decimals="INF">830,469</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824850" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:InventoryRawMaterialsAndSupplies" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,397,034</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory Reserve</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824851" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:InventoryValuationReserves" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121824852" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:InventoryValuationReserves" scale="0" format="ixt:num-dot-decimal" decimals="INF">126,742</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory prepaid</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824853" contextRef="i_2024-09-30" unitRef="USD" name="ycbd:PrepaidInventory" scale="0" format="ixt:num-dot-decimal" decimals="INF">159,006</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824854" contextRef="i_2023-09-30" unitRef="USD" name="ycbd:PrepaidInventory" scale="0" format="ixt:num-dot-decimal" decimals="INF">182,675</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Inventory</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824855" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:InventoryNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,524,193</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824856" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:InventoryNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,235,647</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">45</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Abnormal amounts of idle facility expense, freight, handling costs, scrap, and wasted material (spoilage) are expensed in the period they are incurred and <em style="font: inherit;">no</em> material expenses related to these items occurred in the year ended <em style="font: inherit;"> September 30, 2024</em>. The Company wrote down inventory of $<ix:nonFraction id="c121825306" contextRef="d_2024-07-01_2024-09-30" unitRef="USD" name="us-gaap:InventoryWriteDown" scale="0" format="ixt:num-dot-decimal" decimals="INF">921,314</ix:nonFraction> during the <em style="font: inherit;">fourth</em> quarter of fiscal year ended <em style="font: inherit;"> September 30, 2024</em> primarily related to obsolete and expired stock keeping units (&#8220;SKU&#8221;s).&#160; We work hard to minimize inventory write-downs and slow moving and aging SKUs&#160;and work, as we work to streamline our offerings to higher velocity products and eliminate slow-moving and aging SKUs.</p>
  </ix:nonNumeric>
  <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;</p>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="c2808715" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">4</em> </b>&#8211;<b> PROPERTY AND EQUIPMENT</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Major classes of property and equipment at <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> consist of the following:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="c2808716" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Computers, furniture and equipment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824861" contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-ComputersFurnitureAndEquipmentMember" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,587,411</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824862" contextRef="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-ComputersFurnitureAndEquipmentMember" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,392,776</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Manufacturing equipment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824863" contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-ManufacturingEquipmentMember" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">284,275</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824864" contextRef="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-ManufacturingEquipmentMember" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">284,275</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Leasehold improvements</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824865" contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">487,081</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824866" contextRef="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">487,081</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Automobiles</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824867" contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-AutomobilesMember" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824868" contextRef="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-AutomobilesMember" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">11,087</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824869" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,358,767</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824870" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,175,219</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Less accumulated depreciation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824871" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,904,499</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824872" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,458,640</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Property and equipment, net</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824873" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">454,268</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824874" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">716,579</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Depreciation expense related to property and equipment was $<ix:nonFraction id="c121825310" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease" scale="0" format="ixt:num-dot-decimal" decimals="INF">452,326</ix:nonFraction>&#160;and $<ix:nonFraction id="c121825311" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease" scale="0" format="ixt:num-dot-decimal" decimals="INF">404,280</ix:nonFraction>&#160;for the year ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>, respectively. During the <em style="font: inherit;">third</em> quarter of fiscal year <em style="font: inherit;">2023,</em> the Company sold substantially all the assets of its manufacturing facility and as a result the gross investment and accumulated depreciation was removed from the balance sheet, reducing net PP&amp;E</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="c2808717" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">5</em> </b>&#8211; <b>INTANGIBLE ASSETS</b></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><span style="text-decoration: underline; ">Intangible Assets</span></b></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As of <em style="font: inherit;"> July 1, 2023 </em>the Company determined that based on market forces and the Company&#8217;s outlook it was prudent to adjust the useful lives of cbdMD&#8217;s and DCO intangibles to <ix:nonNumeric contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdmdAndDirectcbdonlineTrademarksMember" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="c121825316" format="ixt-sec:duryear">5</ix:nonNumeric> year useful lives and hempMD&#8217;s trademark to <ix:nonNumeric contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="c121825317" format="ixt-sec:duryear">10</ix:nonNumeric> year amortization to better reflect the outlook of the brands. This re-evaluation of the tradenames became a triggering event for a valuation test under ASC <em style="font: inherit;">360.</em> As a result of a multi-step approach under ASC <em style="font: inherit;">360</em> we determined that the &#8220;cbdMD,&#8221; &#8220;DirectCBDOnline&#8221; tradenames and the technology relieve asset was impaired by <em style="font: inherit;">$6,027,000,</em> and as a result, the amortization was adjusted to account for any changes in the value and estimated useful life of each asset.&#160; Amortization expense for the year ended <em style="font: inherit;"> September 30, 2024</em> was $<ix:nonFraction id="c121825321" contextRef="d_2023-10-01_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarksMember" unitRef="USD" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF">697,510</ix:nonFraction>&#160;and was recorded on the consolidated statements of operations.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">At <em style="font: inherit;"> September 30, 2023, </em>the Company prepared a tradename impairment analysis in accordance with ASC <em style="font: inherit;">360</em> and has determined that based on market sentiment and the sharp decline in combined market capitalization of the common stock and Series A Preferred as a result of the ongoing proxy vote, a triggering event occurred. The Company prepared an impairment analysis and as a result of a multi-step approach under ASC <em style="font: inherit;">360</em> we determined that the &#8220;cbdMD&#8221; DirectCBDOnline&#8221; tradenames and technology relieve were further impaired by $<ix:nonFraction id="c121825324" contextRef="d_2022-10-01_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdmdAndDirectcbdonlineTrademarksMember" unitRef="USD" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" format="ixt:num-dot-decimal" decimals="INF">7,192,000</ix:nonFraction> in fiscal year <em style="font: inherit;">2023,</em> resulting in a total impairment charge of $<ix:nonFraction id="c121825326" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" format="ixt:num-dot-decimal" decimals="INF">13,219,000</ix:nonFraction> for the fiscal year ended <em style="font: inherit;"> September 30, 2023.</em></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">At <em style="font: inherit;"> September 30, 2024, </em>the Company prepared a tradename impairment analysis in accordance with ASC <em style="font: inherit;">360</em> and has determined that <ix:nonFraction id="c121825328" contextRef="d_2023-10-01_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarksMember" unitRef="USD" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" format="ixt-sec:numwordsen" decimals="-3">no</ix:nonFraction> impairment existed.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;">2019,</em> Company&#8217;s subsidiary, CBD Industries, LLC, initiated a trademark cancellation proceeding against Majik Medicine, LLC (&#8220;Majik&#8221;) regarding Majik&#8217;s &#8220;CBD MD&#8221; trademark. In a Settlement, Purchase, and Release Agreement that occurred in <em style="font: inherit;"> August </em>of <em style="font: inherit;">2024,</em> the Company acquired the trademark, resolving all related legal claims. The agreement included a $<ix:nonFraction id="c121825331" contextRef="d_2024-08-01_2024-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember" unitRef="USD" name="ycbd:LitigationSettlementInitialPayment" scale="0" format="ixt:num-dot-decimal" decimals="INF">100,000</ix:nonFraction> initial payment, <em style="font: inherit;">four</em> additional annual payments of $<ix:nonFraction id="c121825333" contextRef="d_2024-08-01_2024-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember" unitRef="USD" name="ycbd:LitigationSettlementMonthlyPaymentAmount" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,000</ix:nonFraction>, the issuance of <ix:nonFraction id="c121825334" contextRef="d_2024-08-01_2024-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">75,000</ix:nonFraction> shares of common stock (the &#8220;Initial Shares&#8221;), and <ix:nonFraction id="c121825335" contextRef="d_2025-08-01_2025-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember_StatementScenarioAxis-ScenarioForecastMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,000</ix:nonFraction> more shares on the <em style="font: inherit;">one</em>-year anniversary. Failure to make the additional payments would reassign the trademark to Majik. Additionally, the Company entered a <span style="-sec-ix-hidden:c121825337">five</span>-year consulting agreement with Majik, granting a <ix:nonFraction id="c121825338" contextRef="d_2024-08-01_2024-08-31_CounterpartyNameAxis-MajikMedicinesMember" unitRef="Pure" name="ycbd:CommissionPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="2">15</ix:nonFraction>% commission on increased sales from Licensed Practitioners, a new customer base. This acquisition strengthens the Company&#8217;s IP portfolio, avoids litigation costs, and expedites trademark issuance. Majik also appointed board member William Raines III as a proxy for the Initial Shares for <em style="font: inherit;">12</em> months. The Company used the Black Scholes method to determine the fair value of the remaining shares to be paid on the <em style="font: inherit;">one</em>-year anniversary.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">At <em style="font: inherit;"> September 30, 2024, </em>the Company prepared a tradename impairment analysis in accordance with ASC <em style="font: inherit;">360</em> and has determined that <ix:nonFraction id="c121825342" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" format="ixt-sec:numwordsen" decimals="-3">no</ix:nonFraction> impairment existed.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Intangible assets as of <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> consisted of the following:</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="c2808718" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Trademark related to cbdMD</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824879" contextRef="i_2024-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToCbdmdMember" unitRef="USD" name="us-gaap:IndefiniteLivedTrademarks" scale="0" format="ixt:num-dot-decimal" decimals="INF">21,585,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824880" contextRef="i_2023-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToCbdmdMember" unitRef="USD" name="us-gaap:IndefiniteLivedTrademarks" scale="0" format="ixt:num-dot-decimal" decimals="INF">21,585,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Trademark for HempMD</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824881" contextRef="i_2024-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember" unitRef="USD" name="us-gaap:IndefiniteLivedTrademarks" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824882" contextRef="i_2023-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember" unitRef="USD" name="us-gaap:IndefiniteLivedTrademarks" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Technology Relief from Royalty related to DirectCBDOnline.com</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824883" contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">667,844</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824884" contextRef="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">667,844</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Tradename related to CBD MD limited mark</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824885" contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdMdLimintedMarkMember" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">368,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824886" contextRef="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdMdLimintedMarkMember" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Tradename related to DirectCBDOnline.com</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824887" contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TradenameRelatedToDirectCBDOnlineComMember" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">749,567</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824888" contextRef="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TradenameRelatedToDirectCBDOnlineComMember" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">749,567</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Impairment of definite lived intangible assets:</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">(<ix:nonFraction id="c121824889" contextRef="i_2024-09-30" unitRef="USD" name="ycbd:FinitelivedIntangibleAssetAccumulatedImpairment" scale="0" format="ixt:num-dot-decimal" decimals="INF">17,504,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">(<ix:nonFraction id="c121824890" contextRef="i_2023-09-30" unitRef="USD" name="ycbd:FinitelivedIntangibleAssetAccumulatedImpairment" scale="0" format="ixt:num-dot-decimal" decimals="INF">17,504,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Amortization of definite lived intangible assets:</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824891" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,026,831</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824892" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,329,321</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824893" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,889,580</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121824894" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,219,090</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">46</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Future amortization of intangible assets as of <em style="font: inherit;"> September 30, 2024</em> is as follow:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="c2808719" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>For the year ended September 30,</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2025</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824895" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="0" format="ixt:num-dot-decimal" decimals="INF">762,457</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824896" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="0" format="ixt:num-dot-decimal" decimals="INF">733,740</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2027</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824897" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="0" format="ixt:num-dot-decimal" decimals="INF">733,740</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2028</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824898" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="0" format="ixt:num-dot-decimal" decimals="INF">569,923</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c121824899" contextRef="i_2024-09-30" unitRef="USD" name="ycbd:FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="0" format="ixt:num-dot-decimal" decimals="INF">89,720</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total future intangibles amortization</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b><ix:nonFraction id="c121824900" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,889,580</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"><b>&#160;</b></td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;&#160;&#160; &#160;&#160;</p>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="c2808720" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">6</em> </b>&#8211;<b> CONTINGENT LIABILITY</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Pursuant to a merger agreement entered into in <em style="font: inherit;">2018,</em> the Company had a contractual obligation to issue <ix:nonFraction id="c121825347" contextRef="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember" unitRef="Share" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">338,889</ix:nonFraction> shares of its common stock, after approval by its shareholders, to the members of Cure Based Development, issued in <em style="font: inherit;">two</em> tranches <ix:nonFraction id="c121825349" contextRef="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-RegisteredCommonStockMember" unitRef="Share" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">144,445</ix:nonFraction> shares and <ix:nonFraction id="c121825350" contextRef="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStock2Member" unitRef="Share" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">194,945</ix:nonFraction> shares, both of which were subject to leak out provisions, and the unrestricted voting rights to <ix:nonFraction id="c121825351" contextRef="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStockMember" unitRef="Share" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">194,445</ix:nonFraction> tranche of shares which vested over a <span style="-sec-ix-hidden:c121825352">five</span> year period and were subject to a voting proxy agreement.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The contractual obligations and earn out provision were accounted for as a contingent liability and fair value was determined using Level <em style="font: inherit;">3</em> inputs, as estimating the fair value of these contingent liabilities require the use of significant and subjective inputs that <em style="font: inherit;"> may </em>and are likely to change over the duration of the liabilities with related changes in internal and external market factors.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The agreement also provided that an additional <ix:nonFraction id="c121825354" contextRef="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember" unitRef="Share" name="ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares" scale="0" format="ixt:num-dot-decimal" decimals="INF">338,889</ix:nonFraction> Earnout Shares would be issued as part of the consideration, upon the satisfaction of certain aggregate net revenue criteria by cbdMD within <ix:nonNumeric contextRef="d_2018-12-20_2018-12-20_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember" name="ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration" id="c121825355" format="ixt-sec:durmonth">60</ix:nonNumeric> months following the closing date of the merger&#160;</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="c2808721" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Aggregate Net Revenues</p> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">Shares Issued/ Each $ of Aggregate Net Revenue Ratio</em></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="width: 48%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 48%;">&#160;</td><td style="width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825661">1</span> - $<span style="-sec-ix-hidden:c121825662">20,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824903" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member" unitRef="Pure" name="ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.004236111</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825663">20,000,001</span> - $<span style="-sec-ix-hidden:c121825664">60,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824904" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member" unitRef="Pure" name="ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.002118056</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825665">60,000,001</span> - $<span style="-sec-ix-hidden:c121825666">140,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824905" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member" unitRef="Pure" name="ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.001059028</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825667">140,000,001</span> - $<span style="-sec-ix-hidden:c121825668">300,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824906" contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween140000001And300000000Member_RangeAxis-MinimumMember" unitRef="Pure" name="ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.005295139</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company determined the final Earnout shares to be issued were <ix:nonFraction id="c121825356" contextRef="d_2024-01-11_2024-01-11_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember" unitRef="Share" name="ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares" scale="0" format="ixt:num-dot-decimal" decimals="INF">19,818</ix:nonFraction> and were issued on <em style="font: inherit;"> January 11, 2024. </em>There is <em style="font: inherit;">no</em> further Earnout obligation.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;&#160;&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">47</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;&#160;</ix:exclude>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="c2808722" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">7</em> </b>&#8211;<b> RELATED PARTY TRANSACTIONS</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><em style="font: inherit;">None.</em></p>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="c2808723" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">8</em> </b>&#8211;<b> SHAREHOLDERS</b>&#8217;<b> EQUITY </b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Preferred Stock &#8211; The Company is authorized to issue <ix:nonFraction id="c121825362" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:PreferredStockSharesAuthorized" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction id="c121825363" contextRef="i_2024-09-30" unitRef="USDPerShare" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.001</ix:nonFraction> per share. In <em style="font: inherit;"> October 2019, </em>the Company designated <ix:nonFraction id="c121825364" contextRef="i_2019-10-31_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" unitRef="Share" name="us-gaap:PreferredStockSharesAuthorized" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction> of these shares as <ix:nonFraction id="c121825365" contextRef="d_2019-10-01_2019-10-31_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" unitRef="Pure" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" format="ixt:num-dot-decimal" decimals="2">8.0</ix:nonFraction>% Series A Cumulative Convertible Preferred Stock. Our <em style="font: inherit;">8.0%</em> Series A Cumulative Convertible Preferred Stock ranks senior to our common stock for liquidation or dividend provisions and holders are entitled to receive cumulative cash dividends at an annual rate of <em style="font: inherit;">8.0%</em> payable monthly in arrears for the prior month. The Company reviewed ASC <em style="font: inherit;">480</em> &#8211; <i>Distinguishing Liabilities from Equity </i>in order to determine the appropriate accounting treatment for the preferred stock and determined that the preferred stock should be treated as equity. There were <ix:nonFraction id="c121825369" contextRef="i_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" unitRef="Share" name="us-gaap:PreferredStockSharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,000,000</ix:nonFraction> shares of <ix:nonFraction id="c121825370" contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" unitRef="Pure" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" format="ixt:num-dot-decimal" decimals="2">8.0</ix:nonFraction>% Series A Cumulative Convertible Preferred Stock issued and outstanding at <em style="font: inherit;"> September 30, 2024</em> and <em style="font: inherit;"> September 30, 2023</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The total amount of dividends declared were $<ix:nonFraction id="c121825371" contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" unitRef="USD" name="us-gaap:DividendsCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,004,001</ix:nonFraction> and $<ix:nonFraction id="c121825372" contextRef="d_2022-10-01_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember" unitRef="USD" name="us-gaap:DividendsCash" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,002,005</ix:nonFraction> for the years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;"> September 30, 2023. </em>The Company suspended payment of the dividend in <em style="font: inherit;"> August </em>of <em style="font: inherit;">2023</em> and as such recorded an accrual of $<ix:nonFraction id="c121825374" contextRef="i_2023-08-30" unitRef="USD" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">667,000</ix:nonFraction> for the dividends declared but <em style="font: inherit;">not</em> paid as of <em style="font: inherit;"> September 30, 2023. </em>As of <em style="font: inherit;"> September 30, 2024, </em>the Accrued liability for the dividends declared but <em style="font: inherit;">not</em> paid totaled $<ix:nonFraction id="c121825377" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,669,000</ix:nonFraction> and continues to grow at approximately $<ix:nonFraction id="c121825378" contextRef="i_2024-09-30" unitRef="USD" name="ycbd:DividendsPayableQuarterlyGrowth" scale="6" format="ixt:num-dot-decimal" decimals="-6">1</ix:nonFraction> million per quarter.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Common Stock &#8211; The Company is authorized to issue <ix:nonFraction id="c121825379" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:CommonStockSharesAuthorized" scale="0" format="ixt:num-dot-decimal" decimals="INF">150,000,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction id="c121825380" contextRef="i_2024-09-30" unitRef="USDPerShare" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.001</ix:nonFraction> per share. There were <ix:nonFraction id="c121825381" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:CommonStockSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,939,057</ix:nonFraction> and <ix:nonFraction id="c121825382" contextRef="i_2023-09-30" unitRef="Share" name="us-gaap:CommonStockSharesIssued" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,960,573</ix:nonFraction> shares of common stock issued and outstanding at <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023,</em> respectively.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On <em style="font: inherit;"> March 2, 2023 </em>Company entered into a purchase agreement (the "ELOC") with Keystone Capital Partners, LLC (&#8220;Keystone&#8221;), pursuant to which Keystone committed to purchase up to <ix:nonFraction id="c121825384" contextRef="i_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember" unitRef="Share" name="ycbd:PurchaseCommitmentMaximumSharesCommitment" scale="0" format="ixt:num-dot-decimal" decimals="INF">281,934</ix:nonFraction> of shares of our common stock. Upon the execution of the ELOC, The Company issued <ix:nonFraction id="c121825385" contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,616</ix:nonFraction> shares of common stock as "Commitment Shares" to Keystone as consideration for its commitment to purchase shares of our common stock under the ELOC. An additional <ix:nonFraction id="c121825386" contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember" unitRef="Share" name="ycbd:ShareNumberStockIssuable" scale="0" format="ixt:num-dot-decimal" decimals="INF">6,104</ix:nonFraction> Commitment Shares were issued <em style="font: inherit;">180</em> days after the date of the ELOC. The <ix:nonFraction id="c121825388" contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember" unitRef="Share" name="ycbd:NumberOfSharesRegisteredForResale" scale="0" format="ixt:num-dot-decimal" decimals="INF">281,934</ix:nonFraction> shares of the Company's common stock were registered for resale and <em style="font: inherit;"> may </em>be issued under the ELOC or sold by us to Keystone at our discretion from time to time over a <em style="font: inherit;">12</em> month period commencing <em style="font: inherit;"> April 1, 2023. </em>The purchase price for the shares that the Company sold to Keystone under the ELOC fluctuated based on the price of the Company's common stock. Keystone purchased an aggregate of <ix:nonFraction id="c121825390" contextRef="d_2024-02-13_2024-02-13_CounterpartyNameAxis-KeystoneMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">180,955</ix:nonFraction> shares (<ix:nonFraction id="c121825391" contextRef="d_2022-10-01_2023-06-30" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits" scale="0" format="ixt:num-dot-decimal" decimals="INF">64,218</ix:nonFraction> of which were purchased during the year ended <em style="font: inherit;"> September 30, 2024) </em>under the ELOC, which expired in the <em style="font: inherit;">first</em> half of fiscal <em style="font: inherit;">2024.</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><span style="text-decoration: underline; ">Preferred stock transactions:</span></b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company had&#160;<em style="font: inherit;">no</em> preferred stock transactions in the year ended&#160;<em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><span style="text-decoration: underline; ">Common stock transactions:</span></b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In the year ended <em style="font: inherit;"> September 30, 2024</em>:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> September 2024, </em>the Company issued <ix:nonFraction id="c121825396" contextRef="d_2024-09-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember" unitRef="Share" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="0" format="ixt:num-dot-decimal" decimals="INF">100,624</ix:nonFraction> shares of common stock pursuant to the partial conversion of certain principal and interest related to the Notes.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> August 2024, </em>the Company issued <ix:nonFraction id="c121825397" contextRef="d_2024-08-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">75,000</ix:nonFraction> shares of common stock pursuant to the settlement agreement with Majik Medicine.&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> April 2024, </em>the Company issued an aggregate of <ix:nonFraction id="c121825398" contextRef="d_2024-04-01_2024-04-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember" unitRef="Share" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="0" format="ixt:num-dot-decimal" decimals="INF">714,229</ix:nonFraction> shares of common stock pursuant to the partial conversion of certain principal and interest related to the Notes.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> March 2024, </em>the company issued <ix:nonFraction id="c121825399" contextRef="d_2024-03-01_2024-03-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF">16,000</ix:nonFraction> of restricted stock awards to the Company&#8217;s board of directors. The shares vest quarterly on <em style="font: inherit;"> June 30, 2024, </em><em style="font: inherit;"> September 30, 2024, </em><em style="font: inherit;"> December 31, 2024, </em>and&#160;<em style="font: inherit;"> March 31, 2025. </em>The stock awards were valued at the fair market price of $<ix:nonFraction id="c121825400" contextRef="d_2024-03-01_2024-03-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember" unitRef="USD" name="ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="0" format="ixt:num-dot-decimal" decimals="INF">13,760</ix:nonFraction> and will amortize over the individual vesting periods.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> January 2024, </em>the Company issued <ix:nonFraction id="c121825401" contextRef="d_2024-01-01_2024-01-31_CounterpartyNameAxis-KeystoneMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">64,218</ix:nonFraction> shares under our ELOC.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> January 2024, </em>the Company issued <ix:nonFraction id="c121825402" contextRef="d_2024-01-01_2024-01-31_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" format="ixt:num-dot-decimal" decimals="INF">19,818</ix:nonFraction> shares as part of the final Earnout.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In the year ended <em style="font: inherit;"> September 30, 2023:</em></p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In <em style="font: inherit;"> September </em>of <em style="font: inherit;">2023,</em> the company issued <ix:nonFraction id="c121825404" contextRef="d_2023-09-01_2023-09-30_CounterpartyNameAxis-KeystoneMember_SubsidiarySaleOfStockAxis-PurchaseagreementMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">102,616</ix:nonFraction> shares under the Purchase Agreement to Keystone.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">In <em style="font: inherit;"> July </em>of <em style="font: inherit;">2023</em> the Company issued <ix:nonFraction id="c121825406" contextRef="d_2023-07-01_2023-07-31_CounterpartyNameAxis-KeystoneMember_SubsidiarySaleOfStockAxis-PurchaseagreementMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,616</ix:nonFraction> shares to Keystone pertaining to the commitment shares under the ELOC.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> May 3, 2023, </em>the Company completed an underwritten public offering of <ix:nonFraction id="c121825407" contextRef="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,350,000</ix:nonFraction> shares of its common stock at a public offering price of $<ix:nonFraction id="c121825408" contextRef="i_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember" unitRef="USDPerShare" name="us-gaap:SharesIssuedPricePerShare" scale="0" format="ixt:num-dot-decimal" decimals="INF">2.10</ix:nonFraction> per share. Gross proceeds from the offering before deducting underwriting discounts and commissions and offering expenses were approximately $<ix:nonFraction id="c121825409" contextRef="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember" unitRef="USD" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" format="ixt:num-dot-decimal" decimals="-5">2.8</ix:nonFraction> million. Under the terms of an underwriting agreement, the Company granted the underwriter an option, exercisable for <em style="font: inherit;">45</em> days, to purchase up to an additional <ix:nonFraction id="c121825411" contextRef="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-OverAllotmentOptionMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">202,500</ix:nonFraction> shares of common stock. The net proceeds to the Company from the offering were approximately $<ix:nonFraction id="c121825412" contextRef="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember" unitRef="USD" name="ycbd:ProceedsFromIssuanceOfCommonStockNet" scale="6" format="ixt:num-dot-decimal" decimals="-5">2.5</ix:nonFraction> million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, and does <em style="font: inherit;">not</em> take into account the exercise by the underwriter of its option to purchase additional shares of common stock. The Company also issued the underwriter a warrant to purchase up to <ix:nonFraction id="c121825414" contextRef="i_2023-05-03_ClassOfWarrantOrRightAxis-WarrantsWithPublicOfferingMember" unitRef="Share" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" format="ixt:num-dot-decimal" decimals="INF">40,500</ix:nonFraction> shares of its common stock exercisable at $<ix:nonFraction id="c121825415" contextRef="i_2023-05-03_ClassOfWarrantOrRightAxis-WarrantsWithPublicOfferingMember" unitRef="USDPerShare" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" format="ixt:num-dot-decimal" decimals="INF">2.52</ix:nonFraction> per share.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">48</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> April 24, 2023 </em>the Company issued a total of <ix:nonFraction id="c121825417" contextRef="d_2023-04-24_2023-04-24" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits" scale="0" format="ixt:num-dot-decimal" decimals="INF">39,533</ix:nonFraction>&#160;shares of common stock to account for rounding up of fractional shares related to the Reverse Stock Split.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> March 2, 2023, </em>the Company entered into the ELOC with Keystone, pursuant to which Keystone has committed to purchase up to <ix:nonFraction id="c121825418" contextRef="i_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember" unitRef="Share" name="ycbd:PurchaseCommitmentMaximumSharesCommitment" scale="0" format="ixt:num-dot-decimal" decimals="INF">281,934</ix:nonFraction> of shares of our common stock. Upon the execution of the ELOC, The Company issued <ix:nonFraction id="c121825419" contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,616</ix:nonFraction> shares of common stock as "Commitment Shares" to Keystone as consideration for its commitment to purchase shares of our common stock under the ELOC. Additional Commitment Shares (<ix:nonFraction id="c121825420" contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember" unitRef="Share" name="ycbd:ShareNumberStockIssuable" scale="0" format="ixt:num-dot-decimal" decimals="INF">6,104</ix:nonFraction>) will be issued over <em style="font: inherit;">180</em> days from <em style="font: inherit;"> March 2, 2023. </em>The <ix:nonFraction id="c121825422" contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember" unitRef="Share" name="ycbd:NumberOfSharesRegisteredForResale" scale="0" format="ixt:num-dot-decimal" decimals="INF">281,934</ix:nonFraction> shares of the Company's common stock were registered for resale and <em style="font: inherit;"> may </em>be issued under the ELOC or sold by us to Keystone at our discretion from time to time over a <em style="font: inherit;">12</em>-month period commencing <em style="font: inherit;"> April 1, 2023, </em>subject to a <em style="font: inherit;">75</em> day blackout period commencing <em style="font: inherit;"> April 30, 2023. </em>The purchase price for the shares that the Company <em style="font: inherit;"> may </em>sell to Keystone under the ELOC will fluctuate based on the price of the Company's common stock. Depending on market liquidity at the time, sales of such shares <em style="font: inherit;"> may </em>cause the trading price of our common stock to fall.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">In <em style="font: inherit;"> April 2023, </em>the Company issued <ix:nonFraction id="c121825425" contextRef="d_2023-04-01_2023-04-30_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" format="ixt:num-dot-decimal" decimals="INF">8,889</ix:nonFraction> shares to Keystone under the ELOC entered into in <em style="font: inherit;"> March </em>of <em style="font: inherit;">2023.</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> February 1, 2023, </em>the Company entered into an Agreement for Advertising Placement with <em style="font: inherit;">a360</em> Media, LLC (<em style="font: inherit;">&#8220;a360&#8221;</em>) in which <em style="font: inherit;">a360</em> will provide professional media support and advertising placement in exchange for up to <ix:nonFraction id="c121825430" contextRef="d_2023-01-30_2023-02-02_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" format="ixt:num-dot-decimal" decimals="INF">134,681</ix:nonFraction> shares of the Company&#8217;s common stock valued at $<ix:nonFraction id="c121825431" contextRef="i_2023-02-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember" unitRef="USDPerShare" name="us-gaap:SharesIssuedPricePerShare" scale="0" format="ixt:num-dot-decimal" decimals="INF">14.85</ix:nonFraction> per share. <em style="font: inherit;">A360</em> will receive the shares by providing the Company with a credit in the amount of $<ix:nonFraction id="c121825433" contextRef="i_2023-06-30_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember" unitRef="USD" name="ycbd:AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,000,000</ix:nonFraction> to be used for media support and advertising placement to the Company, of which $<ix:nonFraction id="c121825434" contextRef="i_2023-06-30_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember" unitRef="USD" name="ycbd:AgreementForAdvertisingPlacementUnutilizedAmount" scale="0" format="ixt:num-dot-decimal" decimals="INF">514,904</ix:nonFraction> remains unutilized as of <em style="font: inherit;"> September </em><em style="font: inherit;">30,2023.</em> The shares are <ix:nonFraction id="c121825436" contextRef="i_2023-06-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember" unitRef="Pure" name="ycbd:PercentageOfSharesFullyVested" scale="-2" format="ixt:num-dot-decimal" decimals="1">70</ix:nonFraction>% fully vested; <ix:nonFraction id="c121825437" contextRef="i_2023-06-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember" unitRef="Pure" name="ycbd:PercentageOfSharesVestUponEachAdvertisingPlacement" scale="-2" format="ixt:num-dot-decimal" decimals="2">15</ix:nonFraction>% of the Shares shall vest upon each advertising placement accrue pro-rata as percentage of the total advertising placement; and <ix:nonFraction id="c121825438" contextRef="i_2023-06-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember" unitRef="Pure" name="ycbd:PercentageOfSharesVestProvidedNoRestrictionsInProductCategories" scale="-2" format="ixt:num-dot-decimal" decimals="2">15</ix:nonFraction>% of the shares shall vest provided there are <em style="font: inherit;">no</em> restrictions in product categories that the Company is able to market with <em style="font: inherit;">a360</em> while the Company utilizes the advertising placement. Any shares which do <em style="font: inherit;">not</em> vest within the term of the agreement shall be forfeited. The Advertising Placement must be used by the Company prior to <em style="font: inherit;"> December 30, 2023, </em>unless otherwise agreed in writing by both parties.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> January </em>of <em style="font: inherit;">2023,</em> the Company issued <ix:nonFraction id="c121825443" contextRef="d_2023-01-01_2023-01-31_CounterpartyNameAxis-TwentyTwoCapitalMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,223</ix:nonFraction> shares of common stock to Twenty Two Capital as the final obligation under the <em style="font: inherit;">2021</em> acquisition agreement upon the expiration of the indemnification period.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">49</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><span style="text-decoration: underline; ">Stock option transactions:</span></b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In the year ended <em style="font: inherit;"> September 30, 2024</em>:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company granted its board of directors an aggregate of <ix:nonFraction id="c121825446" contextRef="d_2024-04-01_2024-04-01_TitleOfIndividualAxis-BoardOfDirectorsMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">8,000</ix:nonFraction> common stock options in <em style="font: inherit;"> April 2024. </em>The options vested immediately, have a strike price of $<ix:nonFraction id="c121825447" contextRef="i_2024-04-01_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.86</ix:nonFraction> and a <span style="-sec-ix-hidden:c121825448">five</span>-year term. The Company has recorded a total prepaid expense of approximately $<ix:nonFraction id="c121825449" contextRef="d_2024-04-01_2024-04-01_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember" unitRef="USD" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,300</ix:nonFraction> and intends to amortize the expense over the <em style="font: inherit;">12</em>-month board term.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In the year ended <em style="font: inherit;"> September 30, 2023:</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> February </em>of <em style="font: inherit;">2023,</em> the Company granted its board of directors an aggregate of <ix:nonFraction id="c121825452" contextRef="d_2023-01-30_2023-02-28_TitleOfIndividualAxis-BoardOfDirectorsMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,667</ix:nonFraction> common stock options. The options vested immediately, have a strike price of $<ix:nonFraction id="c121825453" contextRef="i_2023-02-28_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">12.60</ix:nonFraction> and a <span style="-sec-ix-hidden:c121825454">five</span>-year term. The Company has recorded a total prepaid expense of $<ix:nonFraction id="c121825455" contextRef="d_2023-01-30_2023-02-28_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember" unitRef="USD" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">21,120</ix:nonFraction> and intends to amortize the expense over the <em style="font: inherit;">12</em>-month board term.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> January 2023, </em>the Company issued <ix:nonFraction id="c121825457" contextRef="d_2023-01-01_2023-01-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,334</ix:nonFraction> options to a group of employees. The stock options awards vested at issuance, had a strike price of $<ix:nonFraction id="c121825458" contextRef="i_2023-01-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">10.53</ix:nonFraction>, <span style="-sec-ix-hidden:c121825459">five</span>-year term and a fair market value upon issuance of $<ix:nonFraction id="c121825460" contextRef="d_2023-01-01_2023-01-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember" unitRef="USD" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="0" format="ixt:num-dot-decimal" decimals="INF">15,225</ix:nonFraction>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> December 2022, </em>the Company issued <ix:nonFraction id="c121825461" contextRef="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,223</ix:nonFraction> options to an employee. <ix:nonFraction id="c121825462" contextRef="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,667</ix:nonFraction> options vest equally at each anniversary for the next <em style="font: inherit;">3</em> years, have a strike price of $<ix:nonFraction id="c121825464" contextRef="i_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">11.25</ix:nonFraction> and a <span style="-sec-ix-hidden:c121825465">five</span> year term. The total expense of these options is $<ix:nonFraction id="c121825466" contextRef="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember" unitRef="USD" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">13,150</ix:nonFraction> and will be amortized over the term of the vesting periods. <ix:nonFraction id="c121825467" contextRef="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestUponAchievingCertainRevenuePerformanceMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">556</ix:nonFraction> options vest based on meeting certain direct to consumer revenue requirements by the end of <em style="font: inherit;"> December 2024.</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company has recorded an expense for these options of $<ix:nonFraction id="c121825468" contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember" unitRef="USD" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">11,974</ix:nonFraction>&#160;for the <em style="font: inherit;">twelve</em> months ended <em style="font: inherit;"> September 30, 2024</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The expected volatility rate was estimated based on comparison to the volatility of a blend of the Company's own stock&#160;and a&#160;peer group of companies in similar industries. The expected term used was the full term of the contract for the issuances. The risk-free interest rate for periods within the contractual life of the option is based on U.S. Treasury securities. The pre-vesting forfeiture rate of <em style="font: inherit;">zero</em> is based upon the experience of the Company. As required under ASC <em style="font: inherit;">718,</em> the Company will adjust the estimated forfeiture rate to its actual experience. Management will continue to assess the assumptions and methodologies used to calculate estimated fair value of share-based compensation. Circumstances <em style="font: inherit;"> may </em>change and additional data <em style="font: inherit;"> may </em>become available over time, which could result in changes to these assumptions and methodologies, and thereby materially impact our fair value determination.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The following table summarizes the inputs used for the Black-Scholes pricing model on the options issued in the years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="c2808724" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average exercise price</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;" class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted"><ix:nonFraction id="c121824909" contextRef="i_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.54</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824910" contextRef="i_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">10.35</ix:nonFraction> - <ix:nonFraction id="c121824910a" contextRef="i_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">12.60</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Risk free interest rate</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824911" contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember" unitRef="Pure" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" format="ixt:num-dot-decimal" decimals="2">4</ix:nonFraction>%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824912" contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" unitRef="Pure" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" format="ixt:num-dot-decimal" decimals="4">3.93</ix:nonFraction>% - <ix:nonFraction id="c121824912a" contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" unitRef="Pure" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" format="ixt:num-dot-decimal" decimals="4">4.71</ix:nonFraction>%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Volatility</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824913" contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember" unitRef="Pure" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" format="ixt:num-dot-decimal" decimals="2">107</ix:nonFraction>%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824925" contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" unitRef="Pure" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" format="ixt:num-dot-decimal" decimals="4">106.48</ix:nonFraction>% - <ix:nonFraction id="c121824926" contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" unitRef="Pure" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" format="ixt:num-dot-decimal" decimals="4">106.51</ix:nonFraction>%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected term (in years)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="c121824915" format="ixt-sec:duryear">2.5</ix:nonNumeric></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonNumeric contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="c121824916" format="ixt-sec:duryear">2.5</ix:nonNumeric> - <ix:nonNumeric contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="c121824916a" format="ixt-sec:duryear">4</ix:nonNumeric></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Dividend yield</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">None</em></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">None</em></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">50</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><span style="text-decoration: underline; ">Warrant transactions:</span></b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The Company had <em style="font: inherit;">no</em> warrant transactions during the <em style="font: inherit;">twelve</em> months ended <em style="font: inherit;"> September 30, 2024.</em></p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;&#160;</p>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="c2808725" escape="true">
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>NOTE <em style="font: inherit;">9</em> -STOCK-BASED COMPENSATION</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Equity Compensation Plan &#8211; On <em style="font: inherit;"> June 2, 2015, </em>the Board of Directors of the Company approved the <em style="font: inherit;">2015</em> Equity Compensation Plan (<em style="font: inherit;">&#8220;2015</em> Plan&#8221;). The <em style="font: inherit;">2015</em> Plan made <ix:nonFraction id="c121825480" contextRef="i_2015-06-02_PlanNameAxis-The2015PlanMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" format="ixt:num-dot-decimal" decimals="INF">26,112</ix:nonFraction> common stock shares, either unissued or reacquired by the Company, available for awards of options, restricted stocks, other stock grants, or any combination thereof. The number of shares of common stock available for issuance under the <em style="font: inherit;">2015</em> Plan shall automatically increase on the <em style="font: inherit;">first</em> trading day of our fiscal year during the term of the <em style="font: inherit;">2015</em> Plan, beginning with calendar year <em style="font: inherit;">2016,</em> by an amount equal to <em style="font: inherit;">one</em> percent (<ix:nonFraction id="c121825486" contextRef="i_2015-06-02_PlanNameAxis-The2015PlanMember" unitRef="Pure" name="ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="2">1</ix:nonFraction>%) of the total number of shares of common stock outstanding on the last trading day in <em style="font: inherit;"> September </em>of the immediately preceding fiscal year, but in <em style="font: inherit;">no</em> event shall any such annual increase exceed <ix:nonFraction id="c121825488" contextRef="i_2015-06-02_PlanNameAxis-The2015PlanMember_RangeAxis-MaximumMember" unitRef="Share" name="ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,223</ix:nonFraction> shares of common stock. On <em style="font: inherit;"> April 19, 2019, </em>shareholders approved an amendment to the <em style="font: inherit;">2015</em> Plan and increased the number of shares available for issuance under the <em style="font: inherit;">2015</em> Plan to <ix:nonFraction id="c121825491" contextRef="d_2019-04-19_2019-04-19_PlanNameAxis-The2015PlanMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" format="ixt:num-dot-decimal" decimals="INF">45,445</ix:nonFraction> and retained the annual evergreen increase provision of the plan. Subsequent thereto, on <em style="font: inherit;"> August 7, 2019 </em>the Company&#8217;s Board of Directors approved an amendment to the <em style="font: inherit;">2015</em> Plan changing the date the automatic evergreen increase is determined to the <em style="font: inherit;">first</em> trading day of <em style="font: inherit;"> October </em>each calendar year during the term of the <em style="font: inherit;">2015</em> Plan to coincide with the Company&#8217;s fiscal year.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> January 8, 2021, </em>the Company&#8217;s Board of Directors approved the <em style="font: inherit;">2021</em> Equity Compensation Plan (the <em style="font: inherit;">&#8220;2021</em> Plan&#8221;) and it was subsequently ratified by its shareholders at its annual meeting held on <em style="font: inherit;"> March 12, 2021. </em>The purpose of the <em style="font: inherit;">2021</em> Plan is to advance the interests of the Company by providing an incentive to attract, retain and motivate highly qualified and competent persons who are important to it and upon whose efforts and judgment the success of the Company is largely dependent. The <em style="font: inherit;">2021</em> Plan made <ix:nonFraction id="c121825499" contextRef="i_2021-01-08_PlanNameAxis-The2021PlanMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" format="ixt:num-dot-decimal" decimals="INF">111,112</ix:nonFraction> common shares, either unissued or reacquired by the Company, available for awards of options, restricted stocks, other stock grants, or any combination thereof. The <em style="font: inherit;">2021</em> Plan also contains an &#8220;evergreen formula&#8221; pursuant to which the number of shares of common stock available for issuance under the <em style="font: inherit;">2021</em> Plan will automatically increase on <em style="font: inherit;"> October 1 </em>of each calendar year during the term of the <em style="font: inherit;">2021</em> Plan, beginning with calendar year <em style="font: inherit;">2022,</em> by an amount equal to <ix:nonFraction id="c121825504" contextRef="i_2021-01-08_PlanNameAxis-The2021PlanMember" unitRef="Pure" name="ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="2">1.0</ix:nonFraction>% of the total number of shares of common stock outstanding on <em style="font: inherit;"> September 30 </em>of such calendar year, up to a maximum of <ix:nonFraction id="c121825505" contextRef="i_2021-01-08_PlanNameAxis-The2021PlanMember_RangeAxis-MaximumMember" unitRef="Share" name="ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,556</ix:nonFraction> shares.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for stock-based compensation using the provisions of ASC <em style="font: inherit;">718.</em> ASC <em style="font: inherit;">718</em> codification requires companies to recognize the fair value of stock-based compensation expense in the financial statements based on the grant date fair value of the options. All options are approved by the Compensation, Corporate Governance and Nominating Committee of the Board of Directors. Restricted stock awards that vest in accordance with service conditions are amortized over their applicable vesting period using the straight-line method. The fair value of the Company&#8217;s stock option awards or modifications is estimated at the date of grant using the Black-Scholes option pricing model.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Eligible recipients include employees, officers, directors and consultants who are deemed to have rendered or to be able to render significant services to the Company or its subsidiaries and who are deemed to have contributed or to have the potential to contribute to the success of the Company. Options granted generally have a <span style="-sec-ix-hidden:c121825508">five</span>-to-<span style="-sec-ix-hidden:c121825509">ten</span>-year term and have vesting terms that cover <span style="-sec-ix-hidden:c121825510">one</span> to <span style="-sec-ix-hidden:c121825511">three</span> years from the date of grant. Certain of the stock options granted under the plan have been granted pursuant to various stock option agreements. Each stock option agreement contains specific terms.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Stock Options:</span></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company currently has awards outstanding with service conditions and graded-vesting features. We recognize compensation cost on a straight-line basis over the requisite service period.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The fair value of each time-based award is estimated on the date of grant using the Black-Scholes option valuation model. Our weighted-average assumptions used in the Black-Scholes valuation model for equity awards with time-based vesting provisions granted during the year.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">51</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table summarizes stock option activity under both plans for the fiscal years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="c2808726" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">remaining</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Aggregate</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">contractual term</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">intrinsic value</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Number of shares</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">exercise price</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(in years)</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(in thousands)</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Outstanding at September 30, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824947" contextRef="i_2022-09-30" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" format="ixt:num-dot-decimal" decimals="INF">55,656</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121824948" contextRef="i_2022-09-30" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">151.10</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"><ix:nonNumeric contextRef="d_2021-10-01_2022-09-30" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="c121824949" format="ixt-sec:duryear">4.55</ix:nonNumeric></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824951" contextRef="d_2022-10-01_2023-09-30" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">7,233</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824952" contextRef="d_2022-10-01_2023-09-30" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">11.51</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">-</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824955" contextRef="d_2022-10-01_2023-09-30" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824956" contextRef="d_2022-10-01_2023-09-30" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824959" contextRef="d_2022-10-01_2023-09-30" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF">21,124</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824960" contextRef="d_2022-10-01_2023-09-30" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">88.12</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824963" contextRef="i_2023-09-30" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" format="ixt:num-dot-decimal" decimals="INF">41,765</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824964" contextRef="i_2023-09-30" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">144.43</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonNumeric contextRef="d_2022-10-01_2023-09-30" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="c121824965" format="ixt-sec:duryear">3.65</ix:nonNumeric></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824967" contextRef="d_2023-10-01_2024-09-30" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">8,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824968" contextRef="d_2023-10-01_2024-09-30" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.86</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">-</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824971" contextRef="d_2023-10-01_2024-09-30" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824972" contextRef="d_2023-10-01_2024-09-30" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121824975" contextRef="d_2023-10-01_2024-09-30" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,730</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824976" contextRef="d_2023-10-01_2024-09-30" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">117.35</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824979" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" format="ixt:num-dot-decimal" decimals="INF">44,035</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824980" contextRef="i_2024-09-30" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">123.58</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="c121824981" format="ixt-sec:duryear">3.14</ix:nonNumeric></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="width: 40%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824983" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" format="ixt:num-dot-decimal" decimals="INF">44,035</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121824984" contextRef="i_2024-09-30" unitRef="USDPerShare" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">123.58</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="c121824985" format="ixt-sec:duryear">3.14</ix:nonNumeric></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of <em style="font: inherit;"> September 30, 2024</em>, there was approximately $<ix:nonFraction id="c121825514" contextRef="i_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember" unitRef="USD" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="0" format="ixt:num-dot-decimal" decimals="INF">7,858</ix:nonFraction> of total unrecognized compensation cost related to non-vested stock options which vest over a period of approximately <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="c121825515" format="ixt-sec:duryear">2.3</ix:nonNumeric> years.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Restricted Stock Award transactions:</span></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company issued <ix:nonFraction id="c121825516" contextRef="d_2024-03-01_2024-03-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF">16,000</ix:nonFraction> of restricted stock awards to the Company&#8217;s board of directors. The shares vest quarterly on <em style="font: inherit;"> June 30, 2024,&#160;</em><em style="font: inherit;"> September 30, 2024,&#160;</em><em style="font: inherit;"> December 31, 2024, </em>and&#160;<em style="font: inherit;"> March 31, 2025. </em>The stock awards were valued at the fair market price of <em style="font: inherit;">$4,296</em> upon issuance and will amortize over the individual vesting periods.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In the <em style="font: inherit;">twelve</em> months ended <em style="font: inherit;"> September 30, 2023:</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> February </em>of <em style="font: inherit;">2023,</em> the Company issued <ix:nonFraction id="c121825520" contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF">448</ix:nonFraction>&#160;restricted stock awards to the Company&#8217;s board of directors. The shares vest quarterly <span style="-sec-ix-hidden:c121825521"><span style="-sec-ix-hidden:c121825696">one</span></span> <em style="font: inherit;">fourth</em> on <em style="font: inherit;"> June 30, 2023, </em><em style="font: inherit;"><span style="-sec-ix-hidden:c121825697">one</span></em> fourth, on <em style="font: inherit;"> September 30, 2023, </em><span style="-sec-ix-hidden:c121825524"><span style="-sec-ix-hidden:c121825698">one</span></span> <span style="-sec-ix-hidden:c121825525">fourth</span> on <em style="font: inherit;"> December 31, 2023, </em>and <em style="font: inherit;"><span style="-sec-ix-hidden:c121825699">one</span></em> <span style="-sec-ix-hidden:c121825527">fourth</span> on <em style="font: inherit;"> March 31, 2024. </em>The stock awards were valued at the fair market price of $<ix:nonFraction id="c121825528" contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember" unitRef="USD" name="ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="0" format="ixt:num-dot-decimal" decimals="INF">5,660</ix:nonFraction> upon issuance and will amortize over the individual vesting periods.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> January 2023, </em>the Company issued <ix:nonFraction id="c121825529" contextRef="d_2023-01-01_2023-01-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,889</ix:nonFraction> shares to a group of employees. The shares vested upon issuance, having a fair market value upon issuance of $<ix:nonFraction id="c121825530" contextRef="d_2023-01-01_2023-01-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember" unitRef="USD" name="ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" scale="0" format="ixt:num-dot-decimal" decimals="INF">40,950</ix:nonFraction>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> December 2022, </em>the Company issued <ix:nonFraction id="c121825531" contextRef="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,112</ix:nonFraction> shares of restricted common stock to an employee. <ix:nonFraction id="c121825532" contextRef="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF">556</ix:nonFraction> shares vested upon issuance and the Company recorded a total expense of $<ix:nonFraction id="c121825533" contextRef="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember" unitRef="USD" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">6,250</ix:nonFraction>. <ix:nonFraction id="c121825534" contextRef="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" unitRef="Share" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF">556</ix:nonFraction> shares vest based on meeting certain direct to consumer revenue performance hurdles prior to <em style="font: inherit;"> December 2024.</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">52</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;&#160;</ix:exclude>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="ycbd:WarrantsDisclosureTextBlock" id="c2808727" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">10</em> </b>&#8211;<b> WARRANTS</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Transactions involving the Company equity-classified warrants for the fiscal years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> are summarized as follows:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30_ClassOfWarrantOrRightAxis-EquityClassifiedWarrantsMember" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="c2808728" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Number of shares</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average exercise price</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average remaining contractual term (in years)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Aggregate intrinsic value (in thousands)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824991" contextRef="i_2022-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember" unitRef="Share" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">13,204</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824992" contextRef="i_2022-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">210.45</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonNumeric contextRef="i_2022-10-01_AwardTypeAxis-WarrantsToPurchaseCommonStockMember" name="ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" id="c121824993" format="ixt-sec:duryear">2.30</ix:nonNumeric></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824995" contextRef="d_2022-10-01_2023-09-30" unitRef="Share" name="ycbd:ClassOfWarrantOrRightGrantsInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF">40,500</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824996" contextRef="d_2022-10-01_2023-09-30" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">2.52</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">-</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121824999" contextRef="d_2022-10-01_2023-09-30" unitRef="Share" name="ycbd:ClassOfWarrantOrRightExercisesInPeriod" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825000" contextRef="d_2022-10-01_2023-09-30" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825003" contextRef="d_2022-10-01_2023-09-30" unitRef="Share" name="ycbd:ClassOfWarrantOrRightForfeituresInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,395</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825004" contextRef="d_2022-10-01_2023-09-30" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">242.55</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px; width: 52%;"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Outstanding at September 30, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"><ix:nonFraction id="c121825007" contextRef="i_2023-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember" unitRef="Share" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">50,309</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"><ix:nonFraction id="c121825008" contextRef="i_2023-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">37.75</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"><ix:nonNumeric contextRef="i_2022-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember" name="ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" id="c121825009" format="ixt-sec:duryear">2.30</ix:nonNumeric></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825011" contextRef="d_2023-10-01_2024-09-30" unitRef="Share" name="ycbd:ClassOfWarrantOrRightGrantsInPeriod" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825012" contextRef="d_2023-10-01_2024-09-30" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">-</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825015" contextRef="d_2023-10-01_2024-09-30" unitRef="Share" name="ycbd:ClassOfWarrantOrRightExercisesInPeriod" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825016" contextRef="d_2023-10-01_2024-09-30" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825019" contextRef="d_2023-10-01_2024-09-30" unitRef="Share" name="ycbd:ClassOfWarrantOrRightForfeituresInPeriod" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,352</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825020" contextRef="d_2023-10-01_2024-09-30" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">337.50</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825023" contextRef="i_2024-09-30" unitRef="Share" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">48,957</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825024" contextRef="i_2024-09-30" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">337.50</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonNumeric contextRef="i_2024-09-30" name="ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" id="c121825025" format="ixt-sec:duryear">4.07</ix:nonNumeric></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="width: 52%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121825027" contextRef="i_2024-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember" unitRef="Share" name="ycbd:ClassOfWarrantOrRightExercisable" scale="0" format="ixt:num-dot-decimal" decimals="INF">48,957</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121825028" contextRef="i_2024-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">29.48</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table summarizes outstanding common stock purchase warrants as of <em style="font: inherit;"> September 30, 2024</em>:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30_ClassOfWarrantOrRightAxis-CommonStockPurchaseWarrantsMember" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="c2808729" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Number of shares</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average exercise price</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18.1%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Expiration</em></b></p> </td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $176.06 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825034" contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringSeptember2023Member" unitRef="Share" name="ycbd:ClassOfWarrantOrRightExercisable" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,079</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825035" contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringSeptember2023Member" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">176.06</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">October 2024</em></p> </td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $56.25 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825037" contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringMay2024Member" unitRef="Share" name="ycbd:ClassOfWarrantOrRightExercisable" scale="0" format="ixt:num-dot-decimal" decimals="INF">822</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825038" contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringMay2024Member" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">56.25</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">January 2025</em></p> </td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $168.30 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825040" contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringOctober2024Member" unitRef="Share" name="ycbd:ClassOfWarrantOrRightExercisable" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,357</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825041" contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringOctober2024Member" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">168.30</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">December 2025</em></p> </td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $168.75 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825043" contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringJanuary2025Member" unitRef="Share" name="ycbd:ClassOfWarrantOrRightExercisable" scale="0" format="ixt:num-dot-decimal" decimals="INF">3,199</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825044" contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringJanuary2025Member" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">168.75</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">June 2026</em></p> </td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $2.52 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825046" contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringApril2028Member" unitRef="Share" name="ycbd:ClassOfWarrantOrRightExercisable" scale="0" format="ixt:num-dot-decimal" decimals="INF">40,500</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825047" contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringApril2028Member" unitRef="USDPerShare" name="ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" scale="0" format="ixt:num-dot-decimal" decimals="INF">2.52</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">April 2028</em></p> </td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">48,957</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">37.75</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;</p>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="c2808730" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">11</em> </b>&#8211;<b> COMMITMENTS AND CONTINGENCIES</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Commencing <em style="font: inherit;"> August 2019, </em>the Company&#8217;s executive offices were located at <em style="font: inherit;">8845</em> Red Oak Blvd, Charlotte, NC (the &#8220;Red Oak Facilities&#8221;) which we sub-leased under a sublease agreement dated <em style="font: inherit;"> July 11, 2019 </em>which expires <em style="font: inherit;"> December 2026 (</em>the &#8220;Red Oak Sublease&#8221;). We received a default notice from HSKL, Inc., the sub landlord, in <em style="font: inherit;"> September 2023. </em>Effective <em style="font: inherit;"> March 20, 2024 </em>we entered into a License Agreement, dated as of <em style="font: inherit;"> March 14, 2024, </em>by and between cbdMD, Inc. and HSKL (the &#8220;License Agreement&#8221;) and Lease Forbearance Agreement, dated as of <em style="font: inherit;"> March 14, 2024, </em>by and between cbdMD, Inc. and HSKL (the &#8220;Forbearance Agreement&#8221;). Under the License Agreement we have granted HSKL a license to possess and use a portion of the Red Oak Facilities until the earlier of (i) the termination of the Forbearance Agreement and (ii) <em style="font: inherit;"> July 31, 2024 (</em>the &#8220;Termination Date&#8221;). The termination of the License Agreement will result in termination of the Red Oak Sublease. Pursuant to the Forbearance Agreement HSKL has agreed to forbear from proceeding to exercise its remedies against us under the Red Oak Sublease, and the declaration of default related to past due rent in consideration of the following payments to HSKL: $<ix:nonFraction id="c121825540" contextRef="i_2024-03-20_LeaseContractualTermAxis-ForbearanceAgreementMember" unitRef="USD" name="ycbd:PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement" scale="0" format="ixt:num-dot-decimal" decimals="INF">80,000</ix:nonFraction> upon the execution of the Forbearance Agreement, followed by <em style="font: inherit;">four</em> monthly payments of $<ix:nonFraction id="c121825542" contextRef="i_2024-03-20_LeaseContractualTermAxis-ForbearanceAgreementMember" unitRef="USD" name="ycbd:PastDueRentDefaultDeclarationMonthlyPayment" scale="0" format="ixt:num-dot-decimal" decimals="INF">40,000</ix:nonFraction>. HSKL&#8217;s forbearance shall extend to the Termination Date and HSKL shall dismiss (without prejudice) a Complaint in Summary Ejectment filed in Mecklenburg County, North Carolina on <em style="font: inherit;"> February 27, 2024. </em>In the event of our breach of any of the conditions of the Forbearance Agreement, HSKL&#8217;s obligation to forbear shall cease, and HSKL <em style="font: inherit;"> may </em>immediately exercise any and all of its rights or remedies at law, in equity or under the Red Oak Sublease. The Company made all payments required under the Forbearance Agreement and License Agreement and ultimately made a final settlement payment to completely exit all liability associated with the Red Oak Sublease.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:DebtDisclosureTextBlock" id="c2808731" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">12</em> </b>&#8211;<b> NOTE PAYABLE</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Effective <em style="font: inherit;"> February 1, 2024 (</em>the &#8220;Effective Date&#8221;), the Company entered into a Securities Purchase Agreement dated <em style="font: inherit;"> January 30, 2024 (</em>the &#8220;Purchase Agreement&#8221;) with <em style="font: inherit;">five</em> institutional investors (the &#8220;Investors&#8221;) whereby the Investors advanced the Company an aggregate of $<ix:nonFraction id="c121825545" contextRef="d_2024-01-30_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="USD" name="us-gaap:ProceedsFromConvertibleDebt" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,250,000</ix:nonFraction> gross proceeds and the Company issued each Investor an <ix:nonFraction id="c121825546" contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="Pure" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="2">8</ix:nonFraction>% Senior Secured Original Issue <ix:nonFraction id="c121825547" contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="Pure" name="ycbd:DebtInstrumentDiscountedPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="1">20</ix:nonFraction>% Discount Convertible Promissory Note, in the aggregate principal amount of $<ix:nonFraction id="c121825548" contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="USD" name="us-gaap:DebtInstrumentFaceAmount" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,541,666</ix:nonFraction> (the &#8220;Notes&#8221;). The Company intends to use the proceeds from the issuance of the Notes for working capital and general corporate purposes.&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Each Note bears interest of <ix:nonFraction id="c121825549" contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="Pure" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" format="ixt:num-dot-decimal" decimals="2">8</ix:nonFraction>% per annum and matures on <em style="font: inherit;"> July 30, 2025. </em>The Note is convertible into shares of common stock at any time following the date of issuance at the Investor&#8217;s option at an initial conversion price of $<ix:nonFraction id="c121825550" contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="USDPerShare" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.684</ix:nonFraction> per share (the &#8220;Conversion Price&#8221;), subject to certain adjustments. If <em style="font: inherit;">30</em> calendar days, <em style="font: inherit;">60</em> calendar days, <em style="font: inherit;">90</em> calendar days, <em style="font: inherit;">120</em> calendar days, or <em style="font: inherit;">180</em> calendar days after the effective date of the Registration Statement (as defined below) (the &#8220;Adjustment Dates&#8221;), the Conversion Price then in effect is higher than the Market Conversion Price then in effect on the Adjustment Date, the Conversion Price shall automatically decrease to the Market Conversion Price (as defined under the Note). The Conversion Price is subject to a $<ix:nonFraction id="c121825556" contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember_RangeAxis-MinimumMember" unitRef="USDPerShare" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.30</ix:nonFraction> floor price. As of the filing date of this report, and after the final <em style="font: inherit;">180</em>-day adjustment, the effective Conversion Price is $<ix:nonFraction id="c121825558" contextRef="i_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="USDPerShare" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" format="ixt:num-dot-decimal" decimals="INF">0.5066</ix:nonFraction>.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Furthermore, at any time after the issuance of the Note, the Company <em style="font: inherit;"> may, </em>after written notice to the Investor, prepay any portion or all outstanding Principal Amount by paying an amount equal to <em style="font: inherit;">125%</em> of the Principal Amount then being prepaid (representing a <ix:nonFraction id="c121825560" contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="Pure" name="ycbd:DebtInstrumentPrepaymentPayablePercent" scale="-2" format="ixt:num-dot-decimal" decimals="2">25</ix:nonFraction>% prepayment premium payable to the Investor which shall <em style="font: inherit;">not</em> constitute a principal repayment); provided that a Registration Statement registering all of the Conversion Shares issuable under the Note shall have been declared effective. If the Company elects to prepay the Note, the Investor shall have the right, upon written notice to the Company within <em style="font: inherit;">five</em> trading days of the Investor&#8217;s receipt of a Prepayment Notice, to convert into common stock, up to <em style="font: inherit;">100%</em> of the Prepayment Amount at the Conversion Price, upon the terms provided in the Note.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">53</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Upon the occurrence of any Event of Default (as defined in the Note), the Interest rate shall automatically be increased to the lesser of <ix:nonFraction id="c121825565" contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="Pure" name="ycbd:DebtInstrumentInterestRateInDefault" scale="-2" format="ixt:num-dot-decimal" decimals="2">22</ix:nonFraction>% per annum or the highest amount permitted by law. In the event that such Event of Default is subsequently cured (and <em style="font: inherit;">no</em> other Event of Default then exists), the adjustment shall cease to be effective as of the day immediately following the date of such cure; provided that the Interest as calculated and unpaid at such increased rate during the continuance of such Event of Default shall continue to apply to the extent relating to the days after the occurrence of such Event of Default through and including the date of such cure of such Event of Default.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In addition, upon the occurrence of Event of Default, which has <em style="font: inherit;">not</em> been cured within any applicable cure period, the Company shall be obligated to pay to the Investor the Mandatory Default Amount, which Mandatory Default Amount shall be payable to the Investor on the date the Event of Default giving rise thereto occurs. In the event the Note shall be converted following the occurrence of an Event of Default, the Investor shall have the option to convert the Mandatory Default Amount, upon the terms provided in the Note.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Notes are secured by a <em style="font: inherit;">first</em> priority security interest as evidenced by and to the extent set forth in a Security Agreement, by and between the Company and the Investors.&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company elected the fair value option under ASC <em style="font: inherit;">825</em> Fair Value Measurements for the Notes. The Notes were initially recognized at a fair value of $<ix:nonFraction id="c121825570" contextRef="i_2023-03-31_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="USD" name="us-gaap:NotesPayableFairValueDisclosure" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,702,000</ix:nonFraction> on the balance sheet as of <em style="font: inherit;"> March </em><em style="font: inherit;">31,2024.</em> All subsequent changes in fair value, excluding the impact of the change in fair value related to instrument-specific credit risk are recorded in non-operating income. The changes in fair value related to instrument-specific credit risk is recorded through other comprehensive income (loss).&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The overall change in fair value of the Notes during the year&#160;ended <em style="font: inherit;"> September 30, 2024 </em>was a decrease of $<ix:nonFraction id="c121825572" contextRef="d_2023-10-01_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="USD" name="ycbd:FairValueAdjustmentOfDebt" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1,357,096</ix:nonFraction>. The overall change in principal value related to the conversion of Notes to commons stock during the year&#160;ended <em style="font: inherit;"> September </em><em style="font: inherit;">30,2024</em> was a decrease of $<ix:nonFraction id="c121825574" contextRef="d_2023-10-01_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="USD" name="ycbd:PrincipleAdjustmentsOfDebt" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">508,757</ix:nonFraction>. As of <em style="font: inherit;"> September 30, 2024, </em>total fair value of the Notes is $<ix:nonFraction id="c121825575" contextRef="i_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="USD" name="us-gaap:NotesPayableFairValueDisclosure" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,171,308</ix:nonFraction>, of which $<ix:nonFraction id="c121825576" contextRef="i_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" unitRef="USD" name="us-gaap:NotesPayable" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,032,909</ix:nonFraction> represents the total principal outstanding.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">54</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;&#160;</ix:exclude>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:LesseeOperatingLeasesTextBlock" id="c2808732" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">13</em> </b>&#8211;<b> LEASES</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has lease agreements for its corporate, warehouse and laboratory offices with lease periods expiring between <em style="font: inherit;">2024</em> and <em style="font: inherit;">2025.</em> ASC <em style="font: inherit;">842</em> requires the recognition of leasing arrangements on the consolidated balance sheet as right-of-use assets and liabilities pertaining to the rights and obligations created by the leased assets. The Company determines whether an arrangement is a lease at inception and classify it as finance or operating. All of the Company&#8217;s leases are classified as operating leases. The Company&#8217;s leases do <em style="font: inherit;">not</em> contain any residual value guarantees.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Right-of-use lease assets and corresponding lease liabilities are recognized at commencement date based on the present value of lease payments over the expected lease term. Since the interest rate implicit in our lease arrangements is <em style="font: inherit;">not</em> readily determinable, the Company determined an incremental borrowing rate for each lease based on the approximate interest rate on a collateralized basis with similar remaining terms and payments as of the lease commencement date to determine the present value of future lease payments. The Company&#8217;s lease terms <em style="font: inherit;"> may </em>include options to extend or terminate the lease.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In addition to the monthly base amounts in the lease agreements, the Company is required to pay real estate taxes, insurance and common area maintenance expenses during the lease terms.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Lease costs on operating leases are recognized on a straight-line basis over the lease term and included as a selling, general and administrative expense in the consolidated statements of operations.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Components of operating lease costs are summarized as follows:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:LeaseCostTableTextBlock" id="c9E61A528-94D7-436C-9286-31CA4A1C4B9D" escape="true" continuedAt="c7DFBFACD-79BB-4B41-AE36-23695E5BE969">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Year Ended</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Operating Lease Costs</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825055" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:OperatingLeaseCost" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,328,497</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Supplemental cash flow information related to operating leases is summarized as follows:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:continuation id="c7DFBFACD-79BB-4B41-AE36-23695E5BE969">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Year Ended</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash paid for amounts included in the measurement of operating lease liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825059" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:OperatingLeasePayments" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,421,610</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   </ix:continuation>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of <em style="font: inherit;"> September 30, 2024</em>, our operating leases had a weighted average remaining lease term of <ix:nonNumeric contextRef="i_2024-09-30" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="c121825584" format="ixt-sec:duryear">2.99</ix:nonNumeric> years and a weighted average discount rate of <ix:nonFraction id="c121825585" contextRef="i_2024-09-30" unitRef="Pure" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" format="ixt:num-dot-decimal" decimals="4">4.66</ix:nonFraction>%. Future minimum aggregate lease payments under operating leases as of <em style="font: inherit;"> September 30, 2024</em> are summarized as follows:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="c2808735" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>For the year ended September 30,</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825060" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="0" format="ixt:num-dot-decimal" decimals="INF">99,467</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total future lease payments</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825061" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="0" format="ixt:num-dot-decimal" decimals="INF">99,467</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Less interest</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825062" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="0" format="ixt:num-dot-decimal" decimals="INF">771</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total lease liabilities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121825063" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:OperatingLeaseLiability" scale="0" format="ixt:num-dot-decimal" decimals="INF">98,696</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">55</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:EarningsPerShareTextBlock" id="c2808736" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">14</em> </b>&#8211;<b> LOSS PER SHARE</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table sets forth the computation of basic and diluted earnings per share for the following periods:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="c2808737" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Basic:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825070" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">3,700,126</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825071" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">22,938,209</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividends paid or accrued</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825072" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,004,001</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825073" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,002,000</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net income loss attributable to cbdMD Inc. common shareholders</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121825074" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">7,704,127</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121825075" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">26,940,209</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Shares used in computing basic earnings per share</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction id="c121825076" contextRef="d_2023-10-01_2024-09-30" unitRef="Share" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,312,546</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction id="c121825077" contextRef="d_2022-10-01_2023-09-30" unitRef="Share" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,022,320</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Shares used in computing diluted earnings per share</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction id="c121825078" contextRef="d_2023-10-01_2024-09-30" unitRef="Share" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">4,312,546</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><ix:nonFraction id="c121825079" contextRef="d_2022-10-01_2023-09-30" unitRef="Share" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" format="ixt:num-dot-decimal" decimals="INF">2,022,320</ix:nonFraction></b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Earnings per share Basic:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Basic earnings per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825082" contextRef="d_2023-10-01_2024-09-30" unitRef="USDPerShare" name="us-gaap:EarningsPerShareBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1.79</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825083" contextRef="d_2022-10-01_2023-09-30" unitRef="USDPerShare" name="us-gaap:EarningsPerShareBasic" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">13.32</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Earnings per share Diluted:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Diluted earnings per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825084" contextRef="d_2023-10-01_2024-09-30" unitRef="USDPerShare" name="us-gaap:EarningsPerShareDiluted" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">1.79</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825085" contextRef="d_2022-10-01_2023-09-30" unitRef="USDPerShare" name="us-gaap:EarningsPerShareDiluted" scale="0" format="ixt:num-dot-decimal" decimals="INF" sign="-">13.32</ix:nonFraction></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">At the year ended&#160;<em style="font: inherit;"> September 30, 2024</em>, <ix:nonFraction id="c121825588" contextRef="d_2023-10-01_2024-09-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember" unitRef="Share" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" format="ixt:num-dot-decimal" decimals="INF">100,993</ix:nonFraction>&#160;potential shares underlying options, unvested RSUs and warrants as well as <ix:nonFraction id="c121825589" contextRef="d_2024-04-01_2024-06-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-SeriesACumulativeConvertiblePreferredStockMember" unitRef="Share" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" format="ixt:num-dot-decimal" decimals="INF">185,223</ix:nonFraction> shares&#160;issuable upon conversion of our Series A Preferred stock&#160;which are excluded from the shares used to calculate diluted loss per share as their inclusion would reduce net loss per share.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">56</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;&#160;</ix:exclude>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:IncomeTaxDisclosureTextBlock" id="c2808738" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">15</em> </b>&#8211;<b> INCOME TAXES </b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company generated operating losses for the years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> on which it has recognized a full valuation allowance. The Company accounts for is state franchise and minimum taxes as a component of its general and administrative expenses.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table presents the components of the provision for income taxes from continuing operations for the fiscal years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="c2808739" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended September 30,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Current</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Federal</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825092" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825093" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">State</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825094" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825095" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total current</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825096" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825097" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Federal</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825098" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825099" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">State</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825100" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825101" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total deferred</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825102" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825103" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total provision</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121825104" contextRef="d_2023-10-01_2024-09-30" unitRef="USD" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><ix:nonFraction id="c121825105" contextRef="d_2022-10-01_2023-09-30" unitRef="USD" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" format="ixt:fixed-zero" decimals="INF">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A reconciliation for the federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="c2808740" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended September 30,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Federal statutory income tax rate</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825112" contextRef="d_2023-10-01_2024-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" format="ixt:num-dot-decimal" decimals="2">21.0</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825113" contextRef="d_2022-10-01_2023-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" format="ixt:num-dot-decimal" decimals="2">21.0</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">State income taxes, net of federal benefit</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825114" contextRef="d_2023-10-01_2024-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" format="ixt:num-dot-decimal" decimals="3">2.1</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825115" contextRef="d_2022-10-01_2023-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" format="ixt:num-dot-decimal" decimals="3">1.4</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Permanent differences</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825116" contextRef="d_2023-10-01_2024-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" format="ixt:num-dot-decimal" decimals="3">11.9</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121825117" contextRef="d_2022-10-01_2023-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" format="ixt:num-dot-decimal" decimals="3" sign="-">1.5</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Contingent derivative expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825118" contextRef="d_2023-10-01_2024-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" format="ixt:num-dot-decimal" decimals="3">0.5</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825119" contextRef="d_2022-10-01_2023-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" format="ixt:num-dot-decimal" decimals="3">0.2</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr><td style="font-family: Times New Roman; font-size: 10pt;">Change in value of convertible debt</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121825120" contextRef="d_2023-10-01_2024-09-30" unitRef="Pure" name="ycbd:EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" scale="-2" format="ixt:num-dot-decimal" decimals="3" sign="-">2.5</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825121" contextRef="d_2022-10-01_2023-09-30" unitRef="Pure" name="ycbd:EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" scale="-2" format="ixt:num-dot-decimal" decimals="-3">0.0</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in valuation allowance</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121825122" contextRef="d_2023-10-01_2024-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" format="ixt:num-dot-decimal" decimals="2" sign="-">33.0</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121825123" contextRef="d_2022-10-01_2023-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" format="ixt:num-dot-decimal" decimals="3" sign="-">21.1</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Provision for income taxes</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825124" contextRef="d_2023-10-01_2024-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" format="ixt:num-dot-decimal" decimals="-3">0.0</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825125" contextRef="d_2022-10-01_2023-09-30" unitRef="Pure" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" format="ixt:num-dot-decimal" decimals="-3">0.0</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Significant components of the Company&#8217;s deferred income taxes are shown below:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="c2808741" escape="true">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended September 30,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax assets:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net operating loss carryforwards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825130" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" format="ixt:num-dot-decimal" decimals="INF">15,478,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825131" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" format="ixt:num-dot-decimal" decimals="INF">14,784,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">ROU - Liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825132" contextRef="i_2024-09-30" unitRef="USD" name="ycbd:RightOfUseLiability" scale="0" format="ixt:num-dot-decimal" decimals="INF">22,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825133" contextRef="i_2023-09-30" unitRef="USD" name="ycbd:RightOfUseLiability" scale="0" format="ixt:num-dot-decimal" decimals="INF">824,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Capital loss carryforward</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825134" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="0" format="ixt:num-dot-decimal" decimals="INF">702,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825135" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="0" format="ixt:num-dot-decimal" decimals="INF">702,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Allowance for doubtful accounts</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825136" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="0" format="ixt:num-dot-decimal" decimals="INF">77,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825137" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="0" format="ixt:num-dot-decimal" decimals="INF">9,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Stock compensation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825138" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="0" format="ixt:num-dot-decimal" decimals="INF">481,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825139" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="0" format="ixt:num-dot-decimal" decimals="INF">521,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Intangibles</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121825140" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF">176,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><ix:nonFraction id="c121825141" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="0" format="ixt:num-dot-decimal" decimals="INF">105,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Investments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825142" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsInvestments" scale="0" format="ixt:num-dot-decimal" decimals="INF">573,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825143" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsInvestments" scale="0" format="ixt:num-dot-decimal" decimals="INF">180,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accrued expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825144" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsTaxDeferredExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">101,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825145" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsTaxDeferredExpense" scale="0" format="ixt:num-dot-decimal" decimals="INF">87,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Fixed Assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825146" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="0" format="ixt:num-dot-decimal" decimals="INF">57,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825147" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="0" format="ixt:num-dot-decimal" decimals="INF">45,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory reserve</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825148" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsInventory" scale="0" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825149" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsInventory" scale="0" format="ixt:num-dot-decimal" decimals="INF">28,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Capitalized expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825150" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsOther" scale="0" format="ixt:num-dot-decimal" decimals="INF">146,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825151" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsOther" scale="0" format="ixt:num-dot-decimal" decimals="INF">43,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Charitable contributions</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825152" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards" scale="0" format="ixt:num-dot-decimal" decimals="INF">13,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonFraction id="c121825153" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards" scale="0" format="ixt:num-dot-decimal" decimals="INF">39,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total deferred tax assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825154" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">17,826,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825155" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsGross" scale="0" format="ixt:num-dot-decimal" decimals="INF">17,367,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax liabilities:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid Expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121825156" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="0" format="ixt:num-dot-decimal" decimals="INF">76,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121825157" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="0" format="ixt:num-dot-decimal" decimals="INF">107,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">ROU - Assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121825158" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="0" format="ixt:num-dot-decimal" decimals="INF">19,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(<ix:nonFraction id="c121825159" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="0" format="ixt:num-dot-decimal" decimals="INF">750,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Intangibles</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c121825160" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c121825161" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total deferred tax liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825162" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredIncomeTaxLiabilities" scale="0" format="ixt:num-dot-decimal" decimals="INF">95,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825163" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredIncomeTaxLiabilities" scale="0" format="ixt:num-dot-decimal" decimals="INF">857,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net deferred tax assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c121825164" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">17,731,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c121825165" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="0" format="ixt:num-dot-decimal" decimals="INF">16,510,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Valuation allowance</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825166" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" format="ixt:num-dot-decimal" decimals="INF">17,731,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(<ix:nonFraction id="c121825167" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" format="ixt:num-dot-decimal" decimals="INF">16,510,000</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net deferred tax liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825168" contextRef="i_2024-09-30" unitRef="USD" name="us-gaap:DeferredTaxLiabilities" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><ix:nonFraction id="c121825169" contextRef="i_2023-09-30" unitRef="USD" name="us-gaap:DeferredTaxLiabilities" scale="0" format="ixt:fixed-zero" decimals="INF" sign="-">-</ix:nonFraction></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   </ix:nonNumeric>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <ix:exclude>
    <div class="PGFTR" style="text-align: center; width: 100%">
     <div class="hf-row">
      <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
       <em style="font: inherit;">57</em>
      </div>
     </div>
    </div>
    <hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
    <div class="PGHDR" style="text-align: left; width: 100%">
     <div class="hf-row">
      <div class="hf-cell TOCLink" style="display: inline-block; text-align: left;">
       <a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a>
      </div>
     </div>
    </div>
   </ix:exclude>
   <ix:exclude>&#160;</ix:exclude>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Net deferred tax liability</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has established a valuation allowance against net deferred tax assets due to the uncertainty that such assets will be realized. The deferred tax liabilities that result from indefinite life intangibles cannot be offset by deferred tax assets. The Company periodically evaluates the recoverability of the deferred tax assets. At such time as it is determined that it is more likely than <em style="font: inherit;">not</em> that deferred tax assets will be realizable, the valuation allowance will be reduced. Under Internal Revenue Code (IRC) Section <em style="font: inherit;">382,</em> the use of net operating loss (&#8220;NOL&#8221;) carryforwards <em style="font: inherit;"> may </em>be limited if a change in ownership of a company occurs. During the year ending <em style="font: inherit;"> September 30, 2018, </em>the company determined that a change of ownership under IRC Section <em style="font: inherit;">382</em> had occurred during the years ending <em style="font: inherit;"> September 30, 2017 </em>and <em style="font: inherit;">2015.</em> As a result of these ownership changes, the pre-ownership change NOL carryforwards would be limited and approximately $<ix:nonFraction id="c121825599" contextRef="i_2018-09-30" unitRef="USD" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" scale="6" format="ixt:num-dot-decimal" decimals="-5">2.1</ix:nonFraction> million of such NOLs will expire before being utilized. Therefore, at <em style="font: inherit;"> September 30, 2018 </em>the Company reduced the deferred tax asset and related valuation allowance associated with these NOLs by approximately $<ix:nonFraction id="c121825600" contextRef="i_2018-09-30" unitRef="USD" name="ycbd:DeferredTaxAssetAndRelatedValuationAllowance" scale="6" format="ixt:num-dot-decimal" decimals="-5">0.5</ix:nonFraction> million due to IRC Section <em style="font: inherit;">382.</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> September 30, 2024</em>, the Company has utilizable NOL carryforwards of approximately $<ix:nonFraction id="c121825602" contextRef="i_2024-09-30" unitRef="USD" name="ycbd:DeferredTaxAssetAndRelatedValuationAllowance" scale="6" format="ixt:num-dot-decimal" decimals="-5">69.1</ix:nonFraction>&#160;million which for federal purposes will carryforward indefinitely.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for its state franchise and minimum taxes as a component of its general and administrative expenses.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company files income tax returns in the United States, and various state jurisdictions. The Company&#8217;s policy is to recognize interest expense and penalties related to income tax matters as tax expense. At <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>, there are <em style="font: inherit;">no</em> unrecognized tax benefits, and there are <em style="font: inherit;">no</em> significant accruals for interest related to unrecognized tax benefits or tax penalties.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has had a valuation allowance against the net deferred tax assets, with the exception of the deferred tax liabilities that result from indefinite-life intangibles ("naked credits"). During the year ended <em style="font: inherit;"> September 30, 2021,&#160;</em>the Company generated enough indefinite life deferred tax assets from post-merger NOLs to reduce the naked credits to <em style="font: inherit;">zero</em> during the year and continue to record a valuation allowance on remaining deferred tax assets.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160; &#160;&#160;</p>
  </ix:nonNumeric>
  <div>
   &#160;
  </div>
  <ix:nonNumeric contextRef="d_2023-10-01_2024-09-30" name="us-gaap:SubsequentEventsTextBlock" id="c2808742" escape="true">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">16</em> </b>&#8211;<b> SUBSEQUENT EVENTS</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">During the <em style="font: inherit;">first</em> quarter of fiscal <em style="font: inherit;">2025,</em> the Company issued an aggregate of <ix:nonFraction id="c121825610" contextRef="d_2024-10-01_2024-12-17_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_SubsequentEventTypeAxis-SubsequentEventMember" unitRef="Share" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="0" format="ixt:num-dot-decimal" decimals="INF">1,421,067</ix:nonFraction> shares of common stock pursuant to the partial conversion of certain principal and interest related to the Notes. As of the filing date of this report, the Notes have a principal balance of approximately $<ix:nonFraction id="c121825611" contextRef="i_2024-12-17_SubsequentEventTypeAxis-SubsequentEventMember" unitRef="USD" name="us-gaap:NotesPayable" scale="0" format="ixt:num-dot-decimal" decimals="INF">364,000</ix:nonFraction>.&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Effective <em style="font: inherit;"> November 26, 2024, </em>cbdMD, Inc. entered into a Second Amendment to Lease (the &#8220;Amendment&#8221;) to extend the Warehouse Lease entered into on <em style="font: inherit;"> August 27, 2019 (</em>the &#8220;Lease&#8221;) for approximately <ix:nonFraction id="c121825612" contextRef="i_2024-11-26_LeaseContractualTermAxis-WarehouseLeaseMember_SubsequentEventTypeAxis-SubsequentEventMember" unitRef="SquareFoot" name="us-gaap:AreaOfRealEstateProperty" scale="0" format="ixt:num-dot-decimal" decimals="INF">80,000</ix:nonFraction> square feet of space located at <em style="font: inherit;">2101</em> Westinghouse Boulevard, Suite A, Charlotte, North Carolina <em style="font: inherit;">28273,</em> which facility also serves as the Company&#8217;s executive offices. The Amendment extends the term of the Lease for a period of <span style="-sec-ix-hidden:c121825615">nineteen</span> months beginning on <em style="font: inherit;"> March 1, 2025 </em>with a new expiration date of <em style="font: inherit;"> September 30, 2026. </em>The Company has <em style="font: inherit;">no</em> further rights to extend or renew the terms of the Lease. The Amendment provides for the monthly base rent of $<ix:nonFraction id="c121825617" contextRef="i_2026-02-28_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember" unitRef="USD" name="ycbd:LesseeOperatingLeasesMonthlyBaseRent" scale="0" format="ixt:num-dot-decimal" decimals="INF">65,000</ix:nonFraction>, with an annual base rent of $<ix:nonFraction id="c121825618" contextRef="d_2025-03-01_2026-02-28_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember" unitRef="USDPerPerShare" name="ycbd:OperatingLeasesRentExpensePerSquareFoot" scale="0" format="ixt:num-dot-decimal" decimals="INF">9.75</ix:nonFraction> per square feet from <em style="font: inherit;"> March 1, 2025 </em>through <em style="font: inherit;"> February 28, 2026, </em>and $<ix:nonFraction id="c121825619" contextRef="i_2026-09-30_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember" unitRef="USD" name="ycbd:LesseeOperatingLeasesAnnualBaseRent" scale="0" format="ixt:num-dot-decimal" decimals="INF">67,600</ix:nonFraction> with an annual base rent of $<ix:nonFraction id="c121825620" contextRef="d_2026-03-01_2026-09-30_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember" unitRef="USDPerPerShare" name="ycbd:OperatingLeasesRentExpensePerSquareFoot" scale="0" format="ixt:num-dot-decimal" decimals="INF">10.14</ix:nonFraction> per square feet from <em style="font: inherit;"> March 1, 2026 </em>through <em style="font: inherit;"> September 30, 2026. </em>The Company shall also continue to pay Additional Rent and all other amounts (other than &#8220;Monthly Base Rent&#8221;) in accordance with the terms of the Lease, except the &#8220;Controllable CAM Charges provision in Section <em style="font: inherit;">3</em> of Exhibit C to the Lease shall be deemed deleted from the Lease. Furthermore, as set forth under the Amendment the landlord has approved certain subleases entered into by and between the Company and sub tenants for portions of the facility.</p>
   <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
   <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During <em style="font: inherit;"> November 2024, </em>the Company engaged a consultant and issued <ix:nonFraction id="c121825622" contextRef="d_2024-11-01_2024-11-30_AwardTypeAxis-RestrictedStockMember_CounterpartyNameAxis-ConsultantMember_SubsequentEventTypeAxis-SubsequentEventMember" unitRef="Share" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" format="ixt:num-dot-decimal" decimals="INF">175,000</ix:nonFraction> shares of restricted common stock for advisory services.&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
  </ix:nonNumeric>
  <div class="LAST-PAGE-BREAK">
   <div class="PGFTR">
    <div class="hf-row">
     <div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">
      58
     </div>
    </div>
   </div>
  </div>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ex_722096.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html><head>
	<title>ex_722096.htm</title>
	<!-- Generated by ThunderDome Portal - 12/17/2024 9:37:31 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>EXHIBIT 23.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Consent of Independent Registered Public Accounting Firm</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">We hereby consent to the incorporation by reference of our report dated December 17,&nbsp;2024, relating to the audits of the consolidated balance sheets of cbdMD, Inc. and subsidiaries (the &#8220;Company&#8221;) as of September 30, 2024 and 2023 and the related consolidated statements of operations, comprehensive income (loss), shareholders&#8217; (deficit) equity, and cash flows for the years then ended, included in the Company&#8217;s Annual Report on Form 10-K for the year ended September&nbsp;30, 2024, which is filed with the United States Securities and Exchange Commission (the &#8220;SEC&#8221;), in the Company&#8217;s (i) Registration Statement on Form&nbsp;S&#8209;1, as amended<br>
(SEC File No. 333-270502), as declared effective by the SEC on September 28, 2018; (ii) Registration Statement on Form S-8 (SEC File No. 333-227746) as filed with the SEC on October&nbsp;9, 2018; (iii) Registration Statement on Form S-3, as amended (SEC File No. 333-264143), as declared effective by the SEC on April 21, 2022; (iv) Registration Statement on Form S-8 (SEC File No.&nbsp;333-233291) as filed with the SEC on August 15, 2019; (v) Registration Statement on Form S-8 (SEC File No. 333-252481) as filed with the SEC on January 27, 2021; (vi) Registration Statement on Form&nbsp;S&#8209;8 (SEC File No. 333-254974) as filed with the SEC on April 1, 2021; and (vii) Registration Statement on Form S-1 (SEC File No. 333-277124) as filed with the SEC on February 16, 2024.</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">.</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">/s/ Cherry Bekaert LLP</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Charlotte, North Carolina</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">December 18, 2024</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex_722097.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html><head>
	<title>ex_722097.htm</title>
	<!-- Generated by ThunderDome Portal - 12/17/2024 9:37:53 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>EXHIBIT 31.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Rule 13a-14(a)/15d-14(a) Certification</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">I, T. Ronan Kennedy, certify that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">I have reviewed this report on Form 10-K for the year ended&nbsp;<a data-tblloc="5x1" data-tblname="300139" data-tblv="8" id="led300139F20229111665515551710">September 30, 2024</a> of cbdMD, Inc.;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">3.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">4.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(a)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(b)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(c)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(d)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">5.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(a)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(b)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:26.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dated: December 18, 2024</p>
			</td>
			<td style="vertical-align:middle;width:1.6%;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:18.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ T. Ronan Kennedy</p>
			</td>
			<td style="vertical-align:middle;width:6.4%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">T. Ronan Kennedy, Chief Executive Officer (Principal executive officer)</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex_722098.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html><head>
	<title>ex_722098.htm</title>
	<!-- Generated by ThunderDome Portal - 12/17/2024 9:38:11 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>EXHIBIT 31.2</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Rule 13a-14(a)/15d-14(a) Certification</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">I, T. Ronan Kennedy, certify that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">I have reviewed this report on Form 10-K for the year ended&nbsp;<a data-tblloc="5x1" data-tblname="300139" data-tblv="8" id="led300139F20229111665515616257">September 30, 2024</a> of cbdMD, Inc.;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">3.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">4.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(a)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(b)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(c)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(d)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">5.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(a)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(b)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dated: December 18, 2024</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:18.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ T. Ronan Kennedy</p>
			</td>
			<td style="vertical-align:middle;width:6.4%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">T. Ronan Kennedy, Chief Financial Officer and principal financial officer</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>ex_722099.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html><head>
	<title>ex_722099.htm</title>
	<!-- Generated by ThunderDome Portal - 12/17/2024 9:38:32 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>EXHIBIT 32.1</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Section 1350 Certification</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">In connection with the Annual Report of cbdMD, Inc. (the &#8220;Company&#8221;) on Form 10-K for the year ended&nbsp;<a data-tblloc="5x1" data-tblname="300139" data-tblv="8" id="led300139F20229111665515649037">September 30, 2024</a> as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), I, T. Ronan Kennedy, Chief Executive Officer and Chief Financial Officer, of the Company, do hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes- Oxley Act of 2002, that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:2.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:auto;">December 18, 2024</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:18.8%;">/s/ T. Ronan Kennedy</td>
			<td style="vertical-align:middle;width:6.4%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">T. Ronan Kennedy, Chief Executive Officer and principal executive officer</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">December 18, 2024</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ T. Ronan Kennedy</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">T. Ronan Kennedy, Chief Financial Officer and principal financial officer</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ycbd-20240930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 06:03PM UTC 2024-12-18--><xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ycbd="http://www.cbdmd.com/20240930" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cbdmd.com/20240930">
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xsd:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd"/>
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
  <xsd:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xsd:import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xsd:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd"/>
  <xsd:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ycbd-20240930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ycbd-20240930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ycbd-20240930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ycbd-20240930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="statement-document-and-entity-information" roleURI="http://www.cbdmd.com/20240930/role/statement-document-and-entity-information">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-balance-sheets-" roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">001 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-balance-sheets-parentheticals" roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">002 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statements-of-operations" roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statements-of-comprehensive-loss" roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">004 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statement-of-cash-flows" roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">005 - Statement - Consolidated Statement of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-condensed-consolidated-statements-of-shareholders-equity" roleURI="http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">006 - Statement - Condensed Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-organization-and-summary-of-significant-accounting-policies" roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995453 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-marketable-securities-and-investment-other-securities" roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995454 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-inventory" roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995455 - Disclosure - Note 3 - Inventory</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment" roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995456 - Disclosure - Note 4 - Property and Equipment</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-intangible-assets" roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995457 - Disclosure - Note 5 - Intangible Assets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-contingent-liability" roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995458 - Disclosure - Note 6 - Contingent Liability</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-related-party-transactions" roleURI="http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995459 - Disclosure - Note 7 - Related Party Transactions</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-shareholders-equity" roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995460 - Disclosure - Note 8 - Shareholders' Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stock-based-compensation-" roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995461 - Disclosure - Note 9 - Stock Based Compensation</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-warrants" roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995462 - Disclosure - Note 10 - Warrants</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-commitments-and-contingencies-" roleURI="http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995463 - Disclosure - Note 11 - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-note-payable" roleURI="http://www.cbdmd.com/20240930/role/statement-note-12-note-payable">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995464 - Disclosure - Note 12 - Note Payable</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-leases" roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995465 - Disclosure - Note 13 - Leases</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-14-loss-per-share" roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995466 - Disclosure - Note 14 - Loss Per Share</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-15-income-taxes" roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995467 - Disclosure - Note 15 - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-16-subsequent-events" roleURI="http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995468 - Disclosure - Note 16 - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-significant-accounting-policies-policies" roleURI="http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995469 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995470 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-marketable-securities-and-investment-other-securities-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995471 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-inventory-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995472 - Disclosure - Note 3 - Inventory (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995473 - Disclosure - Note 4 - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-intangible-assets-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995474 - Disclosure - Note 5 - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-contingent-liability-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995475 - Disclosure - Note 6 - Contingent Liability (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-shareholders-equity-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995476 - Disclosure - Note 8 - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stock-based-compensation-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995477 - Disclosure - Note 9 - Stock Based Compensation (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-warrants-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995478 - Disclosure - Note 10 - Warrants (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-leases-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995479 - Disclosure - Note 13 - Leases (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-14-loss-per-share-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995480 - Disclosure - Note 14 - Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-15-income-taxes-tables" roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995481 - Disclosure - Note 15 - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995482 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995483 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-marketable-securities-and-investment-other-securities-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995484 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995485 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities - Assets Valued at Fair Value (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-inventory-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995486 - Disclosure - Note 3 - Inventory (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-inventory-schedule-of-inventory-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995487 - Disclosure - Note 3 - Inventory - Schedule of Inventory (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995488 - Disclosure - Note 4 - Property and Equipment (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995489 - Disclosure - Note 4 - Property and Equipment - Major Classes of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-intangible-assets-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995490 - Disclosure - Note 5 - Intangible Assets (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-intangible-assets-schedule-of-intangible-assets-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995491 - Disclosure - Note 5 - Intangible Assets - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995492 - Disclosure - Note 5 - Intangible Assets - Future Amortization of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-contingent-liability-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995493 - Disclosure - Note 6 - Contingent Liability (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-contingent-liability-contingent-liability-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995494 - Disclosure - Note 6 - Contingent Liability - Contingent Liability (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-contingent-liability-contingent-liability-details-parentheticals" roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995495 - Disclosure - Note 6 - Contingent Liability - Contingent Liability (Details) (Parentheticals)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-shareholders-equity-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995496 - Disclosure - Note 8 - Shareholders' Equity (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995497 - Disclosure - Note 8 - Shareholders' Equity - Fair Value Assumptions of Stock Options (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stock-based-compensation-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995498 - Disclosure - Note 9 - Stock Based Compensation (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995499 - Disclosure - Note 9 - Stock Based Compensation - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-warrants-schedule-of-equityclassified-warrants-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995500 - Disclosure - Note 10 - Warrants - Schedule of Equity-Classified Warrants (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995501 - Disclosure - Note 10 - Warrants - Summary of Outstanding Common Stock Purchase Warrants (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-commitments-and-contingencies-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995502 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-note-payable-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995503 - Disclosure - Note 12 - Note Payable (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-leases-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995504 - Disclosure - Note 13 - Leases (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995505 - Disclosure - Note 13 - Leases - Operating Lease Costs and Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-leases-future-minimum-aggregate-lease-payments-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995506 - Disclosure - Note 13 - Leases - Future Minimum Aggregate Lease Payments (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-14-loss-per-share-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995507 - Disclosure - Note 14 - Loss Per Share (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995508 - Disclosure - Note 14 - Loss Per Share - Basic and Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-15-income-taxes-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995509 - Disclosure - Note 15 - Income Taxes (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995510 - Disclosure - Note 15 - Income Taxes - Components of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995511 - Disclosure - Note 15 - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995512 - Disclosure - Note 15 - Income Taxes - Significant Components of Deferred Income Taxes (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-16-subsequent-events-details-textual" roleURI="http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">995513 - Disclosure - Note 16 - Subsequent Events (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="ycbd_A360MediaLlcMember" name="A360MediaLlcMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_AdvertisingPlacementAgreementMember" name="AdvertisingPlacementAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement" name="AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_AgreementForAdvertisingPlacementUnutilizedAmount" name="AgreementForAdvertisingPlacementUnutilizedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="ycbd_BoardOfDirectorsMember" name="BoardOfDirectorsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue" name="BusinessAcquisitionContingentConsiderationAggregateNetRevenue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" name="BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares" name="BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration" name="BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod" name="BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="ycbd_CapitalRaiseMember" name="CapitalRaiseMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_CaseWithMajikMedicinesMember" name="CaseWithMajikMedicinesMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_CbdMdLimintedMarkMember" name="CbdMdLimintedMarkMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" name="CbdmdAndDirectcbdonlineTrademarksMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_ClassOfWarrantOrRightExercisable" name="ClassOfWarrantOrRightExercisable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" name="ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_ClassOfWarrantOrRightExercisesInPeriod" name="ClassOfWarrantOrRightExercisesInPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" name="ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_ClassOfWarrantOrRightForfeituresInPeriod" name="ClassOfWarrantOrRightForfeituresInPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" name="ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_ClassOfWarrantOrRightGrantsInPeriod" name="ClassOfWarrantOrRightGrantsInPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" name="ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" name="ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" name="ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" name="CollectionOnDiscontinuedOperationsAccountsReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_CommissionPercentage" name="CommissionPercentage" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_CommitmentSharesMember" name="CommitmentSharesMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_CommonStockPurchaseWarrantsMember" name="CommonStockPurchaseWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" name="ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_ComputersFurnitureAndEquipmentMember" name="ComputersFurnitureAndEquipmentMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_ConsultantMember" name="ConsultantMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_ContingentLiabilityMember" name="ContingentLiabilityMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_ConversionOfNotesIntoCommonStockMember" name="ConversionOfNotesIntoCommonStockMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_ConvertibleNotesMember" name="ConvertibleNotesMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_CureBasedDevelopmentLlcMember" name="CureBasedDevelopmentLlcMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_DebtInstrumentDiscountedPercentage" name="DebtInstrumentDiscountedPercentage" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_DebtInstrumentInterestRateInDefault" name="DebtInstrumentInterestRateInDefault" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_DebtInstrumentPrepaymentPayablePercent" name="DebtInstrumentPrepaymentPayablePercent" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_DecreaseInApicIssuanceOfStock" name="DecreaseInApicIssuanceOfStock" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_DeferredTaxAssetAndRelatedValuationAllowance" name="DeferredTaxAssetAndRelatedValuationAllowance" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_DividendsPayableQuarterlyGrowth" name="DividendsPayableQuarterlyGrowth" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="ycbd_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" name="EarnoutSharesForRevenueBetween140000001And300000000Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_EarnoutSharesForRevenueBetween1And20000000Member" name="EarnoutSharesForRevenueBetween1And20000000Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" name="EarnoutSharesForRevenueBetween20000001And60000000Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" name="EarnoutSharesForRevenueBetween60000001And140000000Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" name="EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_EquipmentSoldValue" name="EquipmentSoldValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_EquityClassifiedWarrantsMember" name="EquityClassifiedWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_FairValueAdjustmentOfDebt" name="FairValueAdjustmentOfDebt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment" name="FinitelivedIntangibleAssetAccumulatedImpairment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" name="FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="ycbd_ForbearanceAgreementMember" name="ForbearanceAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_IncreaseDecreaseInPrepaidInventoryTotal" name="IncreaseDecreaseInPrepaidInventoryTotal" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" name="Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest" name="IssuanceOfSharesForConversionOfDebtAndAccruedInterest" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_KeystoneMember" name="KeystoneMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_LengthOfConsultingAgreement" name="LengthOfConsultingAgreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_LesseeOperatingLeasesAnnualBaseRent" name="LesseeOperatingLeasesAnnualBaseRent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_LesseeOperatingLeasesMonthlyBaseRent" name="LesseeOperatingLeasesMonthlyBaseRent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" name="LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_LitigationSettlementInitialPayment" name="LitigationSettlementInitialPayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_LitigationSettlementMonthlyPaymentAmount" name="LitigationSettlementMonthlyPaymentAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" name="LongtermDebtExcludingConvertibleNotesNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="ycbd_MajikMedicinesMember" name="MajikMedicinesMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_ManufacturingEquipmentMember" name="ManufacturingEquipmentMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_MerchantReceivableAndReservePolicyTextBlock" name="MerchantReceivableAndReservePolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_Merchantprocessingfee" name="Merchantprocessingfee" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_NetIncomeLossIncludingImpairment" name="NetIncomeLossIncludingImpairment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_NoteToFinancialStatementDetailsTextual" name="NoteToFinancialStatementDetailsTextual" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_NotesToFinancialStatements" name="NotesToFinancialStatements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_NumberOfMajorCustomers" name="NumberOfMajorCustomers" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_NumberOfSharesRegisteredForResale" name="NumberOfSharesRegisteredForResale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_OperatingExpensesExcludingImpairment" name="OperatingExpensesExcludingImpairment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_OperatingLeasesRentExpensePerSquareFoot" name="OperatingLeasesRentExpensePerSquareFoot" nillable="true" substitutionGroup="xbrli:item" type="srt-types:perUnitItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" name="OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" name="OtherthantemporaryImpairmentsOnOtherInvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_PastDueRentDefaultDeclarationMonthlyPayment" name="PastDueRentDefaultDeclarationMonthlyPayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement" name="PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_PercentageOfSharesFullyVested" name="PercentageOfSharesFullyVested" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories" name="PercentageOfSharesVestProvidedNoRestrictionsInProductCategories" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement" name="PercentageOfSharesVestUponEachAdvertisingPlacement" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_PreferredDividendsAccruedNotYetPaid" name="PreferredDividendsAccruedNotYetPaid" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_PrepaidInventory" name="PrepaidInventory" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_PrepaidSponsorship" name="PrepaidSponsorship" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_PrincipleAdjustmentsOfDebt" name="PrincipleAdjustmentsOfDebt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_ProceedsFromIssuanceOfCommonStockNet" name="ProceedsFromIssuanceOfCommonStockNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_PublicOfferingMember" name="PublicOfferingMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_PurchaseCommitmentMaximumSharesCommitment" name="PurchaseCommitmentMaximumSharesCommitment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="ycbd_PurchaseagreementMember" name="PurchaseagreementMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_RegisteredCommonStockMember" name="RegisteredCommonStockMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_ReverseStockSplitMember" name="ReverseStockSplitMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_RightOfUseLiability" name="RightOfUseLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_SalesAllowances" name="SalesAllowances" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_SalesChannelMember" name="SalesChannelMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_SeriesACumulativeConvertiblePreferredStockMember" name="SeriesACumulativeConvertiblePreferredStockMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_ShareNumberStockIssuable" name="ShareNumberStockIssuable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage" name="SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:percentItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares" name="SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_SharebasedPaymentArrangementTrancheFourMember" name="SharebasedPaymentArrangementTrancheFourMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_SoftwareMember" name="SoftwareMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_SteadyStateLlcMember" name="SteadyStateLlcMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_StockIssuedDuringPeriodValueReverseStockSplits" name="StockIssuedDuringPeriodValueReverseStockSplits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" name="TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_The2015PlanMember" name="The2015PlanMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_The2021PlanMember" name="The2021PlanMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_TrademarkRelatedToCbdmdMember" name="TrademarkRelatedToCbdmdMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_TrademarkRelatedToHempMdMember" name="TrademarkRelatedToHempMdMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_TradenameRelatedToDirectCBDOnlineComMember" name="TradenameRelatedToDirectCBDOnlineComMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_TwentyTwoCapitalMember" name="TwentyTwoCapitalMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_UnregisteredCommonStock2Member" name="UnregisteredCommonStock2Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_UnregisteredCommonStockMember" name="UnregisteredCommonStockMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" name="VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_VestUponAchievingCertainRevenuePerformanceMember" name="VestUponAchievingCertainRevenuePerformanceMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_VestingAnnuallyOverThreeYearsMember" name="VestingAnnuallyOverThreeYearsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_WarehouseLeaseMember" name="WarehouseLeaseMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_WarrantsDisclosureTextBlock" name="WarrantsDisclosureTextBlock" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_WarrantsExpiringApril2028Member" name="WarrantsExpiringApril2028Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_WarrantsExpiringJanuary2025Member" name="WarrantsExpiringJanuary2025Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_WarrantsExpiringMay2024Member" name="WarrantsExpiringMay2024Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_WarrantsExpiringOctober2024Member" name="WarrantsExpiringOctober2024Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_WarrantsExpiringSeptember2023Member" name="WarrantsExpiringSeptember2023Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_WarrantsToPurchaseCommonStockMember" name="WarrantsToPurchaseCommonStockMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_WarrantsWithPublicOfferingMember" name="WarrantsWithPublicOfferingMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="ycbd_WorkingCapital" name="WorkingCapital" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="ycbd_WriteOffOfPrepaidAssets" name="WriteOffOfPrepaidAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" name="statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" name="statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details" name="statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" name="statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-10-warrants-tables" name="statement-statement-note-10-warrants-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details" name="statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" name="statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-13-leases-tables" name="statement-statement-note-13-leases-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" name="statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-14-loss-per-share-tables" name="statement-statement-note-14-loss-per-share-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" name="statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" name="statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" name="statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-15-income-taxes-tables" name="statement-statement-note-15-income-taxes-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" name="statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-tables" name="statement-statement-note-2-marketable-securities-and-investment-other-securities-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-3-inventory-schedule-of-inventory-details" name="statement-statement-note-3-inventory-schedule-of-inventory-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-3-inventory-tables" name="statement-statement-note-3-inventory-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" name="statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-4-property-and-equipment-tables" name="statement-statement-note-4-property-and-equipment-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" name="statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details" name="statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-5-intangible-assets-tables" name="statement-statement-note-5-intangible-assets-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details" name="statement-statement-note-6-contingent-liability-contingent-liability-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals" name="statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-6-contingent-liability-tables" name="statement-statement-note-6-contingent-liability-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" name="statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-8-shareholders-equity-tables" name="statement-statement-note-8-shareholders-equity-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" name="statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-note-9-stock-based-compensation-tables" name="statement-statement-note-9-stock-based-compensation-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ycbd_statement-statement-significant-accounting-policies-policies" name="statement-statement-significant-accounting-policies-policies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>ycbd-20240930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 06:03PM UTC 2024-12-18--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows" xlink:href="ycbd-20240930.xsd#statement-consolidated-statement-of-cash-flows" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="us-gaap_GainLossOnTerminationOfLease" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockExpense" xlink:label="us-gaap_RestrictedStockExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:label="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FairValueAdjustmentOfDebt" xlink:label="ycbd_FairValueAdjustmentOfDebt" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_IncreaseDecreaseInPrepaidInventoryTotal" xlink:label="ycbd_IncreaseDecreaseInPrepaidInventoryTotal" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:label="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WriteOffOfPrepaidAssets" xlink:label="ycbd_WriteOffOfPrepaidAssets" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_RestrictedStockExpense" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_StockOptionPlanExpense" xlink:type="arc"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InventoryWriteDown" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ycbd_WriteOffOfPrepaidAssets" xlink:type="arc"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" xlink:type="arc"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:type="arc"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:type="arc"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ycbd_FairValueAdjustmentOfDebt" xlink:type="arc"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnTerminationOfLease" xlink:type="arc"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="arc"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ycbd_IncreaseDecreaseInPrepaidInventoryTotal" xlink:type="arc"/>
    <link:calculationArc order="21" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" xlink:type="arc"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:label="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:href="ycbd-20240930.xsd#statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations" xlink:href="ycbd-20240930.xsd#statement-consolidated-statements-of-operations" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="us-gaap_InterestIncomeExpenseNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:label="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FairValueAdjustmentOfDebt" xlink:label="ycbd_FairValueAdjustmentOfDebt" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OperatingExpensesExcludingImpairment" xlink:label="ycbd_OperatingExpensesExcludingImpairment" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SalesAllowances" xlink:label="ycbd_SalesAllowances" xlink:type="locator"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="ycbd_SalesAllowances" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfRevenue" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_Revenues" xlink:type="arc"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="ycbd_OperatingExpensesExcludingImpairment" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestIncomeExpenseNet" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="ycbd_FairValueAdjustmentOfDebt" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" xlink:type="arc"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:type="arc"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss" xlink:href="ycbd-20240930.xsd#statement-consolidated-statements-of-comprehensive-loss" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" xlink:label="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" xlink:type="arc"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details" xlink:href="ycbd-20240930.xsd#statement-note-3-inventory-schedule-of-inventory-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsAndSupplies" xlink:label="us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrepaidInventory" xlink:label="ycbd_PrepaidInventory" xlink:type="locator"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryValuationReserves" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="ycbd_PrepaidInventory" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoods" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:href="ycbd-20240930.xsd#statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedTrademarks" xlink:label="us-gaap_IndefiniteLivedTrademarks" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FinitelivedIntangibleAssetAccumulatedImpairment" xlink:label="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedTrademarks" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:label="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInvestments" xlink:label="us-gaap_DeferredTaxAssetsInvestments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_RightOfUseLiability" xlink:label="ycbd_RightOfUseLiability" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInvestments" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:type="arc"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" xlink:type="arc"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="ycbd_RightOfUseLiability" xlink:type="arc"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInventory" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsGross" xlink:type="arc"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-" xlink:href="ycbd-20240930.xsd#statement-consolidated-balance-sheets-" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:label="us-gaap_AccountsReceivableGrossCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermInvestments" xlink:label="us-gaap_OtherLongTermInvestments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:label="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrepaidInventory" xlink:label="ycbd_PrepaidInventory" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrepaidSponsorship" xlink:label="ycbd_PrepaidSponsorship" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="ycbd_PrepaidSponsorship" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="ycbd_PrepaidInventory" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryGross" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherLongTermInvestments" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_DepositsAssetsNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssets" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DividendsPayableCurrent" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_NotesPayableCurrent" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:href="ycbd-20240930.xsd#statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareBasic" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>ycbd-20240930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 06:03PM UTC 2024-12-18--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants" xlink:href="ycbd-20240930.xsd#statement-note-10-warrants" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-10-warrants" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsDisclosureTextBlock" xlink:label="ycbd_WarrantsDisclosureTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="ycbd_WarrantsDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions" xlink:href="ycbd-20240930.xsd#statement-note-7-related-party-transactions" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-document-and-entity-information" xlink:href="ycbd-20240930.xsd#statement-document-and-entity-information" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-document-and-entity-information" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
    <link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
    <link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
    <link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" xlink:type="arc"/>
    <link:definitionArc order="24" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" xlink:type="arc"/>
    <link:definitionArc order="25" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" xlink:type="arc"/>
    <link:definitionArc order="26" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" xlink:type="arc"/>
    <link:definitionArc order="27" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:type="arc"/>
    <link:definitionArc order="28" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" xlink:type="arc"/>
    <link:definitionArc order="29" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
    <link:definitionArc order="30" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" xlink:type="arc"/>
    <link:definitionArc order="31" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc"/>
    <link:definitionArc order="32" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" xlink:type="arc"/>
    <link:definitionArc order="33" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" xlink:type="arc"/>
    <link:definitionArc order="34" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="35" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" xlink:type="arc"/>
    <link:definitionArc order="36" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" xlink:type="arc"/>
    <link:definitionArc order="37" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals" xlink:href="ycbd-20240930.xsd#statement-consolidated-balance-sheets-parentheticals" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies" xlink:href="ycbd-20240930.xsd#statement-note-1-organization-and-summary-of-significant-accounting-policies" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:label="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:label="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ManufacturingEquipmentMember" xlink:label="ycbd_ManufacturingEquipmentMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ReverseStockSplitMember" xlink:label="ycbd_ReverseStockSplitMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SoftwareMember" xlink:label="ycbd_SoftwareMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToHempMdMember" xlink:label="ycbd_TrademarkRelatedToHempMdMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonmonetaryTransactionTypeDomain" xlink:to="ycbd_ReverseStockSplitMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="ycbd_ManufacturingEquipmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="ycbd_SoftwareMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_TrademarkRelatedToHempMdMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities" xlink:href="ycbd-20240930.xsd#statement-note-2-marketable-securities-and-investment-other-securities" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SteadyStateLlcMember" xlink:label="ycbd_SteadyStateLlcMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ycbd_SteadyStateLlcMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory" xlink:href="ycbd-20240930.xsd#statement-note-3-inventory" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-3-inventory" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment" xlink:href="ycbd-20240930.xsd#statement-note-4-property-and-equipment" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CaseWithMajikMedicinesMember" xlink:label="ycbd_CaseWithMajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:label="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MajikMedicinesMember" xlink:label="ycbd_MajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToHempMdMember" xlink:label="ycbd_TrademarkRelatedToHempMdMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_TrademarkRelatedToHempMdMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_TrademarksMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_LitigationCaseAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="ycbd_CaseWithMajikMedicinesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_MajikMedicinesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability" xlink:href="ycbd-20240930.xsd#statement-note-6-contingent-liability" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CureBasedDevelopmentLlcMember" xlink:label="ycbd_CureBasedDevelopmentLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_RegisteredCommonStockMember" xlink:label="ycbd_RegisteredCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_UnregisteredCommonStock2Member" xlink:label="ycbd_UnregisteredCommonStock2Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_UnregisteredCommonStockMember" xlink:label="ycbd_UnregisteredCommonStockMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ycbd_CureBasedDevelopmentLlcMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_RegisteredCommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_UnregisteredCommonStock2Member" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_UnregisteredCommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity" xlink:href="ycbd-20240930.xsd#statement-note-8-shareholders-equity" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_A360MediaLlcMember" xlink:label="ycbd_A360MediaLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_AdvertisingPlacementAgreementMember" xlink:label="ycbd_AdvertisingPlacementAgreementMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BoardOfDirectorsMember" xlink:label="ycbd_BoardOfDirectorsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommitmentSharesMember" xlink:label="ycbd_CommitmentSharesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConversionOfNotesIntoCommonStockMember" xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CureBasedDevelopmentLlcMember" xlink:label="ycbd_CureBasedDevelopmentLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_KeystoneMember" xlink:label="ycbd_KeystoneMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MajikMedicinesMember" xlink:label="ycbd_MajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PublicOfferingMember" xlink:label="ycbd_PublicOfferingMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PurchaseagreementMember" xlink:label="ycbd_PurchaseagreementMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TwentyTwoCapitalMember" xlink:label="ycbd_TwentyTwoCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:label="ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestingAnnuallyOverThreeYearsMember" xlink:label="ycbd_VestingAnnuallyOverThreeYearsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsWithPublicOfferingMember" xlink:label="ycbd_WarrantsWithPublicOfferingMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_CommitmentSharesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_KeystoneMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_MajikMedicinesMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ycbd_BoardOfDirectorsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ycbd_CureBasedDevelopmentLlcMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ycbd_PurchaseagreementMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ycbd_PublicOfferingMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ycbd_WarrantsWithPublicOfferingMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_A360MediaLlcMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ycbd_AdvertisingPlacementAgreementMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_TwentyTwoCapitalMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_GranteeStatusAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain-default" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_VestingAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="ycbd_VestingAnnuallyOverThreeYearsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-" xlink:href="ycbd-20240930.xsd#statement-note-9-stock-based-compensation-" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BoardOfDirectorsMember" xlink:label="ycbd_BoardOfDirectorsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:label="ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_The2015PlanMember" xlink:label="ycbd_The2015PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_The2021PlanMember" xlink:label="ycbd_The2021PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:label="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ycbd_The2015PlanMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ycbd_The2021PlanMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ycbd_BoardOfDirectorsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_VestingAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_GranteeStatusAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-" xlink:href="ycbd-20240930.xsd#statement-note-11-commitments-and-contingencies-" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ForbearanceAgreementMember" xlink:label="ycbd_ForbearanceAgreementMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_LeaseContractualTermAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="ycbd_ForbearanceAgreementMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-12-note-payable" xlink:href="ycbd-20240930.xsd#statement-note-12-note-payable" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-12-note-payable" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:label="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases" xlink:href="ycbd-20240930.xsd#statement-note-13-leases" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-13-leases" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share" xlink:href="ycbd-20240930.xsd#statement-note-14-loss-per-share" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events" xlink:href="ycbd-20240930.xsd#statement-note-16-subsequent-events" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConsultantMember" xlink:label="ycbd_ConsultantMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConversionOfNotesIntoCommonStockMember" xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarehouseLeaseMember" xlink:label="ycbd_WarehouseLeaseMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_LeaseContractualTermAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="ycbd_WarehouseLeaseMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_ConsultantMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies" xlink:href="ycbd-20240930.xsd#statement-significant-accounting-policies-policies" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositContractsPolicy" xlink:label="us-gaap_DepositContractsPolicy" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" xlink:label="ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MerchantReceivableAndReservePolicyTextBlock" xlink:label="ycbd_MerchantReceivableAndReservePolicyTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PolicyTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ycbd_MerchantReceivableAndReservePolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DepositContractsPolicy" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BusinessCombinationsPolicy" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DebtPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:href="ycbd-20240930.xsd#statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:href="ycbd-20240930.xsd#statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables" xlink:href="ycbd-20240930.xsd#statement-note-3-inventory-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables" xlink:href="ycbd-20240930.xsd#statement-note-4-property-and-equipment-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables" xlink:href="ycbd-20240930.xsd#statement-note-6-contingent-liability-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables" xlink:href="ycbd-20240930.xsd#statement-note-8-shareholders-equity-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables" xlink:href="ycbd-20240930.xsd#statement-note-9-stock-based-compensation-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables" xlink:href="ycbd-20240930.xsd#statement-note-10-warrants-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommonStockPurchaseWarrantsMember" xlink:label="ycbd_CommonStockPurchaseWarrantsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EquityClassifiedWarrantsMember" xlink:label="ycbd_EquityClassifiedWarrantsMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ycbd_CommonStockPurchaseWarrantsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ycbd_EquityClassifiedWarrantsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables" xlink:href="ycbd-20240930.xsd#statement-note-13-leases-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables" xlink:href="ycbd-20240930.xsd#statement-note-14-loss-per-share-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashUninsuredAmount" xlink:label="us-gaap_CashUninsuredAmount" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet" xlink:label="us-gaap_ContractWithCustomerAssetNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:label="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DebtInstrumentDiscountedPercentage" xlink:label="ycbd_DebtInstrumentDiscountedPercentage" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:label="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ManufacturingEquipmentMember" xlink:label="ycbd_ManufacturingEquipmentMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Merchantprocessingfee" xlink:label="ycbd_Merchantprocessingfee" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NetIncomeLossIncludingImpairment" xlink:label="ycbd_NetIncomeLossIncludingImpairment" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NumberOfMajorCustomers" xlink:label="ycbd_NumberOfMajorCustomers" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ReverseStockSplitMember" xlink:label="ycbd_ReverseStockSplitMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SoftwareMember" xlink:label="ycbd_SoftwareMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToHempMdMember" xlink:label="ycbd_TrademarkRelatedToHempMdMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WorkingCapital" xlink:label="ycbd_WorkingCapital" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonmonetaryTransactionTypeDomain" xlink:to="ycbd_ReverseStockSplitMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="ycbd_ManufacturingEquipmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="ycbd_SoftwareMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_TrademarkRelatedToHempMdMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_Merchantprocessingfee" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountsReceivableNetCurrent" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ContractWithCustomerAssetNet" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MarketingAndAdvertisingExpense" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashUninsuredAmount" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_NumberOfMajorCustomers" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_NetIncomeLossIncludingImpairment" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_WorkingCapital" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DebtInstrumentDiscountedPercentage" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-2-marketable-securities-and-investment-other-securities-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:label="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EquipmentSoldValue" xlink:label="ycbd_EquipmentSoldValue" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SteadyStateLlcMember" xlink:label="ycbd_SteadyStateLlcMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ycbd_SteadyStateLlcMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_EquipmentSoldValue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Investments" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-3-inventory-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryWriteDown" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-4-property-and-equipment-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:label="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CaseWithMajikMedicinesMember" xlink:label="ycbd_CaseWithMajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:label="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommissionPercentage" xlink:label="ycbd_CommissionPercentage" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LengthOfConsultingAgreement" xlink:label="ycbd_LengthOfConsultingAgreement" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LitigationSettlementInitialPayment" xlink:label="ycbd_LitigationSettlementInitialPayment" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LitigationSettlementMonthlyPaymentAmount" xlink:label="ycbd_LitigationSettlementMonthlyPaymentAmount" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MajikMedicinesMember" xlink:label="ycbd_MajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToHempMdMember" xlink:label="ycbd_TrademarkRelatedToHempMdMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_TrademarkRelatedToHempMdMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_TrademarksMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_LitigationCaseAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="ycbd_CaseWithMajikMedicinesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_MajikMedicinesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_LitigationSettlementInitialPayment" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_LitigationSettlementMonthlyPaymentAmount" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_LengthOfConsultingAgreement" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_CommissionPercentage" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-6-contingent-liability-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares" xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration" xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod" xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CureBasedDevelopmentLlcMember" xlink:label="ycbd_CureBasedDevelopmentLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_RegisteredCommonStockMember" xlink:label="ycbd_RegisteredCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_UnregisteredCommonStock2Member" xlink:label="ycbd_UnregisteredCommonStock2Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_UnregisteredCommonStockMember" xlink:label="ycbd_UnregisteredCommonStockMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ycbd_CureBasedDevelopmentLlcMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_RegisteredCommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_UnregisteredCommonStock2Member" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_UnregisteredCommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:href="ycbd-20240930.xsd#statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue" xlink:label="ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-8-shareholders-equity-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCash" xlink:label="us-gaap_DividendsCash" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_A360MediaLlcMember" xlink:label="ycbd_A360MediaLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_AdvertisingPlacementAgreementMember" xlink:label="ycbd_AdvertisingPlacementAgreementMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement" xlink:label="ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_AgreementForAdvertisingPlacementUnutilizedAmount" xlink:label="ycbd_AgreementForAdvertisingPlacementUnutilizedAmount" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BoardOfDirectorsMember" xlink:label="ycbd_BoardOfDirectorsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommitmentSharesMember" xlink:label="ycbd_CommitmentSharesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConversionOfNotesIntoCommonStockMember" xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CureBasedDevelopmentLlcMember" xlink:label="ycbd_CureBasedDevelopmentLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DividendsPayableQuarterlyGrowth" xlink:label="ycbd_DividendsPayableQuarterlyGrowth" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_KeystoneMember" xlink:label="ycbd_KeystoneMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MajikMedicinesMember" xlink:label="ycbd_MajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NumberOfSharesRegisteredForResale" xlink:label="ycbd_NumberOfSharesRegisteredForResale" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PercentageOfSharesFullyVested" xlink:label="ycbd_PercentageOfSharesFullyVested" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories" xlink:label="ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement" xlink:label="ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ProceedsFromIssuanceOfCommonStockNet" xlink:label="ycbd_ProceedsFromIssuanceOfCommonStockNet" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PublicOfferingMember" xlink:label="ycbd_PublicOfferingMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PurchaseCommitmentMaximumSharesCommitment" xlink:label="ycbd_PurchaseCommitmentMaximumSharesCommitment" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PurchaseagreementMember" xlink:label="ycbd_PurchaseagreementMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ShareNumberStockIssuable" xlink:label="ycbd_ShareNumberStockIssuable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TwentyTwoCapitalMember" xlink:label="ycbd_TwentyTwoCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:label="ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestingAnnuallyOverThreeYearsMember" xlink:label="ycbd_VestingAnnuallyOverThreeYearsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsWithPublicOfferingMember" xlink:label="ycbd_WarrantsWithPublicOfferingMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_CommitmentSharesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_KeystoneMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_MajikMedicinesMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ycbd_BoardOfDirectorsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ycbd_CureBasedDevelopmentLlcMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ycbd_PurchaseagreementMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ycbd_PublicOfferingMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ycbd_WarrantsWithPublicOfferingMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_A360MediaLlcMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ycbd_AdvertisingPlacementAgreementMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_TwentyTwoCapitalMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_GranteeStatusAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain-default" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_VestingAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="ycbd_VestingAnnuallyOverThreeYearsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DividendsCash" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DividendsPayableQuarterlyGrowth" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PurchaseCommitmentMaximumSharesCommitment" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ShareNumberStockIssuable" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_NumberOfSharesRegisteredForResale" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:type="arc"/>
    <link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc"/>
    <link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" xlink:type="arc"/>
    <link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc"/>
    <link:definitionArc order="24" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ProceedsFromIssuanceOfCommonStockNet" xlink:type="arc"/>
    <link:definitionArc order="25" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc"/>
    <link:definitionArc order="26" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc"/>
    <link:definitionArc order="27" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc"/>
    <link:definitionArc order="28" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement" xlink:type="arc"/>
    <link:definitionArc order="29" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_AgreementForAdvertisingPlacementUnutilizedAmount" xlink:type="arc"/>
    <link:definitionArc order="30" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PercentageOfSharesFullyVested" xlink:type="arc"/>
    <link:definitionArc order="31" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement" xlink:type="arc"/>
    <link:definitionArc order="32" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories" xlink:type="arc"/>
    <link:definitionArc order="33" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc"/>
    <link:definitionArc order="34" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="35" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc"/>
    <link:definitionArc order="36" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc"/>
    <link:definitionArc order="37" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-9-stock-based-compensation-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BoardOfDirectorsMember" xlink:label="ycbd_BoardOfDirectorsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage" xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares" xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:label="ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_The2015PlanMember" xlink:label="ycbd_The2015PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_The2021PlanMember" xlink:label="ycbd_The2021PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:label="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ycbd_The2015PlanMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ycbd_The2021PlanMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ycbd_BoardOfDirectorsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_VestingAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_GranteeStatusAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-11-commitments-and-contingencies-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ForbearanceAgreementMember" xlink:label="ycbd_ForbearanceAgreementMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PastDueRentDefaultDeclarationMonthlyPayment" xlink:label="ycbd_PastDueRentDefaultDeclarationMonthlyPayment" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement" xlink:label="ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_LeaseContractualTermAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="ycbd_ForbearanceAgreementMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PastDueRentDefaultDeclarationMonthlyPayment" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-12-note-payable-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableFairValueDisclosure" xlink:label="us-gaap_NotesPayableFairValueDisclosure" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DebtInstrumentDiscountedPercentage" xlink:label="ycbd_DebtInstrumentDiscountedPercentage" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DebtInstrumentInterestRateInDefault" xlink:label="ycbd_DebtInstrumentInterestRateInDefault" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DebtInstrumentPrepaymentPayablePercent" xlink:label="ycbd_DebtInstrumentPrepaymentPayablePercent" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FairValueAdjustmentOfDebt" xlink:label="ycbd_FairValueAdjustmentOfDebt" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:label="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrincipleAdjustmentsOfDebt" xlink:label="ycbd_PrincipleAdjustmentsOfDebt" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DebtInstrumentDiscountedPercentage" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DebtInstrumentPrepaymentPayablePercent" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DebtInstrumentInterestRateInDefault" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesPayableFairValueDisclosure" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_FairValueAdjustmentOfDebt" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PrincipleAdjustmentsOfDebt" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesPayable" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-13-leases-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-14-loss-per-share-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DeferredTaxAssetAndRelatedValuationAllowance" xlink:label="ycbd_DeferredTaxAssetAndRelatedValuationAllowance" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DeferredTaxAssetAndRelatedValuationAllowance" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-16-subsequent-events-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConsultantMember" xlink:label="ycbd_ConsultantMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConversionOfNotesIntoCommonStockMember" xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LesseeOperatingLeasesAnnualBaseRent" xlink:label="ycbd_LesseeOperatingLeasesAnnualBaseRent" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LesseeOperatingLeasesMonthlyBaseRent" xlink:label="ycbd_LesseeOperatingLeasesMonthlyBaseRent" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OperatingLeasesRentExpensePerSquareFoot" xlink:label="ycbd_OperatingLeasesRentExpensePerSquareFoot" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarehouseLeaseMember" xlink:label="ycbd_WarehouseLeaseMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_LeaseContractualTermAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="ycbd_WarehouseLeaseMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_ConsultantMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesPayable" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_LesseeOperatingLeasesMonthlyBaseRent" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_OperatingLeasesRentExpensePerSquareFoot" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_LesseeOperatingLeasesAnnualBaseRent" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows" xlink:href="ycbd-20240930.xsd#statement-consolidated-statement-of-cash-flows" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="us-gaap_GainLossOnTerminationOfLease" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockExpense" xlink:label="us-gaap_RestrictedStockExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:label="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FairValueAdjustmentOfDebt" xlink:label="ycbd_FairValueAdjustmentOfDebt" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_IncreaseDecreaseInPrepaidInventoryTotal" xlink:label="ycbd_IncreaseDecreaseInPrepaidInventoryTotal" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest" xlink:label="ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:label="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PreferredDividendsAccruedNotYetPaid" xlink:label="ycbd_PreferredDividendsAccruedNotYetPaid" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WriteOffOfPrepaidAssets" xlink:label="ycbd_WriteOffOfPrepaidAssets" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_RestrictedStockExpense" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ycbd_WriteOffOfPrepaidAssets" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryWriteDown" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ycbd_FairValueAdjustmentOfDebt" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnTerminationOfLease" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="ycbd_IncreaseDecreaseInPrepaidInventoryTotal" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_StockIssued1" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="ycbd_PreferredDividendsAccruedNotYetPaid" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:label="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:href="ycbd-20240930.xsd#statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:href="ycbd-20240930.xsd#statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisable" xlink:label="ycbd_ClassOfWarrantOrRightExercisable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisesInPeriod" xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightForfeituresInPeriod" xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightGrantsInPeriod" xlink:label="ycbd_ClassOfWarrantOrRightGrantsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsToPurchaseCommonStockMember" xlink:label="ycbd_WarrantsToPurchaseCommonStockMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="ycbd_WarrantsToPurchaseCommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightGrantsInPeriod" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisesInPeriod" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightForfeituresInPeriod" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisable" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:href="ycbd-20240930.xsd#statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisable" xlink:label="ycbd_ClassOfWarrantOrRightExercisable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringApril2028Member" xlink:label="ycbd_WarrantsExpiringApril2028Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringJanuary2025Member" xlink:label="ycbd_WarrantsExpiringJanuary2025Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringMay2024Member" xlink:label="ycbd_WarrantsExpiringMay2024Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringOctober2024Member" xlink:label="ycbd_WarrantsExpiringOctober2024Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringSeptember2023Member" xlink:label="ycbd_WarrantsExpiringSeptember2023Member" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ycbd_WarrantsExpiringSeptember2023Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ycbd_WarrantsExpiringMay2024Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ycbd_WarrantsExpiringOctober2024Member" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ycbd_WarrantsExpiringJanuary2025Member" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="ycbd_WarrantsExpiringApril2028Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisable" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:href="ycbd-20240930.xsd#statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseLiability" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations" xlink:href="ycbd-20240930.xsd#statement-consolidated-statements-of-operations" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="us-gaap_InterestIncomeExpenseNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:label="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FairValueAdjustmentOfDebt" xlink:label="ycbd_FairValueAdjustmentOfDebt" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OperatingExpensesExcludingImpairment" xlink:label="ycbd_OperatingExpensesExcludingImpairment" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SalesAllowances" xlink:label="ycbd_SalesAllowances" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_SalesAllowances" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostOfRevenue" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GrossProfit" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_OperatingExpensesExcludingImpairment" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_FairValueAdjustmentOfDebt" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestIncomeExpenseNet" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss" xlink:href="ycbd-20240930.xsd#statement-consolidated-statements-of-comprehensive-loss" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" xlink:label="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:href="ycbd-20240930.xsd#statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelAxis" xlink:label="us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelDomain" xlink:label="us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelDomain" xlink:label="us-gaap_ContractWithCustomerSalesChannelDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelDirectlyToConsumerMember" xlink:label="us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelThroughIntermediaryMember" xlink:label="us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SalesChannelMember" xlink:label="ycbd_SalesChannelMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="us-gaap_ContractWithCustomerSalesChannelDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="ycbd_SalesChannelMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details" xlink:href="ycbd-20240930.xsd#statement-note-3-inventory-schedule-of-inventory-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsAndSupplies" xlink:label="us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrepaidInventory" xlink:label="ycbd_PrepaidInventory" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryFinishedGoods" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryValuationReserves" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PrepaidInventory" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryNet" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:href="ycbd-20240930.xsd#statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AutomobilesMember" xlink:label="us-gaap_AutomobilesMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ComputersFurnitureAndEquipmentMember" xlink:label="ycbd_ComputersFurnitureAndEquipmentMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ManufacturingEquipmentMember" xlink:label="ycbd_ManufacturingEquipmentMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="ycbd_ComputersFurnitureAndEquipmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="ycbd_ManufacturingEquipmentMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_AutomobilesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedTrademarks" xlink:label="us-gaap_IndefiniteLivedTrademarks" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdMdLimintedMarkMember" xlink:label="ycbd_CbdMdLimintedMarkMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FinitelivedIntangibleAssetAccumulatedImpairment" xlink:label="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" xlink:label="ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToCbdmdMember" xlink:label="ycbd_TrademarkRelatedToCbdmdMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToHempMdMember" xlink:label="ycbd_TrademarkRelatedToHempMdMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TradenameRelatedToDirectCBDOnlineComMember" xlink:label="ycbd_TradenameRelatedToDirectCBDOnlineComMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_TrademarkRelatedToCbdmdMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_TrademarkRelatedToHempMdMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_CbdMdLimintedMarkMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ycbd_TradenameRelatedToDirectCBDOnlineComMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IndefiniteLivedTrademarks" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details" xlink:href="ycbd-20240930.xsd#statement-note-6-contingent-liability-contingent-liability-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" xlink:label="ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:label="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity" xlink:href="ycbd-20240930.xsd#statement-condensed-consolidated-statements-of-shareholders-equity" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="us-gaap_DividendsPreferredStockCash" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CapitalRaiseMember" xlink:label="ycbd_CapitalRaiseMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommitmentSharesMember" xlink:label="ycbd_CommitmentSharesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConversionOfNotesIntoCommonStockMember" xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DecreaseInApicIssuanceOfStock" xlink:label="ycbd_DecreaseInApicIssuanceOfStock" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MajikMedicinesMember" xlink:label="ycbd_MajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" xlink:label="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PublicOfferingMember" xlink:label="ycbd_PublicOfferingMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="ycbd_StockIssuedDuringPeriodValueReverseStockSplits" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ycbd_CommitmentSharesMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ycbd_PublicOfferingMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ycbd_CapitalRaiseMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ycbd_MajikMedicinesMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ycbd_CommitmentSharesMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DividendsPreferredStockCash" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DecreaseInApicIssuanceOfStock" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_StockIssuedDuringPeriodValueReverseStockSplits" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:href="ycbd-20240930.xsd#statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseCost" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasePayments" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInvestments" xlink:label="us-gaap_DeferredTaxAssetsInvestments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_RightOfUseLiability" xlink:label="ycbd_RightOfUseLiability" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_RightOfUseLiability" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsInvestments" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsInventory" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsOther" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilities" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-" xlink:href="ycbd-20240930.xsd#statement-consolidated-balance-sheets-" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:label="us-gaap_AccountsReceivableGrossCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract" xlink:label="us-gaap_OtherAssetsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermInvestments" xlink:label="us-gaap_OtherLongTermInvestments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:label="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrepaidInventory" xlink:label="ycbd_PrepaidInventory" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrepaidSponsorship" xlink:label="ycbd_PrepaidSponsorship" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryGross" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="ycbd_PrepaidInventory" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="ycbd_PrepaidSponsorship" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssetsAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherLongTermInvestments" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssets" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_Assets" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DividendsPayableCurrent" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleDebtCurrent" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableCurrent" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_Liabilities" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:href="ycbd-20240930.xsd#statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:href="ycbd-20240930.xsd#statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:href="ycbd-20240930.xsd#statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueAdjustment" xlink:label="us-gaap_EquityFairValueAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="us-gaap_FairValueNetAssetLiability" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="us-gaap_LiabilitiesFairValueAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ContingentLiabilityMember" xlink:label="ycbd_ContingentLiabilityMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConvertibleNotesMember" xlink:label="ycbd_ConvertibleNotesMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ycbd_ContingentLiabilityMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ycbd_ConvertibleNotesMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueNetAssetLiability" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EquityFairValueAdjustment" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesFairValueAdjustment" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:type="arc"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>ycbd-20240930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 06:03PM UTC 2024-12-18--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DocumentAndEntityInformation" xlink:label="ycbd_DocumentAndEntityInformation" xlink:type="locator"/>
    <link:label xlink:label="ycbd_DocumentAndEntityInformation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document And Entity Information</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_DocumentAndEntityInformation" xlink:to="ycbd_DocumentAndEntityInformation-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:label xlink:label="ycbd_NoteToFinancialStatementDetailsTextual-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note To Financial Statement Details Textual</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="ycbd_NoteToFinancialStatementDetailsTextual-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sale of other investment securities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-significant-accounting-policies-policies" xlink:label="ycbd_statement-statement-significant-accounting-policies-policies" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-significant-accounting-policies-policies-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-significant-accounting-policies-policies" xlink:to="ycbd_statement-statement-significant-accounting-policies-policies-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:label="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 1 - Organization and Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:to="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:label="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 2 - Marketable Securities and Investment Other Securities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:to="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risk free interest rate</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConvertibleNotesMember" xlink:label="ycbd_ConvertibleNotesMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ConvertibleNotesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes [Member]</link:label>
    <link:label xlink:label="ycbd_ConvertibleNotesMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Relating to convertible notes.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ConvertibleNotesMember" xlink:to="ycbd_ConvertibleNotesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-3-inventory-tables" xlink:label="ycbd_statement-statement-note-3-inventory-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-3-inventory-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 3 - Inventory</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-3-inventory-tables" xlink:to="ycbd_statement-statement-note-3-inventory-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ContingentLiabilityMember" xlink:label="ycbd_ContingentLiabilityMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ContingentLiabilityMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Liability [Member]</link:label>
    <link:label xlink:label="ycbd_ContingentLiabilityMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Relating to contingent liability.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ContingentLiabilityMember" xlink:to="ycbd_ContingentLiabilityMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-4-property-and-equipment-tables" xlink:label="ycbd_statement-statement-note-4-property-and-equipment-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-4-property-and-equipment-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 4 - Property and Equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-4-property-and-equipment-tables" xlink:to="ycbd_statement-statement-note-4-property-and-equipment-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-5-intangible-assets-tables" xlink:label="ycbd_statement-statement-note-5-intangible-assets-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-5-intangible-assets-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 5 - Intangible Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-5-intangible-assets-tables" xlink:to="ycbd_statement-statement-note-5-intangible-assets-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-6-contingent-liability-tables" xlink:label="ycbd_statement-statement-note-6-contingent-liability-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-6-contingent-liability-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 6 - Contingent Liability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-6-contingent-liability-tables" xlink:to="ycbd_statement-statement-note-6-contingent-liability-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Volatility</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesNoncurrentAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long term liabilities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-8-shareholders-equity-tables" xlink:label="ycbd_statement-statement-note-8-shareholders-equity-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-8-shareholders-equity-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 8 - Shareholders' Equity</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-8-shareholders-equity-tables" xlink:to="ycbd_statement-statement-note-8-shareholders-equity-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-9-stock-based-compensation-tables" xlink:label="ycbd_statement-statement-note-9-stock-based-compensation-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-9-stock-based-compensation-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 9 - Stock Based Compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-9-stock-based-compensation-tables" xlink:to="ycbd_statement-statement-note-9-stock-based-compensation-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-10-warrants-tables" xlink:label="ycbd_statement-statement-note-10-warrants-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-10-warrants-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 10 - Warrants</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-10-warrants-tables" xlink:to="ycbd_statement-statement-note-10-warrants-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-13-leases-tables" xlink:label="ycbd_statement-statement-note-13-leases-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-13-leases-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 13 - Leases</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-13-leases-tables" xlink:to="ycbd_statement-statement-note-13-leases-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-14-loss-per-share-tables" xlink:label="ycbd_statement-statement-note-14-loss-per-share-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-14-loss-per-share-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 14 - Loss Per Share</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-14-loss-per-share-tables" xlink:to="ycbd_statement-statement-note-14-loss-per-share-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-15-income-taxes-tables" xlink:label="ycbd_statement-statement-note-15-income-taxes-tables" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-15-income-taxes-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 15 - Income Taxes</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-15-income-taxes-tables" xlink:to="ycbd_statement-statement-note-15-income-taxes-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:label="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 1 - Organization and Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:to="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LiabilitiesCurrent</link:label>
    <link:label xlink:label="us-gaap_LiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:label="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 2 - Marketable Securities and Investment Other Securities - Assets Valued at Fair Value (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:to="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-3-inventory-schedule-of-inventory-details" xlink:label="ycbd_statement-statement-note-3-inventory-schedule-of-inventory-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-3-inventory-schedule-of-inventory-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 3 - Inventory - Schedule of Inventory (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-3-inventory-schedule-of-inventory-details" xlink:to="ycbd_statement-statement-note-3-inventory-schedule-of-inventory-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:label="ycbd_statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 4 - Property and Equipment - Major Classes of Property and Equipment (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:to="ycbd_statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected term (in years) (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:label="ycbd_statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 5 - Intangible Assets - Schedule of Intangible Assets (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:to="ycbd_statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:label="ycbd_statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 5 - Intangible Assets - Future Amortization of Intangible Assets (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:to="ycbd_statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details" xlink:label="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 6 - Contingent Liability - Contingent Liability (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details" xlink:to="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:label="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 6 - Contingent Liability - Contingent Liability (Details) (Parentheticals)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:to="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:label="ycbd_statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 8 - Shareholders' Equity - Fair Value Assumptions of Stock Options (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:to="ycbd_statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:label="ycbd_statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 9 - Stock Based Compensation - Summary of Stock Option Activity (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:to="ycbd_statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:label="ycbd_statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 10 - Warrants - Schedule of Equity-Classified Warrants (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:to="ycbd_statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:label="ycbd_statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 10 - Warrants - Summary of Outstanding Common Stock Purchase Warrants (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:to="ycbd_statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:label="ycbd_statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 13 - Leases - Operating Lease Costs and Supplemental Cash Flow Information (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:to="ycbd_statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:label="ycbd_statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 13 - Leases - Future Minimum Aggregate Lease Payments (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:to="ycbd_statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:label="ycbd_statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 14 - Loss Per Share - Basic and Diluted Earnings Per Share (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:to="ycbd_statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NetIncomeLossIncludingImpairment" xlink:label="ycbd_NetIncomeLossIncludingImpairment" xlink:type="locator"/>
    <link:label xlink:label="ycbd_NetIncomeLossIncludingImpairment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_NetIncomeLossIncludingImpairment</link:label>
    <link:label xlink:label="ycbd_NetIncomeLossIncludingImpairment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Including Impairment</link:label>
    <link:label xlink:label="ycbd_NetIncomeLossIncludingImpairment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents net income (loss) for the period including impairments.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_NetIncomeLossIncludingImpairment" xlink:to="ycbd_NetIncomeLossIncludingImpairment-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:label="ycbd_statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 15 - Income Taxes - Components of Provision for Income Taxes (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:to="ycbd_statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:label="ycbd_statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 15 - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:to="ycbd_statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:label="ycbd_statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:type="locator"/>
    <link:label xlink:label="ycbd_statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 15 - Income Taxes - Significant Components of Deferred Income Taxes (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:to="ycbd_statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatements" xlink:label="ycbd_NotesToFinancialStatements" xlink:type="locator"/>
    <link:label xlink:label="ycbd_NotesToFinancialStatements-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes To Financial Statements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_NotesToFinancialStatements" xlink:to="ycbd_NotesToFinancialStatements-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:label xlink:label="ycbd_NotesToFinancialStatementsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes To Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="ycbd_NotesToFinancialStatementsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="us-gaap_GainLossOnTerminationOfLease" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GainLossOnTerminationOfLease-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GainLossOnTerminationOfLease</link:label>
    <link:label xlink:label="us-gaap_GainLossOnTerminationOfLease-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gain on termination of operating lease</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnTerminationOfLease" xlink:to="us-gaap_GainLossOnTerminationOfLease-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:label="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease</link:label>
    <link:label xlink:label="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation, Excluding Lessor Asset under Operating Lease</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:to="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of goodwill and other intangible assets</link:label>
    <link:label xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="ycbd_StockIssuedDuringPeriodValueReverseStockSplits" xlink:type="locator"/>
    <link:label xlink:label="ycbd_StockIssuedDuringPeriodValueReverseStockSplits-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fractional share true-up</link:label>
    <link:label xlink:label="ycbd_StockIssuedDuringPeriodValueReverseStockSplits-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">value of equity increase resulting from reverse stock splits.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_StockIssuedDuringPeriodValueReverseStockSplits" xlink:to="ycbd_StockIssuedDuringPeriodValueReverseStockSplits-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommitmentSharesMember" xlink:label="ycbd_CommitmentSharesMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_CommitmentSharesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitment Shares [Member]</link:label>
    <link:label xlink:label="ycbd_CommitmentSharesMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents commitment shares.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_CommitmentSharesMember" xlink:to="ycbd_CommitmentSharesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_UnregisteredCommonStock2Member" xlink:label="ycbd_UnregisteredCommonStock2Member" xlink:type="locator"/>
    <link:label xlink:label="ycbd_UnregisteredCommonStock2Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unregistered Common Stock 2 [Member]</link:label>
    <link:label xlink:label="ycbd_UnregisteredCommonStock2Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unregistered Common Stock 2</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_UnregisteredCommonStock2Member" xlink:to="ycbd_UnregisteredCommonStock2Member-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:type="locator"/>
    <link:label xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue</link:label>
    <link:label xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value</link:label>
    <link:label xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:to="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsWithPublicOfferingMember" xlink:label="ycbd_WarrantsWithPublicOfferingMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_WarrantsWithPublicOfferingMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants With Public Offering [Member]</link:label>
    <link:label xlink:label="ycbd_WarrantsWithPublicOfferingMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents warrants with public offering.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_WarrantsWithPublicOfferingMember" xlink:to="ycbd_WarrantsWithPublicOfferingMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ProceedsFromIssuanceOfCommonStockNet" xlink:label="ycbd_ProceedsFromIssuanceOfCommonStockNet" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ProceedsFromIssuanceOfCommonStockNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_ProceedsFromIssuanceOfCommonStockNet</link:label>
    <link:label xlink:label="ycbd_ProceedsFromIssuanceOfCommonStockNet-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance of Common Stock, Net</link:label>
    <link:label xlink:label="ycbd_ProceedsFromIssuanceOfCommonStockNet-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net amount of cash inflow from issuance of common stock.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ProceedsFromIssuanceOfCommonStockNet" xlink:to="ycbd_ProceedsFromIssuanceOfCommonStockNet-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PublicOfferingMember" xlink:label="ycbd_PublicOfferingMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PublicOfferingMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Public Offering [Member]</link:label>
    <link:label xlink:label="ycbd_PublicOfferingMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents public offering.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PublicOfferingMember" xlink:to="ycbd_PublicOfferingMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, weighted average exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ReverseStockSplitMember" xlink:label="ycbd_ReverseStockSplitMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ReverseStockSplitMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reverse Stock Split [Member]</link:label>
    <link:label xlink:label="ycbd_ReverseStockSplitMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The conversion of a reverse stock split where there is a reduction in the shares outstanding.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ReverseStockSplitMember" xlink:to="ycbd_ReverseStockSplitMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_KeystoneMember" xlink:label="ycbd_KeystoneMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_KeystoneMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Keystone [Member]</link:label>
    <link:label xlink:label="ycbd_KeystoneMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Keystone.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_KeystoneMember" xlink:to="ycbd_KeystoneMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NotesPayableCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ShareNumberStockIssuable" xlink:label="ycbd_ShareNumberStockIssuable" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ShareNumberStockIssuable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_ShareNumberStockIssuable</link:label>
    <link:label xlink:label="ycbd_ShareNumberStockIssuable-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Number, Stock Issuable (in shares)</link:label>
    <link:label xlink:label="ycbd_ShareNumberStockIssuable-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of shares issuable during a period of time.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ShareNumberStockIssuable" xlink:to="ycbd_ShareNumberStockIssuable-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PurchaseCommitmentMaximumSharesCommitment" xlink:label="ycbd_PurchaseCommitmentMaximumSharesCommitment" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PurchaseCommitmentMaximumSharesCommitment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_PurchaseCommitmentMaximumSharesCommitment</link:label>
    <link:label xlink:label="ycbd_PurchaseCommitmentMaximumSharesCommitment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase Commitment, Maximum Shares Commitment (in shares)</link:label>
    <link:label xlink:label="ycbd_PurchaseCommitmentMaximumSharesCommitment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum number of shares committed to purchase under purchase commitment.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PurchaseCommitmentMaximumSharesCommitment" xlink:to="ycbd_PurchaseCommitmentMaximumSharesCommitment-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding, weighted average remaining contractual term (Year)</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, weighted average remaining contractual term (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NumberOfSharesRegisteredForResale" xlink:label="ycbd_NumberOfSharesRegisteredForResale" xlink:type="locator"/>
    <link:label xlink:label="ycbd_NumberOfSharesRegisteredForResale-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_NumberOfSharesRegisteredForResale</link:label>
    <link:label xlink:label="ycbd_NumberOfSharesRegisteredForResale-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares Registered for Resale (in shares)</link:label>
    <link:label xlink:label="ycbd_NumberOfSharesRegisteredForResale-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents number of shares that are registered for resale.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_NumberOfSharesRegisteredForResale" xlink:to="ycbd_NumberOfSharesRegisteredForResale-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A Cumulative Convertible Preferred Stock [Member]</link:label>
    <link:label xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Series A Cumulative Convertible Preferred Stock.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:to="ycbd_SeriesACumulativeConvertiblePreferredStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding, weighted average exercise price (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, weighted average exercise price (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, weighted average exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConvertibleDebtCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible notes, at fair value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forfeited, weighted average exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted, weighted average exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercised, weighted average exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccruedLiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AccruedLiabilitiesCurrent</link:label>
    <link:label xlink:label="us-gaap_AccruedLiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConversionOfNotesIntoCommonStockMember" xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Notes into Common Stock [Member]</link:label>
    <link:label xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents conversion of notes into common stock.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:to="ycbd_ConversionOfNotesIntoCommonStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LesseeOperatingLeasesTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DividendsPayableCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued dividends</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrent" xlink:to="us-gaap_DividendsPayableCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountsPayableCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding (in shares)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding (in shares)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MajikMedicinesMember" xlink:label="ycbd_MajikMedicinesMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_MajikMedicinesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Majik Medicines [Member]</link:label>
    <link:label xlink:label="ycbd_MajikMedicinesMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Majik Medicines.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_MajikMedicinesMember" xlink:to="ycbd_MajikMedicinesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TrademarksMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CaseWithMajikMedicinesMember" xlink:label="ycbd_CaseWithMajikMedicinesMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_CaseWithMajikMedicinesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Case With Majik Medicines [Member]</link:label>
    <link:label xlink:label="ycbd_CaseWithMajikMedicinesMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Case With Majik Medicines.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_CaseWithMajikMedicinesMember" xlink:to="ycbd_CaseWithMajikMedicinesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PolicyTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PolicyTextBlockAbstract</link:label>
    <link:label xlink:label="us-gaap_PolicyTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_PolicyTextBlockAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TwentyTwoCapitalMember" xlink:label="ycbd_TwentyTwoCapitalMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_TwentyTwoCapitalMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Twenty Two Capital [Member]</link:label>
    <link:label xlink:label="ycbd_TwentyTwoCapitalMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents twenty two capital.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_TwentyTwoCapitalMember" xlink:to="ycbd_TwentyTwoCapitalMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssued1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of shares for intangible asset</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsToAcquireIntangibleAssets</link:label>
    <link:label xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</link:label>
    <link:label xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-cash financial/investing activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GranteeStatusDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_GranteeStatusDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GranteeStatusAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesCurrentAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_VestingAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_VestingDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating lease liability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SupplementalCashFlowInformationAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Payments for:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Assets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_Assets</link:label>
    <link:label xlink:label="us-gaap_Assets-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PlanNameAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PlanNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</link:label>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</link:label>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</link:label>
    <link:label xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Loss attributable to common shareholders</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_The2015PlanMember" xlink:label="ycbd_The2015PlanMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_The2015PlanMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2015 Plan [Member]</link:label>
    <link:label xlink:label="ycbd_The2015PlanMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the 2015 equity compensation plan ("2015 plan").</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_The2015PlanMember" xlink:to="ycbd_The2015PlanMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ContingentConsiderationByTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationByTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage" xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage" xlink:type="locator"/>
    <link:label xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage</link:label>
    <link:label xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Percentage</link:label>
    <link:label xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the annual increase of authorized shares.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage" xlink:to="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ContingentConsiderationTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="us-gaap_ContingentConsiderationTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:label="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:type="locator"/>
    <link:label xlink:label="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other-than-temporary impairment on other investments</link:label>
    <link:label xlink:label="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of other0than-temporary impairment on other investments.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:to="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet" xlink:label="us-gaap_ContractWithCustomerAssetNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ContractWithCustomerAssetNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ContractWithCustomerAssetNet</link:label>
    <link:label xlink:label="us-gaap_ContractWithCustomerAssetNet-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetNet" xlink:to="us-gaap_ContractWithCustomerAssetNet-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares" xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares" xlink:type="locator"/>
    <link:label xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares</link:label>
    <link:label xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Shares (in shares)</link:label>
    <link:label xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the annual increase in shares for shares authorized.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares" xlink:to="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OtherAssets</link:label>
    <link:label xlink:label="us-gaap_OtherAssets-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred dividends</link:label>
    <link:label xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Preferred dividends</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_The2021PlanMember" xlink:label="ycbd_The2021PlanMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_The2021PlanMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2021 Plan [Member]</link:label>
    <link:label xlink:label="ycbd_The2021PlanMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the 2021 equity compensation plan ("the 2021 plan").</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_The2021PlanMember" xlink:to="ycbd_The2021PlanMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FinitelivedIntangibleAssetAccumulatedImpairment" xlink:label="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment" xlink:type="locator"/>
    <link:label xlink:label="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_FinitelivedIntangibleAssetAccumulatedImpairment</link:label>
    <link:label xlink:label="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairment of definite lived intangible assets:</link:label>
    <link:label xlink:label="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of accumulated impairment of finite-lived intangible assets.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment" xlink:to="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AwardTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Loss</link:label>
    <link:label xlink:label="us-gaap_NetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss</link:label>
    <link:label xlink:label="us-gaap_NetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Loss</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Amortization of definite lived intangible assets:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsNet</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future intangibles amortization</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill-label" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IntangibleAssetsNetExcludingGoodwill</link:label>
    <link:label xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill), Total</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RestrictedStockUnitsRSUMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Definite lived intangible assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RestrictedStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeStockOptionMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedTrademarks" xlink:label="us-gaap_IndefiniteLivedTrademarks" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IndefiniteLivedTrademarks-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite lived trademark</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedTrademarks" xlink:to="us-gaap_IndefiniteLivedTrademarks-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</link:label>
    <link:label xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentNet-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BoardOfDirectorsMember" xlink:label="ycbd_BoardOfDirectorsMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_BoardOfDirectorsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Board of Directors [Member]</link:label>
    <link:label xlink:label="ycbd_BoardOfDirectorsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the companies board of directors.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_BoardOfDirectorsMember" xlink:to="ycbd_BoardOfDirectorsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Investments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_Investments</link:label>
    <link:label xlink:label="us-gaap_Investments-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments, Total</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarningsPerShareAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Loss per share:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermInvestments" xlink:label="us-gaap_OtherLongTermInvestments" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherLongTermInvestments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment in other securities, noncurrent</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermInvestments" xlink:to="us-gaap_OtherLongTermInvestments-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarningsPerShareTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ForbearanceAgreementMember" xlink:label="ycbd_ForbearanceAgreementMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ForbearanceAgreementMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forbearance Agreement [Member]</link:label>
    <link:label xlink:label="ycbd_ForbearanceAgreementMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Forbearance Agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ForbearanceAgreementMember" xlink:to="ycbd_ForbearanceAgreementMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PastDueRentDefaultDeclarationMonthlyPayment" xlink:label="ycbd_PastDueRentDefaultDeclarationMonthlyPayment" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PastDueRentDefaultDeclarationMonthlyPayment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_PastDueRentDefaultDeclarationMonthlyPayment</link:label>
    <link:label xlink:label="ycbd_PastDueRentDefaultDeclarationMonthlyPayment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Past Due Rent Default Declaration, Monthly Payment</link:label>
    <link:label xlink:label="ycbd_PastDueRentDefaultDeclarationMonthlyPayment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of monthly payment for past due rent.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PastDueRentDefaultDeclarationMonthlyPayment" xlink:to="ycbd_PastDueRentDefaultDeclarationMonthlyPayment-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FairValueAdjustmentOfDebt" xlink:label="ycbd_FairValueAdjustmentOfDebt" xlink:type="locator"/>
    <link:label xlink:label="ycbd_FairValueAdjustmentOfDebt-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase in fair value of convertible debt</link:label>
    <link:label xlink:label="ycbd_FairValueAdjustmentOfDebt-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment of Debt</link:label>
    <link:label xlink:label="ycbd_FairValueAdjustmentOfDebt-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Increase in fair value of convertible debt</link:label>
    <link:label xlink:label="ycbd_FairValueAdjustmentOfDebt-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of addition (reduction) to the amount of debt.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_FairValueAdjustmentOfDebt" xlink:to="ycbd_FairValueAdjustmentOfDebt-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement" xlink:label="ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement</link:label>
    <link:label xlink:label="ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Past Due Rent Default Declaration, Payment Upon Execution of Agreement</link:label>
    <link:label xlink:label="ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of payment upon execution of agreement for past due rent.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement" xlink:to="ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Benefit (expense) for income taxes</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total provision</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" xlink:label="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" xlink:type="locator"/>
    <link:label xlink:label="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in far value of debt related to credit risk</link:label>
    <link:label xlink:label="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Change in far value of debt related to credit risk</link:label>
    <link:label xlink:label="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of equity impact on other comprehensive income loss due to changes in fair value of debt related to credit risk.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" xlink:to="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:label="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Realized and unrealized loss on marketable and other securities, including impairments</link:label>
    <link:label xlink:label="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Security, Gain (Loss)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:to="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DebtInstrumentConvertibleConversionPrice1</link:label>
    <link:label xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AllocatedShareBasedCompensationExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AllocatedShareBasedCompensationExpense</link:label>
    <link:label xlink:label="us-gaap_AllocatedShareBasedCompensationExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ComprehensiveIncomeNetOfTax-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ComprehensiveIncomeNetOfTax</link:label>
    <link:label xlink:label="us-gaap_ComprehensiveIncomeNetOfTax-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Loss available to common shareholders</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
    <link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_UseOfEstimates-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockSplits-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Roundup fractional shares resulting from reverse split (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockSplits-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fractional share true-up (in shares)</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Reverse Stock Splits (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharesOutstanding</link:label>
    <link:label xlink:label="us-gaap_SharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label xlink:label="us-gaap_SharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label xlink:label="us-gaap_CommonStockSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding, Ending Balance (in shares)</link:label>
    <link:label xlink:label="us-gaap_PreferredStockSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:label xlink:label="dei_CurrentFiscalYearEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DebtInstrumentInterestRateStatedPercentage</link:label>
    <link:label xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</link:label>
    <link:label xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentFiscalPeriodFocus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInDepositOtherAssets</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deposits</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeaseCost-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Operating Lease Costs</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentFiscalYearFocus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConsolidationPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LeaseCostTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</link:label>
    <link:label xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCash" xlink:label="us-gaap_DividendsCash" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DividendsCash-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DividendsCash</link:label>
    <link:label xlink:label="us-gaap_DividendsCash-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends, Cash</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCash" xlink:to="us-gaap_DividendsCash-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentFaceAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DebtInstrumentFaceAmount</link:label>
    <link:label xlink:label="us-gaap_DebtInstrumentFaceAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xlink:type="locator"/>
    <link:label xlink:label="dei_EntitySmallBusiness-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityShellCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="us-gaap_DividendsPreferredStockCash" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DividendsPreferredStockCash-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DividendsPreferredStockCash</link:label>
    <link:label xlink:label="us-gaap_DividendsPreferredStockCash-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Preferred dividend declared, not paid</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AreaOfRealEstateProperty-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AreaOfRealEstateProperty</link:label>
    <link:label xlink:label="us-gaap_AreaOfRealEstateProperty-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of Real Estate Property (Square Foot)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityPublicFloat-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityFilerCategory-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityCurrentReportingStatus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityVoluntaryFilers-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityWellKnownSeasonedIssuer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInAccountsReceivable</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskPercentage1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ConcentrationRiskPercentage1</link:label>
    <link:label xlink:label="us-gaap_ConcentrationRiskPercentage1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueByLiabilityClassAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CustomerConcentrationRiskMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maxim transaction expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" xlink:type="locator"/>
    <link:label xlink:label="ecd_NonRule10b51ArrTrmntdFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ecd_NonRule10b51ArrTrmntdFlag</link:label>
    <link:label xlink:label="ecd_NonRule10b51ArrTrmntdFlag-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AmortizationOfIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangibles amortization</link:label>
    <link:label xlink:label="us-gaap_AmortizationOfIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" xlink:type="locator"/>
    <link:label xlink:label="ecd_Rule10b51ArrTrmntdFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ecd_Rule10b51ArrTrmntdFlag</link:label>
    <link:label xlink:label="ecd_Rule10b51ArrTrmntdFlag-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" xlink:type="locator"/>
    <link:label xlink:label="ecd_Rule10b51ArrAdoptedFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ecd_Rule10b51ArrAdoptedFlag</link:label>
    <link:label xlink:label="ecd_Rule10b51ArrAdoptedFlag-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" xlink:type="locator"/>
    <link:label xlink:label="ecd_NonRule10b51ArrAdoptedFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ecd_NonRule10b51ArrAdoptedFlag</link:label>
    <link:label xlink:label="ecd_NonRule10b51ArrAdoptedFlag-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskByTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="locator"/>
    <link:label xlink:label="ecd_MtrlTermsOfTrdArrTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AllowanceForDoubtfulAccountsReceivable</link:label>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityCommonStockSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_MarketingAndAdvertisingExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_MarketingAndAdvertisingExpense</link:label>
    <link:label xlink:label="us-gaap_MarketingAndAdvertisingExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketing and Advertising Expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SalesRevenueNetMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInInventories-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInInventories</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInInventories-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
    <link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" xlink:label="ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" xlink:type="locator"/>
    <link:label xlink:label="ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Contingent Consideration, Shares Issued Per Aggregate Net Revenue Ratio</link:label>
    <link:label xlink:label="ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the shares issued per dollar of net revenue for contingent consideration.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" xlink:to="ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:type="locator"/>
    <link:label xlink:label="ycbd_EarnoutSharesForRevenueBetween1And20000000Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnout Shares for Revenue Between $1 and $20,000,000 [Member]</link:label>
    <link:label xlink:label="ycbd_EarnoutSharesForRevenueBetween1And20000000Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents shares issued for revenue between $1-$20,000,000.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:to="ycbd_EarnoutSharesForRevenueBetween1And20000000Member-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Common stock - DCO (in shares)</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Common Stock, Convertible Notes</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Common Stock, Convertible Notes (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:type="locator"/>
    <link:label xlink:label="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnout Shares for Revenue Between $20,000,001 and $60,000,000 [Member]</link:label>
    <link:label xlink:label="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents shares issued for revenue between $20,000,001-$60,000,000.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:to="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:type="locator"/>
    <link:label xlink:label="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnout Shares for Revenue Between $60,000,001 and $140,000,000 [Member]</link:label>
    <link:label xlink:label="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents shares issued for revenue between $60,000,001-$140,000,000.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:to="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
    <link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:type="locator"/>
    <link:label xlink:label="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnout Shares for Revenue Between $140,000,001 and $300,000,000 [Member]</link:label>
    <link:label xlink:label="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents shares issued for revenue between $140,000,001-$300,000,000.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:to="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Common stock - DCO</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_TableTextBlock</link:label>
    <link:label xlink:label="us-gaap_TableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Tables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_TableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightGrantsInPeriod" xlink:label="ycbd_ClassOfWarrantOrRightGrantsInPeriod" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightGrantsInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted, warrants (in shares)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightGrantsInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of grants made during the period on warrant or right.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ClassOfWarrantOrRightGrantsInPeriod" xlink:to="ycbd_ClassOfWarrantOrRightGrantsInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of options for share based compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forfeited, warrant, weighted average exercise price (in dollars per share)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average price at which grantees could have acquired the underlying warrant or right.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of restricted stock for share based compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisesInPeriod" xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriod" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercised, warrants (in shares)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exercised, warrants (in shares)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of warrants or rights exercised during the current period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ClassOfWarrantOrRightExercisesInPeriod" xlink:to="ycbd_ClassOfWarrantOrRightExercisesInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Investment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RelatedPartyDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightForfeituresInPeriod" xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriod" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forfeited, warrants (in shares)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited, warrants (in shares)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of warrant or right forfeitures in period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ClassOfWarrantOrRightForfeituresInPeriod" xlink:to="ycbd_ClassOfWarrantOrRightForfeituresInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted, warrant, weighted average exercise price (in dollars per share)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average per share amount at which grantees can acquire warrant or right.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" xlink:to="ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercised, warrant, weighted average exercise price (in dollars per share)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average price at which warrant holders acquired warrants or right.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" xlink:to="ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue" xlink:label="ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue" xlink:type="locator"/>
    <link:label xlink:label="ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate net revenue</link:label>
    <link:label xlink:label="ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents aggregate net revenue for contingent consideration for business acquisition.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue" xlink:to="ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringSeptember2023Member" xlink:label="ycbd_WarrantsExpiringSeptember2023Member" xlink:type="locator"/>
    <link:label xlink:label="ycbd_WarrantsExpiringSeptember2023Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Expiring September 2023 [Member]</link:label>
    <link:label xlink:label="ycbd_WarrantsExpiringSeptember2023Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents warrants expiring October 2022.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_WarrantsExpiringSeptember2023Member" xlink:to="ycbd_WarrantsExpiringSeptember2023Member-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringOctober2024Member" xlink:label="ycbd_WarrantsExpiringOctober2024Member" xlink:type="locator"/>
    <link:label xlink:label="ycbd_WarrantsExpiringOctober2024Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Expiring October 2024 [Member]</link:label>
    <link:label xlink:label="ycbd_WarrantsExpiringOctober2024Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Warrants Expiring October 2024</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_WarrantsExpiringOctober2024Member" xlink:to="ycbd_WarrantsExpiringOctober2024Member-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of stock (in shares)</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Common stock - A360</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Common stock - A360 (in shares)</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:label="ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_SharebasedPaymentArrangementTrancheFourMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Four [Member]</link:label>
    <link:label xlink:label="ycbd_SharebasedPaymentArrangementTrancheFourMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents share-based payment arrangement tranche four.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:to="ycbd_SharebasedPaymentArrangementTrancheFourMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesAndStockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LiabilitiesAndStockholdersEquity</link:label>
    <link:label xlink:label="us-gaap_LiabilitiesAndStockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashUninsuredAmount" xlink:label="us-gaap_CashUninsuredAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashUninsuredAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CashUninsuredAmount</link:label>
    <link:label xlink:label="us-gaap_CashUninsuredAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, Uninsured Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsToPurchaseCommonStockMember" xlink:label="ycbd_WarrantsToPurchaseCommonStockMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_WarrantsToPurchaseCommonStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants to Purchase Common Stock [Member]</link:label>
    <link:label xlink:label="ycbd_WarrantsToPurchaseCommonStockMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Warrants to Purchase Common Stock.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_WarrantsToPurchaseCommonStockMember" xlink:to="ycbd_WarrantsToPurchaseCommonStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of stock</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringJanuary2025Member" xlink:label="ycbd_WarrantsExpiringJanuary2025Member" xlink:type="locator"/>
    <link:label xlink:label="ycbd_WarrantsExpiringJanuary2025Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Expiring January 2025 [Member]</link:label>
    <link:label xlink:label="ycbd_WarrantsExpiringJanuary2025Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents warrants expiring January 2025.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_WarrantsExpiringJanuary2025Member" xlink:to="ycbd_WarrantsExpiringJanuary2025Member-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive other expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositContractsPolicy" xlink:label="us-gaap_DepositContractsPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DepositContractsPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deposit Contracts, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositContractsPolicy" xlink:to="us-gaap_DepositContractsPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableFairValueDisclosure" xlink:label="us-gaap_NotesPayableFairValueDisclosure" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NotesPayableFairValueDisclosure-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NotesPayableFairValueDisclosure</link:label>
    <link:label xlink:label="us-gaap_NotesPayableFairValueDisclosure-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable, Fair Value Disclosure</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableFairValueDisclosure" xlink:to="us-gaap_NotesPayableFairValueDisclosure-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DisclosureTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DisclosureTextBlockAbstract</link:label>
    <link:label xlink:label="us-gaap_DisclosureTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes to Financial Statements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsDisclosureTextBlock" xlink:label="ycbd_WarrantsDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="ycbd_WarrantsDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Disclosure [Text Block]</link:label>
    <link:label xlink:label="ycbd_WarrantsDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The entire disclosure for warrants.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_WarrantsDisclosureTextBlock" xlink:to="ycbd_WarrantsDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InventoryDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SubsequentEventMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating leases - long term portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeaseLiability-label" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label xlink:label="us-gaap_OperatingLeaseLiability-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeaseLiability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredIncomeTaxesAndTaxCredits</link:label>
    <link:label xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SubsequentEventTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeaseLiabilityCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating leases &#8211; current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SubsequentEventTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SubsequentEventsTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DepositsAssetsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deposits for facilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:label="ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_VestUponAchievingCertainRevenuePerformanceMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vest Upon Achieving Certain Revenue Performance [Member]</link:label>
    <link:label xlink:label="ycbd_VestUponAchievingCertainRevenuePerformanceMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the options vest upon achieving certain revenue performance.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:to="ycbd_VestUponAchievingCertainRevenuePerformanceMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeaseRightOfUseAsset-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating lease assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EquipmentSoldValue" xlink:label="ycbd_EquipmentSoldValue" xlink:type="locator"/>
    <link:label xlink:label="ycbd_EquipmentSoldValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_EquipmentSoldValue</link:label>
    <link:label xlink:label="ycbd_EquipmentSoldValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment Sold Value</link:label>
    <link:label xlink:label="ycbd_EquipmentSoldValue-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The total value of equipment sold.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_EquipmentSoldValue" xlink:to="ycbd_EquipmentSoldValue-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</link:label>
    <link:label xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SteadyStateLlcMember" xlink:label="ycbd_SteadyStateLlcMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_SteadyStateLlcMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Steady State, LLC [Member]</link:label>
    <link:label xlink:label="ycbd_SteadyStateLlcMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Steady State, LLC.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_SteadyStateLlcMember" xlink:to="ycbd_SteadyStateLlcMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Less interest</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConsultantMember" xlink:label="ycbd_ConsultantMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ConsultantMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consultant [Member]</link:label>
    <link:label xlink:label="ycbd_ConsultantMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the consultant.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ConsultantMember" xlink:to="ycbd_ConsultantMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths-label" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Employee [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockOptionPlanExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock based compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockExpense" xlink:label="us-gaap_RestrictedStockExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RestrictedStockExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted stock expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockExpense" xlink:to="us-gaap_RestrictedStockExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</link:label>
    <link:label xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationsPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetUsefulLife</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarningsPerSharePolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion Description [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Revenues-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_Revenues</link:label>
    <link:label xlink:label="us-gaap_Revenues-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Net Sales</link:label>
    <link:label xlink:label="us-gaap_Revenues-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues, Total</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtConversionNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="us-gaap_DebtConversionNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisable" xlink:label="ycbd_ClassOfWarrantOrRightExercisable" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightExercisable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercisable, warrants (in shares)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightExercisable-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of warrants or rights that are exercisable.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ClassOfWarrantOrRightExercisable" xlink:to="ycbd_ClassOfWarrantOrRightExercisable-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding, warrant, weighted average exercise price (in dollars per share)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, warrant, weighted average exercise price (in dollars per share)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, warrant, weighted average exercise price (in dollars per share)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of warrants or rights outstanding.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:to="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercisable, warrant, weighted average exercise price (in dollars per share)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of warrants or rights that are exercisable.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:to="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="us-gaap_LiabilitiesFairValueAdjustment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in value of liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueAdjustment" xlink:to="us-gaap_LiabilitiesFairValueAdjustment-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding, warrant, contractual term (Year)</link:label>
    <link:label xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual term for warrants and rights outstanding.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" xlink:to="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueAdjustment" xlink:label="us-gaap_EquityFairValueAdjustment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EquityFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in value of equities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityFairValueAdjustment" xlink:to="us-gaap_EquityFairValueAdjustment-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="us-gaap_FairValueNetAssetLiability" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueNetAssetLiability-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FairValueNetAssetLiability</link:label>
    <link:label xlink:label="us-gaap_FairValueNetAssetLiability-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:label xlink:label="us-gaap_FairValueNetAssetLiability-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetAssetLiability" xlink:to="us-gaap_FairValueNetAssetLiability-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Depreciation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</link:label>
    <link:label xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EquityClassifiedWarrantsMember" xlink:label="ycbd_EquityClassifiedWarrantsMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_EquityClassifiedWarrantsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Classified Warrants [Member]</link:label>
    <link:label xlink:label="ycbd_EquityClassifiedWarrantsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents equity classified warrants.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_EquityClassifiedWarrantsMember" xlink:to="ycbd_EquityClassifiedWarrantsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommonStockPurchaseWarrantsMember" xlink:label="ycbd_CommonStockPurchaseWarrantsMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_CommonStockPurchaseWarrantsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Purchase Warrants [Member]</link:label>
    <link:label xlink:label="ycbd_CommonStockPurchaseWarrantsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents common stock purchase warrants.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_CommonStockPurchaseWarrantsMember" xlink:to="ycbd_CommonStockPurchaseWarrantsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharesIssuedPricePerShare-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharesIssuedPricePerShare</link:label>
    <link:label xlink:label="us-gaap_SharesIssuedPricePerShare-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares Issued, Price Per Share (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AssetsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AssetsCurrent</link:label>
    <link:label xlink:label="us-gaap_AssetsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringMay2024Member" xlink:label="ycbd_WarrantsExpiringMay2024Member" xlink:type="locator"/>
    <link:label xlink:label="ycbd_WarrantsExpiringMay2024Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Expiring May 2024 [Member]</link:label>
    <link:label xlink:label="ycbd_WarrantsExpiringMay2024Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Warrants expiring in May, 2024.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_WarrantsExpiringMay2024Member" xlink:to="ycbd_WarrantsExpiringMay2024Member-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PurchaseagreementMember" xlink:label="ycbd_PurchaseagreementMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PurchaseagreementMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Agreement [Member]</link:label>
    <link:label xlink:label="ycbd_PurchaseagreementMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the Purchase Agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PurchaseagreementMember" xlink:to="ycbd_PurchaseagreementMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase/(Decrease) in contingent liability</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Decrease of contingent liability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, authorized 150,000,000 shares, $0.001 par value, 3,939,057 and 2,960,573 shares issued and outstanding, respectively</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used by operating activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label xlink:label="us-gaap_CommonStockSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockSharesIssued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label xlink:label="us-gaap_CommonStockSharesIssued-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockParOrStatedValuePerShare-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_CommonStockParOrStatedValuePerShare-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockholdersEquityPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxAssetsValuationAllowance</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:label xlink:label="srt_RangeMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasePayments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash paid for amounts included in the measurement of operating lease liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:label xlink:label="srt_MaximumMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:label xlink:label="srt_MinimumMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:label xlink:label="srt_RangeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis" xlink:type="locator"/>
    <link:label xlink:label="srt_LitigationCaseAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="srt_LitigationCaseTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="srt_LitigationCaseTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred stock, authorized 50,000,000 shares, $0.001 par value, 5,000,000 and 5,000,000 shares issued and outstanding, respectively</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxAssetsLiabilitiesNet</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockSharesIssued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued (in shares)</link:label>
    <link:label xlink:label="us-gaap_PreferredStockSharesIssued-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InterestPaidNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_InterestPaidNet</link:label>
    <link:label xlink:label="us-gaap_InterestPaidNet-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsOther-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxAssetsGross</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsGross-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized (in shares)</link:label>
    <link:label xlink:label="us-gaap_PreferredStockSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredIncomeTaxLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredIncomeTaxLiabilities</link:label>
    <link:label xlink:label="us-gaap_DeferredIncomeTaxLiabilities-label" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InventoryNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_InventoryNet</link:label>
    <link:label xlink:label="us-gaap_InventoryNet-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Inventory</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Sales</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsAndSupplies" xlink:label="us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InventoryRawMaterialsAndSupplies-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Components</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsAndSupplies" xlink:to="us-gaap_InventoryRawMaterialsAndSupplies-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InventoryValuationReserves-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_InventoryValuationReserves</link:label>
    <link:label xlink:label="us-gaap_InventoryValuationReserves-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventory Reserve</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInvestments" xlink:label="us-gaap_DeferredTaxAssetsInvestments" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsInvestments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInvestments" xlink:to="us-gaap_DeferredTaxAssetsInvestments-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueInputsLevel3Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InventoryFinishedGoods-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finished Goods</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsInventory-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory reserve</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangibles</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InventoryGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_InventoryGross</link:label>
    <link:label xlink:label="us-gaap_InventoryGross-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueInputsLevel1Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueInputsLevel2Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fixed Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PropertyPlantAndEquipmentUsefulLife</link:label>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred revenue / customer deposits</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="us-gaap_InterestIncomeExpenseNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InterestIncomeExpenseNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest (expense) income</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNet" xlink:to="us-gaap_InterestIncomeExpenseNet-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockDividendRatePercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PreferredStockDividendRatePercentage</link:label>
    <link:label xlink:label="us-gaap_PreferredStockDividendRatePercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:label="us-gaap_AccountsReceivableGrossCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountsReceivableGrossCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableGrossCurrent" xlink:to="us-gaap_AccountsReceivableGrossCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountsReceivableNetCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AccountsReceivableNetCurrent</link:label>
    <link:label xlink:label="us-gaap_AccountsReceivableNetCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DividendsPayableQuarterlyGrowth" xlink:label="ycbd_DividendsPayableQuarterlyGrowth" xlink:type="locator"/>
    <link:label xlink:label="ycbd_DividendsPayableQuarterlyGrowth-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_DividendsPayableQuarterlyGrowth</link:label>
    <link:label xlink:label="ycbd_DividendsPayableQuarterlyGrowth-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends Payable, Quarterly Growth</link:label>
    <link:label xlink:label="ycbd_DividendsPayableQuarterlyGrowth-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount by which the accrued liability for dividends declared but not paid grows per quarter.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_DividendsPayableQuarterlyGrowth" xlink:to="ycbd_DividendsPayableQuarterlyGrowth-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LitigationSettlementMonthlyPaymentAmount" xlink:label="ycbd_LitigationSettlementMonthlyPaymentAmount" xlink:type="locator"/>
    <link:label xlink:label="ycbd_LitigationSettlementMonthlyPaymentAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_LitigationSettlementMonthlyPaymentAmount</link:label>
    <link:label xlink:label="ycbd_LitigationSettlementMonthlyPaymentAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Monthly Payment Amount</link:label>
    <link:label xlink:label="ycbd_LitigationSettlementMonthlyPaymentAmount-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of cash paid as a monthly payment for the settlement of litigation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_LitigationSettlementMonthlyPaymentAmount" xlink:to="ycbd_LitigationSettlementMonthlyPaymentAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdditionalPaidInCapital-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional paid in capital</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LitigationSettlementInitialPayment" xlink:label="ycbd_LitigationSettlementInitialPayment" xlink:type="locator"/>
    <link:label xlink:label="ycbd_LitigationSettlementInitialPayment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_LitigationSettlementInitialPayment</link:label>
    <link:label xlink:label="ycbd_LitigationSettlementInitialPayment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Initial Payment</link:label>
    <link:label xlink:label="ycbd_LitigationSettlementInitialPayment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of cash paid as the initial payment for the settlement of litigation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_LitigationSettlementInitialPayment" xlink:to="ycbd_LitigationSettlementInitialPayment-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommissionPercentage" xlink:label="ycbd_CommissionPercentage" xlink:type="locator"/>
    <link:label xlink:label="ycbd_CommissionPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_CommissionPercentage</link:label>
    <link:label xlink:label="ycbd_CommissionPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commission Percentage</link:label>
    <link:label xlink:label="ycbd_CommissionPercentage-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percentage of commission granted under an agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_CommissionPercentage" xlink:to="ycbd_CommissionPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LengthOfConsultingAgreement" xlink:label="ycbd_LengthOfConsultingAgreement" xlink:type="locator"/>
    <link:label xlink:label="ycbd_LengthOfConsultingAgreement-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_LengthOfConsultingAgreement</link:label>
    <link:label xlink:label="ycbd_LengthOfConsultingAgreement-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Length of Consulting Agreement (Year)</link:label>
    <link:label xlink:label="ycbd_LengthOfConsultingAgreement-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the length of a consulting agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_LengthOfConsultingAgreement" xlink:to="ycbd_LengthOfConsultingAgreement-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestingAnnuallyOverThreeYearsMember" xlink:label="ycbd_VestingAnnuallyOverThreeYearsMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_VestingAnnuallyOverThreeYearsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Annually Over Three Years [Member]</link:label>
    <link:label xlink:label="ycbd_VestingAnnuallyOverThreeYearsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Relating to vesting annually over three years.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_VestingAnnuallyOverThreeYearsMember" xlink:to="ycbd_VestingAnnuallyOverThreeYearsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:label="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:type="locator"/>
    <link:label xlink:label="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in value of convertible debt</link:label>
    <link:label xlink:label="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to a change in value of convertible debt.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:to="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OperatingLeasesRentExpensePerSquareFoot" xlink:label="ycbd_OperatingLeasesRentExpensePerSquareFoot" xlink:type="locator"/>
    <link:label xlink:label="ycbd_OperatingLeasesRentExpensePerSquareFoot-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_OperatingLeasesRentExpensePerSquareFoot</link:label>
    <link:label xlink:label="ycbd_OperatingLeasesRentExpensePerSquareFoot-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense Per Square Foot (in USD per Per Share)</link:label>
    <link:label xlink:label="ycbd_OperatingLeasesRentExpensePerSquareFoot-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the rent expense for an operating lease per square foot.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_OperatingLeasesRentExpensePerSquareFoot" xlink:to="ycbd_OperatingLeasesRentExpensePerSquareFoot-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WriteOffOfPrepaidAssets" xlink:label="ycbd_WriteOffOfPrepaidAssets" xlink:type="locator"/>
    <link:label xlink:label="ycbd_WriteOffOfPrepaidAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Write off of prepaid assets due to termination of contractual obligation</link:label>
    <link:label xlink:label="ycbd_WriteOffOfPrepaidAssets-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of prepaid assets written off during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_WriteOffOfPrepaidAssets" xlink:to="ycbd_WriteOffOfPrepaidAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarehouseLeaseMember" xlink:label="ycbd_WarehouseLeaseMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_WarehouseLeaseMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warehouse Lease [Member]</link:label>
    <link:label xlink:label="ycbd_WarehouseLeaseMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the warehouse lease.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_WarehouseLeaseMember" xlink:to="ycbd_WarehouseLeaseMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Charitable contributions</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockholdersEquityAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">cbdMD, Inc. shareholders' equity:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital loss carryforward</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LeaseholdImprovementsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:label="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long term liabilities</link:label>
    <link:label xlink:label="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:to="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdMdLimintedMarkMember" xlink:label="ycbd_CbdMdLimintedMarkMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_CbdMdLimintedMarkMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CBD MD Liminted Mark [Member]</link:label>
    <link:label xlink:label="ycbd_CbdMdLimintedMarkMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents CBD MD Liminted Mark.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_CbdMdLimintedMarkMember" xlink:to="ycbd_CbdMdLimintedMarkMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LesseeOperatingLeasesAnnualBaseRent" xlink:label="ycbd_LesseeOperatingLeasesAnnualBaseRent" xlink:type="locator"/>
    <link:label xlink:label="ycbd_LesseeOperatingLeasesAnnualBaseRent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_LesseeOperatingLeasesAnnualBaseRent</link:label>
    <link:label xlink:label="ycbd_LesseeOperatingLeasesAnnualBaseRent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases, Annual Base Rent</link:label>
    <link:label xlink:label="ycbd_LesseeOperatingLeasesAnnualBaseRent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of annual base rent of operating lease of the lessee.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_LesseeOperatingLeasesAnnualBaseRent" xlink:to="ycbd_LesseeOperatingLeasesAnnualBaseRent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LesseeOperatingLeasesMonthlyBaseRent" xlink:label="ycbd_LesseeOperatingLeasesMonthlyBaseRent" xlink:type="locator"/>
    <link:label xlink:label="ycbd_LesseeOperatingLeasesMonthlyBaseRent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_LesseeOperatingLeasesMonthlyBaseRent</link:label>
    <link:label xlink:label="ycbd_LesseeOperatingLeasesMonthlyBaseRent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases, Monthly Base Rent</link:label>
    <link:label xlink:label="ycbd_LesseeOperatingLeasesMonthlyBaseRent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of monthly base rent of operating lease of the lessee.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_LesseeOperatingLeasesMonthlyBaseRent" xlink:to="ycbd_LesseeOperatingLeasesMonthlyBaseRent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringApril2028Member" xlink:label="ycbd_WarrantsExpiringApril2028Member" xlink:type="locator"/>
    <link:label xlink:label="ycbd_WarrantsExpiringApril2028Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Expiring April 2028 [Member]</link:label>
    <link:label xlink:label="ycbd_WarrantsExpiringApril2028Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents warrants expiring April 2028.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_WarrantsExpiringApril2028Member" xlink:to="ycbd_WarrantsExpiringApril2028Member-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AssetsCurrentAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CapitalRaiseMember" xlink:label="ycbd_CapitalRaiseMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_CapitalRaiseMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Raise [Member]</link:label>
    <link:label xlink:label="ycbd_CapitalRaiseMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents capital raise.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_CapitalRaiseMember" xlink:to="ycbd_CapitalRaiseMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</link:label>
    <link:label xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, beginning of year</link:label>
    <link:label xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, end of year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InventoryPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_RightOfUseLiability" xlink:label="ycbd_RightOfUseLiability" xlink:type="locator"/>
    <link:label xlink:label="ycbd_RightOfUseLiability-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ROU - Liability</link:label>
    <link:label xlink:label="ycbd_RightOfUseLiability-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of right of use liability.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_RightOfUseLiability" xlink:to="ycbd_RightOfUseLiability-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_AgreementForAdvertisingPlacementUnutilizedAmount" xlink:label="ycbd_AgreementForAdvertisingPlacementUnutilizedAmount" xlink:type="locator"/>
    <link:label xlink:label="ycbd_AgreementForAdvertisingPlacementUnutilizedAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_AgreementForAdvertisingPlacementUnutilizedAmount</link:label>
    <link:label xlink:label="ycbd_AgreementForAdvertisingPlacementUnutilizedAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Agreement for Advertising Placement, Unutilized Amount</link:label>
    <link:label xlink:label="ycbd_AgreementForAdvertisingPlacementUnutilizedAmount-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount unutilized of agreement for advertising placement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_AgreementForAdvertisingPlacementUnutilizedAmount" xlink:to="ycbd_AgreementForAdvertisingPlacementUnutilizedAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OverAllotmentOptionMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DeferredTaxAssetAndRelatedValuationAllowance" xlink:label="ycbd_DeferredTaxAssetAndRelatedValuationAllowance" xlink:type="locator"/>
    <link:label xlink:label="ycbd_DeferredTaxAssetAndRelatedValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_DeferredTaxAssetAndRelatedValuationAllowance</link:label>
    <link:label xlink:label="ycbd_DeferredTaxAssetAndRelatedValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset And Related Valuation Allowance</link:label>
    <link:label xlink:label="ycbd_DeferredTaxAssetAndRelatedValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_DeferredTaxAssetAndRelatedValuationAllowance" xlink:to="ycbd_DeferredTaxAssetAndRelatedValuationAllowance-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NetCashProvidedByUsedInFinancingActivities</link:label>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash provided (used) by financing activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract" xlink:label="us-gaap_OtherAssetsAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherAssetsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other assets:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Liabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_Liabilities</link:label>
    <link:label xlink:label="us-gaap_Liabilities-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</link:label>
    <link:label xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OperatingExpensesExcludingImpairment" xlink:label="ycbd_OperatingExpensesExcludingImpairment" xlink:type="locator"/>
    <link:label xlink:label="ycbd_OperatingExpensesExcludingImpairment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating expenses</link:label>
    <link:label xlink:label="ycbd_OperatingExpensesExcludingImpairment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Excludes impairment of assets.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_OperatingExpensesExcludingImpairment" xlink:to="ycbd_OperatingExpensesExcludingImpairment-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommitmentsAndContingencies-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies (Note 11)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SubsidiarySaleOfStockAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" xlink:label="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments</link:label>
    <link:label xlink:label="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label xlink:label="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount after tax before income adjustments of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" xlink:to="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingIncomeLoss</link:label>
    <link:label xlink:label="us-gaap_OperatingIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:label="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:type="locator"/>
    <link:label xlink:label="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vest Based on Certain Performance Hurdles Prior to December 2024 [Member]</link:label>
    <link:label xlink:label="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Relating to vest based on certain performance hurdles prior to December 2024.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:to="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NetCashProvidedByUsedInOperatingActivities</link:label>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash used by operating activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NetCashProvidedByUsedInInvestingActivities</link:label>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash (used) provided by investing activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxLiabilities</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilities-label" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax liability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Intangibles</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CostOfRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GrossProfit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GrossProfit</link:label>
    <link:label xlink:label="us-gaap_GrossProfit-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:label xlink:label="srt_CounterpartyNameAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:label xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrepaidInventory" xlink:label="ycbd_PrepaidInventory" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PrepaidInventory-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory prepaid</link:label>
    <link:label xlink:label="ycbd_PrepaidInventory-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of consideration paid in advance for inventory that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PrepaidInventory" xlink:to="ycbd_PrepaidInventory-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InventoryWriteDown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory and materials impairment</link:label>
    <link:label xlink:label="us-gaap_InventoryWriteDown-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory Write-down</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrepaidSponsorship" xlink:label="ycbd_PrepaidSponsorship" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PrepaidSponsorship-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid sponsorship</link:label>
    <link:label xlink:label="ycbd_PrepaidSponsorship-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of consideration paid in advance for sponsorships.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PrepaidSponsorship" xlink:to="ycbd_PrepaidSponsorship-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">ROU - Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest" xlink:label="ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest" xlink:type="locator"/>
    <link:label xlink:label="ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest</link:label>
    <link:label xlink:label="ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of shares for conversion of debt and accrued interest</link:label>
    <link:label xlink:label="ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The proceeds from the issuance of shares for the conversion of debt and accrued interest</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest" xlink:to="ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</link:label>
    <link:label xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Other-than-Temporary Impairment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrincipleAdjustmentsOfDebt" xlink:label="ycbd_PrincipleAdjustmentsOfDebt" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PrincipleAdjustmentsOfDebt-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_PrincipleAdjustmentsOfDebt</link:label>
    <link:label xlink:label="ycbd_PrincipleAdjustmentsOfDebt-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principle Adjustments of Debt</link:label>
    <link:label xlink:label="ycbd_PrincipleAdjustmentsOfDebt-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The change in the principle value of debt.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PrincipleAdjustmentsOfDebt" xlink:to="ycbd_PrincipleAdjustmentsOfDebt-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskCreditRisk-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SalesAllowances" xlink:label="ycbd_SalesAllowances" xlink:type="locator"/>
    <link:label xlink:label="ycbd_SalesAllowances-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_SalesAllowances</link:label>
    <link:label xlink:label="ycbd_SalesAllowances-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Allowances</link:label>
    <link:label xlink:label="ycbd_SalesAllowances-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of sales allowance.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_SalesAllowances" xlink:to="ycbd_SalesAllowances-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid Expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock</link:label>
    <link:label xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Preferred dividend distribution</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:label="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:type="locator"/>
    <link:label xlink:label="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collection on discontinued operations accounts receivable</link:label>
    <link:label xlink:label="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of accounts receivable collected from discontinued operations.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:to="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_IncreaseDecreaseInPrepaidInventoryTotal" xlink:label="ycbd_IncreaseDecreaseInPrepaidInventoryTotal" xlink:type="locator"/>
    <link:label xlink:label="ycbd_IncreaseDecreaseInPrepaidInventoryTotal-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_IncreaseDecreaseInPrepaidInventoryTotal</link:label>
    <link:label xlink:label="ycbd_IncreaseDecreaseInPrepaidInventoryTotal-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid inventory</link:label>
    <link:label xlink:label="ycbd_IncreaseDecreaseInPrepaidInventoryTotal-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the increase (decrease) in prepaid inventory.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_IncreaseDecreaseInPrepaidInventoryTotal" xlink:to="ycbd_IncreaseDecreaseInPrepaidInventoryTotal-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CostOfSalesPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:label xlink:label="srt_ScenarioUnspecifiedDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xlink:type="locator"/>
    <link:label xlink:label="srt_ScenarioForecastMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forecast [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RetainedEarningsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:label xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:label xlink:label="srt_TitleOfIndividualAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xlink:type="locator"/>
    <link:label xlink:label="srt_StatementScenarioAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdditionalPaidInCapitalMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CurrentFederalTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementEquityComponentsAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EquityComponentDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CurrentIncomeTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ManufacturingEquipmentMember" xlink:label="ycbd_ManufacturingEquipmentMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ManufacturingEquipmentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufacturing Equipment [Member]</link:label>
    <link:label xlink:label="ycbd_ManufacturingEquipmentMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents manufacturing equipment.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ManufacturingEquipmentMember" xlink:to="ycbd_ManufacturingEquipmentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</link:label>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SoftwareMember" xlink:label="ycbd_SoftwareMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_SoftwareMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software [Member]</link:label>
    <link:label xlink:label="ycbd_SoftwareMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents software.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_SoftwareMember" xlink:to="ycbd_SoftwareMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevenueRemainingPerformanceObligation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_RevenueRemainingPerformanceObligation</link:label>
    <link:label xlink:label="us-gaap_RevenueRemainingPerformanceObligation-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CureBasedDevelopmentLlcMember" xlink:label="ycbd_CureBasedDevelopmentLlcMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_CureBasedDevelopmentLlcMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cure Based Development, Llc [Member]</link:label>
    <link:label xlink:label="ycbd_CureBasedDevelopmentLlcMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Cure Based Development, LLC.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_CureBasedDevelopmentLlcMember" xlink:to="ycbd_CureBasedDevelopmentLlcMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NotesPayable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NotesPayable</link:label>
    <link:label xlink:label="us-gaap_NotesPayable-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MerchantReceivableAndReservePolicyTextBlock" xlink:label="ycbd_MerchantReceivableAndReservePolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="ycbd_MerchantReceivableAndReservePolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Merchant Receivable and Reserve [Policy Text Block]</link:label>
    <link:label xlink:label="ycbd_MerchantReceivableAndReservePolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for merchant receivables and reserve.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_MerchantReceivableAndReservePolicyTextBlock" xlink:to="ycbd_MerchantReceivableAndReservePolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_UnregisteredCommonStockMember" xlink:label="ycbd_UnregisteredCommonStockMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_UnregisteredCommonStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unregistered Common Stock [Member]</link:label>
    <link:label xlink:label="ycbd_UnregisteredCommonStockMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents unregistered common stock.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_UnregisteredCommonStockMember" xlink:to="ycbd_UnregisteredCommonStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod" xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod" xlink:type="locator"/>
    <link:label xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod</link:label>
    <link:label xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)</link:label>
    <link:label xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the vesting period of issued and/or issuable shares issued for acquisition.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod" xlink:to="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Merchantprocessingfee" xlink:label="ycbd_Merchantprocessingfee" xlink:type="locator"/>
    <link:label xlink:label="ycbd_Merchantprocessingfee-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_Merchantprocessingfee</link:label>
    <link:label xlink:label="ycbd_Merchantprocessingfee-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MerchantProcessingFee</link:label>
    <link:label xlink:label="ycbd_Merchantprocessingfee-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents agreed percentage for merchant processing fees.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_Merchantprocessingfee" xlink:to="ycbd_Merchantprocessingfee-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding, warrants (in shares)</link:label>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, warrants (in shares)</link:label>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, warrants (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</link:label>
    <link:label xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before provision for income taxes</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</link:label>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NumberOfMajorCustomers" xlink:label="ycbd_NumberOfMajorCustomers" xlink:type="locator"/>
    <link:label xlink:label="ycbd_NumberOfMajorCustomers-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_NumberOfMajorCustomers</link:label>
    <link:label xlink:label="ycbd_NumberOfMajorCustomers-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Major Customers</link:label>
    <link:label xlink:label="ycbd_NumberOfMajorCustomers-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents number of major customers.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_NumberOfMajorCustomers" xlink:to="ycbd_NumberOfMajorCustomers-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SalesChannelMember" xlink:label="ycbd_SalesChannelMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_SalesChannelMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Channel [Member]</link:label>
    <link:label xlink:label="ycbd_SalesChannelMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents type of sales channel.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_SalesChannelMember" xlink:to="ycbd_SalesChannelMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_A360MediaLlcMember" xlink:label="ycbd_A360MediaLlcMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_A360MediaLlcMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">a360 Media, LLC [Member]</link:label>
    <link:label xlink:label="ycbd_A360MediaLlcMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents a360 Media, LLC.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_A360MediaLlcMember" xlink:to="ycbd_A360MediaLlcMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement" xlink:label="ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement</link:label>
    <link:label xlink:label="ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of Shares Vest Upon Each Advertising Placement</link:label>
    <link:label xlink:label="ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents percentage of shares vest upon each advertising placement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement" xlink:to="ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:type="locator"/>
    <link:label xlink:label="dei_IcfrAuditorAttestationFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories" xlink:label="ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories</link:label>
    <link:label xlink:label="ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of Shares Vest Provided No Restrictions in Product Categories</link:label>
    <link:label xlink:label="ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of shares vested provided no restrictions in product categories.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories" xlink:to="ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_AdvertisingPlacementAgreementMember" xlink:label="ycbd_AdvertisingPlacementAgreementMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_AdvertisingPlacementAgreementMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Placement Agreement [Member]</link:label>
    <link:label xlink:label="ycbd_AdvertisingPlacementAgreementMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents advertising placement agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_AdvertisingPlacementAgreementMember" xlink:to="ycbd_AdvertisingPlacementAgreementMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement" xlink:label="ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement" xlink:type="locator"/>
    <link:label xlink:label="ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement</link:label>
    <link:label xlink:label="ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Agreement for Advertising Placement, Credit for Media Support and Advertising Placement</link:label>
    <link:label xlink:label="ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit for media support and advertising placement for agreement for advertising placement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement" xlink:to="ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PercentageOfSharesFullyVested" xlink:label="ycbd_PercentageOfSharesFullyVested" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PercentageOfSharesFullyVested-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_PercentageOfSharesFullyVested</link:label>
    <link:label xlink:label="ycbd_PercentageOfSharesFullyVested-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of Shares Fully Vested</link:label>
    <link:label xlink:label="ycbd_PercentageOfSharesFullyVested-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents percentage of shares fully vested.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PercentageOfSharesFullyVested" xlink:to="ycbd_PercentageOfSharesFullyVested-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AutomobilesMember" xlink:label="us-gaap_AutomobilesMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AutomobilesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Automobiles [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AutomobilesMember" xlink:to="us-gaap_AutomobilesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentAnnualReport-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountingPoliciesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentTransitionReport-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentFinStmtErrorCorrectionFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityInteractiveDataCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
    <link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
    <link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromConvertibleDebt-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ProceedsFromConvertibleDebt</link:label>
    <link:label xlink:label="us-gaap_ProceedsFromConvertibleDebt-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ComputersFurnitureAndEquipmentMember" xlink:label="ycbd_ComputersFurnitureAndEquipmentMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_ComputersFurnitureAndEquipmentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computers, Furniture, and Equipment [Member]</link:label>
    <link:label xlink:label="ycbd_ComputersFurnitureAndEquipmentMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Computers, furniture, equipment.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_ComputersFurnitureAndEquipmentMember" xlink:to="ycbd_ComputersFurnitureAndEquipmentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NonmonetaryTransactionTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonmonetary Transaction Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonmonetaryTransactionTypeDomain" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ProceedsFromRepaymentsOfNotesPayable</link:label>
    <link:label xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Note payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:to="us-gaap_ProceedsFromRepaymentsOfNotesPayable-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToHempMdMember" xlink:label="ycbd_TrademarkRelatedToHempMdMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_TrademarkRelatedToHempMdMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademark Related to Hemp MD [Member]</link:label>
    <link:label xlink:label="ycbd_TrademarkRelatedToHempMdMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the trademark "HempMD".</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_TrademarkRelatedToHempMdMember" xlink:to="ycbd_TrademarkRelatedToHempMdMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NonmonetaryTransactionTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonmonetary Transaction Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToCbdmdMember" xlink:label="ycbd_TrademarkRelatedToCbdmdMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_TrademarkRelatedToCbdmdMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademark Related to cbdMD [Member]</link:label>
    <link:label xlink:label="ycbd_TrademarkRelatedToCbdmdMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the trademark "cbdMD".</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_TrademarkRelatedToCbdmdMember" xlink:to="ycbd_TrademarkRelatedToCbdmdMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName" xlink:type="locator"/>
    <link:label xlink:label="dei_AuditorName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" xlink:type="locator"/>
    <link:label xlink:label="dei_AuditorFirmId-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PreferredDividendsAccruedNotYetPaid" xlink:label="ycbd_PreferredDividendsAccruedNotYetPaid" xlink:type="locator"/>
    <link:label xlink:label="ycbd_PreferredDividendsAccruedNotYetPaid-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred dividends accrued but not paid</link:label>
    <link:label xlink:label="ycbd_PreferredDividendsAccruedNotYetPaid-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the value of dividends accrued but not paid for the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_PreferredDividendsAccruedNotYetPaid" xlink:to="ycbd_PreferredDividendsAccruedNotYetPaid-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" xlink:type="locator"/>
    <link:label xlink:label="dei_AuditorLocation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</link:label>
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</link:label>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Shares used in computing diluted earnings per share (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLossCarryforwardsValuationAllowance</link:label>
    <link:label xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="us-gaap_OperatingLossCarryforwardsValuationAllowance-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementOfFinancialPositionAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarningsPerShareDiluted-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EarningsPerShareDiluted</link:label>
    <link:label xlink:label="us-gaap_EarningsPerShareDiluted-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per share (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic-label" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares used in computing basic earnings per share (in shares)</link:label>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average number of shares Basic and Diluted: (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateContinuingOperations</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarningsPerShareBasic-label" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per share (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_EarningsPerShareBasic-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic and Diluted loss per share (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementOfCashFlowsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LeaseContractualTermDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementOfStockholdersEquityAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LeaseContractualTermAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeStatementAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</link:label>
    <link:label xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term (Month)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelAxis" xlink:label="us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ContractWithCustomerSalesChannelAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="us-gaap_ContractWithCustomerSalesChannelAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelDomain" xlink:label="us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ContractWithCustomerSalesChannelDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="us-gaap_ContractWithCustomerSalesChannelDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelDirectlyToConsumerMember" xlink:label="us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SalesChannelDirectlyToConsumerMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="us-gaap_SalesChannelDirectlyToConsumerMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelThroughIntermediaryMember" xlink:label="us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SalesChannelThroughIntermediaryMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="us-gaap_SalesChannelThroughIntermediaryMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</link:label>
    <link:label xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent derivative expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Permanent differences</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DecreaseInApicIssuanceOfStock" xlink:label="ycbd_DecreaseInApicIssuanceOfStock" xlink:type="locator"/>
    <link:label xlink:label="ycbd_DecreaseInApicIssuanceOfStock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_DecreaseInApicIssuanceOfStock</link:label>
    <link:label xlink:label="ycbd_DecreaseInApicIssuanceOfStock-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Issuance of stock</link:label>
    <link:label xlink:label="ycbd_DecreaseInApicIssuanceOfStock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the decrease in APIC related to he issuance of common stock.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_DecreaseInApicIssuanceOfStock" xlink:to="ycbd_DecreaseInApicIssuanceOfStock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" xlink:label="ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology Relief From Royalty Related To Direct C B D Online Com Member</link:label>
    <link:label xlink:label="ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Technology Relief From Royalty Related To Direct C B D Online Com.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" xlink:to="ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TradenameRelatedToDirectCBDOnlineComMember" xlink:label="ycbd_TradenameRelatedToDirectCBDOnlineComMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_TradenameRelatedToDirectCBDOnlineComMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tradename Related To Direct C B D Online Com Member</link:label>
    <link:label xlink:label="ycbd_TradenameRelatedToDirectCBDOnlineComMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Tradename Related To Direct C B D Online Com.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_TradenameRelatedToDirectCBDOnlineComMember" xlink:to="ycbd_TradenameRelatedToDirectCBDOnlineComMember-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent liability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LiabilitiesNoncurrent</link:label>
    <link:label xlink:label="us-gaap_LiabilitiesNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total long term liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares" xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares" xlink:type="locator"/>
    <link:label xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares</link:label>
    <link:label xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)</link:label>
    <link:label xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the additional shares issued or issuable for business acquisition.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares" xlink:to="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_RegisteredCommonStockMember" xlink:label="ycbd_RegisteredCommonStockMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_RegisteredCommonStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Registered Common Stock [Member]</link:label>
    <link:label xlink:label="ycbd_RegisteredCommonStockMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents registered shares of common stock.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_RegisteredCommonStockMember" xlink:to="ycbd_RegisteredCommonStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration" xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration" xlink:type="locator"/>
    <link:label xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration</link:label>
    <link:label xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares, Expiration (Month)</link:label>
    <link:label xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the expiration period for additional shares issuable.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration" xlink:to="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Federal statutory income tax rate</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DividendsPayableCurrentAndNoncurrent</link:label>
    <link:label xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends Payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:label="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="locator"/>
    <link:label xlink:label="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label xlink:label="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of operating lease asset</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_StockholdersEquity</link:label>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cbdMD, Inc. shareholders' equity</link:label>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DebtInstrumentDiscountedPercentage" xlink:label="ycbd_DebtInstrumentDiscountedPercentage" xlink:type="locator"/>
    <link:label xlink:label="ycbd_DebtInstrumentDiscountedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_DebtInstrumentDiscountedPercentage</link:label>
    <link:label xlink:label="ycbd_DebtInstrumentDiscountedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Discounted Percentage</link:label>
    <link:label xlink:label="ycbd_DebtInstrumentDiscountedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percent of discount convertible promissory note issued to investors.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_DebtInstrumentDiscountedPercentage" xlink:to="ycbd_DebtInstrumentDiscountedPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementClassOfStockAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ClassOfStockDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:label="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investors 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note [Member]</link:label>
    <link:label xlink:label="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the Investors 8% Senior Secured Original Issue and the 20% Discount Convertible Promissory Note.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:to="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DebtInstrumentPrepaymentPayablePercent" xlink:label="ycbd_DebtInstrumentPrepaymentPayablePercent" xlink:type="locator"/>
    <link:label xlink:label="ycbd_DebtInstrumentPrepaymentPayablePercent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_DebtInstrumentPrepaymentPayablePercent</link:label>
    <link:label xlink:label="ycbd_DebtInstrumentPrepaymentPayablePercent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Prepayment Payable Percent</link:label>
    <link:label xlink:label="ycbd_DebtInstrumentPrepaymentPayablePercent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the prepayment payable percent.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_DebtInstrumentPrepaymentPayablePercent" xlink:to="ycbd_DebtInstrumentPrepaymentPayablePercent-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:label="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="locator"/>
    <link:label xlink:label="ycbd_CbdmdAndDirectcbdonlineTrademarksMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">cbdMD and directCBDonline Trademarks [Member]</link:label>
    <link:label xlink:label="ycbd_CbdmdAndDirectcbdonlineTrademarksMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Relating to cbdMD and directCBDonline trademarks.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:to="ycbd_CbdmdAndDirectcbdonlineTrademarksMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WorkingCapital" xlink:label="ycbd_WorkingCapital" xlink:type="locator"/>
    <link:label xlink:label="ycbd_WorkingCapital-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_WorkingCapital</link:label>
    <link:label xlink:label="ycbd_WorkingCapital-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Working Capital</link:label>
    <link:label xlink:label="ycbd_WorkingCapital-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the value of total current assets net of current liabilities as of the balance sheet date.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_WorkingCapital" xlink:to="ycbd_WorkingCapital-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" xlink:label="ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liquidity and Going Concern Considerations, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for liquidity and going concern considerations.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" xlink:to="ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DebtInstrumentInterestRateInDefault" xlink:label="ycbd_DebtInstrumentInterestRateInDefault" xlink:type="locator"/>
    <link:label xlink:label="ycbd_DebtInstrumentInterestRateInDefault-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ycbd_DebtInstrumentInterestRateInDefault</link:label>
    <link:label xlink:label="ycbd_DebtInstrumentInterestRateInDefault-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate In Default</link:label>
    <link:label xlink:label="ycbd_DebtInstrumentInterestRateInDefault-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the interest rate in default.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ycbd_DebtInstrumentInterestRateInDefault" xlink:to="ycbd_DebtInstrumentInterestRateInDefault-label" xlink:type="arc"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>ycbd-20240930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 06:03PM UTC 2024-12-18--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants" xlink:href="ycbd-20240930.xsd#statement-note-10-warrants" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-10-warrants" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsDisclosureTextBlock" xlink:label="ycbd_WarrantsDisclosureTextBlock" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="ycbd_WarrantsDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions" xlink:href="ycbd-20240930.xsd#statement-note-7-related-party-transactions" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-document-and-entity-information" xlink:href="ycbd-20240930.xsd#statement-document-and-entity-information" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-document-and-entity-information" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" xlink:type="arc"/>
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" xlink:type="arc"/>
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" xlink:type="arc"/>
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" xlink:type="arc"/>
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:type="arc"/>
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" xlink:type="arc"/>
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" xlink:type="arc"/>
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc"/>
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" xlink:type="arc"/>
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" xlink:type="arc"/>
    <link:presentationArc order="33" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" xlink:type="arc"/>
    <link:presentationArc order="34" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" xlink:type="arc"/>
    <link:presentationArc order="35" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" xlink:type="arc"/>
    <link:presentationArc order="36" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals" xlink:href="ycbd-20240930.xsd#statement-consolidated-balance-sheets-parentheticals" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_Rule10b51ArrAdoptedFlag-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_NonRule10b51ArrAdoptedFlag-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_Rule10b51ArrTrmntdFlag-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_NonRule10b51ArrTrmntdFlag-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies" xlink:href="ycbd-20240930.xsd#statement-note-1-organization-and-summary-of-significant-accounting-policies" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:label="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:label="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ManufacturingEquipmentMember" xlink:label="ycbd_ManufacturingEquipmentMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ReverseStockSplitMember" xlink:label="ycbd_ReverseStockSplitMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SoftwareMember" xlink:label="ycbd_SoftwareMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToHempMdMember" xlink:label="ycbd_TrademarkRelatedToHempMdMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="ycbd_ReverseStockSplitMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ycbd_ManufacturingEquipmentMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ycbd_SoftwareMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_TrademarkRelatedToHempMdMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_SalesRevenueNetMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities" xlink:href="ycbd-20240930.xsd#statement-note-2-marketable-securities-and-investment-other-securities" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SteadyStateLlcMember" xlink:label="ycbd_SteadyStateLlcMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ycbd_SteadyStateLlcMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory" xlink:href="ycbd-20240930.xsd#statement-note-3-inventory" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-3-inventory" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment" xlink:href="ycbd-20240930.xsd#statement-note-4-property-and-equipment" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CaseWithMajikMedicinesMember" xlink:label="ycbd_CaseWithMajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:label="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MajikMedicinesMember" xlink:label="ycbd_MajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToHempMdMember" xlink:label="ycbd_TrademarkRelatedToHempMdMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_TrademarkRelatedToHempMdMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_TrademarksMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_LitigationCaseAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseAxis" xlink:to="ycbd_CaseWithMajikMedicinesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_MajikMedicinesMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability" xlink:href="ycbd-20240930.xsd#statement-note-6-contingent-liability" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CureBasedDevelopmentLlcMember" xlink:label="ycbd_CureBasedDevelopmentLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_RegisteredCommonStockMember" xlink:label="ycbd_RegisteredCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_UnregisteredCommonStock2Member" xlink:label="ycbd_UnregisteredCommonStock2Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_UnregisteredCommonStockMember" xlink:label="ycbd_UnregisteredCommonStockMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="ycbd_CureBasedDevelopmentLlcMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_RegisteredCommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_UnregisteredCommonStock2Member" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_UnregisteredCommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity" xlink:href="ycbd-20240930.xsd#statement-note-8-shareholders-equity" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_A360MediaLlcMember" xlink:label="ycbd_A360MediaLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_AdvertisingPlacementAgreementMember" xlink:label="ycbd_AdvertisingPlacementAgreementMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BoardOfDirectorsMember" xlink:label="ycbd_BoardOfDirectorsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommitmentSharesMember" xlink:label="ycbd_CommitmentSharesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConversionOfNotesIntoCommonStockMember" xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CureBasedDevelopmentLlcMember" xlink:label="ycbd_CureBasedDevelopmentLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_KeystoneMember" xlink:label="ycbd_KeystoneMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MajikMedicinesMember" xlink:label="ycbd_MajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PublicOfferingMember" xlink:label="ycbd_PublicOfferingMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PurchaseagreementMember" xlink:label="ycbd_PurchaseagreementMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TwentyTwoCapitalMember" xlink:label="ycbd_TwentyTwoCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:label="ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestingAnnuallyOverThreeYearsMember" xlink:label="ycbd_VestingAnnuallyOverThreeYearsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsWithPublicOfferingMember" xlink:label="ycbd_WarrantsWithPublicOfferingMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_CommitmentSharesMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_KeystoneMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_MajikMedicinesMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="ycbd_BoardOfDirectorsMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="ycbd_CureBasedDevelopmentLlcMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="ycbd_PurchaseagreementMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="ycbd_PublicOfferingMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="ycbd_WarrantsWithPublicOfferingMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_A360MediaLlcMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="ycbd_AdvertisingPlacementAgreementMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_TwentyTwoCapitalMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_GranteeStatusAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_VestingAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="ycbd_VestingAnnuallyOverThreeYearsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-" xlink:href="ycbd-20240930.xsd#statement-note-9-stock-based-compensation-" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BoardOfDirectorsMember" xlink:label="ycbd_BoardOfDirectorsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:label="ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_The2015PlanMember" xlink:label="ycbd_The2015PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_The2021PlanMember" xlink:label="ycbd_The2021PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:label="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="ycbd_The2015PlanMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="ycbd_The2021PlanMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="ycbd_BoardOfDirectorsMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_VestingAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_GranteeStatusAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-" xlink:href="ycbd-20240930.xsd#statement-note-11-commitments-and-contingencies-" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ForbearanceAgreementMember" xlink:label="ycbd_ForbearanceAgreementMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_LeaseContractualTermAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="ycbd_ForbearanceAgreementMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-12-note-payable" xlink:href="ycbd-20240930.xsd#statement-note-12-note-payable" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-12-note-payable" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:label="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases" xlink:href="ycbd-20240930.xsd#statement-note-13-leases" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-13-leases" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share" xlink:href="ycbd-20240930.xsd#statement-note-14-loss-per-share" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events" xlink:href="ycbd-20240930.xsd#statement-note-16-subsequent-events" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConsultantMember" xlink:label="ycbd_ConsultantMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConversionOfNotesIntoCommonStockMember" xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NotesToFinancialStatementsAbstract" xlink:label="ycbd_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarehouseLeaseMember" xlink:label="ycbd_WarehouseLeaseMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_LeaseContractualTermAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="ycbd_WarehouseLeaseMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_ConsultantMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies" xlink:href="ycbd-20240930.xsd#statement-significant-accounting-policies-policies" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositContractsPolicy" xlink:label="us-gaap_DepositContractsPolicy" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" xlink:label="ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MerchantReceivableAndReservePolicyTextBlock" xlink:label="ycbd_MerchantReceivableAndReservePolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-significant-accounting-policies-policies" xlink:label="ycbd_statement-statement-significant-accounting-policies-policies" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-significant-accounting-policies-policies" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PolicyTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ycbd_MerchantReceivableAndReservePolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DepositContractsPolicy" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BusinessCombinationsPolicy" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DebtPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:href="ycbd-20240930.xsd#statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:label="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:href="ycbd-20240930.xsd#statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:label="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables" xlink:href="ycbd-20240930.xsd#statement-note-3-inventory-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-3-inventory-tables" xlink:label="ycbd_statement-statement-note-3-inventory-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-3-inventory-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables" xlink:href="ycbd-20240930.xsd#statement-note-4-property-and-equipment-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-4-property-and-equipment-tables" xlink:label="ycbd_statement-statement-note-4-property-and-equipment-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-4-property-and-equipment-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-5-intangible-assets-tables" xlink:label="ycbd_statement-statement-note-5-intangible-assets-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-5-intangible-assets-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables" xlink:href="ycbd-20240930.xsd#statement-note-6-contingent-liability-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-6-contingent-liability-tables" xlink:label="ycbd_statement-statement-note-6-contingent-liability-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-6-contingent-liability-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables" xlink:href="ycbd-20240930.xsd#statement-note-8-shareholders-equity-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-8-shareholders-equity-tables" xlink:label="ycbd_statement-statement-note-8-shareholders-equity-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-8-shareholders-equity-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables" xlink:href="ycbd-20240930.xsd#statement-note-9-stock-based-compensation-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-9-stock-based-compensation-tables" xlink:label="ycbd_statement-statement-note-9-stock-based-compensation-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-9-stock-based-compensation-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables" xlink:href="ycbd-20240930.xsd#statement-note-10-warrants-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommonStockPurchaseWarrantsMember" xlink:label="ycbd_CommonStockPurchaseWarrantsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EquityClassifiedWarrantsMember" xlink:label="ycbd_EquityClassifiedWarrantsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-10-warrants-tables" xlink:label="ycbd_statement-statement-note-10-warrants-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-10-warrants-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="ycbd_CommonStockPurchaseWarrantsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="ycbd_EquityClassifiedWarrantsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables" xlink:href="ycbd-20240930.xsd#statement-note-13-leases-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-13-leases-tables" xlink:label="ycbd_statement-statement-note-13-leases-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-13-leases-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables" xlink:href="ycbd-20240930.xsd#statement-note-14-loss-per-share-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-14-loss-per-share-tables" xlink:label="ycbd_statement-statement-note-14-loss-per-share-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-14-loss-per-share-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-15-income-taxes-tables" xlink:label="ycbd_statement-statement-note-15-income-taxes-tables" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-15-income-taxes-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashUninsuredAmount" xlink:label="us-gaap_CashUninsuredAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet" xlink:label="us-gaap_ContractWithCustomerAssetNet-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:label="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DebtInstrumentDiscountedPercentage" xlink:label="ycbd_DebtInstrumentDiscountedPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:label="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ManufacturingEquipmentMember" xlink:label="ycbd_ManufacturingEquipmentMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Merchantprocessingfee" xlink:label="ycbd_Merchantprocessingfee-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NetIncomeLossIncludingImpairment" xlink:label="ycbd_NetIncomeLossIncludingImpairment-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NumberOfMajorCustomers" xlink:label="ycbd_NumberOfMajorCustomers-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ReverseStockSplitMember" xlink:label="ycbd_ReverseStockSplitMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SoftwareMember" xlink:label="ycbd_SoftwareMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToHempMdMember" xlink:label="ycbd_TrademarkRelatedToHempMdMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WorkingCapital" xlink:label="ycbd_WorkingCapital-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="ycbd_ReverseStockSplitMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ycbd_ManufacturingEquipmentMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ycbd_SoftwareMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_TrademarkRelatedToHempMdMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_SalesRevenueNetMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_Merchantprocessingfee-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountsReceivableNetCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ContractWithCustomerAssetNet-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MarketingAndAdvertisingExpense-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashUninsuredAmount-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_NumberOfMajorCustomers-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_NetIncomeLossIncludingImpairment-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_WorkingCapital-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DebtInstrumentDiscountedPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-2-marketable-securities-and-investment-other-securities-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:label="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EquipmentSoldValue" xlink:label="ycbd_EquipmentSoldValue-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SteadyStateLlcMember" xlink:label="ycbd_SteadyStateLlcMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ycbd_SteadyStateLlcMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_EquipmentSoldValue-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Investments-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-3-inventory-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryWriteDown-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-4-property-and-equipment-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease" xlink:label="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CaseWithMajikMedicinesMember" xlink:label="ycbd_CaseWithMajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:label="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommissionPercentage" xlink:label="ycbd_CommissionPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LengthOfConsultingAgreement" xlink:label="ycbd_LengthOfConsultingAgreement-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LitigationSettlementInitialPayment" xlink:label="ycbd_LitigationSettlementInitialPayment-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LitigationSettlementMonthlyPaymentAmount" xlink:label="ycbd_LitigationSettlementMonthlyPaymentAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MajikMedicinesMember" xlink:label="ycbd_MajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToHempMdMember" xlink:label="ycbd_TrademarkRelatedToHempMdMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_CbdmdAndDirectcbdonlineTrademarksMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_TrademarkRelatedToHempMdMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_TrademarksMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_LitigationCaseAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseAxis" xlink:to="ycbd_CaseWithMajikMedicinesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_MajikMedicinesMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_LitigationSettlementInitialPayment-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_LitigationSettlementMonthlyPaymentAmount-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_LengthOfConsultingAgreement-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_CommissionPercentage-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-6-contingent-liability-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares" xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration" xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod" xlink:label="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CureBasedDevelopmentLlcMember" xlink:label="ycbd_CureBasedDevelopmentLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_RegisteredCommonStockMember" xlink:label="ycbd_RegisteredCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_UnregisteredCommonStock2Member" xlink:label="ycbd_UnregisteredCommonStock2Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_UnregisteredCommonStockMember" xlink:label="ycbd_UnregisteredCommonStockMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="ycbd_CureBasedDevelopmentLlcMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_RegisteredCommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_UnregisteredCommonStock2Member" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_UnregisteredCommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:href="ycbd-20240930.xsd#statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue" xlink:label="ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:label="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-8-shareholders-equity-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCash" xlink:label="us-gaap_DividendsCash-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_A360MediaLlcMember" xlink:label="ycbd_A360MediaLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_AdvertisingPlacementAgreementMember" xlink:label="ycbd_AdvertisingPlacementAgreementMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement" xlink:label="ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_AgreementForAdvertisingPlacementUnutilizedAmount" xlink:label="ycbd_AgreementForAdvertisingPlacementUnutilizedAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BoardOfDirectorsMember" xlink:label="ycbd_BoardOfDirectorsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommitmentSharesMember" xlink:label="ycbd_CommitmentSharesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConversionOfNotesIntoCommonStockMember" xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CureBasedDevelopmentLlcMember" xlink:label="ycbd_CureBasedDevelopmentLlcMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DividendsPayableQuarterlyGrowth" xlink:label="ycbd_DividendsPayableQuarterlyGrowth-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_KeystoneMember" xlink:label="ycbd_KeystoneMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MajikMedicinesMember" xlink:label="ycbd_MajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NumberOfSharesRegisteredForResale" xlink:label="ycbd_NumberOfSharesRegisteredForResale-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PercentageOfSharesFullyVested" xlink:label="ycbd_PercentageOfSharesFullyVested-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories" xlink:label="ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement" xlink:label="ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ProceedsFromIssuanceOfCommonStockNet" xlink:label="ycbd_ProceedsFromIssuanceOfCommonStockNet-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PublicOfferingMember" xlink:label="ycbd_PublicOfferingMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PurchaseCommitmentMaximumSharesCommitment" xlink:label="ycbd_PurchaseCommitmentMaximumSharesCommitment-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PurchaseagreementMember" xlink:label="ycbd_PurchaseagreementMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ShareNumberStockIssuable" xlink:label="ycbd_ShareNumberStockIssuable-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TwentyTwoCapitalMember" xlink:label="ycbd_TwentyTwoCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:label="ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestingAnnuallyOverThreeYearsMember" xlink:label="ycbd_VestingAnnuallyOverThreeYearsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsWithPublicOfferingMember" xlink:label="ycbd_WarrantsWithPublicOfferingMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_CommitmentSharesMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_KeystoneMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_MajikMedicinesMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="ycbd_BoardOfDirectorsMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="ycbd_CureBasedDevelopmentLlcMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="ycbd_PurchaseagreementMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="ycbd_PublicOfferingMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="ycbd_WarrantsWithPublicOfferingMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_A360MediaLlcMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="ycbd_AdvertisingPlacementAgreementMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_TwentyTwoCapitalMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_GranteeStatusAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_VestingAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="ycbd_VestingAnnuallyOverThreeYearsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="ycbd_VestUponAchievingCertainRevenuePerformanceMember" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendRatePercentage-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DividendsCash-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DividendsPayableQuarterlyGrowth-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PurchaseCommitmentMaximumSharesCommitment-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ShareNumberStockIssuable-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_NumberOfSharesRegisteredForResale-2" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits-2" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1-2" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue-2" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions-2" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare-2" xlink:type="arc"/>
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock-2" xlink:type="arc"/>
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ProceedsFromIssuanceOfCommonStockNet-2" xlink:type="arc"/>
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights-2" xlink:type="arc"/>
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-2" xlink:type="arc"/>
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices-2" xlink:type="arc"/>
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement-2" xlink:type="arc"/>
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_AgreementForAdvertisingPlacementUnutilizedAmount-2" xlink:type="arc"/>
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PercentageOfSharesFullyVested-2" xlink:type="arc"/>
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement-2" xlink:type="arc"/>
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories-2" xlink:type="arc"/>
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-2" xlink:type="arc"/>
    <link:presentationArc order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense-2" xlink:type="arc"/>
    <link:presentationArc order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-9-stock-based-compensation-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BoardOfDirectorsMember" xlink:label="ycbd_BoardOfDirectorsMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage" xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares" xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:label="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:label="ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_The2015PlanMember" xlink:label="ycbd_The2015PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_The2021PlanMember" xlink:label="ycbd_The2021PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:label="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="ycbd_The2015PlanMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="ycbd_The2021PlanMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="ycbd_BoardOfDirectorsMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_VestingAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="ycbd_SharebasedPaymentArrangementTrancheFourMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_GranteeStatusAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-11-commitments-and-contingencies-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ForbearanceAgreementMember" xlink:label="ycbd_ForbearanceAgreementMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PastDueRentDefaultDeclarationMonthlyPayment" xlink:label="ycbd_PastDueRentDefaultDeclarationMonthlyPayment-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement" xlink:label="ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_LeaseContractualTermAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="ycbd_ForbearanceAgreementMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PastDueRentDefaultDeclarationMonthlyPayment-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-12-note-payable-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableFairValueDisclosure" xlink:label="us-gaap_NotesPayableFairValueDisclosure-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DebtInstrumentDiscountedPercentage" xlink:label="ycbd_DebtInstrumentDiscountedPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DebtInstrumentInterestRateInDefault" xlink:label="ycbd_DebtInstrumentInterestRateInDefault-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DebtInstrumentPrepaymentPayablePercent" xlink:label="ycbd_DebtInstrumentPrepaymentPayablePercent-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FairValueAdjustmentOfDebt" xlink:label="ycbd_FairValueAdjustmentOfDebt-n2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:label="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrincipleAdjustmentsOfDebt" xlink:label="ycbd_PrincipleAdjustmentsOfDebt-n2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DebtInstrumentDiscountedPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DebtInstrumentPrepaymentPayablePercent-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DebtInstrumentInterestRateInDefault-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesPayableFairValueDisclosure-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_FairValueAdjustmentOfDebt-n2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PrincipleAdjustmentsOfDebt-n2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesPayable-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-13-leases-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-14-loss-per-share-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:label="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="ycbd_SeriesACumulativeConvertiblePreferredStockMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DeferredTaxAssetAndRelatedValuationAllowance" xlink:label="ycbd_DeferredTaxAssetAndRelatedValuationAllowance-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsValuationAllowance-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DeferredTaxAssetAndRelatedValuationAllowance-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual" xlink:href="ycbd-20240930.xsd#statement-note-16-subsequent-events-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConsultantMember" xlink:label="ycbd_ConsultantMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConversionOfNotesIntoCommonStockMember" xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LesseeOperatingLeasesAnnualBaseRent" xlink:label="ycbd_LesseeOperatingLeasesAnnualBaseRent-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LesseeOperatingLeasesMonthlyBaseRent" xlink:label="ycbd_LesseeOperatingLeasesMonthlyBaseRent-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_NoteToFinancialStatementDetailsTextual" xlink:label="ycbd_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OperatingLeasesRentExpensePerSquareFoot" xlink:label="ycbd_OperatingLeasesRentExpensePerSquareFoot-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarehouseLeaseMember" xlink:label="ycbd_WarehouseLeaseMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_LeaseContractualTermAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="ycbd_WarehouseLeaseMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_ConsultantMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesPayable-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_LesseeOperatingLeasesMonthlyBaseRent-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_OperatingLeasesRentExpensePerSquareFoot-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_LesseeOperatingLeasesAnnualBaseRent-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows" xlink:href="ycbd-20240930.xsd#statement-consolidated-statement-of-cash-flows" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations-4" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations-5" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="us-gaap_GainLossOnTerminationOfLease-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockExpense" xlink:label="us-gaap_RestrictedStockExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:label="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FairValueAdjustmentOfDebt" xlink:label="ycbd_FairValueAdjustmentOfDebt-n8" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_IncreaseDecreaseInPrepaidInventoryTotal" xlink:label="ycbd_IncreaseDecreaseInPrepaidInventoryTotal-n8" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest" xlink:label="ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest-2" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:label="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PreferredDividendsAccruedNotYetPaid" xlink:label="ycbd_PreferredDividendsAccruedNotYetPaid" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WriteOffOfPrepaidAssets" xlink:label="ycbd_WriteOffOfPrepaidAssets" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_RestrictedStockExpense" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ycbd_WriteOffOfPrepaidAssets" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryWriteDown" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ycbd_FairValueAdjustmentOfDebt-n8" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ycbd_OtherthantemporaryImpairmentsOnOtherInvestments" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnTerminationOfLease-n8" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable-n8" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="ycbd_IncreaseDecreaseInPrepaidInventoryTotal-n8" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-n8" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities-3" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRepaymentsOfNotesPayable-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities-3" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect-3" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations-4" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations-5" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_StockIssued1" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="ycbd_PreferredDividendsAccruedNotYetPaid" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:label="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:label="ycbd_statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:href="ycbd-20240930.xsd#statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:label="ycbd_statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:href="ycbd-20240930.xsd#statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding-4" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding-5" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisable" xlink:label="ycbd_ClassOfWarrantOrRightExercisable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisesInPeriod" xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisesInPeriod" xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriod-n8" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightForfeituresInPeriod" xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightForfeituresInPeriod" xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriod-n8" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightGrantsInPeriod" xlink:label="ycbd_ClassOfWarrantOrRightGrantsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice-4" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice-5" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" xlink:label="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsToPurchaseCommonStockMember" xlink:label="ycbd_WarrantsToPurchaseCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:label="ycbd_statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="ycbd_WarrantsToPurchaseCommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice-4" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightGrantsInPeriod" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisesInPeriod-n8" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightForfeituresInPeriod-n8" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding-5" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice-5" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisesInPeriod" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightForfeituresInPeriod" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisable" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:href="ycbd-20240930.xsd#statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisable" xlink:label="ycbd_ClassOfWarrantOrRightExercisable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:label="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringApril2028Member" xlink:label="ycbd_WarrantsExpiringApril2028Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringJanuary2025Member" xlink:label="ycbd_WarrantsExpiringJanuary2025Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringMay2024Member" xlink:label="ycbd_WarrantsExpiringMay2024Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringOctober2024Member" xlink:label="ycbd_WarrantsExpiringOctober2024Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_WarrantsExpiringSeptember2023Member" xlink:label="ycbd_WarrantsExpiringSeptember2023Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:label="ycbd_statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="ycbd_WarrantsExpiringSeptember2023Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="ycbd_WarrantsExpiringMay2024Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="ycbd_WarrantsExpiringOctober2024Member" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="ycbd_WarrantsExpiringJanuary2025Member" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="ycbd_WarrantsExpiringApril2028Member" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisable" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:href="ycbd-20240930.xsd#statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths-1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability-1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:label="ycbd_statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths-1" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue-3" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseLiability-1" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations" xlink:href="ycbd-20240930.xsd#statement-consolidated-statements-of-operations" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="us-gaap_InterestIncomeExpenseNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:label="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FairValueAdjustmentOfDebt" xlink:label="ycbd_FairValueAdjustmentOfDebt" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OperatingExpensesExcludingImpairment" xlink:label="ycbd_OperatingExpensesExcludingImpairment" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SalesAllowances" xlink:label="ycbd_SalesAllowances-n8" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_SalesAllowances-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostOfRevenue" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GrossProfit-3" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_OperatingExpensesExcludingImpairment" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss-3" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1-n8" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_FairValueAdjustmentOfDebt" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestIncomeExpenseNet" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-3" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit-n8" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss-3" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic-3" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss" xlink:href="ycbd-20240930.xsd#statement-consolidated-statements-of-comprehensive-loss" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments" xlink:label="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments-3" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments-3" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:href="ycbd-20240930.xsd#statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelAxis" xlink:label="us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelDomain" xlink:label="us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelDirectlyToConsumerMember" xlink:label="us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelThroughIntermediaryMember" xlink:label="us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_SalesChannelMember" xlink:label="ycbd_SalesChannelMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:label="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="ycbd_SalesChannelMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_SalesRevenueNetMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details" xlink:href="ycbd-20240930.xsd#statement-note-3-inventory-schedule-of-inventory-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsAndSupplies" xlink:label="us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrepaidInventory" xlink:label="ycbd_PrepaidInventory" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-3-inventory-schedule-of-inventory-details" xlink:label="ycbd_statement-statement-note-3-inventory-schedule-of-inventory-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-3-inventory-schedule-of-inventory-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryFinishedGoods" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryValuationReserves-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_PrepaidInventory" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryNet-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:href="ycbd-20240930.xsd#statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AutomobilesMember" xlink:label="us-gaap_AutomobilesMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ComputersFurnitureAndEquipmentMember" xlink:label="ycbd_ComputersFurnitureAndEquipmentMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ManufacturingEquipmentMember" xlink:label="ycbd_ManufacturingEquipmentMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:label="ycbd_statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ycbd_ComputersFurnitureAndEquipmentMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ycbd_ManufacturingEquipmentMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_AutomobilesMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:href="ycbd-20240930.xsd#statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedTrademarks" xlink:label="us-gaap_IndefiniteLivedTrademarks" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CbdMdLimintedMarkMember" xlink:label="ycbd_CbdMdLimintedMarkMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_FinitelivedIntangibleAssetAccumulatedImpairment" xlink:label="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment-n9" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" xlink:label="ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToCbdmdMember" xlink:label="ycbd_TrademarkRelatedToCbdmdMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TrademarkRelatedToHempMdMember" xlink:label="ycbd_TrademarkRelatedToHempMdMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_TradenameRelatedToDirectCBDOnlineComMember" xlink:label="ycbd_TradenameRelatedToDirectCBDOnlineComMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:label="ycbd_statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_TrademarkRelatedToCbdmdMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_TrademarkRelatedToHempMdMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_CbdMdLimintedMarkMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ycbd_TradenameRelatedToDirectCBDOnlineComMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IndefiniteLivedTrademarks" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_FinitelivedIntangibleAssetAccumulatedImpairment-n9" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization-n8" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details" xlink:href="ycbd-20240930.xsd#statement-note-6-contingent-liability-contingent-liability-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" xlink:label="ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:label="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details" xlink:label="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="ycbd_EarnoutSharesForRevenueBetween1And20000000Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:label="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:label="ycbd_statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity" xlink:href="ycbd-20240930.xsd#statement-condensed-consolidated-statements-of-shareholders-equity" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="us-gaap_DividendsPreferredStockCash-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding-4" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding-5" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity-4" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity-5" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CapitalRaiseMember" xlink:label="ycbd_CapitalRaiseMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_CommitmentSharesMember" xlink:label="ycbd_CommitmentSharesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConversionOfNotesIntoCommonStockMember" xlink:label="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_DecreaseInApicIssuanceOfStock" xlink:label="ycbd_DecreaseInApicIssuanceOfStock-n9" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_MajikMedicinesMember" xlink:label="ycbd_MajikMedicinesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" xlink:label="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" xlink:label="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk-n8" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PublicOfferingMember" xlink:label="ycbd_PublicOfferingMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="ycbd_StockIssuedDuringPeriodValueReverseStockSplits" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="ycbd_CommitmentSharesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="ycbd_PublicOfferingMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="ycbd_ConversionOfNotesIntoCommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="ycbd_CapitalRaiseMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="ycbd_MajikMedicinesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="ycbd_CommitmentSharesMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity-4" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DividendsPreferredStockCash-n8" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk-n8" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_DecreaseInApicIssuanceOfStock-n9" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_StockIssuedDuringPeriodValueReverseStockSplits" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding-5" xlink:type="arc"/>
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity-5" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:href="ycbd-20240930.xsd#statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:label="ycbd_statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeaseCost" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasePayments" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:label="ycbd_statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits-3" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:href="ycbd-20240930.xsd#statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities-n10" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInvestments" xlink:label="us-gaap_DeferredTaxAssetsInvestments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities-n10" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_RightOfUseLiability" xlink:label="ycbd_RightOfUseLiability" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:label="ycbd_statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ycbd_RightOfUseLiability" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsInvestments" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsInventory" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsOther" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross-3" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses-n8" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements-n8" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets-n8" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredIncomeTaxLiabilities-n10" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet-3" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance-n8" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilities-n10" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-" xlink:href="ycbd-20240930.xsd#statement-consolidated-balance-sheets-" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:label="us-gaap_AccountsReceivableGrossCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill-1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract" xlink:label="us-gaap_OtherAssetsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermInvestments" xlink:label="us-gaap_OtherLongTermInvestments" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:label="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrepaidInventory" xlink:label="ycbd_PrepaidInventory" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_PrepaidSponsorship" xlink:label="ycbd_PrepaidSponsorship" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryGross-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="ycbd_PrepaidInventory" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="ycbd_PrepaidSponsorship" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent-3" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssetsAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill-1" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherLongTermInvestments" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssets-3" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_Assets-3" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DividendsPayableCurrent" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleDebtCurrent" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableCurrent" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent-3" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_Liabilities-3" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity-3" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:href="ycbd-20240930.xsd#statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod-n8" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-4" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-5" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-4" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-5" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-2" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-n8" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:label="ycbd_statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-4" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-n8" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod-n8" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-5" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-5" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:href="ycbd-20240930.xsd#statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic-1" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-3" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic-1" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:label="ycbd_statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic-1" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-3" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic-1" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:href="ycbd-20240930.xsd#statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueAdjustment" xlink:label="us-gaap_EquityFairValueAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="us-gaap_FairValueNetAssetLiability-4" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="us-gaap_FairValueNetAssetLiability-5" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="us-gaap_LiabilitiesFairValueAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ContingentLiabilityMember" xlink:label="ycbd_ContingentLiabilityMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_ConvertibleNotesMember" xlink:label="ycbd_ConvertibleNotesMember" xlink:type="locator"/>
    <link:loc xlink:href="ycbd-20240930.xsd#ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:label="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="ycbd_ContingentLiabilityMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="ycbd_ConvertibleNotesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueNetAssetLiability-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EquityFairValueAdjustment" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesFairValueAdjustment" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueNetAssetLiability-5" xlink:type="arc"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>c02.jpg
<TEXT>
begin 644 c02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _OXHHHH
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MO.V%Q'E_<\_P?8?]D9C_ - >,?\ W*U_+_IVO6_KZ'VQ^\_SBC]Y_G%?%/\
MP\-_8LVA_P#AI'X8;&#%7_X2*UV$+PQ#>=@A2#D@D @@],4UO^"AW[%04,W[
M2/PPVLI=<>(K7YTYRR?O26'!P5R,Y';%/^Q<S_Z L?\ ^$N(\O\ IWY_@Q+*
M<Q=O]BQ?_A+7\O[G][\#[8R_^<4FYO7\\5\5P?\ !0S]BV?B']I'X7#/ \[Q
M+91_7F6=#P,_UXK<MOVZ_P!C^Z"M%^TE\( 'Z%_'7AN <\=)]11EQ_M 'ZBI
M_L?,G_S!XVW_ &#5[]+?\N[=>^HUD^9/_F!Q?3_F&KWUMT]GW=N_D?7 <^S?
MBH^M.#@X!P#Z;E/]:^8(OVSOV2FP?^&E/@D Q &?B5X.7/U!U;(^I''/M6C#
M^UY^RK<.GD_M)? AMS*!O^*?@:,Y)'&Z37%"]>IP!WJ'EV/@G?!8RT5=R>&K
M62\VX+1=S*>78^G?FP6+22NV\-726EW=NFMEN?2)..M .>E4K*_L=5M8;S3[
MNVOK2XBCGM[JSN(KJVGAE4/%-!/ \D,T4L;*\<B,R.C!D)!S5P   #D?G^M<
MC33::::W3337JCC::;3336Z:::]4+1112$%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4R3[C?2GTQ^48>HH&MUZK\RN"=RC^\H'YY_S^-9
MNH36]C97=S?RK#90QW%U<3RL(UB@BAW.08RLA555BQ^^/7 %:6T[E]L#)XZ=
M_P :YCQS")/"7B@<-YFB:DGS .$9K24-PV1@C'R]#T8$"KIW;C9[M?Y)_CIY
MZ%8*A'%8I8*M=4<5BZ5&5[-VJ5(1=NE[.[W3VW/S?UK_ (+(_P#!/+PGKFI^
M']:_: L+;4M(GEL[ZT3P?XTN([:XMIGMI$2\M]!DAG<2Q,K%9I"-N1PP-8TG
M_!</_@FC%\K_ +1-L'Z87P1X\8Y] !X=.3V YR>W45_G_P#QG@AC^+?Q*LHE
MQY7CCQ-!"Q9FS-+JMUM^_D ([!MHP!D#&, >5DVRJTCB&+DB.,K$'>2, -$K
MR*=K%AD$D!=P).W%=/(I)2]G#>WV];6WM+?\U\S_ $2P7T-N&:^3Y;F5;.LZ
M@L7@L-7<:$L#&G%U*,)M0OA+VC>RNV_YFW=G^B#<?\%S_P#@FA!][]H-F.<<
M?#_X@ _^HSS]!^'2JA_X+P?\$QE''Q]N6<<'_BW7Q#P<>A_X1G'X_7WK_/+F
M6,&Y;" K$CQQLK.X+=?WP!M\^[''85:TS3[C4]2T[1;2."+4M5N[:VTH7LUM
M]AN[N\=+=+"YO;=Q;Z=Y;E96-[-;OLFRS;"N%*G=+W(K;;FU7S>VG3MY%U/H
M>\"4,)5QF(XFSC#4L/#VM657V-1U(1MS0C'#X9R4^MVK::ZZK_0?;_@O#_P3
M.)R/CI<X'\1^'OQ"P<_7PV/Q]>]2C_@O!_P3,*$'X]7 X^Z/A[\0NN,<'_A&
M?ZBOY]/@+_P;\>.?%KKK'QG^/'P]\,>&[WPXFI:);>&=?\/:AJ<^M7]@+JPL
M;N3S[RU%JDLL,<XAVSE=VU@Q!KX&_;5_X)7_ !C_ &)/"%K\0/&7C[X7>-_"
M]]KDVC*OAKQ%I]MJ5NMQ,J67G6-]?)>W5Y'#/#)(+&!X=QQMQQ5JG)V7LE9.
M-W[_ 'CO^\=K]]-^I^;Y=X.>!6:YI#*,MXJSQXUUHTW:FE[9\R5J,OJ$5*34
M6_C?+O*T=7_8/;_\%VO^"8T[",?'^YC?IAOAW\0-N#G^,>&"<>I'H ,]*_E<
M_P""KGQY^"O[3G[6NN?%7X(Z_'XQ\):KX5@L9M:N=-N[$3)!%<!GALM6M;2_
MMPK,Z>5<01R':7V;74G\7_+:-5ECABFAMSY5W^]5Y%EDYB8K ^X8#)P -V.G
M6O4_#1C&D6PX8B%UWJKQLP9WR&R [#!VX?G QTP:_3_"*A&7$N)GR*\82@K:
MIJ3@]4[W=TK;?*Y]WB_H_<-^'..><95C<\J\].48+-)4'#5Q;=Z48MN\;;N-
MKW5TFK2VME)'NCL[<P/(7C=[>+>WRK&0<I]T;.#^ J06=IL?_1;;HW_+"+/3
M_=KI_"6A_P#"9^,?"'A-M1M-$C\2Z]I'A7^V+UT@LM(&LWT=E#J$Y8K$J6<D
MYG=I 58*1)E>*^L[?]B/QA?7=QIUE\4/A2UPMW;V,"S>(+:/=+]NEM_,N2+U
M=B7<8C:1@4"*V4*'FOZ/Q.(PF'3I5:*E-3;<E%=7'RZ+3?\ 4\?$8K#T*LJ6
M(IPJU-&YPC>+4N5Q?1-I->1\,O:6NW_CUM_^_,?K_N\_C70^$/A[XH^(.OVW
MA7P+X2U'Q7XDU"SN;FTT_P .:='?W\MK;HSW-E<VXAE^QVC1JQ;552%U#M_I
M8$2[/K9/V'_')9_[1^)?PQTI1H&J:F,:[:/&VH6YO(;/3K5VO',TDTMJC1@L
M[-YRCIBNY_9[^%7QA^$6H>"_CU\#OC)\-],^(4MI?>1HMQJNGV5S96,EU<Z3
M?66LMX@F33KF.X%I-*(;??\ :(IQ'8*;K>*Y<3CF\'-Y9'!T:\4W?'.I"FU9
M6472IU9<UW_+9ZL\O'9C3CAIO!4L)3K6=GC?:Q@]OA=*G5DYMI-)I*UW<U_A
M_P#\$@?VT_B'\./&_P 3[/X,7'AV+P1!+_9OACQ&BVFL^(=.M+1+Z2PT33VE
MB^V,TDL["Z,,CW+2^0LLGEB-?BGXI_LX_&;X'OI0^+?PI\8^ (-0DNX](N?$
M>A+9V%\RP))-9VEPULHD-N9-Y D)"R GK7[\^'?^"BG_  4NOO$/BKPGJG[4
M?P*\/ZOX8TWPM=V-G?Z7X0-CK=WXKU*XT32M(TWQ$FGG0I?LUW:"75IWO66T
MM9T)DBF60CXY_;%^(?[5_P"UG!X#\,_M _M"?#CQ/9>"]3T?59-+TZ#P_I4/
M@RX^(>MR^#K?4KS6=+MK*TU>*.?23/?64=W>>1I@AN+:&*6<RO\ %9/F/%,\
M;)9A/(5AE/WK5L8JG);54T\(XSF]ES2@M5V][XW(\XSZIC9K'PR'ZKSR3<:N
M-53ELDE34L'RU)2:]WFG35I6^S[WXTR6EKA<VMMW_P"6$?IV^7^?^.:[6-FY
M"_9+0\G/[B'(Z#^YWZ<U]VG]B3Q%?Z@L.B?%CX2ZK:W-^+*UDAUOR%9H_+$A
M'VF\1E$N?NR?/:9^TW0CM9(F,6D_L)^/;\:VDWQ'^%5AJ.E:7-?V]G<^(K41
MZE<1RW*+:1.+\;F<0I@QOSO&#TQ]LLRR]?\ ,-V^SOMZ:IKTW[GW/]JX3_H&
M?_@%^WGZZ_T_B!M'LC$I^Q6G.<?Z/#R>YX3]*KKI]@@/^A6A !R#;0\]B.4X
M^GYU[E\8/A9JOP>US2_#&K:YH.MW]WHMOJ]U+X?O([ZSM)+B:X@^Q^;'+,N4
M6 /R^[Y^>U>6:3IHUG6M*T=KN'3UU;4;/3FO[E@EO9+>3)";J=V^5(8-WF2,
MW 52348RI1K97CZE*FHP=!I+E5TURJ^W=W]2<95IU\KQE6G3Y8RIR7*XJ^D;
M/OO8_P!0WX!6\=K\&/A>D*JH/P^\&DA0,;3X>T_H!T&.!]/:O94^Z/Q_F:\>
M^!\#V_PE^'$ NDN/[/\  GABU::V*/;7PAT*RC66)_F)C;;O0JPSGTP*]@CX
M1>G3/&<<\]Z_BC,;_P!I8J^_M*O_ *6K?AMV/XJS3_D88N^K]O4U_P"WM/PM
MU\NFCZ***YC@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,/&[,[]=B!?$)+OA@<#) (R,$4G3JO1M:>2UV_X.UOP9XE'Z2_AK3GCL(_\
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M*;4/ <WBW6M&MO$EQH\5W/ITDNIP17=ND4_]HV5Z%7R8_P!P(B02V3^Z"_\
M!';]@!PA@^#!B%UNAM,^,/'$W[Z/B;RL>(7#$'E\9*G[P%?H[\ /@UX&^$G@
M#PY\(OAGI)T/P9X)L)=)T/3%NYKE;&T^TW&H2P&XU&>XOI"+B\GF9KJ=Y%$@
M&5CV@?0\.9UF'#N+EBL'4A#$U/C=2E&HM>T7HO5?H?'>)?T@\CS7*\/0X?\
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MM'R\OZMZ'\KUQ_P1V_;2FC,]SIGA:<"1#+=W?BS3I9D:8B..'S;O5F8P[O\
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M0Y.>,<G./3&3VS69D>S^8GJW_?#_ /Q-'F+ZG_OEO\*^=+GXG>(8W*J8!QG
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M8'J;J #\]] %RBLN36]'CQOU33ESZWML/YRU%_PD.A]/[8TP'MF_M!^>9NE
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M@_"_XLZ5;0:S:0>'YM5N/"6NZ5(OSPZ3+JUY?7IO(C#.V&N#&'9?DQ7X _\
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M,!E))JTM->O_  ?ZN> H8NC&I#%Q]FX5Y4XJ:492M>UKV;O;I?H9-E\%?"H
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MGN$*BWW,RY^;RGQ#R3/\=4RRE%.K3E*G%)>]*4;*T4E=\KW2U5UW/I\V\/\
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MS+P5,BMM/(]O+]-^$MS;LZ1ZS->#,9@B.G:6LUL()6GA3;8V,,K+#,S2*H!
M8],GE5.),3":AC,TIPQ&T4ZEG?3HUIUWL>_2S?B.4N>A1G+"WUDHMJUEZ=+:
MGPS\"OV<?BK\-/VE/[6OFU[5OA7X4B\77,VO3^)I-2M-=;7M @M+;2I+)[R;
M-CH<T9O(0L2H)+B09+9 _9K]O3Q'!X3_ ."7_P >;^Z3^U7NO@CXPT-(8X))
MH&AUC1=3@BD6&)2_^C";)9.05XQ7R)HGPTO?#?B:#4S>V4K007\0B:^\06\T
M4=W&XF^VV%YJ(TV<3!F2-A9F1"#AMH7'Z3?M$>&(/&?[#GQA\+RV0OYM4^ ?
MCBTL+&VMTN!)>R^'-36S^SQE) 9Q<.IA*@L7V]>E<F+Q=7&MRK556J<L??33
MO&RY==%HGYZZ:GFYMBZF+Q%"=72;:4T^ZM';6^O7Y'\?7_!(?]OWQU^R'X@\
M'^"-2O4_X4-\1]=TL>/UU2VU2>/PS#YD":AJ&BQ,Y\F2XL"L3LB-Q%@XP17]
M#'_!5S]NN_\ AW\*O!_@WX,>(-<T;Q)\3H-)\7:5XVTZR8Z;-X/BNV_XEUM=
MFV=OWL5M/YBM,6#R/C'1?XR? /A37=+\-:G:6TKW^JZ1>S^']$TN9RUS/=37
MLT=PKP$A=T/FA"63*;< K@5^P^M>'OB3\2?^":W@3XI:VFH:MXN^#/Q!UKP-
M=#4C-<7=GX4CL=*U&S%G&A$<FG6=WJE^PD9)/G$L;R,J!%\ZG62;INS=M/G:
MR:]'^ESDQ5*];ELVZM%16EK[>O\ 6_0_-;P[XU^,;?&KPCI'P9\8>*[+XF^-
M?%ME;Z7J4'B"YTN"[\3ZOJ*16-O?I'<6ZRVCWTBM,D@V(DC.0H;)_K]^+W[.
MO[27[5O_  3VO?@G\>[?1_#7Q\%KI>MVITBX@:QN?$W@]UU70Q<WHFGA":Q/
M';17DK3A<,Q=AR1_&OX,\=Q_#?\ :"^''Q%GU)-+;0_&/AW6KFY@BBECATRW
MOK274KJ!)HYT2Y6&*0#8 \916C"OS7^AYX7\2:-XL\#^%M=\/:M_;>EZMH6B
MZSI6IM.TANO/M(9;S9/O_?+ ,D;BX\P/%T78.W"XG$X&M3K0BW&-2,^]K233
MT[7_ *1XN/P6%Q^$J914<>>4)JSW]Z/9^3[G\G&JR_MF:M\&;WX(Q?LR?%3_
M (;KU/QW#X?/[0EKX8T!/"=OX U*STCPQX@N&\9:EHLOAU+;5?#%D=(:VAO5
MO[".V%]";:683O\ :/Q%_P""?7Q8T3_@F]\$OV6/ASJS7OQ>TG]I+]GSXD^,
M?&&BR:=8R>&+[1_BK8Z[XR\9Z<_B1)M'N(_#NCPQ7%O8ZO!>Z;K6H6-Q;V=I
M<EVA/[Q7US<!GB$\PC=S(RB60*6SUV@@ \#.  <=,5@S* I X6.3S@ 3AG^7
M&_G,J*1N2*0O%&Y9XU5V9C[&<\0U<RBXS3][?S=DK];::?U8^/X0X!PV2YA6
MKP2]UMKS^%O\[]]?+3\=Y_\ @E3>S^(+?XZWW[4OQ(OOVO[+QM/XTT[]I671
MO MYJ.DF\TK2?#EWX>7P-IGA5=!N/#1TK0[5/[3;PW+J-I<SWTYU..W2V$7.
M^&?^"/VJ^'?#.I6NC?M1?$#2O$_CNTUG1/C)XR_X1[P?=2>._"6J7=[J$=A'
MIK>%I4\./%?ZKJL^G-;6NFO/<7)7=-C:/V7;*RQS+%',R?(MO$ZV]Y,\IQ$E
MH0560"3F:W=9(Y4.TH=S9_)#XO?ML?%WPI^U)XT^"]KJ&F_#WPCX:BN%TK7]
M1%G%'XEU";2X;BROM4AU;S+F:TBO9/LKC3A!;QBV=X@DI>0_%SK^Q7(J#J6]
M[FBKIW:T773R[VTT/W_@+@7-_$3'XS+<BQ.!RN>%C?&8K%UE06*II*T5.*<[
M1BTDK7T?+HCZX\*?L*:K8_!_Q!X U3XOZMK?Q8\1_&+PW\>-/^(,FFZ2D&G_
M !(\!:7X7T_P)>76GG2T(T*UA\(: -4TZ6'^T+EH[PVQ598<>:^-/^"?7Q<^
M)'B=+GXB_M!:+J?AOQE:?#VW^,0M?#&E0>)O$US\/?&6I^*M%7PM-8:5#::;
M837U^\-Q9S0"]959R0T@8\9X/_:C^,M_"D8^/WPINKK4-303K$MH7@LX!"6N
M5D,V\;2)!]_^#D8XJ[=?M>?%^XT2PO;+XO\ P<TR^6>:'5K;Q!]GCCAG6ZE@
M;4+"XBNK?R(I;5(7\NYD>02!WCV[E-<3QS4:D?JTO?@H_#YQO\O-GWZ^C_Q'
M2Q-#+\!B^&\1"OB/85W6S7.4Z,E%RE77+A90Z-7YG\2MO8^G?V.?@'\3O@1I
M_P 1]*^*?CGP1X\U/QG\3=7\4Z7=>!?"VI^&+'P[X>31M&TG2/#FM1ZC%'_:
M/B&UM-*2[U"\@)BD%W&!M"\_?6M>,K?P1\/[SQ#.0?),J6Z$A?-E1<QH.>-[
MD+Q^E?GQ^Q/\>O&GQ[\/>--5\8R>'+_4?"?C>^\+P:_X1,PT'6[2ST[3;Y[B
M"*XGN)'N'6^:.6\WLLJ(B1M^[ KN_P!KCXBV=C8_"[X1V]\MG<^-M8BMM42*
M1?.M[>\N8[>.X?)+Q^4=SJ1C.W!R.!Y^>9UA\JR2ISTI0JU*<U3NFOWDH^[O
M;[6M_0^&J\!XO+N-_P#4K'O"RJ824<14QV#K5:]"4*7[QPC4K1BVY644M'K=
M]SSKPY^T;XP^)OQONOA7/8ZCK&CZ!HUYJ6M>.M(+VNA65_<132C0[EE*P3W-
MA9K:S08W,9[C R<J/@_]MCX^_&;X40^/_&'[,U_8>$?'TND3WOB+QC/;VVI:
MC?:7H<4DG]JZQYT=P5M;98I1;V[I&"T,A5&+\_3^L>)?#GPF^$M_K%O*FCM:
MS75^9H7:&^\0:U9R-#8&5L^;<,\MM"OED&*8821'4D'^9?\ :;\9_M9_%5_%
MMUX2^&GCB/P-\0=6T[1_$NJ:/INLZE>-92W[16:&&TCG:RTS4I99(+Q$AA3R
MM['8&W'\KX<QN?8FK"HJLGL[WNMX[K?;O\]3]$S?*LLPV%E3I45;DM%*%K-6
MZKHTEIIV=]C^C;Q>WQP_;R_X)9Z!>&"PUSX^6[>'?&6MZ2BPVMAXKUSP=JHU
M=K=[,>7;K9:WI]O:6Z0E$4RR2[,.>/R]^*,WC3X^?"KP[\&?A7\&O';_ +2?
MQ@NG\%_M :#XK\)?$6S^'GPVTRTMH-*T'4](UOQ+&G@JQM;.Y$]\+S3KH+$=
MTOF1A5(_>G_@ECX%\5^ OV0O!-KXM2-+K59I=7T5\21WW]C?9;;3T2]BN&-U
M!+%>V%Y'Y,H1<(#Y8+$M]Y3VMC#--<1V5C;S7$:)<W$=K:PR311.\JBYG6)6
ME56=F8SLPP2')7BOW[*<=B)8&C#%>]7491DW>]N?FC+_ !)-1OMRNUCY/*O$
M;$\*8/&9-2RW_9Z=2I6CBHJ*E)UJ:4J<M+NG&3YK+EE[2+;E;0_G._;9_8E_
M:"^)O[0G[.?@GX6>$?A%XIT[PG^R/XF^%6N>-/VC_ ?BGQEX$T[6_$WAO6=
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M%+X(7_P&UJ[1O&_P<,5KX?MI&)NM6\%2D74=U;*3YTKVU]+J<<Y)?%M%$H
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M91;YV[N.JNM/S^9_1F0X*GQ%GM+)*L(NM1G'ZT[*//%-<Z79M-ZK;R/Z$?\
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MK61Y7^U1X$T^_P#A/XDUVU2\O$T^.0V-O&63S;O9EY44 ?-NP2<<XZU\H?\
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M*,*[2DFI+FO?==7MY,WG6P:HU(QC/ZXZF'NU&33^!+5*VB6O;KIH?DK^UO\
M CPW\8/%G@^31/B=9>#/%1AU'0O$5AXQ\*:P;>].KS3V=L;#556UL56,2*4R
M[\DL#SBOPY^+GP.\2_LW?%+Q5\,/$D[S3>''L;F[DTVZ@-GJL>IN)8YL$R%5
M6%TE;#KF-E7.X'/],/[37A+Q<OP@/B_X8ZIXEC\4V&I*VJZ?IWA:/Q5->R1W
MK/%;Z1LTJ]FCF@!5AAI-FY2U?SI>*/#/Q^\1WWQ ^(GQ8\*?$+Q#XUUW[=HP
MN->\-7]O?2);6J_8+J:"*PM8458Y(X8VB@CC'DE.9%>OQ#$JAAZV-6$P.)]O
M+.(2G)4*KBZ?M+N2?+9Z[V5O)']1<&8FM7S/A:>*S##4\+@Z5&M:IB*--QG3
ME%<KO*-E;5=UK=WN_&/V#OBQ??!__@H%\(M4AN_LT7B34W^'=U DJ"PNSXON
M#IEO>7,.=\D5G]O#M$[%W\MO*96/'];_ ,3Y]>T71]5O/"MOI\E_9NIL#>6]
MW<61A$S3:B#;6<L5ZZS1NV%MI4G 8;&#8-?Q$?#;P-\6M%_:1^%_B&\^'GC:
M)M!^*/A'6)-2_P"$;UC[%%::3K-E?O)]J-MY*1!0RR2&3 "G<<"O[B-5U/3=
M2T_2YH]4L90^G0SR1I=POYLNIV$,4B%4?<S0N&\P+AD.<X(K][Y98G 8EJ2Y
MI87!I1O9MI4;Z7NVK.ZULM]='];]*RED]7B/@;,LHQ6"Q5;-LNDL=5PE>A75
M*=##\T%6=*<U!N5-)*=KMV1^:6C? /P/I%QJTVC?"SPWI/\ ;4D$TES'I/CS
M>\L-]/JRI>,=:)\EM4N[JX,MIY%ZL4HC2Y#(A7E_V@/@WX<\._ _XE:EH?AS
MPE:ZC'H']H6R6^@:[!>VT&FK<7D[K=ZA=S%MTAE\MY"[ X,C$\G]'TTZWN]T
M*P378486&QBO)Y#_ +*)$[L>F, $UY[\9/AEXD\7_!GXE^&O#/P\\?:SK6M>
M ?%MAIAD\/:K%9QW(T>Y:VM+2X>S7SKB>64"&+S9)7D<*F20*TRNI%9C0HII
M5?K6%]_^5JG%.3ET5]W=KTL?S)EN<YF\VP5-U(I*K'>2TLTM6]E:][K3JCP_
M]AC2HYOAUX;T^&>YM;73+?3=LXB86T?VJ02IY[JN#$;B5QN) 4AB<<U^F7A6
M\U1I;]M<B)\F6W%KLECA6XB:4PJL$[_NI]P3?^[W8#!3SFOQ1_X)Z_$FZTX:
M7X2\4P7>@:CHE]!X<\2:?J)D+Z:MA=%M2%Y9_++'<I9RJ84F 96PVWD9_774
MO&?BFT\:ZGIGA'X<:+XM\(C5-.M_"GCG2_C3\.[>2WT65+=]8FO_  U?337]
MK?6QENC:PW,*NTJJJHQPI_#,5PE7QW&&?JKBH4\4\VQM1RJ5%"HX5,1*5.5F
MTW%PLXRM9IIWUN?N'%&<5<#2H2KT9UU4P]-QE"FYP]V%-249Q3CSZWY5VEIH
MK]OXA\21?\(9J=Y>R2W<EU/)9)+;127,<:YV""6! [@P*=SR'"[3QC%?@!^U
M%INH:SXV87;O!I&NV]]H&I(X8I#%-&R2B0_<=S;SJUL ,1RL?.#J,5^XESK6
MG^+].^(%KK6A>+OAMJO@+P@-:MKO6+W2KKPOXEO-0N=2MVMX=0LK&&SGOA%:
M0O)!#<"6..>%RH5T)_!_]ISQO&]QJ%J?(@L-/2:_@\B7?(EWL'R2.SO('9D#
MJK_,5D7;\I%;SR;$X;.LGP5.I[:JLRPK_=>_)Q=6,7:,6V]V[6V3EJC'A*H\
MRJU*BPU:-*<.1Q=*I&*<N2:=W'5<K2NM$URO9GU=_P $D/C9<_$#X&>,/@GK
M5W)>ZO\  CQ9>Z?I<4LP>ZMO -W.LVE13,Y,DA34Y=4E#@[=CA  $X_1/Q48
M&:_>4KY(C0I($D8,&^7RW"$.V OS;"&(.%Q7\UO_  2/^(MWHG[:/B3PU]I%
MM8?%#P7XN.I#S BW$_A[3+W4=,@8$A6N);F7;#'@22.5503BOZ/?B!:W5YH>
MJ6&G1RS_ &RRN[5%L[B&WNTEEMRD/EW5P'@M)VE.V*>X4Q)*,R*0I%?U-Q[E
MM'),WPV75Z$O8X[*\#B:JE!V<X0HU7&=U:_NM-?)^?YAQ[EKRG._;4G[)5)6
M;NX[N/?K^M['YI^#OVJOC1XIU/4[?4/@SKD;:9HFIW%CJ\7AC7#;1:I!JFK:
M?I=S.+:-)KN*&*RL[J5() \L3A$(?)KLG_:6_:-2>#^R/@)/JL$=K/>B]NO#
MGBBV_MG[/ '-S9V=S<"YT]9YDDMXX[W<P>,R?ZMU%>K7/P]UCR)9&7Q7!97.
MDCS+2X\2:)')9.C2QM$&T^VMFE?<AF*99G\P,.&S706'A/2H+6UC2?5KF/[*
M-+:]?6K\WH2$&X:8I%<JN&:X: ,L05O*(Y.:^-EC<LYO:83 4J3754XIWZ]/
M\K=M3P?[5A"'LJTZE2+2T=W?;MMZ.VOR19^%GCSQ]XUT/Q1-\0O!LG@_4-)U
M&>WBLI-(U;3WOLZ;9W<<T%UJ+O;S)&UP81%#F6-XGD?,;H!Y)_P6F^.M_P#!
MGX-?L50Z=*R%OBQ:>,;]&FB4G_A O["\1Z9*QD^10MXK[&E!B1@6?*U]":':
M0:3X>O8T:^).HB$S:E<W<L\V\1KYN+J1\1;2$$B@!RI7/R@#X(_X+&PZ=XM^
M*G[&?@CQ).UOI=KX6OM<<GRMT,]V]Q:MY4=RDENUSY-I$R1312*X*;HV1@I]
M'(FL=FM>K6Y8+ZCBDKOEC=82I&*OM=MZ+J]#\L\4L3/#<.PJX!3:Q>:Y:I4Z
M<9.:4<7A^:3C'5)6=Y::=C]Y?%ITGXS?#[0;QK'Q'>P7_A#1=174-.T74;F-
MH;O1+.]BN8I+6W:&2!+^:Y65T!5Q&P! Q7S+\,OASXQL] UE?%&B^(Y_^)V8
MP^L:%JD,WEP-$0^G+)!']H2WLO)F)C60,6V<L"*[_P =_"WP%XZN_AU/)XW^
M)N@ZIH_P]T#P'92^ O&V@Z=I\4']EQW-OK&K6*V4UA"N[4FB\Z>!(M]LT?)C
M(''ZU\.4M;>VAU/XX_'N%H(;N^T+7[KQ1X'FB6;ROL,BVUK!X90:D&2T41K&
MDI=N!EB:^,KTZ<:F'P[G&*E@Z4)*4E%K2%U*\MUY_B?5\]:E##U5&I4A/#\R
M<(N2YW*/51:YK7TOLGLK'#?MCW<NC_LV_&77K"VN]/U#3OAUKL,-IJ*&UU(0
MV^F7;F>2&18RD%P'*0GRP0RMN8\5_&]X>N6N?$,MU*6\S4;*XD;!!$\ODL[2
M+MX^7<%/NI/&17]5_P#P4%^)<G@K]AW6O"_C7QQJ/BWQA?Z3K7AZT\5^(3H]
MAJ?B:#4+>1?L=M:V%CIS74NEVES')<%8I/+5PQ"@YK^03X>Z^]HVFSW3AS;)
M>V"F5@K$W@>)#SC++N&.W'I7ZSX4XR.&S*6 4U[).Z::Y6[KJW;K;>_ELC^<
M/I*Y9S\,8?,TG[:,E.5-J7M+1LVN6W-LNVQK^-;&UU"_<W5NF$7:&50)AU'W
M^5!QRO&1UY%?/WB#1=4\.WMAXH\/:A>VD^F:G936.HV\SQ7_ (?NK6X2>PU"
MSF4C9<V]T3-;NJE1(@\Q77BO?-<U:TN+^2,W$ 9BV5,L8;)XX4MDY/YGI7G?
MC:6TBT:XMI9&\Z\ACM;51A8FF>1EMYY2> L$K[W<G"J,D@=/Z:QV'P^.R^=*
M:BG*+6MKNZ6BZ:_\%:G^;N58_'91Q'#V4JG/CL1'$4)IS2HQ<U.UT_==M_17
M1_;I_P $V_VJT_:^_9;\'?$'49K=_'VA[?!/CNSMG38FM:';VR170@4EX/M>
MG36,\WG9>2ZDGDR%=5'Z!6CP1PM)<LBVP\Q+QI+A;2*W &2L]U(42W5P<>>7
M18N69@ 37\E/_!O7\5[_ $?XS?&CX,3S".V\=^$K3Q)I=F)<VUOXCT WLVL:
MC:IN*A;C2;73XGD3C]UR:_K';3[?7-*U+1[FWAN;;7;#[->6-V+CR;E&:6"Z
M\\6DD%W]D,(S</:S0S+%EDEC;##^.>.<!#+>(,7AZ4;4X*E)146_CIQD]/75
M^I_K7X3<15.).",HQ=>3>)<:V%G)OWY/#5/8IO79I73[:ZK5_)1\7?M;'XS^
M(F\.ZKX7F^%4/B+Q ^BZMK/B#PNME-HMMX9TIM%C;3I'BU&]FAUH7ZP7RN]M
MN WA@C9\_P#$NM?MFWUJP\+_ !+\,6^F"ZU*73K;Q%X_^%^H>)Y-:CC$D4VO
MSZ9':V?_  BZ3&-8M+CM;>_6V1UDN&D</7U:WPYAT670)ETK1I)[#0M3TFV_
ML/1?%L]I!$_VHV,=Q%=:A>(SI+,29I!NV[26( K2D\+V-O#!!'X8CT^*YM8+
M7;:Z'*^ZXNYI(I9;RYFBF^RNY;/[UTPFTXQBO$IYC1IT8J5-W4E>\;=%N_7?
MS\SZS$Y'4JUY3JUI*$M(J+?Q::)*RVL]/4_/?5_VC/C?^S_^SIX_\1_%WQCH
MGC/XFWWBU].TJ?1-5T"\BTY]7M+"Q:XTK^RP6@TC34*W36UT\TLC^>(75F&/
MQ^N/C%\2?$>N:KXOU'Q?J^M:C=7:WT5W;W;6]O>-<A876"$ 30M;B,!WD;!Q
ME<8K]!/^"C/AS[;\)-0\,Z1>6&E^-=#U^TU6TT!KJP6]FBCN8VO3):1>7<N9
M;.)/+60$#(*@<D_SNQ?'35/!$TMEJ^C:]:KJ,?V SR:=>):Z:OG217<JR-%L
M69EW20ACEB4(!R*^"XHK4\Q:LXVC9VNM$K-K?^NNA^A\*4</E-*?.ZD>:$DF
MU*-VTK6YN_17_$_3W6OC-\1O%.F"P\0ZK:3V<\;6LD3V5FUSY,Z^1<)/>2P-
M<R*T 4*4F5@^YLX.*QO#WP3\/:/I;>-/#6I1"Y@N[/\ M#3+T2M9VKWESLTZ
M;2 &5DMH;TR3SK.\S2.951E! KYZ\(^,M \56NDGP[?G4I_W?VM+F4*PDX)5
MU^5E<C&5.#R.YKVC3/C;\+_#FKR>#-;L_$FM^(]42'?:^%-:TJQL=,MHB3:P
MWUQJEM?6HN(KGSIV0&-PCH2,\U\;*E0IU<)6A%2<)P=U9Z74K[]-K]OQ_1LM
MSC X'$Y56J<T_9UJ;E=/1*47[UME:VK/G2;3X=$^*UZL$BQ&[M9+OR[B:);:
MT:26=9;:Z;Y4NV9D:X06[*T<4Z+)DC-1^(PSH8XUMA'<^?$T4.)+>X>3*X16
M+[=Y;&21C.1@U] Z3^QE\7_BOXEN=<^!FC-XL-K!+?>(])\2>(](M-7TZ&[9
MVM;^*9S:6][93X-LKV<)1'@D);' []_^"='[;DBP)/\ #72S:>3(\D-OXJT%
MYHT8L <B9VB)Q\CL ,C/-?N^4XM8C!8>49+E<%&\6G:UEWT[M>=K']R9?Q]P
M9C,)DM;,L_I8.IAH4OJ=".)I0]E4BHIN:Y_=YI+F]ZVZTMH?AQ\1/$&J? ?X
MM> _C/\ #FZ;1_$_A+Q3I_C/3X[9F@M[#7-"NH+M#;)D9TZ]%I!%J5KEVN8Q
M*%*[Z_T-/V??B[H_QX^!OPO^,FB.USIWQ \#Z5XC2XA'F0/?.LEEJD:21KY9
M/]J65XPP<*&53A@:_BS^,7_!)[_@H;X]UC37L/@AI;Z1I+>1&ESXW\/02727
M5Q(CO)NND.$1MSMCY%R6(%?TP_\ !,#P+\9_V:?V'/"7PI_:.T&+PGXL\!7^
MHZ;H-EI>L6NM6]KI1O9-3BC:>TEN4EMGDO9?WB/Y9<NF=RMCMQ48>R<E*&BO
M*S][3J]=K7/ROZ5.+X3XCX1R3,<ISC!X_BA9I&G7E3Q%*I+^S?JLW9\DW>7M
M(TK7U5Y+1-GLW[8#^!/%?AT>"OBFDC^ ]-U?P_XJN+O2O%_AS1-2U.^T?4$O
M8-&M+75%DOFC\R!/[5.GB/4!:2@V-S:SA9J_-?4?B7^Q1<V/A[P_J-O<6VA>
M#_",'@W2(/%,%W%<7/A^Q\0ZWX@TZUO;FR%A'?WEIK6M:E,+C2_*GO+1[:"9
MYW4L9/VX/BY_PE,K>&-/EB,LD=U=WMQ B;P9=\,4.9Q)LFS"&V0>7(-PW<$5
M^;M[X8LK73;>S9M2(9V%Q/*MI+&+?RDE>0+>6TTSQJ7D'^CLDC$8C97Z?E>=
M<6O+ZLJ=/WI0>G+[SNDFN^E[[_A<_EOA/!XQY7RU>6#6D9RM>+TM)7=W;==+
MGZY_#7XJ_L/_  XUG3M4\(KX.T5].L(()+TZ/XLDU>>6*>:^MFM+N\U.:WAC
M2>X;<LL;,RC%=AX+_P""HNB6WQ<MO"/PI\/Z?XE'Q#UWPQX*NM6UBX>1+ SZ
MT\$UY:6L$\#I"T5X L$JO)YB._.X"OQ+U^233;+5=15+2?2-)1 QDM/)D=HK
M>.0Q\A&\W8RML^\ ZG&,&O@/]DS]H6?4?VTO VDP6K:99O\ %KPAJ%K%<J]N
M?L$>NV<4]T(Y=I%M&;>5Y)<>6H#,Q !(\V?%.<9M@W&G>+:V5T[.W1.[NKW_
M "9>)RG +$*KFV;U9QO%NRDUHT[^NB:>FJUZ']B_B;Q';7]]\7OB)?M+OO-9
M,UJ(TEE\^YL+"TBG$+G=%#$QA$<60,,#O9A7TZMUJD?P6L[BV=C<11V,^ RK
M+<Q7BQMB,8#*8]Q5LYR1\N.WSAX[_9-_:$&B?V-X8M=!\4:#J82_N8FUVQTZ
M[M(]2F>\\^-);J-[LS0W"1E$5BBH&X# G[,\ ?#WQ%I/P_\ "]GXCT>\M;R#
M1A%J.F^7+>YFLWF58V,8<*[JJ;"<$AE(!!!KQL%EN9.DJV(C6<YSGS6C)W5]
M%HGTVOHMM",;F640?U; UE6P].,.2K5:C.3:5]&[Z2O9;):=4SD_@MX/.C:9
MJ6K:@N^^UV*:-Y9ED+"*X4KL!8YSAFY!P3@@#BORT_:+^&]O\/?BKJ*VV8M.
M?5%>WBPV7CNUCD9XV;Y<"5Y#WY!Q7[86B7MG$(IM*O8(0 8$:TF3;Q\O#(.G
MO7Y>?MO>'?%NI_$'2;W3_#VM:E9?V%%<RSZ?IEY=P1W:7%T!!))!$ZI.$CC)
MC8A]K(=O(-?E_BUPXZ^04L3+!XBM/#XOVRA3HU9S;5)[*,6[=U8_6/ _B+ZM
MQ/7HK%T*%/$X%TI3JUH4X).O2EK*<E'3U]3Y9U2,B&7R_GBC)3RF"D2_ND<F
M0GG80X"@8.03FOEGXH^&8)-/N-7T^ VMWMD$XM7VNZ '<$)W!'(R V!@G-?3
MHT[Q9)"COX5\2R>:N&CCT:_9X2(PNZ5?))0';QN S@@<UX_\2-#\6P:+<)9^
M$/%-S<7D<T*I%H>HRF)I%VK)(J6Y*(I)9B0 !R37\KYQE>-Q&1_7,!E.:4<7
MAY<T+8'%*?/3UB[>R4G=I/;4_LK*,WP6'SOZECLWRFKA,1!0?-F&$=-1FDFK
M^UY5=/OMO=6/UE_X)R_'"Z^+'P6C\/:Y=&]\1_#W4WTEI'F1GN-*$%NVG3A!
M^\5;N>2:PC,A)$]O(Q)4@5]E^.WU]_#.HOX6UDZ9KD36:6MW]D.IQ6S6]R]Q
M+:S6,4<DYDF5PBO]Q202", _B#_P3#_X3+P)\:_$>A:KX8\1Z-H?B;0(VFO]
M7TJ_T_3([K1GN=1L_P#2KJ&*W$LUU,55=^YP%4 GK^CG[4GQEU;P3X<N;CPO
M/IIU6P\R>.#4IU%K+"Q8%L64UK/O+J^P3S.YXQP1C^\O G.<SXC\,,/ALWIX
MC"8W 4HRJO&PG0J5/9Q6G+646VU9+N?Y^>/&44N'/$W$U\FJX3%X''59*FL%
M4IXFE3]I)^\G1<HI7OI=6O=]#/U[Q)X8\-ZCJ6FW?Q&^'_A?4]0L+?Y+Z#PS
MI>KZ9<2&0W$THU2#['?L\[23"SO+:YA3?_I$+JS;H&\>?#*#3Y=.?XV^&;JY
M^RK,TVF>)_AA:RS7D.YUF>%;#S%9CM L[$0VQV_+;AW<M_/7X[U'7_'_ (LU
MG5=;U>]>=Y'U%Y+EBU@MS=,8WL;%W7S@T2Q(YCEFE/ER(5P3D^;1:''I_P!L
MO%,.H7GSJ(A<2>;&2/E9XDF61!GO@'K@YYKW9\81J/V-/)*->%&3HQKS@DYN
MFU"3?,M;-7OKLM[GS4.&:N&BJF+SJM1K5$JKI4VY1C"JHSBKQTNDUS+OH^K?
M])GC7]HKX0>!/!4-UJOCZQU0K"J>1_:&GWEW<.&9F$7]BB!%9LX'R9'3I7EG
MQ+_X+7^$O!_A?1] ^#?PHUO4]973UMX]1\3F1]"TV6,,@8-;K:7$ZNX,P/VE
M@ ^TG(K^5_\ :L^*ND?#3P_X?EU&XN4U2YU*&VCL8=2E3]\7B;R3%-+(V\+(
MKE"-VUE;'(KOOA;\0%\=^&;>.)+NXFOH8G4S7=J+.UD"+F&*81KN8#:[J)&8
M%L'!-7B.)L7/"\D,OA@80=_:4E&\G9+EO&^[UT6^NS9C1X=P=?$Q<L?/&2TY
MH56^6*NO?5]/+7OJN_ZF:O\ \%9/VTO$>M+J,GQ(M/!UM'=F:+1O"GAVTGM)
M[9&#26]Z^K6>JN(DB_U;0R0R&1GWNZA0O]2'[(?Q0UGXS_ CP)\0/$4SW&L:
MS8++?3R0):S/<1.582QQQQ1DMM63,<:IM<*.037\+=[_ &FGE:=%>I8I*#;R
MM]D+[O.S'"\-P4*RHDI83.A8*JY8J*_IW_X)!?M?6_CSPO\ \,^>,);*W\8>
M&K>6_P##[P/%%%JFE6\>V5(!G$\\(MGFE6,ED#98?,*KAK,ZV+K_ +ZJXKFT
M4Y6N_=_F:W;_ "MW//XJR6A@J4)8>--V46_9I.T4E=^[LUOKI9??^YU%)D<\
MCCKST^OI^-+7Z0? $+8^\/Q'I@?RQ7P'_P %+/$5OX-_8_\ BQXON++5]3AT
M&RCOY+72[9I[M5@_>'R4CAD?R1C<[X8 D@MQ@??F" !WR?KV[?AZ5R?BWPAX
M:\>^'?$/@[Q;HL'B#PYXBTV?1==T:_67[)J&G74<D<ULQ5HSM9)G'F1.LBEO
MED!7CSLPP%+-L%C,KQ'\"M3E1D[;PFHI+HO\]C?"8NIE^.HXRA?FI5(S5M7>
M#37JK+;=^>J?\(7BC_@H-\$]8\%V%IJB:QI=S<Z<OFK-:S2J)@'CA<P10A_/
MMI4\QP?F V\#C/T9^QY_P5S_ &*/@M\'_$O@'XJ?$[QGI6JP^.KC6?#8L/AG
MXTU6*+2KRPTR);8R6%H\;1+=P74K8./WAS7Z[?$+_@W9_P""?7CC5M1U+1K'
MXF?#=-1DN9I=*\'>(;(Z;%)=Y\X0KXCT;79U0[CM1+D;>H.*\0E_X-A?V(S,
M]U-\7_VB62,%Q"VJ^!714"@;"!X',C+M&T@,&QT92<U^1<)^"F2<(\48'B/+
MW%U<)+$RDHQM[U:4I:]]_/U5KO\ 1,Z\0,5GF0XS*JU[XB5!JZ;25)16]K*_
M+=:I[]3P#QA_P5Y_8V^+GP^^(7PG\!W_ (Q\6:Q\0_ WB'PG8W]]X.\4:#")
M=9TVYLT.S4H(U +7(Z] ?S^!_#6C6\_@6#3IE$J)ILD9G.1>Z>J/*JVL>?G5
M&4!F&#@N1WK]O]%_X-[_ -A_X1^%/$?B31IOB7XI\<Z+X>U74?#?B7Q5XATW
M_0-9MK.>?3Y8['2-*TJW8I.L(*312(5 &2<K7\H0_:S\7>$;KQ+X4O\ 3= D
MOM$UK7-$>+S)F\10QV.J7ELGVFQ2[!2>2)$E4/; E'1E 0BOZAX#XGHY%A<P
MAC5>..S*51W_ )6G=][7;?DF?RQXP\ 8KCC$9?F64S=/%8#+H863>GP^S?+I
MTYEI=?(_3S_@FO\ '*;X+_M@:%\/-1=HO!7Q?AU/P;JEAJ1\W2X-1ACDD\-W
M$<;807%WJ=^8CSEMBX7.37],FNW?A._#Z'=6-K=(L773(1:LBVMQ,Z'*Y!*O
MN(Z^U?P$^'OVO=1^'_Q5^'GQ0@\!:IJX^'OC_P ->.I=-$<\=QJB^'=6M=3N
M;<AU\SRVCML;%VJVX@@@XK]7M6_X.*_$%]>+?C]DJV=Y+?$":N^JVZ;&GF?+
MBSO+-RA5@'^8'&0".WF>(>.R/,53K8*E&<^92FHJ[MIS)V\M&N]SW_"7AOB[
M(\K=',<5.-&*VD_BCHN7U>NFOH?UB6>G:0GAR>UT6QO%25IK.3SY6?&;:)CG
M/7(DY].GL/XY/VF/VHOA]!XC\?>$=4:[@OM \5ZF\P@TV_N8+N2"Z*1VS21*
M8I#F/HG][UKK_$G_  <"?M1:S;+X/^&'PM^"G@V^U6XL;>V=_P"W]5\:W=[J
MTPM3+H\!\3RV<=S;0^2L2W.FW$0:-?,C?YMW[UZ'_P $*?V,/C3\+O"?C?XB
MZ%X[\/?%#QQH^E^,?&OB#1]?BCU*X\3:Q!'J%U.UK>V-[80D/*@2&*T2(*J[
MHR2V?C,NJOV3_LZ#P[6B;371;+I=N^]T?IF(C2G5_>[-I:IMM:/U_P"'^1^.
M'[!'_!5S]CS]G_X ^)OAG\8_B3XNTW7T^(>IZ[H=OIG@WQ%J]O'H%_I>DQPV
M30Z?:R2JD-Y!>.H5E)9R.HK[9B_X+M_L3>'K"YU/PU+\2?B$QL+B-+?3_#.K
M^$"6$;[4>3Q1IMPJ[B0"XVJ.M>U77_!L1^P[/=I<VWQ/_:&M%BRYB_M?P)."
M79F81L_@0R9.22':3;P !7JO@#_@W&_X)X^$K^#4M>TSXG_$]8Y8I#I_CSQ-
M8Q:;+Y; E+FW\-:1X;N&MY,8E2.97*<(RGD7SYE*K_M$G4E9.4[IMJRM]UK>
M7SUN<,#"*Y)/FT?P26NG5I+OUZ=M_P!%/V _B_:?M$_LV>%?CG:>%];\'6/Q
M*EU'Q'I_A'Q.VG7U[ID F;2X YM+.V;;-_9WVE0 &83$@D$ ?8S>'="N@1<>
M']'E3 _U^E6$F_(R?EFMW?[Q/WB3WSFLWP%X#\(?#3PIH?@;P'HEGX=\*^&K
M*#3=)TC3U?[+8VENFV*"(RO+*54=WD=R3EF9B2>S&T?+^G)Z\]3_ (UW1ARQ
M5TN9K5?Y].BM;_*_![1\S<6TKZ:]%JOZOY''?\(9X4,G'A3PLN 2K#0-(,BG
MU'^AY''.3QZ^]Y?#NB!0T.E:0R)\H0:7I0B3'.3LM%8 =U5@?3%=#M 8$)ST
MW>W3W_SZ4K*A&T@#)!P!WXP2!^'7K5WU5_G9+;Y?J5*M.=N9WY7;57?WRN[^
MEC%AT;2(L-'I&EQRK_RT@TVWCX''#+$#^O'KVJAXFM+^[\/ZY9:1)%;ZA<Z1
M>VVEE@(8H]2EMY4MG#+LQ^\:/D$$8SD=:ZD*H4YY!Q]/TJ/RXV(&. P8 Y/S
M#G<">G/3_(H7N58U8*S3N]O)W^]=]MO*85)4ZT:T+>ZXR5^\6FORMOM?N?S2
M_ 7_ ()K?M9_"?Q'\4]<\16/A;Q1<>-?&.J^(]+N[3Q/IUG=P+>.I9+S^T+R
M7S5:&.-52%4=&W,YPP ^OOA/^SW\6_!?BF3Q!XX\(W,&FQVTYAL-)SK2/>J)
M/*F*:;Y@FR^P[5!+X ')K]G1'$6;Y 23DY&><!3@GGH #1L(QM7 7.!NX&>O
M?_\ 5VKQ\5DN%QF=U\ZJIK$5Z5&$]='[*G&G&W;17ZZ:V6I]E7X\SBM@J6"D
MX2HTG[JC&2:[\SYY7Z6LHM*^]S^</]H[P?\ 'N4^*QH'PY^+.OIXCE6"UBT_
MPKXI:SMH_NAF@CMF"*!CDXXXSQFOR0^/WP!_:AGL9K.P^ ?QCU2YNU N;BU^
M'WBR:(.8D4LLBZ>V0HP"2Y^92*_NL,>X#+,I]F;_ !/]:B:WC*>5LRO/7+9W
M#G[V?IUP.3BKRW+*67<08+.H)RE@ZJK1C[J3E&VG-K;79VMUU/6ROQ,S7+**
MIPIP=[*34I*5G:^CC)7O;9[]K:_P%?L'_LZ?M+_#K]KOX6>+?$7P"^,VAZ-I
M^HWD>JZS<_#_ ,2VMI%9Z@D<$YN'NM,*,B1AF^4J5ZGK7]2VOZ9J]Q,]I#X8
M\2W^+B>1V7PYK$=S'F-)++]Q'"C32^>6"1!6:1N I) K]6EL8$5AY28((.57
M)##! (&X<>AS^-2?983M80Q!OERP10W[LY1BV-Q*D CG((XK] XHXOQ7$^8T
ML3BX<L:5'V<:?-S[144U)Q2=DK[6[/J?-<1\15N(IQGB(M2C)2OS<VW*[:I=
M4^O^9^/">%?%Y8J_@'QU,DN=QE\">)L#MD_Z*/\ /TK=LOA_XZN0EOIGPZU]
M"H(C:[\-ZGI@Y)/S2WL"HO)/WJ_7+8?[Y_7_ !I/+_VVY_VFQ^6['Z5\F> J
M[TT]?Z[GY4R?L]_'+7(Q$OA6TL+(I(9C=:[HR-)O3]RJP/ME4QL"WJ,C'O[1
MXA_9H^%WQ)TOP7:_&SX:Z!XH\8>&-'N=.AU&\@U&_G@M9$E'EP3:?=Q8?#MM
M*$,#]T@U]V,@&W/J3GGCIVS7#^*?#$VJ+)=Z>[BZBC9D@28P?:G096 SN=L(
MEX3S&(5,[C@9-:T*]2E4DM>1V7WVO;];W1R5\-1QTE'$V5-6:3VOIY?Y6U=T
M?*GA7]DK]G+P=XJO/&OA;P$FA:_K(M;?4'C\8^([M9;2TC2.,/I&KZY?0V2X
M5@ MO%M'.!WZG4O@]X(NH=*CDM+BT&@I+!8P-="^MG66YFN 4E!9'7=,<$/P
M3MXP:TM5O/&NARM]O\*:M+$(O+WZ5$-=<1\G!.G0R.QY/4[LYW>E<-<_%K[)
M+-;7F@^-[%4<++-?^#M;L[4G"_,LL]FJ*H  RK $@DG.:Y:F7X;$5ZE6K:\X
MZ7L]6UW[_=^G70^MN/U3#5?94L-:O%MV4G%J%ETU4K_=T/D;X_?\$P_V>OVA
M]1%Y\1]9^)5P(WEGMM)TG51%IE@]R@BEF@BGM)T7SXT6,F,@X0;B1Q7RXW_!
M#?\ 8OLX6M+"Y^)=IY99HYGU/3_-23JLB&73"@=&PREU900"0:_4.Z^-'A$%
M3<^(;:W;IMEN$@E4#J'CD8,%&>A YK!N?C=\-<$W7CG1( @)?[1J%LH 'WB[
M>:ORCN21@=QS73E>-Q.3SE]43YOL-/53TY7H^CMZ+N>+G&59;Q+>AG]!8F,-
ME*-XSM;W=K6>S]=3\NI_^"(?['22;I==^*\MS_ST.J>'B2?J-"ZYYX_ C-<M
MK'_!"O\ 8ZUJ17N_$?Q@PAR576- V#IPH_L(CISC/-?J3<_'?X/Q\CXC>##G
M/S?VQ:'K_P!O1_P^HK*?X^_"$LQ'Q&\'$L><:S9#KW/^E\>V!^9YKWWQAQM;
M_?FN_OVML_YOS_X;XG_B$GAY4Q4:O^J.%LFG=0A>ZM\[]K=&?&/[,O\ P2K_
M &</V4?BUI_QA^$]_P#$&_\ &.F:9JNBV,'B34=/GT]X=;M'L9\K8:;9'(CD
MR?.D=3_"%.37Z86<C_O)(IQ,UN8]Y3]VUN\SM'*B\Y:($$..1MSSS7BK?'7X
M5S*4A\?^%+E%>.4I!J44K*T3;XFS;W0="'Z%CM;&"" <M?XZ_#TF,)XGTR9D
M011?92"2"Q8)A)"96+.Q!;<Y+  GBO"QV8YGCZTL3F%1U<5.RG/>ZBE&.OHE
MHNK6[/O,LR#)<BH4Z.5X2& PD&W2PL$HJ#DTYV2WYI>\_5W\OI"WO[B./B4C
MD]&QTKQWXP_$&Z\+>'[^]CNF7-K.(U#'<;BVC,RR$ \X\Q>3T"BN3_X71I]Q
MQHVE>*O$&3P-%\)ZWJNX]!_QY02DYZ#_ #GQOXFV_P 5/BI:S:=X/^%_Q%GN
M)HIX8?[5\&:]H-I;27$?EEY;C4[)(3D8R=P 7ICK7CS]O5IUHV;2IN3]=+=_
M*QZCY:E6A)M<D:BEY=NWW:_D?A)XA\=^)?B%\0?$^J>([V76)-2UF^$EW-+D
MVEE $6.-6/(+;63&3@ <<UY#XK^&GA/Q?'-?6<,;I'=K:FSN4R+BX9E4-\P'
M#,P&X''?%>M?$[X-^-?@SXRU3P]\1;63PQ*D]SJ*HP<11M<EFD4W&[8Y4#<R
MEB%!Z#O\M^(OCYX6\.6EYI<GC718?*F?;))=V$=P<8'R)N#O)_=P"Y.,<U^6
MXBAF/UFMR4Y3A[S=K[:7[;V[:W;UT/TRG4RZKA**J2CS14+:KI:V_P NG3>Y
M7F^&_@^)]1TNZL]0\-RJS1P76ESF R7'E(%"L@()W8QCZYSU^,_@I81^&_B!
MJ^@:G<:CJE_I>O7%N;C49FENS9/*)TDN)& )8+,1EOX HYQ7UHOC[P5\1I[#
M3M*\2V5YJD-S'=0V$.HV]WJVHS*L95;/3;.07DLKE=J((W)8C@]*^7/!/@KX
MK77QJ\6:]/\ "/XS_8];UQH;1I/A]XC@CN[1(+>V7]XVE!=CLC%'3#%&#;CP
M:Z,)3DZ/^Z2V5_=;[>6O;6_GU3RJU\!:_.OO[66OIO\ +;>_] O["?QDMO 7
MQH\)2Z_J<6E:#XDAO?#U[=W%]#:V[V\=LK:='*9V"RHMS<2E54]2<YK]X;SX
MR_#EXXVG^('@G<LLD#,=<LK::*.)O-B=R;Q8R5$F?G4J.-P.,5^$G[%O[(OQ
M?^(NI>&[Z7X;:IX9L]&UG3M1GU'Q>ATJ:&T@N8I8ET[3-52*?5Y@R2-/;6*/
M-%&4:4;'6OZGO#W@+X<RVD.E7'@_PP]Y8P6\5]%-X>T^&2YNO(CBEN#;W-LU
MTJ,4#;BP3KZ5]MP]5Q,*,*:A*%-.;LTUO+56\M?Z5CXW.71E4YZ4K\RCL]FD
MK]?RNKK4^(KGXV?#*+D?$SPA)@$''B?1#C/TN.<=^G6OE;]H']H7P+:Z/<?V
M=XU\.W]TJM%"VG:M;7LD,C+E1,EO</$[98,-D8&, CO7[4#X6?#52?\ B@O!
M_/3_ (IW2R>/K;<X_P XIZ_#3X>1LOE^ O!JJI/'_",:,Q)(X;<UDQW#C!.3
MCBOHJU.I6C4C"I[.<X<KEKLVM.G7SW7S/(HUW2E3=9.I"G)24+MJZ=D]M-/6
MU]MT?QNZM'X(\0^(YM9US7EU36=:=UU'?>V\4-I:1$R6<D%L-K1,\LD@9FSO
M"J ,C-!TKPA91W5_8>(=,$NBHU\$OY(ID6"T4S'>C-^\0!3N7!#+QWK^EG]H
M#_@F=^RA^T7XBMO%OC#P')HWB.'>&UKP7?2^'KJX4QB-([RUB<Z9)' 07A\J
MQ5_,9C(T@( ^5]0_X(9_LMSW4EU9_$/XYZ5)+&T*K8^(?#DD2HX*["MWX4N4
M9<'&)21C[QQFOS3%\%8^OB95?;QLY-MN2O9M=W>^EO+J?I>#XVP%#"PI/#R3
M48JW+=;1OK']+7:/Y)OVQOB@?"?@^>QTV>&UU+QC?6FDVVI12C[+J$VH3B*Z
MO;6$,5006DT(+#.T1Y/2OR<^(FKVGPN^(_@WQEX=N%L[K1IDO[B[,SNM[&8(
M#=+<SQ2+);(LB2O %DB'F.V,DFO]$/1_^"$'_!/F=].?XJ^ O$OQ^N-$:X_L
M<_$OQ->PQZ0UTH$\EI%X//A6)F88P9Q<%3C85P*]-T#_ ((F_P#!+30=0;5[
M+]C[P!=:EM@B2YU#5O'6IJL%K,TUO"(;[Q9<6;"*9Y&+>06?.R0LH KU<!PI
MC<+9O$6ZN[>FW:[WTVL_-:GD8[BS XM-1P[?;3?9=>JOLK6/&OV(_P#@IQ\%
MOCO\$_ .H>/_ !CX2\!_$:#P_I&DZEHFI:W8Z3HU[):6<-M;2:1?:G<AK^]D
M@6&6^@BNYG@1U=DC# G]*=.^(&BZM9K?Z;?Z7J5E*F^.[TC44U6W9",B1[JU
MFE@A3!'[UR$0?,W'%?)GC;_@CM^P#XRGMBWP.TWP_!;R-+]C\.ZKXCL89&>-
M(CN"ZM(8%"(H0VI@<?Q.P"@=3X&_X)2_L-?#SRO[ ^#VHAXV1P]Q\2?BFT6Y
M"""]N/&B6Q3(^:/R1&1P5(XKZ:A]<P]L/)\T8V:EWOR]_/1=3YBM/!XA^VC&
M4)36L==+62UTBMMK^MK'T5<>)K1T_?HFQA^[E6Z@E'/0KC.?S_I7+WUYI\V3
M,D%PJ,3^^BBD'0'+';SUQ_C73P?LG? '3[2.RTKP1)IJ1 ")[7Q#XLN"G/&T
MWFMW2G!Z;@??-1O^S%X 4,+74?%MFK9&VWU'>JX'(47$,[  ?WB3[]*]&5*A
M5II8FFJBNG:SMS66O1:*^GR..E6KTJE\/.4&U9M;VTTTU^[INSSBX_LZX/F_
M9]*2,DA5@LH5<D8_UIQR,=!C\S6)-;:6VX?V9I;DY!>6TA(4?WFR.0#R0:]-
ME_96\+R@+%XY^(MFJDG%K?Z2F=W9C/I$^0.HV[3G.21Q6;)^R%X9<Y/Q,^*R
M@G)4:MX="D9Y!SX>[_YZ5SO!Y9)-+#17-'1VV;2_KY:[LZ5C\R33^LST::5W
MKLUTOK?MI8\:\1ZQI&AZ?=W\5OI]O/%:N!):6L* $*>1A3CL1UZ<>M?C!^T]
MX@\2_$R\O?#NB:K);6S7!75;TK$)(UML7'EQ'9WC;^'.,Y'>OWRO?V)_A]J5
MO)::EXV^).HVLH82PRZSHBAE/4'R=%A;\B.O%?,GQI_X).?"3QOX.U&Q^&GB
MWQ5\/O'KN]Q9>+9[]M3MUN'0*[:M9"(+<(R(H*VYMSL Q@_-7G9G@:D<OG1P
M:YKQ:2C9:M+3T].AU9;FDO[0IUL8WRJ:NY:Z76M]7WUUUT70_GXC^&0-E#=0
M7TUU;7<T<49O&1/],B(CEE/$>Y9-JH,YSC'-<+XVT*P\*)<VVIVBQ:E;O#?;
M[=P3/!%MD*MMR2"%((Z<^QK]+;K_ ((R?MBV=L]IIG[3/PMURU5(%M&E\)^)
M++)AFDE7<7UPJT^YLR/&RJQ[ 86L"]_X(W_MI^(M6:+Q!\3OA'#'-8M8#Q0-
M*UJ[?3D=7C%\=-772]VUIN\[[,BB28#RU.2,?ET>&^(*T4ESP@JDG%?]O_)=
M]G:VMS]1K\3Y Z44^2=50C=I:[*S2;4KK71J_1J^_P#*+^T7JEI\:/$'CP(M
MO+H?@:W;3[*]8J6;6H4:[:^5LXSMGM[;=ZV^,Y4UM_L0>+8_$.E/X+U1IH+O
M0KTM:R1/B6YBD8)YA&2>=I4<=O6OZ4?"_P#P:X6EAINK6'B7]KGQ%.WBN\-Y
MK[:%X:@L(-LLIEEBTL:A!?-;EF=RGVN6X=2P!W( E?6?@3_@VZ_9-^$6DR7O
MP^^)_P 8O^%GM:1PKXT\3WFA:C8374>YE>[TK3?#FGQ"%68@>7(K; ,MG+5]
M32X6S&I@HT*E:TH6G;FW>UM&UK=?+3U^;_UIRVG6YZ=%N,G9M)I]'>W:ZTTO
MW/Q-M/"&D7M@+NWUNWL380:G8RI?RH6:\%H);-(PY4K)Y\P[<[AQ7=? CQ!J
M7P;^)WA'XF>&]:,&K>#Y+;4+V*WG5/[0TZWNGGU6V"@Y=9[0,CJO53@\=?T6
M\0_\$ OCIK%_=R6G[6G@NPLKF_74(H(OA]XCD>:[C9<27\BZV8B1'%$ (%MT
M9E.5()6O4OA)_P $'/$>@>-]&\4?%']HW3_&FC:3/";GP[X>\/7^C6>J6RN/
MMFGWS7=Y>2^1?1 P3^7/'*$8^6R-AJ\O"\)YQA\7":JWA"K3E+WTW:,XR:WV
M:OI^1V8SB?)\1AJD73?M9TIJ*<'\4HV6K7??6W0_H&^%?C5?B)\/_"/C)8]B
M>(]$M-0E4KC;)-&25_'Z9KT5<X'&*Y+P;X4T?P/X:T+P?HD(M=+T.QBM+*WC
M+F-8(LA%#2%V('098MC&3Z]8A8J"R[3SD=<<G^G-?JL-OG^B/RT:$(ZGH<\?
MY_\ UTC1!B=Q)!(./Z9&#^IJ6BM$VFVM+[_U\N@)<JLOQU_,K_9P&RIV@\'E
MB2.P^]QBG>2 V4P 3\P.3D=^IQD\]0?3&*FHK*E2C1<W#F_>.\KR;UM;2^P[
MO\+&?]C8J!*RSL%=<RKN1]^00\?"E=N 1CD=.<Y^#OC5_P $M?V"?VA=5N-<
M^*_[-O@37]9N[A[N[U.S_MGP_=W=U( 'GN'\/ZII@D=MH))'/?-?H#13=.#W
MCTMV[:W6M]-]R::]DI*#DE)WE[S=WIY^2^>NY^(.M?\ !O3_ ,$Q]5G::W^#
M5]HX9B!;Z;XL\2"!(7^6:.,7>IW4@\R/Y,O*^.N*J:5_P;O_ /!,G3;E;F;X
M3:YJS*H3RM3\7ZW+ T8)/ELD%S VP@[6PX;'W66OW)HJ(4*5._+"]]^9N?\
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M)V[?<(>01ZBD ( &?K_GV_\ UTZBF(3MSS^%)@CH>/3']:=12<5*UUL[I]4
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M/N>#_"BG/)7P[I(_+;:#]:F'@[PL.%\,^'5'3"Z)I@_]M*Z:BJ3=K7OZZO\
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M>XR,<>_I[\T^BJM:V^CON_\ ,7];$+0YQM=H\$<J!DX[,6#9'T I6C)QAV4
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?LM.W;TU[C=H/W@#CH0.0.W7/-*,@>OO2T4DDMA'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>c03.jpg
<TEXT>
begin 644 c03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _OXHHHH
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MZ*V #DZ?<# .<8SJ1ZXYZ5 WQL\:JP4PZ*<]-MA.>_./^)E^5"JQOJTEWO\
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MX@D)-G$SDLUT9']##\OR]B6R.1C;Q]ZL&XO4CE-I"8\-!L0G/[S'5DQG*\<
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M:W<<%_=:+!>:K!/=:GH&IWUU*NKR:K9RSM<:9KGE(L4< /BC4B(X52)*^M?
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M6M+CAU=O^$8O-<S^@S:3Y&_>;LEWV>^VVNY^=2FHQI1;7,HJ377E<8V:T?\
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MCV5KK=I)?:A?0@LUA!9!UN%O&7YXK2X2"[GC^>"WE J8)IZKI_DQG=Q0^6B
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MX^%O&NH>!-%U#Q1X=^RFUM=,UFYMH;N]METT*L6G2NY,T^FEBVG7,TMD[R/
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M2]WI=ZNQ\[S*-:I*5K14I2Y[N#26O-:^EEK;I>USA[O4?BE%XFU^+3=/T9O
ML7@V)M!O+:YN#KP\4 -Y5I/:.PMY))XI8(Y9% (BM40E6,Y/DWA_XE_M$2Z9
MI\.I?"^^N+JWM_#^G7EQ=J;6^O))-(N#K<\P@N%MH?M>M6D=QY,"M;0I<;4
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M(K#3PUQ]IL= U*3[3X:@NS.5%KJW_"/S6IUS3HCNTW7'O[7<;=EW?(T7P/\
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M[6+:O\>-;;5;SQ=XZT2_^$/B'Q)XMTG4=,\,:>--UGX>-I5WX3T:+0=)\/\
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M[2AT^!/(M7F^#W@-[V>+S[PM'>AO#93RQ86AN5GG>Z?S&,6W8 3-L/TQ=/\
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M>ZYXBT6+6Q=3ZSX=O9=0D335U&;]H[Q?K$^GZ<HN-62ZU+5"C2.8Y'DMO*G
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M$BA=]J&R?LHW+7^P'T3:4,3X#<'5^2BY+*,':-6*G&[WYH/1QWM?2^NZN?\
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ME?3S^=C(G\1>'-02".#X4>&M-,4=U!/*NK>(;HWOVFTEM(,?;K^X)^Q/,MW
M6?$4T,<A#@>6>X^&?@VX>X@NGCD\NV/$C?.B18)5#<-@D@?*"1S@#J>.\\/?
M"B5VADF@*@ .&DW$JKY!!0EA&^#CHQ.  <XKVB^TBT\/>&+N.S6.*2*V9F=5
M_>$XPV6! '!(& >W7.*]52I4D\/0<Y.K[BYE;65NOW?\$_,.(.*O[2G2I1MS
M2G&-TDX7;2NVGHM?S^7[ _\ !&CQ-#J\'[9VDVIC6+0_@W"@DV@XEDM=<!+_
M #;656&=H53QUSS7SK::YI&FZ?+%?WT< 2\G8V[:GXBC46Z6EFULUQ#H]TDY
MCN)I;ILQH55$12A8!CW/_!!=X[NT_;N,A+RI\+X4E#M@LBVVNR)OQV)!!;/(
M.,5\Q^--;L=/EAM[B'4YII+1I@UA9/=Q!879%#SQ)O+@. @RHQD<X%?X2_M'
M,[GD_C#DT(1C*IB*5:$%+:3PF$RB=7F;:45RS]RV[O>Q_P!$'[*G+:6*\*,?
MA:U2=.52I2E-TDFE&6*SB\HN2:<M%9237WZ=!K'C#PPES=6D>N:=OFEMKFUU
M*TUSXD&PLE@?[2UA<1W;VT[>=+%'PB; $9?,R5-<%J>M_#W6;&&VU.\TN<W\
M85A/?^-+A[62RGNG1G&HW+VZO.]Y*5=(Q(L($:X7S&;R[7M1L 8YS9:[AHVN
M,KHMY([@$*8Y!*6R<ONX( *C'6N:2\M);BU@_L[7P^HR+#'-/H\T4(9@6'FN
MP 4*%(#9!7G@GI_!.,\0*_U=WA1CR1][FG3V5FVDFWW?7<_V(P/#65T:5.K#
M'XM3I)/WXX>*4K+6\8*23[K;TVZ"?7O#C75];1^ ?#-RL9%M9Z@UWJQW,HVI
M=K'+..0H8'!R2_3 K:\-:2]N'O'2&&(*TH2%&\F, A@JN[NY '&"<]>N#6KI
MOA%XBCLN-N.X<$$Y .[(&>"5QG(Z@#!U/$<;6FAW45N%#>4R#;\G+*=IP/4\
M'"\^E?B?$?%M;/L71PE%PCSUJ,)->[%+VL'*S5^B:7JMCUZ^,H7HX##5I359
MJG4G-Z7TL[\SWTL[>>B/W&_8+U1=;_X)^_M.&' 2'4O%MHAP2/W6EP]?F&<Y
M'(*_G7XZ0_$1O#-D-,N-(.H06K,H,GB#7[*)D^T1W#HJV&HQ[II)(T6(L D>
M' 5BYQ^G_P#P3T\<:+X<_8-^,6B7D<UW>^+?%?CFS5+53(ELD&D6H$US@$QQ
M-*3&'; 9_EK\F?B381Z=?SQ16.IW#^7#*6M--GN+8R2\JP>$C#(>1G@$X'!)
MK_=?Z)]##4_!O@^ASM4)</Y>J;[5;*4^;?E6]GWZ:G_)!^UGP6;4OI'9MB\K
MI*J\'BL]HRM=U)3>,H?PU9\R:<M;KJS+OOC'<6RW<9T!%-Q/<3HW_"9>, T=
MM<27$D=G.PU(EY(&NKC##RPJ/$-O!+<)JGQ2T;48$COOASIVJ3))>RQRZGXK
M\2ZI#]HOY(I)/*BN+HM CM&051AN CWLQC%<=J[W-M)<+-I6N.RQB5_+TN[;
MS7ESMW*V2I4*22.N>2,<Y-AIM_JVJ6NEQZ1K-M<7$#2137.F3P6OSXWEI'.(
MW4;/+(R1EOI7]+QP.%G))XA);O5K;7_AM[]C_(VMFO%.+56C/+\9**TLZ&\D
MXN+3O\/,E)[:+=IV+>H>+O"[7%[<0?#7PY;VMSITEA'8R7VJ2/;7TP'G7B)<
M7'SR(RHUDRX6 >:)%EWH5N?#?2M3L?!^MW[1N+P^,/#1MHW"[R!!?^3M++ME
M,8PI)P.F5)KT?3?A4;9%NM4D21X(RRH^'&]<<DD$L3D9Z8P*W[:U;_A$?%IM
M(QMTCQ)X7N]P V1A;>^R[YQF,8&4&!GJ><T5<1AH8BG0PKE)>SJ*4FE:_LW;
M6][7_I:M>O2X4SBKPGGN?9Q16%JX'!U:M)4>:<W322FO9QC=S=-M1C?632?<
M_0Z\\3>,T\#:9.^@&2\-C9SRW26YCN([J*V>.WE+0S>2UO<PS-:W,;P[I8\!
M6CQNK\__ !9XK\6PZQJ*W'P^%KITE]<7(N()]2L-1BNIK>Y75;D:M%/+:6EL
MMK=+$[36,KVME;6"H93"=_W-=>.M6D^'^@7L=IH%R5TZS?>MG-LN3'!&R>?'
M#=JK*I)5E;!;KTK\_P#Q-\4=:_X2+4%O=!\+W5O(+FW>QN;"\:UNO/E>427,
M U "7[/(Y%N<H$P$D$J*%'F8*AB?:U/W7M5*3:6T;76^G3=63LUYW/=\0,SP
M-'+\GJU,SQV$J?V3E=2%:6!=6G"-7!TUR2BY)J;>C71[7U,:?XNZE/86.G1:
M8;)8=/.F)/=:G_:MM<0_\)!_;MQ<WEE>:>9)I[Y);E/M$URT$\-U/<PVMM+=
M$1[;?%'7/$I:$V:+<ZDA:[:ZN+:YB,LMO>6UR]I'!"D]K=M)>W%PIN;BXDC(
MM#M\F%(VY&X\7SZA:75H/"7@C3I+D01-=Z9H<D-\HMPXC\B>6]F6)7\Y_,41
ML')&-@ 6O4O#6FW_ (AO+SQ?K=AIME%INFW$LB:781:9;,T$&^&8P1AD,[-)
MAY.LBJ@. F3])0H5*485)T:5.[44XRO-RE96:LM-^;4_%L%F.89SC:>799B:
MF;_O'B)Q67PPU*-*A"52=6>(E-*')!)\KMS7L?NK_P $:YWN-+^)DKE!)-JN
MLW%W&A.R.:Y;PHY09)9=IX5"?DC$:\G);]T(U7G P1@!ARP7:,#<V3CKQV[8
MK^?'_@AAK$NM>$_C)J+R/))/XPUK!;LJKX/5$0=%7 !VCU(..W]!T&[:V_&2
M<\#M@8!^G\\]L5_/_$].4<ZQ[;7\;9;_  QZ?/IHMO7_ 'V^CY6]OX/\!U'"
M4'+A["S2DHVLZDXZ.,FFURZV[HDV+_=4^Y4<^_2DV)UV)G_='^%/HKY\_9QF
MQ#U53Z JN!].._>EV+W4'W*C/\J=10 F !@  >F./RI:** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ I#T/T-+10"=M2HP/ !P0""?[IV\$YZ5^'O_
M  4H\1S>&OB1:7=M;BYO(_"&ES"&=Q;PR0_VDEK(SRC.=@E>4J0PV*>#C!_<
M?9PVX!00<\X[8R>H []/PQQ7R?\ &C]D#X5_';Q-;^+?&,_B--5@L8M/VZ5K
M12TDM+=Q)#MM9H9H(F60"0LD(WL/F##BOP?Z17AWGOBAX=XSA;AZ>!IYCB,=
MEF)A+,:U:AAG#!UW4JQE4H4,14C*2:4+4VF]VMS].\(.+LGX(XUP7$&?4L95
MP.'PN-H2IY?3IUJ[J8CE5-J%6K0@XI+WFYIKHF?S=V_Q+2]L+6:?1+>XU"Z@
MO+LPVNLVF/*L&=G=C/ @PT:$1J2H#8(8'YJ@L?B)HTMWY-U:Q:7;%/--W-JE
MI-^] R+<K;2.S!CD?NPSG/RJ6P*_>U?^";?P'C V:CX\5D0QHPUBPWJA8LRJ
MQT,D*Y'S#HP.""#BD'_!-OX%[3'_ &MX_"$Y*C6]/ SSSC^P,?I@Y&:_SNK?
M06\6*_Q4>$(2Z2CQ!G#Y6MI<KR=7?6STNM3^OE]*'P\4I*.7\0QIM6C;!X3F
M3MH]<P6U^_1IGXFZ7JFDZI"MQIUU!>QQ[E6>!CL4MUCV2Q*6;. ''S#L>XU&
M.X8P00#AB@(7((S@@@XZD'-?M/!_P3D^"5L-L.N?$"./.3$NM::L;>NY%T$!
ML]R>?>K/_#NWX)@Y.K^/.^?^)Q9']!HH)_ BOGY_0$\:54E4ACN$6FOM9GF7
ME9Z90]O\]M6>;/Z2_ 3G":H<2S<91DG/!83IRM?\Q[3^[MW/R8_8]\!QM^V!
M\)_$D+N/LVHZE*PQM#8L),@@<=^X]1P:_+?]I_X@W?A[XX?%."WM[2[BG^*'
MC"TF26\%N($_MG"LZI$WW7F8EL$MD G X_K=\#_L0_"OX>>(]-\6>%]8\=6N
MO:0\LFGW4VJ6\J1-,FR3,4^DRPG(Z%T.,8'4Y^?_ !-_P2'_ &6/%OB;7?&&
MMS_$N?6O$6J7^LZK./&<ABDU'4I?.NYHK=M-V0AY,%8HE5(Q_JT45_K3^S\X
M?S'Z,_"O$62^(4J.,Q6:YI/&8>7#TY8ZE&E+#QHQ566,AE\HS4EK&,9>[U>Q
M_G9].FAF'TE,VX0Q_",XX9</8;$8:JLZ<L)-QJ1FH>Q6&CC$TN?7GE#9G\F=
M]XXL)/,W:-%<>1<^1=7-MJUCY:#RFD#)YEOD"0@0DKUWX[YJ#3O&OAW+-=I;
M:+*)#Y$;727DLD;_ +M/+CA@# EC\S*5*KEF^4$'^KC_ (<U_LCE6C$OQ+P^
M2V[Q:2&)&"6WZ858XZ%LX/(P<5!_PY@_9&WAS/\ $QB%"@/XO5U !R,*VFD
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M^S1A/^)A\1LHNQ6_X26W9PH)8*'.DLP4%B0,X&3Q3/\ AT[^S2)%D34?B*)
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MY444P#:#V'\OY4FQ?3^?^-%%.[[L5EV7W!M4=OZ_SI<#T'Y"BBB[[L=K;+\
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6J]DTW2K"74;R_P!8EU;5=3*** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>cbd01.jpg
<TEXT>
begin 644 cbd01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _OXHHHH
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M4RQ_+NWG>"%QS7\KDW[:WC&V031^"_#<A4 A'N]4VG [[90?3MWQFNC\!?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI7UYH5G>:WY,%]+")+M$#1PQ2M)(NV))99IHXMJ*5CFGGE0E@\S]J4DW9?\
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M89FBD6&8J)%BE*,L<I0D+($D*OL)&\*5) )-?BU[KXDK]>BV^:6W2ZTTV/\
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M@Z=HS?:++Q)IEGXETF6PNIKK24MX=92]2WB,Z1&PVR>?(&17CC\MB&7<%)4
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M8#,LBQ&.YJTJ<95*<5ELL12G)+VE:O.52%-01^?_ (;U 1/'N;Y9 H89!SG
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M;[>T7PEX&^$.BS75K:V\4XC9I[V94-U.P&<*Q'RKD<*N*^*O&G[4/[47PO\
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M@_I?@OX?[-,\.:-HGAG3Q'=3RV>D65MI\$D[[(_-E2WC3S93G8&??(<") 2
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M_:?_ &F-"T7Q-'9QW,23?8(I';>%98 \H*M$X:7=+N&&5<Q !;A8;EY;2/\
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MJ4,/F%'/LOQ&!S+$Y3EF7X/&0Q>"HX; T>,,S>.K5L-"M5S&C@*RTRW"U5\
M>,?VI/CEXX\26FM77C?5-!N(=/AT<6GA&ZO= L)8 YDFFFMK6Z8SWEW*?,FN
M9)&<$(D BC0*?8O WA;6?%WPP\7%EGDDO[;64DN9F:22>>ZMB#*\TA/FL[EG
MD9I#(_S2<C+UO>#_ -EF[^VP/=VC?*-PWH_R2,R[9 Y7SG5$8X22*-\G-PEO
M.QLXOU(^$/P/T_P_\-]61X%!6WO<MM.WS3;QAWR"-V]@68G:S\-G:8HD_/\
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MZ9#/J*:UINA6,>L6.M-=110Z9-K(CU*S,$6C7+'4+4CS"9$D9MB(P?X$\!_
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M<[:][EI1A!7UM$^)?%$VB^"?#FO>*+JU5[3PWH^HZU*B*J/)'IMK/.MO&V"
M\VP6\0(*(T@RI!<M\QZ!\6_'^M_#Z+6IO%/B?3?$OCK0]3\3^"M!TS0U'AC3
M-.>*^.CV.M3I=W"Q/K;V3HHBCU3[*C6]WJLY-Y+'%]>^)M$L/$>BZUX>U2(R
MZ;KFEW^D7T? 9K74;:6TG"D@A9 DQ:-L?)(J-U6O!=$^$WQ<\-_"J3PCI5CH
M^J1^&=/\7Z'X'\4B_FL+;1M#\0VKVLJ7FFK>JLYM(9I&LHKJ%WTN3=':F_AC
MM4KX+Z,.=\ 8?+>,_P#6EY#5XJK4<3['$<6XK*J&"_U=7#V;J,,#7SS!8_"V
MI\32RJMQ%A,-&AF>-R6_U*6+6&Q&78W\R\=,GXUKYEPV^&HYU3X;HX67MJ'#
M&'S*MBWGO]L95>>,I91B\'B>:?#_ /:-'(<57=?+\)F_^^1PWMZ&/PG[:_LT
M^)?^$R^ 7PD\6>4+=O$G@?1-:D@ P()M1MQ=3P ;GPL,TKQJ-[\*/G?[Q]PK
MQK]GGP];^$O@A\,/"]H4:V\/>$-*T:%HT,:.NG1&U\Q8RS;%D,1<)N;;NV[F
MQD^RU_O1P!/*Y\!\$SR.$Z>23X1X;ED].HI*I3RN638)Y?"HI7ESQPCHQES/
MFYD[ZG%0CF4*-&&<SA4S>%*G'-:E.W)/,HP2QTX<MH\DL4JKCRKELU;0*_QZ
MOAA??$K0/ GBJ[\%?"WX:?$.V\1Z]J6B3+\1/!LGBRVD"7EI=W%B5&HV5J^F
MPRV5E>W.E7ZR)<[9WB5O.>O]A1C@$^@)].WKVK_('^#?@[X#>)OA/\5KWXK?
M%#5?#?BJRN]7A\$^"_#OB7Q!X>UB\>*-KR[\0W1L/#>MZ9?:2D9N=/DMWNK+
M4(KA?M##[,@,OV$.3F7.I./:#2>ZZN,E^!SX]8]X=_V=5P='$\T5&>.H5<10
M4=>:].ABL)4OLU+VMM''EO)..%'\3OVF?'O@GXE^#/%WA#X6Z;X6TK3_  OJ
M6I1^#?!D7AC5=&TKPCX<\+6EA:_;X]6$FJPV>DZ-I=W/+XB37-6MY+[4H-/N
M;2+5OLP_HQ^,'B2/PA^P[_P0T\2SSBUCT']EKXZ:LTS:='JR1_8_&OPGE#RZ
M7++"E_#N4">U,T321%Q&ZR;37\M'P]^%?PO\+^"?B7JVK_$L1?%&QM-'NO#^
MD:AJ?BYSX[DN=;M='\3V.GV-]X;MHQJ-KIE[#KDT^K:C:V<>F:!>P"6YU&XL
M+1_Z7?VJ6/\ P[M_X(N(.-W['7[1#=1_#XO^$W^.?;O5QJ*E5A5HJ<'2J0JQ
M<Y)^]"49Q=X1IM*Z5W>^[36EM,K_ +2C:688C 8BJI0=-X'"UL+3BE3C[135
M;'XV4VZBE*#C*ERP<82C*5ZDORP\4_M??L\6S^(_#;Z%KFG+K&M:R][]DL-9
MU71O#EWXE^&<OA+5=8\(+J.IPZ[:Z-8:P2L6C-J%KJ":;<W/]FSV\?E0Q^ 6
MG[3O@W_A#K+PY<>*H+;QEX \1^%]>\"^/H?AUK#:-?:3X6T631-'\-7&BPZ_
M#K-Q+H,/^E6%]XLGUJ"_N[^]2_B>"*&0^$/XBT.'6]0<?!73?&-[H=Y:R7FJ
M_:]=E7[4VJ[[6XU&S@N'LW2["K8?9)8EMIV!^60N8VBGO=+2VV2?LS"(VIDO
M);JYN_%$4HMI;I0[3JKP+Y;&&2VB<@1QLS^2JMD'].CQ=G6+PV'G]=R>"CAJ
ML%"CE6>4DJ=54X^SE+ T8T54H5*7/0K4GST*E&U.NH2G3?T?M9NSO'9[1FM[
M:::75O=:V:/V)^%GQ)AT:'3M'UC6-:U6]^)G[+7PKT>R\/7>F-;Z?9ZO9^*%
M\27'B:YDC?\ LZVU."TM9;66PM8UN;2?4(X>+12K?J]\?+SQQ;_&K_@G.O@Z
MY\7V]I-_P2Z\ KXC_P"$3OM3TZ2XL+;QIX@N8+6]NM/21(VE,%Q_9[7D3QBY
M5B@!WL/YK?V7]=L=:^)MU]D\(6O@N6Q%]9WNDVUU?7.VZC<B03B^D=H)X9A+
M&8HA'&,A!&HC45_2A\<;_5H_CS_P33TS3?$EYX;M-:_X)A>$(M3N;6>X@%Q;
M6/C+7I8X9/LT-Q)*_P"\EBME,3HMQ.K, !N7X'BG-*F=9GB:W+1G&$*="C&H
M\14I2C"?/.526(I0KN3K2JSY94::A)J*@E'GEE5J<U2$FYQC'G5Z;:FER]'*
MV[NFM-.9+8_$']KGXKW-E\7=2C?P;^T_=(GB#9=ZA<?'SQUI&E>'I%\/W!$<
MFF:9Y<$EK=WMUI.NQ:?J&IVLR64 NEU6XL9O[/N/U+_8SU'QAJOPO_:CN?&V
MHZ_JNI)%^P)%:7/B.^U#5+L:8OB7XYBVBMKW4_W\]I!*]RBR(!$UR+D@+(9*
M_)O]JGPKHW_"]=935?C]\0-(TK4]?CU/5M&_MW4&O+S48YK'1H[V&PF\*7NF
M7%A%I>F+IUSY]W UM#)HT%M&0LT:?KI^R6;]/!O[8FE7WB=_%ZZ)JO[!VC6.
MOF:[ECU"PMO%'QNDMY[=KZWL[M89FGDG*W%K;R>=+*S1(6J>!,/.AQ=D<YX3
M+Z">986U3"P<:K]^-^9^SC]IO53>G2Y^:^,U6-3PKXXC&MBJK_U;S'W*S3@O
MW3VO.73I;>_0^MOVMM5^U6D%QH_P)\$>+=_A2]L4OM2TZ+48;.+5]0.DPW,F
MF1Z9%>3P6^I7@@M[E)H+PSVX6/6X_)NF?O?^":.N6VN_M-_LU21>$?#_ (+N
M+'7?BM8:CH_ARVM;73X]2MOA)XDM;X0PV5E8VT4(N+9Y8;>**9(6N+@)>7,3
M1>7X_P#M8^*=3^'XLHK>ZL=:C-DD-Y9276LZ1>:+:VNHPZBZ326DEO<364%Y
MFY986>&*>ZF^]Y\BOZ!_P3#>WTO]H#]G37;OQ$GB%+G5/C#KVIZO#;2Q$2_\
M*G\6W5^A@?\ >/+;QA3\B*C[PL0P"!^D87.^(:_^N.$SBCD%#AS"91F=7AK,
M<%CL94S',*+P.)>*^O8:OC\52H?484ZGUFI4P>7PJ2JT)8)5Z4<34I_R3@LC
MQ&!XKX0QSP^<TZT^)N%XYY2QF7Y=A\!@JSS?+987ZOB:&"H5ZOUA2C[.,<3B
MY4N2I#&RH570IS_JB\5R-%H,\H5W,=I-($C.)'*1EQ'&1SO;&Q6'4D&OQJ^(
M&L?%P73:E!XG^)0L)-12,^'SX+\#RW]M;W=^-SO>$Q(T5I:F2-)7W/&JK/+'
M<D.K?I?JO[1?P=O-%AN8?&$8AF@WQM)IFL1G:RY&0U@=IZ#\OJ?S8^+6I_LV
M:KJ,VLGQ+;:==RW%M<*]AHVJY\^"83"<M_9Y:83,C":";S;60.P:%AQ7\QYC
MQ=PSCHTJN7>)G#.505*?,X8_AO'QJ^T<'1KWQM>:A[*TK*%H5%4O44N6%O[B
ME6I2MRXFG%?XZ;UNK/5[KHMG?T:S?@U??&#_ (6?I&HZKXM\<ZAX7N=7AMY_
M"M_X)\)6-O!!/)>1^=<:UIUP-0ACM!/:/,T)DRMG&/+9990_['YSIUA[3Q\]
MONMTQVQ7XQ_!OQ?^RWX'\40Z[8ZYIG]I1RH]IJ!\/:I;7%I,8Y(IY8Y+;2HA
M+-=+M$[S^:[>0F&&TU]C?&;]I_X/ZA\%O&NCZ/XMGN=8U;PAX@TW2UM-+U>)
MOM]UHM[%:G[1+:VZ0XE*DRB0;/OCM3RCC3@_#5HX7'>)O"V;XO&8C"T,.O[4
MX=PM6,ZDU2A2I8? 8F'MZE:K55M'4E+EA!VL<.8YG1RK+,RS"52GB?J&!Q6-
M]BJM.G*K]5P\ZWLE-*7*ZGLU!2Y)<MT^5_"8W[77@SQ5XT7P_INCWZP:-'/=
MW6HV+>&(-?2?58?)32+XW,MK=R:5]AAEU&)C"@%Y;WD]O/OB+QO\4?L\? S7
M/A;X[TNZT>+2]#TB\C:T\16NG?#ZRT'^V=(TVWU!M L)=0CTFUGL5TNZGM[B
M&(7+"X\@QR;S.%C_ ##\4^)M6M;-Y+_5?%=PXG$\LEA\0CI@>RV[?LZ6LET\
MJ7!D96W8+A-P\CJ1Y,OB6^NA,B7WC6.[5+AHI9_BE%-:QLQD2T>:*2ZC:1H&
M423VX=6E5 0$BD##]R?#E5494EBZ#BE*+D\#0E-<UVW[25?G4DY/ED]8VC:W
M*K?Q!5^E%D^*S&GFT^$.)J6*E/#8OZC1\0>(*67N5#ZOR4GEV'X?>7.C46'C
M[:BH>PQ%\1[536(KNI_8CI4J1Z 3(ZH%4<NRKC[IY).!^>*_&/XZ_P#!-OXE
M?%'XK_$'Q]IOQA\'Z7IGBWQ7K^OZ597*>+)KG3[76KU[E("+&*2T=XHS''(;
M=C;R>4N#M K\TX-=\0:AX<@L/[4UK4+FXN(X(;87U]=37,CR1A8X85EDDF9R
M#L6-6+=0"#7]9O[/OQ@\/Z?\+/@MX5O[2[AN(/A[X+TW5]1NVM;*+2-430;%
M)[>^MKZ>&]C2VGS!>3O&I@G#CRWCCDE7Q7Q,_#.K3Q$,^P6"KYS4CEL(XG#T
M9RJ6G"<%&%;V[C%SOSUN2%.G%/VM11N?H^3U.$OI=?6LCXJX!S.CEG!5/#Y_
MAJ^%XFQ\%+%9A&M@ZE*I/+\-E5Y4Z,.:%.=;$2G*2E2HPG#F?\SOQT_9+U;]
MEKP;X4T_6?&ND^-)/%GB">='TG1=7TRVL/[,L'CDW2:M%']J,YNTY@W"+8 Y
MRZU\4_$6XT:XL;^+6_[+C>.WM#:>?IVDV\7E$B*X9ICIMP\TPBD+)$Z')C+E
MMQW+_</\2?ACX#^.EMI;ZSX<^&OQ&T72S=K;#Q#9P:R;.ZE>'S7T[4(H;]+*
M1A"(YU6(E@!NR0NWY,\<_P#!._X*^)4F6Q^!7PSMWG2-9)(]5U/3U8(5(1H[
M&PC#(&R0&XR%;&>*_+^+LESCC/B/&\45LTP&(JYFL)*<_9\D*BPV#H82$HQP
ME/V#7)0CRN"2?Q.\FV_]A_HN_2&\*OHW> W!?@7EW _%M'+>":G$+P5;+\PP
MF.4?[>XHS+B6NHU\ZQRS",G7S.M"K[6I4ZTZ;A2Y(Q_B"TRYTBW\1V?]B_V:
MR7%K=&YCBT_3)3&9'#;VN!I\$D4C;F58%!6V1%,3KNV+]P76L?9?&5Y-=3:I
M<:5$VAM<V5AJUQITD]N-#L0T4%R@G6V)/1Q;R $$;1U'](VA?\$L?A-INK1Z
MG<?!#X07,L$2Q0-?:CK.J%8X\>7"5O=/F"Q*> @RH P .*I^)/\ @EY\ =6U
M?5-0U7X9?$C2=1OI!//<> O&&F3^&F9$2)!IEE>YU"TA*KMBLFTR%;>-% ?!
M517#G#6,R:MBZE>OAZJQ%*G",:/M%RN$E)M^TC'1KM;T[?O& ^FWX4XW,:L\
MRX?XTR["RRO$X-8B>&RK&UZE;$8K#5;R^JYG2JP]G3HR4*\'*HFTDDX\Q_,Y
MX_O+5;.XE?PW\0XW6WCGGNK?X@'R/+ +R3I;/8NZ)<Q#8BO+F%@SJ;@D0+\[
MV[-)-;VX\.?$^6X$MZ\[?\)VJF:"6ZE:P*V[6&;<VMM+:PW#M+)'=R1/=HUO
M'-Y,/]./B_\ X(]_ 76?/V6O[0=H)<DK#/:W7! P,P:).#P3P6ZCGTKR,?\
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MB.-JVEU+<+AL0RQ*TN?Z==8_8D^&^LS23SZ]XJCDDW?<;1\*6)/R@:<H &>
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M>SC;4[.\:,V]S80%T+Q96*,M++')/-=VD-I#<23A5_HS_P"#;;2-2T'XQ?\
M!0K2-8M'L-5T[Q3\-K6]M)'BD>"8:;J<FTO!+-#("DB.KPR21LK*5<YK^=_X
M1?&?QS?^)[LVWQB^*NK73Z%=BX@U77]3CM<7!M8;P(8]0<NABC@A1&C55B15
M4!8XP/Z$/^#:2_GOOBG^WW<WMS/=7UWXD^'TDD]Q+)/-,MM97T!:263<SM&K
MPQ@N^=FU5!5?E^?XNYO[%S>]M*&#V36^-PS^?DSP>*EG:R//_P"U9Y2X/#8%
MTH9='%\T&\RP7+&=7$3M-1A?FDJ47.<N9<D4HGE?Q^^'7B[XD?\ !4;]L'2?
M!VGQZG>Z9%HVLWUN]U#:M'I_VUK"2X3S2/-6&XO;<S*@9HH2\Q!5":^ /VFO
M@/\ %"3QQ:7!^'/BN9&T&P47-O)I,ML\KRW+1;&6ZQLGPT5JQ?;=7++:P&2Z
M'DG[(_:PUK4]'_X*B?M3SZ/J-[IT\UQI2&:PNI[25O)N+IU1I('1RJ3Q)(H)
MVK(BOC*@CYH^/?QM\2^&?BW;:]I?Q7\?)>WO@;^PKZ\U.*/72;">YO8A:1VN
MIRW-OB!&>:SN0JS6-P$EMMCEB/\ -[BBO4HU\S:A7J)YWF4H_5Z&(JN+ABZK
M:F\/S-*?-[B<7S--)-G^N/!4^*J&3^'M7*)9-7H5?"+@66%P^,PN:JK&M2X4
MR53A7Q6 JU5R5I\SA)81RI\BBJ=9R<H_,G@_]F3XI>*+O4HK?P??65UH%YI5
MKJ5KJ^IV6G2V\VJL_P!ED5!#=>=$CVUS'=JC)+:W$%Q8R(+VVG@C^V/ O@'Q
MCX(_;1_8-3Q3H5YHZ:A\</#HTZ2X:!H[P6K6)F:$Q2R/M1)XG!E6,[7 VA@R
MCXAT+XN^(_-NKS4_C%\6+36=9FT]=6;3M6OGCU3^S[JX^P_;+EM0BFE6"&;S
M8O,#,D\]R2"TK,WV=\/O&7B7Q!^VO^PT/$GB37->M-(^-&A26"ZQJ=]J*64)
M:R5S:QW,LOD>9'#%Y@B52^Q0V2,UQ\/U:M3'<DHU8QIYCE4'*M1Q%.$G];A=
MT)UO=JQYKWE!-*+C=WLSU>*Y<6RP7$+S.KDSRV/"7&"E2H83-:6(A)<)8V-5
MX>OBJSHU8/&W<9.G=87E4OWK3C_9!^U+XNT_P/HWA7Q%JEIJUY86VNVMO/'H
MMC_:-[$+Z]LK);MK8S6_^AVKSB>^E60M!;))*L<A4(WR/\7OV@OA38>%(KF/
MQYH0AN+_ $BW5WAO64'4WDCLIW,B6JBVF2.:YA*M)/>6L,LUA!=JIK[/_:#C
MLK[_ (173KR"&[C:_P#.FMKB)987C,L0C+QR(T3XDA8J""5*[L#@GXT^+OP;
M\#WMG<WL?PL^'FIV]V=,BO9M3TBQ9P(YK]W>*T:U>W6Y O90;E$CGE1HXWD9
M+>%$_P ^?I/QX'K_ $AO'O#\3T,\ABZ6&X-Q<,1EV/R;#X3%89\!<-PAA:U/
M.*,H4Z]-T\3.G5HU7*JZD8.B^137^*.73SVED.1U,LGA9T9SQ%&=*IA<=6Q%
M*I]>Q#=:G+ S4W2:=.,U.*4.5RY[2L_E35/V@?ATD&H2:5XHM/$EQI>CZEKN
MH6/AG2=5U6^MM,TFT6]U&Y^RE;1G:RM_,^UVP83VL]O<V=U'#>6T]NOI]G^T
M-\*=/^%]W-JGC"S2Y:WU?[9:VUAJ$]_IMY9V:7MQH^I:39QWU_9:S;6[[9[&
M1&99H;B,NK1L!YQ9?"[1_#=A->^&/A+\,M#U[4;.?2-4@L;&TM+6ZTNYT46T
MUI)>6MDDL]I/</<6%S;R1%9[-I)I%>25]WM>D_#+P5=?#?7+C7_AWX$%_J%[
MJ][=F'0=+NEO)KRVG2ZN[N2>S#7%U=-J&II<22AFDCN9MY;SGS_+67X;PPPL
M<RD\/Q'B,'2RO,HJ>$S[A.6;5JZHPISC*AA\)BJ5/!PG)U*%:DZT:\(QY]5<
M]FGBN):]6E&,J%*O.5&7^U99G4,#"E)\RM4KU*,I8AQBHU*<U"=.3ELF?JI\
M)_\ DG7A/_L%@?E/.*]#KSGX2R(_P[\+A#GRK Q/UX=9Y21T'9@>..?PKT:O
M^B3PB5O"?PP7_5N^"O\ UFLL/RG-/^1GF/\ V'XS_P!2*@AZ'Z'^5?S:?%GX
MC?\ !&#XK:#8:OX4TG_@G+JAO+:Y77X?'7A7P#X%\6+?3*T9D71-;TCPO=)<
M03EI;X:E!OE^95VN=[?TD2Q)/&\4@)1QM8!F4X/HRD$?4$&OR&^*O_!"?_@F
M=\7O$&K^)O$'P'N]%U77=0N]5U0^#/'GC3PM9W&H7\\EU>W*Z?I^LBR@:XN9
M9)GCMX(H59R(XT3"C[ZK]8LO8>QO?WE6Y[=+6</G>Z=]#EI>P?,J_MK.W*Z7
M+?KS7YFNEK.+33ZGYC?!V^_X(Z>!]4-]XH\+_P#!,G1[&QC>6ZOM'M?A7K6O
MW+&!)H?LNEV*ZR;P03^=#/#'91MM:,0-.4=I_OG]IC]CC]F[]O\ \#?LR?%7
MX:7.H6GPH\(?#SXGZ'\*I/AEX&U'3O"0\-?$/5?"S175KX;L=!C@TS2H6\'C
M[-#-H-M;QQR-.C0*P,MGPI_P;T?\$L_"5]'?VWP0\2:L\;*WV?7_ (I>/=2L
MY-ISMEMO[:A216Z,K=1Q7["^ O 7@_X7^#_#OP_\ :!8>%O!GA+2;+0O#7AW
M2T>+3=&TC3X5@L["RB=W,<$$:@*"S,22SLS,27@JF+P]=UZT<'4]V453E25>
MD^>/*W*G7@X-I-N$E%2IR49P<9136LIX>DJ:PJJWAI?$*$UR\O*EKSN3[RE)
MMVOOJ?Q-_$/_ (-O?M6N:IJWAGXXZ1;V-]<W$PAU/0(K24/))*P#>7X-?<T'
MG.(@6/E$# S&N/(8?^#;OQ%!=7,S?'G1]U[<Q7,KP6GF-F*W\B**%3X* 2!!
MB=8<E6N0L\F]RV[^_&BOI(Y_RQC%9)D#<5;F>!K)OS:ABX0N]6[12NWIJQ?6
M9_R4O_ 'Y>=NG;JS^,[]G+_@@AX2^%>L_P!J^*?&?BOQK))%]GDL/!OA*_DN
MY([C<KR2RZ7X2B93)YC>9>2M'Y9VN9XL9'[VZC^P#^R5K/A;X+6GQ ^%NG>-
M/B/\&_@;X?\ A5X2OM8\2:IX?\66O@F&2XNSHUPD>J0J;-=5>=Y[Z;3[J9;D
M3)%-(JB*OU$KY5^/O[&/P'_:1UO1?%7Q&T3Q#;^,?#VG3Z/H_C+P9XQ\2>"?
M$]II%Q,UQ+I1U3P]J%E)<Z>;AWN%M+M)X8YY'EC5'8FO*QV.J8O6.$R[#VDF
MH83"4L)%V37O580J5I:-NTISBW9M72:)5_:\L:EH16MZ5./->R6MY1NM-G+2
M^A_/O\;?^"4_[ /BGXBQWGBS]FFXU:>^U"**>-_C!KMF)3+'B&W58]N'@,5M
M9/LF"A;A)I)E*HDGZC_!K_@GQ^Q#X8\'^)O!OA;X6:/X3M_%FE?"?4?%%AI_
MC?4KG6[BZ\!GQ5<^";:ZOY=9NODTJZU#5Q9&**%;]YIQ*)?+"1>*>*?^#=G_
M ()W^-_%$_B[Q;>_M6Z]JMS>?;IX[W]K?XVKISSAQ(/] MO$]O L>X#]TH"%
M1M((XK[B\%?\$T_V1/ 'PP\3?"?PYX"UV+0/%]QH%WKFN7GC[QM?^.Y[SPH9
MV\,75MXYN=<?Q)82Z UW>/IBV-_!#;M>7C>4QNI]_'0JXG!UJ6(PDY4:].:J
MQK1Q%6-2E5BDXNC44)2C[R^).#C\2BV[''C<+@<SPN(P&94*>+P.*IRP^(PE
M?#4J^'Q&'J>[5IUZ-23ISBXWO"2FIWLVDD?%?[27[!/P,\4WD0N?#OBY+&UC
M\N*%-<NY+E(W42.YN8+B2)T6>1&SF27RM\*!CPO;?LV_L6_ 3X:Z9X7\2>%-
M UG3/'%EIWCV/0+CQ'XG>5/[4\0^!=<TB^GM=+CNKD+!+9W$R>0ZO);QEY1$
M2F^KGQ;_ ."(G[)'QIN;*X\9?$K]LR-+"$00VGA_]KKXQ:#:M$.<3+8ZXLLS
M$XR\DS/@8! KVK]FG_@E?^RA^RIJFF:W\-XOC#KNKZ)!J$.BZA\5/CC\3/BE
M-I#ZK;266IW>FIXR\0:G;VE]>V,T]E->10K,+6>>&)HTFD#>GBL]SO&Y?4RZ
MOC\5]6Q%&KAL326+JI2H8BE.C6C=0_><].<E*,XJ,^9J3L?)X7P\X&P>8/-,
M/PYE5/'1G3K4<2LNPSJTZ]*=.K1G2O?V$Z-2G&5*I3;E3<(N"3/F/4?V9?B_
M8>&;.T?0;*[EAM$5FM-:TWRW(4?,GVF>VD*M@D,8UR.<5\A_$?X$?'F. P67
M@_4%C3$:);^)]/C01JLBQJH75E"JNYC\N/O8X!-?T;#X:^&(H#;6G]L6%NQ9
MG@L]=U6*)W?&7,9NG56P  (PB@  +@#'.W7P/\$7I)N9/$<F22<^(]3P<]>L
MWX<=!TK^99_1IX'47##9QQ;@X\D::]CC\JE)0@K1BIU<EJ2V2O=M2^TF>]_9
ME%:*=5?.#[=X?U^?\S/AK]GSX^75U#;7G@ZY\J)PT;7?BC2Y8XFW,0RQR:NZ
M*4WN 2#C>QZDY^N/!?[+OQ+O_$'@6#Q'I'AR/1#XGT1-8M-8U-+^UNM.N+J.
MVN;6YM-(:6>>&=)BDT:7-L2C-FXA&9%_:"W_ &??AW;2"6)/$08'//B75L=<
M\@3@'GU^E=)8?"/P'87MOJ2:1+=:C:'-K?:AJ6HWT]MQC$ N+IX8^"1N6+?R
M?FY-98'Z,/ .#S'!9I4S3BS&XK 8G"XJA]9S'+(P]I@ZM.M04_JN38>I*,9T
MXW4:L&XKE36ZEY3A)Q<*JE6IRBXSIU53G3J0=E*%2#A:4)J\9P:<91?*U8^&
M_$'_  3?^"7B%I&NOA1\)I'D)9VAN/&=BA;VA2^NP@!["0_7BN''_!*KX()(
M)(?A7\*8B"&!EO?&]R 1R#L^TP@\@'&\?7N/U<BLK>$8C0@  #))QBK7^?6O
MZ7^NXVUOKF+MV^LUDON4[=#PGX>>'[G[1\"<&2FG?FEPMD3=UYO 7/S?\+?L
M!:'X-UK1]?\ "UC\*O#6I:%+-+IT^F>$-<N9XS<6[VSDW.I>(YRDH20[)HXE
M93@[>HKUBQ_97N$G-S?>)+$S;96<VMI=K]JFEB>,FX83POY!+^88E8ON5<3
M Y^R**^"SWP_X5XES.EG&=Y=4QV/I4U3C5GC\PA%P47&*E2IXJ%)N*D^5\M[
MN[N]3[[(\PJ\-9?+*\@H8#*,OE-U'A<ORW 86ESOEYI*%'#P7-)0BG*W-RQ4
M;I))>;?#3X?CX>Z/)IOVZ._DFD#O+%!+;QA5:5U58Y;FY<G?-*Q9Y&;D*"%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ycbd_10klogo.jpg
<TEXT>
begin 644 ycbd_10klogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !% .L# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[+HI,T;J
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M .>@^9?S[5U?5</)\L9ZG#_:6*A^\G"T?0^DQ*LB;E8.#R"*\'^)7_(]2_\
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MX=PZ/-'J&J2+<WJ\J /DC^GJ?>M85,/A(-PES29%2CB,;4C[6'+%&AX-\/\
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5WWI=@HHH -HI=M%% !MI:** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132004996768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 16, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001644903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">cbdMD, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3414576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2101 Westinghouse Blvd., Suite A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Charlotte<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">28273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">445-3060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,832,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,539,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Cherry Bekaert LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Charlotte, North Carolina<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ycbd_SeriesACumulativeConvertiblePreferredStockMember', window );">Series A Cumulative Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">8% Series A Cumulative Convertible Preferred Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">YCBDpA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">common<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">YCBD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ycbd_SeriesACumulativeConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ycbd_SeriesACumulativeConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999576384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,452,553<span></span>
</td>
<td class="nump">$ 1,797,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable</a></td>
<td class="nump">983,910<span></span>
</td>
<td class="nump">1,216,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory</a></td>
<td class="nump">2,365,187<span></span>
</td>
<td class="nump">4,052,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_PrepaidInventory', window );">Inventory prepaid</a></td>
<td class="nump">159,006<span></span>
</td>
<td class="nump">182,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_PrepaidSponsorship', window );">Prepaid sponsorship</a></td>
<td class="nump">21,754<span></span>
</td>
<td class="nump">70,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">406,674<span></span>
</td>
<td class="nump">750,383<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,389,084<span></span>
</td>
<td class="nump">8,070,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">454,268<span></span>
</td>
<td class="nump">716,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">85,817<span></span>
</td>
<td class="nump">3,350,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits for facilities</a></td>
<td class="nump">62,708<span></span>
</td>
<td class="nump">138,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">2,889,580<span></span>
</td>
<td class="nump">3,219,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Investment in other securities, noncurrent</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Total other assets</a></td>
<td class="nump">4,192,373<span></span>
</td>
<td class="nump">8,125,242<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">10,581,457<span></span>
</td>
<td class="nump">16,195,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,541,108<span></span>
</td>
<td class="nump">1,906,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">632,674<span></span>
</td>
<td class="nump">632,195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Accrued dividends</a></td>
<td class="nump">4,671,000<span></span>
</td>
<td class="nump">667,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred Revenue</a></td>
<td class="nump">503,254<span></span>
</td>
<td class="nump">185,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating leases &#8211; current portion</a></td>
<td class="nump">98,696<span></span>
</td>
<td class="nump">1,277,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible notes, at fair value</a></td>
<td class="nump">1,171,308<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Note payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,492<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">8,618,040<span></span>
</td>
<td class="nump">4,670,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent', window );">Long term liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating leases - long term portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,403,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">90,363<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,493,658<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">8,618,040<span></span>
</td>
<td class="nump">7,163,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 11)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>cbdMD, Inc. shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, authorized 50,000,000 shares, $0.001 par value, 5,000,000 and 5,000,000 shares issued and outstanding, respectively</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, authorized 150,000,000 shares, $0.001 par value, 3,939,057 and 2,960,573 shares issued and outstanding, respectively</a></td>
<td class="nump">3,939<span></span>
</td>
<td class="nump">2,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">184,029,565<span></span>
</td>
<td class="nump">183,387,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Comprehensive other expense</a></td>
<td class="num">(7,189)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(182,067,898)<span></span>
</td>
<td class="num">(174,363,772)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total cbdMD, Inc. shareholders' equity</a></td>
<td class="nump">1,963,417<span></span>
</td>
<td class="nump">9,031,284<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 10,581,457<span></span>
</td>
<td class="nump">$ 16,195,283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_PrepaidInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for inventory that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_PrepaidInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_PrepaidSponsorship">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for sponsorships.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_PrepaidSponsorship</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102874400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding, Ending Balance (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">3,939,057<span></span>
</td>
<td class="nump">2,960,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">3,939,057<span></span>
</td>
<td class="nump">2,960,573<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132005364192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Gross Sales</a></td>
<td class="nump">$ 19,922,319<span></span>
</td>
<td class="nump">$ 25,053,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_SalesAllowances', window );">Allowances</a></td>
<td class="num">(440,152)<span></span>
</td>
<td class="num">(898,495)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Net Sales</a></td>
<td class="nump">19,482,167<span></span>
</td>
<td class="nump">24,155,362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">7,486,626<span></span>
</td>
<td class="nump">9,177,703<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">11,995,541<span></span>
</td>
<td class="nump">14,977,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_OperatingExpensesExcludingImpairment', window );">Operating expenses</a></td>
<td class="nump">15,310,951<span></span>
</td>
<td class="nump">24,246,208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment of goodwill and other intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,219,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(3,315,410)<span></span>
</td>
<td class="num">(22,487,549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments', window );">Realized and unrealized loss on marketable and other securities, including impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Decrease of contingent liability</a></td>
<td class="nump">74,580<span></span>
</td>
<td class="nump">185,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_FairValueAdjustmentOfDebt', window );">Increase in fair value of convertible debt</a></td>
<td class="num">(429,789)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest (expense) income</a></td>
<td class="num">(29,507)<span></span>
</td>
<td class="nump">63,702<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before provision for income taxes</a></td>
<td class="num">(3,700,126)<span></span>
</td>
<td class="num">(22,938,209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit (expense) for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(3,700,126)<span></span>
</td>
<td class="num">(22,938,209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred dividends</a></td>
<td class="nump">4,004,001<span></span>
</td>
<td class="nump">4,002,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss attributable to common shareholders</a></td>
<td class="num">$ (7,704,127)<span></span>
</td>
<td class="num">$ (26,940,209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and Diluted loss per share (in dollars per share)</a></td>
<td class="num">$ (1.79)<span></span>
</td>
<td class="num">$ (13.32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares Basic and Diluted: (in shares)</a></td>
<td class="nump">4,312,546<span></span>
</td>
<td class="nump">2,022,320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_FairValueAdjustmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_FairValueAdjustmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_OperatingExpensesExcludingImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Excludes impairment of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_OperatingExpensesExcludingImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_SalesAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sales allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_SalesAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132112794624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (3,700,126)<span></span>
</td>
<td class="num">$ (22,938,209)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments', window );">Comprehensive Loss</a></td>
<td class="num">(3,700,126)<span></span>
</td>
<td class="num">(22,938,209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred dividends</a></td>
<td class="num">(4,004,001)<span></span>
</td>
<td class="num">(4,002,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Loss available to common shareholders</a></td>
<td class="num">$ (7,704,127)<span></span>
</td>
<td class="num">$ (26,940,209)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax before income adjustments of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132005207872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (3,700,126)<span></span>
</td>
<td class="num">$ (22,938,209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock based compensation</a></td>
<td class="nump">5,015<span></span>
</td>
<td class="nump">233,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockExpense', window );">Restricted stock expense</a></td>
<td class="nump">11,885<span></span>
</td>
<td class="nump">109,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_WriteOffOfPrepaidAssets', window );">Write off of prepaid assets due to termination of contractual obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">884,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory and materials impairment</a></td>
<td class="nump">921,314<span></span>
</td>
<td class="nump">175,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangibles amortization</a></td>
<td class="nump">697,510<span></span>
</td>
<td class="nump">1,396,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">452,326<span></span>
</td>
<td class="nump">404,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment of goodwill and other intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,219,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Increase/(Decrease) in contingent liability</a></td>
<td class="num">(74,580)<span></span>
</td>
<td class="num">(185,638)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_FairValueAdjustmentOfDebt', window );">Increase in fair value of convertible debt</a></td>
<td class="nump">429,789<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_OtherthantemporaryImpairmentsOnOtherInvestments', window );">Other-than-temporary impairment on other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Gain on termination of operating lease</a></td>
<td class="nump">696,280<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease asset</a></td>
<td class="nump">670,621<span></span>
</td>
<td class="nump">1,126,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">232,180<span></span>
</td>
<td class="nump">278,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDepositOtherAssets', window );">Deposits</a></td>
<td class="nump">76,000<span></span>
</td>
<td class="nump">105,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">766,472<span></span>
</td>
<td class="nump">27,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_IncreaseDecreaseInPrepaidInventoryTotal', window );">Prepaid inventory</a></td>
<td class="nump">23,670<span></span>
</td>
<td class="nump">328,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">396,311<span></span>
</td>
<td class="nump">2,095,323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(1,124,141)<span></span>
</td>
<td class="num">(1,290,141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(1,151,326)<span></span>
</td>
<td class="num">(1,178,683)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue / customer deposits</a></td>
<td class="nump">318,008<span></span>
</td>
<td class="nump">203,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable', window );">Collection on discontinued operations accounts receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,375<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash used by operating activities</a></td>
<td class="num">(352,792)<span></span>
</td>
<td class="num">(4,302,051)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments', window );">Proceeds from sale of other investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(190,015)<span></span>
</td>
<td class="num">(297,549)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash (used) provided by investing activities</a></td>
<td class="num">(290,015)<span></span>
</td>
<td class="nump">702,451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">50,001<span></span>
</td>
<td class="nump">2,478,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable', window );">Note payable</a></td>
<td class="nump">1,247,499<span></span>
</td>
<td class="num">(132,599)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock', window );">Preferred dividend distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,668,500)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash provided (used) by financing activities</a></td>
<td class="nump">1,297,500<span></span>
</td>
<td class="num">(1,322,774)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash</a></td>
<td class="nump">654,693<span></span>
</td>
<td class="num">(4,922,374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents, beginning of year</a></td>
<td class="nump">1,797,860<span></span>
</td>
<td class="nump">6,720,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents, end of year</a></td>
<td class="nump">2,452,553<span></span>
</td>
<td class="nump">1,797,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Cash Payments for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest expense</a></td>
<td class="nump">74,638<span></span>
</td>
<td class="nump">6,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash financial/investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest', window );">Issuance of shares for conversion of debt and accrued interest</a></td>
<td class="nump">515,601<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of shares for intangible asset</a></td>
<td class="nump">40,725<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_PreferredDividendsAccruedNotYetPaid', window );">Preferred dividends accrued but not paid</a></td>
<td class="nump">$ 4,004,001<span></span>
</td>
<td class="nump">$ 667,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479092/842-20-40-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDepositOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of accounts receivable collected from discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_FairValueAdjustmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_FairValueAdjustmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_IncreaseDecreaseInPrepaidInventoryTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the increase (decrease) in prepaid inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_IncreaseDecreaseInPrepaidInventoryTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proceeds from the issuance of shares for the conversion of debt and accrued interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_OtherthantemporaryImpairmentsOnOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other0than-temporary impairment on other investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_OtherthantemporaryImpairmentsOnOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_PreferredDividendsAccruedNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the value of dividends accrued but not paid for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_PreferredDividendsAccruedNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_WriteOffOfPrepaidAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prepaid assets written off during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_WriteOffOfPrepaidAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131977272800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity - USD ($)<br></strong></div></th>
<th class="th">
<div>Share-Based Payment Arrangement, Option [Member] </div>
<div>Common Stock [Member]</div>
</th>
<th class="th">
<div>Share-Based Payment Arrangement, Option [Member] </div>
<div>Preferred Stock [Member]</div>
</th>
<th class="th">
<div>Share-Based Payment Arrangement, Option [Member] </div>
<div>AOCI Attributable to Parent [Member]</div>
</th>
<th class="th">
<div>Share-Based Payment Arrangement, Option [Member] </div>
<div>Additional Paid-in Capital [Member]</div>
</th>
<th class="th">
<div>Share-Based Payment Arrangement, Option [Member] </div>
<div>Retained Earnings [Member]</div>
</th>
<th class="th"><div>Share-Based Payment Arrangement, Option [Member]</div></th>
<th class="th">
<div>Commitment Shares [Member] </div>
<div>Common Stock [Member]</div>
</th>
<th class="th">
<div>Commitment Shares [Member] </div>
<div>Preferred Stock [Member]</div>
</th>
<th class="th">
<div>Commitment Shares [Member] </div>
<div>AOCI Attributable to Parent [Member]</div>
</th>
<th class="th">
<div>Commitment Shares [Member] </div>
<div>Additional Paid-in Capital [Member]</div>
</th>
<th class="th">
<div>Commitment Shares [Member] </div>
<div>Retained Earnings [Member]</div>
</th>
<th class="th"><div>Commitment Shares [Member]</div></th>
<th class="th">
<div>Public Offering [Member] </div>
<div>Common Stock [Member]</div>
</th>
<th class="th">
<div>Public Offering [Member] </div>
<div>Preferred Stock [Member]</div>
</th>
<th class="th">
<div>Public Offering [Member] </div>
<div>AOCI Attributable to Parent [Member]</div>
</th>
<th class="th">
<div>Public Offering [Member] </div>
<div>Additional Paid-in Capital [Member]</div>
</th>
<th class="th">
<div>Public Offering [Member] </div>
<div>Retained Earnings [Member]</div>
</th>
<th class="th"><div>Public Offering [Member]</div></th>
<th class="th">
<div>Capital Raise [Member] </div>
<div>Common Stock [Member]</div>
</th>
<th class="th">
<div>Capital Raise [Member] </div>
<div>Preferred Stock [Member]</div>
</th>
<th class="th">
<div>Capital Raise [Member] </div>
<div>AOCI Attributable to Parent [Member]</div>
</th>
<th class="th">
<div>Capital Raise [Member] </div>
<div>Additional Paid-in Capital [Member]</div>
</th>
<th class="th">
<div>Capital Raise [Member] </div>
<div>Retained Earnings [Member]</div>
</th>
<th class="th"><div>Capital Raise [Member]</div></th>
<th class="th">
<div>Commitment Shares [Member] </div>
<div>Common Stock [Member]</div>
</th>
<th class="th">
<div>Commitment Shares [Member] </div>
<div>Preferred Stock [Member]</div>
</th>
<th class="th">
<div>Commitment Shares [Member] </div>
<div>AOCI Attributable to Parent [Member]</div>
</th>
<th class="th">
<div>Commitment Shares [Member] </div>
<div>Additional Paid-in Capital [Member]</div>
</th>
<th class="th">
<div>Commitment Shares [Member] </div>
<div>Retained Earnings [Member]</div>
</th>
<th class="th"><div>Commitment Shares [Member]</div></th>
<th class="th">
<div>Conversion of Notes into Common Stock [Member] </div>
<div>Common Stock [Member]</div>
</th>
<th class="th">
<div>Conversion of Notes into Common Stock [Member] </div>
<div>Preferred Stock [Member]</div>
</th>
<th class="th">
<div>Conversion of Notes into Common Stock [Member] </div>
<div>AOCI Attributable to Parent [Member]</div>
</th>
<th class="th">
<div>Conversion of Notes into Common Stock [Member] </div>
<div>Additional Paid-in Capital [Member]</div>
</th>
<th class="th">
<div>Conversion of Notes into Common Stock [Member] </div>
<div>Retained Earnings [Member]</div>
</th>
<th class="th"><div>Conversion of Notes into Common Stock [Member]</div></th>
<th class="th">
<div>Majik Medicines [Member] </div>
<div>Common Stock [Member]</div>
</th>
<th class="th">
<div>Majik Medicines [Member] </div>
<div>Preferred Stock [Member]</div>
</th>
<th class="th">
<div>Majik Medicines [Member] </div>
<div>AOCI Attributable to Parent [Member]</div>
</th>
<th class="th">
<div>Majik Medicines [Member] </div>
<div>Additional Paid-in Capital [Member]</div>
</th>
<th class="th">
<div>Majik Medicines [Member] </div>
<div>Retained Earnings [Member]</div>
</th>
<th class="th"><div>Majik Medicines [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,348,125<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,348<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 178,841,646<span></span>
</td>
<td class="num">$ (147,423,563)<span></span>
</td>
<td class="nump">$ 31,424,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of options for share based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 79,446<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 79,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock for share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">43,449<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">43,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred dividend declared, not paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000,502)<span></span>
</td>
<td class="num">(1,000,502)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,956,062)<span></span>
</td>
<td class="num">(3,956,062)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_DecreaseInApicIssuanceOfStock', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,349,163<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,349<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">178,964,539<span></span>
</td>
<td class="num">(152,380,127)<span></span>
</td>
<td class="nump">26,590,761<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,348,125<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,348<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">178,841,646<span></span>
</td>
<td class="num">(147,423,563)<span></span>
</td>
<td class="nump">$ 31,424,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Fractional share true-up (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,218<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,855,229<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,855<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">183,212,202<span></span>
</td>
<td class="num">(157,488,334)<span></span>
</td>
<td class="nump">$ 25,731,723<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,348,125<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,348<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">178,841,646<span></span>
</td>
<td class="num">(147,423,563)<span></span>
</td>
<td class="nump">31,424,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,938,209)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,960,573<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,961<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">183,387,095<span></span>
</td>
<td class="num">(174,363,772)<span></span>
</td>
<td class="nump">9,031,284<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,349,163<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,349<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">178,964,539<span></span>
</td>
<td class="num">(152,380,127)<span></span>
</td>
<td class="nump">26,590,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,616<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,417<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29,190<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of options for share based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,770<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock for share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">56,801<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">56,801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred dividend declared, not paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000,500)<span></span>
</td>
<td class="num">(1,000,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,336,802)<span></span>
</td>
<td class="num">(1,336,802)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_DecreaseInApicIssuanceOfStock', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of Common stock - A360 (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,277<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of Common stock - A360</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,399,906<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of Common stock - DCO (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of Common stock - DCO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29,998<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockSplits', window );">Roundup fractional shares resulting from reverse split (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,456,696<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,457<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 180,497,196<span></span>
</td>
<td class="num">$ (154,717,429)<span></span>
</td>
<td class="nump">$ 25,786,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,472,730<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,474,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">69,606<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">69,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of options for share based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,663<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock for share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,845<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred dividend declared, not paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000,501)<span></span>
</td>
<td class="num">(1,000,501)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,770,404)<span></span>
</td>
<td class="num">(1,770,404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of Common stock - A360</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 133,200<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 133,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Fractional share true-up (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,533<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_StockIssuedDuringPeriodValueReverseStockSplits', window );">Fractional share true-up</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,855,229<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,855<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">183,212,202<span></span>
</td>
<td class="num">(157,488,334)<span></span>
</td>
<td class="nump">25,731,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,232<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 97,338<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 97,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(112)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of options for share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">33,171<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">33,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock for share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,996<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred dividend declared, not paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000,497)<span></span>
</td>
<td class="num">(1,000,497)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(15,874,941)<span></span>
</td>
<td class="num">(15,874,941)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_DecreaseInApicIssuanceOfStock', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Maxim transaction expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 40,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 40,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,960,573<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,961<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">183,387,095<span></span>
</td>
<td class="num">(174,363,772)<span></span>
</td>
<td class="nump">9,031,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of options for share based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,772<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock for share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred dividend declared, not paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000,501)<span></span>
</td>
<td class="num">(1,000,501)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(996,501)<span></span>
</td>
<td class="num">(996,501)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,961,056<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,961<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">183,389,556<span></span>
</td>
<td class="num">(176,360,774)<span></span>
</td>
<td class="nump">7,036,743<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,960,573<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,961<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">183,387,095<span></span>
</td>
<td class="num">(174,363,772)<span></span>
</td>
<td class="nump">9,031,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,700,126)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,939,057<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,939<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="num">(7,189)<span></span>
</td>
<td class="nump">184,029,565<span></span>
</td>
<td class="num">(182,067,898)<span></span>
</td>
<td class="nump">1,963,417<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,961,056<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,961<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">183,389,556<span></span>
</td>
<td class="num">(176,360,774)<span></span>
</td>
<td class="nump">7,036,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,218<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,930<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 49,936<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,763<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,783<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of options for share based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,080<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock for share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred dividend declared, not paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000,500)<span></span>
</td>
<td class="num">(1,000,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,010,562)<span></span>
</td>
<td class="num">(3,010,562)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk', window );">Change in far value of debt related to credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk', window );">Change in far value of debt related to credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ (0)<span></span>
</td>
<td class="nump">$ (0)<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,045,204<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,045<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="nump">183,456,639<span></span>
</td>
<td class="num">(180,371,836)<span></span>
</td>
<td class="nump">3,086,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of options for share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,376<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5.376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock for share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,167<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7.167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred dividend declared, not paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000,500)<span></span>
</td>
<td class="num">(1,000,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">459,737<span></span>
</td>
<td class="nump">459,737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk', window );">Change in far value of debt related to credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk', window );">Change in far value of debt related to credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ (0)<span></span>
</td>
<td class="nump">$ (0)<span></span>
</td>
<td class="num">(4,800)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of Common Stock, Convertible Notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">714,229<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of Common Stock, Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 714<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 463,980<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 464,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Jun. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,759,433<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,759<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="num">(1,200)<span></span>
</td>
<td class="nump">183,933,162<span></span>
</td>
<td class="num">(180,912,600)<span></span>
</td>
<td class="nump">3,028,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 40,725<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 40,800<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of options for share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock for share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,727<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3.727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred dividend declared, not paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,002,500)<span></span>
</td>
<td class="num">(1,002,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(152,798)<span></span>
</td>
<td class="num">(152,798)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk', window );">Change in far value of debt related to credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,989)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,989)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk', window );">Change in far value of debt related to credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ (0)<span></span>
</td>
<td class="nump">$ (0)<span></span>
</td>
<td class="nump">5,989<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">5,989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of Common Stock, Convertible Notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,624<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of Common Stock, Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 50,875<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 50,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_DecreaseInApicIssuanceOfStock', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,939,057<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,939<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="num">$ (7,189)<span></span>
</td>
<td class="nump">$ 184,029,565<span></span>
</td>
<td class="num">$ (182,067,898)<span></span>
</td>
<td class="nump">$ 1,963,417<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of a stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_DecreaseInApicIssuanceOfStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the decrease in APIC related to he issuance of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_DecreaseInApicIssuanceOfStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity impact on other comprehensive income loss due to changes in fair value of debt related to credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_StockIssuedDuringPeriodValueReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>value of equity increase resulting from reverse stock splits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_StockIssuedDuringPeriodValueReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131977332736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingArrLineItems', window );"><strong>Insider Trading Arr Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingArrLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingArrLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999418432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Organization and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">1</em> </b>&#8211;<b> ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Organization and Nature of Business</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">cbdMD, Inc. ("cbdMD", "we", "us", &#8220;our&#8221;, or the &#8220;Company&#8221;) is a North Carolina corporation formed on <em style="font: inherit;"> March 17, 2015 </em>as Level Beauty Group, Inc. In <em style="font: inherit;"> November 2016 </em>we changed the name of the Company to Level Brands, Inc. and on <em style="font: inherit;"> May 1, 2019 </em>we changed the name of our Company to cbdMD, Inc. We operate from our offices located in Charlotte, North Carolina. Our fiscal year end is established as <em style="font: inherit;"> September 30.</em><br/> &#160;<br/> There have been <em style="font: inherit;">no</em> material changes in the Company's significant accounting policies from those previously disclosed in the <em style="font: inherit;">2023</em> <em style="font: inherit;">10</em>-K.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The accompanying unaudited interim condensed consolidated financial statements of cbdMD have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;) and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the <em style="font: inherit;">2024</em>&#160;<em style="font: inherit;">10</em>-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of consolidated financial position and the consolidated results of operations for the interim periods presented have been reflected herein.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Reverse Stock Split</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> April 12, 2023, </em>the board effected a reverse stock split at a ratio of <em style="font: inherit;">one</em>-for-<span style="-sec-ix-hidden:c121825181">forty</span>-five, effective as of <em style="font: inherit;"> April 24, 2023. </em>Unless otherwise indicated, all share numbers in this filing, including shares of common stock and all securities convertible into, or exercisable for, shares of common stock, give effect to the reverse stock split.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Principles of Consolidation</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries CBDI, Paw CBD, Proline Global, and Therapeutics. All material intercompany transactions and balances have been eliminated in consolidation.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Use of Estimates</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's consolidated financial statements have been prepared in accordance with US GAAP and requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Significant estimates made in the accompanying consolidated financial statements include, but are <em style="font: inherit;">not</em> limited to, allowances for doubtful accounts, inventory valuation reserves, certain assumptions related to the valuation of investments other securities, and acquired intangible and long-lived assets and the recoverability of intangible and long-lived assets.&#160;Actual results could differ from these estimates.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Cash and Cash Equivalents</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For financial statements purposes, the Company considers all highly liquid investments with a maturity of less than <em style="font: inherit;">three</em> months when purchased to be cash equivalents.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Accounts Receivable</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Accounts receivables are stated at cost less an allowance for credit losses, if applicable. Credit is extended to customers after an evaluation of the customer&#8217;s financial condition, and generally collateral is <em style="font: inherit;">not</em> required as a condition of credit extension. Management&#8217;s determination of the allowance for credit losses&#160;is based on an evaluation of the receivables, past experience, current economic conditions, and other risks inherent in the receivables portfolio. As of <em style="font: inherit;"> September 30, 2024</em> and <em style="font: inherit;"> September 30, 2023</em>, we had an allowance for credit losses&#160;of $346,197&#160;and $42,180, respectively.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p><p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"></p>


   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Merchant Receivable</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company primarily sells its products through the internet and has an arrangement to process customer payments with multiple <em style="font: inherit;">third</em>-party payment processors. The Company pays a fee between 2.5% and 4.0% of the transaction amounts processed. Pursuant to these agreements, there can be a waiting period between <em style="font: inherit;">2</em> to <em style="font: inherit;">5</em> days prior to reimbursement to the Company, as well as a calculated reserve which some payment processors hold back. Fees and reserves can change periodically with notice from the processors. At <em style="font: inherit;"> September 30, 2024, </em>the receivable from payment processors included $621,678&#160;for the waiting period amount and is recorded as accounts receivable in the accompanying consolidated balance sheet.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p><p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"></p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Inventory</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Inventory is stated at the lower of cost or net realizable value with cost being determined on a weighted average basis. The cost of inventory includes product cost, freight-in, and production fill and labor (portions of which we outsource to <em style="font: inherit;">third</em> party manufacturers). Write-offs of potentially slow moving or damaged inventory are recorded based on management&#8217;s analysis of inventory levels, forecasted future sales volume and pricing and through specific identification of obsolete or damaged products. We assess inventory quarterly for slow moving products and potential impairments and at a minimum perform a physical inventory count annually near fiscal year end.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Customer Deposits</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Customer deposits consist of payments received in advance of revenue recognition. Revenue is recognized as revenue recognition criteria are met.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Property and Equipment</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Property and equipment items are stated at cost less accumulated depreciation. Expenditures for routine maintenance and repairs are charged to operations as incurred. Depreciation is charged to expense over the estimated useful lives of the assets using the straight-line method. Generally, the useful lives are <span style="-sec-ix-hidden:c121825195">five</span> years for manufacturing equipment and automobiles and <span style="-sec-ix-hidden:c121825196">three</span> years for software, computer, and furniture and equipment. The useful life for leasehold improvements are over the term of the lease or expected life of the asset, whichever is less. The cost and accumulated depreciation of property are eliminated from the accounts upon disposal, and any resulting gain or loss is included in the consolidated statements of operations for the applicable period. Long-lived assets held and used by the Company are reviewed for impairment whenever changes in circumstance indicate the carrying value of an asset <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Fair Value Accounting</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company utilizes accounting standards for fair value, which include the definition of fair value, the framework for measuring fair value, and disclosures about fair value measurements. Fair value is a market-based measurement, <em style="font: inherit;">not</em> an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, fair value accounting standards establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels <em style="font: inherit;">1</em> and <em style="font: inherit;">2</em> of the hierarchy) and the reporting entity&#8217;s own assumptions about market participant assumptions (unobservable inputs classified within Level <em style="font: inherit;">3</em> of the hierarchy).</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Level <em style="font: inherit;">1</em> inputs utilize quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Level <em style="font: inherit;">2</em> inputs are inputs other than quoted prices included in Level <em style="font: inherit;">1</em> that are directly or indirectly observable for the asset or liability. Level <em style="font: inherit;">2</em> inputs <em style="font: inherit;"> may </em>include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability. Level <em style="font: inherit;">3</em> inputs are unobservable inputs for the asset or liability, which are based on an entity&#8217;s own assumptions, as there is little, if any, observable market activity. In instances where the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">When the Company records an investment in marketable securities the carrying value is&#160;recorded at fair value. Any changes in fair value for marketable securities during a given period will be recorded as an unrealized gain or loss in the consolidated statement of operations. For investments other securities without a readily determinable fair value, the Company <em style="font: inherit;"> may </em>elect to estimate its fair value at cost less impairment plus or minus changes resulting from observable price changes. The Company has elected the fair value method and will make individual determinations on and instrument by instrument basis.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>


   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Intangible Assets</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's intangible assets consist of trademarks and other intellectual property, all of which were previously accounted for in accordance with Accounting Standards Codification (ASC) Topic <em style="font: inherit;">350,</em> <i>Intangibles </i>&#8211;<i> Goodwill and Other</i>. The Company employed&#160;the non-amortization approach to account for purchased intangible assets having indefinite lives. Under the non-amortization approach, intangible assets having indefinite lives were <em style="font: inherit;">not</em> amortized into the results of operations, but instead were reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value. We previously performed an annual impairment analysis each fiscal year on the indefinite-lived intangible assets following the steps laid out in ASC <em style="font: inherit;">350</em>-<em style="font: inherit;">30</em>-<em style="font: inherit;">35</em>-<em style="font: inherit;">18.</em> Our annual impairment analysis included a qualitative assessment to determine if it was&#160;necessary to perform the quantitative impairment test. In performing a qualitative assessment, we reviewed events and circumstances that could affect the significant inputs used to determine if the fair value was less than the carrying value of the intangible assets. If a quantitative analysis was necessary, we would analyze various aspects including revenues from the business, associated with the intangible assets. In addition, intangible assets would be tested on an interim basis if an event or circumstance indicates that it is more likely than <em style="font: inherit;">not</em> that an impairment loss has been incurred. The Company analyzed a variety of factors on its business to determine if a circumstance could trigger an impairment loss, and, at the time and based on the information then known, had determined that is it was more likely than <em style="font: inherit;">not</em> that an impairment loss had occurred. See Note <em style="font: inherit;">5</em> more further information on the impairment testing procedures performed at <em style="font: inherit;"> December 31, 2022&#160;</em>and the Company&#8217;s decision to change from indefinite to definite lived status for its trademarks.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company now accounts for its trademarks in accordance with Accounting Standards Codification (ASC) Topic <em style="font: inherit;">360,</em> Property, Plant and Equipment. The Company began amortizing its trademarks over <em style="font: inherit;">20</em> years beginning <em style="font: inherit;"> January 1, 2023&#160;</em>and will perform impairment tests as prescribed by ASC <em style="font: inherit;">360,</em> which states that impairment testing should be completed whenever events or changes in circumstances indicate that the asset group's&#160;carrying value <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable. If there are indications that the asset group's&#160;carrying value <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable, there are <em style="font: inherit;">two</em> further steps involved in long-lived asset impairment testing. Step I of the impairment test, as per ASC <em style="font: inherit;">360,</em> involves estimating the recoverable amount of the asset group and determining the potential for impairment. Step II of the impairment test, as per ASC <em style="font: inherit;">360,</em> if necessary, involves quantifying the fair value of the asset group. As further outlined in Note <em style="font: inherit;">5,</em> during <em style="font: inherit;"> July </em>of fiscal <em style="font: inherit;">2023,</em> the Company determined that based on regulatory uncertainty and ongoing Company performance it was prudent to change the amortization of the &#8220;cbdMD&#8221; and &#8220;directCBDonline&#8221; trademarks to 5 years and &#8220;hempMD&#8221; trademark to 10 years.&#160; This became a triggering event for an impairment test under <em style="font: inherit;">ASC360</em> which resulted in an impairment of the intangibles in <em style="font: inherit;"> July 2023.&#160; </em>As of the end of the <em style="font: inherit;">fourth</em> quarter and fiscal <em style="font: inherit;">2023,</em> a significant decline in market capitalization of both classes of equity as a result of the proxy vote triggered a subsequent impairment test, resulting in additional impairment during the <em style="font: inherit;">fourth</em> quarter of <em style="font: inherit;">2023.</em></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Contingent Liability</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A significant component of the purchase price consideration for the Company&#8217;s acquisition of Cure Based Development includes a fixed number of future shares to be issued as well as a variable number of future shares to be issued based upon the post-acquisition entity reaching certain specified future revenue targets, as further described in Note <em style="font: inherit;">6.</em> The Company made a determination of the fair value of the contingent liabilities as part of the valuation of the assets acquired and liabilities assumed in the business combination.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Revenue Recognition</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Under ASC <em style="font: inherit;">606,</em> <i>Revenue from Contracts with Customers, </i>the Company recognizes revenues when its customer obtains control of promised goods or services, in an amount that reflects the consideration which it expects to receive in exchange for those goods. The Company recognizes revenues following the <em style="font: inherit;">five</em>-step model prescribed under ASC <em style="font: inherit;">606:</em> (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Performance Obligations</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A performance obligation is a promise in a contract to transfer a distinct good or service to a customer. The Company meets that obligation when it has shipped products which have been ordered&#160;by the customer. The Company has reviewed its various revenue streams for its other contracts under the <em style="font: inherit;">five</em>-step approach.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Allocation of Transaction Price</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In the Company&#8217;s current business model, it does <span style="-sec-ix-hidden:c121825240">not</span> have contracts with customers which have multiple elements as revenue is driven purely by online product sales or purchase order-based product sales.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Revenue Recognition</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company records revenue from the sale of its products when risk of loss and title to the product are transferred to the customer, which is upon shipping (and is typically FOB shipping) which is when our performance obligation is met. Net sales are comprised of gross revenues less product returns, trade discounts and customer allowances, which include costs associated with off-invoice mark-downs and other price reductions, as well as trade promotions. These incentive costs are recognized at the later of the date on which the Company recognizes the related revenue or the date on which the Company offers the incentive. The Company currently offers a <em style="font: inherit;">60</em>-day, money-back guarantee.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Disaggregated Revenue</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company&#8217;s product revenue is generated primarily through <em style="font: inherit;">two</em> sales channels, E-commerce sales (formerly referred to as consumer sales) and wholesale sales. The Company believes that these categories appropriately reflect how the nature, amount, timing and uncertainty of revenue and cash flows are impacted by economic factors.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A description of the Company&#8217;s principal revenue generating activities are as follows:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align:middle;width:2.1%;">&#160;</td><td style="vertical-align:top;width:2.1%;"> <p style="font-family:Symbol;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">-</p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">E-commerce sales - consumer products sold through the Company&#8217;s online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due prior to the date of shipment; and</p> </td></tr>
<tr><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:middle;width:auto;">&#160;</td></tr>
<tr><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:top;width:auto;"> <p style="font-family:Symbol;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">-</p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Wholesale sales - products sold to the Company&#8217;s wholesale customers for subsequent resale. Revenue is recognized when control of the goods is transferred to the customer, in accordance with the terms of the applicable agreement. Payment terms vary and can typically be <em style="font: inherit;">30</em> days from the date control over the product is transferred to the customer</p> </td></tr>
</tbody></table>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table represents a disaggregation of revenue by sales channel:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

     <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Fiscal 2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of total</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Fiscal 2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of total</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">E-commerce sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15,655,337</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">80.4</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">19,436,124</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">80.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Wholesale sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">3,826,830</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">19.6</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">4,719,238</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">19.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Net Sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">19,482,167</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;"></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">24,155,362</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;"></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Contract assets represent unbilled receivables and are presented within accounts receivable, net on the consolidated balance sheets. Contract liabilities represent unearned revenues and are presented as deferred revenue or customer deposits on the consolidated balance sheets. The Company had <span style="-sec-ix-hidden:c121825244">no</span> material contract assets or liabilities at the beginning or ending of <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Cost of Sales</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company&#8217;s cost of sales includes costs associated with distribution, fill and labor expense, components, manufacturing overhead, <em style="font: inherit;">third</em>-party providers, and outbound freight for the Company&#8217;s products sales. For the Company&#8217;s product sales, cost of sales also includes the cost of refurbishing products returned by customers that will be offered for resale, if any, and the cost of inventory write-downs associated with adjustments of held inventories to their net realizable value. These expenses are reflected in the Company&#8217;s consolidated statements of operations when the product is sold and net sales revenues are recognized or, in the case of inventory write-downs, when circumstances indicate that the carrying value of inventories is in excess of their net realizable value.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Advertising Costs</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company expenses all costs of advertising and related marketing and promotional costs as incurred. The Company incurred $4.2 million and $6.0&#160;million in advertising and marketing and promotional costs included in operating expenses during the years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> respectively. The Company believes driving its advertising aids in brand awareness and is critical to maintain brand recognition. We are constantly evaluating advertising methods and costs and working to drive down our cost of customer acquisition.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p><p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b></b></p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Income Taxes</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is a North Carolina corporation that is treated as a corporation for federal and state income tax purposes. As of <em style="font: inherit;"> October 1, 2019, </em>CBDI and Paw CBD were wholly owned subsidiaries and are disregarded entities for tax purposes and their entire share of taxable income or loss is included in the tax return of the Company and as of <em style="font: inherit;"> March 15, 2021, </em>Therapeutics is also a wholly owned subsidiary and is a disregarded entity for tax purposes and its entire share of taxable income or loss is included in the tax return of the Company.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for income taxes pursuant to the provisions of the <i>Accounting for Income Taxes </i>topic of the Financial Accounting Standards Board&#160;("FASB") ASC <em style="font: inherit;">740</em> which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. The Company uses the inside basis approach to determine deferred tax assets and liabilities associated with its investment in a consolidated pass-through entity. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than <em style="font: inherit;">not</em> that the net deferred asset will <em style="font: inherit;">not</em> be realized.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">US GAAP requires management to evaluate tax positions taken by the Company and recognize a tax liability (or asset) if the Company has taken an uncertain tax position that more likely than <em style="font: inherit;">not</em> would <em style="font: inherit;">not</em> be sustained upon examination by the Internal Revenue Service. Management has analyzed the tax positions taken by the Company, and has concluded that as of <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>, there were <em style="font: inherit;">no</em> uncertain tax positions taken or expected to be taken that would require recognition of a liability (or asset) or disclosure in the consolidated financial statements.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Concentrations</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) covers <em style="font: inherit;">$250,000</em> for substantially all depository accounts. The Company from time to time <em style="font: inherit;"> may </em>have amounts on deposit in excess of the insured limits. The Company had a $1,893,606&#160;uninsured balance at <em style="font: inherit;"> September 30, 2024</em> and a $1,163,360&#160;uninsured balance at <em style="font: inherit;"> September 30, 2023</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did <span style="-sec-ix-hidden:c121825261">not</span> have any customers that represented a significant amount of our sales for the year ended <em style="font: inherit;"> September 30, 2024</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Stock-Based Compensation</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for its stock compensation under the ASC <em style="font: inherit;">718</em>-<em style="font: inherit;">10</em>-<em style="font: inherit;">30,</em> <i>Compensation - Stock Compensation </i>using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity's equity instruments or that <em style="font: inherit;"> may </em>be settled by the issuance of those equity instruments.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company uses the Black-Scholes model for measuring the fair value of options and warrants. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. The Company recognizes forfeitures when they occur.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Liquidity and Going Concern Considerations</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company experienced a loss of $3.7&#160;million for the fiscal year&#160;ended <em style="font: inherit;"> September 30, 2024</em>,&#160;resulting in a working capital deficit of $1.1 million&#160;at <em style="font: inherit;"> September&#160;</em><em style="font: inherit;">30,</em> <em style="font: inherit;">2024.</em></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">While the Company is taking strong action, believes in the viability of its strategy&#160;and&#160;path to profitability, and in its ability to raise additional funds, there can be&#160;<em style="font: inherit;">no</em>&#160;assurances to that effect.&#160;&#160;The Company&#8217;s working capital position <em style="font: inherit;"> may </em><em style="font: inherit;">not</em>&#160;be sufficient to support the Company&#8217;s daily operations for the <em style="font: inherit;">twelve</em>&#160;months subsequent to the issuance of these annual financial statements.&#160;The Company&#8217;s ability to continue as a going concern is dependent upon its ability to improve profitability and the ability to acquire additional funding. These and other factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern within <em style="font: inherit;">twelve</em> months after the date that the annual financial statements are issued. These financial statements do <em style="font: inherit;">not</em> include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that <em style="font: inherit;"> may&#160;</em>result in the Company <em style="font: inherit;">not</em> being able to continue as a going concern.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Convertible Notes</b></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Effective <em style="font: inherit;"> February 1, 2024 (</em>the &#8220;Effective Date&#8221;), the Company entered into a Securities Purchase Agreement dated <em style="font: inherit;"> January 30, 2024 (</em>the &#8220;Purchase Agreement&#8221;) with <em style="font: inherit;">five</em> institutional investors (the &#8220;Investors&#8221;) whereby the Investors advanced the Company an aggregate of $1,250,000 gross proceeds and the Company issued each Investor an 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note, in the aggregate principal amount of $1,541,666 (the &#8220;Notes&#8221;). The Company is using the proceeds from the issuance of the Notes for working capital and general corporate purposes. The Company elected the fair value option under ASC <em style="font: inherit;">825</em> Fair Value Measurements for the Notes. The Notes were initially recognized at fair value on the balance sheet. All subsequent changes in fair value, excluding the impact of the change in fair value related to instrument-specific credit risk are recorded in non-operating income. The changes in fair value related to instrument-specific credit risk is recorded through other comprehensive income (loss). See Note <em style="font: inherit;">12</em> for more information related to the Notes.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b></b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Earnings (Loss) Per Share</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company uses ASC <em style="font: inherit;">260</em>-<em style="font: inherit;">10,</em> <i>Earnings Per Share </i>for calculating the basic and diluted income (loss) per share. The Company computes basic income (loss) per share by dividing net income (loss) and net income (loss) attributable to common shareholders, after deducting preferred stock dividends, by the weighted average number of common shares outstanding. Common equivalent shares are excluded from the computation of net loss per share if their effect is anti-dilutive.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> February 16, 2023, </em>we held an annual meeting of stockholders. At the annual meeting, our stockholders approved an amendment to our articles of incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of common stock by a ratio of between <em style="font: inherit;">one</em>-for-<span style="-sec-ix-hidden:c121825285">twenty</span> to <span style="-sec-ix-hidden:c121825286">one</span>-for-fifty, inclusive, with the exact ratio to be set at the discretion of our board of directors, at any time after approval of the amendment and prior to <em style="font: inherit;"> February 16, 2024. </em>On <em style="font: inherit;"> April 12, 2023, </em>the board effected a reverse stock split at a ratio of <em style="font: inherit;">one</em>-for-<span style="-sec-ix-hidden:c121825288">forty</span>-five, effective as of <em style="font: inherit;"> April 24, 2023 (</em>the "Reverse Stock Split"). Unless otherwise indicated, all share numbers in this report, including shares of common stock and all securities convertible into, or exercisable for, shares of common stock, give effect to the Reverse Stock Split.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b></b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>New Accounting</b>&#160;<b>Standards</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company adopted ASU <em style="font: inherit;">2016</em>-<em style="font: inherit;">13</em> Financial Instruments &#8211; Credit Losses (Topic <em style="font: inherit;">326</em>): Measurement of Credit Losses on Financial Instruments (ASC <em style="font: inherit;">326</em>) effective <em style="font: inherit;"> October 1, 2023. </em>This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (&#8220;CECL&#8221;) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities, and some off-balance sheet credit exposures such as unfunded commitments to extend credit. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses.&#160;The adoption of&#160;this standard had <em style="font: inherit;">no</em> material impact&#160;on the consolidated financial statements.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160;&#160;</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>


  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102925488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Marketable Securities and Investment Other Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">2</em> </b>&#8211;<b> MARKETABLE SECURITIES AND INVESTMENT OTHER SECURITIES</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On <em style="font: inherit;"> April 7, 2022, </em>the Company&#160;entered into an asset sale agreement to sell substantially all its manufacturing assets to a subsidiary of Steady State, LLC ("Steady State"). The equipment sale was initially valued at approximately $1.8 million for accounting purposes, the sale price consisting of a trade credit for products to be provided to the Company under the manufacturing and supply agreement and $1.4 million of which the Company invested into Steady State in the form of an equity investment consistent with the terms of Steady State's completed Series C financing. &#160; The Company performed a valuation analysis and as of <em style="font: inherit;"> September 30, 2023 </em>determined a $700,000 impairment was needed on the carrying value of this investment. The determination was based on a number of factors, including Steady State&#8217;s financial performance, our experience with production and cbdMD&#8217;s determination to re-source production to other suppliers. As such we believe it was prudent to reassess the carrying value of this non-liquid security. The Company performed an additional valuation analysis as of <em style="font: inherit;"> September 30, 2024 </em>and determined that no further impairment was needed based on factors such as Steady State's financial performance and re-alignment of the business.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">For the year ended <em style="font: inherit;"> September 30, 2024</em> and&#160;<em style="font: inherit;"> September 30, 2023</em> the Company recorded $0 and an unrealized loss of $700,000, respectively of realized and unrealized loss&#160;on marketable and other securities, including impairments.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The table below summarizes the&#160;assets and liabilities related to marketable and other securities valued at fair value as of <em style="font: inherit;"> September 30, 2024</em>:</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">In Active</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><b><em style="font: inherit;">Markets for</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><b><em style="font: inherit;">Significant Other</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><b><em style="font: inherit;">Significant</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Identical Assets</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Observable</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Unobservable</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">and Liabilities</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Inputs</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Inputs</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(Level 1)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(Level 2)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(Level 3)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 55%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at September 30, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(276,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in value of equities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: Times New Roman;">Change in value of contingent liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Additional Investment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">185,638</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at September 30, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(90,362</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in value of contingent liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">-</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">90,362</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr><td style="font-family: Times New Roman; font-size: 10pt;">Fair value of convertible notes</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,171,308</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,171,308</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160; &#160;</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/940-320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph b<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102945008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 - Inventory<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory Disclosure [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">3</em> </b>&#8211;<b> INVENTORY</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Inventory at <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> consists of the following:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Finished Goods</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,534,718</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,782,680</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory Components</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">830,469</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,397,034</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory Reserve</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(126,742</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory prepaid</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">159,006</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">182,675</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Inventory</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,524,193</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,235,647</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Abnormal amounts of idle facility expense, freight, handling costs, scrap, and wasted material (spoilage) are expensed in the period they are incurred and <em style="font: inherit;">no</em> material expenses related to these items occurred in the year ended <em style="font: inherit;"> September 30, 2024</em>. The Company wrote down inventory of $921,314 during the <em style="font: inherit;">fourth</em> quarter of fiscal year ended <em style="font: inherit;"> September 30, 2024</em> primarily related to obsolete and expired stock keeping units (&#8220;SKU&#8221;s).&#160; We work hard to minimize inventory write-downs and slow moving and aging SKUs&#160;and work, as we work to streamline our offerings to higher velocity products and eliminate slow-moving and aging SKUs.</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102843808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment Disclosure [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">4</em> </b>&#8211;<b> PROPERTY AND EQUIPMENT</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Major classes of property and equipment at <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> consist of the following:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Computers, furniture and equipment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,587,411</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,392,776</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Manufacturing equipment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">284,275</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">284,275</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Leasehold improvements</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">487,081</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">487,081</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Automobiles</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">11,087</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,358,767</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,175,219</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Less accumulated depreciation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,904,499</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,458,640</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Property and equipment, net</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">454,268</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">716,579</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Depreciation expense related to property and equipment was $452,326&#160;and $404,280&#160;for the year ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>, respectively. During the <em style="font: inherit;">third</em> quarter of fiscal year <em style="font: inherit;">2023,</em> the Company sold substantially all the assets of its manufacturing facility and as a result the gross investment and accumulated depreciation was removed from the balance sheet, reducing net PP&amp;E</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999525616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets Disclosure [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">5</em> </b>&#8211; <b>INTANGIBLE ASSETS</b></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><span style="text-decoration: underline; ">Intangible Assets</span></b></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As of <em style="font: inherit;"> July 1, 2023 </em>the Company determined that based on market forces and the Company&#8217;s outlook it was prudent to adjust the useful lives of cbdMD&#8217;s and DCO intangibles to 5 year useful lives and hempMD&#8217;s trademark to 10 year amortization to better reflect the outlook of the brands. This re-evaluation of the tradenames became a triggering event for a valuation test under ASC <em style="font: inherit;">360.</em> As a result of a multi-step approach under ASC <em style="font: inherit;">360</em> we determined that the &#8220;cbdMD,&#8221; &#8220;DirectCBDOnline&#8221; tradenames and the technology relieve asset was impaired by <em style="font: inherit;">$6,027,000,</em> and as a result, the amortization was adjusted to account for any changes in the value and estimated useful life of each asset.&#160; Amortization expense for the year ended <em style="font: inherit;"> September 30, 2024</em> was $697,510&#160;and was recorded on the consolidated statements of operations.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">At <em style="font: inherit;"> September 30, 2023, </em>the Company prepared a tradename impairment analysis in accordance with ASC <em style="font: inherit;">360</em> and has determined that based on market sentiment and the sharp decline in combined market capitalization of the common stock and Series A Preferred as a result of the ongoing proxy vote, a triggering event occurred. The Company prepared an impairment analysis and as a result of a multi-step approach under ASC <em style="font: inherit;">360</em> we determined that the &#8220;cbdMD&#8221; DirectCBDOnline&#8221; tradenames and technology relieve were further impaired by $7,192,000 in fiscal year <em style="font: inherit;">2023,</em> resulting in a total impairment charge of $13,219,000 for the fiscal year ended <em style="font: inherit;"> September 30, 2023.</em></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">At <em style="font: inherit;"> September 30, 2024, </em>the Company prepared a tradename impairment analysis in accordance with ASC <em style="font: inherit;">360</em> and has determined that no impairment existed.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;">2019,</em> Company&#8217;s subsidiary, CBD Industries, LLC, initiated a trademark cancellation proceeding against Majik Medicine, LLC (&#8220;Majik&#8221;) regarding Majik&#8217;s &#8220;CBD MD&#8221; trademark. In a Settlement, Purchase, and Release Agreement that occurred in <em style="font: inherit;"> August </em>of <em style="font: inherit;">2024,</em> the Company acquired the trademark, resolving all related legal claims. The agreement included a $100,000 initial payment, <em style="font: inherit;">four</em> additional annual payments of $50,000, the issuance of 75,000 shares of common stock (the &#8220;Initial Shares&#8221;), and 50,000 more shares on the <em style="font: inherit;">one</em>-year anniversary. Failure to make the additional payments would reassign the trademark to Majik. Additionally, the Company entered a <span style="-sec-ix-hidden:c121825337">five</span>-year consulting agreement with Majik, granting a 15% commission on increased sales from Licensed Practitioners, a new customer base. This acquisition strengthens the Company&#8217;s IP portfolio, avoids litigation costs, and expedites trademark issuance. Majik also appointed board member William Raines III as a proxy for the Initial Shares for <em style="font: inherit;">12</em> months. The Company used the Black Scholes method to determine the fair value of the remaining shares to be paid on the <em style="font: inherit;">one</em>-year anniversary.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">At <em style="font: inherit;"> September 30, 2024, </em>the Company prepared a tradename impairment analysis in accordance with ASC <em style="font: inherit;">360</em> and has determined that no impairment existed.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Intangible assets as of <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> consisted of the following:</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Trademark related to cbdMD</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">21,585,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">21,585,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Trademark for HempMD</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">50,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">50,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Technology Relief from Royalty related to DirectCBDOnline.com</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">667,844</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">667,844</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Tradename related to CBD MD limited mark</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">368,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Tradename related to DirectCBDOnline.com</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">749,567</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">749,567</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Impairment of definite lived intangible assets:</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">(17,504,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">(17,504,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Amortization of definite lived intangible assets:</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,026,831</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(2,329,321</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,889,580</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,219,090</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Future amortization of intangible assets as of <em style="font: inherit;"> September 30, 2024</em> is as follow:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>For the year ended September 30,</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2025</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">762,457</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">733,740</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2027</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">733,740</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2028</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">569,923</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">89,720</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total future intangibles amortization</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>2,889,580</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"><b>&#160;</b></td></tr>
</tbody></table>

   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;&#160;&#160; &#160;&#160;</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999245856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Contingent Liability<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">6</em> </b>&#8211;<b> CONTINGENT LIABILITY</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Pursuant to a merger agreement entered into in <em style="font: inherit;">2018,</em> the Company had a contractual obligation to issue 338,889 shares of its common stock, after approval by its shareholders, to the members of Cure Based Development, issued in <em style="font: inherit;">two</em> tranches 144,445 shares and 194,945 shares, both of which were subject to leak out provisions, and the unrestricted voting rights to 194,445 tranche of shares which vested over a <span style="-sec-ix-hidden:c121825352">five</span> year period and were subject to a voting proxy agreement.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The contractual obligations and earn out provision were accounted for as a contingent liability and fair value was determined using Level <em style="font: inherit;">3</em> inputs, as estimating the fair value of these contingent liabilities require the use of significant and subjective inputs that <em style="font: inherit;"> may </em>and are likely to change over the duration of the liabilities with related changes in internal and external market factors.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The agreement also provided that an additional 338,889 Earnout Shares would be issued as part of the consideration, upon the satisfaction of certain aggregate net revenue criteria by cbdMD within 60 months following the closing date of the merger&#160;</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Aggregate Net Revenues</p> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">Shares Issued/ Each $ of Aggregate Net Revenue Ratio</em></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="width: 48%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 48%;">&#160;</td><td style="width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825661">1</span> - $<span style="-sec-ix-hidden:c121825662">20,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.004236111</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825663">20,000,001</span> - $<span style="-sec-ix-hidden:c121825664">60,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.002118056</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825665">60,000,001</span> - $<span style="-sec-ix-hidden:c121825666">140,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.001059028</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825667">140,000,001</span> - $<span style="-sec-ix-hidden:c121825668">300,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.005295139</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company determined the final Earnout shares to be issued were 19,818 and were issued on <em style="font: inherit;"> January 11, 2024. </em>There is <em style="font: inherit;">no</em> further Earnout obligation.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;&#160;&#160;</p>


  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132103897328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions Disclosure [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">7</em> </b>&#8211;<b> RELATED PARTY TRANSACTIONS</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><em style="font: inherit;">None.</em></p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132000626000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">8</em> </b>&#8211;<b> SHAREHOLDERS</b>&#8217;<b> EQUITY </b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Preferred Stock &#8211; The Company is authorized to issue 50,000,000 shares of preferred stock, par value $0.001 per share. In <em style="font: inherit;"> October 2019, </em>the Company designated 5,000,000 of these shares as 8.0% Series A Cumulative Convertible Preferred Stock. Our <em style="font: inherit;">8.0%</em> Series A Cumulative Convertible Preferred Stock ranks senior to our common stock for liquidation or dividend provisions and holders are entitled to receive cumulative cash dividends at an annual rate of <em style="font: inherit;">8.0%</em> payable monthly in arrears for the prior month. The Company reviewed ASC <em style="font: inherit;">480</em> &#8211; <i>Distinguishing Liabilities from Equity </i>in order to determine the appropriate accounting treatment for the preferred stock and determined that the preferred stock should be treated as equity. There were 5,000,000 shares of 8.0% Series A Cumulative Convertible Preferred Stock issued and outstanding at <em style="font: inherit;"> September 30, 2024</em> and <em style="font: inherit;"> September 30, 2023</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The total amount of dividends declared were $4,004,001 and $4,002,005 for the years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;"> September 30, 2023. </em>The Company suspended payment of the dividend in <em style="font: inherit;"> August </em>of <em style="font: inherit;">2023</em> and as such recorded an accrual of $667,000 for the dividends declared but <em style="font: inherit;">not</em> paid as of <em style="font: inherit;"> September 30, 2023. </em>As of <em style="font: inherit;"> September 30, 2024, </em>the Accrued liability for the dividends declared but <em style="font: inherit;">not</em> paid totaled $4,669,000 and continues to grow at approximately $1 million per quarter.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Common Stock &#8211; The Company is authorized to issue 150,000,000 shares of common stock, par value $0.001 per share. There were 3,939,057 and 2,960,573 shares of common stock issued and outstanding at <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023,</em> respectively.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On <em style="font: inherit;"> March 2, 2023 </em>Company entered into a purchase agreement (the "ELOC") with Keystone Capital Partners, LLC (&#8220;Keystone&#8221;), pursuant to which Keystone committed to purchase up to 281,934 of shares of our common stock. Upon the execution of the ELOC, The Company issued 2,616 shares of common stock as "Commitment Shares" to Keystone as consideration for its commitment to purchase shares of our common stock under the ELOC. An additional 6,104 Commitment Shares were issued <em style="font: inherit;">180</em> days after the date of the ELOC. The 281,934 shares of the Company's common stock were registered for resale and <em style="font: inherit;"> may </em>be issued under the ELOC or sold by us to Keystone at our discretion from time to time over a <em style="font: inherit;">12</em> month period commencing <em style="font: inherit;"> April 1, 2023. </em>The purchase price for the shares that the Company sold to Keystone under the ELOC fluctuated based on the price of the Company's common stock. Keystone purchased an aggregate of 180,955 shares (64,218 of which were purchased during the year ended <em style="font: inherit;"> September 30, 2024) </em>under the ELOC, which expired in the <em style="font: inherit;">first</em> half of fiscal <em style="font: inherit;">2024.</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><span style="text-decoration: underline; ">Preferred stock transactions:</span></b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company had&#160;<em style="font: inherit;">no</em> preferred stock transactions in the year ended&#160;<em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><span style="text-decoration: underline; ">Common stock transactions:</span></b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In the year ended <em style="font: inherit;"> September 30, 2024</em>:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> September 2024, </em>the Company issued 100,624 shares of common stock pursuant to the partial conversion of certain principal and interest related to the Notes.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> August 2024, </em>the Company issued 75,000 shares of common stock pursuant to the settlement agreement with Majik Medicine.&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> April 2024, </em>the Company issued an aggregate of 714,229 shares of common stock pursuant to the partial conversion of certain principal and interest related to the Notes.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> March 2024, </em>the company issued 16,000 of restricted stock awards to the Company&#8217;s board of directors. The shares vest quarterly on <em style="font: inherit;"> June 30, 2024, </em><em style="font: inherit;"> September 30, 2024, </em><em style="font: inherit;"> December 31, 2024, </em>and&#160;<em style="font: inherit;"> March 31, 2025. </em>The stock awards were valued at the fair market price of $13,760 and will amortize over the individual vesting periods.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> January 2024, </em>the Company issued 64,218 shares under our ELOC.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In <em style="font: inherit;"> January 2024, </em>the Company issued 19,818 shares as part of the final Earnout.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In the year ended <em style="font: inherit;"> September 30, 2023:</em></p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In <em style="font: inherit;"> September </em>of <em style="font: inherit;">2023,</em> the company issued 102,616 shares under the Purchase Agreement to Keystone.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">In <em style="font: inherit;"> July </em>of <em style="font: inherit;">2023</em> the Company issued 2,616 shares to Keystone pertaining to the commitment shares under the ELOC.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> May 3, 2023, </em>the Company completed an underwritten public offering of 1,350,000 shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering before deducting underwriting discounts and commissions and offering expenses were approximately $2.8 million. Under the terms of an underwriting agreement, the Company granted the underwriter an option, exercisable for <em style="font: inherit;">45</em> days, to purchase up to an additional 202,500 shares of common stock. The net proceeds to the Company from the offering were approximately $2.5 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, and does <em style="font: inherit;">not</em> take into account the exercise by the underwriter of its option to purchase additional shares of common stock. The Company also issued the underwriter a warrant to purchase up to 40,500 shares of its common stock exercisable at $2.52 per share.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>


   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> April 24, 2023 </em>the Company issued a total of 39,533&#160;shares of common stock to account for rounding up of fractional shares related to the Reverse Stock Split.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> March 2, 2023, </em>the Company entered into the ELOC with Keystone, pursuant to which Keystone has committed to purchase up to 281,934 of shares of our common stock. Upon the execution of the ELOC, The Company issued 2,616 shares of common stock as "Commitment Shares" to Keystone as consideration for its commitment to purchase shares of our common stock under the ELOC. Additional Commitment Shares (6,104) will be issued over <em style="font: inherit;">180</em> days from <em style="font: inherit;"> March 2, 2023. </em>The 281,934 shares of the Company's common stock were registered for resale and <em style="font: inherit;"> may </em>be issued under the ELOC or sold by us to Keystone at our discretion from time to time over a <em style="font: inherit;">12</em>-month period commencing <em style="font: inherit;"> April 1, 2023, </em>subject to a <em style="font: inherit;">75</em> day blackout period commencing <em style="font: inherit;"> April 30, 2023. </em>The purchase price for the shares that the Company <em style="font: inherit;"> may </em>sell to Keystone under the ELOC will fluctuate based on the price of the Company's common stock. Depending on market liquidity at the time, sales of such shares <em style="font: inherit;"> may </em>cause the trading price of our common stock to fall.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">In <em style="font: inherit;"> April 2023, </em>the Company issued 8,889 shares to Keystone under the ELOC entered into in <em style="font: inherit;"> March </em>of <em style="font: inherit;">2023.</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> February 1, 2023, </em>the Company entered into an Agreement for Advertising Placement with <em style="font: inherit;">a360</em> Media, LLC (<em style="font: inherit;">&#8220;a360&#8221;</em>) in which <em style="font: inherit;">a360</em> will provide professional media support and advertising placement in exchange for up to 134,681 shares of the Company&#8217;s common stock valued at $14.85 per share. <em style="font: inherit;">A360</em> will receive the shares by providing the Company with a credit in the amount of $2,000,000 to be used for media support and advertising placement to the Company, of which $514,904 remains unutilized as of <em style="font: inherit;"> September </em><em style="font: inherit;">30,2023.</em> The shares are 70% fully vested; 15% of the Shares shall vest upon each advertising placement accrue pro-rata as percentage of the total advertising placement; and 15% of the shares shall vest provided there are <em style="font: inherit;">no</em> restrictions in product categories that the Company is able to market with <em style="font: inherit;">a360</em> while the Company utilizes the advertising placement. Any shares which do <em style="font: inherit;">not</em> vest within the term of the agreement shall be forfeited. The Advertising Placement must be used by the Company prior to <em style="font: inherit;"> December 30, 2023, </em>unless otherwise agreed in writing by both parties.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> January </em>of <em style="font: inherit;">2023,</em> the Company issued 2,223 shares of common stock to Twenty Two Capital as the final obligation under the <em style="font: inherit;">2021</em> acquisition agreement upon the expiration of the indemnification period.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>


   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><span style="text-decoration: underline; ">Stock option transactions:</span></b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In the year ended <em style="font: inherit;"> September 30, 2024</em>:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company granted its board of directors an aggregate of 8,000 common stock options in <em style="font: inherit;"> April 2024. </em>The options vested immediately, have a strike price of $0.86 and a <span style="-sec-ix-hidden:c121825448">five</span>-year term. The Company has recorded a total prepaid expense of approximately $4,300 and intends to amortize the expense over the <em style="font: inherit;">12</em>-month board term.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In the year ended <em style="font: inherit;"> September 30, 2023:</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> February </em>of <em style="font: inherit;">2023,</em> the Company granted its board of directors an aggregate of 2,667 common stock options. The options vested immediately, have a strike price of $12.60 and a <span style="-sec-ix-hidden:c121825454">five</span>-year term. The Company has recorded a total prepaid expense of $21,120 and intends to amortize the expense over the <em style="font: inherit;">12</em>-month board term.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> January 2023, </em>the Company issued 2,334 options to a group of employees. The stock options awards vested at issuance, had a strike price of $10.53, <span style="-sec-ix-hidden:c121825459">five</span>-year term and a fair market value upon issuance of $15,225.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> December 2022, </em>the Company issued 2,223 options to an employee. 1,667 options vest equally at each anniversary for the next <em style="font: inherit;">3</em> years, have a strike price of $11.25 and a <span style="-sec-ix-hidden:c121825465">five</span> year term. The total expense of these options is $13,150 and will be amortized over the term of the vesting periods. 556 options vest based on meeting certain direct to consumer revenue requirements by the end of <em style="font: inherit;"> December 2024.</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company has recorded an expense for these options of $11,974&#160;for the <em style="font: inherit;">twelve</em> months ended <em style="font: inherit;"> September 30, 2024</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The expected volatility rate was estimated based on comparison to the volatility of a blend of the Company's own stock&#160;and a&#160;peer group of companies in similar industries. The expected term used was the full term of the contract for the issuances. The risk-free interest rate for periods within the contractual life of the option is based on U.S. Treasury securities. The pre-vesting forfeiture rate of <em style="font: inherit;">zero</em> is based upon the experience of the Company. As required under ASC <em style="font: inherit;">718,</em> the Company will adjust the estimated forfeiture rate to its actual experience. Management will continue to assess the assumptions and methodologies used to calculate estimated fair value of share-based compensation. Circumstances <em style="font: inherit;"> may </em>change and additional data <em style="font: inherit;"> may </em>become available over time, which could result in changes to these assumptions and methodologies, and thereby materially impact our fair value determination.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The following table summarizes the inputs used for the Black-Scholes pricing model on the options issued in the years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average exercise price</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.54</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">10.35 - 12.60</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Risk free interest rate</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3.93% - 4.71%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Volatility</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">107%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">106.48% - 106.51%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected term (in years)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2.5 - 4</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Dividend yield</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">None</em></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">None</em></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><span style="text-decoration: underline; ">Warrant transactions:</span></b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The Company had <em style="font: inherit;">no</em> warrant transactions during the <em style="font: inherit;">twelve</em> months ended <em style="font: inherit;"> September 30, 2024.</em></p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;&#160;</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132005474576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Stock Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Payment Arrangement [Text Block]</a></td>
<td class="text">
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>NOTE <em style="font: inherit;">9</em> -STOCK-BASED COMPENSATION</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Equity Compensation Plan &#8211; On <em style="font: inherit;"> June 2, 2015, </em>the Board of Directors of the Company approved the <em style="font: inherit;">2015</em> Equity Compensation Plan (<em style="font: inherit;">&#8220;2015</em> Plan&#8221;). The <em style="font: inherit;">2015</em> Plan made 26,112 common stock shares, either unissued or reacquired by the Company, available for awards of options, restricted stocks, other stock grants, or any combination thereof. The number of shares of common stock available for issuance under the <em style="font: inherit;">2015</em> Plan shall automatically increase on the <em style="font: inherit;">first</em> trading day of our fiscal year during the term of the <em style="font: inherit;">2015</em> Plan, beginning with calendar year <em style="font: inherit;">2016,</em> by an amount equal to <em style="font: inherit;">one</em> percent (1%) of the total number of shares of common stock outstanding on the last trading day in <em style="font: inherit;"> September </em>of the immediately preceding fiscal year, but in <em style="font: inherit;">no</em> event shall any such annual increase exceed 2,223 shares of common stock. On <em style="font: inherit;"> April 19, 2019, </em>shareholders approved an amendment to the <em style="font: inherit;">2015</em> Plan and increased the number of shares available for issuance under the <em style="font: inherit;">2015</em> Plan to 45,445 and retained the annual evergreen increase provision of the plan. Subsequent thereto, on <em style="font: inherit;"> August 7, 2019 </em>the Company&#8217;s Board of Directors approved an amendment to the <em style="font: inherit;">2015</em> Plan changing the date the automatic evergreen increase is determined to the <em style="font: inherit;">first</em> trading day of <em style="font: inherit;"> October </em>each calendar year during the term of the <em style="font: inherit;">2015</em> Plan to coincide with the Company&#8217;s fiscal year.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> January 8, 2021, </em>the Company&#8217;s Board of Directors approved the <em style="font: inherit;">2021</em> Equity Compensation Plan (the <em style="font: inherit;">&#8220;2021</em> Plan&#8221;) and it was subsequently ratified by its shareholders at its annual meeting held on <em style="font: inherit;"> March 12, 2021. </em>The purpose of the <em style="font: inherit;">2021</em> Plan is to advance the interests of the Company by providing an incentive to attract, retain and motivate highly qualified and competent persons who are important to it and upon whose efforts and judgment the success of the Company is largely dependent. The <em style="font: inherit;">2021</em> Plan made 111,112 common shares, either unissued or reacquired by the Company, available for awards of options, restricted stocks, other stock grants, or any combination thereof. The <em style="font: inherit;">2021</em> Plan also contains an &#8220;evergreen formula&#8221; pursuant to which the number of shares of common stock available for issuance under the <em style="font: inherit;">2021</em> Plan will automatically increase on <em style="font: inherit;"> October 1 </em>of each calendar year during the term of the <em style="font: inherit;">2021</em> Plan, beginning with calendar year <em style="font: inherit;">2022,</em> by an amount equal to 1.0% of the total number of shares of common stock outstanding on <em style="font: inherit;"> September 30 </em>of such calendar year, up to a maximum of 5,556 shares.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for stock-based compensation using the provisions of ASC <em style="font: inherit;">718.</em> ASC <em style="font: inherit;">718</em> codification requires companies to recognize the fair value of stock-based compensation expense in the financial statements based on the grant date fair value of the options. All options are approved by the Compensation, Corporate Governance and Nominating Committee of the Board of Directors. Restricted stock awards that vest in accordance with service conditions are amortized over their applicable vesting period using the straight-line method. The fair value of the Company&#8217;s stock option awards or modifications is estimated at the date of grant using the Black-Scholes option pricing model.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Eligible recipients include employees, officers, directors and consultants who are deemed to have rendered or to be able to render significant services to the Company or its subsidiaries and who are deemed to have contributed or to have the potential to contribute to the success of the Company. Options granted generally have a <span style="-sec-ix-hidden:c121825508">five</span>-to-<span style="-sec-ix-hidden:c121825509">ten</span>-year term and have vesting terms that cover <span style="-sec-ix-hidden:c121825510">one</span> to <span style="-sec-ix-hidden:c121825511">three</span> years from the date of grant. Certain of the stock options granted under the plan have been granted pursuant to various stock option agreements. Each stock option agreement contains specific terms.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Stock Options:</span></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company currently has awards outstanding with service conditions and graded-vesting features. We recognize compensation cost on a straight-line basis over the requisite service period.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The fair value of each time-based award is estimated on the date of grant using the Black-Scholes option valuation model. Our weighted-average assumptions used in the Black-Scholes valuation model for equity awards with time-based vesting provisions granted during the year.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table summarizes stock option activity under both plans for the fiscal years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">remaining</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Aggregate</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">contractual term</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">intrinsic value</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Number of shares</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">exercise price</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(in years)</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(in thousands)</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Outstanding at September 30, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">55,656</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">151.10</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">4.55</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7,233</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">11.51</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">-</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(21,124</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">88.12</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">41,765</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">144.43</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.65</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">8,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0.86</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">-</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(5,730</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">117.35</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">44,035</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">123.58</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3.14</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="width: 40%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">44,035</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">123.58</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3.14</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of <em style="font: inherit;"> September 30, 2024</em>, there was approximately $7,858 of total unrecognized compensation cost related to non-vested stock options which vest over a period of approximately 2.3 years.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Restricted Stock Award transactions:</span></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company issued 16,000 of restricted stock awards to the Company&#8217;s board of directors. The shares vest quarterly on <em style="font: inherit;"> June 30, 2024,&#160;</em><em style="font: inherit;"> September 30, 2024,&#160;</em><em style="font: inherit;"> December 31, 2024, </em>and&#160;<em style="font: inherit;"> March 31, 2025. </em>The stock awards were valued at the fair market price of <em style="font: inherit;">$4,296</em> upon issuance and will amortize over the individual vesting periods.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In the <em style="font: inherit;">twelve</em> months ended <em style="font: inherit;"> September 30, 2023:</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> February </em>of <em style="font: inherit;">2023,</em> the Company issued 448&#160;restricted stock awards to the Company&#8217;s board of directors. The shares vest quarterly <span style="-sec-ix-hidden:c121825521"><span style="-sec-ix-hidden:c121825696">one</span></span> <em style="font: inherit;">fourth</em> on <em style="font: inherit;"> June 30, 2023, </em><em style="font: inherit;"><span style="-sec-ix-hidden:c121825697">one</span></em> fourth, on <em style="font: inherit;"> September 30, 2023, </em><span style="-sec-ix-hidden:c121825524"><span style="-sec-ix-hidden:c121825698">one</span></span> <span style="-sec-ix-hidden:c121825525">fourth</span> on <em style="font: inherit;"> December 31, 2023, </em>and <em style="font: inherit;"><span style="-sec-ix-hidden:c121825699">one</span></em> <span style="-sec-ix-hidden:c121825527">fourth</span> on <em style="font: inherit;"> March 31, 2024. </em>The stock awards were valued at the fair market price of $5,660 upon issuance and will amortize over the individual vesting periods.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> January 2023, </em>the Company issued 3,889 shares to a group of employees. The shares vested upon issuance, having a fair market value upon issuance of $40,950.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In <em style="font: inherit;"> December 2022, </em>the Company issued 1,112 shares of restricted common stock to an employee. 556 shares vested upon issuance and the Company recorded a total expense of $6,250. 556 shares vest based on meeting certain direct to consumer revenue performance hurdles prior to <em style="font: inherit;"> December 2024.</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>


  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132000058576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 - Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_WarrantsDisclosureTextBlock', window );">Warrants Disclosure [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">10</em> </b>&#8211;<b> WARRANTS</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Transactions involving the Company equity-classified warrants for the fiscal years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> are summarized as follows:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Number of shares</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average exercise price</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average remaining contractual term (in years)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Aggregate intrinsic value (in thousands)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">13,204</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">210.45</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2.30</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">40,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2.52</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">-</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,395</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">242.55</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px; width: 52%;"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Outstanding at September 30, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;">50,309</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;">37.75</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;">2.30</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">-</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,352</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">337.50</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">48,957</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">337.50</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4.07</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="width: 52%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">48,957</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">29.48</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table summarizes outstanding common stock purchase warrants as of <em style="font: inherit;"> September 30, 2024</em>:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Number of shares</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average exercise price</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18.1%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Expiration</em></b></p> </td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $176.06 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,079</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">176.06</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">October 2024</em></p> </td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $56.25 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">822</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">56.25</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">January 2025</em></p> </td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $168.30 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,357</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">168.30</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">December 2025</em></p> </td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $168.75 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,199</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">168.75</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">June 2026</em></p> </td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $2.52 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2.52</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">April 2028</em></p> </td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">48,957</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">37.75</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td></tr>
</tbody></table>

   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102945008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 - Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">11</em> </b>&#8211;<b> COMMITMENTS AND CONTINGENCIES</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Commencing <em style="font: inherit;"> August 2019, </em>the Company&#8217;s executive offices were located at <em style="font: inherit;">8845</em> Red Oak Blvd, Charlotte, NC (the &#8220;Red Oak Facilities&#8221;) which we sub-leased under a sublease agreement dated <em style="font: inherit;"> July 11, 2019 </em>which expires <em style="font: inherit;"> December 2026 (</em>the &#8220;Red Oak Sublease&#8221;). We received a default notice from HSKL, Inc., the sub landlord, in <em style="font: inherit;"> September 2023. </em>Effective <em style="font: inherit;"> March 20, 2024 </em>we entered into a License Agreement, dated as of <em style="font: inherit;"> March 14, 2024, </em>by and between cbdMD, Inc. and HSKL (the &#8220;License Agreement&#8221;) and Lease Forbearance Agreement, dated as of <em style="font: inherit;"> March 14, 2024, </em>by and between cbdMD, Inc. and HSKL (the &#8220;Forbearance Agreement&#8221;). Under the License Agreement we have granted HSKL a license to possess and use a portion of the Red Oak Facilities until the earlier of (i) the termination of the Forbearance Agreement and (ii) <em style="font: inherit;"> July 31, 2024 (</em>the &#8220;Termination Date&#8221;). The termination of the License Agreement will result in termination of the Red Oak Sublease. Pursuant to the Forbearance Agreement HSKL has agreed to forbear from proceeding to exercise its remedies against us under the Red Oak Sublease, and the declaration of default related to past due rent in consideration of the following payments to HSKL: $80,000 upon the execution of the Forbearance Agreement, followed by <em style="font: inherit;">four</em> monthly payments of $40,000. HSKL&#8217;s forbearance shall extend to the Termination Date and HSKL shall dismiss (without prejudice) a Complaint in Summary Ejectment filed in Mecklenburg County, North Carolina on <em style="font: inherit;"> February 27, 2024. </em>In the event of our breach of any of the conditions of the Forbearance Agreement, HSKL&#8217;s obligation to forbear shall cease, and HSKL <em style="font: inherit;"> may </em>immediately exercise any and all of its rights or remedies at law, in equity or under the Red Oak Sublease. The Company made all payments required under the Forbearance Agreement and License Agreement and ultimately made a final settlement payment to completely exit all liability associated with the Red Oak Sublease.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999454576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Note Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt Disclosure [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">12</em> </b>&#8211;<b> NOTE PAYABLE</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Effective <em style="font: inherit;"> February 1, 2024 (</em>the &#8220;Effective Date&#8221;), the Company entered into a Securities Purchase Agreement dated <em style="font: inherit;"> January 30, 2024 (</em>the &#8220;Purchase Agreement&#8221;) with <em style="font: inherit;">five</em> institutional investors (the &#8220;Investors&#8221;) whereby the Investors advanced the Company an aggregate of $1,250,000 gross proceeds and the Company issued each Investor an 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note, in the aggregate principal amount of $1,541,666 (the &#8220;Notes&#8221;). The Company intends to use the proceeds from the issuance of the Notes for working capital and general corporate purposes.&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Each Note bears interest of 8% per annum and matures on <em style="font: inherit;"> July 30, 2025. </em>The Note is convertible into shares of common stock at any time following the date of issuance at the Investor&#8217;s option at an initial conversion price of $0.684 per share (the &#8220;Conversion Price&#8221;), subject to certain adjustments. If <em style="font: inherit;">30</em> calendar days, <em style="font: inherit;">60</em> calendar days, <em style="font: inherit;">90</em> calendar days, <em style="font: inherit;">120</em> calendar days, or <em style="font: inherit;">180</em> calendar days after the effective date of the Registration Statement (as defined below) (the &#8220;Adjustment Dates&#8221;), the Conversion Price then in effect is higher than the Market Conversion Price then in effect on the Adjustment Date, the Conversion Price shall automatically decrease to the Market Conversion Price (as defined under the Note). The Conversion Price is subject to a $0.30 floor price. As of the filing date of this report, and after the final <em style="font: inherit;">180</em>-day adjustment, the effective Conversion Price is $0.5066.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Furthermore, at any time after the issuance of the Note, the Company <em style="font: inherit;"> may, </em>after written notice to the Investor, prepay any portion or all outstanding Principal Amount by paying an amount equal to <em style="font: inherit;">125%</em> of the Principal Amount then being prepaid (representing a 25% prepayment premium payable to the Investor which shall <em style="font: inherit;">not</em> constitute a principal repayment); provided that a Registration Statement registering all of the Conversion Shares issuable under the Note shall have been declared effective. If the Company elects to prepay the Note, the Investor shall have the right, upon written notice to the Company within <em style="font: inherit;">five</em> trading days of the Investor&#8217;s receipt of a Prepayment Notice, to convert into common stock, up to <em style="font: inherit;">100%</em> of the Prepayment Amount at the Conversion Price, upon the terms provided in the Note.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>


   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Upon the occurrence of any Event of Default (as defined in the Note), the Interest rate shall automatically be increased to the lesser of 22% per annum or the highest amount permitted by law. In the event that such Event of Default is subsequently cured (and <em style="font: inherit;">no</em> other Event of Default then exists), the adjustment shall cease to be effective as of the day immediately following the date of such cure; provided that the Interest as calculated and unpaid at such increased rate during the continuance of such Event of Default shall continue to apply to the extent relating to the days after the occurrence of such Event of Default through and including the date of such cure of such Event of Default.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In addition, upon the occurrence of Event of Default, which has <em style="font: inherit;">not</em> been cured within any applicable cure period, the Company shall be obligated to pay to the Investor the Mandatory Default Amount, which Mandatory Default Amount shall be payable to the Investor on the date the Event of Default giving rise thereto occurs. In the event the Note shall be converted following the occurrence of an Event of Default, the Investor shall have the option to convert the Mandatory Default Amount, upon the terms provided in the Note.</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Notes are secured by a <em style="font: inherit;">first</em> priority security interest as evidenced by and to the extent set forth in a Security Agreement, by and between the Company and the Investors.&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company elected the fair value option under ASC <em style="font: inherit;">825</em> Fair Value Measurements for the Notes. The Notes were initially recognized at a fair value of $2,702,000 on the balance sheet as of <em style="font: inherit;"> March </em><em style="font: inherit;">31,2024.</em> All subsequent changes in fair value, excluding the impact of the change in fair value related to instrument-specific credit risk are recorded in non-operating income. The changes in fair value related to instrument-specific credit risk is recorded through other comprehensive income (loss).&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The overall change in fair value of the Notes during the year&#160;ended <em style="font: inherit;"> September 30, 2024 </em>was a decrease of $1,357,096. The overall change in principal value related to the conversion of Notes to commons stock during the year&#160;ended <em style="font: inherit;"> September </em><em style="font: inherit;">30,2024</em> was a decrease of $508,757. As of <em style="font: inherit;"> September 30, 2024, </em>total fair value of the Notes is $1,171,308, of which $1,032,909 represents the total principal outstanding.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102843808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 - Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lessee, Operating Leases [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">13</em> </b>&#8211;<b> LEASES</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has lease agreements for its corporate, warehouse and laboratory offices with lease periods expiring between <em style="font: inherit;">2024</em> and <em style="font: inherit;">2025.</em> ASC <em style="font: inherit;">842</em> requires the recognition of leasing arrangements on the consolidated balance sheet as right-of-use assets and liabilities pertaining to the rights and obligations created by the leased assets. The Company determines whether an arrangement is a lease at inception and classify it as finance or operating. All of the Company&#8217;s leases are classified as operating leases. The Company&#8217;s leases do <em style="font: inherit;">not</em> contain any residual value guarantees.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Right-of-use lease assets and corresponding lease liabilities are recognized at commencement date based on the present value of lease payments over the expected lease term. Since the interest rate implicit in our lease arrangements is <em style="font: inherit;">not</em> readily determinable, the Company determined an incremental borrowing rate for each lease based on the approximate interest rate on a collateralized basis with similar remaining terms and payments as of the lease commencement date to determine the present value of future lease payments. The Company&#8217;s lease terms <em style="font: inherit;"> may </em>include options to extend or terminate the lease.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In addition to the monthly base amounts in the lease agreements, the Company is required to pay real estate taxes, insurance and common area maintenance expenses during the lease terms.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Lease costs on operating leases are recognized on a straight-line basis over the lease term and included as a selling, general and administrative expense in the consolidated statements of operations.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Components of operating lease costs are summarized as follows:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Year Ended</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Operating Lease Costs</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,328,497</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Supplemental cash flow information related to operating leases is summarized as follows:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Year Ended</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash paid for amounts included in the measurement of operating lease liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,421,610</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of <em style="font: inherit;"> September 30, 2024</em>, our operating leases had a weighted average remaining lease term of 2.99 years and a weighted average discount rate of 4.66%. Future minimum aggregate lease payments under operating leases as of <em style="font: inherit;"> September 30, 2024</em> are summarized as follows:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>For the year ended September 30,</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">99,467</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total future lease payments</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">99,467</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Less interest</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">771</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total lease liabilities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">98,696</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102835696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 14 - Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">14</em> </b>&#8211;<b> LOSS PER SHARE</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table sets forth the computation of basic and diluted earnings per share for the following periods:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Basic:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,700,126</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(22,938,209</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividends paid or accrued</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,004,001</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,002,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net income loss attributable to cbdMD Inc. common shareholders</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(7,704,127</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(26,940,209</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Shares used in computing basic earnings per share</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>4,312,546</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>2,022,320</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Shares used in computing diluted earnings per share</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>4,312,546</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>2,022,320</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Earnings per share Basic:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Basic earnings per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1.79</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(13.32</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Earnings per share Diluted:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Diluted earnings per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1.79</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(13.32</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
</tbody></table>

   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">At the year ended&#160;<em style="font: inherit;"> September 30, 2024</em>, 100,993&#160;potential shares underlying options, unvested RSUs and warrants as well as 185,223 shares&#160;issuable upon conversion of our Series A Preferred stock&#160;which are excluded from the shares used to calculate diluted loss per share as their inclusion would reduce net loss per share.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999527920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 15 - Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">15</em> </b>&#8211;<b> INCOME TAXES </b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company generated operating losses for the years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> on which it has recognized a full valuation allowance. The Company accounts for is state franchise and minimum taxes as a component of its general and administrative expenses.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table presents the components of the provision for income taxes from continuing operations for the fiscal years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended September 30,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Current</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Federal</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">State</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total current</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Federal</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">State</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total deferred</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total provision</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A reconciliation for the federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended September 30,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Federal statutory income tax rate</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">21.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">21.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">State income taxes, net of federal benefit</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2.1</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.4</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Permanent differences</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">11.9</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(1.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Contingent derivative expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.2</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr><td style="font-family: Times New Roman; font-size: 10pt;">Change in value of convertible debt</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(2.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in valuation allowance</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(33.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(21.1</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Provision for income taxes</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr>
</tbody></table>

   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Significant components of the Company&#8217;s deferred income taxes are shown below:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended September 30,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax assets:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net operating loss carryforwards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">15,478,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">14,784,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">ROU - Liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">22,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">824,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Capital loss carryforward</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">702,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">702,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Allowance for doubtful accounts</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">77,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">9,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Stock compensation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">481,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">521,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Intangibles</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">176,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">105,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Investments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">573,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">180,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accrued expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">101,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">87,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Fixed Assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">57,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">45,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory reserve</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">28,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Capitalized expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">146,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">43,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Charitable contributions</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">13,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">39,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total deferred tax assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">17,826,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">17,367,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax liabilities:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid Expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(76,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(107,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">ROU - Assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(19,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(750,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Intangibles</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total deferred tax liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(95,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(857,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net deferred tax assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">17,731,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">16,510,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Valuation allowance</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(17,731,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(16,510,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net deferred tax liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Net deferred tax liability</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has established a valuation allowance against net deferred tax assets due to the uncertainty that such assets will be realized. The deferred tax liabilities that result from indefinite life intangibles cannot be offset by deferred tax assets. The Company periodically evaluates the recoverability of the deferred tax assets. At such time as it is determined that it is more likely than <em style="font: inherit;">not</em> that deferred tax assets will be realizable, the valuation allowance will be reduced. Under Internal Revenue Code (IRC) Section <em style="font: inherit;">382,</em> the use of net operating loss (&#8220;NOL&#8221;) carryforwards <em style="font: inherit;"> may </em>be limited if a change in ownership of a company occurs. During the year ending <em style="font: inherit;"> September 30, 2018, </em>the company determined that a change of ownership under IRC Section <em style="font: inherit;">382</em> had occurred during the years ending <em style="font: inherit;"> September 30, 2017 </em>and <em style="font: inherit;">2015.</em> As a result of these ownership changes, the pre-ownership change NOL carryforwards would be limited and approximately $2.1 million of such NOLs will expire before being utilized. Therefore, at <em style="font: inherit;"> September 30, 2018 </em>the Company reduced the deferred tax asset and related valuation allowance associated with these NOLs by approximately $0.5 million due to IRC Section <em style="font: inherit;">382.</em></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At <em style="font: inherit;"> September 30, 2024</em>, the Company has utilizable NOL carryforwards of approximately $69.1&#160;million which for federal purposes will carryforward indefinitely.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for its state franchise and minimum taxes as a component of its general and administrative expenses.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company files income tax returns in the United States, and various state jurisdictions. The Company&#8217;s policy is to recognize interest expense and penalties related to income tax matters as tax expense. At <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>, there are <em style="font: inherit;">no</em> unrecognized tax benefits, and there are <em style="font: inherit;">no</em> significant accruals for interest related to unrecognized tax benefits or tax penalties.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has had a valuation allowance against the net deferred tax assets, with the exception of the deferred tax liabilities that result from indefinite-life intangibles ("naked credits"). During the year ended <em style="font: inherit;"> September 30, 2021,&#160;</em>the Company generated enough indefinite life deferred tax assets from post-merger NOLs to reduce the naked credits to <em style="font: inherit;">zero</em> during the year and continue to record a valuation allowance on remaining deferred tax assets.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160; &#160;&#160;</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999083328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 16 - Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
<td class="text">
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE <em style="font: inherit;">16</em> </b>&#8211;<b> SUBSEQUENT EVENTS</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">During the <em style="font: inherit;">first</em> quarter of fiscal <em style="font: inherit;">2025,</em> the Company issued an aggregate of 1,421,067 shares of common stock pursuant to the partial conversion of certain principal and interest related to the Notes. As of the filing date of this report, the Notes have a principal balance of approximately $364,000.&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Effective <em style="font: inherit;"> November 26, 2024, </em>cbdMD, Inc. entered into a Second Amendment to Lease (the &#8220;Amendment&#8221;) to extend the Warehouse Lease entered into on <em style="font: inherit;"> August 27, 2019 (</em>the &#8220;Lease&#8221;) for approximately 80,000 square feet of space located at <em style="font: inherit;">2101</em> Westinghouse Boulevard, Suite A, Charlotte, North Carolina <em style="font: inherit;">28273,</em> which facility also serves as the Company&#8217;s executive offices. The Amendment extends the term of the Lease for a period of <span style="-sec-ix-hidden:c121825615">nineteen</span> months beginning on <em style="font: inherit;"> March 1, 2025 </em>with a new expiration date of <em style="font: inherit;"> September 30, 2026. </em>The Company has <em style="font: inherit;">no</em> further rights to extend or renew the terms of the Lease. The Amendment provides for the monthly base rent of $65,000, with an annual base rent of $9.75 per square feet from <em style="font: inherit;"> March 1, 2025 </em>through <em style="font: inherit;"> February 28, 2026, </em>and $67,600 with an annual base rent of $10.14 per square feet from <em style="font: inherit;"> March 1, 2026 </em>through <em style="font: inherit;"> September 30, 2026. </em>The Company shall also continue to pay Additional Rent and all other amounts (other than &#8220;Monthly Base Rent&#8221;) in accordance with the terms of the Lease, except the &#8220;Controllable CAM Charges provision in Section <em style="font: inherit;">3</em> of Exhibit C to the Lease shall be deemed deleted from the Lease. Furthermore, as set forth under the Amendment the landlord has approved certain subleases entered into by and between the Company and sub tenants for portions of the facility.</p>
   <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
   <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During <em style="font: inherit;"> November 2024, </em>the Company engaged a consultant and issued 175,000 shares of restricted common stock for advisory services.&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999574560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Stockholders' Equity, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Reverse Stock Split</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> April 12, 2023, </em>the board effected a reverse stock split at a ratio of <em style="font: inherit;">one</em>-for-<span style="-sec-ix-hidden:c121825181">forty</span>-five, effective as of <em style="font: inherit;"> April 24, 2023. </em>Unless otherwise indicated, all share numbers in this filing, including shares of common stock and all securities convertible into, or exercisable for, shares of common stock, give effect to the reverse stock split.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Principles of Consolidation</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries CBDI, Paw CBD, Proline Global, and Therapeutics. All material intercompany transactions and balances have been eliminated in consolidation.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Use of Estimates</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's consolidated financial statements have been prepared in accordance with US GAAP and requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Significant estimates made in the accompanying consolidated financial statements include, but are <em style="font: inherit;">not</em> limited to, allowances for doubtful accounts, inventory valuation reserves, certain assumptions related to the valuation of investments other securities, and acquired intangible and long-lived assets and the recoverability of intangible and long-lived assets.&#160;Actual results could differ from these estimates.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Cash and Cash Equivalents</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For financial statements purposes, the Company considers all highly liquid investments with a maturity of less than <em style="font: inherit;">three</em> months when purchased to be cash equivalents.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Accounts Receivable</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Accounts receivables are stated at cost less an allowance for credit losses, if applicable. Credit is extended to customers after an evaluation of the customer&#8217;s financial condition, and generally collateral is <em style="font: inherit;">not</em> required as a condition of credit extension. Management&#8217;s determination of the allowance for credit losses&#160;is based on an evaluation of the receivables, past experience, current economic conditions, and other risks inherent in the receivables portfolio. As of <em style="font: inherit;"> September 30, 2024</em> and <em style="font: inherit;"> September 30, 2023</em>, we had an allowance for credit losses&#160;of $346,197&#160;and $42,180, respectively.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_MerchantReceivableAndReservePolicyTextBlock', window );">Merchant Receivable and Reserve [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Merchant Receivable</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company primarily sells its products through the internet and has an arrangement to process customer payments with multiple <em style="font: inherit;">third</em>-party payment processors. The Company pays a fee between 2.5% and 4.0% of the transaction amounts processed. Pursuant to these agreements, there can be a waiting period between <em style="font: inherit;">2</em> to <em style="font: inherit;">5</em> days prior to reimbursement to the Company, as well as a calculated reserve which some payment processors hold back. Fees and reserves can change periodically with notice from the processors. At <em style="font: inherit;"> September 30, 2024, </em>the receivable from payment processors included $621,678&#160;for the waiting period amount and is recorded as accounts receivable in the accompanying consolidated balance sheet.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Inventory</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Inventory is stated at the lower of cost or net realizable value with cost being determined on a weighted average basis. The cost of inventory includes product cost, freight-in, and production fill and labor (portions of which we outsource to <em style="font: inherit;">third</em> party manufacturers). Write-offs of potentially slow moving or damaged inventory are recorded based on management&#8217;s analysis of inventory levels, forecasted future sales volume and pricing and through specific identification of obsolete or damaged products. We assess inventory quarterly for slow moving products and potential impairments and at a minimum perform a physical inventory count annually near fiscal year end.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositContractsPolicy', window );">Deposit Contracts, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Customer Deposits</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Customer deposits consist of payments received in advance of revenue recognition. Revenue is recognized as revenue recognition criteria are met.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Property and Equipment</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Property and equipment items are stated at cost less accumulated depreciation. Expenditures for routine maintenance and repairs are charged to operations as incurred. Depreciation is charged to expense over the estimated useful lives of the assets using the straight-line method. Generally, the useful lives are <span style="-sec-ix-hidden:c121825195">five</span> years for manufacturing equipment and automobiles and <span style="-sec-ix-hidden:c121825196">three</span> years for software, computer, and furniture and equipment. The useful life for leasehold improvements are over the term of the lease or expected life of the asset, whichever is less. The cost and accumulated depreciation of property are eliminated from the accounts upon disposal, and any resulting gain or loss is included in the consolidated statements of operations for the applicable period. Long-lived assets held and used by the Company are reviewed for impairment whenever changes in circumstance indicate the carrying value of an asset <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Fair Value Accounting</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company utilizes accounting standards for fair value, which include the definition of fair value, the framework for measuring fair value, and disclosures about fair value measurements. Fair value is a market-based measurement, <em style="font: inherit;">not</em> an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, fair value accounting standards establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels <em style="font: inherit;">1</em> and <em style="font: inherit;">2</em> of the hierarchy) and the reporting entity&#8217;s own assumptions about market participant assumptions (unobservable inputs classified within Level <em style="font: inherit;">3</em> of the hierarchy).</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Level <em style="font: inherit;">1</em> inputs utilize quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Level <em style="font: inherit;">2</em> inputs are inputs other than quoted prices included in Level <em style="font: inherit;">1</em> that are directly or indirectly observable for the asset or liability. Level <em style="font: inherit;">2</em> inputs <em style="font: inherit;"> may </em>include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability. Level <em style="font: inherit;">3</em> inputs are unobservable inputs for the asset or liability, which are based on an entity&#8217;s own assumptions, as there is little, if any, observable market activity. In instances where the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">When the Company records an investment in marketable securities the carrying value is&#160;recorded at fair value. Any changes in fair value for marketable securities during a given period will be recorded as an unrealized gain or loss in the consolidated statement of operations. For investments other securities without a readily determinable fair value, the Company <em style="font: inherit;"> may </em>elect to estimate its fair value at cost less impairment plus or minus changes resulting from observable price changes. The Company has elected the fair value method and will make individual determinations on and instrument by instrument basis.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Intangible Assets</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's intangible assets consist of trademarks and other intellectual property, all of which were previously accounted for in accordance with Accounting Standards Codification (ASC) Topic <em style="font: inherit;">350,</em> <i>Intangibles </i>&#8211;<i> Goodwill and Other</i>. The Company employed&#160;the non-amortization approach to account for purchased intangible assets having indefinite lives. Under the non-amortization approach, intangible assets having indefinite lives were <em style="font: inherit;">not</em> amortized into the results of operations, but instead were reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value. We previously performed an annual impairment analysis each fiscal year on the indefinite-lived intangible assets following the steps laid out in ASC <em style="font: inherit;">350</em>-<em style="font: inherit;">30</em>-<em style="font: inherit;">35</em>-<em style="font: inherit;">18.</em> Our annual impairment analysis included a qualitative assessment to determine if it was&#160;necessary to perform the quantitative impairment test. In performing a qualitative assessment, we reviewed events and circumstances that could affect the significant inputs used to determine if the fair value was less than the carrying value of the intangible assets. If a quantitative analysis was necessary, we would analyze various aspects including revenues from the business, associated with the intangible assets. In addition, intangible assets would be tested on an interim basis if an event or circumstance indicates that it is more likely than <em style="font: inherit;">not</em> that an impairment loss has been incurred. The Company analyzed a variety of factors on its business to determine if a circumstance could trigger an impairment loss, and, at the time and based on the information then known, had determined that is it was more likely than <em style="font: inherit;">not</em> that an impairment loss had occurred. See Note <em style="font: inherit;">5</em> more further information on the impairment testing procedures performed at <em style="font: inherit;"> December 31, 2022&#160;</em>and the Company&#8217;s decision to change from indefinite to definite lived status for its trademarks.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company now accounts for its trademarks in accordance with Accounting Standards Codification (ASC) Topic <em style="font: inherit;">360,</em> Property, Plant and Equipment. The Company began amortizing its trademarks over <em style="font: inherit;">20</em> years beginning <em style="font: inherit;"> January 1, 2023&#160;</em>and will perform impairment tests as prescribed by ASC <em style="font: inherit;">360,</em> which states that impairment testing should be completed whenever events or changes in circumstances indicate that the asset group's&#160;carrying value <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable. If there are indications that the asset group's&#160;carrying value <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable, there are <em style="font: inherit;">two</em> further steps involved in long-lived asset impairment testing. Step I of the impairment test, as per ASC <em style="font: inherit;">360,</em> involves estimating the recoverable amount of the asset group and determining the potential for impairment. Step II of the impairment test, as per ASC <em style="font: inherit;">360,</em> if necessary, involves quantifying the fair value of the asset group. As further outlined in Note <em style="font: inherit;">5,</em> during <em style="font: inherit;"> July </em>of fiscal <em style="font: inherit;">2023,</em> the Company determined that based on regulatory uncertainty and ongoing Company performance it was prudent to change the amortization of the &#8220;cbdMD&#8221; and &#8220;directCBDonline&#8221; trademarks to 5 years and &#8220;hempMD&#8221; trademark to 10 years.&#160; This became a triggering event for an impairment test under <em style="font: inherit;">ASC360</em> which resulted in an impairment of the intangibles in <em style="font: inherit;"> July 2023.&#160; </em>As of the end of the <em style="font: inherit;">fourth</em> quarter and fiscal <em style="font: inherit;">2023,</em> a significant decline in market capitalization of both classes of equity as a result of the proxy vote triggered a subsequent impairment test, resulting in additional impairment during the <em style="font: inherit;">fourth</em> quarter of <em style="font: inherit;">2023.</em></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Contingent Liability</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A significant component of the purchase price consideration for the Company&#8217;s acquisition of Cure Based Development includes a fixed number of future shares to be issued as well as a variable number of future shares to be issued based upon the post-acquisition entity reaching certain specified future revenue targets, as further described in Note <em style="font: inherit;">6.</em> The Company made a determination of the fair value of the contingent liabilities as part of the valuation of the assets acquired and liabilities assumed in the business combination.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Revenue Recognition</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Under ASC <em style="font: inherit;">606,</em> <i>Revenue from Contracts with Customers, </i>the Company recognizes revenues when its customer obtains control of promised goods or services, in an amount that reflects the consideration which it expects to receive in exchange for those goods. The Company recognizes revenues following the <em style="font: inherit;">five</em>-step model prescribed under ASC <em style="font: inherit;">606:</em> (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Performance Obligations</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A performance obligation is a promise in a contract to transfer a distinct good or service to a customer. The Company meets that obligation when it has shipped products which have been ordered&#160;by the customer. The Company has reviewed its various revenue streams for its other contracts under the <em style="font: inherit;">five</em>-step approach.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Allocation of Transaction Price</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In the Company&#8217;s current business model, it does <span style="-sec-ix-hidden:c121825240">not</span> have contracts with customers which have multiple elements as revenue is driven purely by online product sales or purchase order-based product sales.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Revenue Recognition</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company records revenue from the sale of its products when risk of loss and title to the product are transferred to the customer, which is upon shipping (and is typically FOB shipping) which is when our performance obligation is met. Net sales are comprised of gross revenues less product returns, trade discounts and customer allowances, which include costs associated with off-invoice mark-downs and other price reductions, as well as trade promotions. These incentive costs are recognized at the later of the date on which the Company recognizes the related revenue or the date on which the Company offers the incentive. The Company currently offers a <em style="font: inherit;">60</em>-day, money-back guarantee.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Disaggregated Revenue</i></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company&#8217;s product revenue is generated primarily through <em style="font: inherit;">two</em> sales channels, E-commerce sales (formerly referred to as consumer sales) and wholesale sales. The Company believes that these categories appropriately reflect how the nature, amount, timing and uncertainty of revenue and cash flows are impacted by economic factors.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A description of the Company&#8217;s principal revenue generating activities are as follows:</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align:middle;width:2.1%;">&#160;</td><td style="vertical-align:top;width:2.1%;"> <p style="font-family:Symbol;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">-</p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">E-commerce sales - consumer products sold through the Company&#8217;s online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due prior to the date of shipment; and</p> </td></tr>
<tr><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:middle;width:auto;">&#160;</td></tr>
<tr><td style="vertical-align:middle;width:auto;">&#160;</td><td style="vertical-align:top;width:auto;"> <p style="font-family:Symbol;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">-</p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Wholesale sales - products sold to the Company&#8217;s wholesale customers for subsequent resale. Revenue is recognized when control of the goods is transferred to the customer, in accordance with the terms of the applicable agreement. Payment terms vary and can typically be <em style="font: inherit;">30</em> days from the date control over the product is transferred to the customer</p> </td></tr>
</tbody></table>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table represents a disaggregation of revenue by sales channel:</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

     <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Fiscal 2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of total</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Fiscal 2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of total</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">E-commerce sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15,655,337</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">80.4</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">19,436,124</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">80.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Wholesale sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">3,826,830</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">19.6</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">4,719,238</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">19.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Net Sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">19,482,167</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;"></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">24,155,362</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;"></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
</tbody></table>

   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Contract assets represent unbilled receivables and are presented within accounts receivable, net on the consolidated balance sheets. Contract liabilities represent unearned revenues and are presented as deferred revenue or customer deposits on the consolidated balance sheets. The Company had <span style="-sec-ix-hidden:c121825244">no</span> material contract assets or liabilities at the beginning or ending of <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Goods and Service [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Cost of Sales</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company&#8217;s cost of sales includes costs associated with distribution, fill and labor expense, components, manufacturing overhead, <em style="font: inherit;">third</em>-party providers, and outbound freight for the Company&#8217;s products sales. For the Company&#8217;s product sales, cost of sales also includes the cost of refurbishing products returned by customers that will be offered for resale, if any, and the cost of inventory write-downs associated with adjustments of held inventories to their net realizable value. These expenses are reflected in the Company&#8217;s consolidated statements of operations when the product is sold and net sales revenues are recognized or, in the case of inventory write-downs, when circumstances indicate that the carrying value of inventories is in excess of their net realizable value.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Cost [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Advertising Costs</b></p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company expenses all costs of advertising and related marketing and promotional costs as incurred. The Company incurred $4.2 million and $6.0&#160;million in advertising and marketing and promotional costs included in operating expenses during the years ended <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em> respectively. The Company believes driving its advertising aids in brand awareness and is critical to maintain brand recognition. We are constantly evaluating advertising methods and costs and working to drive down our cost of customer acquisition.</p>
   <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Income Taxes</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is a North Carolina corporation that is treated as a corporation for federal and state income tax purposes. As of <em style="font: inherit;"> October 1, 2019, </em>CBDI and Paw CBD were wholly owned subsidiaries and are disregarded entities for tax purposes and their entire share of taxable income or loss is included in the tax return of the Company and as of <em style="font: inherit;"> March 15, 2021, </em>Therapeutics is also a wholly owned subsidiary and is a disregarded entity for tax purposes and its entire share of taxable income or loss is included in the tax return of the Company.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for income taxes pursuant to the provisions of the <i>Accounting for Income Taxes </i>topic of the Financial Accounting Standards Board&#160;("FASB") ASC <em style="font: inherit;">740</em> which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. The Company uses the inside basis approach to determine deferred tax assets and liabilities associated with its investment in a consolidated pass-through entity. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than <em style="font: inherit;">not</em> that the net deferred asset will <em style="font: inherit;">not</em> be realized.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>


   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">US GAAP requires management to evaluate tax positions taken by the Company and recognize a tax liability (or asset) if the Company has taken an uncertain tax position that more likely than <em style="font: inherit;">not</em> would <em style="font: inherit;">not</em> be sustained upon examination by the Internal Revenue Service. Management has analyzed the tax positions taken by the Company, and has concluded that as of <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;">2023</em>, there were <em style="font: inherit;">no</em> uncertain tax positions taken or expected to be taken that would require recognition of a liability (or asset) or disclosure in the consolidated financial statements.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Risk, Credit Risk, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Concentrations</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) covers <em style="font: inherit;">$250,000</em> for substantially all depository accounts. The Company from time to time <em style="font: inherit;"> may </em>have amounts on deposit in excess of the insured limits. The Company had a $1,893,606&#160;uninsured balance at <em style="font: inherit;"> September 30, 2024</em> and a $1,163,360&#160;uninsured balance at <em style="font: inherit;"> September 30, 2023</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did <span style="-sec-ix-hidden:c121825261">not</span> have any customers that represented a significant amount of our sales for the year ended <em style="font: inherit;"> September 30, 2024</em>.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Payment Arrangement [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Stock-Based Compensation</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for its stock compensation under the ASC <em style="font: inherit;">718</em>-<em style="font: inherit;">10</em>-<em style="font: inherit;">30,</em> <i>Compensation - Stock Compensation </i>using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity's equity instruments or that <em style="font: inherit;"> may </em>be settled by the issuance of those equity instruments.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company uses the Black-Scholes model for measuring the fair value of options and warrants. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. The Company recognizes forfeitures when they occur.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock', window );">Liquidity and Going Concern Considerations, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Liquidity and Going Concern Considerations</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company experienced a loss of $3.7&#160;million for the fiscal year&#160;ended <em style="font: inherit;"> September 30, 2024</em>,&#160;resulting in a working capital deficit of $1.1 million&#160;at <em style="font: inherit;"> September&#160;</em><em style="font: inherit;">30,</em> <em style="font: inherit;">2024.</em></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">While the Company is taking strong action, believes in the viability of its strategy&#160;and&#160;path to profitability, and in its ability to raise additional funds, there can be&#160;<em style="font: inherit;">no</em>&#160;assurances to that effect.&#160;&#160;The Company&#8217;s working capital position <em style="font: inherit;"> may </em><em style="font: inherit;">not</em>&#160;be sufficient to support the Company&#8217;s daily operations for the <em style="font: inherit;">twelve</em>&#160;months subsequent to the issuance of these annual financial statements.&#160;The Company&#8217;s ability to continue as a going concern is dependent upon its ability to improve profitability and the ability to acquire additional funding. These and other factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern within <em style="font: inherit;">twelve</em> months after the date that the annual financial statements are issued. These financial statements do <em style="font: inherit;">not</em> include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that <em style="font: inherit;"> may&#160;</em>result in the Company <em style="font: inherit;">not</em> being able to continue as a going concern.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Convertible Notes</b></p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Effective <em style="font: inherit;"> February 1, 2024 (</em>the &#8220;Effective Date&#8221;), the Company entered into a Securities Purchase Agreement dated <em style="font: inherit;"> January 30, 2024 (</em>the &#8220;Purchase Agreement&#8221;) with <em style="font: inherit;">five</em> institutional investors (the &#8220;Investors&#8221;) whereby the Investors advanced the Company an aggregate of $1,250,000 gross proceeds and the Company issued each Investor an 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note, in the aggregate principal amount of $1,541,666 (the &#8220;Notes&#8221;). The Company is using the proceeds from the issuance of the Notes for working capital and general corporate purposes. The Company elected the fair value option under ASC <em style="font: inherit;">825</em> Fair Value Measurements for the Notes. The Notes were initially recognized at fair value on the balance sheet. All subsequent changes in fair value, excluding the impact of the change in fair value related to instrument-specific credit risk are recorded in non-operating income. The changes in fair value related to instrument-specific credit risk is recorded through other comprehensive income (loss). See Note <em style="font: inherit;">12</em> for more information related to the Notes.</p>
   <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Earnings (Loss) Per Share</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company uses ASC <em style="font: inherit;">260</em>-<em style="font: inherit;">10,</em> <i>Earnings Per Share </i>for calculating the basic and diluted income (loss) per share. The Company computes basic income (loss) per share by dividing net income (loss) and net income (loss) attributable to common shareholders, after deducting preferred stock dividends, by the weighted average number of common shares outstanding. Common equivalent shares are excluded from the computation of net loss per share if their effect is anti-dilutive.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> February 16, 2023, </em>we held an annual meeting of stockholders. At the annual meeting, our stockholders approved an amendment to our articles of incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of common stock by a ratio of between <em style="font: inherit;">one</em>-for-<span style="-sec-ix-hidden:c121825285">twenty</span> to <span style="-sec-ix-hidden:c121825286">one</span>-for-fifty, inclusive, with the exact ratio to be set at the discretion of our board of directors, at any time after approval of the amendment and prior to <em style="font: inherit;"> February 16, 2024. </em>On <em style="font: inherit;"> April 12, 2023, </em>the board effected a reverse stock split at a ratio of <em style="font: inherit;">one</em>-for-<span style="-sec-ix-hidden:c121825288">forty</span>-five, effective as of <em style="font: inherit;"> April 24, 2023 (</em>the "Reverse Stock Split"). Unless otherwise indicated, all share numbers in this report, including shares of common stock and all securities convertible into, or exercisable for, shares of common stock, give effect to the Reverse Stock Split.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text"><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>New Accounting</b>&#160;<b>Standards</b></p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
   <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company adopted ASU <em style="font: inherit;">2016</em>-<em style="font: inherit;">13</em> Financial Instruments &#8211; Credit Losses (Topic <em style="font: inherit;">326</em>): Measurement of Credit Losses on Financial Instruments (ASC <em style="font: inherit;">326</em>) effective <em style="font: inherit;"> October 1, 2023. </em>This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (&#8220;CECL&#8221;) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities, and some off-balance sheet credit exposures such as unfunded commitments to extend credit. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses.&#160;The adoption of&#160;this standard had <em style="font: inherit;">no</em> material impact&#160;on the consolidated financial statements.</p>
   <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160;&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 705<br> -Publisher FASB<br> -URI https://asc.fasb.org/705/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositContractsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the treatment of funds received from or paid to insureds, insurers and reinsurers on contracts for which the criteria for transferring or assuming insurance risk has not been satisfied by the insurer or reinsurer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -SubTopic 825<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477037/944-825-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositContractsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for liquidity and going concern considerations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_MerchantReceivableAndReservePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for merchant receivables and reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_MerchantReceivableAndReservePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999280048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Organization and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text">
     <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Fiscal 2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of total</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Fiscal 2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">% of total</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">E-commerce sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15,655,337</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">80.4</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">19,436,124</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">80.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Wholesale sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">3,826,830</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">19.6</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">4,719,238</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">19.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Net Sales</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">19,482,167</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;"></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;">24,155,362</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double black;"></td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
</tbody></table>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132005474576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Marketable Securities and Investment Other Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">In Active</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><b><em style="font: inherit;">Markets for</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><b><em style="font: inherit;">Significant Other</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"><b><em style="font: inherit;">Significant</em></b></td><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Identical Assets</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Observable</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Unobservable</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">and Liabilities</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Inputs</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Inputs</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(Level 1)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(Level 2)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(Level 3)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 55%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at September 30, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(276,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in value of equities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: Times New Roman;">Change in value of contingent liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Additional Investment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">185,638</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at September 30, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(90,362</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in value of contingent liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">-</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">90,362</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr><td style="font-family: Times New Roman; font-size: 10pt;">Fair value of convertible notes</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"></td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,171,308</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Balance at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,171,308</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102916016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 - Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Finished Goods</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,534,718</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,782,680</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory Components</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">830,469</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,397,034</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory Reserve</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(126,742</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory prepaid</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">159,006</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">182,675</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Inventory</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,524,193</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,235,647</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102931328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Computers, furniture and equipment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,587,411</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,392,776</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Manufacturing equipment</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">284,275</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">284,275</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Leasehold improvements</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">487,081</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">487,081</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Automobiles</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">11,087</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,358,767</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,175,219</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Less accumulated depreciation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,904,499</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,458,640</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Property and equipment, net</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">454,268</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">716,579</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102942672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Trademark related to cbdMD</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">21,585,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">21,585,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Trademark for HempMD</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">50,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">50,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Technology Relief from Royalty related to DirectCBDOnline.com</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">667,844</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">667,844</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Tradename related to CBD MD limited mark</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">368,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Tradename related to DirectCBDOnline.com</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">749,567</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">749,567</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Impairment of definite lived intangible assets:</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">(17,504,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">(17,504,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Amortization of definite lived intangible assets:</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,026,831</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(2,329,321</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,889,580</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,219,090</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>For the year ended September 30,</b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2025</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">762,457</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">733,740</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2027</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">733,740</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">2028</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">569,923</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">89,720</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total future intangibles amortization</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>2,889,580</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"><b>&#160;</b></td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102881824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Contingent Liability (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Aggregate Net Revenues</p> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">Shares Issued/ Each $ of Aggregate Net Revenue Ratio</em></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="width: 48%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 48%;">&#160;</td><td style="width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825661">1</span> - $<span style="-sec-ix-hidden:c121825662">20,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.004236111</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825663">20,000,001</span> - $<span style="-sec-ix-hidden:c121825664">60,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.002118056</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825665">60,000,001</span> - $<span style="-sec-ix-hidden:c121825666">140,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.001059028</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">$<span style="-sec-ix-hidden:c121825667">140,000,001</span> - $<span style="-sec-ix-hidden:c121825668">300,000,000</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.005295139</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999519760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average exercise price</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.54</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">10.35 - 12.60</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Risk free interest rate</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3.93% - 4.71%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Volatility</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">107%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">106.48% - 106.51%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected term (in years)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2.5 - 4</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Dividend yield</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">None</em></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">None</em></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999410720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Stock Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">remaining</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Aggregate</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">contractual term</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">intrinsic value</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Number of shares</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">exercise price</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(in years)</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">(in thousands)</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Outstanding at September 30, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">55,656</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">151.10</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0">4.55</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding: 0; margin: 0"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7,233</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">11.51</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">-</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(21,124</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">88.12</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">41,765</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">144.43</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.65</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">8,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0.86</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">-</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(5,730</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">117.35</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">44,035</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">123.58</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3.14</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="width: 40%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 12%;">&#160;</td><td style="width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 40%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">44,035</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">123.58</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3.14</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999391552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 - Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_CommonStockPurchaseWarrantsMember', window );">Common Stock Purchase Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Number of shares</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average exercise price</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18.1%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Expiration</em></b></p> </td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $176.06 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,079</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">176.06</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">October 2024</em></p> </td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $56.25 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">822</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">56.25</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">January 2025</em></p> </td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $168.30 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,357</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">168.30</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">December 2025</em></p> </td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $168.75 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,199</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">168.75</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">June 2026</em></p> </td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at $2.52 per share</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2.52</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><em style="font: inherit;">April 2028</em></p> </td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">48,957</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">37.75</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_EquityClassifiedWarrantsMember', window );">Equity Classified Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Number of shares</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average exercise price</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Weighted-average remaining contractual term (in years)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Aggregate intrinsic value (in thousands)</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2022</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">13,204</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">210.45</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2.30</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">40,500</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2.52</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">-</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,395</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">242.55</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px; width: 52%;"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Outstanding at September 30, 2023</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;">50,309</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;">37.75</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;">2.30</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">-</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&#160;</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercised</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,352</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">337.50</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&#160;</em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Outstanding at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">48,957</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">337.50</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4.07</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="width: 52%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercisable at September 30, 2024</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">48,957</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">29.48</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_CommonStockPurchaseWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ycbd_CommonStockPurchaseWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_EquityClassifiedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ycbd_EquityClassifiedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999454576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 - Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Year Ended</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Operating Lease Costs</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,328,497</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>

    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">Year Ended</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash paid for amounts included in the measurement of operating lease liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,421,610</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>For the year ended September 30,</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">99,467</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total future lease payments</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">99,467</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Less interest</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">771</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total lease liabilities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">98,696</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102931328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 14 - Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">September 30,</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Basic:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,700,126</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(22,938,209</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Preferred dividends paid or accrued</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,004,001</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,002,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net income loss attributable to cbdMD Inc. common shareholders</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(7,704,127</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(26,940,209</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Shares used in computing basic earnings per share</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>4,312,546</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>2,022,320</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Shares used in computing diluted earnings per share</b></p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>4,312,546</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>2,022,320</b></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Earnings per share Basic:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;">&#160;</em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">-</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Basic earnings per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1.79</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(13.32</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Earnings per share Diluted:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Diluted earnings per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1.79</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(13.32</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999418432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 15 - Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended September 30,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Current</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Federal</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">State</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total current</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Federal</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">State</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total deferred</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total provision</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended September 30,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Federal statutory income tax rate</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">21.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">21.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">State income taxes, net of federal benefit</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2.1</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.4</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Permanent differences</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">11.9</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(1.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Contingent derivative expense</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.2</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr><td style="font-family: Times New Roman; font-size: 10pt;">Change in value of convertible debt</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(2.5</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in valuation allowance</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(33.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(21.1</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Provision for income taxes</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
<td class="text">
    <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended September 30,</em></em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2024</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><em style="font: inherit;">2023</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax assets:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net operating loss carryforwards</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">15,478,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">14,784,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">ROU - Liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">22,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">824,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Capital loss carryforward</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">702,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">702,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Allowance for doubtful accounts</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">77,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">9,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Stock compensation</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">481,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">521,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Intangibles</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">176,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">105,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Investments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">573,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">180,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accrued expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">101,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">87,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Fixed Assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">57,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">45,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory reserve</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">28,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Capitalized expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">146,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">43,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Charitable contributions</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">13,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">39,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total deferred tax assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">17,826,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">17,367,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax liabilities:</p> </td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="font-family: Times New Roman; font-size: 10pt;">&#160;</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid Expenses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(76,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(107,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">ROU - Assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(19,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">(750,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Intangibles</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total deferred tax liabilities</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(95,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(857,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net deferred tax assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">17,731,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">16,510,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Valuation allowance</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(17,731,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(16,510,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr>
<tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net deferred tax liability</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#160;</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#160;</td></tr>
</tbody></table>
   <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132001045184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 12, 2023</div></th>
<th class="th"><div>Feb. 16, 2023</div></th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 346,197<span></span>
</td>
<td class="nump">$ 42,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">621,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract with Customer, Asset, after Allowance for Credit Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Marketing and Advertising Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash, Uninsured Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,893,606<span></span>
</td>
<td class="nump">$ 1,163,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_NetIncomeLossIncludingImpairment', window );">Net Income (Loss) Including Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_WorkingCapital', window );">Working Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember', window );">Investors 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="nump">$ 1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_DebtInstrumentDiscountedPercentage', window );">Debt Instrument Discounted Percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 1,541,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_NumberOfMajorCustomers', window );">Number of Major Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_CbdmdAndDirectcbdonlineTrademarksMember', window );">cbdMD and directCBDonline Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToHempMdMember', window );">Trademark Related to Hemp MD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_ManufacturingEquipmentMember', window );">Manufacturing Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_SoftwareMember', window );">Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_Merchantprocessingfee', window );">MerchantProcessingFee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_Merchantprocessingfee', window );">MerchantProcessingFee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionTypeAxis=ycbd_ReverseStockSplitMember', window );">Reverse Stock Split [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stockholders' Equity Note, Stock Split, Conversion Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionTypeAxis=ycbd_ReverseStockSplitMember', window );">Reverse Stock Split [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stockholders' Equity Note, Stock Split, Conversion Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionTypeAxis=ycbd_ReverseStockSplitMember', window );">Reverse Stock Split [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stockholders' Equity Note, Stock Split, Conversion Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_DebtInstrumentDiscountedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percent of discount convertible promissory note issued to investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_DebtInstrumentDiscountedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_Merchantprocessingfee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents agreed percentage for merchant processing fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_Merchantprocessingfee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_NetIncomeLossIncludingImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents net income (loss) for the period including impairments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_NetIncomeLossIncludingImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_NumberOfMajorCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of major customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_NumberOfMajorCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the value of total current assets net of current liabilities as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_CbdmdAndDirectcbdonlineTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_CbdmdAndDirectcbdonlineTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToHempMdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToHempMdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_ManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_ManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_SoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_SoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonmonetaryTransactionTypeAxis=ycbd_ReverseStockSplitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonmonetaryTransactionTypeAxis=ycbd_ReverseStockSplitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132005200256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Organization and Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues, Total</a></td>
<td class="nump">$ 19,482,167<span></span>
</td>
<td class="nump">$ 24,155,362<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=ycbd_SalesChannelMember', window );">Sales Channel [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Sales Channel, Directly to Consumer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues, Total</a></td>
<td class="nump">$ 15,655,337<span></span>
</td>
<td class="nump">$ 19,436,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Sales Channel, Directly to Consumer [Member] | Sales Channel [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">80.40%<span></span>
</td>
<td class="nump">80.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember', window );">Sales Channel, Through Intermediary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues, Total</a></td>
<td class="nump">$ 3,826,830<span></span>
</td>
<td class="nump">$ 4,719,238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember', window );">Sales Channel, Through Intermediary [Member] | Sales Channel [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">19.60%<span></span>
</td>
<td class="nump">19.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=ycbd_SalesChannelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=ycbd_SalesChannelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999310848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Marketable Securities and Investment Other Securities (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Apr. 07, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments', window );">Marketable Security, Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (700,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ycbd_SteadyStateLlcMember', window );">Steady State, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_EquipmentSoldValue', window );">Equipment Sold Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Equity Method Investment, Other-than-Temporary Impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary decline in value that has been recognized against investment accounted for under equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_EquipmentSoldValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total value of equipment sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_EquipmentSoldValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ycbd_SteadyStateLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ycbd_SteadyStateLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132005158880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Marketable Securities and Investment Other Securities - Assets Valued at Fair Value (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityFairValueAdjustment', window );">Change in value of equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions', window );">Additional Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Contingent Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in value of liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in value of liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityFairValueAdjustment', window );">Change in value of equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions', window );">Additional Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Contingent Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in value of liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in value of liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Balance</a></td>
<td class="num">(90,362)<span></span>
</td>
<td class="num">(276,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityFairValueAdjustment', window );">Change in value of equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions', window );">Additional Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Balance</a></td>
<td class="nump">1,171,308<span></span>
</td>
<td class="num">(90,362)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Contingent Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in value of liabilities</a></td>
<td class="nump">90,362<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in value of liabilities</a></td>
<td class="nump">$ 1,171,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross additions to the investment in and advance to the affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ycbd_ContingentLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ycbd_ContingentLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ycbd_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ycbd_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132000543744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 - Inventory (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory Write-down</a></td>
<td class="nump">$ 921,314<span></span>
</td>
<td class="nump">$ 921,314<span></span>
</td>
<td class="nump">$ 175,499<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102912416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 3 - Inventory - Schedule of Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished Goods</a></td>
<td class="nump">$ 1,534,718<span></span>
</td>
<td class="nump">$ 2,782,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSupplies', window );">Inventory Components</a></td>
<td class="nump">830,469<span></span>
</td>
<td class="nump">1,397,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory Reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(126,742)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_PrepaidInventory', window );">Inventory prepaid</a></td>
<td class="nump">159,006<span></span>
</td>
<td class="nump">182,675<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total Inventory</a></td>
<td class="nump">$ 2,524,193<span></span>
</td>
<td class="nump">$ 4,235,647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_PrepaidInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for inventory that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_PrepaidInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999002480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Property and Equipment (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease', window );">Depreciation, Excluding Lessor Asset under Operating Lease</a></td>
<td class="nump">$ 452,326<span></span>
</td>
<td class="nump">$ 404,280<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of depreciation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132004982224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 4 - Property and Equipment - Major Classes of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 2,358,767<span></span>
</td>
<td class="nump">$ 2,175,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(1,904,499)<span></span>
</td>
<td class="num">(1,458,640)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">454,268<span></span>
</td>
<td class="nump">716,579<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_ComputersFurnitureAndEquipmentMember', window );">Computers, Furniture, and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,587,411<span></span>
</td>
<td class="nump">1,392,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_ManufacturingEquipmentMember', window );">Manufacturing Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">284,275<span></span>
</td>
<td class="nump">284,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">487,081<span></span>
</td>
<td class="nump">487,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobiles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11,087<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_ComputersFurnitureAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_ComputersFurnitureAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_ManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ycbd_ManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132001032512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Intangible Assets (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 697,510<span></span>
</td>
<td class="nump">$ 1,396,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">13,219,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ycbd_MajikMedicinesMember', window );">Majik Medicines [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_LengthOfConsultingAgreement', window );">Length of Consulting Agreement (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_CommissionPercentage', window );">Commission Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ycbd_CaseWithMajikMedicinesMember', window );">Case With Majik Medicines [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_LitigationSettlementInitialPayment', window );">Litigation Settlement, Initial Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_LitigationSettlementMonthlyPaymentAmount', window );">Litigation Settlement, Monthly Payment Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ycbd_CaseWithMajikMedicinesMember', window );">Case With Majik Medicines [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in shares)</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_CbdmdAndDirectcbdonlineTrademarksMember', window );">cbdMD and directCBDonline Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,192,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToHempMdMember', window );">Trademark Related to Hemp MD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 697,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_CommissionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of commission granted under an agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_CommissionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_LengthOfConsultingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the length of a consulting agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_LengthOfConsultingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_LitigationSettlementInitialPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid as the initial payment for the settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_LitigationSettlementInitialPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_LitigationSettlementMonthlyPaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid as a monthly payment for the settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_LitigationSettlementMonthlyPaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ycbd_MajikMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ycbd_MajikMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ycbd_CaseWithMajikMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ycbd_CaseWithMajikMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_CbdmdAndDirectcbdonlineTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_CbdmdAndDirectcbdonlineTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToHempMdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToHempMdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132005397824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 5 - Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_FinitelivedIntangibleAssetAccumulatedImpairment', window );">Impairment of definite lived intangible assets:</a></td>
<td class="num">$ (17,504,000)<span></span>
</td>
<td class="num">$ (17,504,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Amortization of definite lived intangible assets:</a></td>
<td class="num">(3,026,831)<span></span>
</td>
<td class="num">(2,329,321)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill), Total</a></td>
<td class="nump">2,889,580<span></span>
</td>
<td class="nump">3,219,090<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember', window );">Technology Relief From Royalty Related To Direct C B D Online Com Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">667,844<span></span>
</td>
<td class="nump">667,844<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_CbdMdLimintedMarkMember', window );">CBD MD Liminted Mark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">368,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TradenameRelatedToDirectCBDOnlineComMember', window );">Tradename Related To Direct C B D Online Com Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">749,567<span></span>
</td>
<td class="nump">749,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToCbdmdMember', window );">Trademark Related to cbdMD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTrademarks', window );">Indefinite lived trademark</a></td>
<td class="nump">21,585,000<span></span>
</td>
<td class="nump">21,585,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToHempMdMember', window );">Trademark Related to Hemp MD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTrademarks', window );">Indefinite lived trademark</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTrademarks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTrademarks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_FinitelivedIntangibleAssetAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment of finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_FinitelivedIntangibleAssetAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_CbdMdLimintedMarkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_CbdMdLimintedMarkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TradenameRelatedToDirectCBDOnlineComMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TradenameRelatedToDirectCBDOnlineComMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToCbdmdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToCbdmdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToHempMdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ycbd_TrademarkRelatedToHempMdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132000239424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 5 - Intangible Assets - Future Amortization of Intangible Assets (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 762,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">733,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">733,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">569,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">89,720<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total future intangibles amortization</a></td>
<td class="nump">$ 2,889,580<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132103901456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Contingent Liability (Details Textual) - Cure Based Development, Llc [Member] - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 11, 2024</div></th>
<th class="th"><div>Dec. 20, 2018</div></th>
<th class="th"><div>Apr. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ycbd_CureBasedDevelopmentLlcMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">338,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)</a></td>
<td class="nump">19,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">338,889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares, Expiration (Month)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ycbd_CureBasedDevelopmentLlcMember', window );">Registered Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,445<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ycbd_CureBasedDevelopmentLlcMember', window );">Unregistered Common Stock 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194,945<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ycbd_CureBasedDevelopmentLlcMember', window );">Unregistered Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod', window );">Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the additional shares issued or issuable for business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the expiration period for additional shares issuable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the vesting period of issued and/or issuable shares issued for acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ycbd_CureBasedDevelopmentLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ycbd_CureBasedDevelopmentLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ycbd_RegisteredCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ycbd_RegisteredCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ycbd_UnregisteredCommonStock2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ycbd_UnregisteredCommonStock2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ycbd_UnregisteredCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ycbd_UnregisteredCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999941616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Contingent Liability - Contingent Liability (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween1And20000000Member', window );">Earnout Shares for Revenue Between $1 and $20,000,000 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio', window );">Business Acquisition, Contingent Consideration, Shares Issued Per Aggregate Net Revenue Ratio</a></td>
<td class="nump">0.004236111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member', window );">Earnout Shares for Revenue Between $20,000,001 and $60,000,000 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio', window );">Business Acquisition, Contingent Consideration, Shares Issued Per Aggregate Net Revenue Ratio</a></td>
<td class="nump">0.002118056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member', window );">Earnout Shares for Revenue Between $60,000,001 and $140,000,000 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio', window );">Business Acquisition, Contingent Consideration, Shares Issued Per Aggregate Net Revenue Ratio</a></td>
<td class="nump">0.001059028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member', window );">Earnout Shares for Revenue Between $140,000,001 and $300,000,000 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio', window );">Business Acquisition, Contingent Consideration, Shares Issued Per Aggregate Net Revenue Ratio</a></td>
<td class="nump">0.005295139<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the shares issued per dollar of net revenue for contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween1And20000000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween1And20000000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132003496384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Contingent Liability - Contingent Liability (Details) (Parentheticals)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween1And20000000Member', window );">Earnout Shares for Revenue Between $1 and $20,000,000 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue', window );">Aggregate net revenue</a></td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween1And20000000Member', window );">Earnout Shares for Revenue Between $1 and $20,000,000 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue', window );">Aggregate net revenue</a></td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member', window );">Earnout Shares for Revenue Between $20,000,001 and $60,000,000 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue', window );">Aggregate net revenue</a></td>
<td class="nump">20,000,001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member', window );">Earnout Shares for Revenue Between $20,000,001 and $60,000,000 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue', window );">Aggregate net revenue</a></td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member', window );">Earnout Shares for Revenue Between $60,000,001 and $140,000,000 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue', window );">Aggregate net revenue</a></td>
<td class="nump">60,000,001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member', window );">Earnout Shares for Revenue Between $60,000,001 and $140,000,000 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue', window );">Aggregate net revenue</a></td>
<td class="nump">140,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member', window );">Earnout Shares for Revenue Between $140,000,001 and $300,000,000 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue', window );">Aggregate net revenue</a></td>
<td class="nump">140,000,001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member', window );">Earnout Shares for Revenue Between $140,000,001 and $300,000,000 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue', window );">Aggregate net revenue</a></td>
<td class="nump">$ 300,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents aggregate net revenue for contingent consideration for business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween1And20000000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween1And20000000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131994348176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Shareholders' Equity (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="12">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2024</div></th>
<th class="th"><div>Feb. 13, 2024</div></th>
<th class="th"><div>May 03, 2023</div></th>
<th class="th"><div>Apr. 24, 2023</div></th>
<th class="th"><div>Mar. 02, 2023</div></th>
<th class="th"><div>Feb. 02, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Aug. 30, 2023</div></th>
<th class="th"><div>Jun. 01, 2023</div></th>
<th class="th"><div>Feb. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,669,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,669,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,669,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_DividendsPayableQuarterlyGrowth', window );">Dividends Payable, Quarterly Growth</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,939,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,960,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,939,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,939,057<span></span>
</td>
<td class="nump">2,960,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,939,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,960,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,939,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,939,057<span></span>
</td>
<td class="nump">2,960,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Stock Issued During Period, Shares, Reverse Stock Splits (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,001<span></span>
</td>
<td class="nump">$ 2,478,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">7,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember', window );">Share-Based Payment Arrangement, Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,334<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember', window );">Share-Based Payment Arrangement, Employee [Member] | Vesting Annually Over Three Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember', window );">Share-Based Payment Arrangement, Employee [Member] | Vest Upon Achieving Certain Revenue Performance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsWithPublicOfferingMember', window );">Warrants With Public Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ycbd_PublicOfferingMember', window );">Public Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ProceedsFromIssuanceOfCommonStockNet', window );">Proceeds From Issuance of Common Stock, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ycbd_CureBasedDevelopmentLlcMember', window );">Cure Based Development, Llc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=ycbd_BoardOfDirectorsMember', window );">Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Employee [Member] | Vesting Annually Over Three Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Payment Arrangement, Expense</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionByUniqueDescriptionAxis=ycbd_ConversionOfNotesIntoCommonStockMember', window );">Conversion of Notes into Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,624<span></span>
</td>
<td class="nump">714,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ycbd_KeystoneMember', window );">Keystone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ycbd_KeystoneMember', window );">Keystone [Member] | Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,616<span></span>
</td>
<td class="nump">2,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ycbd_MajikMedicinesMember', window );">Majik Medicines [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ycbd_A360MediaLlcMember', window );">a360 Media, LLC [Member] | Advertising Placement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement', window );">Agreement for Advertising Placement, Credit for Media Support and Advertising Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_AgreementForAdvertisingPlacementUnutilizedAmount', window );">Agreement for Advertising Placement, Unutilized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 514,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_PercentageOfSharesFullyVested', window );">Percentage of Shares Fully Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement', window );">Percentage of Shares Vest Upon Each Advertising Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories', window );">Percentage of Shares Vest Provided No Restrictions in Product Categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ycbd_TwentyTwoCapitalMember', window );">Twenty Two Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ycbd_SeriesACumulativeConvertiblePreferredStockMember', window );">Series A Cumulative Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Dividends, Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,004,001<span></span>
</td>
<td class="nump">$ 4,002,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ycbd_CommitmentSharesMember', window );">Commitment Shares [Member] | Keystone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_PurchaseCommitmentMaximumSharesCommitment', window );">Purchase Commitment, Maximum Shares Commitment (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ShareNumberStockIssuable', window );">Share Number, Stock Issuable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_NumberOfSharesRegisteredForResale', window );">Number of Shares Registered for Resale (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478790/946-405-45-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit for media support and advertising placement for agreement for advertising placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_AgreementForAdvertisingPlacementUnutilizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount unutilized of agreement for advertising placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_AgreementForAdvertisingPlacementUnutilizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_DividendsPayableQuarterlyGrowth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the accrued liability for dividends declared but not paid grows per quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_DividendsPayableQuarterlyGrowth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_NumberOfSharesRegisteredForResale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of shares that are registered for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_NumberOfSharesRegisteredForResale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_PercentageOfSharesFullyVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of shares fully vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_PercentageOfSharesFullyVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of shares vested provided no restrictions in product categories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of shares vest upon each advertising placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ProceedsFromIssuanceOfCommonStockNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net amount of cash inflow from issuance of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ProceedsFromIssuanceOfCommonStockNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_PurchaseCommitmentMaximumSharesCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares committed to purchase under purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_PurchaseCommitmentMaximumSharesCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ShareNumberStockIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuable during a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ShareNumberStockIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=ycbd_VestingAnnuallyOverThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=ycbd_VestingAnnuallyOverThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=ycbd_VestUponAchievingCertainRevenuePerformanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=ycbd_VestUponAchievingCertainRevenuePerformanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsWithPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsWithPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ycbd_PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ycbd_PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ycbd_CureBasedDevelopmentLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ycbd_CureBasedDevelopmentLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ycbd_BoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ycbd_BoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionByUniqueDescriptionAxis=ycbd_ConversionOfNotesIntoCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionByUniqueDescriptionAxis=ycbd_ConversionOfNotesIntoCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ycbd_KeystoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ycbd_KeystoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ycbd_PurchaseagreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ycbd_PurchaseagreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ycbd_MajikMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ycbd_MajikMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ycbd_A360MediaLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ycbd_A360MediaLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ycbd_AdvertisingPlacementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ycbd_AdvertisingPlacementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ycbd_TwentyTwoCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ycbd_TwentyTwoCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ycbd_SeriesACumulativeConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ycbd_SeriesACumulativeConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ycbd_CommitmentSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ycbd_CommitmentSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131994668880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Shareholders' Equity - Fair Value Assumptions of Stock Options (Details) - Share-Based Payment Arrangement, Option [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Volatility</a></td>
<td class="nump">107.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years) (Year)</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.93%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106.48%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years) (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.71%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106.51%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years) (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131994125616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Stock Based Compensation (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2024</div></th>
<th class="th"><div>Apr. 19, 2019</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jan. 08, 2021</div></th>
<th class="th"><div>Jun. 02, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Payment Arrangement, Expense</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="nump">448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,760<span></span>
</td>
<td class="nump">$ 5,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Board of Directors [Member] | Share-Based Payment Arrangement, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Board of Directors [Member] | Share-Based Payment Arrangement, Tranche Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Board of Directors [Member] | Share-Based Payment Arrangement, Tranche Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Board of Directors [Member] | Share-Based Payment Arrangement, Tranche Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,889<span></span>
</td>
<td class="nump">1,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Vest Based on Certain Performance Hurdles Prior to December 2024 [Member] | Share-Based Payment Arrangement, Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ycbd_The2015PlanMember', window );">The 2015 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ycbd_The2015PlanMember', window );">The 2015 Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ycbd_The2021PlanMember', window );">The 2021 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ycbd_The2021PlanMember', window );">The 2021 Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the annual increase of authorized shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the annual increase in shares for shares authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ycbd_BoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ycbd_BoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=ycbd_SharebasedPaymentArrangementTrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=ycbd_SharebasedPaymentArrangementTrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ycbd_The2015PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ycbd_The2015PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ycbd_The2021PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ycbd_The2021PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132189790304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Stock Based Compensation - Summary of Stock Option Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding (in shares)</a></td>
<td class="nump">41,765<span></span>
</td>
<td class="nump">55,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 144.43<span></span>
</td>
<td class="nump">$ 151.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, weighted average remaining contractual term (Year)</a></td>
<td class="text">3 years 1 month 20 days<span></span>
</td>
<td class="text">3 years 7 months 24 days<span></span>
</td>
<td class="text">4 years 6 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">7,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 11.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(5,730)<span></span>
</td>
<td class="num">(21,124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 117.35<span></span>
</td>
<td class="nump">$ 88.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 123.58<span></span>
</td>
<td class="nump">$ 144.43<span></span>
</td>
<td class="nump">$ 151.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding (in shares)</a></td>
<td class="nump">44,035<span></span>
</td>
<td class="nump">41,765<span></span>
</td>
<td class="nump">55,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 123.58<span></span>
</td>
<td class="nump">$ 144.43<span></span>
</td>
<td class="nump">$ 151.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, weighted average remaining contractual term (Year)</a></td>
<td class="text">3 years 1 month 20 days<span></span>
</td>
<td class="text">3 years 7 months 24 days<span></span>
</td>
<td class="text">4 years 6 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">44,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 123.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable (Year)</a></td>
<td class="text">3 years 1 month 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132005267056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 - Warrants - Schedule of Equity-Classified Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Oct. 01, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm', window );">Outstanding, warrant, contractual term (Year)</a></td>
<td class="text">4 years 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightGrantsInPeriod', window );">Granted, warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, warrant, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisesInPeriod', window );">Exercised, warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, warrant, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightForfeituresInPeriod', window );">Forfeited, warrants (in shares)</a></td>
<td class="nump">1,352<span></span>
</td>
<td class="num">(3,395)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited, warrant, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 337.5<span></span>
</td>
<td class="nump">$ 242.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding, warrants (in shares)</a></td>
<td class="nump">48,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice', window );">Outstanding, warrant, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 337.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisesInPeriod', window );">Exercised, warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightForfeituresInPeriod', window );">Forfeited, warrants (in shares)</a></td>
<td class="num">(1,352)<span></span>
</td>
<td class="nump">3,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding, warrants (in shares)</a></td>
<td class="nump">48,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice', window );">Outstanding, warrant, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 337.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ycbd_WarrantsToPurchaseCommonStockMember', window );">Warrants to Purchase Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding, warrants (in shares)</a></td>
<td class="nump">50,309<span></span>
</td>
<td class="nump">13,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice', window );">Outstanding, warrant, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 37.75<span></span>
</td>
<td class="nump">$ 210.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm', window );">Outstanding, warrant, contractual term (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding, warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice', window );">Outstanding, warrant, weighted average exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding, warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice', window );">Outstanding, warrant, weighted average exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisable', window );">Exercisable, warrants (in shares)</a></td>
<td class="nump">48,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice', window );">Exercisable, warrant, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 29.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights that are exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants or rights that are exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which warrant holders acquired warrants or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrant or right forfeitures in period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying warrant or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on warrant or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire warrant or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for warrants and rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ycbd_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ycbd_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132000147616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 10 - Warrants - Summary of Outstanding Common Stock Purchase Warrants (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringSeptember2023Member', window );">Warrants Expiring September 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisable', window );">Exercisable, warrants (in shares) | shares</a></td>
<td class="nump">1,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice', window );">Exercisable, warrant, weighted average exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 176.06<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringMay2024Member', window );">Warrants Expiring May 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisable', window );">Exercisable, warrants (in shares) | shares</a></td>
<td class="nump">822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice', window );">Exercisable, warrant, weighted average exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 56.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringOctober2024Member', window );">Warrants Expiring October 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisable', window );">Exercisable, warrants (in shares) | shares</a></td>
<td class="nump">3,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice', window );">Exercisable, warrant, weighted average exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 168.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringJanuary2025Member', window );">Warrants Expiring January 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisable', window );">Exercisable, warrants (in shares) | shares</a></td>
<td class="nump">3,199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice', window );">Exercisable, warrant, weighted average exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 168.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringApril2028Member', window );">Warrants Expiring April 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisable', window );">Exercisable, warrants (in shares) | shares</a></td>
<td class="nump">40,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice', window );">Exercisable, warrant, weighted average exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.52<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights that are exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants or rights that are exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringSeptember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringSeptember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringOctober2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringOctober2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringJanuary2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringJanuary2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringApril2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ycbd_WarrantsExpiringApril2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132004944160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 11 - Commitments and Contingencies (Details Textual) - Forbearance Agreement [Member]<br></strong></div></th>
<th class="th">
<div>Mar. 20, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement', window );">Past Due Rent Default Declaration, Payment Upon Execution of Agreement</a></td>
<td class="nump">$ 80,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_PastDueRentDefaultDeclarationMonthlyPayment', window );">Past Due Rent Default Declaration, Monthly Payment</a></td>
<td class="nump">$ 40,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_PastDueRentDefaultDeclarationMonthlyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of monthly payment for past due rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_PastDueRentDefaultDeclarationMonthlyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment upon execution of agreement for past due rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=ycbd_ForbearanceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=ycbd_ForbearanceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131994347472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Note Payable (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_FairValueAdjustmentOfDebt', window );">Fair Value Adjustment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (429,789)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember', window );">Investors 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="nump">$ 1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_DebtInstrumentDiscountedPercentage', window );">Debt Instrument Discounted Percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 1,541,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Instrument, Convertible, Conversion Price (in dollars per share)</a></td>
<td class="nump">$ 0.684<span></span>
</td>
<td class="nump">$ 0.5066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_DebtInstrumentPrepaymentPayablePercent', window );">Debt Instrument, Prepayment Payable Percent</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_DebtInstrumentInterestRateInDefault', window );">Debt Instrument, Interest Rate In Default</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Notes Payable, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,171,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,702,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_FairValueAdjustmentOfDebt', window );">Fair Value Adjustment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,357,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_PrincipleAdjustmentsOfDebt', window );">Principle Adjustments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(508,757)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,032,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember', window );">Investors 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Instrument, Convertible, Conversion Price (in dollars per share)</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_DebtInstrumentDiscountedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percent of discount convertible promissory note issued to investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_DebtInstrumentDiscountedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_DebtInstrumentInterestRateInDefault">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the interest rate in default.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_DebtInstrumentInterestRateInDefault</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_DebtInstrumentPrepaymentPayablePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the prepayment payable percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_DebtInstrumentPrepaymentPayablePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_FairValueAdjustmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_FairValueAdjustmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_PrincipleAdjustmentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in the principle value of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_PrincipleAdjustmentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132001250912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 13 - Leases (Details Textual)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term (Year)</a></td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.66%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132005407712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 - Leases - Operating Lease Costs and Supplemental Cash Flow Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Total Operating Lease Costs</a></td>
<td class="nump">$ 1,328,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities</a></td>
<td class="nump">$ 1,421,610<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999482880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 13 - Leases - Future Minimum Aggregate Lease Payments (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 99,467<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">99,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less interest</a></td>
<td class="nump">771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 98,696<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132102616656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 14 - Loss Per Share (Details Textual) - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ycbd_SeriesACumulativeConvertiblePreferredStockMember', window );">Series A Cumulative Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)</a></td>
<td class="nump">185,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ycbd_SeriesACumulativeConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ycbd_SeriesACumulativeConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132000037888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 14 - Loss Per Share - Basic and Diluted Earnings Per Share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (152,798)<span></span>
</td>
<td class="nump">$ 459,737<span></span>
</td>
<td class="num">$ (3,010,562)<span></span>
</td>
<td class="num">$ (996,501)<span></span>
</td>
<td class="num">$ (15,874,941)<span></span>
</td>
<td class="num">$ (1,770,404)<span></span>
</td>
<td class="num">$ (1,336,802)<span></span>
</td>
<td class="num">$ (3,956,062)<span></span>
</td>
<td class="num">$ (3,700,126)<span></span>
</td>
<td class="num">$ (22,938,209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,004,001<span></span>
</td>
<td class="nump">4,002,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss attributable to common shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,704,127)<span></span>
</td>
<td class="num">$ (26,940,209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in computing basic earnings per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,312,546<span></span>
</td>
<td class="nump">2,022,320<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in computing diluted earnings per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,312,546<span></span>
</td>
<td class="nump">2,022,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.79)<span></span>
</td>
<td class="num">$ (13.32)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.79)<span></span>
</td>
<td class="num">$ (13.32)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132000035072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 15 - Income Taxes (Details Textual) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Operating Loss Carryforwards, Valuation Allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_DeferredTaxAssetAndRelatedValuationAllowance', window );">Deferred Tax Asset And Related Valuation Allowance</a></td>
<td class="nump">$ 69.1<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_DeferredTaxAssetAndRelatedValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_DeferredTaxAssetAndRelatedValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999416608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 15 - Income Taxes - Components of Provision for Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Total deferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision</a></td>
<td class="nump">$ (0)<span></span>
</td>
<td class="nump">$ (0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999422528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 15 - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Permanent differences</a></td>
<td class="nump">11.90%<span></span>
</td>
<td class="num">(1.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Contingent derivative expense</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt', window );">Change in value of convertible debt</a></td>
<td class="num">(2.50%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(33.00%)<span></span>
</td>
<td class="num">(21.10%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Provision for income taxes</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to a change in value of convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46132001840816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 15 - Income Taxes - Significant Components of Deferred Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 15,478,000<span></span>
</td>
<td class="nump">$ 14,784,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_RightOfUseLiability', window );">ROU - Liability</a></td>
<td class="nump">22,000<span></span>
</td>
<td class="nump">824,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital loss carryforward</a></td>
<td class="nump">702,000<span></span>
</td>
<td class="nump">702,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">77,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">481,000<span></span>
</td>
<td class="nump">521,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">176,000<span></span>
</td>
<td class="nump">105,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInvestments', window );">Investments</a></td>
<td class="nump">573,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense', window );">Accrued expenses</a></td>
<td class="nump">101,000<span></span>
</td>
<td class="nump">87,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Fixed Assets</a></td>
<td class="nump">57,000<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Capitalized expenses</a></td>
<td class="nump">146,000<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards', window );">Charitable contributions</a></td>
<td class="nump">13,000<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">17,826,000<span></span>
</td>
<td class="nump">17,367,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Prepaid Expenses</a></td>
<td class="num">(76,000)<span></span>
</td>
<td class="num">(107,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">ROU - Assets</a></td>
<td class="num">(19,000)<span></span>
</td>
<td class="num">(750,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(95,000)<span></span>
</td>
<td class="num">(857,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">17,731,000<span></span>
</td>
<td class="nump">16,510,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(17,731,000)<span></span>
</td>
<td class="num">(16,510,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_RightOfUseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right of use liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_RightOfUseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46131999364560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 16 - Subsequent Events (Details Textual)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 17, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2026 </div>
<div>USD ($) </div>
<div>$ / item</div>
</th>
<th class="th">
<div>Feb. 28, 2026 </div>
<div>USD ($) </div>
<div>$ / item</div>
</th>
<th class="th">
<div>Nov. 26, 2024 </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=ycbd_WarehouseLeaseMember', window );">Warehouse Lease [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_LesseeOperatingLeasesMonthlyBaseRent', window );">Lessee, Operating Leases, Monthly Base Rent | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_OperatingLeasesRentExpensePerSquareFoot', window );">Operating Leases, Rent Expense Per Square Foot (in USD per Per Share) | $ / item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.14<span></span>
</td>
<td class="nump">9.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ycbd_LesseeOperatingLeasesAnnualBaseRent', window );">Lessee, Operating Leases, Annual Base Rent | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionByUniqueDescriptionAxis=ycbd_ConversionOfNotesIntoCommonStockMember', window );">Conversion of Notes into Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,624<span></span>
</td>
<td class="nump">714,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 364,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restricted Stock [Member] | Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services (in shares) | shares</a></td>
<td class="nump">175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Warehouse Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of Real Estate Property (Square Foot) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Lessee, Operating Lease, Remaining Lease Term (Month)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">19 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Conversion of Notes into Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,421,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_LesseeOperatingLeasesAnnualBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of annual base rent of operating lease of the lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_LesseeOperatingLeasesAnnualBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_LesseeOperatingLeasesMonthlyBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of monthly base rent of operating lease of the lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_LesseeOperatingLeasesMonthlyBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ycbd_OperatingLeasesRentExpensePerSquareFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the rent expense for an operating lease per square foot.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ycbd_OperatingLeasesRentExpensePerSquareFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ycbd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=ycbd_WarehouseLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=ycbd_WarehouseLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionByUniqueDescriptionAxis=ycbd_ConversionOfNotesIntoCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionByUniqueDescriptionAxis=ycbd_ConversionOfNotesIntoCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ycbd_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ycbd_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>85
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M<5 <83H@3,]"*+X"-VJAN\FCS$:TT( /^P:&.T7>:QPG4^"N61(%/.4X\FQ
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M5NV8V0:V_WYG)V04 MLD1/SCWKMWY_@EWRG]8BH 2WY*49M14%F[O@M#LZA
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MV12_*>=R_4C&R,MAR]]UC,S5-J_GT&GN10-'AY/Z$>A2V(?1D?6T;;4ANAQ
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MQ!C>R/[=_0B?;VH_6N_?;FIO)\Z(J6SA&9'4FJC60K4VJG50K8MJ/53KH]H
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M#_5"7WWE*U<;[FV^.$GP%!1S_BZC:=CYYQ_HO/8K!+Y(%]V$FK:FDINN\CE
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MUZ7-:/-M[D0^26VGRX>]@&=+)$Z5F066#OKOCO<0O?EC6?E1N@U_H#IW)9(
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MGTQ& 9A>Z_J!H[;3EQ4Y5JO.K/EY0.,#V%\1W[[=P"\P/#B+?P%02P,$%
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M@&S:92-HL;$M:B$T-3P[7=,?!DJC0/NYH,*]%XR#]I]E] -02P,$%     @
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MGI9K>%[<SQ?/B_4_\%IK4S.J$+H^!B7J+6I@6XW^]H!^J#$#+NF<2\I8/.J
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MCMT0)\O13^QGPPD>"=GBUJUA*]>'[35_K#SK/1'5)U?.W.7D?^31>LI.L-V
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M<(J'*E>6 >MCB<M_/;$"FJ?OX%]02P,$%     @ NH"264(IEQ/]!0  Q T
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M#!#F)]ZP+)<AT6(\FUF>B;]_( JY#CT:27VV"[@,N8^[3M'&]%,39"%03@8
MM'A@6V@G_4-2X35\'-1[$Y9^;AJ'=,3V9B=QE?]1[XR&P^[Q\)A>4CI,D[1/
M>3(<8G=$O[?>/>EF@P&E:3),<7K=2BZQ/B)<AJ:LA>HU&FP*-[RAT2C!U/^5
MX 'E:??D>$AIGB?Y@ 8)UENAHVZ_WZ=^,CI^3N:P>X+^^P;*G22#X2]EYI3G
MW3X(TVR0#$>0F>9;^) ES[*]W&,4'XU#.SK \1G9BM"(EK'7C$,-(LRH^^)
MV]$H&Q!C&(KA +5;A)BO;5WLM]\P?4_>.N2MX(-O,P5B&;0)(]5#WS$.D5]H
M;:8=UFM]NP=LZ-)O7+1'Z?HH3LQV/TSH9=[-3H_I0ZQQO^+JG@\$^TPHWO/$
MAH$L)W'F3TUC46^[N@R>W@;VSUN.IZKM?]W3,D]$^/HR$&EQL$&($WUW"XY#
M=[7>SLUZP786_A\<A8$?+]F;T\TORCC>S+?D\?\&"LY0X%3Q%*S]Y 1_!#;^
M,\2--\MP3T<[PJT_+.?XS6(K!/@^-1B6[48$;'[<+O\'4$L#!!0    ( +J
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MR&:D-ALM*CO&%D+34+3+C/Z%H#0.]'PIJ,FW&Q-@_[]F^A]02P,$%     @
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MC1VX+=A9Q#760TBB ;"(I6?PDF.LB<=+SL1JP"IX+R27F> EK"VW2#UF35_
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MGKG(0=GU#=>PA2O]FE@IH&BR&0?U?0MYZ,T:>@M09T9Y3F12,VI:>3(+_?C
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M^+_?U(]*7&1XLY?^P1WZZ?^J;K"A$KR]N"HR78G/N3@O2IV):<+"F(V$R96
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MX-RE^\V>^U*9@G\GMS 54!Q_I**,*ND%/%\96)G_0AN$7TZ>_0]02P,$%
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MH&\2:N= YVM%$MN%2]!]Y:;_ %!+ P04    " "Z@))9%/D6$)$"  "9!0
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M9:.)S1HN58<F<5S8HMP;1:><<";_(0U" A]AKJC0RKP"$R7</+6\H:<W</;
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M_D7? U7WBGIA9.7J<RX-5;N;YM1>4=D .E](RM1F82]H&W;R&U!+ P04
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MT5=!?F;U01J$ES"!K9'Y+6R(8 '7LJ&B:^[N[>(SW]6H+Q>AH7C6*\Q'[,V
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M)]5TS&9B9.6ZU$H:ZGENF--/!I4-H/VUI,O;3FR"[K>5_ )02P,$%     @
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M?FZO0ZZG?X&I[E+W1.:4*\1@;2"#ZZ%Y%V5U/:D&6FQ<A_\HM+DON,?"7.E
M6@.SOA:FRZ\'=H/FDCC['U!+ P04    " "Z@))9(NFI-4X#  #^#0  &0
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M*(V!GM\(G2&7';- 5?)-_P502P,$%     @ NH"26>ISOMJ/!   ,QL  !D
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M>I2<I)[=^KR&\K@%J46R-2;;I4*3B(]9-XM-H94CM"<.:,.)Q &/.TR.,K\
MZ#QS9IFS"^<&P]./PM9.?T-HY2!884)Q98(LN[DE5K%HE[)'5BE07"K4W)QQ
MM-K9:%<F9,4&Q=5&Y0T:QZE-I;+2H%9J4%QK8+,%4P2Y1Y5% [6J@>*RH4H1
M7[)1X\/6SD5#:.4@63%#<35SP1K?/Y]-K$O942LJ**XJJF>SSG:-CED[E0VA
ME?^MM8*&X8*F?BIQP!K;]25 YYE;H<)PH7)Z;K30]..P==/?%%HY"%:S,%RS
M( MP;KE?C]<#K]5E!W5[K!_K=3WO1/4RJR48KB5J[MPX6NW$5)8BS$H1ADN1
MRCLWCE.;RFL10ON=;JM_@H]5(@Q7(MCL>:T6*.W1EM<_G#ZO.QY,L[)S5ELP
M7%M4J>]+=G)\V-JY:0BM'"0K=Q@N=RY8_E^?C1Q=%7I5#]F8E1WLTD.4PXS6
MV,WQ,6NG\_\X0V%6[["F3U%RP,[Y.FU4I[A[UP\AR&5Z*Z/(/-Y$.CN5+]X6
M-S]WZ7W'P?M[>CO)[F\L3':=],CE4D2*!+ PD-Y-SW"4V0U-UM#Q.KWDF,5:
MQV'ZN +N@TPZF.^+V$R>O)$,4-R3C?\%4$L#!!0    ( +J DEGYY,H7+ (
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M_1-:/4/+ETJNW9?436PT\DA::91%"S89%$PT*]VU[W  ,#RG 4$+"(X!MV<
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MC@MIX2?N7<OE*87>K9=P\N$T8XX$>!I6],GF7;+D2+)Q C=:N<K"M2JQ_)>
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MSB(B8:Y>:-7<,TITRS3IW=)Y.SI.<<]RG%ZO)K@IT'$#S[&:%3NE8N>_*IR
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M@&]'U^U"LC2?_J9,*J?RTY4:]X'K '5_P=0$6"ST0%G^@0C_ 5!+ P04
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MO<P*F-_G0NC'BRQ!=<)T_!]02P,$%     @ NH"269-PA$&N P  > X  !D
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M=^2/*[P:@M0&^'XA\+90#O3EH[ILCOX%4$L#!!0    ( +J DEG?8 2N/0(
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M '5_Q9A\OM 3U =JTW\ 4$L#!!0    ( +J DEG3"#2C\ (  "D*   9
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M'%1S4<U#-1_5 E0+42U"M1C5DO[+^*J+E]=H'UCJ7-P_)IJA:Y:C6D%IS1E
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M4%IS2B#64X+V7$'@:$&]SR]\7"Q6=X^'!^3O974]692[.PUUO[]0^RJ?/,5
MDPM1348U!=545--VVL6S?<7>N^%9<U]11VL:J&:BFH5J-JHYJ.:BFH=J/JH%
MJ!:B6M3I[R]&:R:=:J9HS0S5<E0K**W9ZNL$P;,C"8+']O[E[YOV?_C(/9H7
MB&H2JLFHIJ":BFH:JNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1JL6HENRT
MQAFV_N7YBQZ/Q@6B6HYJ!:4U>WP=%[C^D3S"+_SK\)Y]8UIP=S^=_RC+]M,"
MK>MU\@2!U"14DU%-0345U314TU'-0#43U2Q4LU'-0347U3Q4\U$M0+40U2)4
MBU$M0;44U3)4RU&MH+3F/*+.&SP[DC?X=SPM@&86HIJ$:C*J*:BFHIJ&:CJJ
M&:AFHIJ%:C:J.:CFHIJ':OY.>WZ N]][-QPT]WX#M&B(:A&JQ:B6H%J*:AFJ
MY:A64%IS[E!G%IZU9Q827T#X?C^I'@8]?N<P+\?5X6D!FGF(:A*JR:BFH)J*
M:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^4<^'X?"C_5GV>+@408TWQ#5(E2+42U!
MM135,E3+4:V@M.9,H<XW/.N>;_B7G:U8#TK*Q7)SQX2/L]EJ/)W^$#9W4Q:B
MVVJ]V&9>T1Z<U/XD3IY@H%&)J":CFH)J*JIIJ*:CFH%J)JI9J&:CFH-J+JIY
MJ.:C6H!J(:I%J!:C6H)J*:IEJ):C6D%IS4E'':EXUAZI^+<\M8%F,Z*:A&HR
MJBFHIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:AVH^J@4[K7&BI/].'#9/E(1HT0C5
M8E1+4"U%M0S5<E0K**TY=ZA#%\_^^M#%4TYMH$F*J":AFHQJ"JJIJ*:AFHYJ
M!JJ9J&:AFHUJ#JJYJ.:AFH]JP9%/V]=/E(3H>D2H%J-:@FHIJF6HEJ-:06F-
MF<*P3F$<=D]A['AJX\3[.;2OP*F3 U234$U&-0755%334$U'-0/53%2S4,U&
M-0?57%3S4,U'M0#50E2+4"U&M0354E3+4"U'M8+2FA.&.IMQV#V;\>]R6F*W
MRLT CXO1WLT?VY_8R5,'-,,1U1144U%-0S4=U0Q4,U'-0C4;U1Q4<W=:_^SY
M47CQW=Z?L]=M,1]=MP#50E2+4"U&M0354E3+4"U'M8+2FLU>K)O]7YZZ>,IY
MA"-K\_IQMJOVD2?W=C0\$=445%-134,U'=4,5#-1S4(U&]4<5'-1S?O#GQ<^
MNAX!JH6H%J%:C&H)JJ6HEJ%:CFH%I35G!75 X_"O"V@<O@SB.AOLWP/OJGT%
M3F[G:/ BJBFHIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:=^"S0>SWQ=[^'CV:J(AJ
M(:I%J!:C6H)J*:IEJ):C6D%IS=Y=!R^N?VSKW5?SV=>R6FQVQ^>?!6>^+#=W
M3%[.-[OW=^L'P^7\^K?V\_FM!4X^GT]J$JK)J*:@FHIJ&JKIJ&:@FHEJ%JK9
MJ.:@FHMJ'JKYJ!:@6HAJ$:K%J):@6HIJ&:KEJ%906G-"4"<H#ML3%*7RTU*H
M9P5O=S]O[I=<WU?Y[<,1_H6@+Q:K]6\VI^:WI^,7AX_CHPF(J":AFHQJ"JJI
MJ*;MM-'SLZV]WDC<OS72@>7.^V>B>-E<SD#7SD0U"]5L5'-0S44U#]5\5 M0
M+42U"-5B5$M0+46U#-5R5"LHK=G6ZW##87MXEUG^6"SGL_:;(;0;)_=I-)(0
MU6144U!-134-U714,U#-1#4+U6Q4<U#-134/U7Q4"U M1+4(U6)42U M1;4,
MU7)4*RBMV?/KF,+AD9C"[;'[W2ZZM*HV48(/U]P][K^_%9SRV\,2BZ,[\6B<
MX$YK[#Y>]"Z'>]$:$EI51C4%U514TU!-1S4#U<P#[Z31F=B_:+Z1++2HC6H.
MJKFHYJ&:CVH!JH6H%J%:C&H)JJ6HEJ%:CFH%I37[>9T .&Q/ 'RQ#R_\2_!6
MU?7M>%$*'[]4Y</U]ZU[^&A@'ZI)J":CFH)J*JIIJ*:CFH%J)JI9J&:CFH-J
M+JIYJ.:C6H!J(:I%J!:C6H)J*:IEJ):C6D%IS1E!G>LW/)+KQ^[AH[%]J":A
MFHQJ"JJIJ*:AFHYJ!JJ9J&;MM.;E#>*HO_=U<OO <B^7<M!U<U'-0S4?U0)4
M"U$M0K48U1)42U$M0[4<U0I*:[3S41V^-VH/W[/'_V_RFV"7-Y/K]6_:8_3:
MJ5.;-:I)J":CFH)J*JIIJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!:C
M6H)J*:IEJ):C6D%IS=9?Q^B-CL3HH7OR[<5.GAR@07FH)J.:@FHJJFFHIJ.:
M@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD4[K?&%EV%O/](D1HLFJ):B6H9J.:H5
ME-;L^F+=]=L3J<:#46^[OS]^*UC6U?,3^Q]O-M^ZFRRV$X'I>A4>8G4ZG>5O
MKWIR^T>S]%!-1C4%U514TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU M
M1K4$U5)4RU M1[6"TIJSA#I?;]0A7^_QN_9O=VGX7ED]'!@X(1>_O<[)\P(T
ME _59%134$U%-0W5=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"U$M0C58E1+4"U%
MM0S5<E0K=EKC]M!G[R[J[[ U&WX=RK?^\<^>#-C]]O-\/0U8K^=Z2G#\K$!K
MU9/;/ZE)J":CFH)JZDYK7%DV.!M=])L'"#6TJHYJ!JJ9J&:AFHUJ#JJYJ.:A
MFH]J :J%J!:A6HQJ":JEJ):A6HYJ!:4U^W^=P3=JS^"KC_)OVOO!,P%OA:NJ
MO)D\++$]@R"$J_O[>;44QK.;PV,.S@G0:#Y4DU!-1C4%U514TU!-1S4#U4Q4
MLU#-1C4'U5Q4\U#-1[4 U4)4BU MWFF-NR7TMO]I[E@D:-D4U3)4RU&MH+3F
MI*!.\!NU)_AUFA3$L]5R,IW\3[F> MS-5Z_T?#3F#]4D5)-134$U%=4T5--1
MS4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(MWVO.>/^R?7?;.]EL^&N"':AFJ
MY:A64%JSY=<!?J/V #^OK*[7;7W\I=S<G&=W&8"RFDY_"$FY6)8W![L[FM.'
M:A*JR:BFH)J*:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:B6H%J*
M:AFJY3NMWW\V+>J].V_.B0JJ9K.WUV%^H_8POX.]?=/5A?A^/A/D\?7M"4?Q
MT5@_5)-0348U!=545--034<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0+4:U
M!-525,M0+=]I>SV_/]QO^G]%7M^HSNL;M>?UO=[TO6K^=7)3W@C.7 C6#U23
MZ^5D/MO<C'?SNYO5]5*X&B_++_-J4BX.S@'0]#Y4DU!-1C4%U514TU!-1S4#
MU4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU M1K4$U5)4RU MWVE'YP!_1<C?>1WR
M=]X>\A=]6\\ ?@C1M_FZH=]/EN-IZW?YV[53VSJJ2:@FHYJ":BJJ::BFHYJ!
M:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@6HUJ":BFJ9:B6HUI!:<WN7^?\G?_Y
MG+^/U[^O)HO)P_[_D>_TM9<[>7J )OVAFHQJ"JJIJ*:AFHYJ!JJ9J&:AFHUJ
M#JJYJ.:AFG_^,O].%,5!<R<L0&N&J!:A6HQJ":JEJ):A6HYJ!:4UV[Y8M_WV
MH+^PW!RV%SX*5ZN[U72\G'PMA:OY;'MZ_].T%+RJ_%Q6U7I.\#!!:#TB@*;[
MH9J$:C*J*:BFHIJ&:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&J):B6
MHEJ&:CFJ%936G!K4Z7[G[>E^>ZW_\3" \'&UO)U7VZ_R'3L&@,;ZH9J$:C*J
M*:BFHIJ&:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6[K3GQR>&A[XG'Z%E8U1+
M4"U%M0S5<E0K**W9Z^M@O_6/?Z37[\X''.OSK?C)?9[4)%2344U!-175M)UV
M]--(1\L:J&:BFM7U);'1L@ZJN:CFH9J/:@&JA:@6=7TKQ6C9I&O9M.N"&;I^
M.:H5E-;LJ758WGE[6-YK/=5=+1?+\>QF<X;]6&-%0_!034(U&=445%-13=MI
M'1HKFF^':B:J65U?$ALMZZ":BVH>JOFH%J!:B&I1U[=2C)9-NI9-NRZ8H>N7
MHUI!:<W&6@?.G;<'SKUHK-)D\Q6UV8T0C)?E6Z'^,MO!GHJ&S*&:A&HRJBFH
MIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%NZTO:\N]2[V#TFCZ7&HEG1[
M"FFWQ3)TW7)4*RBMV9?K5+CS]E2XQS:\>"M<C1>W!YLOF@&':A*JR:BFH)J*
M:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:B6[+3G>;%GO=[ZO_W]
M+GUP0;'7&^[W:32Y#=4*2FOVZ3KA[;P]X>UJ?G<W66X3VW>'I)_=WMTL?RR6
M\UG9?J4W&NN&:A*JR:BFH)J*:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(
M:A&JQ:B6H%J*:AFJY:A64%IS0E"GOYT?27];5=>WX\7FFU^/,X.W@CW^/KE;
MW3U.$9Y-&HZ=M$;SWE!-0C49U92=UOA^ZD7_<K!WSP05K:JAFHYJ!JJ9J&:A
MFHUJ#JJYJ.:AFH]J :J%J!:A6HQJ":JEJ):A6HYJ!:4UVOY%'?AVT1[XUB7R
MQ2F_/2QQ-/"EO=BI;1_5)%2344W9:8VV/^J/]IH^6E-#-1W5#%0S4<U"-1O5
MG /OHXN+B\OF^\A%:WJHYJ-:@&HAJD6H%J-:@FHIJF6HEJ-:06G-9E[GMUT<
MR6_;=&;!66V.V;\5ZM8^WJ2X'&O=:%8;JDFH)J.:<O$R46K4W[_'H8K6U%!-
M1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU M1K4$U5)4RU M1[6"TIHM7JQ;
M?'M6VT-S?W:#EJ#\,EDLR\V5\)M;KP?E8MRAV:,I;:@FH9J,:LI..WIX'JVJ
MH9J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H5J,:@FJI:B6H5J.:@6E/;3[
M]XO;LEQ*X^7XP\]W9?6EO"JGTX5P/5_-UOPFE>WI4:$J/Z^G _V?/HIOWK]X
M7.O_%/8//)[T?TJWC[^O^0\_WX^_E/:X^C*9+81I^7E=JO=N\_V]:O+E]ND?
MR_G]+V_6DYM/\^5R?K?]\;8<WY359H'U[S_/Y\O'?VP*?)M7OVV?SH?_!5!+
M P04    " "Z@))9_%;\W<<#  "6$   &0   'AL+W=O<FMS:&5E=',O<VAE
M970U,RYX;6R]F-MNVS@0AE]EH%UT$Z"U1,FGI+:!.$W1O4@;Q-@4BZ(7C#2V
MB4BB2M*'O/V2E"+;J<R-4Z,W$4EI?LXW),><#%9</,@YHH)UEN9RZ,V5*LY]
M7\9SS*AL\0)S_6;*14:5[HJ9+PN!-+%&6>J'0=#U,\IR;S2P8S=B-. +E;(<
M;P3(1991\3C&E*^&'O&>!F[9;*[,@#\:%'2&$U3_%#="]_Q:)6$9YI+Q' 1.
MA]X%.;\D76-@O[ACN));;3 H]YP_F,[?R= +C$>88JR,!-6/)5YBFAHE[<>/
M2M2KYS2&V^TG]8\67L/<4XF7//W*$C4?>GT/$IS21:IN^>H35D =HQ?S5-J_
ML*J^#3R(%U+QK#+6'F0L+Y]T705BRX#T]AB$E4'X4H.H,H@L:.F9Q?I %1T-
M!%^!,%]K-=.PL;'6FH;E9ADG2NBW3-NIT6>N$/KP#B9S*G#.TP2%_ NN?BR8
M>M3#'RD3<$?3!<*%U&M=F.!+X%.8*!X_P)=JX.0#*LI2>?HD]6ZL@YO #7W4
MBZ[@0@B:S]"TWU9&\.T:LWL4W[7)G^"#-&9RX"N-99SSXPIA7"*$>Q!("-<\
M5W,)5WF"R:Z K^-1!R5\"LHX="I.L&A!%+R%, C;#0Y=OMP\<K@3U6L46;WV
M'KVO=B_J8-(E"GVV -<H8B81"L%BA!.60\+3E H)!8HRD*=-@2SGZ=MYS %?
MCH)61Q,NM^&<SIBT<BX+&N/0TWE#HEBB-WKS!^D&[QVH[1JU[42]9?(!I@(1
M6*Y0ZRL05&$32RE$R Y,\!S&.=TK83HU3,<)<\=3JEBJ#U*3_YV?_2>MH/?,
M?^<,K_2_6_O?=?I_M2YTLM7[3J]$9G?9(^H]=@HG_^IGXP9S"X:E '0ALP>V
MZ6@Y%5X)W*N!>T[_KEG.LD56)Z8F0J?"R_TK88\DM@/;KV'[ORFK..<Y-"3]
MGU(4"5I1ISX6.ZQG->O9L=**4^A0F%*,A+LY*CJ+FG%(L/G5#GXAM;B-#X6H
MU'8H=*;JMOM[*+;N'N38"<:M>#":VS]WOMJ%#C?0H3O)T/7_)AFWQ,&41U+;
M!=[<7LCONKZX)SHX+*4::6_OZ[#5W;.K-U<8<K0[C%OI8*!V8[II]\@>I,U%
MAOS*3<9M?#!%ISG==/91;*XSY.CW&;?BP6AN_]JE/TV'SM^J\#(4,UOX2HCY
M(E=E75./UL7UA2TIGXV/3=%M*\>-3%FQ7U,Q8[J22W&J)8-63Z^#*(O@LJ-X
M8>O(>ZYT56J;<Z2Z7C0?Z/=3KFO)JF,FJ/\5,?H/4$L#!!0    ( +J DEE1
M]@HZW L  $ND   9    >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;,W=;6_:
M2@*&X;\R8E>K'JFG8&-(TDTCI?&[U3;JVVJUV@\.3 (JX!S;-,WJ_/BUP<$X
M,8.=WLGIES8!YO) _70,/.#CFRC^EDRD3,6/^6R1O.E,TO3Z=;>;C"9R'B:O
MHFNYR*ZYC.)YF&:_QE?=Y#J6X7@U:#[KZKW>L#L/IXO.R?'JLO/XY#A:IK/I
M0I['(EG.YV%\^U;.HILW':US=\''Z=4DS2_HGAQ?AU?RDTR_7)_'V6_=C3*>
MSN4BF48+$<O+-YU3[75@#/,!JUM\G<J;9.MGD=^5BRCZEO_BC=]T>OF,Y$R.
MTIP(L[^^RS,YF^52-H\_"K2SV68^</OG.]U>W?GLSER$B3R+9O^:CM/)F\YA
M1XSE9;B<I1^C&U<6=VB0>Z-HEJS^%#?%;7L=,5HF:30O!F<SF$\7Z[_#'\4#
ML35 ,W8,T(L!>M,!_6) __Z P8X!1C' :+J%03%@T'3 L!@P;#K@H!APT'3
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M912E=[_D&[B)XF^K:9_\'U!+ P04    " "Z@))9_86":5L$   -%@  &0
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M U,!\ON<4K$=J GJ&^#QOU!+ P04    " "Z@))9Q+ =2FD%  ".)@  &0
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ME?X/I5H3F$3UM*9ZJJ1:["#7.!Y46J>=1+2=]EQ>=1M=.\[,:]&H]&THC9K
M)!IG-8VS@33JS-BR;]L]8M-Q)J,6FZM9M\BZHLRV25>.9"CIFL DTFVKV9!;
M@[=K)_.WPI16_NG,F[385'<]=">F%2W0A2;3?J2#[ MVR?KRO>K^9,*KW1P<
M(IUH@2XT.42P"1'4O06I$%5[D---?+5?@UG4A":SV*A!6ZW7+E@=*T1IY>M9
M'WN:]:R/:O<&D_D>"LYN))RMUG"7%>L>F=97K'7J-%\K6J +3::]T7VV6OB]
M>['VSBS6.N6=KQ4MT(4FAZB1B[9:+]9O"3D!]WL:;I&(PXJD*<G  R?A5_#W
M'4X?,?VG-P Z==]**YJO%2W0A2:'J5&EMEJ67E; )IT"YEF.-6O/CFXSVX&6
MVUX0M I/76@RGXWTM-7:\]TKT[0CB$1=FG0*4[<9M*V1VUF,M:I576@R]XU>
MM=6"]3^_Z%;C#ZXZ.M'\$V.'U5MX!Z3EIQ1[^M;K^$ +E/Q=IE&W\!W4K1IS
M:%Q@5ROW5"]?:Z>!+C29]D;=PO]7W:J['QPA^YPBYVOM--"%)D>H$;=0+6XO
MFQ@ZA>D*=I5P[\30JH9[.I4W"3*?C<R%EWSUU)CQ.F7LJD([F?%:M7-/IZU-
M@LQ]HXJA6A57+VK08X('Y/)YJEC=]=!552M:H M-IKU1Q5"MBOMHUYKR/5\\
M9R-WVHZ05E&L%2W0A59&R#PZ=Y-BNBD./#&QX]QGO#RL4C^M#U5]*HX2M9[?
MVC>K\FA4 U.>U+I#=!-G#"1X+2 M41(,0,O#3^4-)[OB=,\CX9RDQ>46HPC3
MO('X?4T(?[W).ZB/H"W_!5!+ P04    " "Z@))9P':NX4H#  !N#0  &0
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M7C4PZE:,N@<S4@WC?X@160%7ZQE!,0Q0SFD$AG',DH1P@7*5=,-9DZ^_=I.
M@DI_6T OZ#A!LP2_DN ?Z(9K\E"8K\T'K:!'^B"H* <OZ(-@QP=]UVW.8:\B
MU'L]-NCMV, /.J[?K*!?*>@?Z(*;2+)R1VAW0BOPD4X85+0'+^B$P8X3/,_O
M-2<2.W45<5Z/&4HNN+N]*P3]CK='Q58MQ <:XAO)EKH2*D/XK89H1S[2$;BN
M;KB]O#W/$R7X$U/@P9XR@>O*A0\O72]G"F^W4BA/]/;L$;BN=KB]W.V:XDP1
M3;0E^NV6:,4]UA)UB</M->Z9EO!W+-%U?,?9D\VZBN'#R]C+>2+8\83;\?^O
M>_;6Z5G_B5P3/J>90 G,5)BC+&0A7ASNBXYDN3E03YE4QW/37*@?(N!Z@'H_
M8^I077;T&;WZQ0K_ 5!+ P04    " "Z@))9^[P1]1X"  !I!   &0   'AL
M+W=O<FMS:&5E=',O<VAE970U."YX;6RE5$V/VC 0_2M6U,.NM"4AL.UJ%2(M
MT*H]4"$H[:'JP223Q%I_I+9#X-]W[(24JG!J)&*//>_->_:0I%7ZU50 EAP%
MEV865-;6SV%HL@H$-2-5@\2=0FE!+8:Z#$VM@>8>)'@81]&[4% F@S3Q:VN=
M)JJQG$E8:V(:(:@^S8&K=A:,@_/"AI65=0MAFM2TA"W87;W6&(4#2\X$2,.4
M)!J*6? R?IY/7+Y/^,:@-1=SXISLE7IUP>=\%D1.$'#(K&.@.!Q@ 9P[(I3Q
MJ^<,AI(.>#D_LW_TWM'+GAI8*/Z=Y;::!4\!R:&@#;<;U7Z"WL^CX\L4-_Y-
MVCXW"DC6&*M$#T8%@LENI,?^'"X <7P#$/> V.ON"GF52VIIFFC5$NVRD<U-
MO%6/1G%,NDO96HV[#'$V_:(LD/&8O"4+)02S>-[6$"ISC*5EL@29,3#D;@F6
M,F[(5SC:AO)[1."Q[(%J*C,@+Z4&<&#R8P5B#_IG$EK4YZJ$6:]EWFF);VA9
M43TB<?2 OWA*=MLEN7MS_S=-B/8&C_'@,?:\TQN\:VHL639 -D[?LKLR'#..
MXEUO/) U/7GQNQH[Y<,1LL;WC"K^&+OFIZO[Z.NZ]C^D3Q$^27BX(G<RR)W\
MK]P5WDW%3V?9UZ1-_I$VO2(MO.@<]R?$*RB9-(1#@;AH]!X)=-?876!5[9MI
MKRRVII]6^"T [1)POU#84'W@^G/XNJ2_ 5!+ P04    " "Z@))9'4K[HNH$
M  "%&P  &0   'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6RU65%OJS84_BL6
MVYUZI=Z"28"D2R*U"=4ZJ5O4[-X]3'MP@M.P"YAK.TTK[<?/!D(P)5[1O#P$
M##[?.?X./OC#DP.A7]D.8PY>TB1C4VO'>7YMVVRSPREB5R3'F;BS)31%7#3I
MD\URBE%4&*6)[3J.;Z<HSJS9I+BVI+,)V?,DSO"2 K9/4T1?;W%"#E,+6L<+
MC_'3CLL+]FR2HR>\POQSOJ2B9=<H49SBC,4D Q1OI]8-O YA( V*'E]B?&"-
M<R"'LB;DJVS<1U/+D1'A!&^XA$#B\(SG.$DDDHCC6P5JU3ZE8?/\B'Y7#%X,
M9HT8GI/D]SCBNZDULD"$MVB?\$=R^ E7 _(DWH8DK/@'AZJO8X'-GG&25L8B
M@C3.RB-ZJ8AH&,#A&0.W,G#;!OX9@T%E,'BOAV%E,'RO@5<9%$.WR[$7Q"T0
M1[,))0= 96^!)D\*]@MKP5><R0=EQ:FX&PL[/ON%< R@"SZ!XFR)7M$ZP>!B
M@3F*$P9^PR]\CY*/HL/GU0)<?/]Q8G/A5UK;F\K'O/3AGO$AX!](QG<,A%F$
M(Q7 %@'74;O'J&]=+>+/*+L" ^<2N(X[[ I(;[["N=9\\7[S08=YJ#=_0%28
MPRYSA8Q!G<)!@3<\@W>'8@J^H&2/P4WTEWADQ#SF@&S! J]Y1WBW6CA9F:Y9
MCC9X:HG2PS!]QM;LA^^@[_S8Q70)YA5@LBH]SSX-W7$P&D_LYR:E;_LY:H_0
M4%@*A\.:PZ&6P_OL&8NY1AD8?0 KG,6$BL-F3W$$?J7Q4YRA!-PS)CAVG0]@
M$;,-V0N6YT084A[+.;.D)(T9(_2UG$M_/.!TC>F?72G01M,W!2;!%B;!0D-@
M2DJ].J6>-J4B'1N,(P:V(B]*HL[-"^_-(PI=SQ$_]4&=:_WVY=LD6&@(3.';
MK_GVM7Q+5L%]QCC=RP)T*<XY%FXX>$0<7X(5%X<(+#'=B-MB$=*5@M(%A,TR
M<>6,6@G0!M(W 2;!0D-@2@*".@%!GP341>I?20^Z2'=;G&M]]^7<)%AH"$SA
M?%1S/NKWT-\)3^ FE;QW43UZ6V*\(?1]O\6VUFM?MDV"A8; %+;'-=OC?FPW
MJOJQ42B8)8U%&B[B#$0D29!XK>=8J*,=HKAK_7I;N@V4">"/AD[C!UL9*DV@
MLJ"Y\AS?/V^ST(ZN;R(,@2F)@,Y)-CC]4K&D.$>O1>$YBHBJZG017J&W:X[7
M(ED?1-]Y8!0M-(6F)J"AV^!_>-V*EECF%'*YDW[827^[YNM#Z$V_2;30%)I*
MOWNBW]72+U?X[/BDR[)?:S#YVDT($]*ADWDM;-^5?X6FO$]@  ?M%=/"J-NP
MPZT;.&YSI:S2>I*RT+"6U>/UYK-$\YMJ%@Z\P!G[;4)-^@U-H:FLG\0OU*M?
M\;K,-G&>-$EG6M:-ZM<*36'=<T:!%[1)-RI.3:&II)_D*=3K4Z6"=))L4AK.
M88>Z=0;NV&E_J#'J-C2%II)\TJ10+TK_S^\ZX&_P$&=QND^UGWKT$?9.HU'M
M:Q0M-(6FYOHD?V$O_6M.'51^X5!9+0W:BR6C"MDH6F@*K<R,W=AN2#%]*O9Y
M&"AF3OD-O[Y:[R7=%#LHK>MS>+TH=X1.,.4&U0.B8FXRD."M@'2N E%&:+GG
M4S8XR8M-C37AG*3%Z0ZC"%/90=S?$C%5JX9T4.^\S?X!4$L#!!0    ( +J
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M&$")!]8)VJK^,XY^;AQ?H83Q3^B'VC0)H.@,J68$6P4-E\/*GL;W< 9(T@N
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M.ELA)_I,%BCLSD(J3HR=JF6H"X4D]R#.PCB*DI 3*H)TX->F*AW(TC J<*I
MEYP3=3]&)C?#H!,\+-S2Y<JXA3 =%&2),S3?BJFRL[!AR2E'H:D4H' Q#$:=
MRTGBSOL#WREN],X87"1S*>_<Y$,^#"+G$#+,C&,@]K7&"3+FB*P;OVO.H#'I
M@+OC!_9W/G8;RYQHG$CV@^9F-0S. \AQ04IF;N7F/=;Q]!U?)IGV3]C49Z,
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M*IAWY][N1K*Z/3INF50'T?;R@%&!N1:HWW=,'1_[&WT:'?[[L/H/4$L#!!0
M   ( +J DED2.J,VY 4  +HL   9    >&PO=V]R:W-H965T<R]S:&5E=#8Y
M+GAM;+6:;6_B.!#'OXK%K4Y=J0=)@(1V*5+;/*VTNX?*[NV+T[T(,)1HDYC:
M#FVE_?!G)VD@%%S8FWO3)K;G9R?Y,V-[/'RD[ =? @CRE"89OVHMA5A==CI\
MMH0TXFVZ@DS6+"A+(R%OV7V'KQA$\\(H33J68=B=-(JSUFA8E(W9:$ASD<09
MC!GA>9I&[/D&$OIXU3);+P5W\?U2J(+.:+B*[F$"XMMJS.1=IZ;,XQ0R'M.,
M,%A<M:[-R]!TE$'1XJ\8'OG6-5&/,J7TA[KY.+]J&6I$D,!,*$0D_ZWA%I)$
MD>0X'BIHJ^Y3&6Y?O]#]XN'EPTPC#K<T^1[/Q?*J-6B1.2RB/!%W]#&$ZH'Z
MBC>C"2_^DL>JK=$BLYP+FE;&<@1IG)7_HZ?J16P96.8! ZLRL(XUZ%8&W6,-
M>I5!;]?@XH!!OS+H[QAT#_5@5P;VL09.9>#L&)B# P:#RF!0?-WR<Q3?THU$
M-!HR^DB8:BUIZJ(01&$M/V&<*>U.!).UL;03HR]4 #%M\@>9Y%,.#SED@GAK
M^9>3,Q=$%"><?(4GD4?)^V%'R"Z586=6X6]*O'4 ;Y+/-!-+3KQL#O,]]I[>
MOON6O:^W=]ZR#]X8OZ4!=.2[KE^X]?+";RPM\0M=MTG7.">68?4(7T8,^)YQ
MW>HI$U@=0W'UE.L5.X;BZ2DNS-K$="K*MXE+SMZ]/TSSCW\RNZ:](QT2"TCW
M?4$]SX=IFUB#XWGA$=_/LJNG78C??S.=P0>-,+KU+[%;@'L'P-_E^UK2G /Y
M!-(9D[\_0SH%]@_Y2:27AEG$15VV[X>HI:L0>,E7T0RN6C+&<6!K:(WDV&WC
MPS[U8<)<3)B'"?,Q80$F+$2"-938JY78TRKQ$W .<$[^7 &+1)S=EXKDYZ4O
M3)[)C1+HG0H5/\F[?6+4=G"J&#%A+B;,PX3YF+"@A/4+F)J_KD=VWS",86>]
MK3*D+ALJZ]<JZVM5]EI=A:"\)SDME^H: R.3AUPZ1>G^J"!G<59X;VE5UJGX
M\E[I[[ KO]&.X%098L)<3)B'"?-+F&EL2<<TVF:O*9U@3[.+MM/?$1C2R!H"
MLVN!V;_HQJZS3$YGW_9B6OZI\L&$N9@P#Q/FVZ\=CV/O.IX L\L0"=80F5.+
MS-&*[)9F:V#%2IXNB%I-<1)G@I);FJ:R<"+H[(=VWJ;EGRHR3)B+"?,P83XF
M+,"$A4BPAA8'M18'6BVZ,!5D(\CSZEK G'S,N&!Y*GW=>1DY.?G(>2YK5%PM
MUVHJF!Y<M=UHNSY5IB7,;H08P[9V8HS[NIEC]BSKHMG,PQR:CPD+,&$A$JPA
MK8M:6A=::>UN#FD]FA9UJE0P82XFS,.$^9BP !,6(L$:LC.-S?:DH15>&5''
MT7,T3>#0/$W/.%5QJ#07E>95M.WI5=?NO5K8^:B]!JBT$(O65-36AK?Y:ZY,
MJNL.9)B,9RIB-B=NLDX&4YXG(GK#^>E[/UF+F#07E>:ATGQ46H!*"[%H3<5:
M&\5:>L464JSF:V[.U%)V#"RF\Y?)W/E+[8(R,I$#B&?2:QX[M:NZ;TS'G->[
M1;?Z89XL1DR:ATKS46D!*BW$HC7%N,E2F/HTA<Y]'DIA[!4=:KX"E>:BTCQ4
MFH]*"U!I(1:M*<U-VL+4YRVN&41J%^8.HH1X7$0"R)C1E5P"/Y.SK<UDY0[W
M9^XJ;:*F+U!I+BK-0Z7YJ+0 E196M.T@-S"V8UQ3=)LLAJE/8QS895;9#'5T
MJ"X@7X&EY*S(H.T_2(&:K$"EN:@T#Y7FH]("5%KXAG;,"Y(6ITMT[F^3[C#U
M^0Y=9/[OV]3ZSD^6)VHV!)7FH=)\5%J 2@NQ:$W!;E(GICYW\K_N5^O[/EFO
MJ(D55)I7T1K+MYYE&K:SNRF$FC9!I858M%**G:T#D2FP^^)P+"<SFF>B/*I7
ME]8'<*^+8Z<[Y3?FI5L>H]U@RE.]GR-V'V><)+"02*/M2%?/RH.RY8V@J^+8
MY90*0=/B<@G1')AJ(.L7<B+Z<J,ZJ(\KC_X%4$L#!!0    ( +J DEG^Y'6E
M80,  , 6   -    >&PO<W1Y;&5S+GAM;-U846_:,!#^*U&Z3JTT-82L*5D!
M:4.J-&F;*K4/>ZL,<<"28V>.Z:"_?KXXA$!]C/9AA05![/MRWWT^GQ.'?JF7
MG-[-*-7>(N>B'/@SK8M/05!.9C0GY84LJ#!()E5.M.FJ:5 6BI*T!*><!]U.
M)PYRPH0_[(MY?I/KTIO(N= #/VE,GCU]30=^&'_T/4LWDBD=^ ]G[W_-I;Y^
MY]GSR8>3D\[#^?6V_:P"SOW 27JY!^E%IX,3 XB1Q_N1[^+&J*\VJ=LZ_ZZK
MYW ^;3Q/,;?$'?.T'1-SONH@@NVQ(=L>&%&X5U)WY!0C[NY9"KMKP=('=4D/
M^YD4Z\J.?&LP\4E.O4?"!_Z(<#96#+PRDC.^M.8N&":22^5ILZ2,H! LY9.%
M0]N#U5;SY$Q(5<6V$>SON+Y\"UCU0"#CO!'8]:UAV"^(UE2)&].I+JZ,SR"O
M;M\O"Z-PJL@R[%[Z:X?J9(*,I4JI:L*$_LHT['.:@1S%IC,X:UD$ &HM<]-(
M&9E*02H-*X^Z86@GE/,[N!7]S#:X%UEK9JO*$TW3"*J;EL9V@+_-9KG;M/&K
M>+V"/4K]96Z&(ZH^E N]531CBZJ_R!H!&'N(LY.BX,O/G$U%3NW@]PXX[).5
MGS>3BCV9:% J$V.@RO<>J=)LTK;\5J2XIPN]*J=%AFON'J'F?YOG*154$=X6
M;6K_D+/\:L7UL_LM-%>WE6W%3I'1U>%KK/<KARXR/@:11S#=47+X&NO=Y*&+
M/(9,7KW9G?TE(L-C$-D]2)%!O:=L;5PWMJV-U8/7@X'_ UY'^#JH-YXSKIFH
M>S.6IE0\V[T:>DW&YO5\@]]<G]*,S+F^;\"!OVY_IRF;YTESU2TDHKYJW?X&
MPS-;X=6[B8G%1$H7-!W5734=5TW/-$S4^@"';>2F.MP(YF,Q-P(8%@=3@/E8
M+RS._S2>'CH>BV':>DZDA_KT4!_KY4)&U0>+X_9)S.$>:9)$41QC&1V-G I&
M6-[B&+YN-DP;>&!Q(-++<HW/-EXAN^L F]-=%8*-%*]$;*1XK@%QYPT\DL0]
MVU@<\,!F :L=B.^. S7E]HDBF%5,&[:"<21), 1JT5VC<8QD)X:/>WZP51)%
M2>)& ',KB"(,@=6((Y@"T( A450]![>>1\'J.16L_[,>_@%02P,$%     @
MNH"269>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC '
MT"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2
M:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=
MI3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8
M%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+
M P04    " "Z@))9%)8I\VT%   D+@  #P   'AL+W=O<FMB;V]K+GAM;,6:
M6V_C*!2 _PK*RW8?NHFOO:BMU&T[NY4ZTVA2S3Z.J$T:5!LR@'O[]7/ VQUH
MXJ-],7E*;!/["P:^<X"39ZD>[Z5\)"]M(_3I9&7,^G@ZU=6*M53_(==,P)6E
M5"TU<*@>IGJM&*WUBC'3-M-T-BNG+>5B<G;R?J^YFOH'TK#*<"G@I#WQC;-G
M_>NZ/21/7/-[WG#S>CIQWQLV(2T7O.5OK#Z=S"9$K^3SWU+Q-RD,;1:5DDUS
M.DGZ"]^8,KS:.+VPD'?T7KLSAMY_I0!R.BEG<,,E5]JX$N[^%!B?&!3NCSHC
M/_'&,'5)#?M+R6[-Q8.]#?R+J?<W7#V\?_:5>*S^3S7*Y9)7[%)67<N$Z>M1
ML<8""KWB:STA@K;L=/)>A)R+FEP) Y5$KD5_*RAK_RD\^KKN_[4!7*\.U3&'
M"^JZ=N#C05[ L6QX#4^OR9^TH:)BQ%6N]@!3!##=&2#9FU,/,D,@LXB0"PMA
M?Z")7)+;-5,>9(Y YCN#O)#MVH,L$,AB%Y".D>H5\2!+!+(<';)F0@/A5EP/
M\@"!/!@7\EIH7C-%[A2M80@DYTI1\="_<X_P$"$\')?P"PB&)&2?W*H'*OB;
M*T$HC):+KFW]KGV$0!Y%@$P!\C-5CPQ4U,#PPZI.<<.9]AMD,L.&\5D$S PP
MK\43E)3JU2=#!3.R81Q9#F004,!8"!*T;_CJ1\?7]I<^)J:99&3/.,S"5:"!
M?F*?3LZU#CV88(Y)1I:,(RR!$ 8= SW:CHLWG/;AEP^).28963(.\@ @O]JK
M,"C.J7WE, @)#9&:CXE9)AE9,P[S$# 7*ZK82C8P4NK?7*L,ZQ*S3#*R9ASD
MD84TLGJ$X*<W3@NWU%#:Q\0\DXPLFGX8GP'G/]0Z)NPQF%^2*())7)=I6V[Z
M>,<./ZX+^9B889(8BDFL8]RW.7VE#N!7^(V9)8UAEL2JY89!"PS2 LPK:0RO
M)%8L-U)K,H=0QW5FGP_-6V(()>F-4LF6D3OZ$M8>)I,TADP2:Y-%=Z_9C\[:
MY.KI0W"88BI)1U;)@C\(#F6I3:&K2G;.>F0.\7;%PYK$5)+&4,E0%/L]]3$Q
MF:0Q9#(4QX:8F$S2&#()XEBR=V=A]>\^(F:5-(95A@+:L"8QJZ0QK+(UH'4U
MZD^<8'K)8NAE**HE>SXF9ILLAFV& L80$Y-.%D,Z0R%CT#8S=+HLBGW\D'%;
M+\\P^V0Q$ADO[-D*B'DGB^*=S?CG7U ?$_-.%L,[&V'0UMK$O)-%26*&+)[Y
MF)A[LEU.F7W/?4S,/=DN)\V"VLPQ]^0QW#.(Z==FCKDGC^&>#S'1)>#R1I,[
M]N)C8N[)8[@GQ 0/P8WK#NI5^IB8>_(8[AD,WX*VB2[6Q/#/(&;0-C$+Y3$L
M-!!E0AOU,3$+Y3$LM!W3ME$?$[-0'L-"0YB?.A\3LU >PT)#,7L09>:8A?(8
M%AI,+?;]!4_,0L4N,Z!@0"HP"Q6[S(""EUY@%BIB6&@P40M>.F:A(H:%!A.U
MX*5C%BIB6&@0T[=0@6X:B)(+!?GD0.A18!8JHN1"'S'M6C?$2G+I8V(6*J+D
M0@/+)F%/QRQ41,F%/BZ;_!<:^YB8A8HHJSO^1((7NQO?Z25FH3+R,H_-,2'N
MI&[._<:?3B@Q"Y515GT"S$^=Z10CG^VN0Q\3LU 99?%GV^2,>_D^)F:A,LH\
MW!;,?3O4!YB8A<HH<W&;<TB;/;W$+%1&L= &IAM&U\&&SQ+=O+:;&3F[9:.2
MPL^%2LQ"910+;<'LUP5]3,Q"910+;5U(M0W4Q\0L5#H+35UA?792LR47K/X"
MC]!POJ)--5?$?O0;I?+"[EA8=DUS >=NQ8VD]?LFY_<-VF<_ 5!+ P04
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MOK=<'W]9?I]$G!<7G--M17WZ"U!+ P04    " "Z@))9UD@C+O<!   K*
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M09'5H,AJ4&0U_RGKO7/K/XX?GV5GF_XMGXW_$5R\ %!+ 0(4 Q0    ( +J
MDED'04UB@0   +$    0              "  0    !D;V-0<F]P<R]A<' N
M>&UL4$L! A0#%     @ NH"268S-8B#O    *P(  !$              ( !
MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ NH"269E<G",0!@
MG"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " "Z@))9^3A(P4T(  #S.@  &               @($."   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ NH"26=E3E:=1!P
MWR   !@              ("!D1   'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    ( +J DEF_4*ZRP@(  &\)   8              " @1@8
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "Z@))9/ F[
MU$(%  !1$@  &               @($0&P  >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ NH"266=9722' @  P 8  !@
M ("!B"   'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( +J
MDEEP0C;,HP@  &,F   8              " @44C  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    " "Z@))9?ZL_A&E)  !>#P8 &
M        @($>+   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ NH"269GHFF9% @  H08  !@              ("!O74  'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( +J DEE 0E' '1$  +TL   8
M              " @3AX  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    " "Z@))91$M\0IX#  !>"   &0              @(&+B0  >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( +J DED4I2IU#0,
M 'P&   9              " @6"-  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ NH"266(ZG? ] P  _P8  !D              ("!
MI)   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " "Z@))9
MY=Y3'[0#  "_"   &0              @($8E   >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    ( +J DEF?2WCDS ,  /('   9
M      " @0.8  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ NH"266I+V1,] @  Z 0  !D              ("!!IP  'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " "Z@))9H=GFP!@&   &#P
M&0              @(%ZG@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    ( +J DEE"*9<3_04  ,0-   9              " @<FD  !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ NH"261B\)A[6
M P  XP@  !D              ("!_:H  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    " "Z@))9..JHZ98"  "I!0  &0
M@($*KP  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( +J
MDEEN\8A KP,  .4'   9              " @=>Q  !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ NH"26=$EEEM1!   T D  !D
M         ("!O;4  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    " "Z@))9;;RL3TP#  !\!P  &0              @(%%N@  >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( +J DEE05=1N? 8  #$0
M   9              " @<B]  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ NH"26?W/0FR, @  KP4  !D              ("!>\0
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " "Z@))9W_Q7
MO_41  !%.0  &0              @($^QP  >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    ( +J DEDM1T;^I (  + %   9
M  " @6K9  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
MNH"269U@+J\" P  \08  !D              ("!1=P  'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    " "Z@))9%/D6$)$"  "9!0  &0
M            @(%^WP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    ( +J DEDAK8@*S0(   D&   9              " @4;B  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ NH"268X^!PMM P
M/0@  !D              ("!2N4  'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    " "Z@))9=/CY.)0"  #)!0  &0              @('N
MZ   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( +J DED%
MTTB<O@(  +P%   9              " @;GK  !X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ NH"26?_TR948 P  S@8  !D
M     ("!KNX  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +J DEE997Z*1P@  !M"   9              "
M@10! 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ NH"2
M67 ")2B3 P  , X  !D              ("!D@D! 'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    " "Z@))9(NFI-4X#  #^#0  &0
M        @(%<#0$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   ( +J DEGJ<[[:CP0  #,;   9              " @>$0 0!X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ NH"26?GDRA<L @  ? 4
M !D              ("!IQ4! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    " "Z@))9:<23H6\"  "4!@  &0              @($*& $
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( +J DEF+ 3-@
M/ (  -@$   9              " @; : 0!X;"]W;W)K<VAE971S+W-H965T
M-#0N>&UL4$L! A0#%     @ NH"268\KQB=  P  3 P  !D
M ("!(QT! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " "Z
M@))90.8(%*\%  !M*@  &0              @(&:( $ >&PO=V]R:W-H965T
M<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( +J DEF3<(1!K@,  '@.   9
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M970U,2YX;6Q02P$"% ,4    " "Z@))9XHW'5[0A  !#AP( &0
M    @(%\-P$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (
M +J DEG\5OS=QP,  )80   9              " @6=9 0!X;"]W;W)K<VAE
M971S+W-H965T-3,N>&UL4$L! A0#%     @ NH"265'V"CK<"P  2Z0  !D
M             ("!95T! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"
M% ,4    " "Z@))9_86":5L$   -%@  &0              @(%X:0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( +J DEG$L!U*:04
M (XF   9              " @0IN 0!X;"]W;W)K<VAE971S+W-H965T-38N
M>&UL4$L! A0#%     @ NH"26<!VKN%* P  ;@T  !D              ("!
MJG,! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " "Z@))9
M^[P1]1X"  !I!   &0              @($K=P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4X+GAM;%!+ 0(4 Q0    ( +J DED=2ONBZ@0  (4;   9
M      " @8!Y 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%
M  @ NH"264>;69<' @  300  !D              ("!H7X! 'AL+W=O<FMS
M:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " "Z@))9^?BZ/TL"  #L!
M&0              @('?@ $ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+
M 0(4 Q0    ( +J DED-57#L'@(  .X$   9              " @6&# 0!X
M;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ NH"268OPP#77
M @  <P@  !D              ("!MH4! 'AL+W=O<FMS:&5E=',O<VAE970V
M,RYX;6Q02P$"% ,4    " "Z@))9$.P/#8\$  #>'   &0
M@('$B $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( +J
MDEF\3#T,2 (  " %   9              " @8J- 0!X;"]W;W)K<VAE971S
M+W-H965T-C4N>&UL4$L! A0#%     @ NH"2657(#G6, @  &@@  !D
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M<R\N<F5L<U!+ 0(4 Q0    ( +J DED4EBGS;04  "0N   /
M  "  ?VD 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "Z@))9EW=RY"P"
M  #V*   &@              @ &7J@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " "Z@))9UD@C+O<!   K*   $P
M@ '[K $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     30!- !(5   CKP$
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>374</ContextCount>
  <ElementCount>379</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>86</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statement of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows</Role>
      <ShortName>Consolidated Statement of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Condensed Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995453 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies</Role>
      <ShortName>Note 1 - Organization and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995454 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities</Role>
      <ShortName>Note 2 - Marketable Securities and Investment Other Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Note 3 - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-3-inventory</Role>
      <ShortName>Note 3 - Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995456 - Disclosure - Note 4 - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment</Role>
      <ShortName>Note 4 - Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995457 - Disclosure - Note 5 - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets</Role>
      <ShortName>Note 5 - Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995458 - Disclosure - Note 6 - Contingent Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability</Role>
      <ShortName>Note 6 - Contingent Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995459 - Disclosure - Note 7 - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions</Role>
      <ShortName>Note 7 - Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995460 - Disclosure - Note 8 - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity</Role>
      <ShortName>Note 8 - Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995461 - Disclosure - Note 9 - Stock Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-</Role>
      <ShortName>Note 9 - Stock Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995462 - Disclosure - Note 10 - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-10-warrants</Role>
      <ShortName>Note 10 - Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995463 - Disclosure - Note 11 - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-</Role>
      <ShortName>Note 11 - Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995464 - Disclosure - Note 12 - Note Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-12-note-payable</Role>
      <ShortName>Note 12 - Note Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Note 13 - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-13-leases</Role>
      <ShortName>Note 13 - Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995466 - Disclosure - Note 14 - Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share</Role>
      <ShortName>Note 14 - Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995467 - Disclosure - Note 15 - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes</Role>
      <ShortName>Note 15 - Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995468 - Disclosure - Note 16 - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events</Role>
      <ShortName>Note 16 - Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995469 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995470 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables</Role>
      <ShortName>Note 1 - Organization and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995471 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables</Role>
      <ShortName>Note 2 - Marketable Securities and Investment Other Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995472 - Disclosure - Note 3 - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables</Role>
      <ShortName>Note 3 - Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-3-inventory</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995473 - Disclosure - Note 4 - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables</Role>
      <ShortName>Note 4 - Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995474 - Disclosure - Note 5 - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables</Role>
      <ShortName>Note 5 - Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995475 - Disclosure - Note 6 - Contingent Liability (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables</Role>
      <ShortName>Note 6 - Contingent Liability (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995476 - Disclosure - Note 8 - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables</Role>
      <ShortName>Note 8 - Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995477 - Disclosure - Note 9 - Stock Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables</Role>
      <ShortName>Note 9 - Stock Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995478 - Disclosure - Note 10 - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables</Role>
      <ShortName>Note 10 - Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-10-warrants</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995479 - Disclosure - Note 13 - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables</Role>
      <ShortName>Note 13 - Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-13-leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995480 - Disclosure - Note 14 - Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables</Role>
      <ShortName>Note 14 - Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995481 - Disclosure - Note 15 - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables</Role>
      <ShortName>Note 15 - Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995482 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual</Role>
      <ShortName>Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995483 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details</Role>
      <ShortName>Note 1 - Organization and Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995484 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual</Role>
      <ShortName>Note 2 - Marketable Securities and Investment Other Securities (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995485 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities - Assets Valued at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details</Role>
      <ShortName>Note 2 - Marketable Securities and Investment Other Securities - Assets Valued at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995486 - Disclosure - Note 3 - Inventory (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual</Role>
      <ShortName>Note 3 - Inventory (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995487 - Disclosure - Note 3 - Inventory - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details</Role>
      <ShortName>Note 3 - Inventory - Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995488 - Disclosure - Note 4 - Property and Equipment (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual</Role>
      <ShortName>Note 4 - Property and Equipment (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995489 - Disclosure - Note 4 - Property and Equipment - Major Classes of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details</Role>
      <ShortName>Note 4 - Property and Equipment - Major Classes of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995490 - Disclosure - Note 5 - Intangible Assets (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual</Role>
      <ShortName>Note 5 - Intangible Assets (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995491 - Disclosure - Note 5 - Intangible Assets - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details</Role>
      <ShortName>Note 5 - Intangible Assets - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995492 - Disclosure - Note 5 - Intangible Assets - Future Amortization of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details</Role>
      <ShortName>Note 5 - Intangible Assets - Future Amortization of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995493 - Disclosure - Note 6 - Contingent Liability (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual</Role>
      <ShortName>Note 6 - Contingent Liability (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995494 - Disclosure - Note 6 - Contingent Liability - Contingent Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details</Role>
      <ShortName>Note 6 - Contingent Liability - Contingent Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995495 - Disclosure - Note 6 - Contingent Liability - Contingent Liability (Details) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals</Role>
      <ShortName>Note 6 - Contingent Liability - Contingent Liability (Details) (Parentheticals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995496 - Disclosure - Note 8 - Shareholders' Equity (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual</Role>
      <ShortName>Note 8 - Shareholders' Equity (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995497 - Disclosure - Note 8 - Shareholders' Equity - Fair Value Assumptions of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details</Role>
      <ShortName>Note 8 - Shareholders' Equity - Fair Value Assumptions of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995498 - Disclosure - Note 9 - Stock Based Compensation (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual</Role>
      <ShortName>Note 9 - Stock Based Compensation (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995499 - Disclosure - Note 9 - Stock Based Compensation - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details</Role>
      <ShortName>Note 9 - Stock Based Compensation - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995500 - Disclosure - Note 10 - Warrants - Schedule of Equity-Classified Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details</Role>
      <ShortName>Note 10 - Warrants - Schedule of Equity-Classified Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995501 - Disclosure - Note 10 - Warrants - Summary of Outstanding Common Stock Purchase Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details</Role>
      <ShortName>Note 10 - Warrants - Summary of Outstanding Common Stock Purchase Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995502 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual</Role>
      <ShortName>Note 11 - Commitments and Contingencies (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995503 - Disclosure - Note 12 - Note Payable (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual</Role>
      <ShortName>Note 12 - Note Payable (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-12-note-payable</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995504 - Disclosure - Note 13 - Leases (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual</Role>
      <ShortName>Note 13 - Leases (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>995505 - Disclosure - Note 13 - Leases - Operating Lease Costs and Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details</Role>
      <ShortName>Note 13 - Leases - Operating Lease Costs and Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>995506 - Disclosure - Note 13 - Leases - Future Minimum Aggregate Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details</Role>
      <ShortName>Note 13 - Leases - Future Minimum Aggregate Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>995507 - Disclosure - Note 14 - Loss Per Share (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual</Role>
      <ShortName>Note 14 - Loss Per Share (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>995508 - Disclosure - Note 14 - Loss Per Share - Basic and Diluted Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details</Role>
      <ShortName>Note 14 - Loss Per Share - Basic and Diluted Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>995509 - Disclosure - Note 15 - Income Taxes (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual</Role>
      <ShortName>Note 15 - Income Taxes (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>995510 - Disclosure - Note 15 - Income Taxes - Components of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details</Role>
      <ShortName>Note 15 - Income Taxes - Components of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>995511 - Disclosure - Note 15 - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details</Role>
      <ShortName>Note 15 - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>995512 - Disclosure - Note 15 - Income Taxes - Significant Components of Deferred Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details</Role>
      <ShortName>Note 15 - Income Taxes - Significant Components of Deferred Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ycbd20240930c_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>995513 - Disclosure - Note 16 - Subsequent Events (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual</Role>
      <ShortName>Note 16 - Subsequent Events (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events</ParentRole>
      <Position>69</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ycbd-20240930.xsd</File>
    <File>ycbd-20240930_cal.xml</File>
    <File>ycbd-20240930_def.xml</File>
    <File>ycbd-20240930_lab.xml</File>
    <File>ycbd-20240930_pre.xml</File>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="ycbd20240930c_10k.htm">ycbd20240930c_10k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>c02.jpg</File>
    <File>c03.jpg</File>
    <File>cbd01.jpg</File>
    <File>ycbd_10klogo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="995">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>92
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ycbd20240930c_10k.htm": {
   "nsprefix": "ycbd",
   "nsuri": "http://www.cbdmd.com/20240930",
   "dts": {
    "schema": {
     "local": [
      "ycbd-20240930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ycbd-20240930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ycbd-20240930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ycbd-20240930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ycbd-20240930_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ycbd20240930c_10k.htm"
     ]
    }
   },
   "keyStandard": 309,
   "keyCustom": 70,
   "axisStandard": 30,
   "axisCustom": 0,
   "memberStandard": 27,
   "memberCustom": 54,
   "hidden": {
    "total": 71,
    "http://fasb.org/us-gaap/2024": 49,
    "http://www.cbdmd.com/20240930": 12,
    "http://xbrl.sec.gov/dei/2024": 6,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "contextCount": 374,
   "entityCount": 1,
   "segmentCount": 86,
   "elementCount": 583,
   "unitCount": 9,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 995,
    "http://xbrl.sec.gov/dei/2024": 40,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-",
     "longName": "001 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
     "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R4": {
     "role": "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
     "longName": "003 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss",
     "longName": "004 - Statement - Consolidated Statements of Comprehensive Loss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "ycbd:ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
     "longName": "005 - Statement - Consolidated Statement of Cash Flows",
     "shortName": "Consolidated Statement of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:StockOptionPlanExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
     "longName": "006 - Statement - Condensed Consolidated Statements of Shareholders' Equity",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "i_2022-09-30_StatementEquityComponentsAxis-CommonStockMember",
      "name": "us-gaap:SharesOutstanding",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R9": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
     "longName": "995453 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies",
     "shortName": "Note 1 - Organization and Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities",
     "longName": "995454 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities",
     "shortName": "Note 2 - Marketable Securities and Investment Other Securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-3-inventory",
     "longName": "995455 - Disclosure - Note 3 - Inventory",
     "shortName": "Note 3 - Inventory",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment",
     "longName": "995456 - Disclosure - Note 4 - Property and Equipment",
     "shortName": "Note 4 - Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
     "longName": "995457 - Disclosure - Note 5 - Intangible Assets",
     "shortName": "Note 5 - Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
     "longName": "995458 - Disclosure - Note 6 - Contingent Liability",
     "shortName": "Note 6 - Contingent Liability",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions",
     "longName": "995459 - Disclosure - Note 7 - Related Party Transactions",
     "shortName": "Note 7 - Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
     "longName": "995460 - Disclosure - Note 8 - Shareholders' Equity",
     "shortName": "Note 8 - Shareholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
     "longName": "995461 - Disclosure - Note 9 - Stock Based Compensation",
     "shortName": "Note 9 - Stock Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-10-warrants",
     "longName": "995462 - Disclosure - Note 10 - Warrants",
     "shortName": "Note 10 - Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "ycbd:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "ycbd:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-",
     "longName": "995463 - Disclosure - Note 11 - Commitments and Contingencies",
     "shortName": "Note 11 - Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
     "longName": "995464 - Disclosure - Note 12 - Note Payable",
     "shortName": "Note 12 - Note Payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-13-leases",
     "longName": "995465 - Disclosure - Note 13 - Leases",
     "shortName": "Note 13 - Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share",
     "longName": "995466 - Disclosure - Note 14 - Loss Per Share",
     "shortName": "Note 14 - Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes",
     "longName": "995467 - Disclosure - Note 15 - Income Taxes",
     "shortName": "Note 15 - Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
     "longName": "995468 - Disclosure - Note 16 - Subsequent Events",
     "shortName": "Note 16 - Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies",
     "longName": "995469 - Disclosure - Significant Accounting Policies (Policies)",
     "shortName": "Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:StockholdersEquityPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:StockholdersEquityPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables",
     "longName": "995470 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Tables)",
     "shortName": "Note 1 - Organization and Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables",
     "longName": "995471 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities (Tables)",
     "shortName": "Note 2 - Marketable Securities and Investment Other Securities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables",
     "longName": "995472 - Disclosure - Note 3 - Inventory (Tables)",
     "shortName": "Note 3 - Inventory (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables",
     "longName": "995473 - Disclosure - Note 4 - Property and Equipment (Tables)",
     "shortName": "Note 4 - Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables",
     "longName": "995474 - Disclosure - Note 5 - Intangible Assets (Tables)",
     "shortName": "Note 5 - Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables",
     "longName": "995475 - Disclosure - Note 6 - Contingent Liability (Tables)",
     "shortName": "Note 6 - Contingent Liability (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables",
     "longName": "995476 - Disclosure - Note 8 - Shareholders' Equity (Tables)",
     "shortName": "Note 8 - Shareholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables",
     "longName": "995477 - Disclosure - Note 9 - Stock Based Compensation (Tables)",
     "shortName": "Note 9 - Stock Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables",
     "longName": "995478 - Disclosure - Note 10 - Warrants (Tables)",
     "shortName": "Note 10 - Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30_ClassOfWarrantOrRightAxis-CommonStockPurchaseWarrantsMember",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ycbd:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30_ClassOfWarrantOrRightAxis-CommonStockPurchaseWarrantsMember",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ycbd:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables",
     "longName": "995479 - Disclosure - Note 13 - Leases (Tables)",
     "shortName": "Note 13 - Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables",
     "longName": "995480 - Disclosure - Note 14 - Loss Per Share (Tables)",
     "shortName": "Note 14 - Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables",
     "longName": "995481 - Disclosure - Note 15 - Income Taxes (Tables)",
     "shortName": "Note 15 - Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
     "longName": "995482 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)",
     "shortName": "Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details",
     "longName": "995483 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "shortName": "Note 1 - Organization and Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "true",
      "lang": null,
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual",
     "longName": "995484 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities (Details Textual)",
     "shortName": "Note 2 - Marketable Securities and Investment Other Securities (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2022-04-07_2022-04-07_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember",
      "name": "ycbd:EquipmentSoldValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details",
     "longName": "995485 - Disclosure - Note 2 - Marketable Securities and Investment Other Securities - Assets Valued at Fair Value (Details)",
     "shortName": "Note 2 - Marketable Securities and Investment Other Securities - Assets Valued at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member",
      "name": "us-gaap:FairValueNetAssetLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member",
      "name": "us-gaap:FairValueNetAssetLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual",
     "longName": "995486 - Disclosure - Note 3 - Inventory (Details Textual)",
     "shortName": "Note 3 - Inventory (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "d_2024-07-01_2024-09-30",
      "name": "us-gaap:InventoryWriteDown",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R43": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details",
     "longName": "995487 - Disclosure - Note 3 - Inventory - Schedule of Inventory (Details)",
     "shortName": "Note 3 - Inventory - Schedule of Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual",
     "longName": "995488 - Disclosure - Note 4 - Property and Equipment (Details Textual)",
     "shortName": "Note 4 - Property and Equipment (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details",
     "longName": "995489 - Disclosure - Note 4 - Property and Equipment - Major Classes of Property and Equipment (Details)",
     "shortName": "Note 4 - Property and Equipment - Major Classes of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
     "longName": "995490 - Disclosure - Note 5 - Intangible Assets (Details Textual)",
     "shortName": "Note 5 - Intangible Assets (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2024-08-01_2024-08-31_CounterpartyNameAxis-MajikMedicinesMember",
      "name": "ycbd:CommissionPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details",
     "longName": "995491 - Disclosure - Note 5 - Intangible Assets - Schedule of Intangible Assets (Details)",
     "shortName": "Note 5 - Intangible Assets - Schedule of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "ycbd:FinitelivedIntangibleAssetAccumulatedImpairment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "ycbd:FinitelivedIntangibleAssetAccumulatedImpairment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details",
     "longName": "995492 - Disclosure - Note 5 - Intangible Assets - Future Amortization of Intangible Assets (Details)",
     "shortName": "Note 5 - Intangible Assets - Future Amortization of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual",
     "longName": "995493 - Disclosure - Note 6 - Contingent Liability (Details Textual)",
     "shortName": "Note 6 - Contingent Liability (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember",
      "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember",
      "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
     "longName": "995494 - Disclosure - Note 6 - Contingent Liability - Contingent Liability (Details)",
     "shortName": "Note 6 - Contingent Liability - Contingent Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member",
      "name": "ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member",
      "name": "ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals",
     "longName": "995495 - Disclosure - Note 6 - Contingent Liability - Contingent Liability (Details) (Parentheticals)",
     "shortName": "Note 6 - Contingent Liability - Contingent Liability (Details) (Parentheticals)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R52": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
     "longName": "995496 - Disclosure - Note 8 - Shareholders' Equity (Details Textual)",
     "shortName": "Note 8 - Shareholders' Equity (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:DividendsPayableCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2023-08-30",
      "name": "us-gaap:DividendsPayableCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
     "longName": "995497 - Disclosure - Note 8 - Shareholders' Equity - Fair Value Assumptions of Stock Options (Details)",
     "shortName": "Note 8 - Shareholders' Equity - Fair Value Assumptions of Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "i_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "USDPerShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual",
     "longName": "995498 - Disclosure - Note 9 - Stock Based Compensation (Details Textual)",
     "shortName": "Note 9 - Stock Based Compensation (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "i_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details",
     "longName": "995499 - Disclosure - Note 9 - Stock Based Compensation - Summary of Stock Option Activity (Details)",
     "shortName": "Note 9 - Stock Based Compensation - Summary of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "i_2023-09-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
      "unitRef": "USDPerShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details",
     "longName": "995500 - Disclosure - Note 10 - Warrants - Schedule of Equity-Classified Warrants (Details)",
     "shortName": "Note 10 - Warrants - Schedule of Equity-Classified Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ycbd:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ycbd:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details",
     "longName": "995501 - Disclosure - Note 10 - Warrants - Summary of Outstanding Common Stock Purchase Warrants (Details)",
     "shortName": "Note 10 - Warrants - Summary of Outstanding Common Stock Purchase Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringSeptember2023Member",
      "name": "ycbd:ClassOfWarrantOrRightExercisable",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ycbd:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringSeptember2023Member",
      "name": "ycbd:ClassOfWarrantOrRightExercisable",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ycbd:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual",
     "longName": "995502 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual)",
     "shortName": "Note 11 - Commitments and Contingencies (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "i_2024-03-20_LeaseContractualTermAxis-ForbearanceAgreementMember",
      "name": "ycbd:PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-03-20_LeaseContractualTermAxis-ForbearanceAgreementMember",
      "name": "ycbd:PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual",
     "longName": "995503 - Disclosure - Note 12 - Note Payable (Details Textual)",
     "shortName": "Note 12 - Note Payable (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "ycbd:FairValueAdjustmentOfDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember",
      "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1",
      "unitRef": "USDPerShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual",
     "longName": "995504 - Disclosure - Note 13 - Leases (Details Textual)",
     "shortName": "Note 13 - Leases (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details",
     "longName": "995505 - Disclosure - Note 13 - Leases - Operating Lease Costs and Supplemental Cash Flow Information (Details)",
     "shortName": "Note 13 - Leases - Operating Lease Costs and Supplemental Cash Flow Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details",
     "longName": "995506 - Disclosure - Note 13 - Leases - Future Minimum Aggregate Lease Payments (Details)",
     "shortName": "Note 13 - Leases - Future Minimum Aggregate Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual",
     "longName": "995507 - Disclosure - Note 14 - Loss Per Share (Details Textual)",
     "shortName": "Note 14 - Loss Per Share (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details",
     "longName": "995508 - Disclosure - Note 14 - Loss Per Share - Basic and Diluted Earnings Per Share (Details)",
     "shortName": "Note 14 - Loss Per Share - Basic and Diluted Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "d_2024-07-01_2024-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual",
     "longName": "995509 - Disclosure - Note 15 - Income Taxes (Details Textual)",
     "shortName": "Note 15 - Income Taxes (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "i_2018-09-30",
      "name": "us-gaap:OperatingLossCarryforwardsValuationAllowance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2018-09-30",
      "name": "us-gaap:OperatingLossCarryforwardsValuationAllowance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details",
     "longName": "995510 - Disclosure - Note 15 - Income Taxes - Components of Provision for Income Taxes (Details)",
     "shortName": "Note 15 - Income Taxes - Components of Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details",
     "longName": "995511 - Disclosure - Note 15 - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)",
     "shortName": "Note 15 - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-10-01_2024-09-30",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details",
     "longName": "995512 - Disclosure - Note 15 - Income Taxes - Significant Components of Deferred Income Taxes (Details)",
     "shortName": "Note 15 - Income Taxes - Significant Components of Deferred Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2024-09-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
     "longName": "995513 - Disclosure - Note 16 - Subsequent Events (Details Textual)",
     "shortName": "Note 16 - Subsequent Events (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "i_2026-02-28_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember",
      "name": "ycbd:LesseeOperatingLeasesMonthlyBaseRent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "i_2026-02-28_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember",
      "name": "ycbd:LesseeOperatingLeasesMonthlyBaseRent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ycbd20240930c_10k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ycbd_A360MediaLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "A360MediaLlcMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "a360 Media, LLC [Member]",
        "documentation": "Represents a360 Media, LLC."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r697"
     ]
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableGrossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r224",
      "r651"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_AccountsReceivableNetCurrent",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_AccruedLiabilitiesCurrent",
        "terseLabel": "Accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
        "negatedLabel": "Less accumulated depreciation",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r140",
      "r523"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive other expense",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r67",
      "r148",
      "r518",
      "r538",
      "r539"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r10",
      "r17",
      "r429",
      "r432",
      "r482",
      "r534",
      "r535",
      "r740",
      "r741",
      "r742",
      "r750",
      "r751",
      "r752",
      "r754"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r697",
      "r854"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r750",
      "r751",
      "r752",
      "r754",
      "r827",
      "r855"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maxim transaction expenses",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r88"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used by operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Cost [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ycbd_AdvertisingPlacementAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "AdvertisingPlacementAgreementMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Placement Agreement [Member]",
        "documentation": "Represents advertising placement agreement."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement",
        "terseLabel": "Agreement for Advertising Placement, Credit for Media Support and Advertising Placement",
        "documentation": "Credit for media support and advertising placement for agreement for advertising placement."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_AgreementForAdvertisingPlacementUnutilizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "AgreementForAdvertisingPlacementUnutilizedAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_AgreementForAdvertisingPlacementUnutilizedAmount",
        "terseLabel": "Agreement for Advertising Placement, Unutilized Amount",
        "documentation": "Amount unutilized of agreement for advertising placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_AllocatedShareBasedCompensationExpense",
        "terseLabel": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r382"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_AllowanceForDoubtfulAccountsReceivable",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r225",
      "r231",
      "r232",
      "r233",
      "r852"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangibles amortization",
        "terseLabel": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r241",
      "r248",
      "r664"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AreaOfRealEstateProperty",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_AreaOfRealEstateProperty",
        "terseLabel": "Area of Real Estate Property (Square Foot)",
        "documentation": "Area of a real estate property."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_Assets",
        "totalLabel": "Total assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r114",
      "r143",
      "r173",
      "r209",
      "r213",
      "r218",
      "r219",
      "r228",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r424",
      "r426",
      "r455",
      "r513",
      "r587",
      "r661",
      "r662",
      "r697",
      "r712",
      "r788",
      "r789",
      "r840"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_AssetsCurrent",
        "totalLabel": "Total current assets",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r152",
      "r173",
      "r228",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r424",
      "r426",
      "r455",
      "r697",
      "r788",
      "r789",
      "r840"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r716",
      "r717",
      "r718"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r716",
      "r717",
      "r718"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r716",
      "r717",
      "r718"
     ]
    },
    "us-gaap_AutomobilesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AutomobilesMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Automobiles [Member]",
        "documentation": "Vehicles that are used primarily for transporting people."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372"
     ]
    },
    "ycbd_BoardOfDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "BoardOfDirectorsMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors [Member]",
        "documentation": "Represents the companies board of directors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r419",
      "r675",
      "r676"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r419",
      "r675",
      "r676"
     ]
    },
    "ycbd_BusinessAcquisitionContingentConsiderationAggregateNetRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "BusinessAcquisitionContingentConsiderationAggregateNetRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate net revenue",
        "documentation": "Represents aggregate net revenue for contingent consideration for business acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Contingent Consideration, Shares Issued Per Aggregate Net Revenue Ratio",
        "documentation": "Represents the shares issued per dollar of net revenue for contingent consideration."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)",
        "documentation": "Represents the additional shares issued or issuable for business acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares, Expiration (Month)",
        "documentation": "Represents the expiration period for additional shares issuable."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)",
        "documentation": "Represents the vesting period of issued and/or issuable shares issued for acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase/(Decrease) in contingent liability",
        "negatedLabel": "Decrease of contingent liability",
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement."
       }
      }
     },
     "auth_ref": [
      "r421",
      "r743"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r98"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r420"
     ]
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r96",
      "r97"
     ]
    },
    "ycbd_CapitalRaiseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "CapitalRaiseMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Raise [Member]",
        "documentation": "Represents capital raise."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_CaseWithMajikMedicinesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "CaseWithMajikMedicinesMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Case With Majik Medicines [Member]",
        "documentation": "Represents Case With Majik Medicines."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r138",
      "r649"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
        "periodStartLabel": "Cash and cash equivalents, beginning of year",
        "periodEndLabel": "Cash and cash equivalents, end of year",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r75",
      "r169"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
        "totalLabel": "Net increase (decrease) in cash",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r75"
     ]
    },
    "us-gaap_CashUninsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashUninsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_CashUninsuredAmount",
        "terseLabel": "Cash, Uninsured Amount",
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_CbdMdLimintedMarkMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "CbdMdLimintedMarkMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CBD MD Liminted Mark [Member]",
        "documentation": "Represents CBD MD Liminted Mark."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_CbdmdAndDirectcbdonlineTrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "CbdmdAndDirectcbdonlineTrademarksMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "cbdMD and directCBDonline Trademarks [Member]",
        "documentation": "Relating to cbdMD and directCBDonline trademarks."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r144",
      "r145",
      "r146",
      "r173",
      "r197",
      "r198",
      "r201",
      "r203",
      "r211",
      "r212",
      "r228",
      "r272",
      "r274",
      "r275",
      "r276",
      "r279",
      "r280",
      "r308",
      "r309",
      "r312",
      "r315",
      "r321",
      "r455",
      "r544",
      "r545",
      "r546",
      "r547",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r575",
      "r596",
      "r616",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r725",
      "r745",
      "r755"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ClassOfWarrantOrRightExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ClassOfWarrantOrRightExercisable",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercisable, warrants (in shares)",
        "documentation": "Number of warrants or rights that are exercisable."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercisable, warrant, weighted average exercise price (in dollars per share)",
        "documentation": "Weighted average exercise price of warrants or rights that are exercisable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
        "terseLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "ycbd_ClassOfWarrantOrRightExercisesInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ClassOfWarrantOrRightExercisesInPeriod",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised, warrants (in shares)",
        "negatedLabel": "Exercised, warrants (in shares)",
        "documentation": "Number of warrants or rights exercised during the current period."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised, warrant, weighted average exercise price (in dollars per share)",
        "documentation": "Weighted average price at which warrant holders acquired warrants or right."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ClassOfWarrantOrRightForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ClassOfWarrantOrRightForfeituresInPeriod",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forfeited, warrants (in shares)",
        "negatedLabel": "Forfeited, warrants (in shares)",
        "documentation": "The number of warrant or right forfeitures in period."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forfeited, warrant, weighted average exercise price (in dollars per share)",
        "documentation": "Weighted average price at which grantees could have acquired the underlying warrant or right."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ClassOfWarrantOrRightGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ClassOfWarrantOrRightGrantsInPeriod",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted, warrants (in shares)",
        "documentation": "The number of grants made during the period on warrant or right."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted, warrant, weighted average exercise price (in dollars per share)",
        "documentation": "Weighted average per share amount at which grantees can acquire warrant or right."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
        "terseLabel": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding, warrants (in shares)",
        "periodStartLabel": "Outstanding, warrants (in shares)",
        "periodEndLabel": "Outstanding, warrants (in shares)",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding, warrant, weighted average exercise price (in dollars per share)",
        "periodStartLabel": "Outstanding, warrant, weighted average exercise price (in dollars per share)",
        "periodEndLabel": "Outstanding, warrant, weighted average exercise price (in dollars per share)",
        "documentation": "Weighted average exercise price of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding, warrant, contractual term (Year)",
        "documentation": "Weighted average remaining contractual term for warrants and rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_CollectionOnDiscontinuedOperationsAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "CollectionOnDiscontinuedOperationsAccountsReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collection on discontinued operations accounts receivable",
        "documentation": "Represents the amount of accounts receivable collected from discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_CommissionPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "CommissionPercentage",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_CommissionPercentage",
        "terseLabel": "Commission Percentage",
        "documentation": "Represents the percentage of commission granted under an agreement."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_CommitmentSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "CommitmentSharesMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitment Shares [Member]",
        "documentation": "Represents commitment shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies (Note 11)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r106",
      "r515",
      "r574"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r264",
      "r265",
      "r642",
      "r782",
      "r787"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r701",
      "r702",
      "r703",
      "r705",
      "r706",
      "r707",
      "r708",
      "r750",
      "r751",
      "r754",
      "r827",
      "r853",
      "r855"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value (in dollars per share)",
        "terseLabel": "Common Stock, Par or Stated Value Per Share (in dollars per share)",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ycbd_CommonStockPurchaseWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "CommonStockPurchaseWarrantsMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Purchase Warrants [Member]",
        "documentation": "Represents common stock purchase warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, authorized (in shares)",
        "terseLabel": "Common Stock, Shares Authorized (in shares)",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r575"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, issued (in shares)",
        "terseLabel": "Common Stock, Shares, Issued (in shares)",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, outstanding (in shares)",
        "terseLabel": "Common Stock, Shares, Outstanding (in shares)",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r58",
      "r575",
      "r593",
      "r855",
      "r856"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, authorized 150,000,000 shares, $0.001 par value, 3,939,057 and 2,960,573 shares issued and outstanding, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r517",
      "r697"
     ]
    },
    "ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments",
        "totalLabel": "Comprehensive Loss",
        "documentation": "Amount after tax before income adjustments of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ComprehensiveIncomeNetOfTax",
        "totalLabel": "Comprehensive Loss available to common shareholders",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r154",
      "r156",
      "r162",
      "r505",
      "r528",
      "r529"
     ]
    },
    "ycbd_ComputersFurnitureAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ComputersFurnitureAndEquipmentMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computers, Furniture, and Equipment [Member]",
        "documentation": "Represents Computers, furniture, equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r43",
      "r44",
      "r222",
      "r641"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r43",
      "r44",
      "r222",
      "r541",
      "r641"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r43",
      "r44",
      "r222",
      "r641",
      "r729"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r123"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ConcentrationRiskPercentage1",
        "terseLabel": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r43",
      "r44",
      "r222"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r43",
      "r44",
      "r222",
      "r641"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r655"
     ]
    },
    "ycbd_ConsultantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ConsultantMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant [Member]",
        "documentation": "Represents the consultant."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContingentConsiderationByTypeAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration by Type [Axis]",
        "documentation": "Information by type of contingent consideration."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContingentConsiderationTypeDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration Type [Domain]",
        "documentation": "Description of contingent payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ContingentLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ContingentLiabilityMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Liability [Member]",
        "documentation": "Relating to contingent liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetNet",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ContractWithCustomerAssetNet",
        "terseLabel": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r326",
      "r329"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325",
      "r329"
     ]
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerSalesChannelAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Sales Channel [Axis]",
        "documentation": "Information by sales channel for delivery of good or service in contract with customer."
       }
      }
     },
     "auth_ref": [
      "r671",
      "r791"
     ]
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerSalesChannelDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Sales Channel [Domain]",
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary."
       }
      }
     },
     "auth_ref": [
      "r671",
      "r791"
     ]
    },
    "ycbd_ConversionOfNotesIntoCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ConversionOfNotesIntoCommonStockMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Notes into Common Stock [Member]",
        "documentation": "Represents conversion of notes into common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible notes, at fair value",
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "ycbd_ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ConvertibleNotesMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes [Member]",
        "documentation": "Relating to convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r173",
      "r228",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r455",
      "r661",
      "r788"
     ]
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Goods and Service [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered."
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r175",
      "r176",
      "r285",
      "r310",
      "r488",
      "r498",
      "r509",
      "r652",
      "r654"
     ]
    },
    "ycbd_CureBasedDevelopmentLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "CureBasedDevelopmentLlcMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cure Based Development, Llc [Member]",
        "documentation": "Represents Cure Based Development, LLC."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_CurrentFederalTaxExpenseBenefit",
        "terseLabel": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r748",
      "r826"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_CurrentIncomeTaxExpenseBenefit",
        "totalLabel": "Total current",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r748"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_CurrentStateAndLocalTaxExpenseBenefit",
        "terseLabel": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r748",
      "r826"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r222"
     ]
    },
    "us-gaap_DebtConversionByUniqueDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionByUniqueDescriptionAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion Description [Axis]",
        "documentation": "Information by description of debt issuances converted in a noncash or part noncash transaction."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r25"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DebtConversionConvertedInstrumentSharesIssued1",
        "terseLabel": "Debt Conversion, Converted Instrument, Shares Issued (in shares)",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r25"
     ]
    },
    "us-gaap_DebtConversionNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionNameDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Name [Domain]",
        "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r25"
     ]
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r171",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r270",
      "r271",
      "r281",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r297",
      "r304",
      "r305",
      "r306",
      "r463"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r47",
      "r48",
      "r102",
      "r105",
      "r177",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r687",
      "r746",
      "r783",
      "r784",
      "r785",
      "r833",
      "r834"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DebtInstrumentConvertibleConversionPrice1",
        "terseLabel": "Debt Instrument, Convertible, Conversion Price (in dollars per share)",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r284"
     ]
    },
    "ycbd_DebtInstrumentDiscountedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "DebtInstrumentDiscountedPercentage",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_DebtInstrumentDiscountedPercentage",
        "terseLabel": "Debt Instrument Discounted Percentage",
        "documentation": "Represents the percent of discount convertible promissory note issued to investors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DebtInstrumentFaceAmount",
        "terseLabel": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r463",
      "r464",
      "r666",
      "r667",
      "r687"
     ]
    },
    "ycbd_DebtInstrumentInterestRateInDefault": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "DebtInstrumentInterestRateInDefault",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_DebtInstrumentInterestRateInDefault",
        "terseLabel": "Debt Instrument, Interest Rate In Default",
        "documentation": "Represents the interest rate in default."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DebtInstrumentInterestRateStatedPercentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r283"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r177",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r687",
      "r746",
      "r783",
      "r784",
      "r785",
      "r833",
      "r834"
     ]
    },
    "ycbd_DebtInstrumentPrepaymentPayablePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "DebtInstrumentPrepaymentPayablePercent",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_DebtInstrumentPrepaymentPayablePercent",
        "terseLabel": "Debt Instrument, Prepayment Payable Percent",
        "documentation": "Represents the prepayment payable percent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ycbd_DecreaseInApicIssuanceOfStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "DecreaseInApicIssuanceOfStock",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_DecreaseInApicIssuanceOfStock",
        "negatedTerseLabel": "Issuance of stock",
        "documentation": "Represents the decrease in APIC related to he issuance of common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details": {
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r748",
      "r825",
      "r826"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DeferredIncomeTaxLiabilities",
        "negatedTotalLabel": "Total deferred tax liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r103",
      "r399"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
        "totalLabel": "Total deferred",
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details": {
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r748",
      "r825",
      "r826"
     ]
    },
    "ycbd_DeferredTaxAssetAndRelatedValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "DeferredTaxAssetAndRelatedValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_DeferredTaxAssetAndRelatedValuationAllowance",
        "terseLabel": "Deferred Tax Asset And Related Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital loss carryforward",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsCharitableContributionCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Charitable contributions",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangibles",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DeferredTaxAssetsGross",
        "totalLabel": "Total deferred tax assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInventory",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory reserve",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxAssetsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments)."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
        "totalLabel": "Net deferred tax assets",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized expenses",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "documentation": "Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DeferredTaxAssetsValuationAllowance",
        "negatedLabel": "Valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DeferredTaxLiabilities",
        "negatedTotalLabel": "Net deferred tax liability",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
        "negatedLabel": "Intangibles",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DeferredTaxLiabilitiesLeasingArrangements",
        "negatedLabel": "ROU - Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses",
        "negatedLabel": "Prepaid Expenses",
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DepositContractsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepositContractsPolicy",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposit Contracts, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the treatment of funds received from or paid to insureds, insurers and reinsurers on contracts for which the criteria for transferring or assuming insurance risk has not been satisfied by the insurer or reinsurer."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepositsAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits for facilities",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r33"
     ]
    },
    "us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationExcludingLessorAssetUnderOperatingLease",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DepreciationExcludingLessorAssetUnderOperatingLease",
        "terseLabel": "Depreciation, Excluding Lessor Asset under Operating Lease",
        "documentation": "Amount, excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of depreciation expense."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r479"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r343",
      "r374",
      "r375",
      "r377",
      "r678"
     ]
    },
    "us-gaap_DisclosureTextBlockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureTextBlockAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DisclosureTextBlockAbstract",
        "terseLabel": "Notes to Financial Statements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsCash",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DividendsCash",
        "terseLabel": "Dividends, Cash",
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r88"
     ]
    },
    "us-gaap_DividendsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued dividends",
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DividendsPayableCurrentAndNoncurrent",
        "terseLabel": "Dividends Payable",
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r52",
      "r104",
      "r709",
      "r849"
     ]
    },
    "ycbd_DividendsPayableQuarterlyGrowth": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "DividendsPayableQuarterlyGrowth",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_DividendsPayableQuarterlyGrowth",
        "terseLabel": "Dividends Payable, Quarterly Growth",
        "documentation": "The amount by which the accrued liability for dividends declared but not paid grows per quarter."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPreferredStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsPreferredStockCash",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_DividendsPreferredStockCash",
        "negatedLabel": "Preferred dividend declared, not paid",
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r88"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r716",
      "r717",
      "r718"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r716",
      "r717",
      "r718",
      "r720"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss per share:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details": {
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic earnings per share (in dollars per share)",
        "label": "Basic and Diluted loss per share (in dollars per share)",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r194",
      "r197",
      "r201",
      "r202",
      "r203",
      "r208",
      "r417",
      "r423",
      "r436",
      "r437",
      "r506",
      "r530",
      "r658"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_EarningsPerShareDiluted",
        "totalLabel": "Diluted earnings per share (in dollars per share)",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r197",
      "r201",
      "r202",
      "r203",
      "r208",
      "r417",
      "r423",
      "r436",
      "r437",
      "r506",
      "r530",
      "r658"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r205"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r204",
      "r206",
      "r207"
     ]
    },
    "ycbd_EarnoutSharesForRevenueBetween140000001And300000000Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "EarnoutSharesForRevenueBetween140000001And300000000Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout Shares for Revenue Between $140,000,001 and $300,000,000 [Member]",
        "documentation": "Represents shares issued for revenue between $140,000,001-$300,000,000."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_EarnoutSharesForRevenueBetween1And20000000Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "EarnoutSharesForRevenueBetween1And20000000Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout Shares for Revenue Between $1 and $20,000,000 [Member]",
        "documentation": "Represents shares issued for revenue between $1-$20,000,000."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_EarnoutSharesForRevenueBetween20000001And60000000Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "EarnoutSharesForRevenueBetween20000001And60000000Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout Shares for Revenue Between $20,000,001 and $60,000,000 [Member]",
        "documentation": "Represents shares issued for revenue between $20,000,001-$60,000,000."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_EarnoutSharesForRevenueBetween60000001And140000000Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "EarnoutSharesForRevenueBetween60000001And140000000Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout Shares for Revenue Between $60,000,001 and $140,000,000 [Member]",
        "documentation": "Represents shares issued for revenue between $60,000,001-$140,000,000."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
        "totalLabel": "Provision for income taxes",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r681"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal statutory income tax rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r388",
      "r408",
      "r681"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r681",
      "r749",
      "r819"
     ]
    },
    "ycbd_EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in value of convertible debt",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to a change in value of convertible debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent differences",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r749",
      "r819"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent derivative expense",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r681",
      "r749",
      "r819",
      "r820"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State income taxes, net of federal benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r681",
      "r749",
      "r819"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
        "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
        "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables",
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r723"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "ycbd_EquipmentSoldValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "EquipmentSoldValue",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_EquipmentSoldValue",
        "terseLabel": "Equipment Sold Value",
        "documentation": "The total value of equipment sold."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_EquityClassifiedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "EquityClassifiedWarrantsMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Classified Warrants [Member]",
        "documentation": "Represents equity classified warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r133",
      "r158",
      "r159",
      "r160",
      "r178",
      "r179",
      "r180",
      "r182",
      "r187",
      "r189",
      "r191",
      "r210",
      "r229",
      "r230",
      "r257",
      "r323",
      "r406",
      "r407",
      "r414",
      "r415",
      "r416",
      "r418",
      "r422",
      "r423",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r465",
      "r467",
      "r482",
      "r527",
      "r534",
      "r535",
      "r536",
      "r553",
      "r616"
     ]
    },
    "us-gaap_EquityFairValueAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityFairValueAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in value of equities",
        "documentation": "Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment",
        "terseLabel": "Equity Method Investment, Other-than-Temporary Impairment",
        "documentation": "Amount of other-than-temporary decline in value that has been recognized against investment accounted for under equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ycbd_FairValueAdjustmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "FairValueAdjustmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in fair value of convertible debt",
        "terseLabel": "Fair Value Adjustment of Debt",
        "negatedLabel": "Increase in fair value of convertible debt",
        "documentation": "Amount of addition (reduction) to the amount of debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r828",
      "r829"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r449",
      "r450",
      "r452",
      "r493",
      "r494",
      "r495",
      "r666",
      "r667",
      "r672",
      "r673",
      "r674",
      "r682",
      "r683"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r331",
      "r336",
      "r439",
      "r450",
      "r493",
      "r672",
      "r673",
      "r674",
      "r682"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r331",
      "r336",
      "r439",
      "r440",
      "r450",
      "r494",
      "r666",
      "r667",
      "r672",
      "r673",
      "r674",
      "r682"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r439",
      "r440",
      "r441",
      "r442",
      "r450",
      "r495",
      "r666",
      "r667",
      "r672",
      "r673",
      "r674",
      "r682",
      "r683"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r449",
      "r450",
      "r452",
      "r493",
      "r494",
      "r495",
      "r666",
      "r667",
      "r672",
      "r673",
      "r674",
      "r682",
      "r683"
     ]
    },
    "us-gaap_FairValueNetAssetLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueNetAssetLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_FairValueNetAssetLiability",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "documentation": "Fair value of asset after deduction of liability."
       }
      }
     },
     "auth_ref": [
      "r828",
      "r829"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_FiniteLivedIntangibleAssetUsefulLife",
        "terseLabel": "Finite-Lived Intangible Asset, Useful Life (Year)",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization",
        "negatedLabel": "Amortization of definite lived intangible assets:",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r238",
      "r247",
      "r664"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
        "terseLabel": "2025",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r646",
      "r664"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
        "terseLabel": "2028",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r646",
      "r664"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
        "terseLabel": "2027",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r646",
      "r664"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
        "terseLabel": "2026",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r646",
      "r664"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r242",
      "r243",
      "r244",
      "r246",
      "r247",
      "r251",
      "r252",
      "r502",
      "r503",
      "r646"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Definite lived intangible assets",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r247",
      "r503",
      "r664"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r242",
      "r243",
      "r244",
      "r246",
      "r247",
      "r251",
      "r252",
      "r646"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_FiniteLivedIntangibleAssetsNet",
        "totalLabel": "Total future intangibles amortization",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r777"
     ]
    },
    "ycbd_FinitelivedIntangibleAssetAccumulatedImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "FinitelivedIntangibleAssetAccumulatedImpairment",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_FinitelivedIntangibleAssetAccumulatedImpairment",
        "negatedTerseLabel": "Impairment of definite lived intangible assets:",
        "documentation": "Amount of accumulated impairment of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ForbearanceAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ForbearanceAgreementMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forbearance Agreement [Member]",
        "documentation": "Represents Forbearance Agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnTerminationOfLease",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_GainLossOnTerminationOfLease",
        "negatedLabel": "Gain on termination of operating lease",
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of goodwill and other intangible assets",
        "terseLabel": "Goodwill and Intangible Asset Impairment",
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r254",
      "r256"
     ]
    },
    "us-gaap_GranteeStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GranteeStatusAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grantee Status [Axis]",
        "documentation": "Information by status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r342",
      "r344",
      "r345",
      "r346",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372"
     ]
    },
    "us-gaap_GranteeStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GranteeStatusDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grantee Status [Domain]",
        "documentation": "Status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r342",
      "r344",
      "r345",
      "r346",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_GrossProfit",
        "totalLabel": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r70",
      "r113",
      "r173",
      "r228",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r455",
      "r660",
      "r661",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r788"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r716",
      "r717",
      "r718"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
        "totalLabel": "Loss before provision for income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r108",
      "r113",
      "r507",
      "r525",
      "r660",
      "r661",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r384",
      "r388",
      "r394",
      "r395",
      "r396",
      "r397",
      "r403",
      "r409",
      "r411",
      "r412",
      "r413",
      "r549",
      "r681"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      },
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_IncomeTaxExpenseBenefit",
        "negatedLabel": "Benefit (expense) for income taxes",
        "totalLabel": "Total provision",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r130",
      "r190",
      "r191",
      "r209",
      "r216",
      "r219",
      "r387",
      "r388",
      "r410",
      "r531",
      "r681"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r385",
      "r386",
      "r397",
      "r398",
      "r402",
      "r404",
      "r543"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued expenses",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_IncreaseDecreaseInAccountsReceivable",
        "negatedLabel": "Accounts receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenue / customer deposits",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r647"
     ]
    },
    "us-gaap_IncreaseDecreaseInDepositOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDepositOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_IncreaseDecreaseInDepositOtherAssets",
        "negatedLabel": "Deposits",
        "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_IncreaseDecreaseInInventories",
        "negatedLabel": "Inventory",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r731",
      "r743"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
        "negatedLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ycbd_IncreaseDecreaseInPrepaidInventoryTotal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "IncreaseDecreaseInPrepaidInventoryTotal",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_IncreaseDecreaseInPrepaidInventoryTotal",
        "negatedLabel": "Prepaid inventory",
        "documentation": "Represents the increase (decrease) in prepaid inventory."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r245",
      "r250",
      "r664"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r245",
      "r250",
      "r664"
     ]
    },
    "us-gaap_IndefiniteLivedTrademarks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedTrademarks",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite lived trademark",
        "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r779"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r721"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r253",
      "r255",
      "r645",
      "r646"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets",
        "label": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
        "totalLabel": "Intangible Assets, Net (Excluding Goodwill), Total",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r777",
      "r779"
     ]
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest (expense) income",
        "documentation": "Amount of interest income (expense) classified as operating."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r758"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_InterestPaidNet",
        "terseLabel": "Interest expense",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r167",
      "r168"
     ]
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Text Block]",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r234"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finished Goods",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_InventoryGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryGross",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_InventoryGross",
        "terseLabel": "Inventory",
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_InventoryNet",
        "totalLabel": "Total Inventory",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r650",
      "r697"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r137",
      "r150",
      "r234",
      "r235",
      "r237",
      "r500",
      "r656"
     ]
    },
    "us-gaap_InventoryRawMaterialsAndSupplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterialsAndSupplies",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Components",
        "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed."
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "us-gaap_InventoryValuationReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryValuationReserves",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_InventoryValuationReserves",
        "negatedLabel": "Inventory Reserve",
        "documentation": "Amount of valuation reserve for inventory."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r738"
     ]
    },
    "us-gaap_InventoryWriteDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWriteDown",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory and materials impairment",
        "terseLabel": "Inventory Write-down",
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "us-gaap_Investments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Investments",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_Investments",
        "terseLabel": "Investments, Total",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r511",
      "r699",
      "r700"
     ]
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Investment",
        "documentation": "Gross additions to the investment in and advance to the affiliate."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r132",
      "r226",
      "r227",
      "r453",
      "r454",
      "r848"
     ]
    },
    "ycbd_Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investors 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note [Member]",
        "documentation": "Represents the Investors 8% Senior Secured Original Issue and the 20% Discount Convertible Promissory Note."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "IssuanceOfSharesForConversionOfDebtAndAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_IssuanceOfSharesForConversionOfDebtAndAccruedInterest",
        "terseLabel": "Issuance of shares for conversion of debt and accrued interest",
        "documentation": "The proceeds from the issuance of shares for the conversion of debt and accrued interest"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_KeystoneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "KeystoneMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Keystone [Member]",
        "documentation": "Represents Keystone."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseContractualTermAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseContractualTermAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Contractual Term [Axis]",
        "documentation": "Information by contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r730"
     ]
    },
    "us-gaap_LeaseContractualTermDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseContractualTermDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Contractual Term [Domain]",
        "documentation": "Contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r730"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r477"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables",
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_LengthOfConsultingAgreement": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "LengthOfConsultingAgreement",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_LengthOfConsultingAgreement",
        "terseLabel": "Length of Consulting Agreement (Year)",
        "documentation": "Represents the length of a consulting agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
        "totalLabel": "Total future lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2024",
        "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm",
        "terseLabel": "Lessee, Operating Lease, Remaining Lease Term (Month)",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r835"
     ]
    },
    "ycbd_LesseeOperatingLeasesAnnualBaseRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "LesseeOperatingLeasesAnnualBaseRent",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_LesseeOperatingLeasesAnnualBaseRent",
        "terseLabel": "Lessee, Operating Leases, Annual Base Rent",
        "documentation": "Amount of annual base rent of operating lease of the lessee."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_LesseeOperatingLeasesMonthlyBaseRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "LesseeOperatingLeasesMonthlyBaseRent",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_LesseeOperatingLeasesMonthlyBaseRent",
        "terseLabel": "Lessee, Operating Leases, Monthly Base Rent",
        "documentation": "Amount of monthly base rent of operating lease of the lessee."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_Liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r47",
      "r48",
      "r49",
      "r51",
      "r52",
      "r53",
      "r56",
      "r173",
      "r228",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r425",
      "r426",
      "r427",
      "r455",
      "r573",
      "r659",
      "r712",
      "r788",
      "r840",
      "r841"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_LiabilitiesAndStockholdersEquity",
        "totalLabel": "Total liabilities and shareholders' equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r107",
      "r520",
      "r697",
      "r747",
      "r768",
      "r832"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_LiabilitiesCurrent",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r136",
      "r173",
      "r228",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r425",
      "r426",
      "r427",
      "r455",
      "r697",
      "r788",
      "r840",
      "r841"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in value of liabilities",
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_LiabilitiesNoncurrent",
        "totalLabel": "Total long term liabilities",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r51",
      "r52",
      "r53",
      "r56",
      "r173",
      "r228",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r425",
      "r426",
      "r427",
      "r455",
      "r788",
      "r840",
      "r841"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity and Going Concern Considerations, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for liquidity and going concern considerations."
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseTypeDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_LitigationSettlementInitialPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "LitigationSettlementInitialPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_LitigationSettlementInitialPayment",
        "terseLabel": "Litigation Settlement, Initial Payment",
        "documentation": "The amount of cash paid as the initial payment for the settlement of litigation."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_LitigationSettlementMonthlyPaymentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "LitigationSettlementMonthlyPaymentAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_LitigationSettlementMonthlyPaymentAmount",
        "terseLabel": "Litigation Settlement, Monthly Payment Amount",
        "documentation": "The amount of cash paid as a monthly payment for the settlement of litigation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_LongtermDebtExcludingConvertibleNotesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "LongtermDebtExcludingConvertibleNotesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term liabilities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_MajikMedicinesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "MajikMedicinesMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Majik Medicines [Member]",
        "documentation": "Represents Majik Medicines."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_ManufacturingEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ManufacturingEquipmentMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing Equipment [Member]",
        "documentation": "Represents manufacturing equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Realized and unrealized loss on marketable and other securities, including impairments",
        "terseLabel": "Marketable Security, Gain (Loss)",
        "documentation": "Amount of realized and unrealized gain (loss) on investment in marketable security."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketingAndAdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_MarketingAndAdvertisingExpense",
        "terseLabel": "Marketing and Advertising Expense",
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r269",
      "r338",
      "r383",
      "r442",
      "r499",
      "r532",
      "r533",
      "r540",
      "r565",
      "r566",
      "r625",
      "r627",
      "r630",
      "r631",
      "r633",
      "r643",
      "r644",
      "r663",
      "r670",
      "r677",
      "r683",
      "r684",
      "r685",
      "r686",
      "r698",
      "r790",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847"
     ]
    },
    "ycbd_MerchantReceivableAndReservePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "MerchantReceivableAndReservePolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merchant Receivable and Reserve [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for merchant receivables and reserve."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_Merchantprocessingfee": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "Merchantprocessingfee",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_Merchantprocessingfee",
        "terseLabel": "MerchantProcessingFee",
        "documentation": "Represents agreed percentage for merchant processing fees."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r269",
      "r338",
      "r383",
      "r442",
      "r499",
      "r532",
      "r533",
      "r540",
      "r565",
      "r566",
      "r625",
      "r627",
      "r630",
      "r631",
      "r633",
      "r643",
      "r644",
      "r663",
      "r670",
      "r677",
      "r683",
      "r684",
      "r685",
      "r698",
      "r790",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
        "totalLabel": "Cash provided (used) by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
        "totalLabel": "Cash (used) provided by investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
        "totalLabel": "Cash used by operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r76",
      "r77"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss": {
       "parentTag": "ycbd_ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss",
        "terseLabel": "Net Loss",
        "totalLabel": "Net Loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r77",
      "r109",
      "r134",
      "r153",
      "r155",
      "r160",
      "r173",
      "r181",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r190",
      "r191",
      "r199",
      "r228",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r417",
      "r423",
      "r437",
      "r455",
      "r526",
      "r595",
      "r614",
      "r615",
      "r710",
      "r788"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
        "totalLabel": "Net Loss attributable to common shareholders",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r183",
      "r184",
      "r185",
      "r186",
      "r194",
      "r195",
      "r200",
      "r203",
      "r423"
     ]
    },
    "ycbd_NetIncomeLossIncludingImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "NetIncomeLossIncludingImpairment",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_NetIncomeLossIncludingImpairment",
        "terseLabel": "Net Income (Loss) Including Impairment",
        "documentation": "Represents net income (loss) for the period including impairments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ecd_NonRule10b51ArrAdoptedFlag",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ecd_NonRule10b51ArrTrmntdFlag",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash financial/investing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonmonetaryTransactionTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonmonetaryTransactionTypeAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonmonetary Transaction Type [Axis]",
        "documentation": "Information by nature of the nonmonetary transaction or group of similar transactions, such as a barter or exchange."
       }
      }
     },
     "auth_ref": [
      "r480",
      "r481",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696"
     ]
    },
    "us-gaap_NonmonetaryTransactionTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonmonetaryTransactionTypeDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonmonetary Transaction Type [Domain]",
        "documentation": "Identifies the nature of the nonmonetary transaction or group of similar transactions, such as a barter or exchange."
       }
      }
     },
     "auth_ref": [
      "r480",
      "r481",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696"
     ]
    },
    "ycbd_NoteToFinancialStatementDetailsTextual": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "NoteToFinancialStatementDetailsTextual",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note To Financial Statement Details Textual"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_NotesPayable",
        "terseLabel": "Notes Payable",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r105",
      "r850",
      "r851"
     ]
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note payable",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48"
     ]
    },
    "us-gaap_NotesPayableFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_NotesPayableFairValueDisclosure",
        "terseLabel": "Notes Payable, Fair Value Disclosure",
        "documentation": "Fair value portion of notes payable."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r47",
      "r48",
      "r829",
      "r831"
     ]
    },
    "ycbd_NotesToFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "NotesToFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes To Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_NumberOfMajorCustomers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "NumberOfMajorCustomers",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_NumberOfMajorCustomers",
        "terseLabel": "Number of Major Customers",
        "documentation": "Represents number of major customers."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_NumberOfSharesRegisteredForResale": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "NumberOfSharesRegisteredForResale",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_NumberOfSharesRegisteredForResale",
        "terseLabel": "Number of Shares Registered for Resale (in shares)",
        "documentation": "Represents number of shares that are registered for resale."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_OperatingExpensesExcludingImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "OperatingExpensesExcludingImpairment",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Excludes impairment of assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_OperatingIncomeLoss",
        "totalLabel": "Loss from operations",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r660",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Operating Lease Costs",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r688"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total lease liabilities",
        "label": "us-gaap_OperatingLeaseLiability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r470"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases \u2013 current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r470"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases - long term portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r470"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for amounts included in the measurement of operating lease liabilities",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r473"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r469"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of operating lease asset",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r475",
      "r688"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term (Year)",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r688"
     ]
    },
    "ycbd_OperatingLeasesRentExpensePerSquareFoot": {
     "xbrltype": "perUnitItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "OperatingLeasesRentExpensePerSquareFoot",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_OperatingLeasesRentExpensePerSquareFoot",
        "terseLabel": "Operating Leases, Rent Expense Per Square Foot (in USD per Per Share)",
        "documentation": "Represents the rent expense for an operating lease per square foot."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_OperatingLossCarryforwardsValuationAllowance",
        "terseLabel": "Operating Loss Carryforwards, Valuation Allowance",
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_OtherAssets",
        "totalLabel": "Total other assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r142",
      "r512",
      "r662",
      "r712"
     ]
    },
    "us-gaap_OtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets:"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in far value of debt related to credit risk",
        "negatedLabel": "Change in far value of debt related to credit risk",
        "documentation": "Amount of equity impact on other comprehensive income loss due to changes in fair value of debt related to credit risk."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLongTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in other securities, noncurrent",
        "documentation": "Amount of long-term investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r510",
      "r734"
     ]
    },
    "ycbd_OtherthantemporaryImpairmentsOnOtherInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "OtherthantemporaryImpairmentsOnOtherInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other-than-temporary impairment on other investments",
        "documentation": "Amount of other0than-temporary impairment on other investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_PastDueRentDefaultDeclarationMonthlyPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PastDueRentDefaultDeclarationMonthlyPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_PastDueRentDefaultDeclarationMonthlyPayment",
        "terseLabel": "Past Due Rent Default Declaration, Monthly Payment",
        "documentation": "Amount of monthly payment for past due rent."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement",
        "terseLabel": "Past Due Rent Default Declaration, Payment Upon Execution of Agreement",
        "documentation": "Amount of payment upon execution of agreement for past due rent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock",
        "negatedLabel": "Preferred dividend distribution",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_PaymentsToAcquireIntangibleAssets",
        "negatedLabel": "Purchase of intangible assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment",
        "negatedLabel": "Purchase of property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ycbd_PercentageOfSharesFullyVested": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PercentageOfSharesFullyVested",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_PercentageOfSharesFullyVested",
        "terseLabel": "Percentage of Shares Fully Vested",
        "documentation": "Represents percentage of shares fully vested."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PercentageOfSharesVestProvidedNoRestrictionsInProductCategories",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_PercentageOfSharesVestProvidedNoRestrictionsInProductCategories",
        "terseLabel": "Percentage of Shares Vest Provided No Restrictions in Product Categories",
        "documentation": "Percentage of shares vested provided no restrictions in product categories."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PercentageOfSharesVestUponEachAdvertisingPlacement",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_PercentageOfSharesVestUponEachAdvertisingPlacement",
        "terseLabel": "Percentage of Shares Vest Upon Each Advertising Placement",
        "documentation": "Represents percentage of shares vest upon each advertising placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ]
    },
    "us-gaap_PolicyTextBlockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PolicyTextBlockAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_PolicyTextBlockAbstract",
        "terseLabel": "Accounting Policies"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_PreferredDividendsAccruedNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PreferredDividendsAccruedNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred dividends accrued but not paid",
        "documentation": "Represents the value of dividends accrued but not paid for the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockDividendRatePercentage",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_PreferredStockDividendRatePercentage",
        "terseLabel": "Preferred Stock, Dividend Rate, Percentage",
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r626",
      "r628",
      "r629",
      "r634"
     ]
    },
    "us-gaap_PreferredStockDividendsIncomeStatementImpact": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockDividendsIncomeStatementImpact",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 0.0
      },
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 0.0
      },
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred dividends",
        "negatedLabel": "Preferred dividends",
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r701",
      "r702",
      "r705",
      "r706",
      "r707",
      "r708",
      "r853",
      "r855"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share (in dollars per share)",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share (in dollars per share)",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r308"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized (in shares)",
        "terseLabel": "Preferred Stock, Shares Authorized (in shares)",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r575"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Issued (in shares)",
        "terseLabel": "Preferred Stock, Shares Issued (in shares)",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r308"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding, Ending Balance (in shares)",
        "terseLabel": "Preferred Stock, Shares Outstanding (in shares)",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r575",
      "r593",
      "r855",
      "r856"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, authorized 50,000,000 shares, $0.001 par value, 5,000,000 and 5,000,000 shares issued and outstanding, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r516",
      "r697"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "ycbd_PrepaidInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PrepaidInventory",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory prepaid",
        "documentation": "Amount of consideration paid in advance for inventory that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_PrepaidSponsorship": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PrepaidSponsorship",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid sponsorship",
        "documentation": "Amount of consideration paid in advance for sponsorships."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_PrincipleAdjustmentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PrincipleAdjustmentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_PrincipleAdjustmentsOfDebt",
        "terseLabel": "Principle Adjustments of Debt",
        "documentation": "The change in the principle value of debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ProceedsFromConvertibleDebt",
        "terseLabel": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of common stock",
        "terseLabel": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ycbd_ProceedsFromIssuanceOfCommonStockNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ProceedsFromIssuanceOfCommonStockNet",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_ProceedsFromIssuanceOfCommonStockNet",
        "terseLabel": "Proceeds From Issuance of Common Stock, Net",
        "documentation": "Net amount of cash inflow from issuance of common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromRepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRepaymentsOfNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ProceedsFromRepaymentsOfNotesPayable",
        "terseLabel": "Note payable",
        "documentation": "Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of other investment securities",
        "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r477"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r124",
      "r128",
      "r129"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r139",
      "r524"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r477",
      "r508",
      "r524",
      "r697"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r124",
      "r128",
      "r522"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r477"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_PropertyPlantAndEquipmentUsefulLife",
        "terseLabel": "Property, Plant and Equipment, Useful Life (Year)",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_PublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PublicOfferingMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Offering [Member]",
        "documentation": "Represents public offering."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_PurchaseCommitmentMaximumSharesCommitment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PurchaseCommitmentMaximumSharesCommitment",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_PurchaseCommitmentMaximumSharesCommitment",
        "terseLabel": "Purchase Commitment, Maximum Shares Commitment (in shares)",
        "documentation": "Maximum number of shares committed to purchase under purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_PurchaseagreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "PurchaseagreementMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Agreement [Member]",
        "documentation": "Represents the Purchase Agreement."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r269",
      "r330",
      "r338",
      "r369",
      "r370",
      "r371",
      "r383",
      "r442",
      "r496",
      "r497",
      "r499",
      "r532",
      "r533",
      "r540",
      "r565",
      "r566",
      "r625",
      "r627",
      "r630",
      "r631",
      "r633",
      "r643",
      "r644",
      "r663",
      "r670",
      "r677",
      "r683",
      "r684",
      "r685",
      "r686",
      "r698",
      "r703",
      "r786",
      "r790",
      "r830",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r269",
      "r330",
      "r338",
      "r369",
      "r370",
      "r371",
      "r383",
      "r442",
      "r496",
      "r497",
      "r499",
      "r532",
      "r533",
      "r540",
      "r565",
      "r566",
      "r625",
      "r627",
      "r630",
      "r631",
      "r633",
      "r643",
      "r644",
      "r663",
      "r670",
      "r677",
      "r683",
      "r684",
      "r685",
      "r686",
      "r698",
      "r703",
      "r786",
      "r790",
      "r830",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847"
     ]
    },
    "ycbd_RegisteredCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "RegisteredCommonStockMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Common Stock [Member]",
        "documentation": "Represents registered shares of common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r337",
      "r486",
      "r487",
      "r514",
      "r521",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r592",
      "r594",
      "r624"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r337",
      "r486",
      "r487",
      "r514",
      "r521",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r592",
      "r594",
      "r624",
      "r839"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r484",
      "r485",
      "r487",
      "r489",
      "r550",
      "r551",
      "r552",
      "r599",
      "r600",
      "r601",
      "r621",
      "r623"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r175",
      "r176",
      "r285",
      "r310",
      "r488",
      "r498",
      "r509",
      "r653",
      "r654"
     ]
    },
    "us-gaap_RestrictedStockExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock expense",
        "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r88",
      "r519",
      "r537",
      "r539",
      "r548",
      "r576",
      "r697"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r178",
      "r179",
      "r180",
      "r182",
      "r187",
      "r189",
      "r191",
      "r229",
      "r230",
      "r257",
      "r406",
      "r407",
      "r414",
      "r415",
      "r416",
      "r418",
      "r422",
      "r423",
      "r428",
      "r430",
      "r431",
      "r433",
      "r435",
      "r465",
      "r467",
      "r534",
      "r536",
      "r553",
      "r855"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross Sales",
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r209",
      "r214",
      "r215",
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r327",
      "r328",
      "r501"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r597",
      "r648",
      "r657"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_RevenueRemainingPerformanceObligation",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_Revenues",
        "totalLabel": "Total Net Sales",
        "terseLabel": "Revenues, Total",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r161",
      "r173",
      "r209",
      "r214",
      "r215",
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r228",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r455",
      "r507",
      "r661",
      "r788"
     ]
    },
    "ycbd_ReverseStockSplitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ReverseStockSplitMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock Split [Member]",
        "documentation": "The conversion of a reverse stock split where there is a reduction in the shares outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_RightOfUseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "RightOfUseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ROU - Liability",
        "documentation": "Amount of right of use liability."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ecd_Rule10b51ArrAdoptedFlag",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ecd_Rule10b51ArrTrmntdFlag",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_SalesAllowances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "SalesAllowances",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations": {
       "parentTag": "us-gaap_Revenues",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_SalesAllowances",
        "negatedLabel": "Allowances",
        "documentation": "Amount of sales allowance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesChannelDirectlyToConsumerMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Channel, Directly to Consumer [Member]",
        "documentation": "Contract with customer in which good or service is transferred directly to consumer."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ycbd_SalesChannelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "SalesChannelMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Channel [Member]",
        "documentation": "Represents type of sales channel."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesChannelThroughIntermediaryMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Channel, Through Intermediary [Member]",
        "documentation": "Contract with customer in which good or service is transferred through intermediary."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r728"
     ]
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r339",
      "r753"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r192",
      "r339",
      "r726",
      "r753"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r681",
      "r819"
     ]
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r770"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r64",
      "r65",
      "r66"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r90"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r664",
      "r778"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r715"
     ]
    },
    "ycbd_SeriesACumulativeConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "SeriesACumulativeConvertiblePreferredStockMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Cumulative Convertible Preferred Stock [Member]",
        "documentation": "Represents Series A Cumulative Convertible Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price (in dollars per share)",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volatility",
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
        "terseLabel": "Exercisable (in shares)",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
        "terseLabel": "Exercisable, weighted average exercise price (in dollars per share)",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
        "negatedLabel": "Forfeited (in shares)",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted (in shares)",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodEndLabel": "Outstanding (in shares)",
        "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
        "periodStartLabel": "Outstanding (in shares)",
        "periodEndLabel": "Outstanding (in shares)",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding, weighted average exercise price (in dollars per share)",
        "periodStartLabel": "Outstanding, weighted average exercise price (in dollars per share)",
        "periodEndLabel": "Outstanding, weighted average exercise price (in dollars per share)",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised, weighted average exercise price (in dollars per share)",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forfeited, weighted average exercise price (in dollars per share)",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted, weighted average exercise price (in dollars per share)",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Tranche Three [Member]",
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r347",
      "r366",
      "r367",
      "r368",
      "r369",
      "r372",
      "r378",
      "r379",
      "r380",
      "r381"
     ]
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Employee [Member]",
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r344",
      "r345",
      "r346",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372"
     ]
    },
    "ycbd_ShareNumberStockIssuable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "ShareNumberStockIssuable",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_ShareNumberStockIssuable",
        "terseLabel": "Share Number, Stock Issuable (in shares)",
        "documentation": "Number of shares issuable during a period of time."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Percentage",
        "documentation": "Represents the annual increase of authorized shares."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Shares Authorized, Shares (in shares)",
        "documentation": "Represents the annual increase in shares for shares authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r792"
     ]
    },
    "ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r679"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected term (in years) (Year)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
        "terseLabel": "Exercisable (Year)",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding, weighted average remaining contractual term (Year)",
        "terseLabel": "Outstanding, weighted average remaining contractual term (Year)",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "ycbd_SharebasedPaymentArrangementTrancheFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "SharebasedPaymentArrangementTrancheFourMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Tranche Four [Member]",
        "documentation": "Represents share-based payment arrangement tranche four."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_SharesIssuedPricePerShare",
        "terseLabel": "Shares Issued, Price Per Share (in dollars per share)",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_SharesOutstanding",
        "periodStartLabel": "Balance (in shares)",
        "periodEndLabel": "Balance (in shares)",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r170"
     ]
    },
    "ycbd_SoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "SoftwareMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software [Member]",
        "documentation": "Represents software."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r144",
      "r145",
      "r146",
      "r173",
      "r197",
      "r198",
      "r201",
      "r203",
      "r211",
      "r212",
      "r228",
      "r272",
      "r274",
      "r275",
      "r276",
      "r279",
      "r280",
      "r308",
      "r309",
      "r312",
      "r315",
      "r321",
      "r455",
      "r544",
      "r545",
      "r546",
      "r547",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r575",
      "r596",
      "r616",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r725",
      "r745",
      "r755"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r58",
      "r61",
      "r62",
      "r133",
      "r158",
      "r159",
      "r160",
      "r178",
      "r179",
      "r180",
      "r182",
      "r187",
      "r189",
      "r191",
      "r210",
      "r229",
      "r230",
      "r257",
      "r323",
      "r406",
      "r407",
      "r414",
      "r415",
      "r416",
      "r418",
      "r422",
      "r423",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r465",
      "r467",
      "r482",
      "r527",
      "r534",
      "r535",
      "r536",
      "r553",
      "r616"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables",
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r210",
      "r467",
      "r501",
      "r542",
      "r564",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r575",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r594",
      "r597",
      "r598",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r616",
      "r704"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r192",
      "r339",
      "r726",
      "r727",
      "r753"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-comprehensive-loss",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-",
      "http://www.cbdmd.com/20240930/role/statement-note-11-commitments-and-contingencies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable",
      "http://www.cbdmd.com/20240930/role/statement-note-12-note-payable-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-future-minimum-aggregate-lease-payments-details",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-components-of-provision-for-income-taxes-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-schedule-of-inventory-details",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-contingent-liability-details-parentheticals",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-7-related-party-transactions",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables",
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r210",
      "r223",
      "r467",
      "r501",
      "r542",
      "r564",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r575",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r594",
      "r597",
      "r598",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r616",
      "r704"
     ]
    },
    "ycbd_SteadyStateLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "SteadyStateLlcMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Steady State, LLC [Member]",
        "documentation": "Represents Steady State, LLC."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for intangible asset",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r25"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common stock - DCO (in shares)",
        "terseLabel": "Stock Issued During Period, Shares, Acquisitions (in shares)",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r88"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Stock, Convertible Notes (in shares)",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r35",
      "r58",
      "r61",
      "r88",
      "r298"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common stock - A360 (in shares)",
        "terseLabel": "Stock Issued During Period, Shares, Issued for Services (in shares)",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of stock (in shares)",
        "terseLabel": "Stock Issued During Period, Shares, New Issues (in shares)",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r57",
      "r58",
      "r88",
      "r544",
      "r616",
      "r636"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesReverseStockSplits",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fractional share true-up (in shares)",
        "terseLabel": "Stock Issued During Period, Shares, Reverse Stock Splits (in shares)",
        "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised",
        "negatedLabel": "Exercised (in shares)",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r57",
      "r58",
      "r88",
      "r353"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockSplits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockSplits",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Roundup fractional shares resulting from reverse split (in shares)",
        "documentation": "Number of shares issued during the period as a result of a stock split."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r57",
      "r58",
      "r88"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common stock - DCO",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r58",
      "r61",
      "r62",
      "r88"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Stock, Convertible Notes",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r58",
      "r61",
      "r62",
      "r88"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common stock - A360",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of stock",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r57",
      "r58",
      "r88",
      "r553",
      "r616",
      "r636",
      "r711"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of restricted stock for share based compensation",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r57",
      "r58",
      "r88"
     ]
    },
    "ycbd_StockIssuedDuringPeriodValueReverseStockSplits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "StockIssuedDuringPeriodValueReverseStockSplits",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fractional share true-up",
        "documentation": "value of equity increase resulting from reverse stock splits."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of options for share based compensation",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r58",
      "r61",
      "r62",
      "r88"
     ]
    },
    "us-gaap_StockOptionPlanExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionPlanExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation",
        "documentation": "Amount of noncash expense for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_StockholdersEquity",
        "totalLabel": "Total cbdMD, Inc. shareholders' equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r61",
      "r62",
      "r80",
      "r577",
      "r593",
      "r617",
      "r618",
      "r697",
      "r712",
      "r747",
      "r768",
      "r832",
      "r855"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-balance-sheets-"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "cbdMD, Inc. shareholders' equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r172",
      "r307",
      "r309",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r323",
      "r434",
      "r619",
      "r622",
      "r640"
     ]
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1",
        "terseLabel": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityPolicyTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r620"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r491"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r491"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r491"
     ]
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r492"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-condensed-consolidated-statements-of-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Payments for:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TableTextBlock": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TableTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-13-leases-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-15-income-taxes-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-2-marketable-securities-and-investment-other-securities-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-3-inventory-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-4-property-and-equipment-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-tables",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_TableTextBlock",
        "terseLabel": "Notes Tables"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technology Relief From Royalty Related To Direct C B D Online Com Member",
        "documentation": "Represents Technology Relief From Royalty Related To Direct C B D Online Com."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_The2015PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "The2015PlanMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The 2015 Plan [Member]",
        "documentation": "Represents the 2015 equity compensation plan (\"2015 plan\")."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_The2021PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "The2021PlanMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The 2021 Plan [Member]",
        "documentation": "Represents the 2021 equity compensation plan (\"the 2021 plan\")."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r762",
      "r838"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r116",
      "r117",
      "r764",
      "r765",
      "r766"
     ]
    },
    "ycbd_TrademarkRelatedToCbdmdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "TrademarkRelatedToCbdmdMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trademark Related to cbdMD [Member]",
        "documentation": "Represents the trademark \"cbdMD\"."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_TrademarkRelatedToHempMdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "TrademarkRelatedToHempMdMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies",
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trademark Related to Hemp MD [Member]",
        "documentation": "Represents the trademark \"HempMD\"."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TrademarksMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets",
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trademarks [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r664",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r779",
      "r780",
      "r781"
     ]
    },
    "ycbd_TradenameRelatedToDirectCBDOnlineComMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "TradenameRelatedToDirectCBDOnlineComMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-5-intangible-assets-schedule-of-intangible-assets-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tradename Related To Direct C B D Online Com Member",
        "documentation": "Represents Tradename Related To Direct C B D Online Com."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_TwentyTwoCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "TwentyTwoCapitalMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Twenty Two Capital [Member]",
        "documentation": "Represents twenty two capital."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_UnregisteredCommonStock2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "UnregisteredCommonStock2Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unregistered Common Stock 2 [Member]",
        "documentation": "Unregistered Common Stock 2"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_UnregisteredCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "UnregisteredCommonStockMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability",
      "http://www.cbdmd.com/20240930/role/statement-note-6-contingent-liability-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unregistered Common Stock [Member]",
        "documentation": "Represents unregistered common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-significant-accounting-policies-policies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r121",
      "r122",
      "r125",
      "r126"
     ]
    },
    "ycbd_VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vest Based on Certain Performance Hurdles Prior to December 2024 [Member]",
        "documentation": "Relating to vest based on certain performance hurdles prior to December 2024."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_VestUponAchievingCertainRevenuePerformanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "VestUponAchievingCertainRevenuePerformanceMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vest Upon Achieving Certain Revenue Performance [Member]",
        "documentation": "Represents the options vest upon achieving certain revenue performance."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_VestingAnnuallyOverThreeYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "VestingAnnuallyOverThreeYearsMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Annually Over Three Years [Member]",
        "documentation": "Relating to vesting annually over three years."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingAxis",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingDomain",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-",
      "http://www.cbdmd.com/20240930/role/statement-note-9-stock-based-compensation-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ]
    },
    "ycbd_WarehouseLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "WarehouseLeaseMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events",
      "http://www.cbdmd.com/20240930/role/statement-note-16-subsequent-events-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warehouse Lease [Member]",
        "documentation": "Represents the warehouse lease."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_WarrantsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "WarrantsDisclosureTextBlock",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Disclosure [Text Block]",
        "documentation": "The entire disclosure for warrants."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_WarrantsExpiringApril2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "WarrantsExpiringApril2028Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expiring April 2028 [Member]",
        "documentation": "Represents warrants expiring April 2028."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_WarrantsExpiringJanuary2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "WarrantsExpiringJanuary2025Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expiring January 2025 [Member]",
        "documentation": "Represents warrants expiring January 2025."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_WarrantsExpiringMay2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "WarrantsExpiringMay2024Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expiring May 2024 [Member]",
        "documentation": "Represents Warrants expiring in May, 2024."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_WarrantsExpiringOctober2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "WarrantsExpiringOctober2024Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expiring October 2024 [Member]",
        "documentation": "Represents Warrants Expiring October 2024"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_WarrantsExpiringSeptember2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "WarrantsExpiringSeptember2023Member",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expiring September 2023 [Member]",
        "documentation": "Represents warrants expiring October 2022."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_WarrantsToPurchaseCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "WarrantsToPurchaseCommonStockMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-10-warrants-schedule-of-equityclassified-warrants-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to Purchase Common Stock [Member]",
        "documentation": "Represents Warrants to Purchase Common Stock."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_WarrantsWithPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "WarrantsWithPublicOfferingMember",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity",
      "http://www.cbdmd.com/20240930/role/statement-note-8-shareholders-equity-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants With Public Offering [Member]",
        "documentation": "Represents warrants with public offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
        "totalLabel": "Shares used in computing diluted earnings per share (in shares)",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r203"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statements-of-operations",
      "http://www.cbdmd.com/20240930/role/statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares used in computing basic earnings per share (in shares)",
        "label": "Weighted average number of shares Basic and Diluted: (in shares)",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r203"
     ]
    },
    "ycbd_WorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "WorkingCapital",
     "crdr": "debit",
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ycbd_WorkingCapital",
        "terseLabel": "Working Capital",
        "documentation": "Represents the value of total current assets net of current liabilities as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_WriteOffOfPrepaidAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "WriteOffOfPrepaidAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.cbdmd.com/20240930/role/statement-consolidated-statement-of-cash-flows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Write off of prepaid assets due to termination of contractual obligation",
        "documentation": "Amount of prepaid assets written off during the period."
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-disaggregation-of-revenue-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 1 - Organization and Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 1 - Organization and Summary of Significant Accounting Policies"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-10-warrants-schedule-of-equityclassified-warrants-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 10 - Warrants - Schedule of Equity-Classified Warrants (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-10-warrants-summary-of-outstanding-common-stock-purchase-warrants-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 10 - Warrants - Summary of Outstanding Common Stock Purchase Warrants (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-10-warrants-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-10-warrants-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 10 - Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-13-leases-future-minimum-aggregate-lease-payments-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 13 - Leases - Future Minimum Aggregate Lease Payments (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-13-leases-operating-lease-costs-and-supplemental-cash-flow-information-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 13 - Leases - Operating Lease Costs and Supplemental Cash Flow Information (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-13-leases-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-13-leases-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 13 - Leases"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-14-loss-per-share-basic-and-diluted-earnings-per-share-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 14 - Loss Per Share - Basic and Diluted Earnings Per Share (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-14-loss-per-share-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-14-loss-per-share-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 14 - Loss Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-15-income-taxes-components-of-provision-for-income-taxes-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 15 - Income Taxes - Components of Provision for Income Taxes (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-15-income-taxes-reconciliation-of-effective-income-tax-rate-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 15 - Income Taxes - Reconciliation of Effective Income Tax Rate (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-15-income-taxes-significant-components-of-deferred-income-taxes-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 15 - Income Taxes - Significant Components of Deferred Income Taxes (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-15-income-taxes-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-15-income-taxes-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 15 - Income Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-2-marketable-securities-and-investment-other-securities-assets-valued-at-fair-value-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 2 - Marketable Securities and Investment Other Securities - Assets Valued at Fair Value (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-2-marketable-securities-and-investment-other-securities-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-2-marketable-securities-and-investment-other-securities-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 2 - Marketable Securities and Investment Other Securities"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-3-inventory-schedule-of-inventory-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-3-inventory-schedule-of-inventory-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 3 - Inventory - Schedule of Inventory (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-3-inventory-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-3-inventory-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 3 - Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-4-property-and-equipment-major-classes-of-property-and-equipment-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 4 - Property and Equipment - Major Classes of Property and Equipment (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-4-property-and-equipment-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-4-property-and-equipment-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 4 - Property and Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-5-intangible-assets-future-amortization-of-intangible-assets-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 5 - Intangible Assets - Future Amortization of Intangible Assets (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-5-intangible-assets-schedule-of-intangible-assets-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 5 - Intangible Assets - Schedule of Intangible Assets (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-5-intangible-assets-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-5-intangible-assets-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 5 - Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-6-contingent-liability-contingent-liability-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 6 - Contingent Liability - Contingent Liability (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-6-contingent-liability-contingent-liability-details-parentheticals",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 6 - Contingent Liability - Contingent Liability (Details) (Parentheticals)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-6-contingent-liability-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-6-contingent-liability-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 6 - Contingent Liability"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-8-shareholders-equity-fair-value-assumptions-of-stock-options-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 8 - Shareholders' Equity - Fair Value Assumptions of Stock Options (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-8-shareholders-equity-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-8-shareholders-equity-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 8 - Shareholders' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-9-stock-based-compensation-summary-of-stock-option-activity-details",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 9 - Stock Based Compensation - Summary of Stock Option Activity (Details)"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-note-9-stock-based-compensation-tables": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-note-9-stock-based-compensation-tables",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 9 - Stock Based Compensation"
       }
      }
     },
     "auth_ref": []
    },
    "ycbd_statement-statement-significant-accounting-policies-policies": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cbdmd.com/20240930",
     "localname": "statement-statement-significant-accounting-policies-policies",
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477037/944-825-05-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805/tableOfContent"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/942-320/tableOfContent"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "b",
   "Publisher": "SEC"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479092/842-20-40-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-13"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482864/845-10-50-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482864/845-10-50-3"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482819/845-10-05-4"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482819/845-10-05-4"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482819/845-10-05-4"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482819/845-10-05-4"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482819/845-10-05-5"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482819/845-10-05-6"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482819/845-10-05-6"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482819/845-10-05-6"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-14"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-9"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478790/946-405-45-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r728": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r729": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r730": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r733": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "705",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/705/tableOfContent"
  },
  "r734": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r741": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r742": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r743": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r744": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r745": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r751": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r752": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r753": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r754": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r755": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r756": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r759": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r760": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r761": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r762": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r763": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r765": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r766": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r769": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r770": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r771": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r778": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r779": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r780": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r781": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r783": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r787": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r788": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/940-320/tableOfContent"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>93
<FILENAME>0001437749-24-037840-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-24-037840-xbrl.zip
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MSS4#]:OO&*\>="FW+GY9J'ST:/#$@"*/[;?SPDM!<M0')/<,'=K:;!.6_;M
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M48/)RR7H@>^9AE_<ASWZVQS?Q=:ES,6+GWD5303V+T!6C#"^3DJQF8MM K_
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M.#.XY48MZ:^>:T2V,CH1HEICQ*MMFIFQ/51.JU6-2"].Z<GP)JDS:9$DJCX
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MK/OS"J7*KB:YZ1&/6XVB/@3%W:=>[MP*[A-LG_T^M-4PLW(:E/?4RI\&"*%
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M0\^>?K=A@G]M2A)\BU?9T_015??U5&V%[6'I[IUF(BX$'BVI-+H>E]KS54>
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MQ-<6TD1::B%"V8 07*5*ZJYZ<,7=IAG_ZUZ92]/+JHI=P'=V1$W/_&&KG(Z
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M54TTKYG\N!LWP.B(5H[^T=&0NP,\83I'::?*DG?QQJ39_DY(Z598N4ES3%4
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MXUY14LVG7:YKI"A5'26AE/!OI0OYM:S2@X3H$6>:-E#>Q.%[T[GH[B1\?RJ
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MS>C)5=.=:Z<P8JC3/"JN@#C,OU"?^N79M<GDEOLUYDR"S$O$3LW@_::Z:86
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ME' !.\NE-"_C' '_;C9^O>;+U*0PT1\R2/!:,EJ]Q"1JOX;?@1(S2N=ARG?
M@'!BE(W=LXH;?6,(KP7@SUZVTKIKWF':W,OPG[&J\H<URJ.271B1]VO9Q7PV
M3*4OW[ZU=ET*_/7J;5A=O@78GW,]6G2HM =SYY!Y\7&/NZ1KO'HI8TLXHX @
M/=UJ6N.-JMZ+.F%2C5:!%??CA4)WO$>)8C6U!$!<W^ID]_YO'!*7"2L@JB$@
MY:;2BWE/:O;0S)2TYC[C=>3.(YK^Q@D3*_PJ 2KX^VC,#V=745F+]H5ZM2;L
M[C]:RQHILKN:RSR4V3D=TV]V[#[F/GXXR@V(WUOE%EJ)N-J0YI48('CAN\<M
MSX+_#-R@Z4]Y0 #&')9GLHK!L[%UC QP2^Y5%.4?'[:H+@E0Y.+GC1!Q'U"B
M!\>]Q:K"4&OIY[3KU4;@UH3-=P6/-\W5^C!*ROG@L3QPWPW*R[#6P.FPVF-(
M[,"S"%!=#D>*G%DVP(<%+"<U\W,TLJ;)X"(UE "TXK_S >1XO9;QPR%@[]HK
M;2T#X.Z^&RZH_L'CDJ<]7UK.MPHSJABB>%@0B!GFT^VTF\U6Z^JT856N!Q:U
MR9]74'QB*EWTT&;(/5'H!U.&R[N=6ZBU%8KGA$*5@2SU/]R!'DZ:4ORTM?3S
MW;'2!AOYMI:S_VF_5!ON7TV]L'[%NZ,*$8]G4=_C@RE;-K)<SO8?5ZA9>2(L
MXON^YJKG&XGL).W'MWXE,=+^W7MF9_^6'&88]UUNJMN*1]15EL=OLA#\.%04
M]6/O>F6(4P0X='5-XV:+T5FNPV0]?;_,:MLF5$/^6I!-P);]I+DO0@E$LM[C
MIK+:4C^NL.A=)8K(4XD.(2/WS'EZ17&*:V_8CMCU:KI88X*D'-R!@2V.+(C<
M_SI4.SRL8B2$.GRA"ZS+Q\A.=@#-RHX:3A;H O%@#"O0OW3@3A?B"?K>L_;F
M"\EMB6Z)8^C4_D)WT:%@[O,JK28MC'<=?O@YUN727XRK9$TT8<#_E18E%QKN
M%K2+6]UNDE;R"$O]]>?=-=F"+V=LW=J89C?+M_-)"P1D]]X\[=L.:;W+B3/^
M5+I,_BB'LDN:C1=/HY7K?_Z4PAF4HTHK0;PJ?5)Y0GMZ8[FB!)/_J*H%UPFJ
M]-(6FE-6D4Q;A:S<CT",4JD,SFF[8=(3<2NPK>A:2?V@?1&7H=OU!5?[$?[9
MPK= EQ,F)92+XW<M+=7$W3U7EII?27)N=;0[C7$SJU7GBN5]Z^])O0Z_!7:R
MM_GZ0@_8D\O?F+&XZ.IB[.7E*P79FB]T3QJ4MEB"UQGP"9PC))YY9JJ-@I+%
M YP<I@V;6UJ:7@O]K'3\.W$N,BJETXXYYL_K;P]3)K27GMVFGJ64D35&L.]+
M849]#L3<WOB'N8\Y>LZZ%1M)R=^(XUP%?1E@N__$DI"I.JQ]0.U.O%F@U?V^
M3+5MM8=0?IU0MI2!\-+>47S>T7:O]_M^?+Y/A#</^X7?]F5?W#TB\3[R9C\'
MMVI)$GT=N.Y> (_&(H)0_FWQ$497*4L]IS6GK0(W!);YV'05:8Q]?ZVI1>%6
M^H#J[E./6ZA1J @8T8#O+IDRN.( P_<'X7T]0?G);;1?C9A+X3=;&@:-SGC=
M^*0]+JQ?'6MIM91,2$!W:KQ&%^66B-C9Z928B_PT;$_J6UYH*F15DW,8^;'=
M?,4S:5,)HUNSZ<J))=DUA6CX:T+<RG%X9X4@D'.<TOJ."*^$QKGF2[:.;ER9
M'$&(^([9JBV='U^\!;>C3!\FKY4*0^?E%W6=%%W ^Y/?&1_@\O%=GE.?G_C>
M%3"U#38K*7!!5>U.;A3OS"*,CE^>,/DY(L![K[7"HZ^DC5'7NR;0:1C'$O!:
MLE\O5/=\]%E3#-N?-]'9Q^SF6(E8RUHCJ??1$OBO#7$R.>;Q_.&&[FG71-M:
M_MIJ%O;$O 0-QM-YD 17%*F-V+3#6E*BR!%/X>1T=5"M/)?GB-:=?G>55F7[
M""9&[8.A-HNHS@.D>P\S!PG5&OQ4Z!=CK]#FLS[1% %S?S6!\Y?[E?I%&(]2
MOO8B@%1HWLP/[>#SJ=6G9>KPSM5IX(NML^1LB2W6]-\)TZW &M#KH3]?IGPK
M;Z@42[642GVQY"I8.F$:B:SY]_R$J="^DU9H;$-&)G^($^F=#04D+"F]O!/K
MAMV5KR6RSN%6W#\;GI43#7S+@>+ZO@.:7.]-3WBNO(V@:=!ODKQ?$ASU;)9O
MP?4AQ? [4X?M,I'YRCM6E]5&GRF;]<02&::A9Z'L_[P%QZ^DIKFY@6)!M:A.
M$/^I?K\>30C5S.W"<E'=R(!>@;RFU-(7FQY.K?&@YFF9C#SIO*L0VEA=:Y^D
M+9M0+A^MB?R-'D)%DE V5/]E<\ YR$2W1@99LXDH#Y9X,$V_5I7+_WPF_3_G
M3F$_3<*NAQRS0C54) (>B[=)SOMH^P-77K;?U/UO@=Y:T*+D:)^@,N?,)]2G
M_67\\^>1:LGKUF^G5^HG].T]_I933RDLVTK4MTBNGM0^DW4J1E5.C8G@SS@K
M7A4GO^>ETZ]8V5(^YVKV$9=LKKZHZSTSQ-<'^==PBF$ZT5.:$KQ89A#]PDS-
M. 9*>M8+(=# @OG5P$[KC%"QZ;JL=3/*[,1FX ]3.-"0^P73.GF/TG*<BP$2
MD1Q@K/($RI!2O(RZX !S[>[.>RK "N6,_UBTOVZ-K:MU_Z-9SC;;5'=; #YG
M8G*767;UA&F^OS]:_[B (4_E6?%YI9&?+P;MRN6WLP%S%;-:7?[M_:NLK63K
MDH!O2]'8$-];&_6@@7!)X\L^(L:_Z6+9V&M=[H]71NR*Q"M+)M#E@BW&[XWM
M\DW-9L#Z8ML( RJRQP'%&4RO%TBMEJ@\?@[3&P@R/DI'SB\!!GQ\=O<:9P'-
MJ;?[UWG6RN9C_&^]D X5?$,D.B00N9[>JTK4%'SW0R>I+_NE/-<;SJ,6O6?/
M(U..B,W05P !/2'R%J$I+EJ&>F%S9JO[^3$J/_"<EHJS\V^!Y8Q*1YV^8<IJ
M.?>7_BOLS2LU*@LFG_A4U&*_B?YG1&097 [5\WBC,]NS=KDB>^9?D69^Z,)J
M2N8S^WG?[/;GH(I_:8ZIQ2F#O]<=;I!S1/BS*_K,K,W,CD7"T=4(P+TU$&Z%
M:)R&Y6+\0/)%7X6K3W8TP*&$47:7Q=_W@>@5<'V"$BM$WC>FK)DQ=*DI^K%9
M+P;#]R00]%9X?2?XRT:1&%4MLIAN=&J%_<3L3ICZ@JCY1/MT3ZJ&6W@%S.I;
MD?#8@?)EV,MON"_W"+"UAM=K68[U_GX4P W<+<Q\0+:[0D>[M;$HN1V3L6"I
MI/=9NA'38/Y9:=LKJ#6U/OE5YL"YQIX*FI.J:>$7M3R2<MH1-UV.RD.^UXN\
M!#]#^$/T!W3;3X*= I*7]SA*<'#[0)<[E7[VFA2<R4N'F[@K>9$"2<O./9]N
M7<MP.+OIY5 E9N"L=..MC_2>%D37;"()^T_1@%8D XXA.HN9>NP[[PEE=P6F
M[,3V3'</E&7Y!;S]]"M_0U'+X$P\):UH[UNK<]$9$C3F$)G(CQ!<C>\UX",=
MQ1P %^UF";V]:3$5"_=\&_\])?XC4N2WYOC-[V<HKDITG+%]'6%73S.BVS?4
M4B'1IP.7KP'!TB2$^XD=+#_A^A,[TFW-39"2R=V:B2USTX_Y#]! [V;SL%B!
M_1@63*U!!P&9AN2'ZX<2$K'\U'B&P%L!5U'S41ZX2?XW<3:24?6GG\X+]8L;
M35\[":D<BO8T51OI[!<3_H:_4O_KFAC<<O6HC)[L0%O$=P,XJ,56D7N7J;D]
M!AKD^SKH5TO,I-1I2@S!Z@+0<<MIM2^+PLEA'%C6OI0=*/5HSF]$LSA4P2L]
M7[16,>I2Y^JTK-"-R[^R&JLC#!)U2_]N>:P%ZD'ZU26W.V:5I%ZM^+:XJ5!1
MOIF;?_TJ(8C(R*,I6A.#I9=L!:16D/"]X4X]K?Z-]:5TD^EM#7D7V6Y^5\'Q
M QAQHB%.V&U244&A9M(Z2>"1"E;55+H-^./E4(8CUN6X1",*Z'#<B('H#__!
MIB^GLVV$&X@H7N<?VVQI@>'!V@X3#]-^+;_]?6<-BSF.UP.N '@W$,(74];:
M<ORUB.@NV/-E6*0A"9L"UPA<3F?QNX:WFE0(*=1RRJ2PTD9NXQ>I:1#:T7>N
M'XU@""\""1#!N,]TD&R@_# [6*;5)3S5X'AIQI4_LLV%:QV]I"I8<L2^VA^K
MU?RD_%H'%SG4IOQNFCA7BF^%<JCA+; _;TZ;%L-L?6_IT@KYUJMUX,WAX ?]
M8AK2AP6A6@FHX>U/JT[U!=N+J/#Z;7@J[4[T^!&>]X3)%QG'X!JG'^L24*_I
M]H14<^>FHK6S'+7@,C_-(YWW<=<;B:Q_/[4V)J[9W0_Q?I/-=W1QYTS5A@U<
MCN2:B" > [K$1:9+R-*C2;*DAEH<?J';O[PWD+ %A"Q8>XSFS:<9XY-SWEQ8
M/D_UL",58F,DTG?V_ _D\5R;_P)JB1V7\ FQ$!W[.+?,@WMNX@6B+CJEAZ5_
MA.ZSW1TH7!%"93.N_8^CLW!KPGO;.+824M(EDI+2(3*+%I :S;Y(,T8W PPZ
MI:4E)S$F,3JDI84!DY$; M(;.6",U]_['SS7\]SG/I_[.N<Z!ZI&D(Q3N58R
MMXP988YW*=T\5__*EV,N[WJ"@?_9(;6E!^W"D-8) ?_=&KA]YP>^K8*2:"$K
M,$*9EN# ?#;?EE2YK3^Q'JYNKR@"52N8&A+ID4"R#6[K#:L0='W*YAJ6JCSX
MSNG_;1:OR>A@TSXXU0"H?J"E(@U! G1E7E'\N'V^!KW4^/&F4J#I]CNGUFG9
MBR]RXA:;G[]L1!T(?WTATAANYS[W?51]5CUPG::VC_:*0NQTP]>=W[#:]";-
MO!4WF.A^67B\"%II2B31$PI[@Q.G K-Z%>Q,XF;[?K*8H<3SM"1R?6NIQYRD
M-?A-2_-37O>7VG,F[Z!7)@8 =TFA1 .L1QPW=6O4OBY!+K[Z>[\7YY29Z\DD
M[2[XF:Y!-ESB7^W3:H"LQPE]6Y1U:9?7C,3-S%]*Z1-]2^<A)-]5(<?E0Q<(
M'.RGRK%Y!XM9R1LN\$M_6V$J.OX86V'4J^Y=^=WO+RI2Y?5Z :%"3B3VV:.\
MS%CU*XHGY.5ENDY%J 3Q*58\_,0?Y2=NB7M$"B'>PP9!G\+,YUA:\<GQ8;R;
M&*?8(R.YRW^SG]NVL#^51X$#:GBG;DX$>?EY@"G328+H<# M460C-LT&OY[(
MT[_-\V [6+(G1%=([Q?I!C;PT132@X'D1O@G/S7N+!S<HX<EC /9HLI6.P7W
MD M]!TYDU&R,XK(Y>N6\+W-%89(3([;=\7#:9H(J_F>Z5H5Z7)U\OK1R47V[
MYQ(P._BUX0L9?H).\VW.H^^6'FI)2S)B"J)B@DNLNX9[2OYA>^=:="+S<T,=
M[KS10YD.IJD+L6727"[3QJC$M/5D4;W'FW[(X[\UIW^AIC2$);7/_Q6EXZ2A
M,*8O(8KO,@$LM ZZUNH2Z5;_H9&&KCJ.QQ#1IV36P*;^0G:H4"GT!1[6[_'[
MXLVD'^@NB1,/[ Q3_;=A^.$G<(YM002>OK!'!.:<UN/,V/) I[Z*FN]@<571
M#FZT3NMTPZX%YHK"?'K5^H8!BH]'-= '>%DRWP_$J)?AD<O @E.;^F9\XN#.
M();#X]X\D4H+/Y!=\Q? N-POBM\3%2:!X>#6J%K8\C__"^\@#R'K:J>*6I?X
M+VZ<]'V_+*T)DR>9IFFB.B5=E66@5%U-Q.M7%)3D0;L5#EHN60O\S)UDE5WE
MK9T@3RYE2X?4DUEPH^ S8?BZ12>DL(<'__990-_IB>JS&?:@8W&/_MF4K3!*
M)$$\.D*LO/F?.N^J<%PFW]J=/H<76P86[D)$P$T!P";VGUV!?/2:?$S4$BS9
MTXFR9<+(MM;=$'/7AOF]J>56?*/;(>>#VM_!YM?3TIV43/J %6I+4AM>989,
MAMI:0\*E*/_$8P]4N-U3?8Q.GZHT,;R2I([O;,'7#,EYQ 7?B84WT'Y<HL'O
MPF(;N!A?-,U E:I&OO'<&*RQY*&S!ND6;]U&&S0E6>H(S\JICQ0N >8NALGS
MA(X16(JH2S!4OU.*VU;+W?])[/68:*&'WW@_"*6"\:<GP42O"\\YD@;1 ,>3
MV-C)U]ST2\4(=TEE[$+2NLENC8Z$DYZ63I1LF;+[^@SL-&$B^W>K&3[?&L5K
MW73(ITR>3W[_MF*F/8"I_9MMFGI#'$#NMQ;S1=6!^:RCM)CMW+26T$VA.TR1
MKF_+HBHHO=Z:\ F/9*)=9RU(-85C/!&!;19(Z,:=V (9\3YADX[O<E+2B?OP
M#&U/RZ5+201B;6/W15#H2B%F:DO<6U17J-=&:HIO=ME(W.T]AX<JAXS7QI[D
MVH*E;(W=#^'NX#A2[C]/RX$E0656NSX5TAV%JE^CB:QNM1Z/FMV4R$NM0JYU
M+$YST%3WFD7M<5@:2,N^TQS*MI&)NY3_WUV6P! ;#Q8H8%9%1G;U+8'G U0-
M>_>=_.'P_>+,TSHS*XN@YRR^+1W4.[G?B_2>KW?QJ,H&EIQD$(>$>H<@OA/4
M@9_>1 WV^BLG)DS6"$X?<<PV.CM^&;]5FRK,RR*Q4V#(=<#$QG=HU44;W;W!
M]*YX4>EII^.&T&A:0.:VY9G U*"<BH3",S-MLZ"#%U@CE[(PYQ>B^S5#IZ$!
M (_PE5SEB3[K&R<O/O4M<R#-+$YQM/'05^$KKY,4(=P;.N11U.ZN[ @8_#JF
M;\R/>O*),,,BFU,ZOQA[Q_U#S5_M$()0CV%@Y0GJ36VH]W25_I,#]BVM=W&#
M>O'K-)RG390/U3,:!WD9F@]^4VZ\PV<E05_A94[<VW_Y5H7?[X=MME9'ZS#>
M<($MN_ZZHK"_M_J*U^"DJDHC @%PBI-MY65^OGL@%(ND2F:L^UMBUAZ%?H[F
M/MBWB'+2&9*K,N>[KN, ^M+K(';WES0O\+.4X: <<2.V73=BN+Y=7'NZS%2B
M&U>!1D3!QB@S2IA3#2HXQN1$=71W:Y(&MPH>X,-D%'\X-H,@K.M^0J [.DS\
M^<H/<C(6*I _]]TM.Q!USN08-619A)39)J'.'-/]P)F5LV^$H2+R"WZ'@N&V
M595H0@!"F?BI?(L=_:G=NL2%/E;.VK(W>#:_7'TJY@9H<4Z7IK)A].?WJC?#
MU)&?'SZ-IW9LKS^Q(T[P]'O<ZK:M6!(-G.C]K 8#^[_^(/[KHYQ.J-[=Y'W!
MJ!!;2I7M5H#RXQ*:5OD;BS6CWLS)WC\ME&38.]G2;W3=TG2@O$;]([$]54/N
MXN1%[MJ"46J[^VWI NN\%;OH/HM21%1QA3KW@*XVOL*^>"T,O$!BC)&&HB,4
ML_^KK4\4F9.0PSTAXY#!PS! (TQ4HX!SB01<0!@W NA(!E<4-R^)PV1:?'_!
M)]R<Q_$%&,%-_-3/O%EC/4]EF2WK?#^QM)O_](-]2TMK],^F5.E?T0X_!\#A
M?5WU/ .6.AXLRPL++NP"J7]5)5)7__GTJFVI6A!/#.E6.3%$#[]XL+Q-%^X4
MF@RL:W4^SIZEX=3R[ >-?EQ!;_=]U1Q_[8HJD2VYA%)F>7Y5#F%9*@Z<<C!Z
M+- -ZNH/--V]@=\V(\+PZR":319E*_;+SOJBP+BI>6#2N2Y5'W,8ZS2+:>$+
M]%=D@1!$TL WY_>\&K^"4:R#\>?]-V&A2?A<OEZLEUEU9Y*\K,M+0ZU5@K0_
MT'7<,'SCM.1HYTZBRJML.\] %7=)&@O#*CT1$T]?>R08V%J#;JSZ29K%.W5[
M<)H1G70[PCF(0GW*>O$E1 D,@-8*^A95BI+K4- G"%RNC6=7@OW)#W65@R0V
M,M?X9J;6Q(3BG'?IE\#FZ<'*4.:XPYZIWF*H'EYWO,T'*WE[TY,81QM[,@:Q
MJW3I5";<1R(NDTC$#_!UL#C5V^\H"0LEGE!DNFOS2HZJ'%'<JWI+&4GN(-S
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M>LRPCA(+G0Y'Z&()-AGS3V$OB!LK56 NP:VEB0$;VFDAM,HS+U^[**6:)>$
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MW>4_76:#*S)77P4HC9&S7!@0&'N!KA ?,5' Z*MW#L=,YP(7IH&&-$_[T>?
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M!#LERN6#<,SPTOKYQ3F):'_WLH0BG7>U;SS9I.I9A[KO=!F!DI<9UFJ["&^
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MLHTP?F)PGWX9^IP82[#K*:1K?[5J';"+>=*,;I<+]PA]9&F!^"U1_E&4RLP
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M66Y2*UI\&28W<5TERS',3:8YW!6V, VQ*PJWNC:D6GUSU-*N0.9"J:KUS(]
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M/2W/67/?KO+?ANROU0'R5%-;G #4MH>RA8T)Z6NZ%2$ZZF,UECYN;6Y@XNP
M^FV7CY_[%S4,F_&]:(/3L[=>PX04= H($/A);4;E:8@M+IG6E:4Q;3,G/WU6
M.;%]@NF*(GH/[LX00O-RW('/8:QC4L:RM<+@$:V4=2 "BI8#Z\2?\2G0W7XW
M9R1F6Q>(U;'_0W8J"UI.+&N(5V]NS%0_1/ FS<ZH,PMF_W%H*C ,I+J)Z%C(
M$TE(O:._6>W/0YLTLJ'M^GA8' QN*RO>1)"8*LCN:V8D?X,^SQ/#BHFD/@WZ
MERYC(E(^1DC4J773D:G&R>8_8YV_K$2==%YFDK@(=PQR%DFA1;MX_:2=W7QY
M0631_#R_Z<M; BL7-OER"8=!<T$2I05O(OT,SF\YXS6HM+Q_-O:.Z@RD8B&/
MFBCLJT\-'^CX>7IM9*G%9SI2,(*&]$D<:(+-%<6_J$0H6>D[O+O;'H 5U6=P
M\7]G-6])3'ZN4 ]F3ZQT%V%>U4*B<$&,R8O>X/-!B.JRU112G'M]B2,7XM^[
M@\Y4>+<ZU*+N\E_K87_I9^O+SSTRGB?UKZ3[,[7LW)Z0E5;S;DHO/>S';JI/
MKU1HJ:EU)>79'QW/G!=N@R(6U(QB%?F$^]%I@5GLO\V'NL+T:8Q^EQ_/E?E>
M@"MG2.E0ZPM+G@3R(X_[6YTLN5ACU4>$&W];&^MQM%3P=(QX4Y1O^:0=1%DC
MWJ CA\L95,TRO ]IIL%^E(?^@]I6]&YNJ&OOOPC$0)+R**>":ULKS_?9 (B@
M;X$%NJZ*?2FZB(ER#;#3%<7=UC=V9@W-NY#]V3DN^V87SF>A%LOW;2<=?@E:
MBZJGAM!0&4U!NKX?@9@G7&[JGY38<?696D3B9$KK&1P_N\\W9#ZDG$KK.9''
M=]\,8TW6CUN?I;)N;.5$M.+V7!YE6HYD%^?NU*S57Z#?"*(2WK5K!R6R^[XK
MTUW4LB$TJ;4=+T^,GH_J:1C"@_3@+L(ZFM^:""[%VB/@9\_T)T)!)PG$Y0L
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M?V/_ (L>+[BRU?4X=!LH[^2UTNV:>[58/WA\E(X9'\D8W.^& )(+<8'WY@@
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M+&WMG?\ M_5?&MW>ZM,+4RZ/ ?$\MG'<VT/DK$MSIMQ$&C7S(W^;=^]>A_\
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M./,7D] HKD_^%T:?<<:-I7BKQ!D\#1?">MZKN/0?\>4$I.>@_P Y\;^)MO\
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MG^*O@+Q+\?KC1&N/['/Q+\37L,>D-=*!/):1>#SX5B9F&,&<7!4XV%<"O3=
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M"M%)<\(*I)Q7_;_R7?9VMK<_4:_$^0.E%/DG54(W:6NRLTFU*ZUT:OT:OO\
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ML*Y\<',LIN R_S!BLC$DH>@*D#RD*K>[MC=S--!F\O()?MNY>WYY3A1S=[1
M@A=+3)O3,#76V?_\CD)H7SKX4=KKE1K2SF=;@ZDFS0]X_8"!EL2!&$EXA0'&
M+L?C3UO\B&=PIP3?')S:X?ZF?W*A2HG,Z%]_P]20.[$\TV6'U G6[A\*Q S)
MZOIF$X*9GDH3L!3?H)Y+"&:!5JV((61]13>K7^PQJZ.3 B[\>=S$2I]\>!RR
M\'+FTG!>.XWE<D2L ;+)L_F;6$X/=_ND3;Q;@8O6I]DVT- >NYO+7X+Z1X?-
M]47MA@*YYYW$=J8/DW^:3C#_F3FA-(S3#1IUH'8=74>P?Q_?4K%$J,7+YI)L
M%,M<Q9;&'>HMLRHV_<M"^>F:5Y,*!B7KTS3'H6^<Z!*W:)-3=5Q'\4,\;XGB
MH84@7U<.O:ID1>O\9-\Q%V[[AEC-)A:#^^W\]:EK!B"9NE'F-Y#H$R0#T4K[
MG.^2&3/%T2EQ6\HV0WQ-L[XB6<?5Q6'L4"OE57WM9<>_NG\R;7 <-S%_Y[?=
MA:J.B,Q/O7 ]\7.8O@+8$JX $]_^>,P+D@9P*,HN\O84T ^K.6WN8G<_42JH
M"G-RJHM;7VACW-;,K.R'NE HZE<.++:35Y./F:H6=P5@ ,V+CZ68C6@.F#65
MTQMX<KJM?'=#)IGG/_!U>&;DDOX9F/B3&15.0'S*OO>=4![^_5$#[MTH.O:C
MU>5J_TL(0TA]E;#1PD!Z[UZC!E=RAK?KY.[[8?VJBMJX,4-TU%!?82H8]JX:
MAJM/ ,F)QC.;=6?[6%NICC[(I)1@K/D;NQJO.>=T;%MX<@4P>>LI9%XMKV27
M(WAB!)2Y*V7*%[J4O#M$H7S U%E]KN^X4N42?U?N40?93;7"!&F;LJC2,L [
M8[.ZE^TY]9%-TX;WHH"/>EAK4\UV?(=I]]Q7_>!R)3C]8O%,2WU%QS@-FJ\?
M('7([9NCSR[U(2#>S]J/6#ZSN1QWOI,GTX6,0D)_-?ZKYM1A_9#Y;-6/WM (
ML5;.Y;BH#J$5NSWNEH=JXYM7@#NPVA<!UOH:8P?1:;T%#!<I%A,.(Z*?-?>U
M"!OZ!<[!5+2WBR%JF^GW9YX;=OS-9"-<GY1&S<VZZ$+G+&KP%(NO3Z)_TJ0(
MA+$U^)9K3XE5*ZO2O,S2'L,UC&]MY06J S,/0,E3M1^"\//@,<>@-Z$S9*;,
ME6J_0H4[']45:Q8_*)BL2:JW35P%F2]8HANW.D^$=OJM*B""$SM)DS^P<] K
MP.WA/HAG1Q#7R*6,E;D3YAZ!C#0IYF/+H$F81S"#7_Q] ?NXI:\;X/##FB3<
M+5VR/GDLX0]7YLY5_?<G6C?'YCV7/-[MB%5;ZYRG(20GX?]X3:O7-KW JC53
M(%4GYC-\H5"Y_*+V%G #NM+O]I)NI322GWP?(JYF=S*%%X'X823F-0*+22*6
MS;_A0/4X+]M03_CKT=4IF69C=&'8J;[E)L\=&[!IJF;:L*]J)E+U<ZJB@^TV
MES$J^<&K@VA<QN'$']+;H_P];EM&;<\C"?GA,\$+(<M[[%YQ<_8WV%Z:M=4U
M_!30%B/ [X26A"5[FK %&03'PMMSBBUO1!F[RTZI-V^#%"W$9_8VIVW6YF'1
MT:'^TZH/W[/-2X[T$L8*@3R?8'"N!T./7J\]16?3@'^-Z6H.@O(R\2!)S0)2
MHY$98Y[/Z/.?KNV][[B?)Q13KE!?+Y?N]N7$=EMM(^:^J@")KC,=%JN?<)&H
MPJ8)V6C(TP/I#<EI"PMJ&-9:Q9GEO0CRH7>G=K16U(/WX&\^)ZLC3*G- C)U
M#'A7%&,%],/T-ZR$R*^%-=G4)GOZ;',\B&E6$AOCUOE91+\KB'/,:SVTJRS2
M#E9JXBEBUN;Y *SIA_[+C>M<9?7J,?J9#M"HS/H6S[,CW%7KE=%XGM-2 +]%
M>HBPYH4-AV&DRR.J00?F:#^9F;1 F0V-WO&A[PG=I]KALM&P+#FYJ')?RBB9
M1GWO.-W\M-=2YOR0L^+,.Z9+P+"M^X3RC*,3B29SA[P-9A^3U5%SWD]F-:FG
M\UQ/I;W"@9BHH?E5T&+]S;CD*6H[L>6*K\- ]?!SD1_.#8)E=G16,']KK<"'
M\M/:SN\:T=' !GF06)J(QD4B5W<(;U.<7,!#,?6JPD^OF<NA*IG7"2(.;PF^
M829.QR%Q"!I0I+NK0\S-":O'^ST/=9[%E3D&*T)0!169RJ:-^U4QUI/)ERV+
M_Q:&]V&"'Y=4:;I?6,\Y>2P,0\'NG+>/7_HY<>LTS17%=)O->K KXL,,8XIZ
M-3(S%4ALV%D&]'*P4GS,&T+ 4HM:=>F!M9!N0.&8S  U0Y$!8U7?6Y"=$Y0;
M*U&E*=!AT7&SN<ZL@BZ)>M?+Z5V<+I_S&/+-['EO(T^_Y+LG0O?4C%^U<%26
MZI6U)_BE/?-@&I> #-E91!O&(@(Y*;0,6D7Y*\-ZV#3Y$S]F_-D.]NM)M0X,
M&]7@L[,/B45R: W$]3:Z=>YPKJVT;OD=@B^4]O0_^CI"!+9@^GZ#]5)Y+O7J
M_/'A84_SO^I4-#9\J&3:RXO2Y0$MQ@>JR#>$&/$_U;Z9F'365_5+S3+4@;-
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ML$%?OF%BVB;TF>C40UL,V5MO:/!C$^P,DG?Z?[';'IR"69G,5$^*3^^5F%\
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ML5EHX'$^;>DFKF_*LUK+Z*3"/?SE> @I?614Z&'O().[0<N8>N.>0,&87%I
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MG2L&+W7"XE\\-AB6=M>\DK>2TMW07!3&EN0BCT;XO9NQ-\8@<]E?&"HN"2,
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MDU[-[8&S2D<;&G995$MWX4(6,!"I,A@L0$KYX.BJ]1PAC/?(G"E$YQ?W_;T
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MGEX II<*</\VE8=L)]FK#2_))3#.=A2Y%*N$Z#5-]E80^,'?S@H.CB6$%#^
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M9(39,\JA__CCM9B3G:6\[A#F\SY>>F(P-U4D5F," [0K6[0*<;)IS5F9;)J
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M$9+\T6;]Q2LW9,2@+:OMT0NJI/8^&S8SZDM*)#Z!6R)&3+8?HW:SC8U\ 8A
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M&Z(^@85A0S@YQ"UL9FAG1EOR;:M^+KIA[5"N<3/\=3E?JW!7[?S07%<<W+)
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MU\ ;R&O9[^A*[V=5<G\N[?+Y4_HZ^;<7OFBQ)3+L2HC^GYKD: [/*H17(?H
M*Z^8=H1TJZO#U<?T\*PFI"=P?6V%+NT^(;3D-,--7-.)]%Q0(;#]TZW<\D>O
M6J2+C.\;/6X58-?5/2F>(D_Q-E(X/S<++N$_*P_U2:$3?NV+R#PV#TGC,\K.
ML]WS74TPKZY>77'?&-1V_!E@P :F3APOOD?X.._6;'$*J(HP! ?XD$O*O_G;
MQW\YR)&#6*TV6DJ4KVG-E,?SPBD?.BYXY?:Z_<"RXW57;8 E^ +6H=E.Q_/2
M4LW $LVRT#ST8I*X'+WTPG./N1G5')=^S[^)S-D9L8V!2P$_(&QE$@YPJU]K
MP ^%;0Y1]USE*((:=+$/$03.T.=@GL>"D%-@4/I'MS]J:3-G&B1:]_KH&+$0
ME>]3FQSG*(*U.\OPH+)ANP^YC[\6]X/%,FZ'9AMA\_W""@@./OW*?=WN)Z6,
M\.V"Q2=35'2V+!S1E]N_730_<TFE+AU.3S1=Y,#LG>7P$T8=D]J;O:)G*385
MP3;S YO:DQM[ZZQR$>M4/XC#>)5LGH=)*K8;>TI9P:>_Q'9#WM-.8[-44\B6
M%8Q!K#H<T/$B<0RZ8*_=SZMM@P,962'85%=U^OHJGET&J@K>70X6!PXF31@/
M[PK6U7_).:@QV%;@MH1Z*N\*WDJY;PCCO4]9Q\2+0O^I;'O[RX9@%0[RK-,]
M_5]\(S+]JL#(:..AHE'TCIF*W"[MC0HJBQV+$FWG%&__0'C0$5(F(Z3A]\K+
M#[^9A$VH8YU\WB,D-CO*EMC.,A*>9;'\'>^#]+%^?KW9IF_<:=;1VE::W""O
M'X *,QL9FYJN=CN'1,,81-H&%#X^#G=U++8T3N+ \F"$]$"D=)TA$,!&ILX?
M6IBIIJ_V.HC' "^TF/%,':T#$]#2:^KNZQD42@AG>;Z?;?XNY#]2>2J4=(W0
MA&@*]\LOID2KI",JR/W/N^A5E9!W-[%'#N3Q3D]&0M?>W"W"%T*U9;X]W=8@
MLP'G^3\ON7Y6X_A/GA?3JNCK1E?"VE'9@V?_75(Q.>9J<ZVE'A^3\KL4=Z,N
MA,Y\JH@7B,P/&VIW,0 )P6#1',V'$$E&B-?U8C38;[G/<WNM[4\_(VKTE4XK
MP5)\Y9+*1LWI@@-AOS@?ZX_D7S&/]][/Z_<T(TZZ_^.\'?B13:H>L.2"-VRD
MT2&?8$X]UCX UJ:)SS?R3F[,1CRZ8S(R7Q^6^;="HR/W*7&_7[P>F-\G,#;S
M!&;+F<SH#E"+\12J:H&OJK%934% $6X^<XUF2!=<0^W0(GRI-P*X;:XN6KQN
M2T-@X((Q=FW:U9#TD2B+V2D;,)-8ZJ:J5,;62/="\CUWUGKNLNX..=KBZ5:"
MJ(I@%][2DR^]1JGII41=F18B U&C;$GJZVSOK)>/.62(5MQ>R4T:]VLOG)FQ
M;= K92,8EUC-&!3^9I<-9N],_$UUSY_^?>V^?DH^%DG*2#P,#3:.!NK(\#):
M6KB]I5])\'6OLK6S ;I([&)Z=JE'.6RR-0"UR88U<'&%ATF_NME87QDH'K>?
M1_?5AM/:I9A'<<C[&" 0]W>AVWH0KPT\<O6.$E,,2E_6C4#:RQHW3!.B5LFI
MRU<J194F9H($_/[:F)M0(!)%CZ8&"R6CFOL%=HH"?0CT$,"$?[\^\ 50":K6
MAK>+/53 T *WG;_5- $C)WCPHFA3H8:1EFKG,;ZUUZ.JG!M[P(#%<[67B M.
MJ^)+JDIETXJ-.4[B6;4@ABH7YB71Z!I.E]I9R&X[KK1[=WT"-]+-*-ZTW$\.
MI QA4F0Z/^37"SI20XL0;!+7C;[D6>8XU2A]BQ-.+'ORZZ>2=<VP]6R/O,^B
MI:>$E_W- ;#RWQQ;RT)6G?)OTL]K/OY(57")^;[#6>\=-I!\V[GVK>T(3<_V
MU[2TIB@>.??!I8],H$,]F7.)9E%5PDO?/!&+(O,IW>R\/A%*;&$!O#JAJ'<B
MK1S7''VP_6]>VR(5);<=I6.R>BGZIKHQSA',@(# I#G.%-FMP$\O;DSF NN0
M;NPNRA-JK''*DC<R:"9 P-ARS./%6A9RQI]>K)IK+'HI:0._)PQ=8!49_@42
M^MC#QQ)SEO76B\)'7:JQ:(>O+)3H;&: .Z7@ 3<H 1GVS48=U'P/7).FE"=^
MG8RXL[)X"=2P/NV*>0C^&FWD-F3X-&.:!N>!;(E6:%M\)MC2Q5"THW3O/2F:
M[D=LG6F?*7M/X=@<KZB59N'YYM;(6^B;<.PE5=7@@Y\DW@^U6ZH017\;NO%<
MP334KR6VT,!G8R6G27@EI=W) [1=9S-;1) 3Z:JEU>RD#KY.T:6B;./NG,74
M;"."A?7>>E^H$)XC^&^Y%Q]" )=J4%4?.?=H 9=CO1%V-=;# ;[_$C'>U\D"
MLFWP/<KT-YH'%^>R9NX%I)J0WJ0'D'4"N#4LX@'.-9 E+^ZF@JZ%Q_!&)NMD
M2Z5?P[M)_]VV']F1__V[[0K?%4_3%+C9^[VZQT^I3'OKCQ&5JBCG55WR$2+%
M*]81_"U3]O9?%AEG^&S**,"93[*O\9GK39%(M4@2V]EP#JM(SU@!H>*V8>=0
M]GBF5H&HWP@4O>1:D3-XN"9.+(H6J9=".'],<]=]+"QV-:W&3%>7?NYDZ]02
M[+G957^1H]+_A7A^/CVIEV\)]%[!< )XS@95.A+]P"H7J&6=WXY2>6/E<#>T
M/8Q@JNVR)#,=#?ZT,]O*GA)?>]-E-QM.4;5VO//[ONGSR-VV2RHWY\:J[F5[
MAO0O!4Z#7Q[0"'3Q.RD\>PI\*GS%<9IGT<8@^@LJ5V9Z[*?3#&TD/UVVL[=!
MN)UUW!DNWH_.Y:&0+=K]%:IW\3D:A!DQCZLNL36"F^TW[-6=E%][V+-'Q]2^
M2(3)B[@K?R[C0[ 85G_P_3?J2#'C*O<1L\:*?.T#\]/;,VQJKROP<EN_'KE)
M!@3.^3ZG'D9_AM=Q#O:]:X1;7)FX3S2"%9UJM)-F-DB4Q)7<8<"C4W[0[W@R
MQ(H"E3F:=G+"/9F577X;0MXA&UFALIY\P5$A@\+:_USYMS#.S_-_Y_ C[1PO
M6N-U/SCZ]XCT)CRAF5-TC#M+5)4D)2$+\-VH^.@1^IHI8^?P0+# **Y$:0YP
M?Y3!\T@\@)E1V(:<5Q76*R\>_H/W!?Y5!X6^=>Q8N$XL_Z;;6%RVY]'JAZ'N
M8#O@9GW=)=4C7@RM8O=R"R!DC2&RPT'8N,- P>BD- NYLR^DX%OO^Q'928\J
M_TY^N7VF&?3--JM KAIDW5\LPW)%.WX-&S>.)W"K.D4Y-6C::-DQAKM8I %+
MT-^L?M&OU!1S_B:V,.5(0#ACE)6^;J0"?/A'P!F*59"28'OJW")".O(5#HL(
M_V$OT\ M=W=BG/6I6+RW,]SJVW <'I>LRD\;7_IYBP.P/.PZXG*M;0AXRUB%
MG$<>JTGJ5>)4.@ZXZPPI5;)Z4RN':'[[BUR\-!C@%3,G,>(47#K[J.WQ&@>J
M8 *GZ))?V!?*B2VEGC&_9E#_(\YP=5,^@Z*3?\_.IN'=#^GIY/7;,H1L!^(Q
M*)Q,PUQ1F'$,;CJU_7M)]>0IW3ZKZEN,W\N+K N8 ;M>X39&,V9X>]H@CKSA
MQQ&5OL3'C%.;RCS1=!E_+#OS8Y ^,ELQ@4$N+=JD&3$P<#^M=-"5[HC)0 KP
M\M7,(V:[P/,O%9A2+XKN0:*-%W070^^EBQO9/F0?Y[24--9O2"+L7&^"=[(\
MA=!Y]P4RW_TOR?%7K1%[F#>2,!_W+8G8-%0?MTHK^FP1#C43+LL;V5[$84]9
M\B EDQL('_XW&R-6Z/W.0+Y4D<5')GB**XFIPV@=G_YS5! '5>KB\"=/C,.#
MY)_KZ0D&E]@X66:2A3FH_R73?L##)( &0' IJ:6DMU& ;>CGR!'G6KZ6S!KF
M? KU[4WUW#I2/H/$S57-7$WGHA;[%"3C@K(2+TTJ3W=_ZI,(Z)(MU<_.$>X9
MB_,9-S3;:0$WVJ#!AA26B?ZQQJ=,J$AX#5^G+2=\3* ND>59\Z2L4>R#ZSI#
M,KJM;%0&@BV"C8$!4!Y<B8T5Y4.[#WYVT(NQBC+87A\2*!R@D/=^:*"./9.V
M":A75X.MC1&<CE>(=4$(VTJ.-FET</CGWAQN'D*#3\L]\H/*RV4,;D[).?P(
M9/5RE8_B_ TQB=$":*5UY.&<6"H&U#AMW8Y8/\G.81:S CYOO%+-K#>(.#R6
M Y,G\-C,'S,:B_>M:"ZI:EP54>A2_HA)B%^?=*^34:ZGJ95<:R]&D;%=ZW'M
MO@-'B3Y>:&=O@ZQ[T8#\HRH\3'1412$(?AYJ,;7LNKD,[.HKM;]+9PVH;WJ"
M?JPF3@<FRYY6#]08L%&*M.M')?PKN&"/"*&.ZF/*HK  WIBP:VYV ))@EI=]
M*5Y;$/5=%OUYU#\RH@T =:ZIB_K3R+)GU=&MF*K6J:+6SI$1DYP0CE66+5#F
M4*T0BFH6H6AWL&"E-^7J/ZSC/;^%J"QQZY[J7PP#Z;6XY59JUIUIJ9=9?/&-
M<H->G; D""T4= (5;5>414>6;G^VI;BVUJ/ZF\:^[DF<Q6]*TH+-=J O&3TM
M-1M]T W?^GQ4#Y*-7Y'D.VC/;^_^5Y\;#%4,*N.!U<Q*&@SEU3</]9]Q> 0*
M 4=D&DH'M[(2-4RLG)H%A:G)>2L_NTSJ5+NXU^Z+=)KE6BDKP;.7HHO83%=!
MA07?:D!"PT"_XTNJF*>2-\>M8MN)AW;WPW%\>D9][BYLO^L1-Z?EX.3#)['F
MR^XGD@'3<^M>,X,4@?F/C<:$EFA5<5+NA\5+*GH*TFKH+(A[EXR,NW@4\ISX
ML6I>SQ%<;)'\PTV1I0*U8<;**J4I/C&-#_)\HQXC;GI_1\VK45G9437'+YAP
M+OE\..#>LX]3?Q7)):46M,HORDI"0PLH;U?R@QP#Y7:+CGVV$A&KX=+_(3\A
MB5I6.8X7][L[>.FF0[. VB3NU<I@_G&H^&]?*_6\3@B44?F40_C;:*$Q_P5T
MZ/%5=O+/^RV0Z9<3@@ ^I'DE?+:;AB7RT0"M+U FLZ&4+I<!KK26/4$(,0>A
M7FYRZO>HFX#L3(:3]8Z\/!$M+UKP@_G3WQIY%IX-).08;(%D<P6-:F8V+$V,
M$\^/ 6B7L9VL:8U^V3Z,2[J)J/!,,1_-D3F_'\<C+KAO9Z#32JSLWF!',E,/
MJE3S^LLC>4ZX#-U__]V0?W9->8F/[@K7A\G0_ #B!>' &8.*YV.WX?-XY[^F
M^-DZV8DWT?MM]-9QD;O1%\\SPV($_[V5=;)Z-[>\SGY(T4ANDV;(MWPE7&$E
M]CPH5<V_*"X?$/Q=K\>W2=P-6W$<=%&Q]Z%CV';#2'_"2V;[X54K)TMOTUMP
MMKX330G7A.ZJ_W9:<T:6>>4HTPLJ&1TJ+^:FP?5)B67607]F(""3(8MY(#3H
MVK3MMQYR$!\FER 7:V52$T?O(("+%<?<<H!O*"7/KH>[&-#I:M!['AJ0OAQ,
M:TN.\#.[40FUS"T?,"^>2L%>7*LV&?WTR:0*9/5X+4(KZ*9RLG[C83EHDB,=
M5!]?;1#0M%M]KK]U)S"N3T2D[HUT.6-!AMB,?8 (M$A8=DVXR+^>-YI#Z.<E
MU;40?H-M/<#.X>[]&4V&$\\\D=EY N/OYF \"/3 )0E@V/B>#3YG?SUO*8DZ
M>E=R,F)O?(G %V3\#()^:M40-[4$BXCE"PA__()?DU'J=<R=R3\B@O>>,Q0'
M\$Z:+V!;_,B#]UKB92'1KT>D)A(3C#[)%9^JH+[?2G<TU2N1[*^I>U!Y?]V.
M[G\=FH_AMPYK__=Q'1A4B RG1W4FV(9A@@*O6EF73WWB1]?N]+P&:;4SOGU-
M3YPTL!>=$G*J",:5V:WC-+CZ9$L^CY$G8P<PYIR*R5H7>E,03+UG*/6]WK4D
M T]M];F"PN^1;.S==?P7KJF4D=)&TO,XX:]7_W]UG4^UY3W?,8=>['GG)56S
M-L6X^.N-;=[M\'F#"YE<T G#Z4HX)3.4F6I0//3F^5[+F1Z/!;>JW;=_(C(5
MGJX:X4US\/66,_LOA>4K$[P=2B2[.#7BJPDLCC*UJ-10!Q]@"U'SY-@S5HB:
M?^QM#L/YIWO/2\&2/^>O&F1?L\-X NA3IOE&BB8FBBLZ6BB/^0V1,6]8C<6J
M-*"+P>P\HF[]'54_@B8N5+H QS2FW?P+A):,L R+-01%_;/#@SH4U_R#H?6
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MPA8W5 ;/[MHL-=2<-R1\;"PA-C.G*;VN$L<V//+J=E"GKO[UK#.D>TG/L]L
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M9,!OU->V,XB)*&MX7<?1? \Q&L*P,2KM1BN^*9$&!(OY;H2)DB1*&/"2RW$
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MOFH-.\:^'<LUVEMHLHD/D1M=)>2R1O\ NT\N.& ,"6/S,I4JN6;Y00?ZN/\
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M2Z3X^T*]@MQ>WEKI>J7(=FTSSEOI809(T@4_9VD($R/NWG"+@+D$J#_3T?\
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MU?ZYK4MW%I\NG1IF;P=;HL<,TL[F-1',Q<, _F8V#R\M^WL>,<9/.,GOCO\
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MHM;:=;7\&C6;W9NKV33=*L)=1O+_ %B75M5U,HHH __94$L#!!0    ( +J
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M(3)N('I->:CX/8!CD4074VM?<':<A2&,Q[2L9ITO(BC&+%>,S[0<'A1X]X
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M-V09-/"\!WP9F\MS1M1'F$P11E2!)EJU"@@UA?(D)Q.JH*4*)*8#3:'/]DV
M$> @?=][@%WX])&YC=X2DXJ]T3APZ$/B[UU6K]2 A?V30Y5;L3U+RA#RO74.
M1,O#J23=SX[@GWH.RI1/N$F.7-"=+4WUG' H-W:4^I*9,HQ7HAZ.OD[HME:B
MR37<M1S.\\1%#)5"I05X\3O4S3@!W*PZ2LQAAL<-5 B)2:_%[(L3%+O#T0G\
M9&E%?:&33?2\_!V09,-LQ7@5,*^DU>@%9%;:>8+WKDK27IVN6:OG*(1:@K>
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MN]!)0M"%]-UT9*J.%5'*,8C6[T\JQ8@>;=@;R^?+*)G:0AL:5-70#]Y8AGL
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M(H#Y*)=@&0N.,-XG+_&KZXI&\8=;52-#=%Y?AWZQP96M.N_OQS!I*/09!"1
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M+^[_1K#QC":CRG! >_"C,&\\2=).#;='AJJ'\:<ZLG+6KE+GLPQEW0]*N_>
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M7-JS\K1N4?;..8^&I540R>F]=+ZLH15^*RY5_^6Y0T\HH 6_$=6ANO5AK9/
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M*CJ_/I$:OI_*G4+U;;!HW6+EC$).ZG9;F5\[@9$3D8(D[BFH!Q:0"&!&<D"
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M[=K)J[ADLPH.DPLJ>:0P29(H7^,6F.K&\P"S!D($O#0AQ^O51[ITY!R</0H
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M_WJ(W T)[==S:A!2QD+]U'N0V9(ZZ2*K8*&"0]9O;LY#'DCX(+>?9Q;5I_>
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MTI:]^\XNX/L#A0IWO;U;?R39N3Y,VJ_QOTC%4%GIK8#T6%:'W9T^MV6FB\5
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M<3SJHW_ 98+BT=88F"\Q\BM]C6X.O03(/")-=<X+I7(T>U^E>,>GRHF\;*9
M[IO5+YO.SNZN^0D'%:[5LVN<C:X<(53(!K%G;NGRNSKS .M@@9:].#4.<G82
MR,?JV8J68](H\!-UU*N!ST;$VS7LW+6B?R]4?UEW*<]*#8!35P0,O1K3!*_
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M!J$XNB6&H_=WIE%$#)8(A/Y71Q*J=RY;,[?"H'Q=2P<]J8>A17,=T&"6W%_
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MARM$9;,-P^\E(*R&AH'R(<"C5^0R?&*GGA2,?MG*SHT[SZRNS*-Z*\@ZH/G
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MO59P5^98U/XHO<UXUTE>Z9*T03CW.0W]U3\G8R4XX+SA!NC';M,&FMQ\Y#C
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M%B=(+3ZX)E[\]O_C )[/_Q]02P,$%     @ NH"262^Y5"U4!   9@T   T
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MO;]HO?UT<?:!KFXOU%Z]?W?]Z4Y9EK:L&:\64L!A5^]__\?'^6S8@NZ?K_E
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M=7QT_-8>'=NC=[;]XX=GX;X7SIPNB 44^.(]?/AX,)<R?']X^/3T].;IY$W
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MU<9F-*SW'>J(65=3_2VZ"'Z=E]&*HG7-=%2/S'5HIQT)./[H8_,R_ZR=R4O
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M ^3JAM/D"%)R=C41@YZQ!NB!\ 93.@R5*W\<,D?M_<!$/YDJLY:SU PTV/5
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MAH72-\>ETRFY-Y:&WZYP'%K^U5\#TCF&:W6/-*71.>&IU!YBX^4=DS@T5H6
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M%BK$M_\B:R69BG;]TT>72RJD!Z%=WBTB,5.SLJBB)-.\2>* =^J?\EJ4K'=
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M[0!J90L-'!-SJ6/3_&8=A@I#(TI!"U6&AE[6OOG'784J/!7)0@6F$:2*H:S
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M3-RQZ1I,H<,'[+NY/[ J8Y9<5'6B;X@X%).[1<0(_T*>JT?JN;;I[!67X?I
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MRBJOUOU. \V@'!>B'AKIA/NX%9]W^OC(Q+%9D"^DN"5/)&^^&-W)@ Z O1#
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M6!B8KX".B2V,P-0F"@<E_SHVCR-7(3I]8E,8@5_UWSG*;2]@B3 @VK^BVY:
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M:D-"Y1#4:J_\-)8K'@/%@YZ)VR1B#5,T-1F$1NW$ZJY"P$OGH-]>6_WOB&Q
MI<!AJ/XJSEI^>_?5AOKF/EY1M+:$5_^S2?:LA0Z5K-/'*\8Q1RU#XES-7Z>(
MO-'/[4M#M/>Y;7[]..9V&^\S39)*@8@R54Z,J^F$OW%<,^AKWL8Q6QW*R=A.
M6.=KJ\*<M:]%/.S<5<0*4/&"S!07:G<8 1G"JNA)1XP-8V!#^4R[8CP>82"$
MT$I*2H!VI9A\XFL3-' HXM=QM*]SWINFHJ]WC6/65%$VKF9*'\7C:W:4X2K'
M,-5Q+8/0>]]P8;6^D5<Z&VI.'1&IK!'FET*M,*.YUQ KE5UD)<5MR_K[! [O
M6(;</##,5>EU";?K/&9$/'JMRB@/!-^OQ3Q)];^]3M#+5PXY.9W3*9W,EZ.D
M3D=3^%I,W C"5[1DZFVBU0 ."+]?D _OWO\DE4LU<<I&K@CX\!Y 0%,C!P3(
MHZ(2\&?YIB;B03'$OY<LR0B_$7S#[ND%B:NWRT'4Q#H94 =LN*MD+>L4M@K,
M]G8+\.O(0&H(T<.$0!_7\^8OFC^MV[D;/? 4YOO&A"=<OOU&+]]6AY!X_ECF
M;!UU57V(+ 2M/N.<]W35KNVV#PSUKAU=<Z@(_D?#<RII@QIS/%#Q&52:PL!9
MCG8 M3*"!HZ)N=2I.M ""FC6NEX8QK7FO<CEO=T!$Z[Y'7I9^^8?=U=$X[D2
M/%R!/(*[6E!>@8SG&F^CTQ -]^J-+N;=W!P5A(IOVYB@1G+F./B"BG@@OR*G
M)ZBJ\"Z_YV7GNZ,Z^*;0?=:!I"9=P@EPCAR5*@JW+X;;%P%V9PQ"DI-+[QQY
M8H'('170"A?@A0OP3N\"O)Z3;?#)&CU6LF\;18=.]!QRDIHBZ= =<9[6%C0!
MT*^T.GQU12>%-;'5U>PO,QPX(=B*;PY0MP8X4UAJMO<^4X "2L IPU+7?=@Z
M E A$4M)>(]I9M"IP2) HXB/ATX:%OEZV$H3T-G"(FCO/.Z=*FY[J"G]_KVL
MJ[RYC9)/HES66<[EFB=YG!+>L;)TV^']U)?N1EVH,FVV(9U:E6F+O,I/I+H
M-B]8%$OFN2=LJ4E6-34?G'9M@JBYPUCI'[8R2,@=;Z)3D7HFE)T'$DD/*ME=
M_Z3.*S.W=D#23<2+BU(<TGEQ4?/1!8FSJ+: ?!;\MLC6&R&IB<86W?LF>O.Z
MZMJE;R0NY6^S^6X&K5$ QPL)?%[R:HRG$+7?\_WB=.B0AQW)Z/SR@.]"+?=
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M5+VAE?I4=#!.BYT%E]I:$C%"-@EJU%HNPH32[+ZA5CXT3-C 5M2W=#<U2.]
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MZ")0-*8G-!N]2MR@1EL>JJT:*DZ=R-5WP6UOO6*"V[Y'GV_/%ANO7L/WLFZ
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M'+D;6HI,:7ZDD1)<3Z5\ME^0FO%?+"F$3'(@)80-M8<J_&);9#"J]71W)%S
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MNC 2+(8FM:W:T#Q271^C,8Y.9X?E3 [(^$>BUC'H[NB+=Z^_;KMBTG*955!
MX3<*SB>:GC_1,GF@S5_H39DM51'B@:&'OM6;83G[2[W9<H+>Z7U3&F%_]'!9
MD"\--B21Z!#:X$,V@)"XA*<LSY.R A^MO) _L_LX4B9=7,=MMM_27#@)7U1;
M#!-#,4:#8DK?JJ0!V\0C"<!XV\'9&G#FP]TCY89Q 3@TB63)4-0M^?)((0I9
M_&]6B4'I5H0H@S,-'E_:UY)]'>H(!L@4DS$3JL^_W_RDY-_2=9)!)45HI@<Q
MY=LD]]*(WAZ3T!WJ\1@'-57"+@UMMLQ]!^Q,&/+BSS0I(UHDD43RV#J)N<N6
MELI_TAT_SPJJ-E"&1V#LDL.9?*N+%AK>!K'%U]IST2(0P6)0[#K3($TP^T 4
MG. R!<)SL2U+JLQ&'1F)/%\'9@Q20VDC0491N6-49 :D>38&Y.%[;1=MX\M*
MG (7R114H?5<[#T5_C&,.G>TC!-/HHP8T0_>G*D]."E\#HT^/2YXCN[^#]L!
M,]([G/@N?(G/,W362\0CN^6QU+.]O3[7(+=)>?#C/A_:)A<Y/W+>KAP @!JZ
MB$Z-1>?/#,P9+LME #@N^<')*K!6!9'0V[;-+0+Z(N9U5<@8&@&Z2[JH9-0,
MK"H5Y2I(TG8.X4/J;!WCFCXI$\R(F-91,K*GYK[:P?OD*[0.DT4/]K\>#ITQ
M_!@73Z,))$RLG2XVB- ;;^O$1-VU36OW<!>D0:@M1](K4&*C-#PN'*=%VF46
MQ]I$5B^!2U3-2-N-MJEVU_US7^(D2MB2J40RNUUX-HZA7GMF3:_]#YY\1A:8
M1'(G(3#VK8Q[* U$Y90M6A 1T.(EZLQJO7\]8RHB5+U74L[4=60C@PZ]2M8L
M85OB79QP38NMZK:K]?.6E;>T2H8O==H?H0J\3TT>IG'D%!;FW17=KPO3.K*S
M:!H3;H^(R$F7J%A9<QX6:M]'\MB0JQ^3FL =N#Q<?RDPC-% 4ENF&([.MDX?
M?FNFU?G%=KW-$V@I="$B[6JHNWI3-AU+Q"U5'96 G0/E)#*$Y;VYH\"'G),]
M1J2'$NEP:KPQZ  (_PNWED9#6L1PT6 YE3G9A6?SBJ0V7T(DC1A"C_3BI(EE
MW/N2@RR&9T8]Z0;^6"=E[?*V]%^5D&\*P]XOWLDXTP= 4Z7E\%D0Q0+!SJ+>
M"7E)[^OQX,#QP4A-/SRI_RK?>\L'.@56"\+O)JNN@E@4+I^@+S,CVGSLF6I"
M1/CE:46S>LOWJPWU\6'8>$+#EX7C&%WO'2<D.C3]QSI8?#&-R0GCE1-"'C7"
MI0K5:RZV5<W6M'R7)?=9GM6[R8-'^U/\,30)PK<(=8U\(;NPB'<(Z=.:V1#P
M^1Q0A[6<8YQ-YAC$.I;T,?4M3DT-T/]:YQ&"45P>1=C=?SZZH%U$5'6 0B*6
M1C!"UK=2:(']%U,+.(9QJ1DLN""8<CA?+LLM35NS):/5N%TZ.1XI<LIY0^5-
M*!' .%$=K@;Q^-Y Y\(-7$LGVHIZDM]I1F'&]++N[-<6;;E>B434JZ)FO<*
M8YW^3+[$=?[3@1#&1]B6M1%X0)=:=MA.S*([H)]%.N@6V%]WL5]WY *8AGS'
M+.@<[,2!;M:4'O:PKN[HU_HU!_6[XMC1^PAY]HQ/[EOF)/3%<1?SBGP&%(C
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M3=0<;NWV85C>.WH-2<B>#1:D08D(G.*F@^(V:=HRU*%\N )F)U4*)QY-IS_
M%BY33NP]Y52"(_D>@SA/H!JT9>8$"\9+C9X>N4 ,C$!R2V\FW^S1'MH1;PM#
M=&,:Q B]]:,.T\$Q=ML?QDG:,4!,[^@P]4Z9(*I']*I8EE F\9+*_UX5A^43
MNX82"A8Q_AX=6:\)QWN#P:Y.9@YPNR-H%RE6WI3\S)JF,[+;KPM;J_UD!F\V
M>P=I-A8[QVCN]OKI]AA9ZPJ:SXB#[[XPVWOG\0S^;ITMI-EP,)0<F#D'GVZ/
MV7USF.;A.'B[V>2"ZDE^D52/;W/VY:I8L7(M41V_>AI^C>5</2@!ZB ]MNPJ
M*@/$N9*:TIQ9$C)<.>2Q(@%.*@&$3??'Y_1C\:P9WU@S1_H=?!(S2U^=BA\U
MWQY2TR!Q=,1U,C0$FW?9F\HW>P*L)@LXGOMDD'9,AR#!.6#4@S(\R)(+POA0
M>GP0TXNBH.  +T3UH[Q9;W*VH_0C+9^R)1TV[#XPD>U"Y2-9)71K_^\7K*H_
ML/K/M+ZE2_900%2E*-S3%.I5,%E0V$C>#8)CJ),[R&(PAL%,J6SY@#]X!>Q6
MT;[72^P6!-"'WE%D1VNR7\&"G*^A7&$4)1960EE4AGC^*E>&]KUE9?,K&*<*
M]XV#Q-R4\""RSUX;#ZYJ5FK9$=V#Z&>E7FX"CJ&48F\9,0.0(PEU"+VMP3'A
MJ@'0^JI8LC5]QZKJ_"G)<NB?=-=O%?C(\I0S)U]ZME1H8.0LV,H 9M!"Z4!#
MM#!*S/O*$=XICA,!=$A2UV5VOZT!)=)KG ERTV 5IT0"DCF9([H'D^6WUK4G
M$3,@9=@ DF_Y?3M>;_)^=U";+Z)##K,[S ') [;IK)8YJ[8EO5[U#]%;FD.9
M-CA+JY.LH,G&L8YF1;?]M((>^9DW?@=:5[O'/&W)'+2[03U6Y"SNM7R,.JSC
MFGYN-5BQ6Z6G\MW57E7UX'BD/[Q\]1.\#(RTWU -0G7>.)[,>].-1TH (A'O
M-/A^&_9XV[?::)<"14SK'1CO^X2M#2SOQ3?B[_#S-]_&Z,.A9!6F1\=@FOJ"
MB8X\G*[\IRI+J:Q,]'IWQS$8L;ZUOT-JX\GYO4?G= B0 PS Q@8<8AK7^L1G
M:(I::E1\/F!1;).\#34^K1JC3"\.#1:C]0.@YULN0JW#^&2:)6W1GO)[S53D
M^\%49+$BTBYIL&B5?FKR<Z&U$[LBD:3+>J1+]H6^9)&O" 9%2+W&8FUR;*,'
M#L+1"ZGV=VZ-GOW\T8P>:?'$O&'JTW[:YE$1U-+FN>8*I*P?H:++>L/*I-Q=
MK3=)5@J7S'4A_BSK%XO?#-DOR"DPMH@A*.]Y<@#O#/ YZQ B68<1X4S(8 C)
M]C@9GUO>UXP[@V2D$9PU8HDOS:@0X3C"LBESL0]!CPG(7X".R!?;JF9K6@J'
MU >J2F#1^<3B<%!-'>K9> P'S!NQVS4AC.T6 ?(%NG6W*"RDEW5!DA6?DYSG
M.?LB&GE"S,E%2=-,/B-'.P@G68QA:#S7*[_\=]#K_B'(65WUY;^?]S5?_GL^
MUTXL3>=\O6]^I5V;^CG0V\L5OR.04._-C_M+_S_2;?](K7F_Z0_M<S#S35B1
MHTF@ R.0QEEOIE"V6 \DQO2RPAB=&"HO+Q'30X>VG&E0)5P"_?*1IMN<"]/K
M;945M*I$D\-*1-Y6KW>]?ZF\&Q,Q1AX@8!/QW6'B/?:H014.VQ99TL<6SNS>
MOR%^7>%+^WPGHDYC!ROY8 ,68&]C%V/9GXK5:-UO\:Q:I%IIOSY!^6H&@$#)
MMY#*$KSQ?=5>M].D,+WU'H7+CN?3T+)L$@4OLR>N!HJTDI'L4!Y=K >\A,KB
M,9@IL)GU!J"\Y]VWN)"TQ0/5NMK/DJR:5YNNS%=) 0QC,1>D=1'6^,,KC;#&
MH4'HL,;^9&'"&G]XY2*LT0YO1V&-?"DC88W=F+BAC8/LPO1H:<G3,DPX'P@3
M/E_R#=B*L/C]:](0QR.GP,B#(:@@7EU#G(QER=^:#P^3.W/GZU7O)75%4KH2
MJ!*!*\GV0?;203%1CRW&=MN^+R=[- Z>E5=$DN),08H(B@8KI<S%7H0K4M<9
MXNI8Z\$QV))U_;E"WL?B14L/DX]IT21.;KN"#P;'N,A+]\T';=JU=1IYD!>Z
MF-CB4]KCIZL/B=8(/>:0C-@["?@96=;9WP\.UJ/-Q4_D/B51 3#4XY,Y9AAI
M\KI^&\]$'Z0#2S)\4N84O^KE96IMPASD7!VPI_>1>_D-&+0WCH5CN<0%[F&?
MDU?;>EO2GKQ5)-'6.>&E3A&A9T+.8-(T@,F;K\M\FV;%PZ^,I5^R/%?(E,FG
M2,G2 6'.AT^TO&?&/H5C98^1*#_KP>D+'5SFLT:$[ABHI@!6](L.&]*B\^V"
M"$43J5>/@1@Q&SH'4RJWM*K+;%DW3R&?N-ZK;C]^&NUHHO4-4HV,SNU;WO;
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M ;P61.8""]06_5!!@5V\A& ,LQZG"J-WP4&KJ'HG+B?9*J-I<S^IU 7:];[
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M."]D'$4U3D2F39E@BNH\385F3_(;\39SD6RR.LE'/4U:WR!5T>C<OKEG#YP
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M7.2[BQC5:K08B9G3,IC"A0:)U4VR&Z@O-38$J5+[4X6R@?LP,::N'<X(BU8
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M]3^&^!H_"X;OS:$%L;3,T3(6FQ KQQ3XW[\)P7U'/@H#9@10(X ;Z2%'YDT
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M62"B7YG!5Z<.HYU@5N3U]#)RV1P?YT6Q37)^+'";:>!-9&P8XC5D:#KOW-3
M)!(HD5"#/X",4I+IDB>8HKHKDQ2J95S7C[0\E\5"JGT=#5D]0Z&HC+Y%*BHM
M&-[/P 9NOY*,<?483SK*;!.8%67#1?\GU2-'#?X#2=A/20ZF['B5(]2WV$A^
M'1C>:]IQZ,*+('[HX;$@#6_.A4?-MH19T=G3.?JFJ$4M@"4KN;86Q[KHDG0!
M8E/N+EAZG*%O^!7BE-68W7N#(H$".<!A0006D.W08$( E> GL0GQ&9*BX>Z;
M71TOP?T9K<[OJ[I,EJI$SND/L#=0Y<2!CF'A0VY D\\M\$B7TFDJ,W/2!>.J
MC]E#D:VR9<)MT1/<I@Y:LX^1W*8'Q'L<_QX+,LB%L4]8P[U@=@3V?%?EEFDA
M*_!,WE=50RWNK,=3!KNW[@''OKLJJ<I,2.692]YF_&Q>UV_*DI47K"SI<B3F
M4_\C"\Y13QZ,AS@*2;',DIQT/3R)P(?L$2*? :6P>LIP#QB.L)YM_YK"49T]
MT<ND3IJV?2-&_]AP"VM_:-I@9GX'G !T<A&ATZ(VB9DIW3RQ3Y/[O'OS%9+F
M'NB'9#UT5QP;AF"7H>F\FTD-3-(")0 U.'>,4I+IDL<S-[SZX?XNJT\*RX\-
ML>""=BK?'"" P$O.JQ]>W'_;ED/816.!$Q(R';H$NW^):H$T;:NVB#B6^YQ>
MTGO5M5[C"^1-:V3F4)5'1E# 5!5QNB),;$D#GP!?DAX&9'I%GNZ).NS#$!2T
M[5+#UILM4/CMMBRR>EO"PX1&@V*3[U ]:S3F]^[F;W%8D Z+A?#[.VA>[&>!
M]IUL]FM>[=<<LYFQ$:<Q-'4#]K8IUJR@=5+NQ"T^$5>J.PY^M*.8[F?H'CCC
MT_N6M1Y\TD.   9QVXMI$YYAJ1G%Z.$RG^Q &*KKE4:[)9-/'9A!*A Q["$5
M+K:&D;LU(MLYD4W$;DY&#*4PC/0H:&DAB6B-=5+^?DOSI*;I'?L/NMZ\3]6V
MD=X7&*MH?&;O5\S_K[MKZW7;1L)_A2A0; H81=&G;M]\[&1Q@"3G($DW*/HD
M2[1-1!9=79*ZOWXY)"7+/KKP3G5?SL66.!^',\,97F9:ZDB21S5%  "]VYH[
M0J[[Y*0V0]UU]3N.9OM=!,]'48ZH 2,7X.U,E.15>\FYIQ.B..^TGQ.O/J\B
MRY5\'/-*O<HF>+/+3EH6>. %-P:XUW 4^\M0N;6^5AUR;7QY[Y9A>X<D:-ST
MCG+1T^*VS.<RLL,Q\*W!DG:O%?]W7T16G2B[&$/<HC,L\#NL;TAY>KR_\#CZ
MO?G0BG9"#2Y00X_;6.-[QS0ZRPG;RZSL2UR6.-L22"=29-4Z3<L&\HK4O^/Z
M.2'#5UK57S.ZV#K?O&]YZ""@K,4 U5,!!-HU-2IHS4)58G AU$??W-1^2_*&
M[]9-]YA?08?G19F8&/=%-:2/FK+=K_%\"_K0&ZN79N_^"7,#VK84RH2V]&+9
MT!><HPKL"'=TNZA)1O(&SIY<\^"__BO-FPQG8FL-]@GD7<'725F0XE ]XY)?
M=EZ?X%#F2(SJM&W3 ^$N,(1:4G4"UF3--1*73+*]])#V"UJT6-OM[ XMS" M
M7BBA*M(HK)# '+W6A5L=H5Z'-)A1^HRAZ@;.UE]QF1QPF_%_"]W!F<BR,%^=
MT+ 50T.C22V42=&$96(\O/?<H/J6S)725,PB, U/N:C#K8A,H$*X-0G,;10&
M(+HI,)57ZF@H@JFW+/Q5'* FV"8IRPOSX;\E95;]E_G\W""M\YQ^2XIT;*_5
MI E#Q=8A%4JK=3"9J+3?/AM,^QT@Q.OJW4!:H0X44NRU)PTVDDKJ@NWA+N6U
M-S<^39R$&'[(])+=36/>3XEW-U-$FI=(-^:&&4C5N!)>&)[VW=V>9RHN7<W<
M -9YU59P)DB$$R<6AESO/[4P8M\0UAJ%(>E39FTPF;P/9*3O,R*&,T\;2MY(
MJZ&\@Q'R)HZ LYX8^/#;:5<]HWF>E+U/XWCM<Q)$-9D9.\A^$20\)!5)]4+L
MZ3;<!MC#M/0%E+6ZH[INZ6B8N0,05D%F%";HV9L6#$H$FEXU29G)D\/@UP&D
MK/^ZU"A[1F3G8VR5(0@W">[WF%\G[6IJ?^")8EZ6WAZ;%[4;,)TJE0D%FSV5
M$1E-J![[:S#'/B^K,KV!V%%[W@93RX>F(@6NJG7Z9T.DMSQ^Q'/F:4.%&VG5
MMW:U9%&/;LS#G'/,I9H<BQ;?3+EGD\\ZBFU"NEL/4UZ5;CS@M7N:RG'O)J$<
M5CG_$?'.J)^DP,FHAA?^+/'TC4+E]QP:XYOV8YCE%6HQQ+U5J,[\&6,]P='(
M'OD'#'P@.>%NR88G^W@LMO)L&'MH756X5M\6\T3%J6]OC,;[77:1%8:9VJ_=
M?E(2=3_)UW#.^LR.QBC&1@2DXWW#T,RE(%5YQ7[CX47303<<>.YE3GY!&PWC
MW![>8)AA83 9>XN3B@>3@*%)\D^X/$TZ#_,O&,K7>,.^I8M31CW2"&C'=1,4
MV$SU>1?#='VL:?KE2/,,EQ4DXJ@OZC9L_EU[8S9.(ZA5Z\/X%Q) %F3?%$9B
MV-"ILC>JQ9M8KYI[W*&U"[%B-6;KXJU9S3)XQLY%7+42WF4G[#-V;>9I0T$:
M:=6W' FRO92WD4W5''.I)L<"FB,6=.#K&3F0\ \8IN[V/Q#R4>.D\[*QJ5(A
M$FHC2PV-R2*IKWX:' P54%:H=T 4Z*]0AT=\((SWJW?,(A[C+)QJ2B"U8W<P
MK6SGF,^D/FZ:JF8&H_R8Y+B"58."<7/<8=!YU5 C54CXSY$H,*!O# 1J4:P0
MQX$DD)A^A=8X4!OF+D8J)P-WO9<]26:8@%Y1-F/&]YJCH2&?<>/^/A "50/R
MRR?*(%<-@SE9ME?G5=.H7X&$]Z"_+X,KU,* C#XMD+A%?[7&@=HP-XI4?CJ6
MM#D<>7&"$U2U+R_*8CG[K@.Y'*416# E#M0'LAS!G!^)$<E49&_,/7RQ2L81
MXJJN'JNJP=E3";_A5LSMT4SQK?I&OT7C[DX#&( (%5ZZ06L2?L;BDT%X.GR^
M0JY9MW"1  0U*5O *_2^.TLM#YG'/CCM6$6FSVQ8CV>X&3,]XJS)\=,>\BG0
M0J3:[7;37_]UQD6%'W"!]Z0>+LY^/\?9MV@ZNYI3]C[G2FA\6[L#!__)]56&
M#TF Z)6$^(.\Q!F]QK"+(:4>QBF"EKPX1+(NLK<DV9&<)RC1U!"CUJRU0XMJ
M2,UH@7%M$-#XL=(>N.6IA-D8#JJ#Q< LZB3@>UIDK$LI+V@CU?FI/HZ&7D[:
M]'C*;Y1VB/4M4AQ@VRW#)?F:\+Q16"!8[)F^^:'2/,&GR/\(TX$*>LTYP;Q)
MZXE!GW3(V:%#U_>9 ""Z1;B\*<)B2 ?G"=MQ6OQDX7B>B#1%>,^JB\M34O#)
M@3"()68BN:2+CQH#XV!"B#X7L'"?C0X@ZIRW_U":?2-YKCD%:+=D;?F5*88T
M^%=0_6"@Q;4\,Z\_;(/6W7 L+'.7;W%:PEF,QV)])BE?J6)=E\<Z[R16_063
M?.63#?N6OWD$VCG*7?7GWZ(_!3[P A3ZJ[DM:9[A(FI77"9:SR0FN/FT?G[<
MH/):.H5]37J=9O/)B?F'O.\1,JVK:0S5Y[5M\1V<'@N:T\/E \X)WO/":_22
MY/6EJW8B-GHW#]NG@C6(-_0T49O'07M&I7LLZ'JO[--A0P(< G1(PNO*_7RB
M\J  VJ 'M$4")2P9(X%3O_Q/4*98:[0UGV)4$G(A[]3Y>+DHR54D)VQF [3?
M-B[6I40E2.4N0.)3E3WVUEYQ-1@0J]J7GCQ22[8O:I6%WX* [02F7WGW'-9+
MH*77I,?5EC'202[RW>296J$"\VM]>YSA,LG13FQ;+G899G;4-)=BU(8B^#$K
MII,[4HC[_]TF"IQ1))G,HM5NK%W>L]XT98E'"\$X:=/R4)41[8#;4WE+/>KA
M'KL1&CC3XX#MP43_34)*2&DAEXW>L>"Q*7'V5'R ^BFES.E8S2U#FC9C*."Z
MY'S+-.#A&?FAR(Y8=6PQ(5J@#A5/#KJ8XPC&@T9=C42X>Y37 Q&SEGOR6=-;
MDD-M!KL4.43<Z ZDFUX8Y.S\!*^@G#(5@J/9W<Q!(NU=3<L(U6*99<@]>Y)T
M["#I.LOXTTD.:>MH4XN3I4.!N2\:)N&[:RQ!-@=<@]9>!HC/M4@GR:_XD>R
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M<53=F=,B7Q"*_X..*^89S!B6@]+H!Z;^]>AA*9=7*3&98I6'U\D6AIO";/*
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M9XV:U71Z!T0?&*H;FZP/N>CB>9XEHW0"24A3D:6I .7=L3O]3CI%Q:;[V]%
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M@4YT\-\HH$ @6 &"%>!DK0!ZV9,T$/1\04=O( #*[KY83$#+I<F-#@;H@R\
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M?'@I7XE:>_09QTB.N<E#AO(O[:P%E\)8H#PKE&.'I%HC"6M&#TVY^JC2C>_
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M+NN=%M88($#<J7<2=F.P@&')/=SOOU2 964SE<3%<]NDI@08H#_[L*(4)13
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M"PN;JF:D($E^[U0-KVI&"D.![]= J&I&BDV9E>FR#'(MHXE37!*MC*JJ9J1
M]/B.S;VJ9F03D3JG_?G'?=3ECNV8P?C>=)F>174;=0%,-SU0=H$SBDT+"S<>
M\[]Y%OQD]E86%"M*S#9%WQ<QSF5'5O18E/#6^R+2MYN4%>6N,P;WSJCU5=9E
M1:%K"12^+]*<T]"L:/+M-+D9Y%7A=^F6KCPF[DR'%SST4%P[=QJ&%17.;>5N
M'"&NQ\:M:'%9%N[&$6B![-N*:A=IW6X>I:[7MJVH<R&6[<:1Y;KLVG=+CYM
M6N\<M\X;S-C"XK0 Z;OIZD<=60NH\*RJX3819:5/1BUR:NC:D5O&U,VB)5*N
M&XGE2G0L3-KATM%6@&JQI>Q1*=[[B>)]6.EI2]7 ]_-KX(>+M:[F0W*EW[T;
M5%=ZX0I+ADI#%)4^^7Z17^FAFX7N NBOA87-(G-KRMF+MWCY-2OO EP6:IPW
MQV83"7)->38532XSUV83";5(^385]2XZYV8C*7;->3<5E2XL]V83R7-M^3?O
MF2XWA<0J'*_" BY/7E9QK=^59H25A0JKZI+-KRXI"RU6U24%MW8KJJVJ2XIK
MY5;46567%,FZ?:_TN FD]0YQ&WF.0.QM%+ 8,4-F<OC[6#X"/JK[U2_J;[S_
MA3*D9DO_>.U[8 ,"=P;CA\#TN&GAZ1$WD[QCCRS@H@?C/< T+#;)/+\;23<S
M]K1,XD%0YR0>_=*WEB;M2&EP9WI]@<\KQW.&T;"86.1!>!0O=>L8_TRM=Y$8
MTE*.=](<^]:TZ@R@FS_+!71]O84$>BPF?V=F,"4FHS X^GUN"9E"WFW@PQ+"
M\:T+J^IX-FHW(]SGR3B6C5>F%_5 PD38L">^H)A83CPM+^Y+2LGG=E=(FG@3
M+N_]7OAD!@77B/)C+[V?<N'K F1^R+XYCPSL5WABW^FZK,,Y"_G)^,K\EQ_0
M@'6AS7;MH0V0.',"9H6P<]]SP<Z P]]F0S/X4?# S1Q;54IOO@UO+L;CG=XQ
M\L<]^+^RX>C*WC1$/[_/PN-7VAO-AC1,%:I/X9H CI7?G'!P&O'0'[( S3M^
M.C ]C[E"&FM?"$)WQP\^W,HCN+S8F,ZSP<0ODF>G2S1,"#UY#).=17LLL@C#
M8@@ZM-CN'/[C9'S"/&N +) 0!=IN7L2NF01"UFW)H:X!-[E\X\GO63!.D-XD
M/-_ND7L&(4HWF4++0MY:<=U+7-=*N*Y=B>/"$48K/V$LV(&<31B5.*[$\>:+
MX_5QW2*TXX=!X$?] =@4+!@R"I84GB%>21DSM[J!)W5Y].,R$F ED2N^6YZ&
M7$:.* UI5#KR9A)@)9(KOBN6*E0QRRJ89=-4A8HN*[I\#_)2G5=3UU1$^GHB
MC2]Z'K@;*$RQ=3M2JO;QC'7#2X^'082;(:*[]!X90";@!_?,<_S@GEE1P.R;
MP.D[GNE><AZQ5N/,X98?>2% [Y$%(0;:;P-_Z'#N!^-K/RQXCL_TOJ7T6NCN
MET9#$GTY::BY&!IR*L(I(^&D$T^:"TT\:< )O*=_?%VB>UE2IY>: /_BVU>9
MN#V96H_(S:EFZ9<NH.9F\116Y#SQXE'8LK+4-XW"WA4EE1??+9I@M*]_E*F?
MM[ &'43\9*S_(DRXD)GVF*HQO[E6L1&??UO*<,_8W!)-=P)^'@J8N/2M&FR%
M]M6B7=,_)S"Y /WS4-JSZF.%U#7P\H1O;85NN)V$ G8J"E@?!>SDIX#%^;24
M-!?%+:83_--T(W8RCC_^"A W VLP_@;JC8C@QK]=>J,HY/1#L]B8S[>SQ*_Y
MS!:7)]876:^T )2V-A^EK7>&TO;FH[1=$I3.BLQ6,GC%,K@@P=#%DD(ENRM2
MJ&1^10J9TE-_Q#?'[#HNMD-+&A7 (ARO#]")?]Q\$GKI8'G-8J9A&S>YG@'A
MBH+SG6L5!<]_'E847 @*;E<4_-ICO*+@5WH.*MMR_?Z]]F*=096-N'[_7O%0
M6MEZA4'IK SWRGRKS+=7!(<+5-Y?F6^5^?9N*;@RW]ZK^;8I%)Q;BU"U%5A1
M4?3FM"54(3+ 6]'NHO2'=T:[JU8>*MI=HN;PSFAWU6K#QM.NLUA%89-I;[DN
MWV6UH*]<OFMS^18/I97+MY@HS3/*!4<01B$+^$44>$X8!4R_L-B(S3_@)<\N
MRX';=H7;XN!V2=&W:IS6&L9I+1B7\\C@;\SD;."[]N5P%/B/-""VX%97+E2J
MBY_9W^8)W0J9&\29G2CTAS[8\47W@LR%PJE=;1X75H@K!L?-=&*^9H9=P5$Y
MU]0Z==,R1Q&NWP\X,WFY&EI9J*&5ZT\25FT@#A)!<5!O-__XYH1.GUIZGH+>
M(0@"/F 7< ">\^.*V;!WKZAB'EMO36]!(?J9C2P-NQ+&.>4 XF!1V-U-L+O[
M.NS^06TP<-_W%O-,>+WH_R'_N/"!84Q>4"MX\:20ZY69(!,]X;+AMC3*V\U/
M>;N+I;P,N7**W3M9,,)N*]?F4#E5RB%1LA8?>TXV79:DC+A+SV:]-\U#IM.V
MF*A6*L2<FYPY$EG;:KDLO@K+A<+RDAPR;\=R&6:;+PK-I9IOOF!NKO!<!GZ>
MR\?#K('GNWX?V^ YK'<1^,,[?VRZX3B&A+"'3T_.;L@>/O4+WOMY?LO_+5 H
MEPRH:&,#:*, <@.4G2O[FS-TX%GV%<C-34/[C UN+K=7&-TT'B6=QC.'[#U)
MZ]Q[WEQ.KO!>ZC,9/:?-0^KTWHP_ @F<1!Q=B[QC_1DYW$%GMA#<4<!.3,[L
M,TR8]2F('7>L3CSW!+&;'HVH4%F*0]^COXM-#3,VKL3Z<]M_O0L_GK W"W[:
M(+Q)0"[+[ZNH(H??5U'-@CSYJZ#'.]9W>,@"9E>4^4;*E#-I9L*S(M#7$.AW
M+\@":<$+:PI-H\^#M"+3!9)I1:6+IM)-)%*GHLR*,I^U=":);4Y+)P++CBCM
M"GX8Q$@?,I,#*(^C,#BZ4O>J+]7?>.]LT7I0;[;JK8;^L3*9"D:TJS>9)"GD
MD:(3ERYGQ+WL7 2?."!:#$W7\N?/S<#SH_!^8 :,7_B!G.U^PL(GQKQFQ[-;
M#?$?2:PEF_S[(@0DB<X+A]=3[1JG A>HN<ER*=,LP<3@<E"FN9IIPAM-F14%
M5G0R#3<),P3?7G7$S@9'==*6@$[?SX&[(CJMSMV%T6E%CQ75S 3?7@*^YDYU
M##\#C^H<+@.EOI^#>%646IW$BZ/4BB(KNGG&D["3 +#=J [CYP!2G<:EH-7W
M<QROC%8W_#S&%(QZLZE_K*+*[SVJK$@A)SWJE[X]-P<XH=U\AISNX8F,=TZC
M8>2"Y'ADITGC^]N ]5@0,+L$U/92[LN\^UQ:.@PAY)7I,#,+/BK\%@._RRKD
MJO!;$/PNKF#+CN6S2O"M1/7Z43V14YM7CYR4ZTMHQEC115'H8KWSV0_@<<O&
MX-QGWL%BBUCA_UO9O=_^P<8\]#V6RTQR0OQ)F+S%)/T7VL2E=[M4JT@-:<@
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M]RJ)51%63 D+-).:B2DP.^+Y\ 3K&S\\^:?FR E-MY24DKV)Y2HXN37N!4=
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M7B 950*F$#.=UM9SO;E+"?^M/VY=TTO2\0<,?\+OBDT:^JI5%O[DVI=S*BC
M+4A)R(F'LK'NF_!3*'9="N;EE)3&3KUYJ'^LF'%>":I ET."3E[Z5E.\26'X
M@PRDM9KE19J^]B7IU1)PBS*S\N%A4R1H+OP45((N$/.S/)PEL92J@;<3R"HR
M2[[#B:_-!%DM\>2BM3EJYH=-:^&-.EN) 9Y1;U#U#7_[X52L.H.\$;S%UQDL
MF])24>DD9'OJ#T> #AJZ+5X9F!Z0W$U1FY.7FD)S[RX5YYX.M+^(M8WDD1>B
MW!6/5#Q2$!XID.J]9AYY>/(K'BD=C\18JWAD%3R"*985EY2/2Q*\;22?%,TF
MJ?BDXI/*+B%X=[/3K27 +_PHJ/BD('Q";YH+:=5A4C%)Q23K8Y(U>H&?[P8Q
M@?GOGA/RN_OODOXWL4 _'PND ?%VTBQV6X!"=86H"+0BT$D"+50EYZH(=*KJ
MD^ZZ\60YHE:'^&L4V"[CM["UX,$_8Q;=CSI71>HE*SQ]-8XWB_<<+7UD@N'4
M,+ '7\W;G)HX7Q)Z3\TV>V8[BT1MJF?$0DO65'%)A:TE82ME:2^GP+#"5N'J
M_YXIW:ZP5<Q:;H6MEP=UGO\<.3C&\IZ-0G6>MXN-N;RS.I_9VJ9B\<H<%U_G
MGA=_J4UM*N9NK- OA<4T+_:F-K:I&/R[Z45F@*2ZNUD8G-K8IF*P,PH<%^X\
MV"S\36RK--AKUUN-/[XQTL*\,#"M,#+=!Q8,"7D7?M!E)D906,%']2F\S=J*
M1-OL#2T/8PCB!6*,)EF<L6YX"<\*(G)?(:XNO4?&,<YV<,\\QP_NF14%S+X)
MG+[CF>XEYQ%K-<X<;N&<.@ 1#1+LNNPV\(<.YWXPOO9#Y90L296<0OLT/"3"
M%PJ5M\5*U]"N:"<] &-1TG[9U%=16?'/CC8*MG:SHH4RTH)$W@)H858F6T46
M92&+PB1Z36=#PJIMQXU"YY$1N)S08:!Q6VYD,_L"X(*)HU%(>:,WO7,S\$ 3
MY[<L$ &^<?8#GF^!553"6B(PWEV?U(S!I'O+)KA[6!Y\/(V&D6OB[RD69ST6
M!*F\O'=)AR*;;TY(+8TVYQMANK? UFL'A>FHH#6W.EALL\L=7> W6_7F/BD-
M ME(<R?C[Y[S9\3.&+<"AX01<5)RQ4T/CT1^Z87^5 SIC_NHRQG<[H7GC_ _
M<3AMXOMB<ULNB$B^R0>7U]NP<?9,-F"U])HL""^12^<X08C.%L2E,=EN!*6M
M'ZLI6S6%J#E%3>0Y DOW?T9PY%SX?AA#?<A,#GKW<10&1_S/7JB>H;Y7?^,S
MGL5\L][:F^TX_0W>._ CSNB*39)(+SA8LS:^"2(G39R(_$4Y4O9D6<N<M 0*
M%GFO[RWFF?!&04GRCPL_8);)*U)*>V S@2:\L=F06Q(%[;UIO'4LWK[?GX%:
MK33K&,M4BA,??WCU=31D@1GZP:04=+B_TVKN'\&3GA.$4_?CEV?,\X>.E_78
M<!!Y-@ML?\B.'(#X<\]./>93>@<OR6+2(W?1ER7TR(J5W@<KI?0_B?\\^M_>
MPLJNE.0F/U5%;IM-;FG)O4@;>"\ENRIB>@?$E))=>W/)KL5Z/YO-Q/O2S-M\
MX!2#$RP8P3K'<2=EP!V/7&2$33)T5E=$G074Q*>3 NTFF%*3WIN\-:F23I<8
M<)J=Q7;^9P3[H=^1K&R5_E5L$GXIB>WY76U@S&<NG&NN4U6IL!EH?W%CY<7\
MET_.SZ. <1_VQ3@0 OX]8*9-JP>[\MCX#\/X@A_@7^.__K.YU_B,WZ1_^S(R
M>#AV 7,]>'"]9PX==WQD_->?D1]^?@"(<^.:/1EW_M#TQ)>?#;J2._]F1T:S
M,0KE%X^@30!@CPP/"SS=S\;0#/J.=V3@)5O'8@%?/HW@W2M[Z1?3& 2L]\O6
M?P();+WYI5O'#V;798;?,U"+ V+@7SZ9QW)3@T"]8,"0#H^,]NCG9\/R73\X
M,OZS0?_Y;'1-ZT<_@(/0KD_^].38X0!?U?@K7.<'@$O<F<>2?;5'H='8^I3]
MON;BW]> _]/>N1K$&4CA==-U^O %Z*F@,N2BH(D5?$Y>36].O5B^5WN3?)%<
MB"2@[O'WZ\N'\S/C_J'S<'[_Y5-W7>NX/S_]?G?Y<'E^;W2NSXSS_SG]M7/]
M]=PXO;FZNKR_O[RYQL6M?%F_F7S@>/W0]VK&V?;IMM%J[.X<OK24OTVLY6]Y
M%I-Z]9NP</#J[5[<W%T97T#4 IN0L]"Q#,_$D\]FSM&9;U$V%.J:6X84U7<H
M@&8<REO"Q_+SL=[<:QXVMX[A@G^0*$^>?UQP8.:@G7]%'([Z\10T/UR9P0_C
MQF,?5\%8LU;Q(CK%L/<[-O*#<,N@!@8A8@W>S:RCKN^[7=-U_;#K_WP%UEL(
M_\/]G;W/DX@'1K_^WOEFW)W?WMP]&+??[^Z_=ZX?C(<; Z3! ["\T6P;-W=&
M<_>#_=&XN3 >?CTW-$$1"XG.Z0/^W#QL[Y2?FK)8\\(/C'# C)[#+=,UQLP,
M#-"DF&WD0? MZ5CG0O-*8?C(AF_JH$2& [RM;IOC.CZ\SKQ7H+J]=1R7CQKM
M1LW "S>/W;,0Y <K9NS"2A/LT\8=3&E9ED39D1)E9UJB/-QUKN\O27144B6W
M5 ECE!G"'#-Z@3\4*_I#_<<(?2/^XX_- P8:TPY' QRD+%A!7D1B;":]GY.M
M? &77M.5KR#D770<-.OM@];AX;287)\X <M9O3;35 'S6EG>7YQAWS!=X&[T
M2/S1;/QP_;Z__:]1'^S1P,KX^A/<IJST^-^U;#,D:]=BKCLR;1NT_%^V $'X
M-Q^9EOI[3HNP9M#7-8,#&GL9]J&T2O?0*!5KJ[NL!Z9B2_LF$!8O?@52%^2D
M/89_@D4O!I]MJX<*"[G>]</0'Y*U;7#?=6PCZ'<_P&&.___QLT$9O*"$**H8
M.K;ML@EK>W$+-.8WRE]$0;:)GD'JD_Z6[C%0\]59S;B\/MV.SX0OGT)T8(7!
M\7\L&T?O&/@?SG^:5FA@7 4]5'>L[W \N$+#Y,;]B%GD^38<SW!";IP.S  >
M\G$*09\D,WTB[E^S[!$L%XN=.<70"VL4-'&P^]?/NI@QH]#_G)(R](TN968+
M!2$/4#(H)]L$04IZ%*]N'6SO_'4V%2W%7_/"<7WI67X 6BD5-5#XF&)VP?C4
MM]FTILKQBE'@/^)S7F42[6T=7X,2/#!.S0" YYE3*NN$&)G)ZRG0[FVW_ZJ1
M5/K&#</9@_GS4@93+,+;J_6M_:WCG?UZ>Z>YL[N_]Q(BE#S/BQ+)1BL#'%&O
M 1K\#:CP@?'W*'"X[5BDQ?L]L9$5+27%5;2DH&]ZSK_I[[EI6P(RF[8G;@S]
MT9K ?[E]MWV_;<A"NV"U\$ZQ@W'M;[^=;G.!>VDW9BUZ,?HHO2P[XO*RZ.G8
M=L XE_]\<SS6?(78.=@Z;C4;3>,WT4&6<J",$_?1WJX9]Y$#7-R9%$:UE^Q.
MN:13^'@3//A/KSF;#L'H!37)!0"SURZ I-!-< MGI.-9\T<%6HT&G)"GV4["
M!='B6\[#58N5W#1YZX-RXOX?9R0TE[G!W@2B/&CMMV>Z9\MQ"DIHH$5P&P %
M.B/3-<Y_,HO*4HV;'DA)QI=Z!JUU_T  !E+ :^V<<OKJD$O ./)27BJ;65(%
M.3*H; '4;3@'MF8S%$K/3L#,5[)0:^MXOS$5WZC/?-TW'XCF=N![K_48MAIM
MT&!W=N'KO<8TXR)$7@RO+!X9B27^7_]YT&KN?^;& W/9"#=JB)W6#% 1W0B-
M6P,!GI#LY@1,9CC8 3GDLZ@9\@\EL4S/5E]=B*C>[\P$2#D]=%YX?68;]WBD
M&M],'AHBEK+:U2=%_49 .&8!+&H4!3Q"MTOH&W %::#-UH?N1Y3!&$WH6.'1
M"L,#*_.DD'/M#:Z4F:9+<W][?Z4V-PU[0G0QTQH8%F89YCDAU[GBP"3A<3\>
M=GWW _\XYWH/A+]D9>M57DH",/MI$4,;P"E/ P>^2=AI/E5K?>;NS$--"HEQ
ML]4ELLIUJ"7E+C+%E7)8)Y-U97)NZ@#<V3JVZ(K,>%EAO04SP2<)6]#UDF&W
MNW7\^^G)V89 3A'>N>0N9+EI#R[RWAS.V]<#%QV]O]^?3^<XT;^F]P*CSVFC
M%A@?BQ($<_=92J%C?^OXX*^&>(;1,9*G&-ICC/@Y!CTH%V>4'U,+E3EO0].!
M$$FC*0?8AH)^U4+K;=@YG%>F;;3382YSJ+\N<ZB0'IAKWV-K\T]\B,T=LG0^
MKAL9"ZDGT0,:RMV1463B>!@J.C+:>S)09V/0",SEL6$-F/4#;_F!+@>DU"!)
MJ7"X81I/8#C7?WC^$V"9F=SW3!=^X!'Z<TQNV*P'Z*6,B[L( +S3V%4TK[$*
MD/^V\3M\D"F; C[3__M2O.$W6,P_<"WWM!1F4Z/55_C0FAAP\*=D6IRC7A''
MR\0A]N'YH?@0L#\C!X4AR$#*G0S(6\6SA6,;J23^BY)P$U&Y$%KYI^]&7F@&
ME)T9\%?02+.BD7EHY&G * EA@E ^-#\: Y 42!.V8;IN3!@ZQ729O ">J1-)
MD"8.3:8H[0D)!G_&#&W#CG!\!UTZ"IC%R%_4;!E4W,"-#_ \T+,,'ED#@P]\
MS Y3V<[AP PGU_YDIE=)=$TWRSU\K)$+]T-+[+$+VAK\WOT7[ "OITOA)ER%
M? YJ:)P608M$M^YAP[#-,=]^B:)/(U#4O%!X@5%WIV&HKR#L%BC<& _+INR9
M#'?M&W'*?47\N8@?B0+H8>B$(5 0<X$N M]#\\0=&PR4\+%QB<J*:9%9>F:&
MIG$AA&>*-Y)GZ-)4/W'O6)^T>^";^_J#\0&!N/_9:+5;V_&9# <Z\,P(4R*7
MS2EBP3$#,/[Q1?+6 (%PD-3^"O)NEXB\,<N>--)?MFZ_GOPC#DRD<GE3&>)$
MF>D,\0:6;<M\_.1I%P]W6RG-?"*S5GO%5EPLKVX?].J!_R2^G_P!8RG&[=?K
M[U=;5'>?%-[KE??J4_(A*>:^[7P]KY_<G7?^4>]</)S?'<&Y\ 0B<+)".P4%
M50'>FJL"G&JZ)R#SZUDV9!# ;X7+P\WI-\?[$3_?=OC(-4%D.1X:0O6N"W9V
M6OC0:R4HGZGF?Y+[=SPX %& "<+#*R:_C&5=^NN%I(-GM@=X ??/EW@84SSU
M8O[XS$IZA.5&G2!DA+GP3&:8%E 8MFX$$8LR%2TP+_-;9)]ZQ@\<E@T?I/:"
M$M_RAV"0CVNH:<'#0#W!U?<-X*6G<*!^W@;%B]'*R-ZC*C%*M\%@?ZOQ>=;Z
MZ.?F9W79BQ?,7I^Z$+4M>?&,M:HKE47:;'7K+:4_ZDKC]B;&I]^8Z?]<5E/S
M8/MPL?'3%+R^9=/0W%E;S=;VWC/+7 1B$R5AKH4M%WZ=,D)N[9F%^3SV29EG
M< H [OO!.,-A3Q<1Z"UYT2NJ15K-'7*53HOOUX1LYP#>@M"[-S]C+!>I][/.
ME->N\P4JH?>=1!R4/<X77??>:N[.[*11LLS_):'[/%LK6!*RU=N^TLM.Q;L6
MC_2]F<T."EC56#A]N_>,9EL#/3&GQQM].>3! 8'L^>2 P1H.O K>*AJQ9#11
M ,4:W^6.\>5/#KP:7FMX  (?A=*CPTG >Z9G@:6&"A 6(^+%V(W8-@.;&UA]
MZ-BS HWM#^;'3 5WH]QU+^ YDSA>XZZ3?FIY7F"Z'MH<9A@R+L9@(>RQNABV
M8/;)GQNG/)N<@]#'KQ0^6*_'R*7ER0(%O--!!PP&TE 0!+YK^"")-!I(CBH*
MH,:8WFGL:"FV]V;0->&Q]9N?+AN3&_Q#<]?XOGV_?6KLM_8P'?<C[CO9I Q6
M=UW'$EC3J*WG!$/AVAO!^TV\$@B40GTVK=J,;">4:WO&F7=I]8(.7NH'G01H
M%Z[97[Q<W']&+FX R;]:WO$D3 *(G#=Q>Z9,U+DFH5:N$D^X>H;NOO#$*#DT
MQ\5M,AC2<RE& E]9?A P5;)*HCH(,#SB(R$^.G[$W;&BPZRW/D.+JAW1A>/=
MA\/P'!]\&K]N.31Y4-'DW#XO/!&)=GPX4 7Z$ZI0-*S1&8FI.-R LMKR*9@"
M(MD=<T=(6@\]W2!ZZUT3SU@\A9G'A0S'D ?\1/'&^.TZY<8RG<5U9#[5D05<
MCYT$H!$\(J''2Y#GOLYH*A:ST]AN-L[J36"WS3J;5^8(Y0/TL4O=S?B0D8"2
M<O>!,/LHD@E>,MKPN4M3WP]G]RI30:=WG5 @NA@@PLQ^'U".?R$IL-!X--V(
M*70^^J2IH#Z&#F[YIR@%,!BU/S< D<34Y 'OX7$#3^-$,E$H^)U2'AE650%O
MB@ H\#6H>+(P0QQ*^D,QNLE]UR8W.:T36!V4/Z/KV$(]Y#_P<,7GD.RAN&?J
M&90M)??A8M2_*UT$&/M_1OP,?4["!> %QR!9$@SW 73I>[;J!8FC\>" WS;^
M(@G]@B*I\/9)2K\E[>_"]<UPR\![&?F;<2H3$?3W^[,M8"K+ 7SR7[8NKR_2
MO2*]:%BW?4KSPTO2W"#'Z=$X\A0+M!I;QZW:0;M5:^S$18MJC>DDPLG(7D*[
ME#H(6[HR X!NNRE:2Z[2C;^J>N;;VV^7IYV3;^?&S?6WW[%KX>G-W>W-7>?A
MW+B\O_]^?G=?N,+)(APDR$.R91\R(0Y2 Z:+0K*D45:H:BS);R*1,>8U"N4*
M!I:\RS$K.LVZ:-( IR/I6A35P>ZIL0XZD^^TRA$:\,9ODF5E,J(8 _=65L3)
MFWMI5FQN'>_6=MN'M6;2ES5FQ1AH:1"0"B9U<)1W.DP%<,Y 1!'@FWL;RY=?
MNL=G-Z??K\ZO'^ZQ^YOBR3/CY'?C[OSB_.[\^O2\_&U",R7 +9PPQN7E99Q*
M)!TD3MSW!]Z8.EU!5PY-T,O(F2$#QC-..156?L1R'/_GV(BK&<B!YH0RVQ0G
MQ(E/HE^U<<58*!F;&&8 IS2JZ,E)KJF0ED@I<E'E!^YU1K3F)P=4RCC_D#QT
MY%XY/S5$(Z,N@S4PX^\FO!$4_-8!$?CNLP2^;!&\DL$(SPYB6,+@ASR#&%;1
M]K1*R*H2LJJ$K,4G9"6,-L?T'H'8-:WSF9<OIYS*)%6-2"W$BB7Y69(@7 .X
M?1"6P048!=</J(LD&L?,U2Y6Z<#7%+#EAF!8$06ESP8&PL4G8XX&NI-M->=^
MPD'CK4]HOO4!NZMNX'EK]EFZ;YA$ 06G-QX=BVE4N'*L88'3N\59'F1,/> 9
MV("B@SZJ7[9VMG*^XG#!&8$O(3Q69G \:3->)7JYZW K>@&.V,^!TW445W?N
M'HRFH!&SHI/%T,D\L%D*;63/=8F)HQMGKSU/'Y</YU=&<SN+,N;&8)'WJ;+Y
MWKK315!:2FDE[4=L25H]H"T*0W!JC\<[8O6;0*!W#O]Q 3CR@YPTVBDOD<ZQ
M5[S4D->6D5;UK1XW&YM#KY&'4VS=1V;G(]>3\I)K_JU^CZ]$;V\/_1=#D=!3
M0M+5MGW<W%\.Y29 =D(V;%KY:.ET>V(U<Y/1O.\]'7=9(%/0QJ]_^3K0*#>X
M-!2N@R-MQJW &6$(9A3XHUQ4TRJO )ISN[=P#6Z%E5+L3&[VN'FP.83KLK[I
MPK9R46R[O!2;=Y_?\#J,CUJ,VC64DF+CS6X4J0[1QC)[+!SG(M:=\A)K_IU>
MP97&/5UJG#G<<GT>@9*T;920:K5=+XUNR^\%RX3J!CM06WD=J)>7E0=UV;13
M]","38O=7*?#;GE/AUR;O!*IW9C8E8P-X8;(D#3.9;KT'7.I]IU2)D5:EW&%
M97B!&)LA6C\:MU%@#4R9M2GNU;K$E5%#$C \;AYNCGJ$6]K+1?M[Y:;]%S?Y
M?^\89\$CL_]?22ES;[,H<VB;N>AR_\UJZQI5]I?W>!77,O^-D[(><>[(TN>.
M5E-W$==?GOJ>+0K=\1J@ZL@5!: W(R;:/Y=1]B*HCEL;%'GX\\]\(8?]$D?(
M<NSQO[$4TPG%\ <D6/C"57]KQJG1Z?I1:$@-!>-11:#BV3/8)^'Z^F8*^7D$
MP7W<VEVB-;,.(NKEBR0?E)=-7MYA(MWODUIKY);[:#1RZ6\L@,#NK(7PXA2+
M+P"^F\<6HIM,/MXX+"]OY-RFF,F(#5R(+>#@,/L!DXQ"E4,=T5"%#%K0C3I)
M?Q4:]1@S6'+F5 ?,)",I9&P@-_G4[R<G.Y58)<N[T5-Y'7$'1;;LPL0("L84
M"J*;QQ4^MOMPO)Y_V,W'&"5.CYICKS?4!>72$R7?!3&HB\44.C2/6WM+Y LM
MOR0^N;%3";P]GX%]N,@\K/G7D.@;Z',W ZK<O_ #!J\S_AX%#K<=V6V)FBO=
M!NP1JZ\O/3Z2;9C>L/ZUI,9,PR@FD2K\]MY#M^W\H=LJ=OON8[>V@[WH<E<;
M-,JKG^3>Z9FZL&:<QQWR;E2'/%3G3U5;$.,K=L9#R[<R=C..*07PX];^ABGV
MV#H1.Y;EXYH2%Y+EW6C"*:=:,\J**2:9(H;GYO&$JHOPG[Q\;%'B5/PY]JIF
M8ALW3QX<( -G1!U-9 >I$^8Q.%G0<2I^IP,F"5K+&+1,&$KZ0*F$H<J?-,5B
M.FXVC\MDZ[& B9&(.?6V$M<0S+MAQ5EWZ@;@.)YBHP<<92"Z O*:#'<(5<6X
M]&PVPH$'J-%5K#7EJIW$Q>;QURAP/.R?Y^9CK!+7.^3>Z:VZ4 _Z73 F(^@L
M>,3FP)6N-\DM"8"7RR:5FZ5L/KJ=W#ZZ?U8NNO?NHI-4D5/3*W&)1=Z-GLOK
MI"_.HVYDI-EEI'D9]]: V9%;'5!9S@@)\./6P8:I<3P:PB_Y:E:;)2[-F#]>
M>@&O (JJ_\.X%S"J^&+*@R")9WZVB/60UI81^$_B<S.O3K)&=H%KS! 3E%YT
M9UU^O>X\?+\[OZ_(9I)L$B >MYLO4,Z73TDWUR_Q7$O\8[7-P=/-;W-V+UY=
M%\^;AU_/[XS;\[N'R^OS:U"(KR]N[JXZ#Y<WUWIOX-6T!EX1:O1!(.V=D>@H
MY>) '3&_AT9A&)0A].1P%L^TXS6<,.7A[$XYE2Z>95"C6P' 0_$0.6C^=&(&
MO?S:ZMI79S7UUQ.;_#WB\8]^%.@#[+D#(#$#^28:F("CB.0#+SUKNV:8QC6L
M:&"<F@$H;IYIJ"D+6'*%*6$L<,?&#\]_\G "QS?VR%SC)(#'\_@1-*@C,'C4
MY8[M ' ! Z<G9^B_ WC2G]^^G6:\RX4%HJ;H.F;7<=$MKT9N3;^95BV>(X8N
M/+%D2_"[ N+)V:6$0<VX-9]P(;GV^MQ#Y7-TV(KE/ #6S1&+0#+.O\?GWJ@_
M6'_M+3V5&5]=OVNZ-7SGFU^YE7[HUC: R\ &VPB7FK$E9S_A +(M<2-7$ZW&
M#,A+C*2]9Z-03&9I-VAP15M0AMQ0\I =M9_\CU)#7C9?M/R&$\D<CWSF"7TR
M0!GP5BB&AST];0/U#>UMP.HVDJ#A),F;))%,&E6'4T6B(.LADF%QL7Z$(\?(
M2ALR8%YCY)HA/DV,0\0!Q.@CF9C& F?!=DKBK_A\>G&^AF$L=L+&Y//FGK%A
MS)XF,?63-F?CN7=D*U&S=*XMI=.UE/833SW0/^L?USBW8Q+><T[NF!O:;YS>
M891Y?D<.6GB)FY<U(6.9 GF&CGO:^8[Z;.?N=^/^H?-PCE.XC+OSKYV[L\OK
MKP8HO+_!Q_JWFYM_X-_O5 5^T"9SR1.'H]+V9 9VW?7]'W*P?*@5K<G1S$-F
M>FJ4EIS'W-KOQ-/&DY'2.&D<OFT>MMLT&L\<"O7@ UZWE;YPZZ,,?\D'-L\S
M'J@/K9=/WLEXLG[9UD<Z84&O?V9S<DRP2Z,!?:,7H=EI4&([Q\%>>-;*+Y/!
MTB,6T*&-$\QPZ8[WB'U=E<(+WT2>^!PX_ <P4N3)@*^8MXUG.%5N]$0G8[&*
MH0G*G@DV![T4?HEHSCMU3:@!:X'V3MT3,.#^2/UO]'7X>,O @:ODQGS#=GJH
M*8)R 7QLNJ"1]P)_2+.,Y99>_73V<P3W<CD ?CAR'3$W-7P!WMO&;W#H<#'\
MU(07=Z.0%!6E]X9^;!%UF8LOG+29X-5 *9/?)M/:IJX'GAAF?.^@)+4GOX63
MPYO\+@1V8@"EB:]=YP=SITP^TQE.?H73XZ:^\R-WZN56ZDO=#)3P%B/R F,T
M"*B?D8-\#1S_/,29,3"!.L6(ZY<P9+BX6Z 5I8**@7B& +LIIVWC6-D4J] W
M,8.$<(LMR1HL%HE)HG 3:!)9&/DJOMY2G4)JBB21%'W5)J263,+%3E AZX\G
M7N@Q9L-6+V9O2TZ9%Q2GU&.=ZK1K3>SP<+1^23UQ8KQVG%)*LTL-1VV >B?4
M('TDTI<PF.4Y#/U1K#=I#D;Y!CEK=3IF..O*UZHDDQI)CK/W<&__\/.4&W%J
M87),U,H6IH2S."E )))!%ZHID\@FF!EOXOQ)R0,U2<N Y:.)#25N4<TKJCM%
M)0TMA' 6IM_FL>3F)],%JM^SB&6_-66ZO>D]>1EG@:\L* >69(<ON360?4';
M!AV/YK>[/LZ.!LW*1R,.N=YU_HP<6[CY4$?$/$H\RU!]"TST22MG'IZ2YL@)
M\71%/57Z@>*#46KHXE1.'+O*BXB^8Q\3SB)&6K/1]_& E&^=1(L>7JFXK-@T
M6'&9KJ9*'G'^+3RJI.#Q24X8FC^8TB0=2Q@W5L!$YR\+.)([H5*US9 "M\"5
M3VCG,61F7O%+Q2_%W>%+_#);U=1X)& CL-; #@*[R*-6 -=P:E647U%^@7>8
MYZ0(F.N03XL. FKB"+K3#S8V;*=/^A6Z$#WF5K1>T7J!=YB'UC5Y3GH-NKW@
MG19<[P^I1C($4V 4^#U'. 90)<I']A6%YWJE)+P5TMP$WKL!GMV(=4I]P9IR
MU\6O;(=1JT[X'##X0P8-A$C\7$F]2NH5<8=SG? ^I>X%-J7!C$&X/<7!,(-C
MOUI'U8G#:B(,QF'Z-Z?02W7V5UQ0V!V^A0OP")"_Q':?8@;C$9> .;#H/ &]
MH!^80V*0$,.H<&K =Z&/R?G;5>AAG2)@\9I*)0(6+@)>".X%K!^Y)@4'F/?H
M!+Y'=78X]"A+.8NC?AE)$R)56H\+5GQ9'<T57V;OL,=L#*D;KOF$7&D\81HI
M_'MQUJD9%P^GLI?)><? )*%@%#"1^((Q//;3$2>AY%[XNC*6*EI\]0XI[8CH
MS?4M19,CD2V(9$:N>*(T$/19Q\('F4N'U4M4L@,/&;#A2&15A@/FP'$";W^D
M23:\(M:*6 NYPY=L&LOGPD,54;;RE!TCA+D@>:EP@;@&E2A@E/CH.J'3%_*Z
MLN\K7GCS#D<^YPYISLG$%R0]2N#N98IJ):E!6=^>7T.O$C]+GOCYDH1[P5Q$
MXO+UUI?DN8E+)#3S;W8$IP 4]KS4*PH1O5RP6!ZZ2@Y$/#=[IN,FBB46JTZ>
MI")0)),%*7$0?A\G1*A^PS-5V$*4(V)B88>LW+G^_?[<Z QA"Y;YANS"%X[(
MHA!+:2G#? 1B4,%"0!V/L#L['E9)9FJ%O:)B#QG-9J)9BFC!2LXQH06/J$0?
MVZ]R=58<_!5[3%+5G7$:#<E[07W&/<(>G@"W=%>@9JJ_]B"IG(F5';"^# B-
M)Y^M5%[D.^?E19WI7DBLW""=[>T$,I7JXGA:L@NFK-K.(Y9%VEQ5,"J9)Q;Y
MG+03?H'JH"O:06<[;D3^]VCD"R/;X3P2P6U06K"9/S$6**I#N( C,HT(B#IP
MQU2N/IG%7#.>S"# ":PUPQ\E-:VBZ%P=D;,I9?[@]YH:J:RM=/7*Y[+Q#)4;
MRSIWK+O%JG3'BMR0&!9](U:(]1<1YAZZHK 7K^LSC^H>QT:7C7U9SB1'7&X;
MO_L1(![KI?$[[N D!\2>B=X^?#$:/"B1K<#IBBY><)TG>PQ(,^>YNNFD)K^+
MA<LV,P8@PAUOV[AC\)?<C&428<(+,!Z+&W)-H$J@O8A-9&"\4':-VP[DD]7&
MX V]""$0L$<'T*5U\<$-864+UI$%#,OUD_"PLO=BL"=]A=0>SG]:;"1"S51B
MZHER,+_K2A^I;"! /3%9DC6E=RLB!J.77<AX6N*,(&]L#6N_Z:H0"VX\7WN^
M,#]==,T:HPB^M@CU8JM<+>!Y%-5DG0*"(^G8D'Q'#A-+5 8)41%Y29\ 6][S
M0G^JY?-HU>PHN]E16[ZS:G94-3MZ1;.CN=N:K:<1T@(,VXSW2]:CKDB <<?^
M90NS_YI;1NB$N 3YER2%+>J,3XWRFQO;"DD'ABJ;CN&1?)$"B6AKO6V<G=^?
MWEW>8JLHX^;"./E^?WE]?G__,JQ6<WS,%K[2G'.&?9"$X2];8ZMK_]%L_'#]
MOK_]KU$?)$!@97S]Z7C]70!72!8W9))3H\T-IW_G^ LVTTZ1C,TLV4KU2)I-
M#AZ26\=?A0[^Y1/> E"!FPM \7/+T5DJR%33:IV!U$I20I:Z?*HF7Z(_$2,]
M4[A]3*&L6W[?@W?9U$GW@V5ZZ*.P'=_]:'2I_:YL04M=845_6CT-#37RSL/=
M3^.;V>7B#CP.>Y%GR4X0PX@/ M\?BNY.JKV2:K>$A@E@6.8#C>$P0K,"4[?M
M")U!]%Y0'$(PC:)0KP6B/'#-( G]$?HZY*VH<4O+29W[ $<K(D\+IAR)/"-F
MQ]?K.:N!;]H&30H/HB%M.;Y*M)."S6?^O&T@=PX=:G\%EC]J^''C*[H5L$<)
M4LD3:9F>_\C<FE[SI ?C\4Y0-*A/E0]VU$"8:M1+0)3'82.NYOYG'G?@^3,R
M5:3$=7H,6_*B!PXKK/#I#-XM^U698+(PZLM!YJQE8?.N),XR $4K?AI>P:@K
M%GKCXRV@^>.ZA& .J[+0V"1"\GS'UJ.](O=7M =&U,M6\X &:O<&"F_]Z]6-
M0!!HLD"\V![:Q#:Q,F7ANT=IQ#3J0X+;\0!Z(CXP@3D);0,HQP4BQUXB%@ 7
MZ02(GX>P)C(TX6UR)0+,-66&QDL^/?DJ)H^<7-<D+!FF-",O23,6NYXIXRUD
M\+3!V [\&!"N\>'AU]./V\8U;!(^(778K$>F+C 2,(;_1,^A_G:4EL%"Z0/
M []O/)IJY FGN!=6/\"B3'=,7CYCR,*!;TN@I&F4<D29&YK&88(UN4< "@H7
M)M"M(TY64P0C) ^Y:]4VF,S;(5*:.<3Q8.3(P&T19_?P!ZT9H^QMP44!,W[3
M:C0/C O ++8_%.V%28X($?)DHED.0F0@4L9E92#V'4[6EZ(_40M(K=$"0HED
M*Z\^XF-KX)N"9#7!I 1)+*#BG)=O<$',4%>FQVHX_=D>6RP>*L@'3JI_-2Y!
M=D%F4G"22\%TN1\+WU0;;PQ6FR/J2X?PD"=ZPL?2S2'Z>*B^< +S%I-M( DV
MY%I1F;Y:M[M$$";LAR1J!I:(F]M(:/Y(3!P5K131'8*.EC!9J6%BO8VE==-+
M]_$6"!_X$3;YXR"+5-C 8T\@R04L"M%8>U7'+K*?.#3C\W#BD*'&F@:Z=6,1
M6^\')K;\ RDR=(!C 3= F[8ICXV$;/7C)N5)@X\TA^*ST8^&0P<_R#,1/@&I
M<9R']-FP@95^P!'U4]43HB>/(A+B%V P+ALZNHR-:O+8I$0+TQT2D8%LV!80
M3_=P?Y+M&Y60E7T<+==TAERV']4.>N$B@\.GGV1RH"T0:&Z]0#MH\.B!QUKC
M#')*F9?/>W&>(X.UZ;MS6DJQ.T<Z]6.C"0BOT=2LI>3OE)FT>H,)N4(ID,_Q
MA4&R!7Y[9.C(]>@M]5AORE388MJ'@WO GLC;*BA?OQJ/N;%.<UQ7R>#<5,N+
M[R%B)BNC[WM"3E]+Y=GH>,X09XZ9/3PY3^$,M!PW%M^!T_<#;'IOP@K%0.<A
M8Z',<?]OJ4[=,_1$RX2D[;G,Y"Q746ZBF<TTKQ*56U-$V&CI)"C_T@EPB<N(
M(6,L^W72N;>\PV:FSTQQF&"K"<5)GNO *D)O).74Q\-XAF4FHEL^QJ(I0A6)
M?ALBF8Y,+-23:,P1Q56480+'O0QV]JBU\C#RJ!LSG1@U[%&#E;B/&(X"LAB@
M5MU'6^Q1%)$,?1_,&IJ%KH4VU@W0M"#6A6R*P-LI F]G$/BZ:/U%W_&*U" Y
M_R=V&@#&B5 34YHBK-*TIW;/(#'[HLJ;U3% SM"4E.-$4*AKI>':!?)7SESL
MUAP_T8_[):!E0 7A<*='I)TX,%+&#Y@9UH\ZW%0?^@$0O8'5=&#U!%D*[+(T
MCBK&EAUCVZEB;%6,K1HH,L-=[AS?,60PXRRQZKGP@F^J!SS'87YE>F:?-)A8
M,P<;$F2[9EQ23M; =]'O_&BZD;!AQ2ZZC'E&^.3#"ES[R/C@? 3MRH6[ M"H
MN%!EF!F@-XS'YQ<I3EW'B^NP,6UKZ/Q;I'<%L36+B1_P7,>O&8&T*I*+L(00
M#97(2IHDHT=4>'$>F1<QLM)KL"A8%:?!%KUQ?+OLOQP_87,\,#G0?A:1OU ;
M!H>NB:06).ZKB^XJ_L38B!I,R^*XV)6G8T"Z2NJA[[M,)'@EBH6DJ9I!;D_R
MDPKOI4(']C13=JWG^V& YFFV+AY'4[:-WW%6'3KTQ=0ZV )@&?1T>/_73N=6
M#9V =V"W;DFQ8W38!?Y/&B3BCL6W?VD>;K?$1T"$2\Z:Q'R&IYI.0'Y ?! N
M\B_-]G;+D->B[:Q-YZN)!ZFVW>2TQ^68-F( %G=^\G!YUL$9*W_1GK(]Y2L*
M, HAYGP P?*!,C[LB1?2@G:V#U,;H*"#OE/C+XWM_?0E]A0=Z-LV#<R!IAY"
M7@CWNV0C"7>VNA67QAG._ "IX/;(@DJ>]AZ92H/(GQ$HU-*L3+,:,(H9AFPX
MDCYJ2^2GII-6DT15D04KRK>2K-A$GJ9$M"_&']$PI532]&3FJY[DKMR5W]U0
MD@M1(" <'3RD8< S*2E0^'D"1CTH;7H?IT;W8BM$<^I\H#1.7 @RCQ#23Q3\
M N5,$K:^=G0! 0RWC=](1CRA_2/2,7E$<3>10MD7CB*Q5?%FR2\6TV.6%-"
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M7UJ-1@WL;0EKQ4@V"&L+\.37E0<S1I<FWB2LMX72_-N$3M@S*0%>!%YMS#Z
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M3#<'2QX=<[<O\*M&^3U1" &3,S#.@:2'J0X_+2;[)%V<P1*_XA"9-$/>4N8
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MQP,(E28J_]*V1Z/ 3=F5@B [1&@1<+L 1RR4I1FE<IP&,EP*//!<OQO*<93
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MC+\#?E%W:F(F5:/5E!; 60?VSW%.+_KM 9U(1)%+C@LSB%%PKKPA2BTSC3.
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M&8K\MA)GBSX0MDJT)HD&[\2WD9'%(DJ97KODAN.:U)XPJUU'VX-O2IV$0HZ
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M\;&2-/C]S$5&Y$]765UGHF!F\WH(#&[_<Q+@R#O?'QFK;'T$($WF)9?SE8T
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MMLE, E/7(X! BM:8&H\AG^Y.U;PR)_QO\"U#ID FG)TS-:74+= V^AAE2 7
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M3$;COJD<@S$I8)G$W(,T*:N+<M2 HE9. >=_)2NAP5EG'!!7CP;,O8A@2X0
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MHJKS_[H^S-T':@\1%@(:0!ISD*OZE9RFDL9"R78@3!RN9.\[>C'UI+:CU'@
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MVUXX+^UWR?]!.:#L/@]-CS>TB!YD6E'"R@[JZH-![_EQ7D^_M8Z1+UPG*H+
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M-+Z;*.&[C, 2 *T [ 'X?_**<!L>XJ+& $[WW"</'[>\%V -(#@L'D=:\B(
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M[7N8,H!U4[8'W#B82##K3Y@H!@/?QSB0O<P&GSS/"O!L*;$]4R504\"R]()
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M=HA$H>;:U7'U2><>@62&X'S)V8R*#7$CX 94/K,!L(2#3?%",T,QL )'LM*
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MA*](F#4PQ?9$SCU0@0M<=0^$].1RL?ZZ]-D?$*!4..?F.V,F@,'_4C2-.5A
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M9]MDGA1'28]9@QP5,86 [Q&F6X#E4N8V*:! 3)K#"LZ=T;#<E4)Z$]@+3#
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M.@ )=BA*2=7.:F=JZR#VJDFMM#EYV(:/]68#Y2%UUJ26M.U+I;*KI?6CH8/
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MKA)3ME<[X__,G,R(0F^5LTVCXNQ!I4-[XSO\^]AT?W]]IBO7PIP?> N>!X'
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M2/1(TBX"?E26G%TI_$)[C_0PSQ&/J@*V +8;'"E)&&&G5J''7_#P+V*)BOP
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MU/<I2]LT IY8EM!7NM63"H"3>)$/&V;$J$Q]E QY_V/2,VS?&?%T4[#K!O"
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MI#P3^M^2MJ')J_39<"(ATX3<HL])VGAF5?CG8/)][#**^<5/AF]QFL J!X
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MIT;@N0QS:"CX;&JNNE[ZE)5F3;7TD=AZ/F6".#'O$8_Q(THRAA6Q&B'P-4"
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MWG,A\+ZQUO.#4<+JSFSQZ?1*SQFX3_Z]\?K.L4K.:56>^WYE\EWG_I&H)"E
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M0<?&-(,4<SPU?:<E(\D@,LF7C53W[DG79B? KM9I5CRZ1UZ*V:D 2$:R01D
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M?[XY8UCO=[1VKZWU^RV5L,X>_+N*+H]HSRK6N]O!7I5H'FJ-=E-K#3HJ@;5
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M]*N(141_MO R^CT.RY%_"M4KT2&4&.:S:5#;0"<].J-0^2B&C#3E4\=\]ZM
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M("R\57?@I>X]Y3?5EE.MT&93\XHH#!$9ZB C31C6-+8;Y2&BOD;4JS2U&ZF
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MF&C@L7/'#Y?2()&+)Z.1"</@F'U 7G13).D)!WF$A)3,-*'PV8^G?*DKOF0
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M-)?"JD>!6=5<HF^OM^1\ Y-$YXVI(-\LJBW@4G'-\ ^?;R8A3JV@(4GH3>/
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M'FK:XWVG G^7X)/L1\96,PF?5CC/*D/!CI#Y"S<P$98W$M[;*I6#W-T)-7@
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M@#1+\HT0">!&LGFOT^LS&+Y.H6^K^.@MSTJ$QJ/,[HQDF"Z*),##*KXGND7
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M@T57BDAY8#2Z8@(O5LW%N3K"G8BN#<6,>A]#5>QQ)C#MB%2SJ1%0\M+4<T=
M6_P9?LL ;Z(4<?$># \9.,H4B\5%&OP(7#E?WI7BP,0!$P!<>64J]N&+<+JH
M)@,*9*,1&P95_CG_KZK"<)X#HVOQ7/9YCKMOOC1=@(^0N<7MOQ].IZZ7DLC1
MGDR#+G7B0C4ICC(';C/[B256G, 7QGYR9*;(0$Q[$!C&,QPG1"RH[GJ70RZ!
MT PMPFWE*:/I?/SJ?XX:K DFF;$TZ40)=HDO4IZ^MT XL)@L$J0"3,I6%$.W
M!:DEKD.H!P0X<0,W5 ,_Y[%$(7X^C&@"&<8H8 F'(%+)&0C@<\4!9:)"R&?J
MKYENKD0,D;=+D=-D728%;?E$=/).0-]:F)TCLB8Y,T7E_.A(@,>1Q!4E,%&H
M-<HYB$KPZ8B)Q,G%[R;=\#S><4)S<(TZ5PB:,RF%,CKQF-G(+CVB(RJOG8:%
M+]@@R/: .OD\H .>'EP?*G9".KUV@US5**_2S+DD(86U7EG2XS,;>"'F>M=%
M0M=;D@8H/,3M>_R>"Q"O\AY>3\D72H^EK'943&#2RDP*[3;$:>T@IOMR-+3&
M4ZFR-O4/PZ$]15EF"YM:?&V4($"W>QEO'UE2#262%2AU :-%J"7?)A:ZDG^-
MWX]F692C)Y\QS">#O,%TGJ(F)PNSE4Y,5]7*'ABWCGV5$C\BTUY%T4UJD11M
MHW?/',OU"/[,O/$L(!+#OD)]V:A=@/>&6B?!0;>>.P%MZGHS9*4\W8OAB2%C
MIO\9GDR\"#>U^:UYE+ Q[T<]>NA93\6:D144V^UH"&@,2P4D#!#HF6#NJGW%
M0\-6U;DJO3PE@,+:=T ]E#QCQHVL-FEWVWCS<;%G]"\:/Y8FSJ7)@VETLFQ0
M]HH'2G+LTVO+%VX+OSHZU@H RO=K2=44;YFT5-0:(Y8'4;I"XBH^6T LR?DI
M@%1(K_[9&+)M$VG:K;K>Z2QF%J6$,^E_*9CG.@;@I9V\[(@$",_J6O3ZN"7!
MZW7F/&"4.8_,H72U.&<DKMM,105%&Y;Y"Y9IXH)VQ>4L()HKI\_X_+_H^6_Q
ME4?L_-*.^?)\\Y14+>H2[%GR.@0<B.1N."&FVHY5M;YM)YWCZ-[123RJ:[QR
M0((57%5L+B9 **X*4T]$G1_0L8WHHS*?74/9/;*=C"?J* 'KE;C\G]?+\?,J
M-[?.4N*VR..I[[SVBSO*&%+VV)@Y/AH\HDCO+<9W@;[N&8=U%O[JC3CMD*H(
M+(<3/E) 8HLQ"DMOZG3NEZ2\NS0\;)CG@T*AU)IL)ZI[S&LDN57M+=X:O--@
MRQKM^77>&J6NRU?(XD9G=19,/9$%$X$Z@C&EO: H2-8 <^GK ^6A;C$M.PSB
M@F N:_#"FM>=IQ4,BJ<0A3U_?LDSF!QA6D\6"6JL$$U_3[;SFOMKP+O%Q0&@
MR01$%KUP[-JBI1M%[$!LAD-^K^[)VE.>)T"K,HI>"P^)%]>A$L((&>@'4/UX
M&X2IG8D5?.P41_DR%+\\YQ_%.>?R6W@Z4;YFQMJ<@R4*G^'AZ$HNAH@E6X3Q
MT!WU G "JT+0!U%?D!R10W'"379 /PX*='C6L6BZ\,QXNSKT:WF,%I-E1;]0
MH@!!*6!/I$*YXFLZSS5-?)&7>C\Q_D[0V*:L!\1O&CCMPN;5Y$BM46F 3F')
M"5T_ZE0]R-%J4'<ZSY=Y*_[4MJ(<5^$MBK:$DM@B^HL)DJ>\S/!MN!I^)*O?
M,Z#F.CRL4 %^K^1)X>VU*2KN!#.9Q0L'R?5@1ZQ&3]%Z(VN$%TP4ST;31>=A
M$%[RCT8:/PDODZ.R=8X?K'?SF&0<A-( &R906P$:C.D2V_,R=RJ#X"* HPTP
M*U/K(M3QGD[H40:9,?@%(FM5.9&MH,T^O-S6ZHT489)(I8US0J!;>14I&$$2
MJSO%9N\-2OH(F941H8%%T;/5Y97\:(T6/UHBZ/7F3AR%)U;>XU'>O,-L29M*
M2M!T?<:;'=E&$9@"JURX[.,25]QADNF+5VV"6+)8@,HN\#5Q.&^8<'$QV*?S
M*DSPJRV?-,<(VT"JWZ=KCP@'P:K"!E:<[!7FCQ]*[N_4"(9]QBU7;CW7<;%>
ME[S4/,E5O0->+>0##;X]/A$"2A *9J"+5-X79C6OV>[1,-TI"M?^_??L_)-Z
M9[7E+/I>Q*6A5XF\8+J KG_0>.6NAKX+'//M [7^R4J/:?"5W[U/ADVHK4+J
M32"4U N_7>$41 LD1'ONKEV-9E6VK[+B_'"4R%AV:8K*0-'KDDQ8G@7OVN[C
M3+0/=N*J]X5OR(9DD5F.US&B$S*^%" 1/2P"(O0.66EY?GG^-;KH2+P8+'+X
M)&[=@)L ^IB(>XW$JQ)51 !ZPZ*^\O*[6.XXBF)N\<4];US#XW4 &.SQBWEF
M<9*='FT?Y!1/=Q -ICU LNN0ZJ$:7IY'(E41&QJR Z*(X=G45,D6C9;GMI"N
M*S F\"8*H&'505)?VJ[A+$PF0,NX$K@5."AJ2W#!V"!(Z$Y19$R=PT:C2BK^
M)B%(]<^4A>R'F)_O:Z&#21VTA\G$BM,3@%69(Y%83=#RRH-$K:T3E6%Q,R$1
MBYYKK#!T;1':',P$GHQD:R1R<9-$D$B4(9G!#4S^QR!%^S3B8'4KB&BF 0\Z
M\C>IQBD<LT7#XG^/8V.\WEY*K;*74ME+Z5B]E%0S>Q %'_%Y_LQ?DJOLHE&L
M;&WG7SEX"==W3-[H&0%P2:50<3(&?'C.^^D\> 8JLC[IBHNHY\V\J=[HU7K=
M^D(#]H,'[J]O'BXS[4T1@B6+G>Q&>$C[UK_[Y^5#_]/72^W^\OS[W=7#U>6]
MUK^^T*ZN_W5Y__#M\OI!NWGX_?(N\7G9WSU? *9+YFPC$7^),D=Y84 R(4CV
MR,0J<\V($H$P[Y>)>\=T>P[,B4U/(Q%F#:47)?JZXBB8@!GFC+<7T;6O7\^U
MMV^2?WLC;H;1=IW2NK2-9VHV+V]+Z0J1&TL8V?I)YBK\/?-"_DR5L=.HU(!9
MN\D?[_BUWRT.2'E(%&)^FB4_X</.:..T[Z_V,.OJG1(=+N69[EW;I,OBC:L8
M%E-#M&3Y1Z)R5=Y]\Q0P B:0Q)#)3CPB'FR(S@O"+L271(-7N%69[*:93.N)
M*YGG:$ 8^$@D$1&M[)Y_IDKXV2MJ%-)Y8[2TEJ,%8!P74,:3$G!-R7E)/I 9
M*+@\X<>):V6C!JD"A?AC%$#&RDY_GM/^GBS*O&?46OI<&M]XA</E0.KV2A1Y
M4G VT6 5V]=1U]=<W: 76Z)P$92L0%U!$*IQ"G* 8>+'O=(&U\W?R,6.Z>0&
M([D/8\-YD#UX%=5=:^;2=&M+DNNLZ-4D#!W&S+B*>W'\#KEM,:EPH2JASE&)
MKXEJP8W$59^H/TCZT$EBBJH-8N<M41#,;XWB8 "G3"%+Y  -D(;?+N*2D=2V
M*)N_XL-;ABSY'-XR4=8'"16+WUL)U_N9R>(?[-.+!YMZH2FT%@8=?(R\9T *
MTU=L*N&4,8"YR1$);G"211PJSMBJ,V.",W@Q019OG*F34,_B)-03X@V\JD'^
M> ;OS6=.2KHV>6QAGBE&H4<DH6:.B+AE08T,T\R)1B4=BW@5-[AD5))NKD0[
MH%5ABJ.GL>]L',?GG30:TJ)ZNPUZ:*6T9I0-EJ4XFK7:SN8+H7L6.V9?P"7#
MN/2E3*_+HO5-!C@CM2LT &E<3$R4?<!S53(WE8/8-YM'=& XH$*D+E@ DN6:
M44_-^^'C P5\$&)SX(I"D9/H1(G*NV3\-U9^L70Y;O[?X=N5</B :G6?07A.
ML&/G_WCCDJAT5=77/Y$YN0+,"5<ND1RZB08E,?%^_R.0%)WPMXL*8>HP.8,\
MOB/NP<P;YPZAA*[4)QRSH([V+ P5$K$Q@3B*@Q++8311C+B.?O>GQC#ZG<<=
M0152-"Z*$Z:"I^L%@;F^LJAX%L&/\[1_$].S@RB*NQAS]1X';QMM'" C_O/N
M@T9I#" _I/KC4[K?;#[O>S=#Z1?> D? ?!(LWU@93<\_FYR3< 4CN_("?"]R
M0&QO(1-W.2->.5J?)*_H7R#"<3N&:@'?LCU6WV3!-=E=8LO]_Q8E1A!V2I#N
M!:2_!M['OQQ?K&E"QH.82#@/N\%;SG?O1P0N63M;.G&KE7(<$O+I #!X)?"]
M3W2H)>._A/)^H7Q ^!9$H)5VVF[L-#3"*4V+>QDG8*Z]-A3=#+"')CI?)7(*
MAYSOCGL ])0R]R71#,:[OL91L9*K"X>A*V<:EKKP%2*F%+0[H!817JYP,,#7
MIC\URNPFX-5T#?_O77&(ZNU7]L1LK?YNEW0E7:DD%$J\'@.OC1*O+Q*OS4/C
M-:=RJ&'E;[.WOU"NN'IKMW]9CI,<KTGA19E8\N;CIWC V<+-:D,)=7DO^,NZ
M=+F,AS9^X1:$_K=EFVC\DLZV\;!.XH ;6Y[/T>K558W%&B+3*[I,_C2+?OS=
M8I[A#<<SXB?*\HH^XX86?5#/D^P5/7C- HHD20=GMBR_8V3]9&;E?\QS%W(=
M*PNY'+LC"A6;JPS>'1-C2=U;4G=#-1ER!]3=**F[I.Z#;.QM)GG7]T/>S?V0
M=^[DO$:WHTS..SS)ORN8A[]?P^T\:N,8Y;-3F0C%&PMMMJUZX9[8>(7V:>3*
ME=V[F<5SZN/,P&C80<'TT FJG&+277/O=)?+ "KI[I7176OO=)?+,GDA=%>4
MR-&2])[-DN(7>WLHC X^@.81RZ1D(<!LMP;(>CEA!UYF-\R[+#LLBX%58PKW
M8K D7Q'Y#>=8-4!/GD<$$'V8A_$3]^/%Y_XB4^"+)W1U]X8]6$@EH1>: E\\
MH7</99*5A'Y2>=#[#23UXY8&<1%_P4-(N4.R1_&\=G,=HNI^<H2 5*IU6=\Q
M^WR FO_@]D<C8'<C8'X_B%[_!2>!29):6OI=7IZ4Y+^"_%4-3HX0%RO)OR3_
M(Y!_4]7"Y CAN;V0_\JI<KVVWFDN-KH[+B<4),1WS(2P9FD6'ETPJ-((#F4+
MEEDR)4'OG* ;^R'H,NVK).CC9'HUF_NAZ&-G>IW5]&:G40 B?_6)7ON_<UV7
M\=?J>+D+[EZOQ>::R1%-57+$8C^W\F[UH!D]NZ'@W9/M3DEU!6&J+OUW2Y@O
M[2ZTX,E?+UR0JN[N=TNO!;S27!7?VKLAE3.2M0V;?(Y[MG*#)!HWZK@!IJ"?
M O\<T!O9DLUVXVJK$@R.9-9(<KE&:MDM*_[TK?>.94?C2DO395M"WRUQ[X24
MU;-!CF((%8B47[*Q\]J$M>H"_$BFTQXI?*U[0;W>K>O-VCYO!@]X"?BAP$&G
MK%O 5M%O 5<R9!,8TG1#M%8+5EN\?&=9LJ*E*IW?G37W0N]0FJ=ZA_+ZZ%MU
MZ;T[$Z^D[Y*^CTO?JCOPW1EX![XQ/(B=M@FQ<^/M5S&(YE>:E),8(STW$?K0
M<YZT]'RAXPRI=@+7FZT:--TL_*#IIG+0-(Z3OGZXN?MWCN'1?Y_;^-_S[+P0
MT[LB-*+QONDLRJPAWM%D/C&$UI?S$4>N;;O/6%5S_%EI6W/#_7#,S-!F-Z,(
MH.>AY\%/-"9+S1FM<BC7'D.>A>VO69C&F2F6+KM;OU;\%"8SZI2)YM2:YD:C
M,,L^R"\(I<W7W0*Y6\MJ@;SK.=MO/GZV',L'PT_[XKIFT1OIJ13=H0,@*P(;
MW>6!C=6%9V1T2XP00C:/2+2;+;U;/^+-44E &Q%0;WDN_2$)J*%W>PV]T]MG
MG]/=7#T>+]U]]](X#F6<NY.IZV 9Z@G*Y *V_VNI6LFO)YCOC.=O!A@T%G!)
MWS'OP^G4MMC&'-8#CZC5.2L%=.%;1[95M\WKR>0=TTY=;YYU]5JS57CI?+SJ
M\'U*YSN&$Q)9*9IWPEX9E]TYV0NO\PQ\L4#,!HU(XK*_0M3^%(>*CD8SF36G
M[8PJZET3S4IIW.CHW=:!ZQM.I29TGV)XZK&I89G[Z;Z;*PQXC'$@Q:X4SV1:
M5:%XIJ2?#0?F^UN.Y@CO&_-I^TROU3J'Y-,#$=-A5GD%!-I:5ZOLED QY-)M
M%XQ 7Z&E_^ &HCLHX?/D[/R7GC_8;F_M,ERSC<LR&GJ[T=+K9\V"I?N5M%D(
MVNQL[9EL09LMO=%LZYU6MV"T6>Q4U%0:'?LYM$.3R50VTWJ2V6FW7SX_W&5>
MV"?2U60N7.H-XU'%<Y^CC^8_PZPX[?;+]?=OJ],"<N?!Q:ME93FVVCS'46XL
MRK.=^R7U\S@R"F[[7RXKG^XN^_^L]#\_7-Z]UPS[V9CYDJE0TSHL!: /VI@A
MX[[7&DA PI;X:XW^!\\MF!GBHS>_*E'S^X4:-4B1NT',P\WY5\OY$:UB6O[4
M-F8(1=MR6&6 Z9%IR42+)Q%@:&,/V?^O@3M\DZ+Q9P$,"R2$A28)QS)^8_Z/
MD?62_G,.>TCGU*%K/J!]I)+_E'Z)":[808+?/QEK407Q<XJ'DDPE^6WA._LS
M[9+XD#)@OB7\@']9,R9 <#S!US(!#B-C2)4!&OLY98[/=&WD$9YT;6PX)J#]
M$0C7#Q"B0\^8ZAHF$S\;?L!,6(-'_+6W_M2U;..1O=,,C\EWF=CB"M.(I_ M
MU\0?9_2YY0PQ\=;45B0F.RYGV6@=\6)?\YAMX X"%]_JPRL#-H%3#<6+Q<(S
M9G@:<TR6N8RR(!+6K6H/\ Z\J#2<F?;LN0$#=?D,VC *T  8_[9<5[:;-56[
M%+#CNO.IRKG4YA^P7W8!.]BX3TFCKC?KBY<JFAEZB&F$60:@1F[H!6..D_^&
MA@=800B,+-S-EL#6IA[LU .F2"+7'8"+RP#N2"F ?0N1ZX-H^:']8&R*>T;(
M^=I;K IHU#[<__,[_53_X+^KBC*,/YCV['H_@* ]>ND$I,H$N"J!QV>$; 61
MZ]-2ONT^:Q/W"1? WXU'_ E>[O-W$A/ .X$=?.U9O!]>[0<>,R8H+#6 %0!G
MQ!"P/GXV!K:"4S\QD*+(<5//-<-AP!=D-FS)@6/3TA7ETM7,2I*]%CW,5;+L
MM6KEUG-!8 2S6QOVU'=,'"@WQ2KS554L[<)7L;2452RW=S>WEW</_];ZUQ?:
MY?_[?G7[[?+ZX467M'PS_N-ZW/Q@I(RF NF<&23&#U7P\B+K79;RD9I[.F6E
MRVM,BB],:G19Z5+BITCWO:=,-"=8%E%6NKPXE):5+@>]T\- 10A8\G5M%'K@
M%8.CE#:G3^Z:KVC%"YVLMC5+[>U/LX?9E(G6:P)'GR6&DE_,T]QCZ2HTJ6F+
M<II>5V_5ZV5JX(E19-:PE=.FR.990^]V#YK-5%!3]' ZY)OAA". ,P\'G[+B
M*& >>"<C.S 7KZ:P4P >;?1:>N.PZ5S%UQG%)+V,O+^2],KRH%S*X2LS?#9V
M;5.S)E//?6*3LGQS9PR:D?"7BT$CY%PE<',\_FR!.U'KE>[$":B&C'2^DO)*
MMR&/9NB'L%=W8-GL]-3!*ZCZZ&0T;<G%X@G\[H^Q"])DN1S$6EPZSN@=4QPZ
M7AG9JH-^.F3Z>AZ*+HP[4W0V*Z8-MW'SESUYYWJSW=.[G7U2^0F*Z$+23G?C
MYB_[HIUZMZTWZD=L'/0*+?BOS/<U8S@,)R%/OC;9U /$4/^(TJ8OX%#Z[L9=
M9?HQFB\26(:?;88_ "OW)RX0\__H[TO9?/.KO3.P(UIG!^7P)?DC[PI,UJ^!
MB#?N<G-\(FZ!B=-I';1_9#81%\:&/YS:NE66#>B:PT[OSOJEUXUWUVZ.L]+0
MW*:.O-W2&YVB#30J*;40E+IVEYQ]4FJWWM';W7T:2T?K=W"@ K9#55DG#1%9
MJYRL9EU2Y/9L^-E5Q/6:HHI850"619K)S5U293J@'-T^UZ,A<=\=8)P;V!]\
M S\P?+:Y;&WHS<9BYEY<.YM]W+KBN(WXN+DX\9#'!8NJH6@DSH\+;]JN%GV]
MDD8=",Z?,MC!$[-G5>TB5V5W,+8\,[.P>\7:O"*(EI$%\SYFBOCAP ^ CRS#
MMH'N;9N^@F6?H@D!_#-))1U&'0FH^-G7##Q0: ?TX"-&EJANFP^>YE]:$K8@
MQO+8Q'V"#T:>.Z%7#,0@9'_,6(#0,D,L74234;N]_3_&9/KA\MC5G\<8%0A8
M>L21X,0=_JI:ZV[A:ZW;"[76&CQU=?W0O_YR]>GKI=:_O[]\N,]19GTH]5$H
M78;5/5C7E*II L'G>L1;[T'X@@#%3@<?-&Q9*LE'X_3SVZ_X\,=#0;? @.R3
MG,L2^?\(03362=@WN;!/BE&3@32> )RQ@8H1@/S"SBH@W6"9'R"S0+\,&6\B
MD7B,2+[[ =8. ]MU?X"@)7$X]4(LHD9KQ#!QQ_10Z+-1:&LVZ S:[7!@?KN(
M7H&OOCB_@2U+)%,_BPRADQYWBTU\V%=XMSDO93[-J!' .5:,\VJ$@3DQP6Z^
ML$"*![ -ESH//7B&R?"\T;7MW,3;I4M\IY-]M4;L3=K&Z*1T?,5GP_=FZ*&J
M(]$Q)W])!::@A$ 9L\DT := [G)?T(G <,=MR@?W=]R!N3.@=#. 4J^IH6(D
MHFQX\ $+T'SPV,@&%!)Y21H4718&'@#/Q^XZ%NKG"GN2C:KE-PB2>!H?7C>$
M?\$*",!%?&2\+@';MN!.X<_QLP'8!%PJ@6@_SQPFVZE5N7;H)^P+6-O0P(X(
MK(H?L*EF3,%>-X;CW._DKWQF"RR+1Q+]:8BS=-&B1OZ14_OYIXL;HG;Y:0(*
MDKL#-AP[KNT^4I<<"P#!;2GB;0LXGQKD#&99._U;1Z\UNGJM)LJXYPTMG9MH
M2;3BV[FXX(X,6%S81HJC &34< SDQ7S9=@EQ(DH/021.R#"+F&=$S;<8 I:V
M+KOT)*.UD?.TM?$L<++*PVJH7(Y%JVDS;LV5:Y(\/DZH3;]\4]>D<];5V_5E
MKHEHY05X'V+8A+0*0AN[HF HGQ 'YGO <SH1;R[WF. +U8+HU\,I^^2ZRIV!
MLE^S7TU37U3XU/2=NJ/%$D#PMG!Y#'OF6\1MR(B>2?[,LQ6,<PLITEZ ^57&
MA0\+6I&CA;OTQX8W13*C)E>PA:$[&= +Q"/@%%@! .9_*8D.WYJX:$QBZRY\
MUSUL"7#1UVY!4S#>#2XMC$ES.(\N2GR0Q#]GVI,;,%VE"F3?MW3'MAB0CA)^
M\P[FX12 E/ Y!?^BT']F'L,J[P [BB7E?K:4:^4*K.S'8LL2?CC)[=FR;7C/
MW()7$=XV#I_J];,&:KO%KG= O>N'.#BQ(.TA_X$VQ$[:"?("7>@]LI6= 1NJ
MSH#K!KGV";=Z$Y-PU("3:GG+SG_-JN@040C9?=**I%4P19))^KUC&UM;\ TY
M1< [SP NT(Y)MJDT><O2!3$3@YS!7L&H.HCM=&HD?^5D2V 01ISFYD,<&&.V
M3,OP9KH&NE2[<DQX*9H7NO;UZ[DNN@@',2>0DSY$:K=M;J: IA\R9E+3S4?#
M<L"5! JS?FC?X(]#H&MZ5=1FE#X3ZOH=J(1'PZ-GH[_3QL27<4^QSH\V4(6-
MPH;NP5^V&4];N T]4!_8A1?Y"KQ\O);0^H\>HR]PUDHVN<V2$?WP$>,[!+/L
M"!3)C\4 OC'\;TAV1>22X[;I@L&U>7]2VX[NMVP @HW-_ZR)S^TP(]JWY5 G
M9(1_IE)LJMPP$ >]6#+T*LWZGU\!GX^$N', $+=#X(<_0'(1!B32,H4!33:)
MWQ3CX8HWG;XU9EOI3_"OEU@=]'IMRM^OK^JX*P2M:5KX//9P=IPP?MY?:6HT
MFT6 ZC?8P=B>":CVJ0_UIK!MJT'+(Q>6[X>DR)#HL\"BLH9W"I9[, 79O.ZY
M1Q?H"O;(3'XW=TO=L>F[/HA7^FACA[_;5A.=3Z^GV&[2$WN;\$P$V6M\)U*X
M<5&4"<>V H[M&([MS>#XY[T,/-P/P70!&-$C\I?/+O@;AK_8@N (0%]"CMH$
M]AA!WEEU!^LZC%B]PL.JC@.&C^>#5JMJGPW+QFY>V+S:^,%X@"X6")$D>'9#
MVP2)#%81*->TW,:'"<Y5K1\]:L_TE,BG-F\DIU.7/VCT5*R?E;%E@AGY/L)\
M%R24A6-"Z;*';QR#1\)!BA4 V92TNJX]>G@?C!]GDY7*2E2PYSD*$N:!I1O,
MK@'IHEU%)F."GF4I@07GGX#<P$11YF&S.^,Q3@>H-'*30P.'L"T0PB_$=/S]
M2 B@#A%'&%PS\#*%[J:_6D/>-/^6'L,'J9>;H3E@<PU!E;L3L/<Q0B-"YZ2?
M??JFAHW'G4= I>,KKX&N;K6IZP4CU[9<>.>3:YF^9D<<*7O\BS;K +B )2\T
MI$RM"JL(#NMB?,2U'-3] Q=;JT^X1_('&-:6,='N#(2]=G5UQ:,L/(8C7<>T
MM*$_9_!&O2$F : 2\=-AGM 7)LHGVP"1=C\<NPC4"0O&+D6K(]^$^ZQ@BXL(
MM0@R>7!&4,I D8)7Z19#PXEG6[%M0>SJ0AGY+]FO;35VD*95NJ:'IMH<=PR)
M] :1NF2LO-7?56]ZC,?GZ$Z? JGZY'F MH<^]""0F1G:;/%6"VA<DCNUBE>G
M&O7*QO2[+:;>\BUEX_.R,?TKQ$]ABH)/F6A.L(MYV9C^Q:'TE3:F/^B Z2AT
MD*A_H=R'DZO++%K+[VY&LY<_K\ 4'6V54DH)'7DN4>>6BF]@-^[\@5WHU?'K
M5]TVIO@DV<OH(5.29-F-9G/M@7%A2G(ONMXH9&^G7M:\DNWY,EU]<%#&7'+E
M]JKU1#%),&M 24F"I]^!7OH_L,6$&$]IBYW%IA_B3.@[S(0>\:O3.W=FV$%J
M</1<9G5UZ$YVJT"6'7O7MM]&R^R&TY<LG<GM62-.ULKGC##-$?T9\"S0'/'^
M'([/W4D>.9"QBZWZ%G8Z7;W76IRM_CHH[L43=M8 E9*P]TX*!7&"#JKLHMR&
MA%[CN<2:;4VL0-1<E7KM .R?-9YES7*I;^97P![F37T#[!V3LYN=WIY-V"(3
MTXNGV:S!+H6EV>-.@=B!"GI1_I9*!96NU7'8.6N(R]JE<HC4@MJ;W=:9WM[K
MZ( BT]>+)^.L&2XE&9=NT[8Z*TZ3QKQ9&?.EKDUFHH652.1]7ZJNW2R=V>:]
MM_9\&JK*X:QI*U@ST?U]!YT.NGH;K+:C>$*[FS]0DIZ2],[6'F_SRDBO(&[-
M0<=5)EN-'4])Y$H"+<>'9#'WQC-P,JR^!(,G"67C()M>:W3T7O.@$VGW/NVF
MI.&=T?#&(W .1\/8SOT,_K] -%P0S^:@67'8:JS@:7"O;UC(V<9C;>:9]IH%
MT:0"61>Y.<>"TZ6W%5,)R@$W)<V>;3S@9I\T*QH.GA6-9G<RZF;O,R.H4IL1
M+I@LD3:M)UGU?/OE\\-=9B%8H@Q:UEBGWC >53SW.?IH_C.LMM9NOUQ__[:Z
MW"QW?76\6E;-?*O#*^;EQJ*Y&'._I'X>1Z;#;?_+9>73W67_GY7^YX?+N_>:
M83\;,U\R&^IC''.0JA,?,V3H]UH#"4A8''^MT?_@N05C1'STYE<E:GZ_4*,&
M*7(WB'FX.?]J.3^B54S+G]K&#*&(L?+* ,ONTQ*+%D\BP-#&'HJ%OP;N\$V*
MQI\%,$1K,XEE_,;\'R,;)_WG'%:3SJE#UWQ ^TBE%ZBL'QWZ<Y1M#DZA,-:B
M"N+G% \EF4KRV\)W#L7PG\, NT 9<^&+A7C%1MTI. M9]##O-*%J,W%XD;:;
MYA/N*,-;XG!-.DJ7O/]\1E>*LP)UI<AT-8[8H6(]%T@<N-?^Y:!>U6^#CY\7
MIPS,-17(4RF\UM9RU7R_P#?^-HA>.OAXR #TFOL\'/UAA\2UG/J=X'!'+]_*
M_5D/EFO6'9UE9&QN'E9;5!'7L,##,[.?&#4XW3Q=H-/06^W-TP6V!N;ATP:*
MS)*=DV7)[4/A^^5+55;J'OCRWZ#+'Y[=C=FQV=2[6PQW/P8[OF -V2W9<4_L
MF)%5NG-V''MLXR&[I\B0+U@_]DJ&W!-#JO)C]\20G]W0V[CZO7.FGV$GK1/B
MQY>J(!_&S&/&*&#>B7+E\DR* ?;T+@+7KMYB)E?O.@$6N7@XE]W11PK8EJ][
M9WJW4:K90K UC98;\:!_<OAR\@+@A7#\GF[8=\ST&;?M@RS^/ZNILI"WU>K7
M;..\XZSTD,&>F#WOU?O2$'%1;^"3_]62O\A[+-4F\9+V(VZ6?_4OR7O([:^]
M/H4^#M_PSVDX*PF*"\L?VJX/LD1YH=6H*2^T#@9*P/KUS<-EUJ6EN.5'LJ"Y
M)O4/\)!V?G/]<'7]Y?+Z0?MZU?]T]?7JX=_1A<WR(_Q][@Q_SW.(S+O*HXY+
MN T]G- 2T'1N#>CFD7F)^3MRK@]H$7?%W+A&K=Y3#(,;&SAO TD1)07.'W,'
MMIP>@R_%"4K9XS&ZB^,QZF>56HN3,O^Q6?M3TFX_'F_#R]"!=#_AU)P+]L1L
M=XH'^VH/YZ=%487@S8@F/O'G:. 5_9YO6)1B Y?P4S"[(BCZ@<\G2=UX^"_*
M(N!4>"\L2O-C^*<;9T&!@P+".6N$EQ7XJ3%>ND;&/Q]8_ 2H&<SH._3$V+5-
M&B0$2$*$\BD]]!Z$J$8@U1(PU3DN5\T7#)Y=026>X0S'L+-,Y)\=!_EW[!%G
M: #MGQ@9U%LMO=5:G"4ER6#55+9V[3@ _^YX*I W3@+F9RW];#G,=70EQL@X
MSV-K..9#N/UP\!_PQ)"[;&;\T-PPP$E73Q8.^Q(3M9#M0@>W#^H<NR@\N30
MC2Q6&C>5B4G%4,PC8O)4$*ED'B&K$(>"CS@JGQ@?M/.$4C37[+MV(S7[CN>.
M3&FJ(.%\GC@,B70^!BU2S:]OWE*.S>!X-[6IP04?P-I)<QJ'-T[["FDB'?8-
MIJES^!H .QI!MF4,+!MHD-Z1F /WG![TA:3[J'U%;LF<%28RYIQI2*/S?+"?
M Z!"PK)RTIS/5-NQ )8>HU&[7%+XG#X!)M;(&AHTT<R4M 0D)Y84 \DRDOPF
MQBR>.074#DO^8/:,6O&/P95DG.!Q43/THGQ"_#VY.1J<)AO \ =IMAKV _+X
M0%J<&BA^P99D+(###P/7\TOR7D+>L6U.LQ2)D$TY90ZD3V*\9Z9R4 RQ+911
M37',E=I@F3*()Y5> LL#QW/ML'/;6KQ=3J/D<U0'3%K"P-LX7U0R!TUF Z.:
M.$;7PJF8$NG#'_R1P!*.VF5>8. 0PL=''!$>,,T!SO  T@[(A"%P*7"J@=8Z
M3<8@1D.C.]O]K_<J]4:E44O^> #T[A&=ES^GEB<*%%/$W5Z<;PB"BH: OOG8
MJ2W$5?AX4"T:E,>Q9;LDT$U$@, @=Y"7"H6]#=,[^3SJFY$"^?ZG6>*W\TC%
MG2?Y1!UUJA<HC7JA>JC(P_UDNG2K]\O6(YCVT6(A$GG7(/+NN,CS=S%N*0Y&
MYYEXM>;+-ZWQ3NUJ=VR>CI!FC,#C:HN+W5]!FX%+\S>4=4HT:'?(D&(&UG[F
M7RW%TMZN]!+LL/KB:NMO;+),01JM:*DC'$XB_"V'5]WIU,%YERYU1<OW3 .#
MUMA#A_?1H8<+7B:?@[RV+A7.S$@XJS47'0>%'?#G$FW^:?8PFS*R%5.FW&?7
M$U+F$PN>&7/J?<=L\.+'VH*G<!NN=A26;" 9)KIE7B3H0,Z)#9"4V]13J%5K
MM5:CV:G7#]KSHIC=^PHM,9H)[E];=+30C2A%QYJB0Q%SV(?H$&(#)4CG-"5(
MHU[OU=J=PDN0UVUSM!-"8&T)TL&KNE*$K"M"VH<1(9U8A "63E*&U&OM,\JW
M+[@,>=U62#<I!M86(KTW'YNU4HBL*T0Z!W)A6K$4:=924N3/.[P-HW=\LQQK
M$BZV'"^V=&DWSMKUYN*-R(&E2U%3.PMT82@3\1(7U73);.$5H;R_$DD-@9NX
MO**;\<P[1!4?X05BI5Y/_EC>(?+<$KU77U3'<=*' +N;F3VG_<-P0L.;:?4Z
M;[]3Y3?U5,J#77@RGG5$XMTH]( "O CY<9:$ZM;]A=QIJ?*K7W/KLV[9^JQL
M?7:@UF=+&J =OKQ!C'RY-;Q@]N 9CL^%L+^JQJ%1^!J'KK+&X>[R:__A\D*[
M[=\]_%M[N.M?W_?/'ZYNKN]?6*6#ROR9[]>U''C7(*NJ\;WF44B3S!F1<\_M
MDVLW8*L(LUEXPNPI"?/^]_[=Y>\W7R\N[^ZCC[KTT>7_^WX%Q%H< MT#W&Y!
M*3 /"VL([9J C):TU[&C8AB,70]6,O-5RG14+>$7JP65B=?1EFA'W-3M1^MO
M-^M>.:<D49<RC< ARE*FADR _5OF>7.WT 8O.,>I02_<>.1WF/_"U>.GM@C#
M+1Y\"K8W';ZJ764;^S?#P,5>@IB0J7-#/TBY=)CL2^FUF6!2=&VNGZ%$:M8S
MW*Q[V 70P#D?"& ],3 1*#H'%D,:;OE2^_=$8<L)+$J>EJ4OV:5&'45LF8-)
MIL3N$6+):(\:8!<6)OHZYAVL#H2)SH'Q&)-FI9$;;@V0RM5%>/VB\?UK?2T^
M@98X@C8GMJK:3>AEROYJ[1<N_M=\LP:VV0\?K%;'PA:;KN;"0LG*-<K3MRW0
MDZ9(/_<T4P H449#SK50JI3(#D"S IO+4X\-&>YC&&]I:/CCZ#WP!,^H=ARL
M)?!$&FBN\TZ-&1G6E%AJSS#KW8#C&9Y/.T<FGGIX-OI"-27X/?9DL6?88__^
M/-.%PRIL7$QJC]^LCV O8$ PM/PQU2(DLO%'GCO1N&6!YLU'"X%F,@)O%!NB
MG5$Y(&P/#RPJ(R@G%O8?4.9Y?(24W"9HI\), $#5]_RQS).F=_)$:49;(U
MHE8&GSH9G3&.+-1NPL / !8 M#U(M5AM9H&GJRCC4\6X2V$F18Y,V0<:=F,$
M:BM*99;UPZ8RRW6>XU5!J\I>3LDGRQF?#JA;B3%!,4-#U2+Q"TBV#4]&HC,M
MP:ZBUO%@Y*[HOB'IVS\'C;*I$,#Y?BU=:4(B>64#I*$ 2",&2/-4 =* _U<4
M:(X2K;A]T8M[/;Z-*][6X]LX !]I<#_TIWP+8 ?(B;)4+2=-E.P2>:T?/@*/
M\!=GFQR1Y""2 #7JAT,LNANB;C?)?!D./:J%'*V@F"6S77HK6\U$N+WE5L]Y
M"*3A!'W'O':=(?]E4Y1W.EVU&I0(5XB+09@ILQTWD$::96XR\D"BO+_!M(2$
M%]='Q,!VX_+279V)1"I;)2$V[N"Y3WRW]$[G3(UQ)'!>!AORJ\I'SWTF&QWM
MU9]808M%JMF'7KM+(MTASI_X_X6&!V:N/?L"6PAB>=;)?=A*AQ+6Y\\(VM?&
M/6.(X+]\D;(25K$9?@6\V^A9-U^O/:4;D+B2WE5@HYXO=I;NYY(S<-;+W59L
M6> L<>##1\URNHB]?%->\R%TR^8\^ED3Q)JB3__*ABR]?',^#W&*AG[6J>GM
M[F+WUB4$N3.G*I=QAG 1':A@+U/>],">E0)4L9F;; /TF^&!&=G@Y@X'OI2L
MJ99@AC8-X9N&GVQ,\!9MF#>77V_.W[SC32#^R69 #PZ(9V-JH;N'-[ .=9?Z
M^O5<>XL2O%'[(+]&O]8_O-/Q[5%[,MYQ)7H5TID5!%RZ1[L(IZO:XO26V+GP
M?XT_SZD-B(=%^[-K8"7RA.22N1*3+ J1<6[+D9UT*S8>/_K-^(GY@/P-\9\W
MYME>'61/2QD=CYEV/KY:U;[+Y@3L)QN&R18?B%A]3MD2EV="79VXS:%^) 2D
MKEZY9+P(/9!/M]2.A[\">) ^VCCOJZ%WZHN5',L$)K@C;^)3:#+E#&@Z(GS#
M3S>2(+=!MG83SR598CF6 2ZFZ.."2*UJ_=S]0WKJ'-JCXI,8BO["4_@BO(K"
M_LT<4+U>4W#/ HY2.7P9HK4NH_:F,?-%_SWR^1)=)C@RD,,R4= K* K2';GB
M3GJ4(.T;F^-BJ2R+23QQ/?KW=+-#CJ"X-1FQC4?[61FMC1HBQ=FQ:=;!^R??
MQ3N-F1;Z:78-B.],RQ]ZC/,KWL0$H.&IM2+^*_N'99!-@U,-W1?)?F%X/.9@
M*XOL:-+4LVRMOA"NBB0$?#YD4?1!Y@++VYLHJH7G2YYL#@0C.\2N6ZB1!]0;
M4B@0_O9,W%3CE\I-\=A5U(9@Q77'F>JZ TS]1J7>3/Z8@Q>.JRU /.AG[>7M
M&]]F0D$5!4\'?3LYO(;,$V(!@><S[E-,;= [&TO6EMY0)42G^R3&]&#27N8'
M+J[G1[SCU)^F7%VLQ["=$.]?BA]EO'ED>;X(N(T->X1;'ED(A17N22N=9?8"
M+GGR)-X-/J:*F>@1$R/49+Z\YW($4VH_:,G4*"ZU@T2:YONHPJDHN6&'@F'2
MVAX;IMC;ZE3_^9OW)#0EG<?,M/*UVWCF+^Y^<^>D?YZT5DJZQ\U<S9/H)I?Q
MJ^91GQ+,<H1V5N04QD":NX]:PYN?'\9H1I'5]'7[!1L$_-K8I\+)[X[UWY!=
M,#"%K6E<!Q9]XV:$2<_^E1.X:W<.3J\E+JMQ^(4?>&'LOW"[IKZQ?5:KZ9U&
MI@N2<CJ2 2PRAL'RM,!.&$8[339\!%,9S/FI:(UJB0*UJ(>J> ?!J(QJKD_Z
MXEI]"[I7C") 8N\M5 XKW(QOQG\LH&73&F(]8A&<C6Y[G=NE!5KV61#8HA=M
M%/RE>"\=59-GK1:*1@JUF54$2YY[-KVNY2:K0D:MJ.LO__%%RNUN';S-1N9T
MC%)N%Y4-Q&U4F@V&:XAMQ1 1I/5F3/9-S.SO/QN>&35WN(OF+B2H^<\'S!^_
M&5TYE*03&C9]]Y,+3]Z,+BR/4?ORG-(=_T@5\,C3S/'Y.#[/P^802/J?9O%7
M;GDJ&>U1%K!+%O%OL*#[86PX-\2>_A=X10#\R-7%QL9.9VEA16(HA;BXP'WY
MDM2%C!)E7;XV0/CP[$X!(1[?%MR'8Q1DOHL]6UD"'SIL/J%JHRRLK(<NV% \
M4T\] PR^VDWF!"N>;"="KBE847R+LC5,3<1:J?6_Z(0?Q4VS4CE:\Q/BCD#;
M\]E21+.#U60]V(RL43=PNOX,T**4DXT)O*EW.TM2S9XMVY83$Q,##ZP(.$2U
M-)F#-E-*]@TDN^QFL;%)WJJI8M[4>:06-R$!^B]\Y']9.%R(2!ZRQILDNATL
M"'I?&:VIDNH5M+91PYNMJ"_95'_7#6KBZLGD+(M4_Z"2'-7DN$WLLOE^V5W1
M83OR;!\=S1V0S%GOD)@RF=\):"WI/AO%+)M9L9OY=(EPX%NF!=+DWD"+*4Z7
MD/E<44"D"*JE7LM.0HJO0^7VM7X4T$G<^+^DVYN%>X9LC\.>K5>-LZYF69).
MU8V)LYO3BCDUXLPFS62^R91'6R@)P)7L+[.P%D@YCYET2@2;X[9L95+O3&MR
MW:*P?U"4VBS@$44"X[.'^;6.-@T'MC4$Q3]BE(&1'61LU51!<B#@-GBBR1^S
MZ!07O!'K%8%(ZWJSO;(48WZ\+M4F+4 OIUNO*E3:&G(9!1VIGJ&XQ6W+.!K5
MN@):B2J.+Y[K^]BL8<B8*?H3!#1C4T!JP& ]!N\UPR$YVA%5TE@NRZ?6!+XH
M# -)X,=-'Z*7L)\8@9#YF?E+Q5HU5=!PEV2LJ*R[%<#X#+"@Q%5G"&],A-0W
MJ31K(RX4=KVH-:MJWR.9B:T;B)23(H *-J3&T%.:[9''8\2@6O%]3&5T-'?*
MA]RQG\P;6CYUP\ ,PZR&%NTX,U979/7GGF[8JJO+P=? W<T3\_JV[9)RX=&G
M(L@AV+O>SG]EQX.L#@43!9NE [0*KEN73^HJIWA/?,)+)E8QR34+-N831>:E
MX!,Y+'TC<20FO#*58)*]8@:S)&;X!&C392M:NHHTQ,#XP41)#N_8(FLWD/FB
M=R=Y5"@LSJ<I;DLP619921*B.:3"QET0!-JS@7'?8+TBG59]29$.49+(4?^#
MO_G&N\-.FD1)XD_^'U8PWL2(4+XY2F=GP]"C7CKGAFTS\]-,+B>^N#%7MVJK
MF'K!M$B*53 SLCFTO6]@9A6*JMY_*>B2#(WHPPB.&]_R O\VLFR.@[L#K[>_
M<*_L+USV%SY0?V'%=XKLAXNLGE:RNE:5V"-:(ZUPM^M+W.U6I=%*_%B0HH_F
MF=YN+M:/<SPNR<5)&#54LX5,3/;7E HOQ#MB:V4N[49L7C2+H.V_LKA0OO2:
MI9&A5,5W5.Z5*NS.K-0>&[(V=>UJ[59]21RDK-;>8[5VJ[XD]E%6:Q>J6COV
MTQ;+D;,*!5L-=7?(XY<.'Z9Z^QU/[HF+>2F[)W?1-L5,<@O41/97)DJ6A%&.
MCI*RFGMOU=R5K:NYA;;VP\%_V) $2>:ZW3C"J@UL\(AP_,\FRRN:'ZY939X+
M03[Z21DEY\3&4=WY!F7G%PP;-=*EEB/S+GE;:>S')[:,2 47!TB+B)(Z+(IC
MY3K%T A]WEDY\ PS=0>T(./AL"/#ME^2@;J6+1I5/*@,T1R62V-)GYE6?)'>
MRIWE<5*62T_O]9;7-V0P4<J\7]&8E&NVG)D0K['8?87K_YD-/#Z^+9^W93B)
M3!P4J7V3>O#Z*$5N08(GBJXRUC6:'6' 8$V6(;IN93P@&G+A<Z(9%SW^#NF#
M>W>Y5B/Y3.WX313([HC1G0@8K!/<!XC2Z=3U MZ[-G&R:70R6(_]!+WB/'*5
MLMIC;"ZQ;>O(]OS'QE)#J@];)Q EYA NO;=*X")"17^'J37\[V!GW3/O"13&
MYMD+S9;>Z2EZ*BHMK:AH(Z68XCJ%S+N&IJKG(@?YDNRE/8+\D.D.]5:UI[@\
M3.0[9'!,/\TQ<C)%PGX"2Y3SD6R!(L4%L;ZA@34*)HMLZ1!W4\]&EFI^CF@2
M<PQDI?R.Z)O  *HWG=.)X4/:SSV7)'W'5'UW\VC T@ZL?%1JZ O7(Z\\2U^_
MZW&SFVQ$+;D./0E$?7?"P+*Q%6Z?R'+CF1CUEGZFZL7FL8EA.9C[)Q=:JZOW
MJE(P\'5B:R99M69D]Y]M-3O+L'8$6;@P3CH>NR%]^\^A;<_^Q<"ACBL&UYC$
M40?_4C6(8X2OI6(I9G[(!IBJ)7F! 8:PPLCKI3$<9XJ=]>:9U!?UR"]21XOH
M'E"@S0O0P"("*#+8P1*)0_W_R?JJ>$9@4!U'=!+Y6C&$0_6"#ZLZ%+>:2V+T
M14;;+3=*S6M7ED)BKLZ5 W_'])YS\/P>71R L0<<^@LX%"8RY<]@]I67V7U,
M-G?R$CO7J J=]JX-H\TOAEVP+SK>R((>$N&._+X#*"J;I=XFY*W/C0X5]6!/
MT9D\,==TIILKHXD @YL3-@WF)DH(QNTF.! 'Y!R,F 4BAB<GJ?VD";;_D&H[
MG6\EYG$%F9M+5 774@Y<Z-C@VF@NXN_9DMV0J96<3!"#Y08N1ONPD\#J/@ O
MS"_.69NW?@70&K&A5G.99QC%AI:7BCX\ P'-'IY=T<*Z($5[#;W1R-^.':B;
MGP/^<:-FW(:?J.B+A\$GXD39Z*B+ 33Q<1(,&L8WDU-+7($)+K;@_1/'&EE#
M_F<>B"Z3M Z7I'56)FF525H%2]+:SYCJ-=HP\CPAF1>]61O&/1RB:.J\[,NX
MP;##^<(93 19[(VS3D^O5FM)+\943R_XL1"-BY3MB:@0;/-K+V5X+F7V<%[V
M5T[=B[JM):ZUY;,\?J%9$XKT85F,KHV-)[#T-?3"?K"<A7VM)6/7"$?I)CV7
MDZGMSAA/NTS6(&W1J"<S'KX)1J,>/'VP<B<<6*GT_LW'0/44B5@46=52TKSB
MLV'%^ED96Z;)G/<1H'O8I_N)":%=(5F%3F2Z>@63$^-QB2(0,O48#=(3-3I4
M$9>_(JJUI-W8/$?N']OS6,:*-HP.F&IT7_+C;CZ[K[EL;A^VQ'-X]5G44DDX
M!1S 3ZL]C732#)>:A,^"R/="*9N]-1\Y506]?8PBNKO?/$BQ0[7?7I(OF+KF
M;O1>JMIOZ)V.8IB>2NUS>;]K/=Y><G=*0"_U>.)BO%%=UF(OGR)OMW:JR+.Q
MNB1];)ZK7IKJ;M3U>J. NOMU:9A$A[H-TQ_;2XK!YD/<O)$FPPS'T.?CWA>D
M0BPS)'V?H)9H*HMIA"Z@=&F,-U(A&1.GE*UI4ZZC:-DJM(<1$#*P\P!J#W-M
MY;'DQK2^V*EUN6S9$0Y/2YG4JNW%ZPX]GQXY6Z)'A"Y*]M[E,Y3I[D(B>B52
M.TL3#_?">PH=L7'C7<%Y//=CH;ONYL,RVGJCL7@17@I]Y94RSFK;3.IWELQ]
M:PC*HQ]?D]17WHDFI;X32?MJ-F157M:.(?OGOW@?:7I,_NR )6#;,VQ#]##V
M&/LW"*O3\]+J:B\MZ8MI[+]T4M2I/(O)<2PLV$9#2!81.0#_+"8231=1HON;
MN7,=58:EQ.XA-/(65'!:&KQ>5:B$-=S!3CNEQK4Y=Y#[?0E_#^C'C]U_RU]!
M!ZK;E.(P_,$=PWI3K[>S.N0/6.05FK$KF$S6FF^3GRUP50[,ON&/.9S]X=AB
M3_#7<]YE%+M&."&6!1"XP  \.>G;;BLN4%*R-RJ8G#!&.)(#;7A,$E4E%J^'
M$X;%M000^/>_(7Q*\QED#AVCCHNYS9Q7.09U>:S*B<25T'<)>;52;ZF'@$<C
M?^5$LIPJ[*BBIJZ?=1>]=8Y$:0EDD%CPS&Q4"]&8;'_SU(17YJ(\B' >S?-Y
M<FT#\WJ#F>;A1<0S$&O<OS 2&=1ZW;-\WCR0!'W\(%Z8:@-;R(5T!;;[+ +T
M' 2D^?F/4P9XB.(QO+<[9C&#0/(M  @H>LLQ0S3L9)0FVC5I',KK?9;YC"$6
MCR<4$?()4E5D5DK77KP+#O.C,@+=FYC@A0# KPOEE4Q(EJ_#43"V-8IRZ47F
M$%@:$:R^5^]A"8\9?@A6K1\U$N3K3CU6D4I2I#&'V-Q W@(M)]__,4_D@D>K
M)?,MX5O,62B"KVI]7TIQV?F@?W^>V3>@WE/<9O$).2;2%%\Q(I+Y4V!A,7;&
MY,"*=U;5OAF.\2B+6&V:KP9P".D1P_<QJ9H2OF,KE$R/"0O&KNG:[B/2!Z$=
M=95A#T/L_93<"D9U>#A']M"I<$@-$Z*KJIU;WC"<^ '10\ZZ?EZ6RHN]HE8L
M)A99Y&P_ 5N YY\,(&W*P"/SB;H-\%3YH1O:)N;YAS;5]O$591-7?P5<> M1
M*BD /8W@ ,F KI8%^!OR1A8)\)@,F<5R.$!>GP <N:#>GJF^DK !D(4O1>4-
MEC,- S^N^,._?<(>&I7[X=C%WA#H:>+C$]=DMFQ#$3L>%,9)S-S>3#VM-V_[
M\"EV7'M?H\EH#?.8)@L&]'#,S-"6U3H+=G+"9O'10^7V=<P'E,SZ (M^LJEA
M-EE+C5ZMU\4F> QLDRFF@'HADSFZOW%\\Z1E,ELP]7>*/.T\1K^#MSF,?N=)
MPB/+>1#=B3AH4YG.ZV5L<RK%E'A$96WZ$_-6@X%KSN ?+['B[XQZB$1K+N9,
M>X^#MXUV&^A%_.?=!XVJ84 ^2CX8N$'@3G )4\EW"]M;S!J6F _,S=^B"2A7
M^'[@KW3PN5?#N=#7Q\*JE2GR^9?F9%S!=&V12L,I(+D7; -DF011X#_\OW?(
MEOM(^A6G6$A<SN3REG"D1$+R(9!1XOD(>&X>&,^_!M['OZ#<R18R->QAVNSM
M3<C($HXNR-.EZ,CQFM5I=&\^_D&U&.B/PS&P-#9JGDX19"7<I;S_95VB7,95
M6[SP;\O>U?@E;0)Y>,[MN2C2@E\^_^/?K<K%U360QJ3BF8^58$Q>A0G6;65H
M@Z4?5,"&!7,33.O*N>_?B5\JXV!B5QB?(5X9P[YLC@,@F:4QC];9_&0.:^M
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M,@.;V@(=_L$29D?*L!BZH&V1+N?T(1@3H+^B#OEDRO@6\)-<FNO3ETNMBX8
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MC=7&SOXS>%,[W0OOB0/-R_8,<<&+>E 9<YM<F,1"F&^)F5WT\RGQOU?\RSJ
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M.F6^85SUS%YQY4Q/3(H*7^?1OMJ39AY-UNRQ36&,B?9&U>I_J66N13"JF6/
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M_NA=RK3O=()H1QVHT5Q*+#B<9?B7J*MSA<DU@M?DI^O8&U3(=S#5O=!?ITW
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MZ %"LO&YWMW]LA]V]S[7=3[,?\Y<\YO[S'_NH4Y2%X SID8F1@ ='1UPG_8
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M@O8AA#KU'U!+ 0(4 Q0    ( +J DEG5)BMMD^L  )KM   '
M  "  0    !C,#(N:G!G4$L! A0#%     @ NH"263\N<T_4S0  *,\   <
M             ( !N.L  &,P,RYJ<&=02P$"% ,4    " "Z@))938,YH\/F
M  !(Z0  "0              @ &QN0$ 8V)D,#$N:G!G4$L! A0#%     @
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M2P$"% ,4    " "Z@))9",V-1"X:  #G.P$ $0              @ 'TN@(
M>6-B9"TR,#(T,#DS,"YX<V102P$"% ,4    " "Z@))9' LC$.$1  #F#P$
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M,#(T,#DS,%]P<F4N>&UL4$L! A0#%     @ NH"269(F@0F&3P( O'(= !4
M             ( !=SP$ 'EC8F0R,#(T,#DS,&-?,3!K+FAT;5!+ 0(4 Q0
M   ( +J DEFKE+-=Y1(  )@3   0              "  3",!@!Y8V)D7S$P
?:VQO9V\N:G!G4$L%!@     .  X 60,  $.?!@    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>ycbd20240930c_10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:thunderdome="http://www.RDGFilings.com"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:ycbd="http://www.cbdmd.com/20240930">
    <link:schemaRef xlink:href="ycbd-20240930.xsd" xlink:type="simple"/>
    <context id="d_2023-10-01_2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="i_2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="i_2024-12-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2024-12-16</instant>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="i_2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="i_2022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="i_2023-12-31_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="i_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="i_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="i_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="i_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="i_2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="i_2024-03-31_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="i_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="i_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="i_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="i_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="i_2024-06-30_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="i_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="i_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="i_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="i_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="i_2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="i_2024-09-30_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2022-09-30_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i_2022-09-30_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i_2022-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i_2022-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i_2022-09-30_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i_2022-12-31_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i_2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i_2023-03-31_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i_2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-PublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-PublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-PublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-PublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-PublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_SubsidiarySaleOfStockAxis-PublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-06-30_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="i_2023-06-30_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="i_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="i_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="i_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="i_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="i_2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_SubsidiarySaleOfStockAxis-CommitmentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-09-30_SubsidiarySaleOfStockAxis-CapitalRaiseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:CapitalRaiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-04-12_2023-04-12_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">ycbd:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-12</startDate>
            <endDate>2023-04-12</endDate>
        </period>
    </context>
    <context id="i_2024-09-30_RangeAxis-MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_RangeAxis-MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-ManufacturingEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ycbd:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-SoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ycbd:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdmdAndDirectcbdonlineTrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:CbdmdAndDirectcbdonlineTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TrademarkRelatedToHempMdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ycbd:SalesChannelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-01-30_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-30</startDate>
            <endDate>2024-01-30</endDate>
        </period>
    </context>
    <context id="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-30</instant>
        </period>
    </context>
    <context id="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember_RangeAxis-MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">ycbd:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-16</startDate>
            <endDate>2023-02-16</endDate>
        </period>
    </context>
    <context id="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember_RangeAxis-MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">ycbd:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-16</startDate>
            <endDate>2023-02-16</endDate>
        </period>
    </context>
    <context id="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">ycbd:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-16</startDate>
            <endDate>2023-02-16</endDate>
        </period>
    </context>
    <context id="d_2022-04-07_2022-04-07_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ycbd:SteadyStateLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-07</startDate>
            <endDate>2022-04-07</endDate>
        </period>
    </context>
    <context id="i_2022-04-07_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ycbd:SteadyStateLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-07</instant>
        </period>
    </context>
    <context id="d_2023-09-30_2023-09-30_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ycbd:SteadyStateLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-30</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-09-30_2024-09-30_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ycbd:SteadyStateLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ycbd:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-ComputersFurnitureAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ycbd:ComputersFurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-ComputersFurnitureAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ycbd:ComputersFurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-ManufacturingEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ycbd:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-AutomobilesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-AutomobilesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdmdAndDirectcbdonlineTrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:CbdmdAndDirectcbdonlineTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-08-01_2024-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ycbd:CaseWithMajikMedicinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="d_2025-08-01_2025-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember_StatementScenarioAxis-ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ycbd:CaseWithMajikMedicinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="d_2024-08-01_2024-08-31_CounterpartyNameAxis-MajikMedicinesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="i_2024-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToCbdmdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TrademarkRelatedToCbdmdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToCbdmdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TrademarkRelatedToCbdmdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TrademarkRelatedToHempMdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TrademarkRelatedToHempMdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdMdLimintedMarkMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:CbdMdLimintedMarkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdMdLimintedMarkMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:CbdMdLimintedMarkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TradenameRelatedToDirectCBDOnlineComMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TradenameRelatedToDirectCBDOnlineComMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TradenameRelatedToDirectCBDOnlineComMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ycbd:TradenameRelatedToDirectCBDOnlineComMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-RegisteredCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:RegisteredCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStock2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:UnregisteredCommonStock2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:UnregisteredCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="i_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:UnregisteredCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-30</instant>
        </period>
    </context>
    <context id="d_2018-12-20_2018-12-20_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-20</startDate>
            <endDate>2018-12-20</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member_RangeAxis-MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween1And20000000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member_RangeAxis-MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween1And20000000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween1And20000000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member_RangeAxis-MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween20000001And60000000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member_RangeAxis-MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween20000001And60000000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween20000001And60000000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member_RangeAxis-MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween60000001And140000000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member_RangeAxis-MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween60000001And140000000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween60000001And140000000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween140000001And300000000Member_RangeAxis-MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween140000001And300000000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween140000001And300000000Member_RangeAxis-MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ycbd:EarnoutSharesForRevenueBetween140000001And300000000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-01-11_2024-01-11_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-11</startDate>
            <endDate>2024-01-11</endDate>
        </period>
    </context>
    <context id="i_2019-10-31_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="d_2019-10-01_2019-10-31_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="i_2023-08-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2023-08-30</instant>
        </period>
    </context>
    <context id="i_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-02</instant>
        </period>
    </context>
    <context id="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-02</startDate>
            <endDate>2023-03-02</endDate>
        </period>
    </context>
    <context id="d_2024-02-13_2024-02-13_CounterpartyNameAxis-KeystoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-13</startDate>
            <endDate>2024-02-13</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="d_2024-09-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-08-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:MajikMedicinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-04-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="d_2024-03-01_2024-03-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-01-31_CounterpartyNameAxis-KeystoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-01-31_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ycbd:CureBasedDevelopmentLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="d_2023-09-01_2023-09-30_CounterpartyNameAxis-KeystoneMember_SubsidiarySaleOfStockAxis-PurchaseagreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PurchaseagreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-07-01_2023-07-31_CounterpartyNameAxis-KeystoneMember_SubsidiarySaleOfStockAxis-PurchaseagreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PurchaseagreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-03</startDate>
            <endDate>2023-05-03</endDate>
        </period>
    </context>
    <context id="i_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-03</instant>
        </period>
    </context>
    <context id="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-03</startDate>
            <endDate>2023-05-03</endDate>
        </period>
    </context>
    <context id="i_2023-05-03_ClassOfWarrantOrRightAxis-WarrantsWithPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsWithPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-03</instant>
        </period>
    </context>
    <context id="d_2023-04-24_2023-04-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2023-04-24</startDate>
            <endDate>2023-04-24</endDate>
        </period>
    </context>
    <context id="d_2023-04-01_2023-04-30_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:KeystoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ycbd:CommitmentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="d_2023-01-30_2023-02-02_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:A360MediaLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:AdvertisingPlacementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-30</startDate>
            <endDate>2023-02-02</endDate>
        </period>
    </context>
    <context id="i_2023-02-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:A360MediaLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:AdvertisingPlacementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-01</instant>
        </period>
    </context>
    <context id="i_2023-06-30_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:A360MediaLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:AdvertisingPlacementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="i_2023-06-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:A360MediaLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ycbd:AdvertisingPlacementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-01</instant>
        </period>
    </context>
    <context id="d_2023-01-01_2023-01-31_CounterpartyNameAxis-TwentyTwoCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:TwentyTwoCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-04-01_TitleOfIndividualAxis-BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="i_2024-04-01_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="d_2024-04-01_2024-04-01_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="d_2023-01-30_2023-02-28_TitleOfIndividualAxis-BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-30</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="i_2023-02-28_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="d_2023-01-30_2023-02-28_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-30</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-01-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i_2023-01-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="d_2023-01-01_2023-01-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:VestingAnnuallyOverThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:VestingAnnuallyOverThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="d_2022-12-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:VestingAnnuallyOverThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestUponAchievingCertainRevenuePerformanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:VestUponAchievingCertainRevenuePerformanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="i_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="i_2015-06-02_PlanNameAxis-The2015PlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ycbd:The2015PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-06-02</instant>
        </period>
    </context>
    <context id="i_2015-06-02_PlanNameAxis-The2015PlanMember_RangeAxis-MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ycbd:The2015PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-06-02</instant>
        </period>
    </context>
    <context id="d_2019-04-19_2019-04-19_PlanNameAxis-The2015PlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ycbd:The2015PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-19</startDate>
            <endDate>2019-04-19</endDate>
        </period>
    </context>
    <context id="i_2021-01-08_PlanNameAxis-The2021PlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ycbd:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-08</instant>
        </period>
    </context>
    <context id="i_2021-01-08_PlanNameAxis-The2021PlanMember_RangeAxis-MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ycbd:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-08</instant>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_RangeAxis-MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_RangeAxis-MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2021-10-01_2022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-SharebasedPaymentArrangementTrancheFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:SharebasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-SharebasedPaymentArrangementTrancheFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ycbd:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:SharebasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-01-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ycbd:VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i_2022-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ycbd:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i_2022-10-01_AwardTypeAxis-WarrantsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ycbd:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-01</instant>
        </period>
    </context>
    <context id="i_2023-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ycbd:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ycbd:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringSeptember2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsExpiringSeptember2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringMay2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsExpiringMay2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringOctober2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsExpiringOctober2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringJanuary2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsExpiringJanuary2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringApril2028Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:WarrantsExpiringApril2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2024-03-20_LeaseContractualTermAxis-ForbearanceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:ForbearanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-20</instant>
        </period>
    </context>
    <context id="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember_RangeAxis-MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-30</instant>
        </period>
    </context>
    <context id="i_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="i_2023-03-31_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ycbd:Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-04-01_2024-06-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-SeriesACumulativeConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ycbd:SeriesACumulativeConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="i_2018-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="d_2024-10-01_2024-12-17_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_SubsequentEventTypeAxis-SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">ycbd:ConversionOfNotesIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-17</endDate>
        </period>
    </context>
    <context id="i_2024-12-17_SubsequentEventTypeAxis-SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-17</instant>
        </period>
    </context>
    <context id="i_2024-11-26_LeaseContractualTermAxis-WarehouseLeaseMember_SubsequentEventTypeAxis-SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:WarehouseLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-26</instant>
        </period>
    </context>
    <context id="i_2026-02-28_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:WarehouseLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-28</instant>
        </period>
    </context>
    <context id="d_2025-03-01_2026-02-28_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:WarehouseLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="i_2026-09-30_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:WarehouseLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="d_2026-03-01_2026-09-30_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">ycbd:WarehouseLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="d_2024-11-01_2024-11-30_AwardTypeAxis-RestrictedStockMember_CounterpartyNameAxis-ConsultantMember_SubsequentEventTypeAxis-SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ycbd:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ClassOfWarrantOrRightAxis-EquityClassifiedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="d_2023-10-01_2024-09-30_ClassOfWarrantOrRightAxis-CommonStockPurchaseWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001644903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ycbd:CommonStockPurchaseWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Share">
        <measure>shares</measure>
    </unit>
    <unit id="NonApplicable">
        <measure>thunderdome:item</measure>
    </unit>
    <unit id="USDPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Year">
        <measure>utr:Y</measure>
    </unit>
    <unit id="Month">
        <measure>utr:M</measure>
    </unit>
    <unit id="SquareFoot">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="USDPerPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>thunderdome:item</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="d_2023-10-01_2024-09-30"
      id="thunderdome-EntityCentralIndexKey">0001644903</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName
      contextRef="d_2023-10-01_2024-09-30"
      id="thunderdome-EntityRegistrantName">cbdMD, Inc.</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="d_2023-10-01_2024-09-30" id="ixv-13116">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="d_2023-10-01_2024-09-30" id="ixv-13117">--09-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="d_2023-10-01_2024-09-30" id="ixv-13118">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="d_2023-10-01_2024-09-30" id="ixv-13119">2024</dei:DocumentFiscalYearFocus>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="d_2024-07-01_2024-09-30" id="c121825173">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="d_2024-07-01_2024-09-30" id="c121825647">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="d_2024-07-01_2024-09-30" id="c121825648">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="d_2024-07-01_2024-09-30" id="c121825649">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ycbd:LongtermDebtExcludingConvertibleNotesNoncurrent
      contextRef="i_2024-09-30"
      id="c121824077"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i_2024-09-30"
      id="c121827158"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i_2023-09-30"
      id="c121827159"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825623"
      unitRef="Share">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825624"
      unitRef="Share">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825625"
      unitRef="USDPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825626"
      unitRef="USDPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825627"
      unitRef="Share">5000000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825629"
      unitRef="Share">5000000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825628"
      unitRef="Share">5000000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825630"
      unitRef="Share">5000000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825631"
      unitRef="Share">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825632"
      unitRef="Share">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825633"
      unitRef="USDPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825634"
      unitRef="USDPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825635"
      unitRef="Share">3939057</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825637"
      unitRef="Share">3939057</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825636"
      unitRef="Share">2960573</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825638"
      unitRef="Share">2960573</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="d_2023-04-12_2023-04-12_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember"
      decimals="INF"
      id="c121825181"
      unitRef="Pure">45</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-ManufacturingEquipmentMember"
      id="c121825195">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-SoftwareMember"
      id="c121825196">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i_2024-09-30"
      decimals="-3"
      id="c121825240"
      unitRef="USD">0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i_2024-09-30"
      decimals="-3"
      id="c121825244"
      unitRef="USD">0</us-gaap:ContractWithCustomerAssetNet>
    <ycbd:NumberOfMajorCustomers
      contextRef="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember"
      decimals="-3"
      id="c121825261"
      unitRef="Pure">0</ycbd:NumberOfMajorCustomers>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember_RangeAxis-MinimumMember"
      decimals="INF"
      id="c121825285"
      unitRef="Pure">20</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember_RangeAxis-MaximumMember"
      decimals="INF"
      id="c121825286"
      unitRef="Pure">50</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="d_2023-02-16_2023-02-16_NonmonetaryTransactionTypeAxis-ReverseStockSplitMember"
      decimals="INF"
      id="c121825288"
      unitRef="Pure">45</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <ycbd:LengthOfConsultingAgreement
      contextRef="d_2024-08-01_2024-08-31_CounterpartyNameAxis-MajikMedicinesMember"
      id="c121825337">P5Y</ycbd:LengthOfConsultingAgreement>
    <ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod
      contextRef="i_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStockMember"
      id="c121825352">P5Y</ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod>
    <ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member_RangeAxis-MinimumMember"
      decimals="INF"
      id="c121825661"
      unitRef="USD">1</ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue>
    <ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member_RangeAxis-MaximumMember"
      decimals="INF"
      id="c121825662"
      unitRef="USD">20000000</ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue>
    <ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member_RangeAxis-MinimumMember"
      decimals="INF"
      id="c121825663"
      unitRef="USD">20000001</ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue>
    <ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member_RangeAxis-MaximumMember"
      decimals="INF"
      id="c121825664"
      unitRef="USD">60000000</ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue>
    <ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member_RangeAxis-MinimumMember"
      decimals="INF"
      id="c121825665"
      unitRef="USD">60000001</ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue>
    <ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member_RangeAxis-MaximumMember"
      decimals="INF"
      id="c121825666"
      unitRef="USD">140000000</ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue>
    <ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween140000001And300000000Member_RangeAxis-MinimumMember"
      decimals="INF"
      id="c121825667"
      unitRef="USD">140000001</ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue>
    <ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween140000001And300000000Member_RangeAxis-MaximumMember"
      decimals="INF"
      id="c121825668"
      unitRef="USD">300000000</ycbd:BusinessAcquisitionContingentConsiderationAggregateNetRevenue>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      decimals="INF"
      id="c121825669"
      unitRef="Share">5000000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      decimals="INF"
      id="c121825670"
      unitRef="Share">5000000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      decimals="INF"
      id="c121825671"
      unitRef="Share">5000000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="d_2022-10-01_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      decimals="2"
      id="c121825672"
      unitRef="Pure">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825673"
      unitRef="Share">3939057</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825674"
      unitRef="Share">2960573</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="d_2024-04-01_2024-04-01_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember"
      id="c121825448">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="d_2023-01-30_2023-02-28_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember"
      id="c121825454">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="d_2023-01-01_2023-01-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"
      id="c121825459">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="d_2022-12-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember"
      id="c121825465">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="d_2023-10-01_2024-09-30_RangeAxis-MinimumMember"
      id="c121825508">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="d_2023-10-01_2024-09-30_RangeAxis-MaximumMember"
      id="c121825509">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="d_2023-10-01_2024-09-30_RangeAxis-MinimumMember"
      id="c121825510">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="d_2023-10-01_2024-09-30_RangeAxis-MaximumMember"
      id="c121825511">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheOneMember"
      decimals="4"
      id="c121825521"
      unitRef="Pure">0.0025</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheOneMember"
      decimals="4"
      id="c121825696"
      unitRef="Pure">0.0025</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheTwoMember"
      decimals="4"
      id="c121825697"
      unitRef="Pure">0.0025</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheOneMember"
      decimals="4"
      id="c121825524"
      unitRef="Pure">0.0025</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheThreeMember"
      decimals="4"
      id="c121825698"
      unitRef="Pure">0.0025</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-ShareBasedCompensationAwardTrancheThreeMember"
      decimals="4"
      id="c121825525"
      unitRef="Pure">0.0025</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-SharebasedPaymentArrangementTrancheFourMember"
      decimals="4"
      id="c121825699"
      unitRef="Pure">0.0025</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember_VestingAxis-SharebasedPaymentArrangementTrancheFourMember"
      decimals="4"
      id="c121825527"
      unitRef="Pure">0.0025</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="i_2024-11-26_LeaseContractualTermAxis-WarehouseLeaseMember_SubsequentEventTypeAxis-SubsequentEventMember"
      id="c121825615">P19M</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <dei:DocumentType contextRef="d_2023-10-01_2024-09-30" id="ixv-16191">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="d_2023-10-01_2024-09-30" id="ixv-16192">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="d_2023-10-01_2024-09-30" id="ixv-16193">2024-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="d_2023-10-01_2024-09-30" id="ixv-16194">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="d_2023-10-01_2024-09-30" id="ixv-16195">001-38299</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="d_2023-10-01_2024-09-30" id="ixv-16196">NC</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="d_2023-10-01_2024-09-30" id="ixv-16197">47-3414576</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d_2023-10-01_2024-09-30" id="ixv-16198">2101 Westinghouse Blvd., Suite A</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d_2023-10-01_2024-09-30" id="ixv-16199">Charlotte</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d_2023-10-01_2024-09-30" id="ixv-16200">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d_2023-10-01_2024-09-30" id="ixv-16201">28273</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d_2023-10-01_2024-09-30" id="ixv-16202">704</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d_2023-10-01_2024-09-30" id="ixv-16203">445-3060</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-CommonStockMember"
      id="ixv-16204">common</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-CommonStockMember"
      id="ixv-16205">YCBD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-CommonStockMember"
      id="ixv-16206">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      id="ixv-16207">8% Series A Cumulative Convertible Preferred Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      id="ixv-16208">YCBDpA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      id="ixv-16209">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="d_2023-10-01_2024-09-30" id="ixv-16210">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="d_2023-10-01_2024-09-30" id="ixv-16211">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="d_2023-10-01_2024-09-30" id="ixv-16212">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="d_2023-10-01_2024-09-30" id="ixv-16213">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="d_2023-10-01_2024-09-30" id="ixv-16214">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="d_2023-10-01_2024-09-30" id="ixv-16215">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="d_2023-10-01_2024-09-30" id="ixv-16216">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="d_2023-10-01_2024-09-30" id="ixv-16217">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="d_2023-10-01_2024-09-30" id="ixv-16218">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="d_2023-10-01_2024-09-30" id="ixv-16219">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i_2024-03-31"
      decimals="INF"
      id="ixv-16220"
      unitRef="USD">2832040</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i_2024-12-16"
      decimals="INF"
      id="ixv-16221"
      unitRef="Share">5539124</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorFirmId contextRef="d_2023-10-01_2024-09-30" id="ixv-16222">677</dei:AuditorFirmId>
    <dei:AuditorName contextRef="d_2023-10-01_2024-09-30" id="ixv-16223">Cherry Bekaert LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="d_2023-10-01_2024-09-30" id="ixv-16224">Charlotte, North Carolina</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824026"
      unitRef="USD">2452553</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824027"
      unitRef="USD">1797860</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824028"
      unitRef="USD">983910</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824029"
      unitRef="USD">1216090</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:InventoryGross
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824030"
      unitRef="USD">2365187</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824031"
      unitRef="USD">4052972</us-gaap:InventoryGross>
    <ycbd:PrepaidInventory
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824032"
      unitRef="USD">159006</ycbd:PrepaidInventory>
    <ycbd:PrepaidInventory
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824033"
      unitRef="USD">182675</ycbd:PrepaidInventory>
    <ycbd:PrepaidSponsorship
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824034"
      unitRef="USD">21754</ycbd:PrepaidSponsorship>
    <ycbd:PrepaidSponsorship
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824035"
      unitRef="USD">70061</ycbd:PrepaidSponsorship>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824036"
      unitRef="USD">406674</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824037"
      unitRef="USD">750383</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824038"
      unitRef="USD">6389084</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824039"
      unitRef="USD">8070041</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824040"
      unitRef="USD">454268</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824041"
      unitRef="USD">716579</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824042"
      unitRef="USD">85817</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824043"
      unitRef="USD">3350865</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824044"
      unitRef="USD">62708</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824045"
      unitRef="USD">138708</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824046"
      unitRef="USD">2889580</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824047"
      unitRef="USD">3219090</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherLongTermInvestments
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824048"
      unitRef="USD">700000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824049"
      unitRef="USD">700000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherAssets
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824050"
      unitRef="USD">4192373</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824051"
      unitRef="USD">8125242</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824052"
      unitRef="USD">10581457</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824053"
      unitRef="USD">16195283</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824061"
      unitRef="USD">1541108</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824062"
      unitRef="USD">1906319</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824063"
      unitRef="USD">632674</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824064"
      unitRef="USD">632195</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824065"
      unitRef="USD">4671000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824066"
      unitRef="USD">667000</us-gaap:DividendsPayableCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824067"
      unitRef="USD">503254</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824068"
      unitRef="USD">185246</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824069"
      unitRef="USD">98696</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824070"
      unitRef="USD">1277089</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824071"
      unitRef="USD">1171308</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824072"
      unitRef="USD">0</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824073"
      unitRef="USD">0</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824074"
      unitRef="USD">2492</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824075"
      unitRef="USD">8618040</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824076"
      unitRef="USD">4670341</us-gaap:LiabilitiesCurrent>
    <ycbd:LongtermDebtExcludingConvertibleNotesNoncurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824078"
      unitRef="USD">9</ycbd:LongtermDebtExcludingConvertibleNotesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824079"
      unitRef="USD">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824080"
      unitRef="USD">2403286</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824081"
      unitRef="USD">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824082"
      unitRef="USD">90363</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824083"
      unitRef="USD">0</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824084"
      unitRef="USD">2493658</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824085"
      unitRef="USD">8618040</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824086"
      unitRef="USD">7163999</us-gaap:Liabilities>
    <us-gaap:PreferredStockValue
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824087"
      unitRef="USD">5000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824088"
      unitRef="USD">5000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824089"
      unitRef="USD">3939</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824090"
      unitRef="USD">2961</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824091"
      unitRef="USD">184029565</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824092"
      unitRef="USD">183387095</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824093"
      unitRef="USD">-7189</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824094"
      unitRef="USD">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824095"
      unitRef="USD">-182067898</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824096"
      unitRef="USD">-174363772</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824097"
      unitRef="USD">1963417</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824098"
      unitRef="USD">9031284</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824099"
      unitRef="USD">10581457</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824100"
      unitRef="USD">16195283</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824108"
      unitRef="USD">19922319</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824109"
      unitRef="USD">25053857</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <ycbd:SalesAllowances
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824110"
      unitRef="USD">440152</ycbd:SalesAllowances>
    <ycbd:SalesAllowances
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824111"
      unitRef="USD">898495</ycbd:SalesAllowances>
    <us-gaap:Revenues
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824112"
      unitRef="USD">19482167</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824113"
      unitRef="USD">24155362</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824114"
      unitRef="USD">7486626</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824115"
      unitRef="USD">9177703</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824116"
      unitRef="USD">11995541</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824117"
      unitRef="USD">14977659</us-gaap:GrossProfit>
    <ycbd:OperatingExpensesExcludingImpairment
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824118"
      unitRef="USD">15310951</ycbd:OperatingExpensesExcludingImpairment>
    <ycbd:OperatingExpensesExcludingImpairment
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824119"
      unitRef="USD">24246208</ycbd:OperatingExpensesExcludingImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824120"
      unitRef="USD">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824121"
      unitRef="USD">13219000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:OperatingIncomeLoss
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824122"
      unitRef="USD">-3315410</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824123"
      unitRef="USD">-22487549</us-gaap:OperatingIncomeLoss>
    <us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824124"
      unitRef="USD">0</us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments>
    <us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824125"
      unitRef="USD">-700000</us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824126"
      unitRef="USD">-74580</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824127"
      unitRef="USD">-185638</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <ycbd:FairValueAdjustmentOfDebt
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824128"
      unitRef="USD">-429789</ycbd:FairValueAdjustmentOfDebt>
    <ycbd:FairValueAdjustmentOfDebt
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824129"
      unitRef="USD">0</ycbd:FairValueAdjustmentOfDebt>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824130"
      unitRef="USD">-29507</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824131"
      unitRef="USD">63702</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824132"
      unitRef="USD">-3700126</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824133"
      unitRef="USD">-22938209</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824134"
      unitRef="USD">-0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824135"
      unitRef="USD">-0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824136"
      unitRef="USD">-3700126</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824137"
      unitRef="USD">-22938209</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824138"
      unitRef="USD">4004001</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824139"
      unitRef="USD">4002000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824140"
      unitRef="USD">-7704127</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824141"
      unitRef="USD">-26940209</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824142"
      unitRef="USDPerShare">-1.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824143"
      unitRef="USDPerShare">-13.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824144"
      unitRef="Share">4312546</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824145"
      unitRef="Share">2022320</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824149"
      unitRef="USD">-3700126</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824150"
      unitRef="USD">-22938209</us-gaap:NetIncomeLoss>
    <ycbd:ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824151"
      unitRef="USD">-3700126</ycbd:ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments>
    <ycbd:ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824152"
      unitRef="USD">-22938209</ycbd:ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824153"
      unitRef="USD">4004001</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824154"
      unitRef="USD">4002000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824155"
      unitRef="USD">-7704127</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824156"
      unitRef="USD">-26940209</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824159"
      unitRef="USD">-3700126</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824160"
      unitRef="USD">-22938209</us-gaap:NetIncomeLoss>
    <us-gaap:StockOptionPlanExpense
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824161"
      unitRef="USD">5015</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824162"
      unitRef="USD">233666</us-gaap:StockOptionPlanExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824163"
      unitRef="USD">11885</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824164"
      unitRef="USD">109202</us-gaap:RestrictedStockExpense>
    <ycbd:WriteOffOfPrepaidAssets
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824165"
      unitRef="USD">0</ycbd:WriteOffOfPrepaidAssets>
    <ycbd:WriteOffOfPrepaidAssets
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824166"
      unitRef="USD">884892</ycbd:WriteOffOfPrepaidAssets>
    <us-gaap:InventoryWriteDown
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824167"
      unitRef="USD">921314</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824168"
      unitRef="USD">175499</us-gaap:InventoryWriteDown>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824169"
      unitRef="USD">697510</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824170"
      unitRef="USD">1396459</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:Depreciation
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824171"
      unitRef="USD">452326</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824172"
      unitRef="USD">404280</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824173"
      unitRef="USD">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824174"
      unitRef="USD">13219000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824175"
      unitRef="USD">-74580</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824176"
      unitRef="USD">-185638</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <ycbd:FairValueAdjustmentOfDebt
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824177"
      unitRef="USD">-429789</ycbd:FairValueAdjustmentOfDebt>
    <ycbd:FairValueAdjustmentOfDebt
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824178"
      unitRef="USD">-0</ycbd:FairValueAdjustmentOfDebt>
    <ycbd:OtherthantemporaryImpairmentsOnOtherInvestments
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824179"
      unitRef="USD">0</ycbd:OtherthantemporaryImpairmentsOnOtherInvestments>
    <ycbd:OtherthantemporaryImpairmentsOnOtherInvestments
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824180"
      unitRef="USD">700000</ycbd:OtherthantemporaryImpairmentsOnOtherInvestments>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824181"
      unitRef="USD">-696280</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="d_2022-10-01_2023-09-30"
      id="c121824182"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824183"
      unitRef="USD">670621</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824184"
      unitRef="USD">1126976</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824185"
      unitRef="USD">-232180</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824186"
      unitRef="USD">-278482</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824187"
      unitRef="USD">-76000</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824188"
      unitRef="USD">-105898</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824189"
      unitRef="USD">-766472</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824190"
      unitRef="USD">-27443</us-gaap:IncreaseDecreaseInInventories>
    <ycbd:IncreaseDecreaseInPrepaidInventoryTotal
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824191"
      unitRef="USD">-23670</ycbd:IncreaseDecreaseInPrepaidInventoryTotal>
    <ycbd:IncreaseDecreaseInPrepaidInventoryTotal
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824192"
      unitRef="USD">-328784</ycbd:IncreaseDecreaseInPrepaidInventoryTotal>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824193"
      unitRef="USD">-396311</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824194"
      unitRef="USD">-2095323</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824195"
      unitRef="USD">-1124141</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824196"
      unitRef="USD">-1290141</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824197"
      unitRef="USD">-1151326</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824198"
      unitRef="USD">-1178683</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824199"
      unitRef="USD">318008</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824200"
      unitRef="USD">203341</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <ycbd:CollectionOnDiscontinuedOperationsAccountsReceivable
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824201"
      unitRef="USD">0</ycbd:CollectionOnDiscontinuedOperationsAccountsReceivable>
    <ycbd:CollectionOnDiscontinuedOperationsAccountsReceivable
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824202"
      unitRef="USD">1375</ycbd:CollectionOnDiscontinuedOperationsAccountsReceivable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824203"
      unitRef="USD">-352792</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824204"
      unitRef="USD">-4302051</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824205"
      unitRef="USD">0</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824206"
      unitRef="USD">1000000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824207"
      unitRef="USD">100000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824208"
      unitRef="USD">-0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824209"
      unitRef="USD">190015</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824210"
      unitRef="USD">297549</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824211"
      unitRef="USD">-290015</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824212"
      unitRef="USD">702451</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824213"
      unitRef="USD">50001</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824214"
      unitRef="USD">2478325</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromRepaymentsOfNotesPayable
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824215"
      unitRef="USD">1247499</us-gaap:ProceedsFromRepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromRepaymentsOfNotesPayable
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824216"
      unitRef="USD">-132599</us-gaap:ProceedsFromRepaymentsOfNotesPayable>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824217"
      unitRef="USD">-0</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824218"
      unitRef="USD">3668500</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824219"
      unitRef="USD">1297500</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824220"
      unitRef="USD">-1322774</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824221"
      unitRef="USD">654693</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824222"
      unitRef="USD">-4922374</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824223"
      unitRef="USD">1797860</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i_2022-09-30"
      decimals="INF"
      id="c121824224"
      unitRef="USD">6720234</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824225"
      unitRef="USD">2452553</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824226"
      unitRef="USD">1797860</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824234"
      unitRef="USD">74638</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824235"
      unitRef="USD">6399</us-gaap:InterestPaidNet>
    <ycbd:IssuanceOfSharesForConversionOfDebtAndAccruedInterest
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824236"
      unitRef="USD">515601</ycbd:IssuanceOfSharesForConversionOfDebtAndAccruedInterest>
    <ycbd:IssuanceOfSharesForConversionOfDebtAndAccruedInterest
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824237"
      unitRef="USD">0</ycbd:IssuanceOfSharesForConversionOfDebtAndAccruedInterest>
    <us-gaap:StockIssued1
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824238"
      unitRef="USD">40725</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824239"
      unitRef="USD">0</us-gaap:StockIssued1>
    <ycbd:PreferredDividendsAccruedNotYetPaid
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824240"
      unitRef="USD">4004001</ycbd:PreferredDividendsAccruedNotYetPaid>
    <ycbd:PreferredDividendsAccruedNotYetPaid
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824241"
      unitRef="USD">667000</ycbd:PreferredDividendsAccruedNotYetPaid>
    <us-gaap:SharesOutstanding
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824268"
      unitRef="Share">2960573</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824269"
      unitRef="USD">2961</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824270"
      unitRef="Share">5000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824271"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824272"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824273"
      unitRef="USD">183387095</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824274"
      unitRef="USD">-174363772</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824275"
      unitRef="USD">9031284</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824276"
      unitRef="Share">483</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824277"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824278"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824279"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824280"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824281"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824282"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-10-01_2023-12-31"
      decimals="INF"
      id="c121824283"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824285"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824287"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824288"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824289"
      unitRef="USD">1772</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824290"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-10-01_2023-12-31_AwardTypeAxis-EmployeeStockOptionMember"
      decimals="INF"
      id="c121824291"
      unitRef="USD">1772</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824293"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824295"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824296"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824297"
      unitRef="USD">689</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824298"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-10-01_2023-12-31"
      decimals="INF"
      id="c121824299"
      unitRef="USD">689</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824301"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824303"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824304"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824305"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824306"
      unitRef="USD">1000501</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-10-01_2023-12-31"
      decimals="INF"
      id="c121824307"
      unitRef="USD">1000501</us-gaap:DividendsPreferredStockCash>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824309"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824311"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824312"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824313"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-10-01_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824314"
      unitRef="USD">-996501</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-10-01_2023-12-31"
      decimals="INF"
      id="c121824315"
      unitRef="USD">-996501</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i_2023-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824316"
      unitRef="Share">2961056</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824317"
      unitRef="USD">2961</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824318"
      unitRef="Share">5000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824319"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824320"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824321"
      unitRef="USD">183389556</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824322"
      unitRef="USD">-176360774</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-12-31"
      decimals="INF"
      id="c121824323"
      unitRef="USD">7036743</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824324"
      unitRef="Share">19930</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824325"
      unitRef="USD">20</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824326"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824327"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824328"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824329"
      unitRef="USD">15763</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824330"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31"
      decimals="INF"
      id="c121824331"
      unitRef="USD">15783</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824333"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824335"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824336"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824337"
      unitRef="USD">1080</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824338"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-01-01_2024-03-31_AwardTypeAxis-EmployeeStockOptionMember"
      decimals="INF"
      id="c121824339"
      unitRef="USD">1080</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824341"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824343"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824344"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824345"
      unitRef="USD">303</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824346"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-01-01_2024-03-31"
      decimals="INF"
      id="c121824347"
      unitRef="USD">303</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824349"
      unitRef="USD">-0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824351"
      unitRef="USD">-0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824352"
      unitRef="USD">6000</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824353"
      unitRef="USD">-0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824354"
      unitRef="USD">-0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-01-01_2024-03-31"
      decimals="INF"
      id="c121824355"
      unitRef="USD">6000</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824356"
      unitRef="Share">64218</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824357"
      unitRef="USD">64</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824358"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824359"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824360"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824361"
      unitRef="USD">49936</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824362"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-01-01_2024-03-31_StatementClassOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121824363"
      unitRef="USD">50000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824365"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824367"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824368"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824369"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824370"
      unitRef="USD">1000500</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-01-01_2024-03-31"
      decimals="INF"
      id="c121824371"
      unitRef="USD">1000500</us-gaap:DividendsPreferredStockCash>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824373"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824375"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824376"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824377"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-01-01_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824378"
      unitRef="USD">-3010562</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-01-01_2024-03-31"
      decimals="INF"
      id="c121824379"
      unitRef="USD">-3010562</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i_2024-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824380"
      unitRef="Share">3045204</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824381"
      unitRef="USD">3045</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824382"
      unitRef="Share">5000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824383"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824384"
      unitRef="USD">-6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824385"
      unitRef="USD">183456639</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824386"
      unitRef="USD">-180371836</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-03-31"
      decimals="INF"
      id="c121824387"
      unitRef="USD">3086847</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824389"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824391"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824392"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824393"
      unitRef="USD">5376</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824394"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-04-01_2024-06-30"
      decimals="INF"
      id="c121824395"
      unitRef="USD">5.376</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824397"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824399"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824400"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824401"
      unitRef="USD">7167</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824402"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-04-01_2024-06-30"
      decimals="INF"
      id="c121824403"
      unitRef="USD">7.167</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824405"
      unitRef="USD">-0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824407"
      unitRef="USD">-0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824408"
      unitRef="USD">-4800</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824409"
      unitRef="USD">-0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824410"
      unitRef="USD">0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-04-01_2024-06-30"
      decimals="INF"
      id="c121824411"
      unitRef="USD">-4800</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824412"
      unitRef="Share">714229</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824413"
      unitRef="USD">714</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824414"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824415"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824416"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824417"
      unitRef="USD">463980</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824418"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-04-01_2024-06-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember"
      decimals="INF"
      id="c121824419"
      unitRef="USD">464694</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824421"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824423"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824424"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824425"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824426"
      unitRef="USD">1000500</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-04-01_2024-06-30"
      decimals="INF"
      id="c121824427"
      unitRef="USD">1000500</us-gaap:DividendsPreferredStockCash>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824429"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824431"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824432"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824433"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-04-01_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824434"
      unitRef="USD">459737</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-04-01_2024-06-30"
      decimals="INF"
      id="c121824435"
      unitRef="USD">459737</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i_2024-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824436"
      unitRef="Share">3759433</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824437"
      unitRef="USD">3759</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824438"
      unitRef="Share">5000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824439"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824440"
      unitRef="USD">-1200</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824441"
      unitRef="USD">183933162</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824442"
      unitRef="USD">-180912600</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-06-30"
      decimals="INF"
      id="c121824443"
      unitRef="USD">3028121</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824444"
      unitRef="Share">4000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824445"
      unitRef="USD">4</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824446"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824447"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824448"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ycbd:DecreaseInApicIssuanceOfStock
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824449"
      unitRef="USD">4</ycbd:DecreaseInApicIssuanceOfStock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824450"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-07-01_2024-09-30"
      decimals="INF"
      id="c121824451"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824453"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824455"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824456"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824457"
      unitRef="USD">1080</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824458"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2024-07-01_2024-09-30"
      decimals="INF"
      id="c121824459"
      unitRef="USD">1.08</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824461"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824463"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824464"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824465"
      unitRef="USD">3727</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824466"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2024-07-01_2024-09-30"
      decimals="INF"
      id="c121824467"
      unitRef="USD">3.727</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824469"
      unitRef="USD">-0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824471"
      unitRef="USD">-0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824472"
      unitRef="USD">5989</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824473"
      unitRef="USD">-0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824474"
      unitRef="USD">-0</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk
      contextRef="d_2024-07-01_2024-09-30"
      decimals="INF"
      id="c121824475"
      unitRef="USD">5989</ycbd:OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824476"
      unitRef="Share">75000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824477"
      unitRef="USD">75</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-PreferredStockMember"
      id="c121824478"
      unitRef="Share"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-PreferredStockMember"
      id="c121824479"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      id="c121824480"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824481"
      unitRef="USD">40725</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember_StatementEquityComponentsAxis-RetainedEarningsMember"
      id="c121824482"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2024-07-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember"
      decimals="INF"
      id="c121824483"
      unitRef="USD">40800</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824484"
      unitRef="Share">100624</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824485"
      unitRef="USD">101</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824486"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824487"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824488"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824489"
      unitRef="USD">50875</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824490"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="d_2024-07-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember"
      decimals="INF"
      id="c121824491"
      unitRef="USD">50976</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824493"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824495"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824496"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824497"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824498"
      unitRef="USD">1002500</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2024-07-01_2024-09-30"
      decimals="INF"
      id="c121824499"
      unitRef="USD">1002500</us-gaap:DividendsPreferredStockCash>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824501"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824503"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824504"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824505"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-07-01_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824506"
      unitRef="USD">-152798</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-07-01_2024-09-30"
      decimals="INF"
      id="c121824507"
      unitRef="USD">-152798</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i_2024-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824508"
      unitRef="Share">3939057</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824509"
      unitRef="USD">3939</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824510"
      unitRef="Share">5000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824511"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824512"
      unitRef="USD">-7189</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824513"
      unitRef="USD">184029565</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824514"
      unitRef="USD">-182067898</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824515"
      unitRef="USD">1963417</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i_2022-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824516"
      unitRef="Share">1348125</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824517"
      unitRef="USD">1348</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i_2022-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824518"
      unitRef="Share">5000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824519"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824520"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824521"
      unitRef="USD">178841646</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824522"
      unitRef="USD">-147423563</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-09-30"
      decimals="INF"
      id="c121824523"
      unitRef="USD">31424431</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824524"
      unitRef="Share">1038</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824525"
      unitRef="USD">1</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824526"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824527"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824528"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ycbd:DecreaseInApicIssuanceOfStock
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824529"
      unitRef="USD">1</ycbd:DecreaseInApicIssuanceOfStock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824530"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2022-10-01_2022-12-31"
      decimals="INF"
      id="c121824531"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824533"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824535"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824536"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824537"
      unitRef="USD">79446</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824538"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2022-10-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember"
      decimals="INF"
      id="c121824539"
      unitRef="USD">79446</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824541"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824543"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824544"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824545"
      unitRef="USD">43449</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824546"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2022-10-01_2022-12-31"
      decimals="INF"
      id="c121824547"
      unitRef="USD">43449</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824549"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824551"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824552"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824553"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824554"
      unitRef="USD">1000502</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2022-10-01_2022-12-31"
      decimals="INF"
      id="c121824555"
      unitRef="USD">1000502</us-gaap:DividendsPreferredStockCash>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824557"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824559"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824560"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824561"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-10-01_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824562"
      unitRef="USD">-3956062</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-10-01_2022-12-31"
      decimals="INF"
      id="c121824563"
      unitRef="USD">-3956062</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i_2022-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824564"
      unitRef="Share">1349163</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-12-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824565"
      unitRef="USD">1349</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824566"
      unitRef="Share">5000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-12-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824567"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824568"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824569"
      unitRef="USD">178964539</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-12-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824570"
      unitRef="USD">-152380127</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2022-12-31"
      decimals="INF"
      id="c121824571"
      unitRef="USD">26590761</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824572"
      unitRef="Share">8417</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824573"
      unitRef="USD">8</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824574"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824575"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824576"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ycbd:DecreaseInApicIssuanceOfStock
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824577"
      unitRef="USD">8</ycbd:DecreaseInApicIssuanceOfStock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824578"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-01-01_2023-03-31"
      decimals="INF"
      id="c121824579"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824581"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824583"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824584"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824585"
      unitRef="USD">16770</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824586"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-01-01_2023-03-31_AwardTypeAxis-EmployeeStockOptionMember"
      decimals="INF"
      id="c121824587"
      unitRef="USD">16770</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824589"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824591"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824592"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824593"
      unitRef="USD">56801</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824594"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-01-01_2023-03-31"
      decimals="INF"
      id="c121824595"
      unitRef="USD">56801</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824596"
      unitRef="Share">94277</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824597"
      unitRef="USD">94</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824598"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824599"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824600"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824601"
      unitRef="USD">1399906</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824602"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-01-01_2023-03-31"
      decimals="INF"
      id="c121824603"
      unitRef="USD">1400000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824604"
      unitRef="Share">2223</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824605"
      unitRef="USD">2</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824606"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824607"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824608"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824609"
      unitRef="USD">29998</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824610"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="d_2023-01-01_2023-03-31"
      decimals="INF"
      id="c121824611"
      unitRef="USD">30000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824612"
      unitRef="Share">2616</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824613"
      unitRef="USD">3</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824614"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824615"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824616"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824617"
      unitRef="USD">29190</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824618"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-01-01_2023-03-31_StatementClassOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121824619"
      unitRef="USD">29193</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockSplits
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824621"
      unitRef="Share">1</us-gaap:StockIssuedDuringPeriodSharesStockSplits>
    <us-gaap:StockIssuedDuringPeriodSharesStockSplits
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824623"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesStockSplits>
    <us-gaap:StockIssuedDuringPeriodSharesStockSplits
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824624"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesStockSplits>
    <us-gaap:StockIssuedDuringPeriodSharesStockSplits
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824625"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesStockSplits>
    <us-gaap:StockIssuedDuringPeriodSharesStockSplits
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824626"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesStockSplits>
    <us-gaap:StockIssuedDuringPeriodSharesStockSplits
      contextRef="d_2023-01-01_2023-03-31"
      decimals="INF"
      id="c121824627"
      unitRef="Share">1</us-gaap:StockIssuedDuringPeriodSharesStockSplits>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824629"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824631"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824632"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824633"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824634"
      unitRef="USD">1000500</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-01-01_2023-03-31"
      decimals="INF"
      id="c121824635"
      unitRef="USD">1000500</us-gaap:DividendsPreferredStockCash>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824637"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824639"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824640"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824641"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-01-01_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824642"
      unitRef="USD">-1336802</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-01-01_2023-03-31"
      decimals="INF"
      id="c121824643"
      unitRef="USD">-1336802</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824644"
      unitRef="Share">1456696</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-03-31_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824645"
      unitRef="USD">1457</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824646"
      unitRef="Share">5000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-03-31_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824647"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-03-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824648"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-03-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824649"
      unitRef="USD">180497196</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-03-31_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824650"
      unitRef="USD">-154717429</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-03-31"
      decimals="INF"
      id="c121824651"
      unitRef="USD">25786224</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824652"
      unitRef="Share">9000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824653"
      unitRef="USD">9</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824654"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824655"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824656"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824657"
      unitRef="USD">69606</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824658"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30"
      decimals="INF"
      id="c121824659"
      unitRef="USD">69615</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824661"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824663"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824664"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824665"
      unitRef="USD">34663</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824666"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-04-01_2023-06-30_AwardTypeAxis-EmployeeStockOptionMember"
      decimals="INF"
      id="c121824667"
      unitRef="USD">34663</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824669"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824671"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824672"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824673"
      unitRef="USD">4845</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824674"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-04-01_2023-06-30"
      decimals="INF"
      id="c121824675"
      unitRef="USD">4845</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-PublicOfferingMember"
      decimals="INF"
      id="c121824677"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-PublicOfferingMember"
      decimals="INF"
      id="c121824679"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-PublicOfferingMember"
      decimals="INF"
      id="c121824680"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-PublicOfferingMember"
      decimals="INF"
      id="c121824681"
      unitRef="USD">133200</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-PublicOfferingMember"
      decimals="INF"
      id="c121824682"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="d_2023-04-01_2023-06-30_SubsidiarySaleOfStockAxis-PublicOfferingMember"
      decimals="INF"
      id="c121824683"
      unitRef="USD">133200</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824684"
      unitRef="Share">1350000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824685"
      unitRef="USD">1350</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824686"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824687"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824688"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824689"
      unitRef="USD">2472730</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824690"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-04-01_2023-06-30_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824691"
      unitRef="USD">2474080</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824692"
      unitRef="Share">39533</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <ycbd:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824693"
      unitRef="USD">39</ycbd:StockIssuedDuringPeriodValueReverseStockSplits>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824694"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <ycbd:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824695"
      unitRef="USD">0</ycbd:StockIssuedDuringPeriodValueReverseStockSplits>
    <ycbd:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824696"
      unitRef="USD">0</ycbd:StockIssuedDuringPeriodValueReverseStockSplits>
    <ycbd:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824697"
      unitRef="USD">-39</ycbd:StockIssuedDuringPeriodValueReverseStockSplits>
    <ycbd:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824698"
      unitRef="USD">0</ycbd:StockIssuedDuringPeriodValueReverseStockSplits>
    <ycbd:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="d_2023-04-01_2023-06-30"
      decimals="INF"
      id="c121824699"
      unitRef="USD">0</ycbd:StockIssuedDuringPeriodValueReverseStockSplits>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824701"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824703"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824704"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824705"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824706"
      unitRef="USD">1000501</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-04-01_2023-06-30"
      decimals="INF"
      id="c121824707"
      unitRef="USD">1000501</us-gaap:DividendsPreferredStockCash>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824709"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824711"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824712"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824713"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-04-01_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824714"
      unitRef="USD">-1770404</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-04-01_2023-06-30"
      decimals="INF"
      id="c121824715"
      unitRef="USD">-1770404</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i_2023-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824716"
      unitRef="Share">2855229</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-06-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824717"
      unitRef="USD">2855</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824718"
      unitRef="Share">5000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-06-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824719"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-06-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824720"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-06-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824721"
      unitRef="USD">183212202</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-06-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824722"
      unitRef="USD">-157488334</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-06-30"
      decimals="INF"
      id="c121824723"
      unitRef="USD">25731723</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824724"
      unitRef="Share">112</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="-3"
      id="c121824725"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824726"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824727"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824728"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ycbd:DecreaseInApicIssuanceOfStock
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824729"
      unitRef="USD">112</ycbd:DecreaseInApicIssuanceOfStock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824730"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-07-01_2023-09-30"
      decimals="INF"
      id="c121824731"
      unitRef="USD">-112</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824733"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824735"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824736"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824737"
      unitRef="USD">33171</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824738"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="d_2023-07-01_2023-09-30"
      decimals="INF"
      id="c121824739"
      unitRef="USD">33171</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824741"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824743"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824744"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824745"
      unitRef="USD">3996</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824746"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="d_2023-07-01_2023-09-30"
      decimals="INF"
      id="c121824747"
      unitRef="USD">3996</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121824748"
      unitRef="Share">105232</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121824749"
      unitRef="USD">105</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121824750"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121824751"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121824752"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121824753"
      unitRef="USD">97338</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121824754"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="d_2023-07-01_2023-09-30_SubsidiarySaleOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121824755"
      unitRef="USD">97443</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824757"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824759"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824760"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824761"
      unitRef="USD">40500</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824762"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="d_2023-07-01_2023-09-30_SubsidiarySaleOfStockAxis-CapitalRaiseMember"
      decimals="INF"
      id="c121824763"
      unitRef="USD">40500</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824765"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824767"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824768"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824769"
      unitRef="USD">-0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824770"
      unitRef="USD">1000497</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="d_2023-07-01_2023-09-30"
      decimals="INF"
      id="c121824771"
      unitRef="USD">1000497</us-gaap:DividendsPreferredStockCash>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824773"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824775"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824776"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824777"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-07-01_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824778"
      unitRef="USD">-15874941</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-07-01_2023-09-30"
      decimals="INF"
      id="c121824779"
      unitRef="USD">-15874941</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824780"
      unitRef="Share">2960573</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-CommonStockMember"
      decimals="INF"
      id="c121824781"
      unitRef="USD">2961</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824782"
      unitRef="Share">5000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-PreferredStockMember"
      decimals="INF"
      id="c121824783"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember"
      decimals="INF"
      id="c121824784"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember"
      decimals="INF"
      id="c121824785"
      unitRef="USD">183387095</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30_StatementEquityComponentsAxis-RetainedEarningsMember"
      decimals="INF"
      id="c121824786"
      unitRef="USD">-174363772</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824787"
      unitRef="USD">9031284</us-gaap:StockholdersEquity>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808709">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;1&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Organization and Nature of Business&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;cbdMD, Inc. ("cbdMD", "we", "us", &#x201c;our&#x201d;, or the &#x201c;Company&#x201d;) is a North Carolina corporation formed on &lt;em style="font: inherit;"&gt; March 17, 2015 &lt;/em&gt;as Level Beauty Group, Inc. In &lt;em style="font: inherit;"&gt; November 2016 &lt;/em&gt;we changed the name of the Company to Level Brands, Inc. and on &lt;em style="font: inherit;"&gt; May 1, 2019 &lt;/em&gt;we changed the name of our Company to cbdMD, Inc. We operate from our offices located in Charlotte, North Carolina. Our fiscal year end is established as &lt;em style="font: inherit;"&gt; September 30.&lt;/em&gt;&lt;br/&gt; &#160;&lt;br/&gt; There have been &lt;em style="font: inherit;"&gt;no&lt;/em&gt; material changes in the Company's significant accounting policies from those previously disclosed in the &lt;em style="font: inherit;"&gt;2023&lt;/em&gt; &lt;em style="font: inherit;"&gt;10&lt;/em&gt;-K.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The accompanying unaudited interim condensed consolidated financial statements of cbdMD have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;) and the rules of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the &lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&#160;&lt;em style="font: inherit;"&gt;10&lt;/em&gt;-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of consolidated financial position and the consolidated results of operations for the interim periods presented have been reflected herein.&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Reverse Stock Split&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;On &lt;em style="font: inherit;"&gt; April 12, 2023, &lt;/em&gt;the board effected a reverse stock split at a ratio of &lt;em style="font: inherit;"&gt;one&lt;/em&gt;-for-&lt;span style="-sec-ix-hidden:c121825181"&gt;forty&lt;/span&gt;-five, effective as of &lt;em style="font: inherit;"&gt; April 24, 2023. &lt;/em&gt;Unless otherwise indicated, all share numbers in this filing, including shares of common stock and all securities convertible into, or exercisable for, shares of common stock, give effect to the reverse stock split.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries CBDI, Paw CBD, Proline Global, and Therapeutics. All material intercompany transactions and balances have been eliminated in consolidation.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company's consolidated financial statements have been prepared in accordance with US GAAP and requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Significant estimates made in the accompanying consolidated financial statements include, but are &lt;em style="font: inherit;"&gt;not&lt;/em&gt; limited to, allowances for doubtful accounts, inventory valuation reserves, certain assumptions related to the valuation of investments other securities, and acquired intangible and long-lived assets and the recoverability of intangible and long-lived assets.&#160;Actual results could differ from these estimates.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;For financial statements purposes, the Company considers all highly liquid investments with a maturity of less than &lt;em style="font: inherit;"&gt;three&lt;/em&gt; months when purchased to be cash equivalents.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Accounts Receivable&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;Accounts receivables are stated at cost less an allowance for credit losses, if applicable. Credit is extended to customers after an evaluation of the customer&#x2019;s financial condition, and generally collateral is &lt;em style="font: inherit;"&gt;not&lt;/em&gt; required as a condition of credit extension. Management&#x2019;s determination of the allowance for credit losses&#160;is based on an evaluation of the receivables, past experience, current economic conditions, and other risks inherent in the receivables portfolio. As of &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt; and &lt;em style="font: inherit;"&gt; September 30, 2023&lt;/em&gt;, we had an allowance for credit losses&#160;of $346,197&#160;and $42,180, respectively.&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;&lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/p&gt;


   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Merchant Receivable&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The Company primarily sells its products through the internet and has an arrangement to process customer payments with multiple &lt;em style="font: inherit;"&gt;third&lt;/em&gt;-party payment processors. The Company pays a fee between 2.5% and 4.0% of the transaction amounts processed. Pursuant to these agreements, there can be a waiting period between &lt;em style="font: inherit;"&gt;2&lt;/em&gt; to &lt;em style="font: inherit;"&gt;5&lt;/em&gt; days prior to reimbursement to the Company, as well as a calculated reserve which some payment processors hold back. Fees and reserves can change periodically with notice from the processors. At &lt;em style="font: inherit;"&gt; September 30, 2024, &lt;/em&gt;the receivable from payment processors included $621,678&#160;for the waiting period amount and is recorded as accounts receivable in the accompanying consolidated balance sheet.&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;&lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Inventory&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Inventory is stated at the lower of cost or net realizable value with cost being determined on a weighted average basis. The cost of inventory includes product cost, freight-in, and production fill and labor (portions of which we outsource to &lt;em style="font: inherit;"&gt;third&lt;/em&gt; party manufacturers). Write-offs of potentially slow moving or damaged inventory are recorded based on management&#x2019;s analysis of inventory levels, forecasted future sales volume and pricing and through specific identification of obsolete or damaged products. We assess inventory quarterly for slow moving products and potential impairments and at a minimum perform a physical inventory count annually near fiscal year end.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Customer Deposits&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Customer deposits consist of payments received in advance of revenue recognition. Revenue is recognized as revenue recognition criteria are met.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Property and Equipment&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Property and equipment items are stated at cost less accumulated depreciation. Expenditures for routine maintenance and repairs are charged to operations as incurred. Depreciation is charged to expense over the estimated useful lives of the assets using the straight-line method. Generally, the useful lives are &lt;span style="-sec-ix-hidden:c121825195"&gt;five&lt;/span&gt; years for manufacturing equipment and automobiles and &lt;span style="-sec-ix-hidden:c121825196"&gt;three&lt;/span&gt; years for software, computer, and furniture and equipment. The useful life for leasehold improvements are over the term of the lease or expected life of the asset, whichever is less. The cost and accumulated depreciation of property are eliminated from the accounts upon disposal, and any resulting gain or loss is included in the consolidated statements of operations for the applicable period. Long-lived assets held and used by the Company are reviewed for impairment whenever changes in circumstance indicate the carrying value of an asset &lt;em style="font: inherit;"&gt; may &lt;/em&gt;&lt;em style="font: inherit;"&gt;not&lt;/em&gt; be recoverable.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Fair Value Accounting&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company utilizes accounting standards for fair value, which include the definition of fair value, the framework for measuring fair value, and disclosures about fair value measurements. Fair value is a market-based measurement, &lt;em style="font: inherit;"&gt;not&lt;/em&gt; an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, fair value accounting standards establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels &lt;em style="font: inherit;"&gt;1&lt;/em&gt; and &lt;em style="font: inherit;"&gt;2&lt;/em&gt; of the hierarchy) and the reporting entity&#x2019;s own assumptions about market participant assumptions (unobservable inputs classified within Level &lt;em style="font: inherit;"&gt;3&lt;/em&gt; of the hierarchy).&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Level &lt;em style="font: inherit;"&gt;1&lt;/em&gt; inputs utilize quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Level &lt;em style="font: inherit;"&gt;2&lt;/em&gt; inputs are inputs other than quoted prices included in Level &lt;em style="font: inherit;"&gt;1&lt;/em&gt; that are directly or indirectly observable for the asset or liability. Level &lt;em style="font: inherit;"&gt;2&lt;/em&gt; inputs &lt;em style="font: inherit;"&gt; may &lt;/em&gt;include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability. Level &lt;em style="font: inherit;"&gt;3&lt;/em&gt; inputs are unobservable inputs for the asset or liability, which are based on an entity&#x2019;s own assumptions, as there is little, if any, observable market activity. In instances where the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;When the Company records an investment in marketable securities the carrying value is&#160;recorded at fair value. Any changes in fair value for marketable securities during a given period will be recorded as an unrealized gain or loss in the consolidated statement of operations. For investments other securities without a readily determinable fair value, the Company &lt;em style="font: inherit;"&gt; may &lt;/em&gt;elect to estimate its fair value at cost less impairment plus or minus changes resulting from observable price changes. The Company has elected the fair value method and will make individual determinations on and instrument by instrument basis.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;


   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Intangible Assets&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company's intangible assets consist of trademarks and other intellectual property, all of which were previously accounted for in accordance with Accounting Standards Codification (ASC) Topic &lt;em style="font: inherit;"&gt;350,&lt;/em&gt; &lt;i&gt;Intangibles &lt;/i&gt;&#x2013;&lt;i&gt; Goodwill and Other&lt;/i&gt;. The Company employed&#160;the non-amortization approach to account for purchased intangible assets having indefinite lives. Under the non-amortization approach, intangible assets having indefinite lives were &lt;em style="font: inherit;"&gt;not&lt;/em&gt; amortized into the results of operations, but instead were reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value. We previously performed an annual impairment analysis each fiscal year on the indefinite-lived intangible assets following the steps laid out in ASC &lt;em style="font: inherit;"&gt;350&lt;/em&gt;-&lt;em style="font: inherit;"&gt;30&lt;/em&gt;-&lt;em style="font: inherit;"&gt;35&lt;/em&gt;-&lt;em style="font: inherit;"&gt;18.&lt;/em&gt; Our annual impairment analysis included a qualitative assessment to determine if it was&#160;necessary to perform the quantitative impairment test. In performing a qualitative assessment, we reviewed events and circumstances that could affect the significant inputs used to determine if the fair value was less than the carrying value of the intangible assets. If a quantitative analysis was necessary, we would analyze various aspects including revenues from the business, associated with the intangible assets. In addition, intangible assets would be tested on an interim basis if an event or circumstance indicates that it is more likely than &lt;em style="font: inherit;"&gt;not&lt;/em&gt; that an impairment loss has been incurred. The Company analyzed a variety of factors on its business to determine if a circumstance could trigger an impairment loss, and, at the time and based on the information then known, had determined that is it was more likely than &lt;em style="font: inherit;"&gt;not&lt;/em&gt; that an impairment loss had occurred. See Note &lt;em style="font: inherit;"&gt;5&lt;/em&gt; more further information on the impairment testing procedures performed at &lt;em style="font: inherit;"&gt; December 31, 2022&#160;&lt;/em&gt;and the Company&#x2019;s decision to change from indefinite to definite lived status for its trademarks.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company now accounts for its trademarks in accordance with Accounting Standards Codification (ASC) Topic &lt;em style="font: inherit;"&gt;360,&lt;/em&gt; Property, Plant and Equipment. The Company began amortizing its trademarks over &lt;em style="font: inherit;"&gt;20&lt;/em&gt; years beginning &lt;em style="font: inherit;"&gt; January 1, 2023&#160;&lt;/em&gt;and will perform impairment tests as prescribed by ASC &lt;em style="font: inherit;"&gt;360,&lt;/em&gt; which states that impairment testing should be completed whenever events or changes in circumstances indicate that the asset group's&#160;carrying value &lt;em style="font: inherit;"&gt; may &lt;/em&gt;&lt;em style="font: inherit;"&gt;not&lt;/em&gt; be recoverable. If there are indications that the asset group's&#160;carrying value &lt;em style="font: inherit;"&gt; may &lt;/em&gt;&lt;em style="font: inherit;"&gt;not&lt;/em&gt; be recoverable, there are &lt;em style="font: inherit;"&gt;two&lt;/em&gt; further steps involved in long-lived asset impairment testing. Step I of the impairment test, as per ASC &lt;em style="font: inherit;"&gt;360,&lt;/em&gt; involves estimating the recoverable amount of the asset group and determining the potential for impairment. Step II of the impairment test, as per ASC &lt;em style="font: inherit;"&gt;360,&lt;/em&gt; if necessary, involves quantifying the fair value of the asset group. As further outlined in Note &lt;em style="font: inherit;"&gt;5,&lt;/em&gt; during &lt;em style="font: inherit;"&gt; July &lt;/em&gt;of fiscal &lt;em style="font: inherit;"&gt;2023,&lt;/em&gt; the Company determined that based on regulatory uncertainty and ongoing Company performance it was prudent to change the amortization of the &#x201c;cbdMD&#x201d; and &#x201c;directCBDonline&#x201d; trademarks to 5 years and &#x201c;hempMD&#x201d; trademark to 10 years.&#160; This became a triggering event for an impairment test under &lt;em style="font: inherit;"&gt;ASC360&lt;/em&gt; which resulted in an impairment of the intangibles in &lt;em style="font: inherit;"&gt; July 2023.&#160; &lt;/em&gt;As of the end of the &lt;em style="font: inherit;"&gt;fourth&lt;/em&gt; quarter and fiscal &lt;em style="font: inherit;"&gt;2023,&lt;/em&gt; a significant decline in market capitalization of both classes of equity as a result of the proxy vote triggered a subsequent impairment test, resulting in additional impairment during the &lt;em style="font: inherit;"&gt;fourth&lt;/em&gt; quarter of &lt;em style="font: inherit;"&gt;2023.&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Contingent Liability&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;A significant component of the purchase price consideration for the Company&#x2019;s acquisition of Cure Based Development includes a fixed number of future shares to be issued as well as a variable number of future shares to be issued based upon the post-acquisition entity reaching certain specified future revenue targets, as further described in Note &lt;em style="font: inherit;"&gt;6.&lt;/em&gt; The Company made a determination of the fair value of the contingent liabilities as part of the valuation of the assets acquired and liabilities assumed in the business combination.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Under ASC &lt;em style="font: inherit;"&gt;606,&lt;/em&gt; &lt;i&gt;Revenue from Contracts with Customers, &lt;/i&gt;the Company recognizes revenues when its customer obtains control of promised goods or services, in an amount that reflects the consideration which it expects to receive in exchange for those goods. The Company recognizes revenues following the &lt;em style="font: inherit;"&gt;five&lt;/em&gt;-step model prescribed under ASC &lt;em style="font: inherit;"&gt;606:&lt;/em&gt; (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Performance Obligations&lt;/i&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to a customer. The Company meets that obligation when it has shipped products which have been ordered&#160;by the customer. The Company has reviewed its various revenue streams for its other contracts under the &lt;em style="font: inherit;"&gt;five&lt;/em&gt;-step approach.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Allocation of Transaction Price&lt;/i&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;In the Company&#x2019;s current business model, it does &lt;span style="-sec-ix-hidden:c121825240"&gt;not&lt;/span&gt; have contracts with customers which have multiple elements as revenue is driven purely by online product sales or purchase order-based product sales.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company records revenue from the sale of its products when risk of loss and title to the product are transferred to the customer, which is upon shipping (and is typically FOB shipping) which is when our performance obligation is met. Net sales are comprised of gross revenues less product returns, trade discounts and customer allowances, which include costs associated with off-invoice mark-downs and other price reductions, as well as trade promotions. These incentive costs are recognized at the later of the date on which the Company recognizes the related revenue or the date on which the Company offers the incentive. The Company currently offers a &lt;em style="font: inherit;"&gt;60&lt;/em&gt;-day, money-back guarantee.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Disaggregated Revenue&lt;/i&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company&#x2019;s product revenue is generated primarily through &lt;em style="font: inherit;"&gt;two&lt;/em&gt; sales channels, E-commerce sales (formerly referred to as consumer sales) and wholesale sales. The Company believes that these categories appropriately reflect how the nature, amount, timing and uncertainty of revenue and cash flows are impacted by economic factors.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;A description of the Company&#x2019;s principal revenue generating activities are as follows:&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;width:2.1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align:top;width:2.1%;"&gt; &lt;p style="font-family:Symbol;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;-&lt;/p&gt; &lt;/td&gt;&lt;td style="vertical-align:top;width:auto;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;E-commerce sales - consumer products sold through the Company&#x2019;s online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due prior to the date of shipment; and&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="vertical-align:middle;width:auto;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align:middle;width:auto;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align:middle;width:auto;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="vertical-align:middle;width:auto;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align:top;width:auto;"&gt; &lt;p style="font-family:Symbol;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;-&lt;/p&gt; &lt;/td&gt;&lt;td style="vertical-align:top;width:auto;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Wholesale sales - products sold to the Company&#x2019;s wholesale customers for subsequent resale. Revenue is recognized when control of the goods is transferred to the customer, in accordance with the terms of the applicable agreement. Payment terms vary and can typically be &lt;em style="font: inherit;"&gt;30&lt;/em&gt; days from the date control over the product is transferred to the customer&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The following table represents a disaggregation of revenue by sales channel:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

     &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Fiscal 2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;% of total&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Fiscal 2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;% of total&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;E-commerce sales&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;15,655,337&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;80.4&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;19,436,124&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;80.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Wholesale sales&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;3,826,830&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;19.6&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;4,719,238&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;19.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total Net Sales&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;19,482,167&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;24,155,362&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Contract assets represent unbilled receivables and are presented within accounts receivable, net on the consolidated balance sheets. Contract liabilities represent unearned revenues and are presented as deferred revenue or customer deposits on the consolidated balance sheets. The Company had &lt;span style="-sec-ix-hidden:c121825244"&gt;no&lt;/span&gt; material contract assets or liabilities at the beginning or ending of &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt;.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Cost of Sales&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company&#x2019;s cost of sales includes costs associated with distribution, fill and labor expense, components, manufacturing overhead, &lt;em style="font: inherit;"&gt;third&lt;/em&gt;-party providers, and outbound freight for the Company&#x2019;s products sales. For the Company&#x2019;s product sales, cost of sales also includes the cost of refurbishing products returned by customers that will be offered for resale, if any, and the cost of inventory write-downs associated with adjustments of held inventories to their net realizable value. These expenses are reflected in the Company&#x2019;s consolidated statements of operations when the product is sold and net sales revenues are recognized or, in the case of inventory write-downs, when circumstances indicate that the carrying value of inventories is in excess of their net realizable value.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Advertising Costs&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The Company expenses all costs of advertising and related marketing and promotional costs as incurred. The Company incurred $4.2 million and $6.0&#160;million in advertising and marketing and promotional costs included in operating expenses during the years ended &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt; respectively. The Company believes driving its advertising aids in brand awareness and is critical to maintain brand recognition. We are constantly evaluating advertising methods and costs and working to drive down our cost of customer acquisition.&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;&lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company is a North Carolina corporation that is treated as a corporation for federal and state income tax purposes. As of &lt;em style="font: inherit;"&gt; October 1, 2019, &lt;/em&gt;CBDI and Paw CBD were wholly owned subsidiaries and are disregarded entities for tax purposes and their entire share of taxable income or loss is included in the tax return of the Company and as of &lt;em style="font: inherit;"&gt; March 15, 2021, &lt;/em&gt;Therapeutics is also a wholly owned subsidiary and is a disregarded entity for tax purposes and its entire share of taxable income or loss is included in the tax return of the Company.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company accounts for income taxes pursuant to the provisions of the &lt;i&gt;Accounting for Income Taxes &lt;/i&gt;topic of the Financial Accounting Standards Board&#160;("FASB") ASC &lt;em style="font: inherit;"&gt;740&lt;/em&gt; which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. The Company uses the inside basis approach to determine deferred tax assets and liabilities associated with its investment in a consolidated pass-through entity. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than &lt;em style="font: inherit;"&gt;not&lt;/em&gt; that the net deferred asset will &lt;em style="font: inherit;"&gt;not&lt;/em&gt; be realized.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;US GAAP requires management to evaluate tax positions taken by the Company and recognize a tax liability (or asset) if the Company has taken an uncertain tax position that more likely than &lt;em style="font: inherit;"&gt;not&lt;/em&gt; would &lt;em style="font: inherit;"&gt;not&lt;/em&gt; be sustained upon examination by the Internal Revenue Service. Management has analyzed the tax positions taken by the Company, and has concluded that as of &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt;, there were &lt;em style="font: inherit;"&gt;no&lt;/em&gt; uncertain tax positions taken or expected to be taken that would require recognition of a liability (or asset) or disclosure in the consolidated financial statements.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Concentrations&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) covers &lt;em style="font: inherit;"&gt;$250,000&lt;/em&gt; for substantially all depository accounts. The Company from time to time &lt;em style="font: inherit;"&gt; may &lt;/em&gt;have amounts on deposit in excess of the insured limits. The Company had a $1,893,606&#160;uninsured balance at &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt; and a $1,163,360&#160;uninsured balance at &lt;em style="font: inherit;"&gt; September 30, 2023&lt;/em&gt;.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did &lt;span style="-sec-ix-hidden:c121825261"&gt;not&lt;/span&gt; have any customers that represented a significant amount of our sales for the year ended &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Stock-Based Compensation&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company accounts for its stock compensation under the ASC &lt;em style="font: inherit;"&gt;718&lt;/em&gt;-&lt;em style="font: inherit;"&gt;10&lt;/em&gt;-&lt;em style="font: inherit;"&gt;30,&lt;/em&gt; &lt;i&gt;Compensation - Stock Compensation &lt;/i&gt;using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity's equity instruments or that &lt;em style="font: inherit;"&gt; may &lt;/em&gt;be settled by the issuance of those equity instruments.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company uses the Black-Scholes model for measuring the fair value of options and warrants. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. The Company recognizes forfeitures when they occur.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Liquidity and Going Concern Considerations&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company experienced a loss of $3.7&#160;million for the fiscal year&#160;ended &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;,&#160;resulting in a working capital deficit of $1.1 million&#160;at &lt;em style="font: inherit;"&gt; September&#160;&lt;/em&gt;&lt;em style="font: inherit;"&gt;30,&lt;/em&gt; &lt;em style="font: inherit;"&gt;2024.&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;While the Company is taking strong action, believes in the viability of its strategy&#160;and&#160;path to profitability, and in its ability to raise additional funds, there can be&#160;&lt;em style="font: inherit;"&gt;no&lt;/em&gt;&#160;assurances to that effect.&#160;&#160;The Company&#x2019;s working capital position &lt;em style="font: inherit;"&gt; may &lt;/em&gt;&lt;em style="font: inherit;"&gt;not&lt;/em&gt;&#160;be sufficient to support the Company&#x2019;s daily operations for the &lt;em style="font: inherit;"&gt;twelve&lt;/em&gt;&#160;months subsequent to the issuance of these annual financial statements.&#160;The Company&#x2019;s ability to continue as a going concern is dependent upon its ability to improve profitability and the ability to acquire additional funding. These and other factors raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within &lt;em style="font: inherit;"&gt;twelve&lt;/em&gt; months after the date that the annual financial statements are issued. These financial statements do &lt;em style="font: inherit;"&gt;not&lt;/em&gt; include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that &lt;em style="font: inherit;"&gt; may&#160;&lt;/em&gt;result in the Company &lt;em style="font: inherit;"&gt;not&lt;/em&gt; being able to continue as a going concern.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&lt;b&gt;Convertible Notes&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;Effective &lt;em style="font: inherit;"&gt; February 1, 2024 (&lt;/em&gt;the &#x201c;Effective Date&#x201d;), the Company entered into a Securities Purchase Agreement dated &lt;em style="font: inherit;"&gt; January 30, 2024 (&lt;/em&gt;the &#x201c;Purchase Agreement&#x201d;) with &lt;em style="font: inherit;"&gt;five&lt;/em&gt; institutional investors (the &#x201c;Investors&#x201d;) whereby the Investors advanced the Company an aggregate of $1,250,000 gross proceeds and the Company issued each Investor an 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note, in the aggregate principal amount of $1,541,666 (the &#x201c;Notes&#x201d;). The Company is using the proceeds from the issuance of the Notes for working capital and general corporate purposes. The Company elected the fair value option under ASC &lt;em style="font: inherit;"&gt;825&lt;/em&gt; Fair Value Measurements for the Notes. The Notes were initially recognized at fair value on the balance sheet. All subsequent changes in fair value, excluding the impact of the change in fair value related to instrument-specific credit risk are recorded in non-operating income. The changes in fair value related to instrument-specific credit risk is recorded through other comprehensive income (loss). See Note &lt;em style="font: inherit;"&gt;12&lt;/em&gt; for more information related to the Notes.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Earnings (Loss) Per Share&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;The Company uses ASC &lt;em style="font: inherit;"&gt;260&lt;/em&gt;-&lt;em style="font: inherit;"&gt;10,&lt;/em&gt; &lt;i&gt;Earnings Per Share &lt;/i&gt;for calculating the basic and diluted income (loss) per share. The Company computes basic income (loss) per share by dividing net income (loss) and net income (loss) attributable to common shareholders, after deducting preferred stock dividends, by the weighted average number of common shares outstanding. Common equivalent shares are excluded from the computation of net loss per share if their effect is anti-dilutive.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;On &lt;em style="font: inherit;"&gt; February 16, 2023, &lt;/em&gt;we held an annual meeting of stockholders. At the annual meeting, our stockholders approved an amendment to our articles of incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of common stock by a ratio of between &lt;em style="font: inherit;"&gt;one&lt;/em&gt;-for-&lt;span style="-sec-ix-hidden:c121825285"&gt;twenty&lt;/span&gt; to &lt;span style="-sec-ix-hidden:c121825286"&gt;one&lt;/span&gt;-for-fifty, inclusive, with the exact ratio to be set at the discretion of our board of directors, at any time after approval of the amendment and prior to &lt;em style="font: inherit;"&gt; February 16, 2024. &lt;/em&gt;On &lt;em style="font: inherit;"&gt; April 12, 2023, &lt;/em&gt;the board effected a reverse stock split at a ratio of &lt;em style="font: inherit;"&gt;one&lt;/em&gt;-for-&lt;span style="-sec-ix-hidden:c121825288"&gt;forty&lt;/span&gt;-five, effective as of &lt;em style="font: inherit;"&gt; April 24, 2023 (&lt;/em&gt;the "Reverse Stock Split"). Unless otherwise indicated, all share numbers in this report, including shares of common stock and all securities convertible into, or exercisable for, shares of common stock, give effect to the Reverse Stock Split.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&lt;b&gt;New Accounting&lt;/b&gt;&#160;&lt;b&gt;Standards&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The Company adopted ASU &lt;em style="font: inherit;"&gt;2016&lt;/em&gt;-&lt;em style="font: inherit;"&gt;13&lt;/em&gt; Financial Instruments &#x2013; Credit Losses (Topic &lt;em style="font: inherit;"&gt;326&lt;/em&gt;): Measurement of Credit Losses on Financial Instruments (ASC &lt;em style="font: inherit;"&gt;326&lt;/em&gt;) effective &lt;em style="font: inherit;"&gt; October 1, 2023. &lt;/em&gt;This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (&#x201c;CECL&#x201d;) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities, and some off-balance sheet credit exposures such as unfunded commitments to extend credit. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses.&#160;The adoption of&#160;this standard had &lt;em style="font: inherit;"&gt;no&lt;/em&gt; material impact&#160;on the consolidated financial statements.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;/p&gt;


  </us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827937">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Reverse Stock Split&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;On &lt;em style="font: inherit;"&gt; April 12, 2023, &lt;/em&gt;the board effected a reverse stock split at a ratio of &lt;em style="font: inherit;"&gt;one&lt;/em&gt;-for-&lt;span style="-sec-ix-hidden:c121825181"&gt;forty&lt;/span&gt;-five, effective as of &lt;em style="font: inherit;"&gt; April 24, 2023. &lt;/em&gt;Unless otherwise indicated, all share numbers in this filing, including shares of common stock and all securities convertible into, or exercisable for, shares of common stock, give effect to the reverse stock split.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827938">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries CBDI, Paw CBD, Proline Global, and Therapeutics. All material intercompany transactions and balances have been eliminated in consolidation.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="d_2023-10-01_2024-09-30" id="c121827939">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company's consolidated financial statements have been prepared in accordance with US GAAP and requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Significant estimates made in the accompanying consolidated financial statements include, but are &lt;em style="font: inherit;"&gt;not&lt;/em&gt; limited to, allowances for doubtful accounts, inventory valuation reserves, certain assumptions related to the valuation of investments other securities, and acquired intangible and long-lived assets and the recoverability of intangible and long-lived assets.&#160;Actual results could differ from these estimates.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827940">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;For financial statements purposes, the Company considers all highly liquid investments with a maturity of less than &lt;em style="font: inherit;"&gt;three&lt;/em&gt; months when purchased to be cash equivalents.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="d_2023-10-01_2024-09-30" id="c121827941">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Accounts Receivable&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;Accounts receivables are stated at cost less an allowance for credit losses, if applicable. Credit is extended to customers after an evaluation of the customer&#x2019;s financial condition, and generally collateral is &lt;em style="font: inherit;"&gt;not&lt;/em&gt; required as a condition of credit extension. Management&#x2019;s determination of the allowance for credit losses&#160;is based on an evaluation of the receivables, past experience, current economic conditions, and other risks inherent in the receivables portfolio. As of &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt; and &lt;em style="font: inherit;"&gt; September 30, 2023&lt;/em&gt;, we had an allowance for credit losses&#160;of $346,197&#160;and $42,180, respectively.&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825185"
      unitRef="USD">346197</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825186"
      unitRef="USD">42180</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <ycbd:MerchantReceivableAndReservePolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827942">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Merchant Receivable&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The Company primarily sells its products through the internet and has an arrangement to process customer payments with multiple &lt;em style="font: inherit;"&gt;third&lt;/em&gt;-party payment processors. The Company pays a fee between 2.5% and 4.0% of the transaction amounts processed. Pursuant to these agreements, there can be a waiting period between &lt;em style="font: inherit;"&gt;2&lt;/em&gt; to &lt;em style="font: inherit;"&gt;5&lt;/em&gt; days prior to reimbursement to the Company, as well as a calculated reserve which some payment processors hold back. Fees and reserves can change periodically with notice from the processors. At &lt;em style="font: inherit;"&gt; September 30, 2024, &lt;/em&gt;the receivable from payment processors included $621,678&#160;for the waiting period amount and is recorded as accounts receivable in the accompanying consolidated balance sheet.&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;</ycbd:MerchantReceivableAndReservePolicyTextBlock>
    <ycbd:Merchantprocessingfee
      contextRef="i_2024-09-30_RangeAxis-MinimumMember"
      decimals="3"
      id="c121825189"
      unitRef="Pure">0.025</ycbd:Merchantprocessingfee>
    <ycbd:Merchantprocessingfee
      contextRef="i_2024-09-30_RangeAxis-MaximumMember"
      decimals="2"
      id="c121825190"
      unitRef="Pure">0.04</ycbd:Merchantprocessingfee>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825193"
      unitRef="USD">621678</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827943">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Inventory&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Inventory is stated at the lower of cost or net realizable value with cost being determined on a weighted average basis. The cost of inventory includes product cost, freight-in, and production fill and labor (portions of which we outsource to &lt;em style="font: inherit;"&gt;third&lt;/em&gt; party manufacturers). Write-offs of potentially slow moving or damaged inventory are recorded based on management&#x2019;s analysis of inventory levels, forecasted future sales volume and pricing and through specific identification of obsolete or damaged products. We assess inventory quarterly for slow moving products and potential impairments and at a minimum perform a physical inventory count annually near fiscal year end.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:DepositContractsPolicy contextRef="d_2023-10-01_2024-09-30" id="c121827944">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Customer Deposits&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Customer deposits consist of payments received in advance of revenue recognition. Revenue is recognized as revenue recognition criteria are met.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:DepositContractsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827945">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Property and Equipment&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Property and equipment items are stated at cost less accumulated depreciation. Expenditures for routine maintenance and repairs are charged to operations as incurred. Depreciation is charged to expense over the estimated useful lives of the assets using the straight-line method. Generally, the useful lives are &lt;span style="-sec-ix-hidden:c121825195"&gt;five&lt;/span&gt; years for manufacturing equipment and automobiles and &lt;span style="-sec-ix-hidden:c121825196"&gt;three&lt;/span&gt; years for software, computer, and furniture and equipment. The useful life for leasehold improvements are over the term of the lease or expected life of the asset, whichever is less. The cost and accumulated depreciation of property are eliminated from the accounts upon disposal, and any resulting gain or loss is included in the consolidated statements of operations for the applicable period. Long-lived assets held and used by the Company are reviewed for impairment whenever changes in circumstance indicate the carrying value of an asset &lt;em style="font: inherit;"&gt; may &lt;/em&gt;&lt;em style="font: inherit;"&gt;not&lt;/em&gt; be recoverable.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827946">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Fair Value Accounting&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company utilizes accounting standards for fair value, which include the definition of fair value, the framework for measuring fair value, and disclosures about fair value measurements. Fair value is a market-based measurement, &lt;em style="font: inherit;"&gt;not&lt;/em&gt; an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, fair value accounting standards establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels &lt;em style="font: inherit;"&gt;1&lt;/em&gt; and &lt;em style="font: inherit;"&gt;2&lt;/em&gt; of the hierarchy) and the reporting entity&#x2019;s own assumptions about market participant assumptions (unobservable inputs classified within Level &lt;em style="font: inherit;"&gt;3&lt;/em&gt; of the hierarchy).&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Level &lt;em style="font: inherit;"&gt;1&lt;/em&gt; inputs utilize quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Level &lt;em style="font: inherit;"&gt;2&lt;/em&gt; inputs are inputs other than quoted prices included in Level &lt;em style="font: inherit;"&gt;1&lt;/em&gt; that are directly or indirectly observable for the asset or liability. Level &lt;em style="font: inherit;"&gt;2&lt;/em&gt; inputs &lt;em style="font: inherit;"&gt; may &lt;/em&gt;include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability. Level &lt;em style="font: inherit;"&gt;3&lt;/em&gt; inputs are unobservable inputs for the asset or liability, which are based on an entity&#x2019;s own assumptions, as there is little, if any, observable market activity. In instances where the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;When the Company records an investment in marketable securities the carrying value is&#160;recorded at fair value. Any changes in fair value for marketable securities during a given period will be recorded as an unrealized gain or loss in the consolidated statement of operations. For investments other securities without a readily determinable fair value, the Company &lt;em style="font: inherit;"&gt; may &lt;/em&gt;elect to estimate its fair value at cost less impairment plus or minus changes resulting from observable price changes. The Company has elected the fair value method and will make individual determinations on and instrument by instrument basis.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="d_2023-10-01_2024-09-30" id="c121827947">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Intangible Assets&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company's intangible assets consist of trademarks and other intellectual property, all of which were previously accounted for in accordance with Accounting Standards Codification (ASC) Topic &lt;em style="font: inherit;"&gt;350,&lt;/em&gt; &lt;i&gt;Intangibles &lt;/i&gt;&#x2013;&lt;i&gt; Goodwill and Other&lt;/i&gt;. The Company employed&#160;the non-amortization approach to account for purchased intangible assets having indefinite lives. Under the non-amortization approach, intangible assets having indefinite lives were &lt;em style="font: inherit;"&gt;not&lt;/em&gt; amortized into the results of operations, but instead were reviewed annually or more frequently if events or changes in circumstances indicate that the assets might be impaired, to assess whether their fair value exceeds their carrying value. We previously performed an annual impairment analysis each fiscal year on the indefinite-lived intangible assets following the steps laid out in ASC &lt;em style="font: inherit;"&gt;350&lt;/em&gt;-&lt;em style="font: inherit;"&gt;30&lt;/em&gt;-&lt;em style="font: inherit;"&gt;35&lt;/em&gt;-&lt;em style="font: inherit;"&gt;18.&lt;/em&gt; Our annual impairment analysis included a qualitative assessment to determine if it was&#160;necessary to perform the quantitative impairment test. In performing a qualitative assessment, we reviewed events and circumstances that could affect the significant inputs used to determine if the fair value was less than the carrying value of the intangible assets. If a quantitative analysis was necessary, we would analyze various aspects including revenues from the business, associated with the intangible assets. In addition, intangible assets would be tested on an interim basis if an event or circumstance indicates that it is more likely than &lt;em style="font: inherit;"&gt;not&lt;/em&gt; that an impairment loss has been incurred. The Company analyzed a variety of factors on its business to determine if a circumstance could trigger an impairment loss, and, at the time and based on the information then known, had determined that is it was more likely than &lt;em style="font: inherit;"&gt;not&lt;/em&gt; that an impairment loss had occurred. See Note &lt;em style="font: inherit;"&gt;5&lt;/em&gt; more further information on the impairment testing procedures performed at &lt;em style="font: inherit;"&gt; December 31, 2022&#160;&lt;/em&gt;and the Company&#x2019;s decision to change from indefinite to definite lived status for its trademarks.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company now accounts for its trademarks in accordance with Accounting Standards Codification (ASC) Topic &lt;em style="font: inherit;"&gt;360,&lt;/em&gt; Property, Plant and Equipment. The Company began amortizing its trademarks over &lt;em style="font: inherit;"&gt;20&lt;/em&gt; years beginning &lt;em style="font: inherit;"&gt; January 1, 2023&#160;&lt;/em&gt;and will perform impairment tests as prescribed by ASC &lt;em style="font: inherit;"&gt;360,&lt;/em&gt; which states that impairment testing should be completed whenever events or changes in circumstances indicate that the asset group's&#160;carrying value &lt;em style="font: inherit;"&gt; may &lt;/em&gt;&lt;em style="font: inherit;"&gt;not&lt;/em&gt; be recoverable. If there are indications that the asset group's&#160;carrying value &lt;em style="font: inherit;"&gt; may &lt;/em&gt;&lt;em style="font: inherit;"&gt;not&lt;/em&gt; be recoverable, there are &lt;em style="font: inherit;"&gt;two&lt;/em&gt; further steps involved in long-lived asset impairment testing. Step I of the impairment test, as per ASC &lt;em style="font: inherit;"&gt;360,&lt;/em&gt; involves estimating the recoverable amount of the asset group and determining the potential for impairment. Step II of the impairment test, as per ASC &lt;em style="font: inherit;"&gt;360,&lt;/em&gt; if necessary, involves quantifying the fair value of the asset group. As further outlined in Note &lt;em style="font: inherit;"&gt;5,&lt;/em&gt; during &lt;em style="font: inherit;"&gt; July &lt;/em&gt;of fiscal &lt;em style="font: inherit;"&gt;2023,&lt;/em&gt; the Company determined that based on regulatory uncertainty and ongoing Company performance it was prudent to change the amortization of the &#x201c;cbdMD&#x201d; and &#x201c;directCBDonline&#x201d; trademarks to 5 years and &#x201c;hempMD&#x201d; trademark to 10 years.&#160; This became a triggering event for an impairment test under &lt;em style="font: inherit;"&gt;ASC360&lt;/em&gt; which resulted in an impairment of the intangibles in &lt;em style="font: inherit;"&gt; July 2023.&#160; &lt;/em&gt;As of the end of the &lt;em style="font: inherit;"&gt;fourth&lt;/em&gt; quarter and fiscal &lt;em style="font: inherit;"&gt;2023,&lt;/em&gt; a significant decline in market capitalization of both classes of equity as a result of the proxy vote triggered a subsequent impairment test, resulting in additional impairment during the &lt;em style="font: inherit;"&gt;fourth&lt;/em&gt; quarter of &lt;em style="font: inherit;"&gt;2023.&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdmdAndDirectcbdonlineTrademarksMember"
      id="c121825227">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember"
      id="c121825228">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationsPolicy contextRef="d_2023-10-01_2024-09-30" id="c121827948">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Contingent Liability&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;A significant component of the purchase price consideration for the Company&#x2019;s acquisition of Cure Based Development includes a fixed number of future shares to be issued as well as a variable number of future shares to be issued based upon the post-acquisition entity reaching certain specified future revenue targets, as further described in Note &lt;em style="font: inherit;"&gt;6.&lt;/em&gt; The Company made a determination of the fair value of the contingent liabilities as part of the valuation of the assets acquired and liabilities assumed in the business combination.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827949">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Under ASC &lt;em style="font: inherit;"&gt;606,&lt;/em&gt; &lt;i&gt;Revenue from Contracts with Customers, &lt;/i&gt;the Company recognizes revenues when its customer obtains control of promised goods or services, in an amount that reflects the consideration which it expects to receive in exchange for those goods. The Company recognizes revenues following the &lt;em style="font: inherit;"&gt;five&lt;/em&gt;-step model prescribed under ASC &lt;em style="font: inherit;"&gt;606:&lt;/em&gt; (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Performance Obligations&lt;/i&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to a customer. The Company meets that obligation when it has shipped products which have been ordered&#160;by the customer. The Company has reviewed its various revenue streams for its other contracts under the &lt;em style="font: inherit;"&gt;five&lt;/em&gt;-step approach.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Allocation of Transaction Price&lt;/i&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;In the Company&#x2019;s current business model, it does &lt;span style="-sec-ix-hidden:c121825240"&gt;not&lt;/span&gt; have contracts with customers which have multiple elements as revenue is driven purely by online product sales or purchase order-based product sales.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company records revenue from the sale of its products when risk of loss and title to the product are transferred to the customer, which is upon shipping (and is typically FOB shipping) which is when our performance obligation is met. Net sales are comprised of gross revenues less product returns, trade discounts and customer allowances, which include costs associated with off-invoice mark-downs and other price reductions, as well as trade promotions. These incentive costs are recognized at the later of the date on which the Company recognizes the related revenue or the date on which the Company offers the incentive. The Company currently offers a &lt;em style="font: inherit;"&gt;60&lt;/em&gt;-day, money-back guarantee.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;i&gt;Disaggregated Revenue&lt;/i&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company&#x2019;s product revenue is generated primarily through &lt;em style="font: inherit;"&gt;two&lt;/em&gt; sales channels, E-commerce sales (formerly referred to as consumer sales) and wholesale sales. The Company believes that these categories appropriately reflect how the nature, amount, timing and uncertainty of revenue and cash flows are impacted by economic factors.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;A description of the Company&#x2019;s principal revenue generating activities are as follows:&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;width:2.1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align:top;width:2.1%;"&gt; &lt;p style="font-family:Symbol;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;-&lt;/p&gt; &lt;/td&gt;&lt;td style="vertical-align:top;width:auto;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;E-commerce sales - consumer products sold through the Company&#x2019;s online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due prior to the date of shipment; and&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="vertical-align:middle;width:auto;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align:middle;width:auto;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align:middle;width:auto;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="vertical-align:middle;width:auto;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align:top;width:auto;"&gt; &lt;p style="font-family:Symbol;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;-&lt;/p&gt; &lt;/td&gt;&lt;td style="vertical-align:top;width:auto;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Wholesale sales - products sold to the Company&#x2019;s wholesale customers for subsequent resale. Revenue is recognized when control of the goods is transferred to the customer, in accordance with the terms of the applicable agreement. Payment terms vary and can typically be &lt;em style="font: inherit;"&gt;30&lt;/em&gt; days from the date control over the product is transferred to the customer&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The following table represents a disaggregation of revenue by sales channel:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

     &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Fiscal 2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;% of total&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Fiscal 2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;% of total&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;E-commerce sales&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;15,655,337&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;80.4&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;19,436,124&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;80.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Wholesale sales&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;3,826,830&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;19.6&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;4,719,238&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;19.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total Net Sales&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;19,482,167&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;24,155,362&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Contract assets represent unbilled receivables and are presented within accounts receivable, net on the consolidated balance sheets. Contract liabilities represent unearned revenues and are presented as deferred revenue or customer deposits on the consolidated balance sheets. The Company had &lt;span style="-sec-ix-hidden:c121825244"&gt;no&lt;/span&gt; material contract assets or liabilities at the beginning or ending of &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt;.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808710">
     &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Fiscal 2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;% of total&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Fiscal 2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;% of total&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;E-commerce sales&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;15,655,337&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;80.4&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;19,436,124&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;80.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Wholesale sales&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;3,826,830&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;19.6&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;4,719,238&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;19.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total Net Sales&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;19,482,167&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double black;"&gt;24,155,362&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double black;"&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
    </us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="d_2023-10-01_2024-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember"
      decimals="INF"
      id="c121824792"
      unitRef="USD">15655337</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember"
      decimals="3"
      id="c121824793"
      unitRef="Pure">0.804</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="d_2022-10-01_2023-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember"
      decimals="INF"
      id="c121824794"
      unitRef="USD">19436124</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelDirectlyToConsumerMember"
      decimals="3"
      id="c121824795"
      unitRef="Pure">0.805</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="d_2023-10-01_2024-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember"
      decimals="INF"
      id="c121824796"
      unitRef="USD">3826830</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember"
      decimals="3"
      id="c121824797"
      unitRef="Pure">0.196</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="d_2022-10-01_2023-09-30_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember"
      decimals="INF"
      id="c121824798"
      unitRef="USD">4719238</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember_ContractWithCustomerSalesChannelAxis-SalesChannelThroughIntermediaryMember"
      decimals="3"
      id="c121824799"
      unitRef="Pure">0.195</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824800"
      unitRef="USD">19482167</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="d_2023-10-01_2024-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember"
      id="c121824801"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824802"
      unitRef="USD">24155362</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="d_2022-10-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-SalesChannelMember"
      id="c121824803"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827950">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Cost of Sales&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company&#x2019;s cost of sales includes costs associated with distribution, fill and labor expense, components, manufacturing overhead, &lt;em style="font: inherit;"&gt;third&lt;/em&gt;-party providers, and outbound freight for the Company&#x2019;s products sales. For the Company&#x2019;s product sales, cost of sales also includes the cost of refurbishing products returned by customers that will be offered for resale, if any, and the cost of inventory write-downs associated with adjustments of held inventories to their net realizable value. These expenses are reflected in the Company&#x2019;s consolidated statements of operations when the product is sold and net sales revenues are recognized or, in the case of inventory write-downs, when circumstances indicate that the carrying value of inventories is in excess of their net realizable value.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827951">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Advertising Costs&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The Company expenses all costs of advertising and related marketing and promotional costs as incurred. The Company incurred $4.2 million and $6.0&#160;million in advertising and marketing and promotional costs included in operating expenses during the years ended &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt; respectively. The Company believes driving its advertising aids in brand awareness and is critical to maintain brand recognition. We are constantly evaluating advertising methods and costs and working to drive down our cost of customer acquisition.&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="d_2023-10-01_2024-09-30"
      decimals="-5"
      id="c121825247"
      unitRef="USD">4200000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="d_2022-10-01_2023-09-30"
      decimals="-6"
      id="c121825248"
      unitRef="USD">6000000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827952">&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company is a North Carolina corporation that is treated as a corporation for federal and state income tax purposes. As of &lt;em style="font: inherit;"&gt; October 1, 2019, &lt;/em&gt;CBDI and Paw CBD were wholly owned subsidiaries and are disregarded entities for tax purposes and their entire share of taxable income or loss is included in the tax return of the Company and as of &lt;em style="font: inherit;"&gt; March 15, 2021, &lt;/em&gt;Therapeutics is also a wholly owned subsidiary and is a disregarded entity for tax purposes and its entire share of taxable income or loss is included in the tax return of the Company.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company accounts for income taxes pursuant to the provisions of the &lt;i&gt;Accounting for Income Taxes &lt;/i&gt;topic of the Financial Accounting Standards Board&#160;("FASB") ASC &lt;em style="font: inherit;"&gt;740&lt;/em&gt; which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. The Company uses the inside basis approach to determine deferred tax assets and liabilities associated with its investment in a consolidated pass-through entity. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than &lt;em style="font: inherit;"&gt;not&lt;/em&gt; that the net deferred asset will &lt;em style="font: inherit;"&gt;not&lt;/em&gt; be realized.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;US GAAP requires management to evaluate tax positions taken by the Company and recognize a tax liability (or asset) if the Company has taken an uncertain tax position that more likely than &lt;em style="font: inherit;"&gt;not&lt;/em&gt; would &lt;em style="font: inherit;"&gt;not&lt;/em&gt; be sustained upon examination by the Internal Revenue Service. Management has analyzed the tax positions taken by the Company, and has concluded that as of &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt;, there were &lt;em style="font: inherit;"&gt;no&lt;/em&gt; uncertain tax positions taken or expected to be taken that would require recognition of a liability (or asset) or disclosure in the consolidated financial statements.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="d_2023-10-01_2024-09-30" id="c121827953">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Concentrations&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) covers &lt;em style="font: inherit;"&gt;$250,000&lt;/em&gt; for substantially all depository accounts. The Company from time to time &lt;em style="font: inherit;"&gt; may &lt;/em&gt;have amounts on deposit in excess of the insured limits. The Company had a $1,893,606&#160;uninsured balance at &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt; and a $1,163,360&#160;uninsured balance at &lt;em style="font: inherit;"&gt; September 30, 2023&lt;/em&gt;.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did &lt;span style="-sec-ix-hidden:c121825261"&gt;not&lt;/span&gt; have any customers that represented a significant amount of our sales for the year ended &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashUninsuredAmount
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825259"
      unitRef="USD">1893606</us-gaap:CashUninsuredAmount>
    <us-gaap:CashUninsuredAmount
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825260"
      unitRef="USD">1163360</us-gaap:CashUninsuredAmount>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="d_2023-10-01_2024-09-30" id="c121827954">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Stock-Based Compensation&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company accounts for its stock compensation under the ASC &lt;em style="font: inherit;"&gt;718&lt;/em&gt;-&lt;em style="font: inherit;"&gt;10&lt;/em&gt;-&lt;em style="font: inherit;"&gt;30,&lt;/em&gt; &lt;i&gt;Compensation - Stock Compensation &lt;/i&gt;using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity's equity instruments or that &lt;em style="font: inherit;"&gt; may &lt;/em&gt;be settled by the issuance of those equity instruments.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company uses the Black-Scholes model for measuring the fair value of options and warrants. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. The Company recognizes forfeitures when they occur.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <ycbd:LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827955">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Liquidity and Going Concern Considerations&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company experienced a loss of $3.7&#160;million for the fiscal year&#160;ended &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;,&#160;resulting in a working capital deficit of $1.1 million&#160;at &lt;em style="font: inherit;"&gt; September&#160;&lt;/em&gt;&lt;em style="font: inherit;"&gt;30,&lt;/em&gt; &lt;em style="font: inherit;"&gt;2024.&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;While the Company is taking strong action, believes in the viability of its strategy&#160;and&#160;path to profitability, and in its ability to raise additional funds, there can be&#160;&lt;em style="font: inherit;"&gt;no&lt;/em&gt;&#160;assurances to that effect.&#160;&#160;The Company&#x2019;s working capital position &lt;em style="font: inherit;"&gt; may &lt;/em&gt;&lt;em style="font: inherit;"&gt;not&lt;/em&gt;&#160;be sufficient to support the Company&#x2019;s daily operations for the &lt;em style="font: inherit;"&gt;twelve&lt;/em&gt;&#160;months subsequent to the issuance of these annual financial statements.&#160;The Company&#x2019;s ability to continue as a going concern is dependent upon its ability to improve profitability and the ability to acquire additional funding. These and other factors raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within &lt;em style="font: inherit;"&gt;twelve&lt;/em&gt; months after the date that the annual financial statements are issued. These financial statements do &lt;em style="font: inherit;"&gt;not&lt;/em&gt; include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that &lt;em style="font: inherit;"&gt; may&#160;&lt;/em&gt;result in the Company &lt;em style="font: inherit;"&gt;not&lt;/em&gt; being able to continue as a going concern.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;</ycbd:LiquidityAndGoingConcernConsiderationsPolicyPolicyTextBlock>
    <ycbd:NetIncomeLossIncludingImpairment
      contextRef="d_2023-10-01_2024-09-30"
      decimals="-5"
      id="c121825265"
      unitRef="USD">3700000</ycbd:NetIncomeLossIncludingImpairment>
    <ycbd:WorkingCapital
      contextRef="i_2024-09-30"
      decimals="-5"
      id="c121825266"
      unitRef="USD">1100000</ycbd:WorkingCapital>
    <us-gaap:DebtPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827956">&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&lt;b&gt;Convertible Notes&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;Effective &lt;em style="font: inherit;"&gt; February 1, 2024 (&lt;/em&gt;the &#x201c;Effective Date&#x201d;), the Company entered into a Securities Purchase Agreement dated &lt;em style="font: inherit;"&gt; January 30, 2024 (&lt;/em&gt;the &#x201c;Purchase Agreement&#x201d;) with &lt;em style="font: inherit;"&gt;five&lt;/em&gt; institutional investors (the &#x201c;Investors&#x201d;) whereby the Investors advanced the Company an aggregate of $1,250,000 gross proceeds and the Company issued each Investor an 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note, in the aggregate principal amount of $1,541,666 (the &#x201c;Notes&#x201d;). The Company is using the proceeds from the issuance of the Notes for working capital and general corporate purposes. The Company elected the fair value option under ASC &lt;em style="font: inherit;"&gt;825&lt;/em&gt; Fair Value Measurements for the Notes. The Notes were initially recognized at fair value on the balance sheet. All subsequent changes in fair value, excluding the impact of the change in fair value related to instrument-specific credit risk are recorded in non-operating income. The changes in fair value related to instrument-specific credit risk is recorded through other comprehensive income (loss). See Note &lt;em style="font: inherit;"&gt;12&lt;/em&gt; for more information related to the Notes.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="d_2024-01-30_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="INF"
      id="c121825276"
      unitRef="USD">1250000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="2"
      id="c121825277"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ycbd:DebtInstrumentDiscountedPercentage
      contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="1"
      id="c121825278"
      unitRef="Pure">0.20</ycbd:DebtInstrumentDiscountedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="INF"
      id="c121825279"
      unitRef="USD">1541666</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827957">&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Earnings (Loss) Per Share&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;The Company uses ASC &lt;em style="font: inherit;"&gt;260&lt;/em&gt;-&lt;em style="font: inherit;"&gt;10,&lt;/em&gt; &lt;i&gt;Earnings Per Share &lt;/i&gt;for calculating the basic and diluted income (loss) per share. The Company computes basic income (loss) per share by dividing net income (loss) and net income (loss) attributable to common shareholders, after deducting preferred stock dividends, by the weighted average number of common shares outstanding. Common equivalent shares are excluded from the computation of net loss per share if their effect is anti-dilutive.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;On &lt;em style="font: inherit;"&gt; February 16, 2023, &lt;/em&gt;we held an annual meeting of stockholders. At the annual meeting, our stockholders approved an amendment to our articles of incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of common stock by a ratio of between &lt;em style="font: inherit;"&gt;one&lt;/em&gt;-for-&lt;span style="-sec-ix-hidden:c121825285"&gt;twenty&lt;/span&gt; to &lt;span style="-sec-ix-hidden:c121825286"&gt;one&lt;/span&gt;-for-fifty, inclusive, with the exact ratio to be set at the discretion of our board of directors, at any time after approval of the amendment and prior to &lt;em style="font: inherit;"&gt; February 16, 2024. &lt;/em&gt;On &lt;em style="font: inherit;"&gt; April 12, 2023, &lt;/em&gt;the board effected a reverse stock split at a ratio of &lt;em style="font: inherit;"&gt;one&lt;/em&gt;-for-&lt;span style="-sec-ix-hidden:c121825288"&gt;forty&lt;/span&gt;-five, effective as of &lt;em style="font: inherit;"&gt; April 24, 2023 (&lt;/em&gt;the "Reverse Stock Split"). Unless otherwise indicated, all share numbers in this report, including shares of common stock and all securities convertible into, or exercisable for, shares of common stock, give effect to the Reverse Stock Split.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="d_2023-10-01_2024-09-30" id="c121827958">&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&lt;b&gt;New Accounting&lt;/b&gt;&#160;&lt;b&gt;Standards&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The Company adopted ASU &lt;em style="font: inherit;"&gt;2016&lt;/em&gt;-&lt;em style="font: inherit;"&gt;13&lt;/em&gt; Financial Instruments &#x2013; Credit Losses (Topic &lt;em style="font: inherit;"&gt;326&lt;/em&gt;): Measurement of Credit Losses on Financial Instruments (ASC &lt;em style="font: inherit;"&gt;326&lt;/em&gt;) effective &lt;em style="font: inherit;"&gt; October 1, 2023. &lt;/em&gt;This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (&#x201c;CECL&#x201d;) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities, and some off-balance sheet credit exposures such as unfunded commitments to extend credit. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses.&#160;The adoption of&#160;this standard had &lt;em style="font: inherit;"&gt;no&lt;/em&gt; material impact&#160;on the consolidated financial statements.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808711">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;2&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; MARKETABLE SECURITIES AND INVESTMENT OTHER SECURITIES&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;On &lt;em style="font: inherit;"&gt; April 7, 2022, &lt;/em&gt;the Company&#160;entered into an asset sale agreement to sell substantially all its manufacturing assets to a subsidiary of Steady State, LLC ("Steady State"). The equipment sale was initially valued at approximately $1.8 million for accounting purposes, the sale price consisting of a trade credit for products to be provided to the Company under the manufacturing and supply agreement and $1.4 million of which the Company invested into Steady State in the form of an equity investment consistent with the terms of Steady State's completed Series C financing. &#160; The Company performed a valuation analysis and as of &lt;em style="font: inherit;"&gt; September 30, 2023 &lt;/em&gt;determined a $700,000 impairment was needed on the carrying value of this investment. The determination was based on a number of factors, including Steady State&#x2019;s financial performance, our experience with production and cbdMD&#x2019;s determination to re-source production to other suppliers. As such we believe it was prudent to reassess the carrying value of this non-liquid security. The Company performed an additional valuation analysis as of &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and determined that no further impairment was needed based on factors such as Steady State's financial performance and re-alignment of the business.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;For the year ended &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt; and&#160;&lt;em style="font: inherit;"&gt; September 30, 2023&lt;/em&gt; the Company recorded $0 and an unrealized loss of $700,000, respectively of realized and unrealized loss&#160;on marketable and other securities, including impairments.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The table below summarizes the&#160;assets and liabilities related to marketable and other securities valued at fair value as of &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;:&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;In Active&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Markets for&lt;/em&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Significant Other&lt;/em&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Significant&lt;/em&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Identical Assets&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Observable&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Unobservable&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;and Liabilities&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Inputs&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Inputs&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;(Level 1)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;(Level 2)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;(Level 3)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 55%;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Balance at September 30, 2022&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(276,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Change in value of equities&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: Times New Roman;"&gt;Change in value of contingent liability&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Additional Investment&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;185,638&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Balance at September 30, 2023&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(90,362&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Change in value of contingent liability&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;-&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;90,362&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;Fair value of convertible notes&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;1,171,308&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom;"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Balance at September 30, 2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;1,171,308&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160; &#160;&lt;/p&gt;
  </us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <ycbd:EquipmentSoldValue
      contextRef="d_2022-04-07_2022-04-07_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember"
      decimals="-5"
      id="c121825296"
      unitRef="USD">1800000</ycbd:EquipmentSoldValue>
    <us-gaap:Investments
      contextRef="i_2022-04-07_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember"
      decimals="-5"
      id="c121825297"
      unitRef="USD">1400000</us-gaap:Investments>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="d_2023-09-30_2023-09-30_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember"
      decimals="INF"
      id="c121825298"
      unitRef="USD">700000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="d_2024-09-30_2024-09-30_RelatedPartyTransactionsByRelatedPartyAxis-SteadyStateLlcMember"
      decimals="-3"
      id="c121825299"
      unitRef="USD">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
      contextRef="d_2023-10-01_2024-09-30"
      decimals="-3"
      id="c121825300"
      unitRef="USD">0</us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments>
    <us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825301"
      unitRef="USD">-700000</us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808712">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;In Active&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: Times New Roman; font-size: 10pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Markets for&lt;/em&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Significant Other&lt;/em&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Significant&lt;/em&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Identical Assets&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Observable&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Unobservable&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;and Liabilities&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Inputs&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Inputs&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;(Level 1)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;(Level 2)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;(Level 3)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 55%;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Balance at September 30, 2022&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(276,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Change in value of equities&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: Times New Roman;"&gt;Change in value of contingent liability&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Additional Investment&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;185,638&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Balance at September 30, 2023&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(90,362&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Change in value of contingent liability&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;-&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;90,362&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;Fair value of convertible notes&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;1,171,308&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom;"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Balance at September 30, 2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;1,171,308&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member"
      decimals="INF"
      id="c121824819"
      unitRef="USD">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member"
      decimals="INF"
      id="c121824820"
      unitRef="USD">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i_2022-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member"
      decimals="INF"
      id="c121824821"
      unitRef="USD">-276000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:EquityFairValueAdjustment
      contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member"
      decimals="INF"
      id="c121824822"
      unitRef="USD">0</us-gaap:EquityFairValueAdjustment>
    <us-gaap:EquityFairValueAdjustment
      contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member"
      decimals="INF"
      id="c121824823"
      unitRef="USD">0</us-gaap:EquityFairValueAdjustment>
    <us-gaap:EquityFairValueAdjustment
      contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member"
      decimals="INF"
      id="c121824824"
      unitRef="USD">0</us-gaap:EquityFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"
      decimals="INF"
      id="c121824825"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"
      decimals="INF"
      id="c121824826"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"
      decimals="INF"
      id="c121824827"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions
      contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member"
      decimals="INF"
      id="c121824828"
      unitRef="USD">0</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions
      contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member"
      decimals="INF"
      id="c121824829"
      unitRef="USD">0</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions
      contextRef="d_2022-10-01_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member"
      decimals="INF"
      id="c121824830"
      unitRef="USD">185638</us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member"
      decimals="INF"
      id="c121824831"
      unitRef="USD">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member"
      decimals="INF"
      id="c121824832"
      unitRef="USD">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member"
      decimals="INF"
      id="c121824833"
      unitRef="USD">-90362</us-gaap:FairValueNetAssetLiability>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"
      decimals="INF"
      id="c121824834"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"
      decimals="INF"
      id="c121824835"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ContingentLiabilityMember"
      decimals="INF"
      id="c121824836"
      unitRef="USD">90362</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember"
      id="c121824837"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember"
      id="c121824838"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="d_2023-10-01_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member_FairValueByLiabilityClassAxis-ConvertibleNotesMember"
      decimals="INF"
      id="c121824839"
      unitRef="USD">1171308</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member"
      decimals="INF"
      id="c121824840"
      unitRef="USD">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel2Member"
      decimals="INF"
      id="c121824841"
      unitRef="USD">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i_2024-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member"
      decimals="INF"
      id="c121824842"
      unitRef="USD">1171308</us-gaap:FairValueNetAssetLiability>
    <us-gaap:InventoryDisclosureTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808713">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;3&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; INVENTORY&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Inventory at &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt; consists of the following:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Finished Goods&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,534,718&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2,782,680&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Inventory Components&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;830,469&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,397,034&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Inventory Reserve&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(126,742&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Inventory prepaid&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;159,006&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;182,675&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total Inventory&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;2,524,193&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;4,235,647&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;Abnormal amounts of idle facility expense, freight, handling costs, scrap, and wasted material (spoilage) are expensed in the period they are incurred and &lt;em style="font: inherit;"&gt;no&lt;/em&gt; material expenses related to these items occurred in the year ended &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;. The Company wrote down inventory of $921,314 during the &lt;em style="font: inherit;"&gt;fourth&lt;/em&gt; quarter of fiscal year ended &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt; primarily related to obsolete and expired stock keeping units (&#x201c;SKU&#x201d;s).&#160; We work hard to minimize inventory write-downs and slow moving and aging SKUs&#160;and work, as we work to streamline our offerings to higher velocity products and eliminate slow-moving and aging SKUs.&lt;/p&gt;
  </us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808714">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Finished Goods&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,534,718&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2,782,680&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Inventory Components&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;830,469&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,397,034&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Inventory Reserve&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(126,742&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Inventory prepaid&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;159,006&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;182,675&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total Inventory&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;2,524,193&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;4,235,647&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824847"
      unitRef="USD">1534718</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824848"
      unitRef="USD">2782680</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824849"
      unitRef="USD">830469</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824850"
      unitRef="USD">1397034</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryValuationReserves
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824851"
      unitRef="USD">-0</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824852"
      unitRef="USD">126742</us-gaap:InventoryValuationReserves>
    <ycbd:PrepaidInventory
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824853"
      unitRef="USD">159006</ycbd:PrepaidInventory>
    <ycbd:PrepaidInventory
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824854"
      unitRef="USD">182675</ycbd:PrepaidInventory>
    <us-gaap:InventoryNet
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824855"
      unitRef="USD">2524193</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824856"
      unitRef="USD">4235647</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown
      contextRef="d_2024-07-01_2024-09-30"
      decimals="INF"
      id="c121825306"
      unitRef="USD">921314</us-gaap:InventoryWriteDown>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808715">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;4&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; PROPERTY AND EQUIPMENT&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Major classes of property and equipment at &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt; consist of the following:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Computers, furniture and equipment&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,587,411&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,392,776&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Manufacturing equipment&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;284,275&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;284,275&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Leasehold improvements&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;487,081&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;487,081&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Automobiles&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;11,087&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2,358,767&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2,175,219&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Less accumulated depreciation&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1,904,499&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1,458,640&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;454,268&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;716,579&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;Depreciation expense related to property and equipment was $452,326&#160;and $404,280&#160;for the year ended &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt;, respectively. During the &lt;em style="font: inherit;"&gt;third&lt;/em&gt; quarter of fiscal year &lt;em style="font: inherit;"&gt;2023,&lt;/em&gt; the Company sold substantially all the assets of its manufacturing facility and as a result the gross investment and accumulated depreciation was removed from the balance sheet, reducing net PP&amp;amp;E&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
  </us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808716">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Computers, furniture and equipment&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,587,411&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,392,776&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Manufacturing equipment&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;284,275&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;284,275&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Leasehold improvements&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;487,081&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;487,081&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Automobiles&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;11,087&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2,358,767&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2,175,219&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Less accumulated depreciation&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1,904,499&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1,458,640&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;454,268&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;716,579&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-ComputersFurnitureAndEquipmentMember"
      decimals="INF"
      id="c121824861"
      unitRef="USD">1587411</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-ComputersFurnitureAndEquipmentMember"
      decimals="INF"
      id="c121824862"
      unitRef="USD">1392776</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-ManufacturingEquipmentMember"
      decimals="INF"
      id="c121824863"
      unitRef="USD">284275</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-ManufacturingEquipmentMember"
      decimals="INF"
      id="c121824864"
      unitRef="USD">284275</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember"
      decimals="INF"
      id="c121824865"
      unitRef="USD">487081</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember"
      decimals="INF"
      id="c121824866"
      unitRef="USD">487081</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i_2024-09-30_PropertyPlantAndEquipmentByTypeAxis-AutomobilesMember"
      decimals="INF"
      id="c121824867"
      unitRef="USD">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i_2023-09-30_PropertyPlantAndEquipmentByTypeAxis-AutomobilesMember"
      decimals="INF"
      id="c121824868"
      unitRef="USD">11087</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824869"
      unitRef="USD">2358767</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824870"
      unitRef="USD">2175219</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824871"
      unitRef="USD">1904499</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824872"
      unitRef="USD">1458640</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824873"
      unitRef="USD">454268</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824874"
      unitRef="USD">716579</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825310"
      unitRef="USD">452326</us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease>
    <us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825311"
      unitRef="USD">404280</us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808717">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;5&lt;/em&gt; &lt;/b&gt;&#x2013; &lt;b&gt;INTANGIBLE ASSETS&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&lt;b&gt;&lt;span style="text-decoration: underline; "&gt;Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;As of &lt;em style="font: inherit;"&gt; July 1, 2023 &lt;/em&gt;the Company determined that based on market forces and the Company&#x2019;s outlook it was prudent to adjust the useful lives of cbdMD&#x2019;s and DCO intangibles to 5 year useful lives and hempMD&#x2019;s trademark to 10 year amortization to better reflect the outlook of the brands. This re-evaluation of the tradenames became a triggering event for a valuation test under ASC &lt;em style="font: inherit;"&gt;360.&lt;/em&gt; As a result of a multi-step approach under ASC &lt;em style="font: inherit;"&gt;360&lt;/em&gt; we determined that the &#x201c;cbdMD,&#x201d; &#x201c;DirectCBDOnline&#x201d; tradenames and the technology relieve asset was impaired by &lt;em style="font: inherit;"&gt;$6,027,000,&lt;/em&gt; and as a result, the amortization was adjusted to account for any changes in the value and estimated useful life of each asset.&#160; Amortization expense for the year ended &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt; was $697,510&#160;and was recorded on the consolidated statements of operations.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;At &lt;em style="font: inherit;"&gt; September 30, 2023, &lt;/em&gt;the Company prepared a tradename impairment analysis in accordance with ASC &lt;em style="font: inherit;"&gt;360&lt;/em&gt; and has determined that based on market sentiment and the sharp decline in combined market capitalization of the common stock and Series A Preferred as a result of the ongoing proxy vote, a triggering event occurred. The Company prepared an impairment analysis and as a result of a multi-step approach under ASC &lt;em style="font: inherit;"&gt;360&lt;/em&gt; we determined that the &#x201c;cbdMD&#x201d; DirectCBDOnline&#x201d; tradenames and technology relieve were further impaired by $7,192,000 in fiscal year &lt;em style="font: inherit;"&gt;2023,&lt;/em&gt; resulting in a total impairment charge of $13,219,000 for the fiscal year ended &lt;em style="font: inherit;"&gt; September 30, 2023.&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;At &lt;em style="font: inherit;"&gt; September 30, 2024, &lt;/em&gt;the Company prepared a tradename impairment analysis in accordance with ASC &lt;em style="font: inherit;"&gt;360&lt;/em&gt; and has determined that no impairment existed.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;In &lt;em style="font: inherit;"&gt;2019,&lt;/em&gt; Company&#x2019;s subsidiary, CBD Industries, LLC, initiated a trademark cancellation proceeding against Majik Medicine, LLC (&#x201c;Majik&#x201d;) regarding Majik&#x2019;s &#x201c;CBD MD&#x201d; trademark. In a Settlement, Purchase, and Release Agreement that occurred in &lt;em style="font: inherit;"&gt; August &lt;/em&gt;of &lt;em style="font: inherit;"&gt;2024,&lt;/em&gt; the Company acquired the trademark, resolving all related legal claims. The agreement included a $100,000 initial payment, &lt;em style="font: inherit;"&gt;four&lt;/em&gt; additional annual payments of $50,000, the issuance of 75,000 shares of common stock (the &#x201c;Initial Shares&#x201d;), and 50,000 more shares on the &lt;em style="font: inherit;"&gt;one&lt;/em&gt;-year anniversary. Failure to make the additional payments would reassign the trademark to Majik. Additionally, the Company entered a &lt;span style="-sec-ix-hidden:c121825337"&gt;five&lt;/span&gt;-year consulting agreement with Majik, granting a 15% commission on increased sales from Licensed Practitioners, a new customer base. This acquisition strengthens the Company&#x2019;s IP portfolio, avoids litigation costs, and expedites trademark issuance. Majik also appointed board member William Raines III as a proxy for the Initial Shares for &lt;em style="font: inherit;"&gt;12&lt;/em&gt; months. The Company used the Black Scholes method to determine the fair value of the remaining shares to be paid on the &lt;em style="font: inherit;"&gt;one&lt;/em&gt;-year anniversary.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;At &lt;em style="font: inherit;"&gt; September 30, 2024, &lt;/em&gt;the Company prepared a tradename impairment analysis in accordance with ASC &lt;em style="font: inherit;"&gt;360&lt;/em&gt; and has determined that no impairment existed.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;Intangible assets as of &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt; consisted of the following:&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Trademark related to cbdMD&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;21,585,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;21,585,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Trademark for HempMD&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;50,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;50,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Technology Relief from Royalty related to DirectCBDOnline.com&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;667,844&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;667,844&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Tradename related to CBD MD limited mark&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;368,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Tradename related to DirectCBDOnline.com&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;749,567&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;749,567&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Impairment of definite lived intangible assets:&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;(17,504,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;(17,504,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Amortization of definite lived intangible assets:&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(3,026,831&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(2,329,321&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;2,889,580&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;3,219,090&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Future amortization of intangible assets as of &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt; is as follow:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 85%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;For the year ended September 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;2025&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;762,457&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;2026&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;733,740&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;2027&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;733,740&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;2028&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;569,923&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Thereafter&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;89,720&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total future intangibles amortization&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;2,889,580&lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&#160;&#160; &#160;&#160;&lt;/p&gt;
  </us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdmdAndDirectcbdonlineTrademarksMember"
      id="c121825316">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember"
      id="c121825317">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="d_2023-10-01_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarksMember"
      decimals="INF"
      id="c121825321"
      unitRef="USD">697510</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="d_2022-10-01_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdmdAndDirectcbdonlineTrademarksMember"
      decimals="INF"
      id="c121825324"
      unitRef="USD">7192000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825326"
      unitRef="USD">13219000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="d_2023-10-01_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TrademarksMember"
      decimals="-3"
      id="c121825328"
      unitRef="USD">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <ycbd:LitigationSettlementInitialPayment
      contextRef="d_2024-08-01_2024-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember"
      decimals="INF"
      id="c121825331"
      unitRef="USD">100000</ycbd:LitigationSettlementInitialPayment>
    <ycbd:LitigationSettlementMonthlyPaymentAmount
      contextRef="d_2024-08-01_2024-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember"
      decimals="INF"
      id="c121825333"
      unitRef="USD">50000</ycbd:LitigationSettlementMonthlyPaymentAmount>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-08-01_2024-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember"
      decimals="INF"
      id="c121825334"
      unitRef="Share">75000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2025-08-01_2025-08-31_LitigationCaseAxis-CaseWithMajikMedicinesMember_StatementScenarioAxis-ScenarioForecastMember"
      decimals="INF"
      id="c121825335"
      unitRef="Share">50000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <ycbd:CommissionPercentage
      contextRef="d_2024-08-01_2024-08-31_CounterpartyNameAxis-MajikMedicinesMember"
      decimals="2"
      id="c121825338"
      unitRef="Pure">0.15</ycbd:CommissionPercentage>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="d_2023-10-01_2024-09-30"
      decimals="-3"
      id="c121825342"
      unitRef="USD">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808718">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Trademark related to cbdMD&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;21,585,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;21,585,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Trademark for HempMD&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;50,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;50,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Technology Relief from Royalty related to DirectCBDOnline.com&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;667,844&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;667,844&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Tradename related to CBD MD limited mark&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;368,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Tradename related to DirectCBDOnline.com&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;749,567&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;749,567&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Impairment of definite lived intangible assets:&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;(17,504,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;(17,504,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Amortization of definite lived intangible assets:&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(3,026,831&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(2,329,321&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;2,889,580&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;3,219,090&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:IndefiniteLivedTrademarks
      contextRef="i_2024-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToCbdmdMember"
      decimals="INF"
      id="c121824879"
      unitRef="USD">21585000</us-gaap:IndefiniteLivedTrademarks>
    <us-gaap:IndefiniteLivedTrademarks
      contextRef="i_2023-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToCbdmdMember"
      decimals="INF"
      id="c121824880"
      unitRef="USD">21585000</us-gaap:IndefiniteLivedTrademarks>
    <us-gaap:IndefiniteLivedTrademarks
      contextRef="i_2024-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember"
      decimals="INF"
      id="c121824881"
      unitRef="USD">50000</us-gaap:IndefiniteLivedTrademarks>
    <us-gaap:IndefiniteLivedTrademarks
      contextRef="i_2023-09-30_IndefiniteLivedIntangibleAssetsByMajorClassAxis-TrademarkRelatedToHempMdMember"
      decimals="INF"
      id="c121824882"
      unitRef="USD">50000</us-gaap:IndefiniteLivedTrademarks>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember"
      decimals="INF"
      id="c121824883"
      unitRef="USD">667844</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TechnologyReliefFromRoyaltyRelatedToDirectCBDOnlineComMember"
      decimals="INF"
      id="c121824884"
      unitRef="USD">667844</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdMdLimintedMarkMember"
      decimals="INF"
      id="c121824885"
      unitRef="USD">368000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-CbdMdLimintedMarkMember"
      decimals="INF"
      id="c121824886"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i_2024-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TradenameRelatedToDirectCBDOnlineComMember"
      decimals="INF"
      id="c121824887"
      unitRef="USD">749567</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i_2023-09-30_FiniteLivedIntangibleAssetsByMajorClassAxis-TradenameRelatedToDirectCBDOnlineComMember"
      decimals="INF"
      id="c121824888"
      unitRef="USD">749567</us-gaap:FiniteLivedIntangibleAssetsGross>
    <ycbd:FinitelivedIntangibleAssetAccumulatedImpairment
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824889"
      unitRef="USD">17504000</ycbd:FinitelivedIntangibleAssetAccumulatedImpairment>
    <ycbd:FinitelivedIntangibleAssetAccumulatedImpairment
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824890"
      unitRef="USD">17504000</ycbd:FinitelivedIntangibleAssetAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824891"
      unitRef="USD">3026831</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824892"
      unitRef="USD">2329321</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824893"
      unitRef="USD">2889580</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824894"
      unitRef="USD">3219090</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808719">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 85%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;For the year ended September 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;2025&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;762,457&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;2026&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;733,740&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;2027&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;733,740&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;2028&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;569,923&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Thereafter&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;89,720&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total future intangibles amortization&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;b&gt;2,889,580&lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824895"
      unitRef="USD">762457</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824896"
      unitRef="USD">733740</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824897"
      unitRef="USD">733740</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824898"
      unitRef="USD">569923</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <ycbd:FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824899"
      unitRef="USD">89720</ycbd:FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824900"
      unitRef="USD">2889580</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808720">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;6&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; CONTINGENT LIABILITY&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;Pursuant to a merger agreement entered into in &lt;em style="font: inherit;"&gt;2018,&lt;/em&gt; the Company had a contractual obligation to issue 338,889 shares of its common stock, after approval by its shareholders, to the members of Cure Based Development, issued in &lt;em style="font: inherit;"&gt;two&lt;/em&gt; tranches 144,445 shares and 194,945 shares, both of which were subject to leak out provisions, and the unrestricted voting rights to 194,445 tranche of shares which vested over a &lt;span style="-sec-ix-hidden:c121825352"&gt;five&lt;/span&gt; year period and were subject to a voting proxy agreement.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The contractual obligations and earn out provision were accounted for as a contingent liability and fair value was determined using Level &lt;em style="font: inherit;"&gt;3&lt;/em&gt; inputs, as estimating the fair value of these contingent liabilities require the use of significant and subjective inputs that &lt;em style="font: inherit;"&gt; may &lt;/em&gt;and are likely to change over the duration of the liabilities with related changes in internal and external market factors.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The agreement also provided that an additional 338,889 Earnout Shares would be issued as part of the consideration, upon the satisfaction of certain aggregate net revenue criteria by cbdMD within 60 months following the closing date of the merger&#160;&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 48%; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Aggregate Net Revenues&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;Shares Issued/ Each $ of Aggregate Net Revenue Ratio&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="width: 48%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 48%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;$&lt;span style="-sec-ix-hidden:c121825661"&gt;1&lt;/span&gt; - $&lt;span style="-sec-ix-hidden:c121825662"&gt;20,000,000&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.004236111&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;$&lt;span style="-sec-ix-hidden:c121825663"&gt;20,000,001&lt;/span&gt; - $&lt;span style="-sec-ix-hidden:c121825664"&gt;60,000,000&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.002118056&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;$&lt;span style="-sec-ix-hidden:c121825665"&gt;60,000,001&lt;/span&gt; - $&lt;span style="-sec-ix-hidden:c121825666"&gt;140,000,000&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.001059028&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;$&lt;span style="-sec-ix-hidden:c121825667"&gt;140,000,001&lt;/span&gt; - $&lt;span style="-sec-ix-hidden:c121825668"&gt;300,000,000&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.005295139&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The Company determined the final Earnout shares to be issued were 19,818 and were issued on &lt;em style="font: inherit;"&gt; January 11, 2024. &lt;/em&gt;There is &lt;em style="font: inherit;"&gt;no&lt;/em&gt; further Earnout obligation.&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;


  </us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember"
      decimals="INF"
      id="c121825347"
      unitRef="Share">338889</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-RegisteredCommonStockMember"
      decimals="INF"
      id="c121825349"
      unitRef="Share">144445</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStock2Member"
      decimals="INF"
      id="c121825350"
      unitRef="Share">194945</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-UnregisteredCommonStockMember"
      decimals="INF"
      id="c121825351"
      unitRef="Share">194445</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares
      contextRef="d_2019-04-01_2019-04-30_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember"
      decimals="INF"
      id="c121825354"
      unitRef="Share">338889</ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares>
    <ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration
      contextRef="d_2018-12-20_2018-12-20_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember"
      id="c121825355">P60M</ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808721">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 48%; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Aggregate Net Revenues&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;Shares Issued/ Each $ of Aggregate Net Revenue Ratio&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="width: 48%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 48%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;$&lt;span style="-sec-ix-hidden:c121825661"&gt;1&lt;/span&gt; - $&lt;span style="-sec-ix-hidden:c121825662"&gt;20,000,000&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.004236111&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;$&lt;span style="-sec-ix-hidden:c121825663"&gt;20,000,001&lt;/span&gt; - $&lt;span style="-sec-ix-hidden:c121825664"&gt;60,000,000&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.002118056&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;$&lt;span style="-sec-ix-hidden:c121825665"&gt;60,000,001&lt;/span&gt; - $&lt;span style="-sec-ix-hidden:c121825666"&gt;140,000,000&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.001059028&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 48%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;$&lt;span style="-sec-ix-hidden:c121825667"&gt;140,000,001&lt;/span&gt; - $&lt;span style="-sec-ix-hidden:c121825668"&gt;300,000,000&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 48%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.005295139&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween1And20000000Member"
      decimals="INF"
      id="c121824903"
      unitRef="Pure">0.004236111</ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio>
    <ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween20000001And60000000Member"
      decimals="INF"
      id="c121824904"
      unitRef="Pure">0.002118056</ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio>
    <ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween60000001And140000000Member"
      decimals="INF"
      id="c121824905"
      unitRef="Pure">0.001059028</ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio>
    <ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio
      contextRef="d_2023-10-01_2024-09-30_ContingentConsiderationByTypeAxis-EarnoutSharesForRevenueBetween140000001And300000000Member_RangeAxis-MinimumMember"
      decimals="INF"
      id="c121824906"
      unitRef="Pure">0.005295139</ycbd:BusinessAcquisitionContingentConsiderationSharesIssuedPerAggregateNetRevenueRatio>
    <ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares
      contextRef="d_2024-01-11_2024-01-11_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember_StatementClassOfStockAxis-CommonStockMember"
      decimals="INF"
      id="c121825356"
      unitRef="Share">19818</ycbd:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808722">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;7&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&lt;em style="font: inherit;"&gt;None.&lt;/em&gt;&lt;/p&gt;
  </us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808723">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;8&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; SHAREHOLDERS&lt;/b&gt;&#x2019;&lt;b&gt; EQUITY &lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Preferred Stock &#x2013; The Company is authorized to issue 50,000,000 shares of preferred stock, par value $0.001 per share. In &lt;em style="font: inherit;"&gt; October 2019, &lt;/em&gt;the Company designated 5,000,000 of these shares as 8.0% Series A Cumulative Convertible Preferred Stock. Our &lt;em style="font: inherit;"&gt;8.0%&lt;/em&gt; Series A Cumulative Convertible Preferred Stock ranks senior to our common stock for liquidation or dividend provisions and holders are entitled to receive cumulative cash dividends at an annual rate of &lt;em style="font: inherit;"&gt;8.0%&lt;/em&gt; payable monthly in arrears for the prior month. The Company reviewed ASC &lt;em style="font: inherit;"&gt;480&lt;/em&gt; &#x2013; &lt;i&gt;Distinguishing Liabilities from Equity &lt;/i&gt;in order to determine the appropriate accounting treatment for the preferred stock and determined that the preferred stock should be treated as equity. There were 5,000,000 shares of 8.0% Series A Cumulative Convertible Preferred Stock issued and outstanding at &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt; and &lt;em style="font: inherit;"&gt; September 30, 2023&lt;/em&gt;.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The total amount of dividends declared were $4,004,001 and $4,002,005 for the years ended &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt; September 30, 2023. &lt;/em&gt;The Company suspended payment of the dividend in &lt;em style="font: inherit;"&gt; August &lt;/em&gt;of &lt;em style="font: inherit;"&gt;2023&lt;/em&gt; and as such recorded an accrual of $667,000 for the dividends declared but &lt;em style="font: inherit;"&gt;not&lt;/em&gt; paid as of &lt;em style="font: inherit;"&gt; September 30, 2023. &lt;/em&gt;As of &lt;em style="font: inherit;"&gt; September 30, 2024, &lt;/em&gt;the Accrued liability for the dividends declared but &lt;em style="font: inherit;"&gt;not&lt;/em&gt; paid totaled $4,669,000 and continues to grow at approximately $1 million per quarter.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;Common Stock &#x2013; The Company is authorized to issue 150,000,000 shares of common stock, par value $0.001 per share. There were 3,939,057 and 2,960,573 shares of common stock issued and outstanding at &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023,&lt;/em&gt; respectively.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;On &lt;em style="font: inherit;"&gt; March 2, 2023 &lt;/em&gt;Company entered into a purchase agreement (the "ELOC") with Keystone Capital Partners, LLC (&#x201c;Keystone&#x201d;), pursuant to which Keystone committed to purchase up to 281,934 of shares of our common stock. Upon the execution of the ELOC, The Company issued 2,616 shares of common stock as "Commitment Shares" to Keystone as consideration for its commitment to purchase shares of our common stock under the ELOC. An additional 6,104 Commitment Shares were issued &lt;em style="font: inherit;"&gt;180&lt;/em&gt; days after the date of the ELOC. The 281,934 shares of the Company's common stock were registered for resale and &lt;em style="font: inherit;"&gt; may &lt;/em&gt;be issued under the ELOC or sold by us to Keystone at our discretion from time to time over a &lt;em style="font: inherit;"&gt;12&lt;/em&gt; month period commencing &lt;em style="font: inherit;"&gt; April 1, 2023. &lt;/em&gt;The purchase price for the shares that the Company sold to Keystone under the ELOC fluctuated based on the price of the Company's common stock. Keystone purchased an aggregate of 180,955 shares (64,218 of which were purchased during the year ended &lt;em style="font: inherit;"&gt; September 30, 2024) &lt;/em&gt;under the ELOC, which expired in the &lt;em style="font: inherit;"&gt;first&lt;/em&gt; half of fiscal &lt;em style="font: inherit;"&gt;2024.&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&lt;b&gt;&lt;span style="text-decoration: underline; "&gt;Preferred stock transactions:&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;The Company had&#160;&lt;em style="font: inherit;"&gt;no&lt;/em&gt; preferred stock transactions in the year ended&#160;&lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt;.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&lt;b&gt;&lt;span style="text-decoration: underline; "&gt;Common stock transactions:&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;In the year ended &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;:&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;In &lt;em style="font: inherit;"&gt; September 2024, &lt;/em&gt;the Company issued 100,624 shares of common stock pursuant to the partial conversion of certain principal and interest related to the Notes.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;In &lt;em style="font: inherit;"&gt; August 2024, &lt;/em&gt;the Company issued 75,000 shares of common stock pursuant to the settlement agreement with Majik Medicine.&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;In &lt;em style="font: inherit;"&gt; April 2024, &lt;/em&gt;the Company issued an aggregate of 714,229 shares of common stock pursuant to the partial conversion of certain principal and interest related to the Notes.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;In &lt;em style="font: inherit;"&gt; March 2024, &lt;/em&gt;the company issued 16,000 of restricted stock awards to the Company&#x2019;s board of directors. The shares vest quarterly on &lt;em style="font: inherit;"&gt; June 30, 2024, &lt;/em&gt;&lt;em style="font: inherit;"&gt; September 30, 2024, &lt;/em&gt;&lt;em style="font: inherit;"&gt; December 31, 2024, &lt;/em&gt;and&#160;&lt;em style="font: inherit;"&gt; March 31, 2025. &lt;/em&gt;The stock awards were valued at the fair market price of $13,760 and will amortize over the individual vesting periods.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;In &lt;em style="font: inherit;"&gt; January 2024, &lt;/em&gt;the Company issued 64,218 shares under our ELOC.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;In &lt;em style="font: inherit;"&gt; January 2024, &lt;/em&gt;the Company issued 19,818 shares as part of the final Earnout.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;In the year ended &lt;em style="font: inherit;"&gt; September 30, 2023:&lt;/em&gt;&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;In &lt;em style="font: inherit;"&gt; September &lt;/em&gt;of &lt;em style="font: inherit;"&gt;2023,&lt;/em&gt; the company issued 102,616 shares under the Purchase Agreement to Keystone.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;In &lt;em style="font: inherit;"&gt; July &lt;/em&gt;of &lt;em style="font: inherit;"&gt;2023&lt;/em&gt; the Company issued 2,616 shares to Keystone pertaining to the commitment shares under the ELOC.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;On &lt;em style="font: inherit;"&gt; May 3, 2023, &lt;/em&gt;the Company completed an underwritten public offering of 1,350,000 shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering before deducting underwriting discounts and commissions and offering expenses were approximately $2.8 million. Under the terms of an underwriting agreement, the Company granted the underwriter an option, exercisable for &lt;em style="font: inherit;"&gt;45&lt;/em&gt; days, to purchase up to an additional 202,500 shares of common stock. The net proceeds to the Company from the offering were approximately $2.5 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, and does &lt;em style="font: inherit;"&gt;not&lt;/em&gt; take into account the exercise by the underwriter of its option to purchase additional shares of common stock. The Company also issued the underwriter a warrant to purchase up to 40,500 shares of its common stock exercisable at $2.52 per share.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;On &lt;em style="font: inherit;"&gt; April 24, 2023 &lt;/em&gt;the Company issued a total of 39,533&#160;shares of common stock to account for rounding up of fractional shares related to the Reverse Stock Split.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;In &lt;em style="font: inherit;"&gt; March 2, 2023, &lt;/em&gt;the Company entered into the ELOC with Keystone, pursuant to which Keystone has committed to purchase up to 281,934 of shares of our common stock. Upon the execution of the ELOC, The Company issued 2,616 shares of common stock as "Commitment Shares" to Keystone as consideration for its commitment to purchase shares of our common stock under the ELOC. Additional Commitment Shares (6,104) will be issued over &lt;em style="font: inherit;"&gt;180&lt;/em&gt; days from &lt;em style="font: inherit;"&gt; March 2, 2023. &lt;/em&gt;The 281,934 shares of the Company's common stock were registered for resale and &lt;em style="font: inherit;"&gt; may &lt;/em&gt;be issued under the ELOC or sold by us to Keystone at our discretion from time to time over a &lt;em style="font: inherit;"&gt;12&lt;/em&gt;-month period commencing &lt;em style="font: inherit;"&gt; April 1, 2023, &lt;/em&gt;subject to a &lt;em style="font: inherit;"&gt;75&lt;/em&gt; day blackout period commencing &lt;em style="font: inherit;"&gt; April 30, 2023. &lt;/em&gt;The purchase price for the shares that the Company &lt;em style="font: inherit;"&gt; may &lt;/em&gt;sell to Keystone under the ELOC will fluctuate based on the price of the Company's common stock. Depending on market liquidity at the time, sales of such shares &lt;em style="font: inherit;"&gt; may &lt;/em&gt;cause the trading price of our common stock to fall.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;In &lt;em style="font: inherit;"&gt; April 2023, &lt;/em&gt;the Company issued 8,889 shares to Keystone under the ELOC entered into in &lt;em style="font: inherit;"&gt; March &lt;/em&gt;of &lt;em style="font: inherit;"&gt;2023.&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;On &lt;em style="font: inherit;"&gt; February 1, 2023, &lt;/em&gt;the Company entered into an Agreement for Advertising Placement with &lt;em style="font: inherit;"&gt;a360&lt;/em&gt; Media, LLC (&lt;em style="font: inherit;"&gt;&#x201c;a360&#x201d;&lt;/em&gt;) in which &lt;em style="font: inherit;"&gt;a360&lt;/em&gt; will provide professional media support and advertising placement in exchange for up to 134,681 shares of the Company&#x2019;s common stock valued at $14.85 per share. &lt;em style="font: inherit;"&gt;A360&lt;/em&gt; will receive the shares by providing the Company with a credit in the amount of $2,000,000 to be used for media support and advertising placement to the Company, of which $514,904 remains unutilized as of &lt;em style="font: inherit;"&gt; September &lt;/em&gt;&lt;em style="font: inherit;"&gt;30,2023.&lt;/em&gt; The shares are 70% fully vested; 15% of the Shares shall vest upon each advertising placement accrue pro-rata as percentage of the total advertising placement; and 15% of the shares shall vest provided there are &lt;em style="font: inherit;"&gt;no&lt;/em&gt; restrictions in product categories that the Company is able to market with &lt;em style="font: inherit;"&gt;a360&lt;/em&gt; while the Company utilizes the advertising placement. Any shares which do &lt;em style="font: inherit;"&gt;not&lt;/em&gt; vest within the term of the agreement shall be forfeited. The Advertising Placement must be used by the Company prior to &lt;em style="font: inherit;"&gt; December 30, 2023, &lt;/em&gt;unless otherwise agreed in writing by both parties.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;In &lt;em style="font: inherit;"&gt; January &lt;/em&gt;of &lt;em style="font: inherit;"&gt;2023,&lt;/em&gt; the Company issued 2,223 shares of common stock to Twenty Two Capital as the final obligation under the &lt;em style="font: inherit;"&gt;2021&lt;/em&gt; acquisition agreement upon the expiration of the indemnification period.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;&lt;span style="text-decoration: underline; "&gt;Stock option transactions:&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;In the year ended &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;:&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The Company granted its board of directors an aggregate of 8,000 common stock options in &lt;em style="font: inherit;"&gt; April 2024. &lt;/em&gt;The options vested immediately, have a strike price of $0.86 and a &lt;span style="-sec-ix-hidden:c121825448"&gt;five&lt;/span&gt;-year term. The Company has recorded a total prepaid expense of approximately $4,300 and intends to amortize the expense over the &lt;em style="font: inherit;"&gt;12&lt;/em&gt;-month board term.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;In the year ended &lt;em style="font: inherit;"&gt; September 30, 2023:&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;In &lt;em style="font: inherit;"&gt; February &lt;/em&gt;of &lt;em style="font: inherit;"&gt;2023,&lt;/em&gt; the Company granted its board of directors an aggregate of 2,667 common stock options. The options vested immediately, have a strike price of $12.60 and a &lt;span style="-sec-ix-hidden:c121825454"&gt;five&lt;/span&gt;-year term. The Company has recorded a total prepaid expense of $21,120 and intends to amortize the expense over the &lt;em style="font: inherit;"&gt;12&lt;/em&gt;-month board term.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;In &lt;em style="font: inherit;"&gt; January 2023, &lt;/em&gt;the Company issued 2,334 options to a group of employees. The stock options awards vested at issuance, had a strike price of $10.53, &lt;span style="-sec-ix-hidden:c121825459"&gt;five&lt;/span&gt;-year term and a fair market value upon issuance of $15,225.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;In &lt;em style="font: inherit;"&gt; December 2022, &lt;/em&gt;the Company issued 2,223 options to an employee. 1,667 options vest equally at each anniversary for the next &lt;em style="font: inherit;"&gt;3&lt;/em&gt; years, have a strike price of $11.25 and a &lt;span style="-sec-ix-hidden:c121825465"&gt;five&lt;/span&gt; year term. The total expense of these options is $13,150 and will be amortized over the term of the vesting periods. 556 options vest based on meeting certain direct to consumer revenue requirements by the end of &lt;em style="font: inherit;"&gt; December 2024.&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;The Company has recorded an expense for these options of $11,974&#160;for the &lt;em style="font: inherit;"&gt;twelve&lt;/em&gt; months ended &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;The expected volatility rate was estimated based on comparison to the volatility of a blend of the Company's own stock&#160;and a&#160;peer group of companies in similar industries. The expected term used was the full term of the contract for the issuances. The risk-free interest rate for periods within the contractual life of the option is based on U.S. Treasury securities. The pre-vesting forfeiture rate of &lt;em style="font: inherit;"&gt;zero&lt;/em&gt; is based upon the experience of the Company. As required under ASC &lt;em style="font: inherit;"&gt;718,&lt;/em&gt; the Company will adjust the estimated forfeiture rate to its actual experience. Management will continue to assess the assumptions and methodologies used to calculate estimated fair value of share-based compensation. Circumstances &lt;em style="font: inherit;"&gt; may &lt;/em&gt;change and additional data &lt;em style="font: inherit;"&gt; may &lt;/em&gt;become available over time, which could result in changes to these assumptions and methodologies, and thereby materially impact our fair value determination.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;The following table summarizes the inputs used for the Black-Scholes pricing model on the options issued in the years ended &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt;:&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Weighted average exercise price&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.54&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;10.35 - 12.60&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Risk free interest rate&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;4%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;3.93% - 4.71%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Volatility&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;107%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;106.48% - 106.51%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Expected term (in years)&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2.5 - 4&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Dividend yield&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;None&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;None&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&lt;b&gt;&lt;span style="text-decoration: underline; "&gt;Warrant transactions:&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;The Company had &lt;em style="font: inherit;"&gt;no&lt;/em&gt; warrant transactions during the &lt;em style="font: inherit;"&gt;twelve&lt;/em&gt; months ended &lt;em style="font: inherit;"&gt; September 30, 2024.&lt;/em&gt;&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&#160;&lt;/p&gt;
  </us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825362"
      unitRef="Share">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825363"
      unitRef="USDPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i_2019-10-31_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      decimals="INF"
      id="c121825364"
      unitRef="Share">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="d_2019-10-01_2019-10-31_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      decimals="2"
      id="c121825365"
      unitRef="Pure">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      decimals="INF"
      id="c121825369"
      unitRef="Share">5000000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      decimals="2"
      id="c121825370"
      unitRef="Pure">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DividendsCash
      contextRef="d_2023-10-01_2024-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      decimals="INF"
      id="c121825371"
      unitRef="USD">4004001</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="d_2022-10-01_2023-09-30_StatementClassOfStockAxis-SeriesACumulativeConvertiblePreferredStockMember"
      decimals="INF"
      id="c121825372"
      unitRef="USD">4002005</us-gaap:DividendsCash>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i_2023-08-30"
      decimals="INF"
      id="c121825374"
      unitRef="USD">667000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825377"
      unitRef="USD">4669000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <ycbd:DividendsPayableQuarterlyGrowth
      contextRef="i_2024-09-30"
      decimals="-6"
      id="c121825378"
      unitRef="USD">1000000</ycbd:DividendsPayableQuarterlyGrowth>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825379"
      unitRef="Share">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825380"
      unitRef="USDPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825381"
      unitRef="Share">3939057</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825382"
      unitRef="Share">2960573</us-gaap:CommonStockSharesIssued>
    <ycbd:PurchaseCommitmentMaximumSharesCommitment
      contextRef="i_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121825384"
      unitRef="Share">281934</ycbd:PurchaseCommitmentMaximumSharesCommitment>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121825385"
      unitRef="Share">2616</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <ycbd:ShareNumberStockIssuable
      contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121825386"
      unitRef="Share">6104</ycbd:ShareNumberStockIssuable>
    <ycbd:NumberOfSharesRegisteredForResale
      contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121825388"
      unitRef="Share">281934</ycbd:NumberOfSharesRegisteredForResale>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-02-13_2024-02-13_CounterpartyNameAxis-KeystoneMember"
      decimals="INF"
      id="c121825390"
      unitRef="Share">180955</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits
      contextRef="d_2022-10-01_2023-06-30"
      decimals="INF"
      id="c121825391"
      unitRef="Share">64218</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="d_2024-09-01_2024-09-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember"
      decimals="INF"
      id="c121825396"
      unitRef="Share">100624</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-08-01_2024-09-30_CounterpartyNameAxis-MajikMedicinesMember"
      decimals="INF"
      id="c121825397"
      unitRef="Share">75000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="d_2024-04-01_2024-04-30_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember"
      decimals="INF"
      id="c121825398"
      unitRef="Share">714229</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="d_2024-03-01_2024-03-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember"
      decimals="INF"
      id="c121825399"
      unitRef="Share">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="d_2024-03-01_2024-03-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember"
      decimals="INF"
      id="c121825400"
      unitRef="USD">13760</ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2024-01-01_2024-01-31_CounterpartyNameAxis-KeystoneMember"
      decimals="INF"
      id="c121825401"
      unitRef="Share">64218</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="d_2024-01-01_2024-01-31_BusinessAcquisitionAxis-CureBasedDevelopmentLlcMember"
      decimals="INF"
      id="c121825402"
      unitRef="Share">19818</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-09-01_2023-09-30_CounterpartyNameAxis-KeystoneMember_SubsidiarySaleOfStockAxis-PurchaseagreementMember"
      decimals="INF"
      id="c121825404"
      unitRef="Share">102616</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-07-01_2023-07-31_CounterpartyNameAxis-KeystoneMember_SubsidiarySaleOfStockAxis-PurchaseagreementMember"
      decimals="INF"
      id="c121825406"
      unitRef="Share">2616</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember"
      decimals="INF"
      id="c121825407"
      unitRef="Share">1350000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember"
      decimals="INF"
      id="c121825408"
      unitRef="USDPerShare">2.1</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember"
      decimals="-5"
      id="c121825409"
      unitRef="USD">2800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-OverAllotmentOptionMember"
      decimals="INF"
      id="c121825411"
      unitRef="Share">202500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <ycbd:ProceedsFromIssuanceOfCommonStockNet
      contextRef="d_2023-05-03_2023-05-03_SubsidiarySaleOfStockAxis-PublicOfferingMember"
      decimals="-5"
      id="c121825412"
      unitRef="USD">2500000</ycbd:ProceedsFromIssuanceOfCommonStockNet>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i_2023-05-03_ClassOfWarrantOrRightAxis-WarrantsWithPublicOfferingMember"
      decimals="INF"
      id="c121825414"
      unitRef="Share">40500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i_2023-05-03_ClassOfWarrantOrRightAxis-WarrantsWithPublicOfferingMember"
      decimals="INF"
      id="c121825415"
      unitRef="USDPerShare">2.52</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits
      contextRef="d_2023-04-24_2023-04-24"
      decimals="INF"
      id="c121825417"
      unitRef="Share">39533</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <ycbd:PurchaseCommitmentMaximumSharesCommitment
      contextRef="i_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121825418"
      unitRef="Share">281934</ycbd:PurchaseCommitmentMaximumSharesCommitment>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121825419"
      unitRef="Share">2616</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <ycbd:ShareNumberStockIssuable
      contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121825420"
      unitRef="Share">6104</ycbd:ShareNumberStockIssuable>
    <ycbd:NumberOfSharesRegisteredForResale
      contextRef="d_2023-03-02_2023-03-02_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121825422"
      unitRef="Share">281934</ycbd:NumberOfSharesRegisteredForResale>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="d_2023-04-01_2023-04-30_CounterpartyNameAxis-KeystoneMember_StatementClassOfStockAxis-CommitmentSharesMember"
      decimals="INF"
      id="c121825425"
      unitRef="Share">8889</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="d_2023-01-30_2023-02-02_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember"
      decimals="INF"
      id="c121825430"
      unitRef="Share">134681</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i_2023-02-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember"
      decimals="INF"
      id="c121825431"
      unitRef="USDPerShare">14.85</us-gaap:SharesIssuedPricePerShare>
    <ycbd:AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement
      contextRef="i_2023-06-30_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember"
      decimals="INF"
      id="c121825433"
      unitRef="USD">2000000</ycbd:AgreementForAdvertisingPlacementCreditForMediaSupportAndAdvertisingPlacement>
    <ycbd:AgreementForAdvertisingPlacementUnutilizedAmount
      contextRef="i_2023-06-30_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember"
      decimals="INF"
      id="c121825434"
      unitRef="USD">514904</ycbd:AgreementForAdvertisingPlacementUnutilizedAmount>
    <ycbd:PercentageOfSharesFullyVested
      contextRef="i_2023-06-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember"
      decimals="1"
      id="c121825436"
      unitRef="Pure">0.70</ycbd:PercentageOfSharesFullyVested>
    <ycbd:PercentageOfSharesVestUponEachAdvertisingPlacement
      contextRef="i_2023-06-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember"
      decimals="2"
      id="c121825437"
      unitRef="Pure">0.15</ycbd:PercentageOfSharesVestUponEachAdvertisingPlacement>
    <ycbd:PercentageOfSharesVestProvidedNoRestrictionsInProductCategories
      contextRef="i_2023-06-01_CounterpartyNameAxis-A360MediaLlcMember_SubsidiarySaleOfStockAxis-AdvertisingPlacementAgreementMember"
      decimals="2"
      id="c121825438"
      unitRef="Pure">0.15</ycbd:PercentageOfSharesVestProvidedNoRestrictionsInProductCategories>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="d_2023-01-01_2023-01-31_CounterpartyNameAxis-TwentyTwoCapitalMember"
      decimals="INF"
      id="c121825443"
      unitRef="Share">2223</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="d_2024-04-01_2024-04-01_TitleOfIndividualAxis-BoardOfDirectorsMember"
      decimals="INF"
      id="c121825446"
      unitRef="Share">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i_2024-04-01_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember"
      decimals="INF"
      id="c121825447"
      unitRef="USDPerShare">0.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="d_2024-04-01_2024-04-01_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember"
      decimals="INF"
      id="c121825449"
      unitRef="USD">4300</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="d_2023-01-30_2023-02-28_TitleOfIndividualAxis-BoardOfDirectorsMember"
      decimals="INF"
      id="c121825452"
      unitRef="Share">2667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i_2023-02-28_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember"
      decimals="INF"
      id="c121825453"
      unitRef="USDPerShare">12.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="d_2023-01-30_2023-02-28_AwardTypeAxis-EmployeeStockOptionMember_TitleOfIndividualAxis-BoardOfDirectorsMember"
      decimals="INF"
      id="c121825455"
      unitRef="USD">21120</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="d_2023-01-01_2023-01-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"
      decimals="INF"
      id="c121825457"
      unitRef="Share">2334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i_2023-01-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"
      decimals="INF"
      id="c121825458"
      unitRef="USDPerShare">10.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="d_2023-01-01_2023-01-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"
      decimals="INF"
      id="c121825460"
      unitRef="USD">15225</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"
      decimals="INF"
      id="c121825461"
      unitRef="Share">2223</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember"
      decimals="INF"
      id="c121825462"
      unitRef="Share">1667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember"
      decimals="INF"
      id="c121825464"
      unitRef="USDPerShare">11.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestingAnnuallyOverThreeYearsMember"
      decimals="INF"
      id="c121825466"
      unitRef="USD">13150</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="d_2022-12-01_2022-12-31_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestUponAchievingCertainRevenuePerformanceMember"
      decimals="INF"
      id="c121825467"
      unitRef="Share">556</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember"
      decimals="INF"
      id="c121825468"
      unitRef="USD">11974</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808724">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Weighted average exercise price&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.54&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;10.35 - 12.60&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Risk free interest rate&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;4%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;3.93% - 4.71%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Volatility&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;107%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;106.48% - 106.51%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Expected term (in years)&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2.5 - 4&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Dividend yield&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;None&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;None&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember"
      decimals="INF"
      id="c121824909"
      unitRef="USDPerShare">0.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember"
      decimals="INF"
      id="c121824910"
      unitRef="USDPerShare">10.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember"
      decimals="INF"
      id="c121824910a"
      unitRef="USDPerShare">12.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember"
      decimals="2"
      id="c121824911"
      unitRef="Pure">0.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember"
      decimals="4"
      id="c121824912"
      unitRef="Pure">0.0393</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember"
      decimals="4"
      id="c121824912a"
      unitRef="Pure">0.0471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember"
      decimals="2"
      id="c121824913"
      unitRef="Pure">1.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember"
      decimals="4"
      id="c121824925"
      unitRef="Pure">1.0648</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember"
      decimals="4"
      id="c121824926"
      unitRef="Pure">1.0651</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember"
      id="c121824915">P2Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember"
      id="c121824916">P2Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="d_2022-10-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember"
      id="c121824916a">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808725">
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;9&lt;/em&gt; -STOCK-BASED COMPENSATION&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;Equity Compensation Plan &#x2013; On &lt;em style="font: inherit;"&gt; June 2, 2015, &lt;/em&gt;the Board of Directors of the Company approved the &lt;em style="font: inherit;"&gt;2015&lt;/em&gt; Equity Compensation Plan (&lt;em style="font: inherit;"&gt;&#x201c;2015&lt;/em&gt; Plan&#x201d;). The &lt;em style="font: inherit;"&gt;2015&lt;/em&gt; Plan made 26,112 common stock shares, either unissued or reacquired by the Company, available for awards of options, restricted stocks, other stock grants, or any combination thereof. The number of shares of common stock available for issuance under the &lt;em style="font: inherit;"&gt;2015&lt;/em&gt; Plan shall automatically increase on the &lt;em style="font: inherit;"&gt;first&lt;/em&gt; trading day of our fiscal year during the term of the &lt;em style="font: inherit;"&gt;2015&lt;/em&gt; Plan, beginning with calendar year &lt;em style="font: inherit;"&gt;2016,&lt;/em&gt; by an amount equal to &lt;em style="font: inherit;"&gt;one&lt;/em&gt; percent (1%) of the total number of shares of common stock outstanding on the last trading day in &lt;em style="font: inherit;"&gt; September &lt;/em&gt;of the immediately preceding fiscal year, but in &lt;em style="font: inherit;"&gt;no&lt;/em&gt; event shall any such annual increase exceed 2,223 shares of common stock. On &lt;em style="font: inherit;"&gt; April 19, 2019, &lt;/em&gt;shareholders approved an amendment to the &lt;em style="font: inherit;"&gt;2015&lt;/em&gt; Plan and increased the number of shares available for issuance under the &lt;em style="font: inherit;"&gt;2015&lt;/em&gt; Plan to 45,445 and retained the annual evergreen increase provision of the plan. Subsequent thereto, on &lt;em style="font: inherit;"&gt; August 7, 2019 &lt;/em&gt;the Company&#x2019;s Board of Directors approved an amendment to the &lt;em style="font: inherit;"&gt;2015&lt;/em&gt; Plan changing the date the automatic evergreen increase is determined to the &lt;em style="font: inherit;"&gt;first&lt;/em&gt; trading day of &lt;em style="font: inherit;"&gt; October &lt;/em&gt;each calendar year during the term of the &lt;em style="font: inherit;"&gt;2015&lt;/em&gt; Plan to coincide with the Company&#x2019;s fiscal year.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;On &lt;em style="font: inherit;"&gt; January 8, 2021, &lt;/em&gt;the Company&#x2019;s Board of Directors approved the &lt;em style="font: inherit;"&gt;2021&lt;/em&gt; Equity Compensation Plan (the &lt;em style="font: inherit;"&gt;&#x201c;2021&lt;/em&gt; Plan&#x201d;) and it was subsequently ratified by its shareholders at its annual meeting held on &lt;em style="font: inherit;"&gt; March 12, 2021. &lt;/em&gt;The purpose of the &lt;em style="font: inherit;"&gt;2021&lt;/em&gt; Plan is to advance the interests of the Company by providing an incentive to attract, retain and motivate highly qualified and competent persons who are important to it and upon whose efforts and judgment the success of the Company is largely dependent. The &lt;em style="font: inherit;"&gt;2021&lt;/em&gt; Plan made 111,112 common shares, either unissued or reacquired by the Company, available for awards of options, restricted stocks, other stock grants, or any combination thereof. The &lt;em style="font: inherit;"&gt;2021&lt;/em&gt; Plan also contains an &#x201c;evergreen formula&#x201d; pursuant to which the number of shares of common stock available for issuance under the &lt;em style="font: inherit;"&gt;2021&lt;/em&gt; Plan will automatically increase on &lt;em style="font: inherit;"&gt; October 1 &lt;/em&gt;of each calendar year during the term of the &lt;em style="font: inherit;"&gt;2021&lt;/em&gt; Plan, beginning with calendar year &lt;em style="font: inherit;"&gt;2022,&lt;/em&gt; by an amount equal to 1.0% of the total number of shares of common stock outstanding on &lt;em style="font: inherit;"&gt; September 30 &lt;/em&gt;of such calendar year, up to a maximum of 5,556 shares.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company accounts for stock-based compensation using the provisions of ASC &lt;em style="font: inherit;"&gt;718.&lt;/em&gt; ASC &lt;em style="font: inherit;"&gt;718&lt;/em&gt; codification requires companies to recognize the fair value of stock-based compensation expense in the financial statements based on the grant date fair value of the options. All options are approved by the Compensation, Corporate Governance and Nominating Committee of the Board of Directors. Restricted stock awards that vest in accordance with service conditions are amortized over their applicable vesting period using the straight-line method. The fair value of the Company&#x2019;s stock option awards or modifications is estimated at the date of grant using the Black-Scholes option pricing model.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Eligible recipients include employees, officers, directors and consultants who are deemed to have rendered or to be able to render significant services to the Company or its subsidiaries and who are deemed to have contributed or to have the potential to contribute to the success of the Company. Options granted generally have a &lt;span style="-sec-ix-hidden:c121825508"&gt;five&lt;/span&gt;-to-&lt;span style="-sec-ix-hidden:c121825509"&gt;ten&lt;/span&gt;-year term and have vesting terms that cover &lt;span style="-sec-ix-hidden:c121825510"&gt;one&lt;/span&gt; to &lt;span style="-sec-ix-hidden:c121825511"&gt;three&lt;/span&gt; years from the date of grant. Certain of the stock options granted under the plan have been granted pursuant to various stock option agreements. Each stock option agreement contains specific terms.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;span style="text-decoration: underline; "&gt;Stock Options:&lt;/span&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company currently has awards outstanding with service conditions and graded-vesting features. We recognize compensation cost on a straight-line basis over the requisite service period.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The fair value of each time-based award is estimated on the date of grant using the Black-Scholes option valuation model. Our weighted-average assumptions used in the Black-Scholes valuation model for equity awards with time-based vesting provisions granted during the year.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The following table summarizes stock option activity under both plans for the fiscal years ended &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt;:&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Weighted-average&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;remaining&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Aggregate&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Weighted-average&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;contractual term&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;intrinsic value&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Number of shares&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;exercise price&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;(in years)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;(in thousands)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Outstanding at September 30, 2022&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding: 0; margin: 0"&gt;55,656&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding: 0; margin: 0"&gt;151.10&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding: 0; margin: 0"&gt;4.55&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding: 0; margin: 0"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Granted&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;7,233&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;11.51&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercised&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Forfeited&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(21,124&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;88.12&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Outstanding at September 30, 2023&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;41,765&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;144.43&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;3.65&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Granted&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;8,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;0.86&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercised&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Forfeited&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(5,730&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;117.35&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Outstanding at September 30, 2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;44,035&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;123.58&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3.14&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="width: 40%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at September 30, 2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;44,035&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;123.58&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3.14&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;As of &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;, there was approximately $7,858 of total unrecognized compensation cost related to non-vested stock options which vest over a period of approximately 2.3 years.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;span style="text-decoration: underline; "&gt;Restricted Stock Award transactions:&lt;/span&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The Company issued 16,000 of restricted stock awards to the Company&#x2019;s board of directors. The shares vest quarterly on &lt;em style="font: inherit;"&gt; June 30, 2024,&#160;&lt;/em&gt;&lt;em style="font: inherit;"&gt; September 30, 2024,&#160;&lt;/em&gt;&lt;em style="font: inherit;"&gt; December 31, 2024, &lt;/em&gt;and&#160;&lt;em style="font: inherit;"&gt; March 31, 2025. &lt;/em&gt;The stock awards were valued at the fair market price of &lt;em style="font: inherit;"&gt;$4,296&lt;/em&gt; upon issuance and will amortize over the individual vesting periods.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;In the &lt;em style="font: inherit;"&gt;twelve&lt;/em&gt; months ended &lt;em style="font: inherit;"&gt; September 30, 2023:&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;In &lt;em style="font: inherit;"&gt; February &lt;/em&gt;of &lt;em style="font: inherit;"&gt;2023,&lt;/em&gt; the Company issued 448&#160;restricted stock awards to the Company&#x2019;s board of directors. The shares vest quarterly &lt;span style="-sec-ix-hidden:c121825521"&gt;&lt;span style="-sec-ix-hidden:c121825696"&gt;one&lt;/span&gt;&lt;/span&gt; &lt;em style="font: inherit;"&gt;fourth&lt;/em&gt; on &lt;em style="font: inherit;"&gt; June 30, 2023, &lt;/em&gt;&lt;em style="font: inherit;"&gt;&lt;span style="-sec-ix-hidden:c121825697"&gt;one&lt;/span&gt;&lt;/em&gt; fourth, on &lt;em style="font: inherit;"&gt; September 30, 2023, &lt;/em&gt;&lt;span style="-sec-ix-hidden:c121825524"&gt;&lt;span style="-sec-ix-hidden:c121825698"&gt;one&lt;/span&gt;&lt;/span&gt; &lt;span style="-sec-ix-hidden:c121825525"&gt;fourth&lt;/span&gt; on &lt;em style="font: inherit;"&gt; December 31, 2023, &lt;/em&gt;and &lt;em style="font: inherit;"&gt;&lt;span style="-sec-ix-hidden:c121825699"&gt;one&lt;/span&gt;&lt;/em&gt; &lt;span style="-sec-ix-hidden:c121825527"&gt;fourth&lt;/span&gt; on &lt;em style="font: inherit;"&gt; March 31, 2024. &lt;/em&gt;The stock awards were valued at the fair market price of $5,660 upon issuance and will amortize over the individual vesting periods.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;In &lt;em style="font: inherit;"&gt; January 2023, &lt;/em&gt;the Company issued 3,889 shares to a group of employees. The shares vested upon issuance, having a fair market value upon issuance of $40,950.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;In &lt;em style="font: inherit;"&gt; December 2022, &lt;/em&gt;the Company issued 1,112 shares of restricted common stock to an employee. 556 shares vested upon issuance and the Company recorded a total expense of $6,250. 556 shares vest based on meeting certain direct to consumer revenue performance hurdles prior to &lt;em style="font: inherit;"&gt; December 2024.&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;


  </us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i_2015-06-02_PlanNameAxis-The2015PlanMember"
      decimals="INF"
      id="c121825480"
      unitRef="Share">26112</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage
      contextRef="i_2015-06-02_PlanNameAxis-The2015PlanMember"
      decimals="2"
      id="c121825486"
      unitRef="Pure">0.01</ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage>
    <ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares
      contextRef="i_2015-06-02_PlanNameAxis-The2015PlanMember_RangeAxis-MaximumMember"
      decimals="INF"
      id="c121825488"
      unitRef="Share">2223</ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="d_2019-04-19_2019-04-19_PlanNameAxis-The2015PlanMember"
      decimals="INF"
      id="c121825491"
      unitRef="Share">45445</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i_2021-01-08_PlanNameAxis-The2021PlanMember"
      decimals="INF"
      id="c121825499"
      unitRef="Share">111112</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage
      contextRef="i_2021-01-08_PlanNameAxis-The2021PlanMember"
      decimals="2"
      id="c121825504"
      unitRef="Pure">0.01</ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedPercentage>
    <ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares
      contextRef="i_2021-01-08_PlanNameAxis-The2021PlanMember_RangeAxis-MaximumMember"
      decimals="INF"
      id="c121825505"
      unitRef="Share">5556</ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardAnnualIncreaseOfSharesAuthorizedShares>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808726">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Weighted-average&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;remaining&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Aggregate&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Weighted-average&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;contractual term&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;intrinsic value&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Number of shares&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;exercise price&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;(in years)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;(in thousands)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Outstanding at September 30, 2022&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding: 0; margin: 0"&gt;55,656&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding: 0; margin: 0"&gt;151.10&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding: 0; margin: 0"&gt;4.55&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding: 0; margin: 0"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Granted&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;7,233&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;11.51&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercised&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Forfeited&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(21,124&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;88.12&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Outstanding at September 30, 2023&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;41,765&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;144.43&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;3.65&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Granted&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;8,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;0.86&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercised&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Forfeited&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(5,730&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;117.35&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Outstanding at September 30, 2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;44,035&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;123.58&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3.14&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="width: 40%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 40%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at September 30, 2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;44,035&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;123.58&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;3.14&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i_2022-09-30"
      decimals="INF"
      id="c121824947"
      unitRef="Share">55656</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i_2022-09-30"
      decimals="INF"
      id="c121824948"
      unitRef="USDPerShare">151.1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="d_2021-10-01_2022-09-30" id="c121824949">P4Y6M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824951"
      unitRef="Share">7233</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824952"
      unitRef="USDPerShare">11.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824955"
      unitRef="Share">-0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824956"
      unitRef="USDPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824959"
      unitRef="Share">21124</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824960"
      unitRef="USDPerShare">88.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824963"
      unitRef="Share">41765</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121824964"
      unitRef="USDPerShare">144.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="d_2022-10-01_2023-09-30" id="c121824965">P3Y7M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824967"
      unitRef="Share">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824968"
      unitRef="USDPerShare">0.86</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824971"
      unitRef="Share">-0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824972"
      unitRef="USDPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824975"
      unitRef="Share">5730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121824976"
      unitRef="USDPerShare">117.35</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824979"
      unitRef="Share">44035</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824980"
      unitRef="USDPerShare">123.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="d_2023-10-01_2024-09-30" id="c121824981">P3Y1M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824983"
      unitRef="Share">44035</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121824984"
      unitRef="USDPerShare">123.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="d_2023-10-01_2024-09-30" id="c121824985">P3Y1M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember"
      decimals="INF"
      id="c121825514"
      unitRef="USD">7858</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="d_2023-10-01_2024-09-30_AwardTypeAxis-EmployeeStockOptionMember"
      id="c121825515">P2Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="d_2024-03-01_2024-03-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember"
      decimals="INF"
      id="c121825516"
      unitRef="Share">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember"
      decimals="INF"
      id="c121825520"
      unitRef="Share">448</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="d_2023-02-01_2023-02-28_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-BoardOfDirectorsMember"
      decimals="INF"
      id="c121825528"
      unitRef="USD">5660</ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="d_2023-01-01_2023-01-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"
      decimals="INF"
      id="c121825529"
      unitRef="Share">3889</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="d_2023-01-01_2023-01-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"
      decimals="INF"
      id="c121825530"
      unitRef="USD">40950</ycbd:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"
      decimals="INF"
      id="c121825531"
      unitRef="Share">1112</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"
      decimals="INF"
      id="c121825532"
      unitRef="Share">556</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember"
      decimals="INF"
      id="c121825533"
      unitRef="USD">6250</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="d_2022-12-01_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember_GranteeStatusAxis-ShareBasedPaymentArrangementEmployeeMember_VestingAxis-VestBasedOnCertainPerformanceHurdlesPriorToDecember2024Member"
      decimals="INF"
      id="c121825534"
      unitRef="Share">556</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <ycbd:WarrantsDisclosureTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808727">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;10&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; WARRANTS&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Transactions involving the Company equity-classified warrants for the fiscal years ended &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt; are summarized as follows:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Number of shares&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Weighted-average exercise price&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Weighted-average remaining contractual term (in years)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Aggregate intrinsic value (in thousands)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Outstanding at September 30, 2022&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;13,204&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;210.45&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2.30&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Granted&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;40,500&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2.52&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercised&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Forfeited&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(3,395&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;242.55&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px; width: 52%;"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Outstanding at September 30, 2023&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"&gt;50,309&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"&gt;37.75&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"&gt;2.30&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Granted&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercised&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Forfeited&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1,352&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;337.50&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Outstanding at September 30, 2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;48,957&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;337.50&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;4.07&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="width: 52%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at September 30, 2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;48,957&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;29.48&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The following table summarizes outstanding common stock purchase warrants as of &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Number of shares&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Weighted-average exercise price&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18.1%; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Expiration&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at $176.06 per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,079&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;176.06&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;October 2024&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at $56.25 per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;822&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;56.25&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;January 2025&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at $168.30 per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;3,357&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;168.30&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;December 2025&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at $168.75 per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;3,199&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;168.75&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;June 2026&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at $2.52 per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;40,500&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;2.52&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;April 2028&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;48,957&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;37.75&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;
  </ycbd:WarrantsDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="d_2023-10-01_2024-09-30_ClassOfWarrantOrRightAxis-EquityClassifiedWarrantsMember"
      id="c2808728">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Number of shares&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Weighted-average exercise price&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Weighted-average remaining contractual term (in years)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Aggregate intrinsic value (in thousands)&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Outstanding at September 30, 2022&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;13,204&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;210.45&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2.30&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Granted&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;40,500&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2.52&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercised&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Forfeited&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(3,395&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;242.55&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px; width: 52%;"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Outstanding at September 30, 2023&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"&gt;50,309&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"&gt;37.75&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"&gt;2.30&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0px; margin: 0px;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Granted&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercised&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Forfeited&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1,352&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;337.50&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman; font-size: 10pt; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 1%; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Outstanding at September 30, 2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;48,957&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;337.50&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;4.07&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="width: 52%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at September 30, 2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;48,957&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;29.48&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i_2022-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"
      decimals="INF"
      id="c121824991"
      unitRef="Share">13204</us-gaap:ClassOfWarrantOrRightOutstanding>
    <ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
      contextRef="i_2022-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"
      decimals="INF"
      id="c121824992"
      unitRef="USDPerShare">210.45</ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice>
    <ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm
      contextRef="i_2022-10-01_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"
      id="c121824993">P2Y3M18D</ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm>
    <ycbd:ClassOfWarrantOrRightGrantsInPeriod
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824995"
      unitRef="Share">40500</ycbd:ClassOfWarrantOrRightGrantsInPeriod>
    <ycbd:ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824996"
      unitRef="USDPerShare">2.52</ycbd:ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice>
    <ycbd:ClassOfWarrantOrRightExercisesInPeriod
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121824999"
      unitRef="Share">-0</ycbd:ClassOfWarrantOrRightExercisesInPeriod>
    <ycbd:ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825000"
      unitRef="USDPerShare">0</ycbd:ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice>
    <ycbd:ClassOfWarrantOrRightForfeituresInPeriod
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825003"
      unitRef="Share">3395</ycbd:ClassOfWarrantOrRightForfeituresInPeriod>
    <ycbd:ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825004"
      unitRef="USDPerShare">242.55</ycbd:ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i_2023-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"
      decimals="INF"
      id="c121825007"
      unitRef="Share">50309</us-gaap:ClassOfWarrantOrRightOutstanding>
    <ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
      contextRef="i_2023-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"
      decimals="INF"
      id="c121825008"
      unitRef="USDPerShare">37.75</ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice>
    <ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm
      contextRef="i_2022-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"
      id="c121825009">P2Y3M18D</ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm>
    <ycbd:ClassOfWarrantOrRightGrantsInPeriod
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825011"
      unitRef="Share">0</ycbd:ClassOfWarrantOrRightGrantsInPeriod>
    <ycbd:ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825012"
      unitRef="USDPerShare">0</ycbd:ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice>
    <ycbd:ClassOfWarrantOrRightExercisesInPeriod
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825015"
      unitRef="Share">0</ycbd:ClassOfWarrantOrRightExercisesInPeriod>
    <ycbd:ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825016"
      unitRef="USDPerShare">0</ycbd:ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice>
    <ycbd:ClassOfWarrantOrRightForfeituresInPeriod
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825019"
      unitRef="Share">-1352</ycbd:ClassOfWarrantOrRightForfeituresInPeriod>
    <ycbd:ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825020"
      unitRef="USDPerShare">337.5</ycbd:ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825023"
      unitRef="Share">48957</us-gaap:ClassOfWarrantOrRightOutstanding>
    <ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825024"
      unitRef="USDPerShare">337.5</ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice>
    <ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm contextRef="i_2024-09-30" id="c121825025">P4Y25D</ycbd:ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm>
    <ycbd:ClassOfWarrantOrRightExercisable
      contextRef="i_2024-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"
      decimals="INF"
      id="c121825027"
      unitRef="Share">48957</ycbd:ClassOfWarrantOrRightExercisable>
    <ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
      contextRef="i_2024-09-30_AwardTypeAxis-WarrantsToPurchaseCommonStockMember"
      decimals="INF"
      id="c121825028"
      unitRef="USDPerShare">29.48</ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="d_2023-10-01_2024-09-30_ClassOfWarrantOrRightAxis-CommonStockPurchaseWarrantsMember"
      id="c2808729">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Number of shares&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Weighted-average exercise price&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18.1%; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Expiration&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at $176.06 per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,079&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;176.06&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;October 2024&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at $56.25 per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;822&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;56.25&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;January 2025&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at $168.30 per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;3,357&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt;"&gt;168.30&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;December 2025&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at $168.75 per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;3,199&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;168.75&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;June 2026&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Exercisable at $2.52 per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;40,500&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;2.52&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;em style="font: inherit;"&gt;April 2028&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;48,957&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;&lt;em style="font: inherit;"&gt;37.75&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <ycbd:ClassOfWarrantOrRightExercisable
      contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringSeptember2023Member"
      decimals="INF"
      id="c121825034"
      unitRef="Share">1079</ycbd:ClassOfWarrantOrRightExercisable>
    <ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
      contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringSeptember2023Member"
      decimals="INF"
      id="c121825035"
      unitRef="USDPerShare">176.06</ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice>
    <ycbd:ClassOfWarrantOrRightExercisable
      contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringMay2024Member"
      decimals="INF"
      id="c121825037"
      unitRef="Share">822</ycbd:ClassOfWarrantOrRightExercisable>
    <ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
      contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringMay2024Member"
      decimals="INF"
      id="c121825038"
      unitRef="USDPerShare">56.25</ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice>
    <ycbd:ClassOfWarrantOrRightExercisable
      contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringOctober2024Member"
      decimals="INF"
      id="c121825040"
      unitRef="Share">3357</ycbd:ClassOfWarrantOrRightExercisable>
    <ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
      contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringOctober2024Member"
      decimals="INF"
      id="c121825041"
      unitRef="USDPerShare">168.3</ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice>
    <ycbd:ClassOfWarrantOrRightExercisable
      contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringJanuary2025Member"
      decimals="INF"
      id="c121825043"
      unitRef="Share">3199</ycbd:ClassOfWarrantOrRightExercisable>
    <ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
      contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringJanuary2025Member"
      decimals="INF"
      id="c121825044"
      unitRef="USDPerShare">168.75</ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice>
    <ycbd:ClassOfWarrantOrRightExercisable
      contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringApril2028Member"
      decimals="INF"
      id="c121825046"
      unitRef="Share">40500</ycbd:ClassOfWarrantOrRightExercisable>
    <ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
      contextRef="i_2024-09-30_ClassOfWarrantOrRightAxis-WarrantsExpiringApril2028Member"
      decimals="INF"
      id="c121825047"
      unitRef="USDPerShare">2.52</ycbd:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808730">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;11&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;Commencing &lt;em style="font: inherit;"&gt; August 2019, &lt;/em&gt;the Company&#x2019;s executive offices were located at &lt;em style="font: inherit;"&gt;8845&lt;/em&gt; Red Oak Blvd, Charlotte, NC (the &#x201c;Red Oak Facilities&#x201d;) which we sub-leased under a sublease agreement dated &lt;em style="font: inherit;"&gt; July 11, 2019 &lt;/em&gt;which expires &lt;em style="font: inherit;"&gt; December 2026 (&lt;/em&gt;the &#x201c;Red Oak Sublease&#x201d;). We received a default notice from HSKL, Inc., the sub landlord, in &lt;em style="font: inherit;"&gt; September 2023. &lt;/em&gt;Effective &lt;em style="font: inherit;"&gt; March 20, 2024 &lt;/em&gt;we entered into a License Agreement, dated as of &lt;em style="font: inherit;"&gt; March 14, 2024, &lt;/em&gt;by and between cbdMD, Inc. and HSKL (the &#x201c;License Agreement&#x201d;) and Lease Forbearance Agreement, dated as of &lt;em style="font: inherit;"&gt; March 14, 2024, &lt;/em&gt;by and between cbdMD, Inc. and HSKL (the &#x201c;Forbearance Agreement&#x201d;). Under the License Agreement we have granted HSKL a license to possess and use a portion of the Red Oak Facilities until the earlier of (i) the termination of the Forbearance Agreement and (ii) &lt;em style="font: inherit;"&gt; July 31, 2024 (&lt;/em&gt;the &#x201c;Termination Date&#x201d;). The termination of the License Agreement will result in termination of the Red Oak Sublease. Pursuant to the Forbearance Agreement HSKL has agreed to forbear from proceeding to exercise its remedies against us under the Red Oak Sublease, and the declaration of default related to past due rent in consideration of the following payments to HSKL: $80,000 upon the execution of the Forbearance Agreement, followed by &lt;em style="font: inherit;"&gt;four&lt;/em&gt; monthly payments of $40,000. HSKL&#x2019;s forbearance shall extend to the Termination Date and HSKL shall dismiss (without prejudice) a Complaint in Summary Ejectment filed in Mecklenburg County, North Carolina on &lt;em style="font: inherit;"&gt; February 27, 2024. &lt;/em&gt;In the event of our breach of any of the conditions of the Forbearance Agreement, HSKL&#x2019;s obligation to forbear shall cease, and HSKL &lt;em style="font: inherit;"&gt; may &lt;/em&gt;immediately exercise any and all of its rights or remedies at law, in equity or under the Red Oak Sublease. The Company made all payments required under the Forbearance Agreement and License Agreement and ultimately made a final settlement payment to completely exit all liability associated with the Red Oak Sublease.&lt;/p&gt;
   &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&#160;&lt;/p&gt;
  </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ycbd:PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement
      contextRef="i_2024-03-20_LeaseContractualTermAxis-ForbearanceAgreementMember"
      decimals="INF"
      id="c121825540"
      unitRef="USD">80000</ycbd:PastDueRentDefaultDeclarationPaymentUponExecutionOfAgreement>
    <ycbd:PastDueRentDefaultDeclarationMonthlyPayment
      contextRef="i_2024-03-20_LeaseContractualTermAxis-ForbearanceAgreementMember"
      decimals="INF"
      id="c121825542"
      unitRef="USD">40000</ycbd:PastDueRentDefaultDeclarationMonthlyPayment>
    <us-gaap:DebtDisclosureTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808731">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;12&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; NOTE PAYABLE&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;Effective &lt;em style="font: inherit;"&gt; February 1, 2024 (&lt;/em&gt;the &#x201c;Effective Date&#x201d;), the Company entered into a Securities Purchase Agreement dated &lt;em style="font: inherit;"&gt; January 30, 2024 (&lt;/em&gt;the &#x201c;Purchase Agreement&#x201d;) with &lt;em style="font: inherit;"&gt;five&lt;/em&gt; institutional investors (the &#x201c;Investors&#x201d;) whereby the Investors advanced the Company an aggregate of $1,250,000 gross proceeds and the Company issued each Investor an 8% Senior Secured Original Issue 20% Discount Convertible Promissory Note, in the aggregate principal amount of $1,541,666 (the &#x201c;Notes&#x201d;). The Company intends to use the proceeds from the issuance of the Notes for working capital and general corporate purposes.&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;Each Note bears interest of 8% per annum and matures on &lt;em style="font: inherit;"&gt; July 30, 2025. &lt;/em&gt;The Note is convertible into shares of common stock at any time following the date of issuance at the Investor&#x2019;s option at an initial conversion price of $0.684 per share (the &#x201c;Conversion Price&#x201d;), subject to certain adjustments. If &lt;em style="font: inherit;"&gt;30&lt;/em&gt; calendar days, &lt;em style="font: inherit;"&gt;60&lt;/em&gt; calendar days, &lt;em style="font: inherit;"&gt;90&lt;/em&gt; calendar days, &lt;em style="font: inherit;"&gt;120&lt;/em&gt; calendar days, or &lt;em style="font: inherit;"&gt;180&lt;/em&gt; calendar days after the effective date of the Registration Statement (as defined below) (the &#x201c;Adjustment Dates&#x201d;), the Conversion Price then in effect is higher than the Market Conversion Price then in effect on the Adjustment Date, the Conversion Price shall automatically decrease to the Market Conversion Price (as defined under the Note). The Conversion Price is subject to a $0.30 floor price. As of the filing date of this report, and after the final &lt;em style="font: inherit;"&gt;180&lt;/em&gt;-day adjustment, the effective Conversion Price is $0.5066.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;Furthermore, at any time after the issuance of the Note, the Company &lt;em style="font: inherit;"&gt; may, &lt;/em&gt;after written notice to the Investor, prepay any portion or all outstanding Principal Amount by paying an amount equal to &lt;em style="font: inherit;"&gt;125%&lt;/em&gt; of the Principal Amount then being prepaid (representing a 25% prepayment premium payable to the Investor which shall &lt;em style="font: inherit;"&gt;not&lt;/em&gt; constitute a principal repayment); provided that a Registration Statement registering all of the Conversion Shares issuable under the Note shall have been declared effective. If the Company elects to prepay the Note, the Investor shall have the right, upon written notice to the Company within &lt;em style="font: inherit;"&gt;five&lt;/em&gt; trading days of the Investor&#x2019;s receipt of a Prepayment Notice, to convert into common stock, up to &lt;em style="font: inherit;"&gt;100%&lt;/em&gt; of the Prepayment Amount at the Conversion Price, upon the terms provided in the Note.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;Upon the occurrence of any Event of Default (as defined in the Note), the Interest rate shall automatically be increased to the lesser of 22% per annum or the highest amount permitted by law. In the event that such Event of Default is subsequently cured (and &lt;em style="font: inherit;"&gt;no&lt;/em&gt; other Event of Default then exists), the adjustment shall cease to be effective as of the day immediately following the date of such cure; provided that the Interest as calculated and unpaid at such increased rate during the continuance of such Event of Default shall continue to apply to the extent relating to the days after the occurrence of such Event of Default through and including the date of such cure of such Event of Default.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;In addition, upon the occurrence of Event of Default, which has &lt;em style="font: inherit;"&gt;not&lt;/em&gt; been cured within any applicable cure period, the Company shall be obligated to pay to the Investor the Mandatory Default Amount, which Mandatory Default Amount shall be payable to the Investor on the date the Event of Default giving rise thereto occurs. In the event the Note shall be converted following the occurrence of an Event of Default, the Investor shall have the option to convert the Mandatory Default Amount, upon the terms provided in the Note.&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The Notes are secured by a &lt;em style="font: inherit;"&gt;first&lt;/em&gt; priority security interest as evidenced by and to the extent set forth in a Security Agreement, by and between the Company and the Investors.&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;The Company elected the fair value option under ASC &lt;em style="font: inherit;"&gt;825&lt;/em&gt; Fair Value Measurements for the Notes. The Notes were initially recognized at a fair value of $2,702,000 on the balance sheet as of &lt;em style="font: inherit;"&gt; March &lt;/em&gt;&lt;em style="font: inherit;"&gt;31,2024.&lt;/em&gt; All subsequent changes in fair value, excluding the impact of the change in fair value related to instrument-specific credit risk are recorded in non-operating income. The changes in fair value related to instrument-specific credit risk is recorded through other comprehensive income (loss).&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;The overall change in fair value of the Notes during the year&#160;ended &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;was a decrease of $1,357,096. The overall change in principal value related to the conversion of Notes to commons stock during the year&#160;ended &lt;em style="font: inherit;"&gt; September &lt;/em&gt;&lt;em style="font: inherit;"&gt;30,2024&lt;/em&gt; was a decrease of $508,757. As of &lt;em style="font: inherit;"&gt; September 30, 2024, &lt;/em&gt;total fair value of the Notes is $1,171,308, of which $1,032,909 represents the total principal outstanding.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


  </us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="d_2024-01-30_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="INF"
      id="c121825545"
      unitRef="USD">1250000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="2"
      id="c121825546"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ycbd:DebtInstrumentDiscountedPercentage
      contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="1"
      id="c121825547"
      unitRef="Pure">0.20</ycbd:DebtInstrumentDiscountedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="INF"
      id="c121825548"
      unitRef="USD">1541666</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="2"
      id="c121825549"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="INF"
      id="c121825550"
      unitRef="USDPerShare">0.684</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember_RangeAxis-MinimumMember"
      decimals="INF"
      id="c121825556"
      unitRef="USDPerShare">0.3</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="INF"
      id="c121825558"
      unitRef="USDPerShare">0.5066</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <ycbd:DebtInstrumentPrepaymentPayablePercent
      contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="2"
      id="c121825560"
      unitRef="Pure">0.25</ycbd:DebtInstrumentPrepaymentPayablePercent>
    <ycbd:DebtInstrumentInterestRateInDefault
      contextRef="i_2024-01-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="2"
      id="c121825565"
      unitRef="Pure">0.22</ycbd:DebtInstrumentInterestRateInDefault>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="i_2023-03-31_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="INF"
      id="c121825570"
      unitRef="USD">2702000</us-gaap:NotesPayableFairValueDisclosure>
    <ycbd:FairValueAdjustmentOfDebt
      contextRef="d_2023-10-01_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="INF"
      id="c121825572"
      unitRef="USD">-1357096</ycbd:FairValueAdjustmentOfDebt>
    <ycbd:PrincipleAdjustmentsOfDebt
      contextRef="d_2023-10-01_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="INF"
      id="c121825574"
      unitRef="USD">-508757</ycbd:PrincipleAdjustmentsOfDebt>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="i_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="INF"
      id="c121825575"
      unitRef="USD">1171308</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayable
      contextRef="i_2024-09-30_DebtInstrumentAxis-Investors8SeniorSecuredOriginalIssue20DiscountConvertiblePromissoryNoteMember"
      decimals="INF"
      id="c121825576"
      unitRef="USD">1032909</us-gaap:NotesPayable>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808732">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;13&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; LEASES&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company has lease agreements for its corporate, warehouse and laboratory offices with lease periods expiring between &lt;em style="font: inherit;"&gt;2024&lt;/em&gt; and &lt;em style="font: inherit;"&gt;2025.&lt;/em&gt; ASC &lt;em style="font: inherit;"&gt;842&lt;/em&gt; requires the recognition of leasing arrangements on the consolidated balance sheet as right-of-use assets and liabilities pertaining to the rights and obligations created by the leased assets. The Company determines whether an arrangement is a lease at inception and classify it as finance or operating. All of the Company&#x2019;s leases are classified as operating leases. The Company&#x2019;s leases do &lt;em style="font: inherit;"&gt;not&lt;/em&gt; contain any residual value guarantees.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Right-of-use lease assets and corresponding lease liabilities are recognized at commencement date based on the present value of lease payments over the expected lease term. Since the interest rate implicit in our lease arrangements is &lt;em style="font: inherit;"&gt;not&lt;/em&gt; readily determinable, the Company determined an incremental borrowing rate for each lease based on the approximate interest rate on a collateralized basis with similar remaining terms and payments as of the lease commencement date to determine the present value of future lease payments. The Company&#x2019;s lease terms &lt;em style="font: inherit;"&gt; may &lt;/em&gt;include options to extend or terminate the lease.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;In addition to the monthly base amounts in the lease agreements, the Company is required to pay real estate taxes, insurance and common area maintenance expenses during the lease terms.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Lease costs on operating leases are recognized on a straight-line basis over the lease term and included as a selling, general and administrative expense in the consolidated statements of operations.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Components of operating lease costs are summarized as follows:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Year Ended&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total Operating Lease Costs&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,328,497&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Supplemental cash flow information related to operating leases is summarized as follows:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Year Ended&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,421,610&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;As of &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;, our operating leases had a weighted average remaining lease term of 2.99 years and a weighted average discount rate of 4.66%. Future minimum aggregate lease payments under operating leases as of &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt; are summarized as follows:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr class="finHeading" style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 85%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;For the year ended September 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;99,467&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;Total future lease payments&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;99,467&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Less interest&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;771&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;Total lease liabilities&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;98,696&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
  </us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="d_2023-10-01_2024-09-30"
      id="c9E61A528-94D7-436C-9286-31CA4A1C4B9D">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Year Ended&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total Operating Lease Costs&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,328,497&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;Year Ended&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 85%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1,421,610&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825055"
      unitRef="USD">1328497</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825059"
      unitRef="USD">1421610</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="i_2024-09-30" id="c121825584">P2Y11M26D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i_2024-09-30"
      decimals="4"
      id="c121825585"
      unitRef="Pure">0.0466</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808735">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr class="finHeading" style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 85%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;For the year ended September 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;2024&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;99,467&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;Total future lease payments&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;99,467&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Less interest&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;771&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;Total lease liabilities&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;98,696&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825060"
      unitRef="USD">99467</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825061"
      unitRef="USD">99467</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825062"
      unitRef="USD">771</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825063"
      unitRef="USD">98696</us-gaap:OperatingLeaseLiability>
    <us-gaap:EarningsPerShareTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808736">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;14&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; LOSS PER SHARE&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The following table sets forth the computation of basic and diluted earnings per share for the following periods:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;&lt;em style="font: inherit;"&gt;Year Ended&lt;/em&gt;&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Basic:&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Net loss&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(3,700,126&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(22,938,209&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Preferred dividends paid or accrued&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;4,004,001&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;4,002,000&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Net income loss attributable to cbdMD Inc. common shareholders&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;(7,704,127&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;(26,940,209&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Shares used in computing basic earnings per share&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;4,312,546&lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;2,022,320&lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Shares used in computing diluted earnings per share&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;4,312,546&lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;2,022,320&lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Earnings per share Basic:&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Basic earnings per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1.79&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(13.32&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Earnings per share Diluted:&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Diluted earnings per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1.79&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(13.32&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;At the year ended&#160;&lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;, 100,993&#160;potential shares underlying options, unvested RSUs and warrants as well as 185,223 shares&#160;issuable upon conversion of our Series A Preferred stock&#160;which are excluded from the shares used to calculate diluted loss per share as their inclusion would reduce net loss per share.&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


  </us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808737">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;&lt;em style="font: inherit;"&gt;Year Ended&lt;/em&gt;&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;September 30,&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr class="finHeading" style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Basic:&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Net loss&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(3,700,126&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(22,938,209&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Preferred dividends paid or accrued&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;4,004,001&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;4,002,000&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Net income loss attributable to cbdMD Inc. common shareholders&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;(7,704,127&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;(26,940,209&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Shares used in computing basic earnings per share&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;4,312,546&lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;2,022,320&lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Shares used in computing diluted earnings per share&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;4,312,546&lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&lt;b&gt;2,022,320&lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Earnings per share Basic:&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;em style="font: inherit;"&gt;&#160;&lt;/em&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;&lt;em style="font: inherit;"&gt;-&lt;/em&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Basic earnings per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1.79&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(13.32&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Earnings per share Diluted:&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Diluted earnings per share&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(1.79&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(13.32&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825070"
      unitRef="USD">-3700126</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825071"
      unitRef="USD">-22938209</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825072"
      unitRef="USD">4004001</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825073"
      unitRef="USD">4002000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825074"
      unitRef="USD">-7704127</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825075"
      unitRef="USD">-26940209</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825076"
      unitRef="Share">4312546</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825077"
      unitRef="Share">2022320</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825078"
      unitRef="Share">4312546</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825079"
      unitRef="Share">2022320</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825082"
      unitRef="USDPerShare">-1.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825083"
      unitRef="USDPerShare">-13.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825084"
      unitRef="USDPerShare">-1.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825085"
      unitRef="USDPerShare">-13.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="d_2023-10-01_2024-09-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember"
      decimals="INF"
      id="c121825588"
      unitRef="Share">100993</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="d_2024-04-01_2024-06-30_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-SeriesACumulativeConvertiblePreferredStockMember"
      decimals="INF"
      id="c121825589"
      unitRef="Share">185223</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808738">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;15&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; INCOME TAXES &lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company generated operating losses for the years ended &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt; on which it has recognized a full valuation allowance. The Company accounts for is state franchise and minimum taxes as a component of its general and administrative expenses.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The following table presents the components of the provision for income taxes from continuing operations for the fiscal years ended &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt;:&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;&lt;em style="font: inherit;"&gt;Year Ended September 30,&lt;/em&gt;&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Current&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;Federal&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;State&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total current&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Deferred&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;Federal&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;State&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total deferred&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total provision&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;A reconciliation for the federal statutory income tax rate to the Company&#x2019;s effective income tax rate is as follows:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;&lt;em style="font: inherit;"&gt;Year Ended September 30,&lt;/em&gt;&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Federal statutory income tax rate&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;State income taxes, net of federal benefit&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2.1&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1.4&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Permanent differences&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;11.9&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(1.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Contingent derivative expense&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.2&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;Change in value of convertible debt&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(2.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Change in valuation allowance&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(33.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(21.1&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Provision for income taxes&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;Significant components of the Company&#x2019;s deferred income taxes are shown below:&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;

    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;&lt;em style="font: inherit;"&gt;Year Ended September 30,&lt;/em&gt;&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Deferred tax assets:&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Net operating loss carryforwards&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;15,478,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;14,784,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;ROU - Liability&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;22,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;824,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Capital loss carryforward&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;702,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;702,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Allowance for doubtful accounts&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;77,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;9,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Stock compensation&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;481,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;521,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Intangibles&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;176,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;105,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Investments&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;573,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;180,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Accrued expenses&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;101,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;87,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Fixed Assets&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;57,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;45,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Inventory reserve&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;28,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Capitalized expenses&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;146,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;43,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Charitable contributions&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;13,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;39,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total deferred tax assets&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;17,826,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;17,367,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Deferred tax liabilities:&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Prepaid Expenses&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(76,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(107,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;ROU - Assets&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(19,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(750,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Intangibles&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total deferred tax liabilities&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(95,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(857,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Net deferred tax assets&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;17,731,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;16,510,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Valuation allowance&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(17,731,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(16,510,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Net deferred tax liability&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;

   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&#160;&lt;/p&gt;


   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;Net deferred tax liability&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company has established a valuation allowance against net deferred tax assets due to the uncertainty that such assets will be realized. The deferred tax liabilities that result from indefinite life intangibles cannot be offset by deferred tax assets. The Company periodically evaluates the recoverability of the deferred tax assets. At such time as it is determined that it is more likely than &lt;em style="font: inherit;"&gt;not&lt;/em&gt; that deferred tax assets will be realizable, the valuation allowance will be reduced. Under Internal Revenue Code (IRC) Section &lt;em style="font: inherit;"&gt;382,&lt;/em&gt; the use of net operating loss (&#x201c;NOL&#x201d;) carryforwards &lt;em style="font: inherit;"&gt; may &lt;/em&gt;be limited if a change in ownership of a company occurs. During the year ending &lt;em style="font: inherit;"&gt; September 30, 2018, &lt;/em&gt;the company determined that a change of ownership under IRC Section &lt;em style="font: inherit;"&gt;382&lt;/em&gt; had occurred during the years ending &lt;em style="font: inherit;"&gt; September 30, 2017 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2015.&lt;/em&gt; As a result of these ownership changes, the pre-ownership change NOL carryforwards would be limited and approximately $2.1 million of such NOLs will expire before being utilized. Therefore, at &lt;em style="font: inherit;"&gt; September 30, 2018 &lt;/em&gt;the Company reduced the deferred tax asset and related valuation allowance associated with these NOLs by approximately $0.5 million due to IRC Section &lt;em style="font: inherit;"&gt;382.&lt;/em&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;At &lt;em style="font: inherit;"&gt; September 30, 2024&lt;/em&gt;, the Company has utilizable NOL carryforwards of approximately $69.1&#160;million which for federal purposes will carryforward indefinitely.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company accounts for its state franchise and minimum taxes as a component of its general and administrative expenses.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company files income tax returns in the United States, and various state jurisdictions. The Company&#x2019;s policy is to recognize interest expense and penalties related to income tax matters as tax expense. At &lt;em style="font: inherit;"&gt; September 30, 2024 &lt;/em&gt;and &lt;em style="font: inherit;"&gt;2023&lt;/em&gt;, there are &lt;em style="font: inherit;"&gt;no&lt;/em&gt; unrecognized tax benefits, and there are &lt;em style="font: inherit;"&gt;no&lt;/em&gt; significant accruals for interest related to unrecognized tax benefits or tax penalties.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;The Company has had a valuation allowance against the net deferred tax assets, with the exception of the deferred tax liabilities that result from indefinite-life intangibles ("naked credits"). During the year ended &lt;em style="font: inherit;"&gt; September 30, 2021,&#160;&lt;/em&gt;the Company generated enough indefinite life deferred tax assets from post-merger NOLs to reduce the naked credits to &lt;em style="font: inherit;"&gt;zero&lt;/em&gt; during the year and continue to record a valuation allowance on remaining deferred tax assets.&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&#160;&#160; &#160;&#160;&lt;/p&gt;
  </us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808739">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;&lt;em style="font: inherit;"&gt;Year Ended September 30,&lt;/em&gt;&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Current&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;Federal&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;State&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total current&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Deferred&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;Federal&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"&gt;State&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total deferred&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total provision&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825092"
      unitRef="USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825093"
      unitRef="USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825094"
      unitRef="USD">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825095"
      unitRef="USD">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825096"
      unitRef="USD">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825097"
      unitRef="USD">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825098"
      unitRef="USD">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825099"
      unitRef="USD">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825100"
      unitRef="USD">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825101"
      unitRef="USD">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825102"
      unitRef="USD">0</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825103"
      unitRef="USD">0</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="d_2023-10-01_2024-09-30"
      decimals="INF"
      id="c121825104"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="d_2022-10-01_2023-09-30"
      decimals="INF"
      id="c121825105"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808740">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;&lt;em style="font: inherit;"&gt;Year Ended September 30,&lt;/em&gt;&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Federal statutory income tax rate&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;State income taxes, net of federal benefit&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;2.1&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;1.4&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Permanent differences&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;11.9&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(1.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Contingent derivative expense&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.2&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;Change in value of convertible debt&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(2.5&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Change in valuation allowance&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(33.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(21.1&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Provision for income taxes&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="d_2023-10-01_2024-09-30"
      decimals="2"
      id="c121825112"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="d_2022-10-01_2023-09-30"
      decimals="2"
      id="c121825113"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="d_2023-10-01_2024-09-30"
      decimals="3"
      id="c121825114"
      unitRef="Pure">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="d_2022-10-01_2023-09-30"
      decimals="3"
      id="c121825115"
      unitRef="Pure">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="d_2023-10-01_2024-09-30"
      decimals="3"
      id="c121825116"
      unitRef="Pure">0.119</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="d_2022-10-01_2023-09-30"
      decimals="3"
      id="c121825117"
      unitRef="Pure">-0.015</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="d_2023-10-01_2024-09-30"
      decimals="3"
      id="c121825118"
      unitRef="Pure">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="d_2022-10-01_2023-09-30"
      decimals="3"
      id="c121825119"
      unitRef="Pure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <ycbd:EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt
      contextRef="d_2023-10-01_2024-09-30"
      decimals="3"
      id="c121825120"
      unitRef="Pure">-0.025</ycbd:EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt>
    <ycbd:EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt
      contextRef="d_2022-10-01_2023-09-30"
      decimals="-3"
      id="c121825121"
      unitRef="Pure">0</ycbd:EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="d_2023-10-01_2024-09-30"
      decimals="2"
      id="c121825122"
      unitRef="Pure">-0.33</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="d_2022-10-01_2023-09-30"
      decimals="3"
      id="c121825123"
      unitRef="Pure">-0.211</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="d_2023-10-01_2024-09-30"
      decimals="-3"
      id="c121825124"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="d_2022-10-01_2023-09-30"
      decimals="-3"
      id="c121825125"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808741">
    &lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"&gt;&lt;tbody&gt;&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;&lt;em style="font: inherit;"&gt;Year Ended September 30,&lt;/em&gt;&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2024&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt; &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;em style="font: inherit;"&gt;2023&lt;/em&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Deferred tax assets:&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Net operating loss carryforwards&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;15,478,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;14,784,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;ROU - Liability&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;22,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;824,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Capital loss carryforward&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;702,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;702,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Allowance for doubtful accounts&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;77,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;9,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Stock compensation&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;481,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;521,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt; &lt;p style="margin: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Intangibles&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;176,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;105,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding: 0; margin: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Investments&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;573,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;180,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Accrued expenses&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;101,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;87,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Fixed Assets&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;57,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;45,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Inventory reserve&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;0&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;28,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Capitalized expenses&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;146,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;43,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Charitable contributions&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;13,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;39,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total deferred tax assets&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;17,826,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;17,367,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Deferred tax liabilities:&lt;/p&gt; &lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Prepaid Expenses&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(76,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(107,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;ROU - Assets&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(19,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;(750,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Intangibles&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Total deferred tax liabilities&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(95,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(857,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Net deferred tax assets&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;17,731,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;16,510,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Valuation allowance&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(17,731,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"&gt;(16,510,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"&gt;&lt;td style="font-family: Times New Roman; font-size: 10pt;"&gt; &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Net deferred tax liability&lt;/p&gt; &lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
   </us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825130"
      unitRef="USD">15478000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825131"
      unitRef="USD">14784000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <ycbd:RightOfUseLiability
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825132"
      unitRef="USD">22000</ycbd:RightOfUseLiability>
    <ycbd:RightOfUseLiability
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825133"
      unitRef="USD">824000</ycbd:RightOfUseLiability>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825134"
      unitRef="USD">702000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825135"
      unitRef="USD">702000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825136"
      unitRef="USD">77000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825137"
      unitRef="USD">9000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825138"
      unitRef="USD">481000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825139"
      unitRef="USD">521000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825140"
      unitRef="USD">176000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825141"
      unitRef="USD">105000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825142"
      unitRef="USD">573000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825143"
      unitRef="USD">180000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825144"
      unitRef="USD">101000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825145"
      unitRef="USD">87000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825146"
      unitRef="USD">57000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825147"
      unitRef="USD">45000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i_2024-09-30"
      decimals="-3"
      id="c121825148"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825149"
      unitRef="USD">28000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825150"
      unitRef="USD">146000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825151"
      unitRef="USD">43000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825152"
      unitRef="USD">13000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825153"
      unitRef="USD">39000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825154"
      unitRef="USD">17826000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825155"
      unitRef="USD">17367000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825156"
      unitRef="USD">76000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825157"
      unitRef="USD">107000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825158"
      unitRef="USD">19000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825159"
      unitRef="USD">750000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825160"
      unitRef="USD">-0</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825161"
      unitRef="USD">-0</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825162"
      unitRef="USD">95000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825163"
      unitRef="USD">857000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825164"
      unitRef="USD">17731000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825165"
      unitRef="USD">16510000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825166"
      unitRef="USD">17731000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825167"
      unitRef="USD">16510000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i_2024-09-30"
      decimals="INF"
      id="c121825168"
      unitRef="USD">-0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i_2023-09-30"
      decimals="INF"
      id="c121825169"
      unitRef="USD">-0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="i_2018-09-30"
      decimals="-5"
      id="c121825599"
      unitRef="USD">2100000</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <ycbd:DeferredTaxAssetAndRelatedValuationAllowance
      contextRef="i_2018-09-30"
      decimals="-5"
      id="c121825600"
      unitRef="USD">500000</ycbd:DeferredTaxAssetAndRelatedValuationAllowance>
    <ycbd:DeferredTaxAssetAndRelatedValuationAllowance
      contextRef="i_2024-09-30"
      decimals="-5"
      id="c121825602"
      unitRef="USD">69100000</ycbd:DeferredTaxAssetAndRelatedValuationAllowance>
    <us-gaap:SubsequentEventsTextBlock contextRef="d_2023-10-01_2024-09-30" id="c2808742">
   &lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"&gt;&lt;b&gt;NOTE &lt;em style="font: inherit;"&gt;16&lt;/em&gt; &lt;/b&gt;&#x2013;&lt;b&gt; SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;
   &lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;During the &lt;em style="font: inherit;"&gt;first&lt;/em&gt; quarter of fiscal &lt;em style="font: inherit;"&gt;2025,&lt;/em&gt; the Company issued an aggregate of 1,421,067 shares of common stock pursuant to the partial conversion of certain principal and interest related to the Notes. As of the filing date of this report, the Notes have a principal balance of approximately $364,000.&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;Effective &lt;em style="font: inherit;"&gt; November 26, 2024, &lt;/em&gt;cbdMD, Inc. entered into a Second Amendment to Lease (the &#x201c;Amendment&#x201d;) to extend the Warehouse Lease entered into on &lt;em style="font: inherit;"&gt; August 27, 2019 (&lt;/em&gt;the &#x201c;Lease&#x201d;) for approximately 80,000 square feet of space located at &lt;em style="font: inherit;"&gt;2101&lt;/em&gt; Westinghouse Boulevard, Suite A, Charlotte, North Carolina &lt;em style="font: inherit;"&gt;28273,&lt;/em&gt; which facility also serves as the Company&#x2019;s executive offices. The Amendment extends the term of the Lease for a period of &lt;span style="-sec-ix-hidden:c121825615"&gt;nineteen&lt;/span&gt; months beginning on &lt;em style="font: inherit;"&gt; March 1, 2025 &lt;/em&gt;with a new expiration date of &lt;em style="font: inherit;"&gt; September 30, 2026. &lt;/em&gt;The Company has &lt;em style="font: inherit;"&gt;no&lt;/em&gt; further rights to extend or renew the terms of the Lease. The Amendment provides for the monthly base rent of $65,000, with an annual base rent of $9.75 per square feet from &lt;em style="font: inherit;"&gt; March 1, 2025 &lt;/em&gt;through &lt;em style="font: inherit;"&gt; February 28, 2026, &lt;/em&gt;and $67,600 with an annual base rent of $10.14 per square feet from &lt;em style="font: inherit;"&gt; March 1, 2026 &lt;/em&gt;through &lt;em style="font: inherit;"&gt; September 30, 2026. &lt;/em&gt;The Company shall also continue to pay Additional Rent and all other amounts (other than &#x201c;Monthly Base Rent&#x201d;) in accordance with the terms of the Lease, except the &#x201c;Controllable CAM Charges provision in Section &lt;em style="font: inherit;"&gt;3&lt;/em&gt; of Exhibit C to the Lease shall be deemed deleted from the Lease. Furthermore, as set forth under the Amendment the landlord has approved certain subleases entered into by and between the Company and sub tenants for portions of the facility.&lt;/p&gt;
   &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&#160;&lt;/p&gt;
   &lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;During &lt;em style="font: inherit;"&gt; November 2024, &lt;/em&gt;the Company engaged a consultant and issued 175,000 shares of restricted common stock for advisory services.&#160;&lt;/p&gt;
   &lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"&gt;&#160;&lt;/p&gt;
  </us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="d_2024-10-01_2024-12-17_DebtConversionByUniqueDescriptionAxis-ConversionOfNotesIntoCommonStockMember_SubsequentEventTypeAxis-SubsequentEventMember"
      decimals="INF"
      id="c121825610"
      unitRef="Share">1421067</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:NotesPayable
      contextRef="i_2024-12-17_SubsequentEventTypeAxis-SubsequentEventMember"
      decimals="INF"
      id="c121825611"
      unitRef="USD">364000</us-gaap:NotesPayable>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="i_2024-11-26_LeaseContractualTermAxis-WarehouseLeaseMember_SubsequentEventTypeAxis-SubsequentEventMember"
      decimals="INF"
      id="c121825612"
      unitRef="SquareFoot">80000</us-gaap:AreaOfRealEstateProperty>
    <ycbd:LesseeOperatingLeasesMonthlyBaseRent
      contextRef="i_2026-02-28_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember"
      decimals="INF"
      id="c121825617"
      unitRef="USD">65000</ycbd:LesseeOperatingLeasesMonthlyBaseRent>
    <ycbd:OperatingLeasesRentExpensePerSquareFoot
      contextRef="d_2025-03-01_2026-02-28_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember"
      decimals="INF"
      id="c121825618"
      unitRef="USDPerPerShare">9.75</ycbd:OperatingLeasesRentExpensePerSquareFoot>
    <ycbd:LesseeOperatingLeasesAnnualBaseRent
      contextRef="i_2026-09-30_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember"
      decimals="INF"
      id="c121825619"
      unitRef="USD">67600</ycbd:LesseeOperatingLeasesAnnualBaseRent>
    <ycbd:OperatingLeasesRentExpensePerSquareFoot
      contextRef="d_2026-03-01_2026-09-30_LeaseContractualTermAxis-WarehouseLeaseMember_StatementScenarioAxis-ScenarioForecastMember"
      decimals="INF"
      id="c121825620"
      unitRef="USDPerPerShare">10.14</ycbd:OperatingLeasesRentExpensePerSquareFoot>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="d_2024-11-01_2024-11-30_AwardTypeAxis-RestrictedStockMember_CounterpartyNameAxis-ConsultantMember_SubsequentEventTypeAxis-SubsequentEventMember"
      decimals="INF"
      id="c121825622"
      unitRef="Share">175000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
